Citrus Sinensis ID: 002910

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------
Protein Sequence
MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAATTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHccccccccccccccEEEEcccccccccccccccccccccHHHccccccccccEEEEEEccccccHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHccccEEEEccccccccccHHHHHHHHHHHccccccEEEccccccccccccEEEEEEcccccccHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccEEcEEccccccEEEEEEEcccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEEcEEEEEEccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccccEEEcccccEEEcccccEEEEccccccccccccccccccccccccccccEEEHHHHHHHHHHccccccccccEEEEc
Secondary Structure Prediction (SSPRO)
ccccEEEEccccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccEEEcccccccccccccccccccccccccccccccccccccEEcccccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHEcccEEcccccccccccccccHHHcccccEEEEEcccHHcccccccHHHHccccccccccEEEEEccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHcccEEEEccccccccccHHHHHHHHHHHHccccccEEccccccccccccccEEEEEcccccccccccHHccccccEEEEEcccccccccccccccccccccEEEEEccccccccccccHHHccccccEEEccccccccccccccccccccccHcccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEcHHHHHHHcccccHHHcEccccccEEEEEEEcccEEEEEEEcccccccccHHHHHHHHHHHHHHcccccEEEEEEEcccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEccccccHHHEEEcHHHcEEEcccccccccccccEEEEEEccccccccHHHccccccccHHHHHHHHHHHHccccccccccEEEEc
Coil and Loop (DISEMBL)
mphrttyffprqfpdhrgfdasaspspaaANKQLLENhekntekgtfginendrksaaattsttttttknlknsaaplsvsdlftsgdeKFKVKKQQFAAFCDWLTEkkedrsasrhVKSFQSrlssgadedrepllpppepepvpvpvpdtvtnidndrnfdrqvslprlsstgssyaasslfsgttldgnfssdvkdtstrvstsrqeveeeeskdTAAQRTKESYMLQLTLARRLTLQACifsgplllqesalevsdteTVSYRLWVSGClsyndkisdgfynilgmnpYLWVMCNdleegkrlpslmslkdidsteTSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICmggtfpieqgdlHKRWKMHSKRLRKFRKCivlpigslsmgLCRHRAILFKKLADyiglpcriargcryceadhrssclvkieddrrssREYVVDLvgepgnihgpnfsinggflssmpspfqlsdlkefqkpymdntsycqlpdsrsnsafpesppysgiirkgqklkdiglpksskdalvnqpraekesslvplklqgnpknsdaaagapiqEYSRLVEENVAIEAAYKEEIVVSESSviikqpnatlpsqldkedesklekqgkfpvgpgprylniepslamDWLEISWDELHVKErvgagsfgtvhraewhgsdVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGavtkrphlsivteylprgslyrlihrpaageMMDQRRRLRMALDVAKGinylhnlnppilhwdlkspnllvdknwtvkvcdfglsrfkantfissksvAGTVVFFAAHQTACNSLALIFSLSgwlqssfeesPQMRSLMFIVLE
Flexible Loop (DISEMBL)
mphrttyffprqfpdhRGFDASASPSPAAANKQLLENHEKntekgtfginendrksaaattsttttttknlknsaaplsVSDLFTSGDEKFKVKKQQFAAFCDWLTEkkedrsasrhvksfqsrlssgadedREPLlpppepepvpvpVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFsgttldgnfssdvkdtstrvstsrqeveeeeskdtaaqrtKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGtfpieqgdlhKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCryceadhrssclvkieddrrssREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKsskdalvnqpraekesslvplklqgnpknsdaaagAPIQEYSRLVEENVAIEAAYKEEIVVsessviikqpnatlpsqldkedesklekqgkfpvgpgpryLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLfmgavtkrphlsivteylprgslYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Low Complexity Region (SEG)
MPHRTTYFFPRQFPDHRGFDasaspspaaaNKQLLENHEKNTEKGTFGINENDRksaaattsttttttknlknsaaPLSVSDLFTSGDEkfkvkkqqfaafCDWLTEKKEDRSASRHVKSFQSRLSSGADEDRepllpppepepvpvpvpDTVTNIDNDRNFDRQVSLPRlsstgssyaasslfsgtTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMlqltlarrltlqaCIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKeeivvsessviiKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Disordered region (IsUnstruct)
******************************************************************************************FKVKKQQFAAFCDWLT*************************************************************************************************************************YMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGK******************EVVLIDR***********KAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFL****************************************************************************************************YSRLVEENVAIEAAYKEEIVVSESSVII*******************************RYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQS************F****
Disordered Region (DISOPRED)
**HRTTYFFPRQFPDH*****************************************************************DLFTS******VKKQQFAAFCDWLTE************************************************************************************************************************YMLQLTLARR***************************SYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLH**WKM*SKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIH**********************************************************************************************************************************************************************************LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA*********AGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Disordered Region (DISEMBL)
MPHRTTYFFPRQFPDHRGF*********AANKQLLENHEKNTEKGTFGINEND**************TKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEK****************************LPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFS*****************************TKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLP**************GKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Disordered Region (DISPRO)
***RTTYFFPRQFPDH**FD*****S******************************************************SD*FTSGDEKFKVKKQQFAAFCDWLTEKKEDR**S*H************DEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSR********KDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLK****************QEYSRLVEENVAIEAAYKEEIVVSESSVIIKQ*****************************RY*NIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAATTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLMFIVLE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	867	2.2.26 [Sep-21-2011]
Q05609	821	Serine/threonine-protein	no	no	0.251	0.265	0.633	8e-74
Q9FPR3	933	Serine/threonine-protein	no	no	0.199	0.185	0.617	4e-59
Q54H46	642	Probable serine/threonine	yes	no	0.178	0.241	0.477	3e-36
Q54H45	690	Probable serine/threonine	no	no	0.176	0.221	0.490	4e-36
Q54TM7	1288	Probable serine/threonine	no	no	0.223	0.150	0.415	2e-35
Q55GU0	916	Probable serine/threonine	no	no	0.193	0.183	0.410	5e-35
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.189	0.098	0.377	2e-33
Q86HG9	1024	Probable serine/threonine	no	no	0.201	0.170	0.463	3e-32
Q54TA1	749	Probable serine/threonine	no	no	0.175	0.202	0.462	7e-32
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.181	0.096	0.434	1e-31

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  279 bits (713), Expect = 8e-74,   Method: Compositional matrix adjust.
 Identities = 140/221 (63%), Positives = 171/221 (77%), Gaps = 3/221 (1%)

Query: 612 PNATLPSQLDKEDESKLEK--QGKFPVG-PGPRYLNIEPSLAMDWLEISWDELHVKERVG 668
           P+A +P Q      +++E       P+  P P   N E  L  D ++I W +L++KE++G
Sbjct: 499 PSANMPPQNMMRASNQIEAAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIG 558

Query: 669 AGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728
           AGSFGTVHRAEWHGSDVAVK+L  QDF  +++ EFLREVAIMKR+RHPN+VLFMGAVT+ 
Sbjct: 559 AGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 618

Query: 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK 788
           P+LSIVTEYL RGSLYRL+H+  A E +D+RRRL MA DVAKG+NYLHN NPPI+H DLK
Sbjct: 619 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLK 678

Query: 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           SPNLLVDK +TVKVCDFGLSR KA+TF+SSKS AGT  + A
Sbjct: 679 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 719

Acts as a negative regulator in the ethylene response pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  230 bits (586), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 108/175 (61%), Positives = 135/175 (77%), Gaps = 2/175 (1%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           EI W++L + ER+G GS+G V+ A+WHG++VAVK    QDF    L EF  EV IM+R+R
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HPNVV F+GAVT+ P+LSIVTE+LPRGSLYR++HRP +   +D+RRR++MALDVA G+N 
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKS--HIDERRRIKMALDVAMGMNC 780

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LH   P I+H DLK+PNLLVD NW VKV DFGLSR K NTF+SSKS AGT  + A
Sbjct: 781 LHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  154 bits (390), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 75/157 (47%), Positives = 102/157 (64%), Gaps = 2/157 (1%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           D  +I   ++ +  R+G G++G V+   W GS VAVK L   +  ++ LKEF RE+ +MK
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 424

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            +RHPNV+ F+G+    P + I TEY+PRGSLY ++H  A    +     ++M +D AKG
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQAL--QLQWSLLIKMMIDAAKG 482

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           + YLHN  P ILH DLKS NLLVD+NW VKV DFGLS
Sbjct: 483 VIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLS 519

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  154 bits (388), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 78/159 (49%), Positives = 101/159 (63%), Gaps = 6/159 (3%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           D  +I   ++ +  R+G G+FG V+   W GS VAVK L   +  ++ LKEF RE+ +MK
Sbjct: 382 DGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 441

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL--RMALDVA 769
            +RHPNV+ F+G+    P + I TEY+PRGSLY ++H     E +     L  RM +D A
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHN----EKIKISWSLVKRMMIDAA 497

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           KGI YLH   P ILH DLKS NLLVD+NW VKV DFGLS
Sbjct: 498 KGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLS 536

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  151 bits (382), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 83/200 (41%), Positives = 122/200 (61%), Gaps = 6/200 (3%)

Query: 630  KQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKV 689
            K  +FPV   P  + IE     +W E+   E+ +  R+G G +G V R  W G++VAVK+
Sbjct: 822  KDHQFPVPTIPAKI-IEVEKPFEW-EVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKM 879

Query: 690  LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR 749
            L   +     + +  +EV ++ ++RHPN+VLFMGA T+     IVTEYL RGSL  ++  
Sbjct: 880  LFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLD 939

Query: 750  PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             +    MD   RL++  D A+G+ YLH+ NP I+H DLK+ NLLVD +W VKV DFGL+ 
Sbjct: 940  ESIE--MDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLAT 997

Query: 810  FKANTFISSKSVAGTVVFFA 829
             K++TF  +K++ GT  + A
Sbjct: 998  VKSHTF--AKTMCGTTGWVA 1015

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  150 bits (378), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 71/173 (41%), Positives = 116/173 (67%), Gaps = 5/173 (2%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKR 712
           +EIS+ EL +  ++G G+FG V++  W GS VA+K + + + +++Q L+EF +E+ I+ R
Sbjct: 655 IEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSR 714

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN+VL M A T  P+L  +TEYLP GSLY  +H       M+ +   ++A+ +A+G+
Sbjct: 715 LRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK--MNMQLYKKLAIQIAQGM 772

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
           NYLH     ++H D+KS NLL+D++  VK+CDFGLS+ K+ +   +KS+   +
Sbjct: 773 NYLH--LSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPI 823

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  144 bits (364), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 63/167 (37%), Positives = 112/167 (67%), Gaps = 3/167 (1%)

Query: 653  WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
            W+ I++DE+ + E++G GS+G V+R +W   DVA+K    Q   ++ L     E+A +K+
Sbjct: 1392 WV-INYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKK 1450

Query: 713  VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
            + HPN++  +GA  K+P++ IVTEY+ +G+L R   R    + ++  +++++ +++AKGI
Sbjct: 1451 LHHPNIITMVGASLKKPNICIVTEYMAKGNL-RDAMRTCTPK-LEWHQKIKILVNIAKGI 1508

Query: 773  NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
            +YLH+ +PPI+H D+K  N+L+D+NW VK+ DFG +R K    I ++
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR 1555

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2

 Score =  140 bits (354), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/177 (46%), Positives = 116/177 (65%), Gaps = 2/177 (1%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           L I  +EL   +++G+G+ G V + EW G+ VAVK +       D+ +EF +EV+I+K +
Sbjct: 353 LNIQENELLFIKKIGSGACGEVCQYEWKGTPVAVKTIFKSLLRKDKKEEFEKEVSILKCL 412

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           RHPNVVLFMG      +L+I+TEYL RGSL  ++      E +    +++M +DVA+G+N
Sbjct: 413 RHPNVVLFMGTCLLNGNLAIITEYLNRGSLRDVLTTMNKSE-LSLSVKVKMLIDVAQGMN 471

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
           YLH  +PPI+H DLKS NLLVD N+ VKV DFGLSRF +    SS K+  GT+ + A
Sbjct: 472 YLHTYSPPIIHRDLKSLNLLVDNNFNVKVSDFGLSRFISGGIGSSAKTFCGTLSWIA 528

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  139 bits (351), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 74/160 (46%), Positives = 100/160 (62%), Gaps = 8/160 (5%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVK---VLTVQDFLDDQLKEFLREVAIMKR 712
           I   E+ V+ R+G GS   V    W G  VA+K   +L   D  +D L E  +E  IM +
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDD--EDFLNELAQEATIMSQ 543

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN+  F+G     P + IV EY+P GSLYR++H P+    +D  R   MALD+AKG+
Sbjct: 544 LRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSIS--LDWPRMKSMALDIAKGM 601

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFK 811
           NYLH  +P ++H DLKS NLLVD+++ VK+ DFGLS RFK
Sbjct: 602 NYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFK 641

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  139 bits (350), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 70/161 (43%), Positives = 104/161 (64%), Gaps = 4/161 (2%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI + EL + E +G G +G V+++ W G++VAVK+++ +    D  + F  EV IM 
Sbjct: 778 DW-EIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMT 836

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            +RHPNVVLFM A TK P++ IV E++  GSLY L+      E +    +++MA   +KG
Sbjct: 837 SLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPE-IPYALKIKMAYQASKG 895

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
           +++LH  +  I+H DLKS NLL+D  W VKV DFGL++ K+
Sbjct: 896 MHFLH--SSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKS 934

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	867
359492500	905	PREDICTED: serine/threonine-protein kina	0.889	0.851	0.636	0.0
449437280	925	PREDICTED: serine/threonine-protein kina	0.916	0.859	0.639	0.0
255545998	949	map3k delta-1 protein kinase, putative [	0.930	0.850	0.638	0.0
147781068	1169	hypothetical protein VITISV_043709 [Viti	0.876	0.650	0.623	0.0
356510128	932	PREDICTED: serine/threonine-protein kina	0.904	0.841	0.6	0.0
356551777	952	PREDICTED: serine/threonine-protein kina	0.923	0.841	0.594	0.0
357465219	926	Serine/threonine protein kinase [Medicag	0.911	0.853	0.579	0.0
334186877	956	protein kinase family protein [Arabidops	0.914	0.829	0.551	0.0
297803662	961	hypothetical protein ARALYDRAFT_492397 [	0.916	0.827	0.553	0.0
5051790	963	putative protein kinase [Arabidopsis tha	0.914	0.823	0.546	0.0

>gi|359492500|ref|XP_003634421.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] gi|302142079|emb|CBI19282.3| unnamed protein product [Vitis vinifera]

 Score = 1015 bits (2624), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 548/861 (63%), Positives = 634/861 (73%), Gaps = 90/861 (10%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
           MPHRTTYFFPRQFPD R FDAS+        K+LL  HEK          E++RK    T
Sbjct: 1   MPHRTTYFFPRQFPDRR-FDASS--------KELLA-HEKKIG------GESNRKGTRTT 44

Query: 61  TSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKS 120
              T   T N          SDLFT G +KF+ KKQ  AAFCDWL EKK DRS   HV  
Sbjct: 45  KDVTADRTYN---------ASDLFT-GSDKFRSKKQ-LAAFCDWLVEKKGDRSG--HV-- 89

Query: 121 FQSRLSSGADE-DREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYA 179
              RL S  DE DR+           P P P        D+ FDRQVSLPR+SS GSSYA
Sbjct: 90  ---RLRSRNDEGDRDV-------LLPPPPAPVPEVVAGKDQQFDRQVSLPRVSS-GSSYA 138

Query: 180 ASSLFSGTTLDGNFSSDVKDTSTRV---STSRQEVEEEESKDTAAQRTKESYMLQLTLAR 236
            S LFSGTT++GN SS +KD+ T      ++R+EV+EE  K++AAQ+++ESY LQLTLA+
Sbjct: 139 GS-LFSGTTVEGNVSSGLKDSHTNSHSQESTRREVDEE--KESAAQKSRESYYLQLTLAK 195

Query: 237 RLTLQACIFSGPLL-LQESALEVS----DTETVSYRLWVSGCLSYNDKISDGFYNILGMN 291
           RL  QA +   P+L LQES  E +    D + VSYRLWVSGCLSY DKISDGFYNILGMN
Sbjct: 196 RLASQASLACEPVLFLQESGAEGNAVSFDPDVVSYRLWVSGCLSYTDKISDGFYNILGMN 255

Query: 292 PYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASE 351
           PY+WVMCN+LEEG+RLP LM+LK ++  +TSMEVVL+DR GDSRLKELEDKA +LYCASE
Sbjct: 256 PYVWVMCNELEEGRRLPPLMALKAVEPNDTSMEVVLVDRRGDSRLKELEDKAHQLYCASE 315

Query: 352 NTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRH 411
           NTLVLVE+LGKLVAI MGG+FP+EQGDLHK+WK+ SKRLR F+KCIVLPIGSLSMGLCRH
Sbjct: 316 NTLVLVEQLGKLVAIYMGGSFPVEQGDLHKQWKLVSKRLRDFQKCIVLPIGSLSMGLCRH 375

Query: 412 RAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHG 471
           RAILFKKLADYIGLPCRIARGC+YC ADHRSSCLVKI DD++SSREYVVDLVGEPGN+HG
Sbjct: 376 RAILFKKLADYIGLPCRIARGCKYCVADHRSSCLVKI-DDKQSSREYVVDLVGEPGNVHG 434

Query: 472 PNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKG 531
           P+ SI GG LSSMPSP Q+S LKE+Q+PYMDN S CQ+ +S++   +PE P Y       
Sbjct: 435 PDSSITGGLLSSMPSPLQISHLKEYQQPYMDNESCCQIQNSKNTCIYPEDPLY------- 487

Query: 532 QKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNS------------------DA 573
                +G  K++     +Q     ESS++PL+  GN                      DA
Sbjct: 488 -----LGNEKNTLYTPTDQICERMESSVLPLEFNGNTDRCIIQSAMLQSVQSNVSEAVDA 542

Query: 574 AA-GAPIQEYSRLVEENVAIEAAYKEEIVVSESSVI---IKQPNATLPSQLD-KEDESKL 628
           +A G  I E  R+  E + I+ A+K+EI +S S +    +KQP  +L S+ + KE E +L
Sbjct: 543 SASGVSIHECFRIAGEKIVIQQAHKKEIALSGSPITSKALKQPKVSLSSKSNIKEVEGRL 602

Query: 629 EKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVK 688
           E +G+F     PRYLN+EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEWHGSDVAVK
Sbjct: 603 ENRGRFHTVTIPRYLNLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEWHGSDVAVK 662

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH 748
           VLTVQ+F DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH
Sbjct: 663 VLTVQNFQDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH 722

Query: 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           RP + E++DQRRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLVDKNWTVKVCDFGLS
Sbjct: 723 RPTSAEILDQRRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLVDKNWTVKVCDFGLS 782

Query: 809 RFKANTFISSKSVAGTVVFFA 829
           RFKANTF+SSKSVAGT  + A
Sbjct: 783 RFKANTFLSSKSVAGTPEWMA 803

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449437280|ref|XP_004136420.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus]

 Score = 1009 bits (2608), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 548/857 (63%), Positives = 631/857 (73%), Gaps = 62/857 (7%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
           MPHRTTYFFPRQFPD RGFD+      A+ +K +L +HEK   K TF   E+D K     
Sbjct: 1   MPHRTTYFFPRQFPD-RGFDS------ASTSKHIL-DHEKKINKDTFS-TESDAKPTPRP 51

Query: 61  TSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKS 120
               + T    K+SA    VSDLFT GD+    KK    AF DWL +KK  RSA+ HVK+
Sbjct: 52  ARDFSVT----KSSA----VSDLFT-GDKAQTNKK--LPAFYDWLVDKKATRSATAHVKT 100

Query: 121 FQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDN--DRNFDRQVSLPRLSSTGSSY 178
           + S      DEDRE LLPPP  EP      DT +  D   DRNFDRQVSLPRLSS GSSY
Sbjct: 101 WLSN----CDEDRELLLPPPTSEPEH----DTTSVKDRSVDRNFDRQVSLPRLSS-GSSY 151

Query: 179 AASSLFSGT---TLDGNFSSDVKDTS-TRVSTSR----QEVEEEESKDTAAQRTKESYML 230
           A S LFSGT   T+DGNFSSDVKD+S +++ +S     +E+E  + K+  AQ+  ESY L
Sbjct: 152 AGS-LFSGTGTGTVDGNFSSDVKDSSASKILSSHTARPEEIEVGDDKENIAQKATESYYL 210

Query: 231 QLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGM 290
           QL LA  L   A +   P+L++E  +E++D ETVSYRLWVSGCLSY+DKISDGFYNILGM
Sbjct: 211 QLALAATLRSHANLAGDPVLMEEGRVEITDAETVSYRLWVSGCLSYSDKISDGFYNILGM 270

Query: 291 NPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCAS 350
           NPYLWVMCND EEG+RLPSLMSL+ I+ +ETSMEV+L+DR GDSRLKELEDKAQELYCAS
Sbjct: 271 NPYLWVMCNDFEEGRRLPSLMSLRTIEPSETSMEVILVDRRGDSRLKELEDKAQELYCAS 330

Query: 351 ENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCR 410
           E+TLVLVE+LGKLVAI MGGTFP+EQG LH  WK+ SKRLR+F+KCIVLPIGSLSMGLCR
Sbjct: 331 ESTLVLVEKLGKLVAIYMGGTFPVEQGGLHLHWKVVSKRLREFQKCIVLPIGSLSMGLCR 390

Query: 411 HRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIH 470
           HRAILFKKLADYIGLPCRIARGC+YC ADHRSSCLVKIEDD++S REYVVDLVGEPGNIH
Sbjct: 391 HRAILFKKLADYIGLPCRIARGCKYCVADHRSSCLVKIEDDKKSLREYVVDLVGEPGNIH 450

Query: 471 GPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGI--- 527
           GP+ SINGGF SSMPSP Q+S LKEFQ+PY+++    Q   S+    FPE P  SG    
Sbjct: 451 GPDSSINGGFQSSMPSPLQISHLKEFQEPYVESYFNHQTVGSKQICGFPEYPLRSGFGQY 510

Query: 528 -IRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLK--------LQGNPKNSDAAAGAP 578
            ++ G  L+      +  D LV+Q      S+ + L+        LQ +   S  A  + 
Sbjct: 511 QMKGGSTLRMSS--GAETDKLVDQACMGIGSTQLCLETKVSKECVLQNHIMPSTGADASE 568

Query: 579 IQEY---SRLVEENVAIEAAYKEEIVVSESSVI---IKQPNATLPSQLDKEDESKLEKQG 632
           +      + L E  V IE  Y+EE VV+    +   I     TL +Q D ++   + +  
Sbjct: 569 VLSSVGGASLCENKVVIEEIYQEEAVVAAGISVNETINPSKLTLSTQTDSKE--IVGRSQ 626

Query: 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTV 692
                  P+YL +EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEWHGSDVAVKVLTV
Sbjct: 627 NCSASTYPKYLTLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEWHGSDVAVKVLTV 686

Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA 752
           QDF DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP+ 
Sbjct: 687 QDFHDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPSY 746

Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
           GE+MDQR+RLRMALDVAKGINYLH LNPPI+HWDLKSPNLLVDKNWTVKVCDFGLSRFKA
Sbjct: 747 GELMDQRKRLRMALDVAKGINYLHCLNPPIVHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 806

Query: 813 NTFISSKSVAGTVVFFA 829
           NTFISSKSVAGT  + A
Sbjct: 807 NTFISSKSVAGTPEWMA 823

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545998|ref|XP_002514059.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223547145|gb|EEF48642.1| map3k delta-1 protein kinase, putative [Ricinus communis]

 Score = 1003 bits (2594), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 555/869 (63%), Positives = 642/869 (73%), Gaps = 62/869 (7%)

Query: 1   MPHRTTYFFPRQFPDHR-GFDASASPSPAAANKQLLENHEKNTEKGTFGI-NENDRK--- 55
           MPHRTTYFFPRQFPD   GFDAS++       KQLL++ +K   K TF I N+  RK   
Sbjct: 1   MPHRTTYFFPRQFPDRSSGFDASST-------KQLLDHEKKKLIKDTFNIDNDLPRKDFS 53

Query: 56  ---------SAAATTSTTTTTTKNLKNSAAPLSVSDLFTSGD-EKFKVK-KQQFA----- 99
                         TS   TT+     + A     DLFTS D EK+  K K+QF      
Sbjct: 54  RSSSSNSTAGNGNITSQIQTTSSPTTTATAQTPAFDLFTSSDDEKYHQKEKKQFGEDDKL 113

Query: 100 --------AFCDWLTEKK-EDRSASRHVKSFQSRLSSGADEDREPLLPPPEP-------- 142
                   AF DWL EKK E RS   HVK  Q   S   DEDR  LL P  P        
Sbjct: 114 QKKKKQLAAFYDWLAEKKAEKRSVISHVK-LQRLSSYDDDEDRHLLLTPEPPPAPEPEII 172

Query: 143 -EPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTS 201
            E VP  VP+     D DR FDRQVSLPRLSS GSSYA S LFSGTTLDGNF S++K++ 
Sbjct: 173 GEIVPEIVPEVR---DVDRKFDRQVSLPRLSS-GSSYAGS-LFSGTTLDGNFLSEIKESV 227

Query: 202 TRVSTSRQEVEEEESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDT 261
            +     +E ++++     AQRT+E+Y LQL LARRL+ Q+ + S  +LLQE   E  D 
Sbjct: 228 RQDEEVEEEKKKDDE--KVAQRTRETYYLQLALARRLSFQSGLASEIVLLQEGP-EFPDA 284

Query: 262 ETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTET 321
           ETVSYRLWV+GCLSY+D+ISDGFYNILGMNPYLW+MCND EEG+RLP LMSLK+I+ ++T
Sbjct: 285 ETVSYRLWVTGCLSYSDRISDGFYNILGMNPYLWLMCNDEEEGRRLPPLMSLKEIEPSDT 344

Query: 322 SMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHK 381
           SMEVVL+D  GDSRLKELEDKA ELYCASENTLVLVE+LGKLVA+CMGGTFP+EQGDLHK
Sbjct: 345 SMEVVLVDGLGDSRLKELEDKAHELYCASENTLVLVEKLGKLVAVCMGGTFPVEQGDLHK 404

Query: 382 RWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHR 441
           RWK+ SKRLR+F KCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYC ADHR
Sbjct: 405 RWKIVSKRLREFHKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCVADHR 464

Query: 442 SSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYM 501
           SSCLVKIEDD++ SREYVVDLVG+PGNIHGP+ +INGGF+ S+PSPF++S LK+FQ P M
Sbjct: 465 SSCLVKIEDDKQLSREYVVDLVGQPGNIHGPDSTINGGFIPSIPSPFKISHLKDFQHPCM 524

Query: 502 DNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVP 561
           D+T   Q+  S+   A P + PYSG   + +  + +G  K S     +Q     +SS+VP
Sbjct: 525 DDTPR-QISVSKQLCAVPVN-PYSG---REEGRQSMGNLKLSTYVSADQATLGNDSSVVP 579

Query: 562 LKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLD 621
           L L  + ++ D  +G  I E S L  E V I+  Y++EIV+S +  ++K+    L  Q +
Sbjct: 580 LDLTRSAESLD-VSGPSIHERSDLEVEQVVIQQTYRKEIVMSGNPSVLKRTEVNLSCQSN 638

Query: 622 K-EDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW 680
           K E +SKL+ Q K P    PRYLN+EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEW
Sbjct: 639 KREVDSKLDGQSKLPALSIPRYLNLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEW 698

Query: 681 HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740
           HGSDVAVKVL+VQDF DDQL+EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR
Sbjct: 699 HGSDVAVKVLSVQDFHDDQLREFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 758

Query: 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV 800
           GSLYRLIHRP AGEM+DQRRRLRMALDVAKGINYLH L+PPI+HWDLKSPNLLVDKNWTV
Sbjct: 759 GSLYRLIHRPTAGEMLDQRRRLRMALDVAKGINYLHCLSPPIVHWDLKSPNLLVDKNWTV 818

Query: 801 KVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           KVCDFGLSRFKANTF+SSKSVAGT  + A
Sbjct: 819 KVCDFGLSRFKANTFLSSKSVAGTPEWMA 847

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147781068|emb|CAN68131.1| hypothetical protein VITISV_043709 [Vitis vinifera]

 Score =  971 bits (2509), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 531/851 (62%), Positives = 618/851 (72%), Gaps = 91/851 (10%)

Query: 11  RQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAATTSTTTTTTKN 70
           RQFPD R FDAS+        K+LL  HEK          E++RK    T   T   T N
Sbjct: 38  RQFPDRR-FDASS--------KELLA-HEKKIG------GESNRKGTRTTKDVTADRTSN 81

Query: 71  LKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKSFQSRLSSGAD 130
                     SDLFT G +KF+ KKQ  AAFCDWL EKK DRS   HV     RL S  D
Sbjct: 82  ---------ASDLFT-GSDKFRSKKQ-LAAFCDWLVEKKGDRSG--HV-----RLRSRND 123

Query: 131 E-DREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTL 189
           E DR+           P P P        D+ FDRQVSLPR+SS GSSYA S LFSGTT+
Sbjct: 124 EGDRDV-------LLPPPPAPVPEVVAGKDQQFDRQVSLPRVSS-GSSYAGS-LFSGTTV 174

Query: 190 DGNFSSDVKDTSTRV---STSRQEVEEEESKDTAAQRTKESYMLQLTLARRLTLQACIFS 246
           +GN SS +KD+ T      ++R+EV+EE  K++AAQ+++ESY LQLTLA+RL  QA +  
Sbjct: 175 EGNVSSGLKDSHTNSHSQESTRREVDEE--KESAAQKSRESYYLQLTLAKRLASQASLAC 232

Query: 247 GPLL-LQESALEVS----DTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDL 301
            P+L LQES  E +    D + VSYRLWVSGCLSY DKISDGFYNILGMNPY+WVMCN+L
Sbjct: 233 EPVLFLQESGAEGNAVSFDPDVVSYRLWVSGCLSYTDKISDGFYNILGMNPYVWVMCNEL 292

Query: 302 EEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELG 361
           EEG+RLP LM+LK ++  +TSMEVVL+DR GDSRLKELEDKA +LYCASENTLVLVE+LG
Sbjct: 293 EEGRRLPPLMALKAVEPNDTSMEVVLVDRRGDSRLKELEDKAHQLYCASENTLVLVEQLG 352

Query: 362 KLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLAD 421
           KLVAI MGG+FP+EQGDLHK+WK+ SKRLR F+KCIVLPIGSLSMGLC  R    +KLAD
Sbjct: 353 KLVAIYMGGSFPVEQGDLHKQWKLVSKRLRDFQKCIVLPIGSLSMGLCT-RFSHMQKLAD 411

Query: 422 YIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFL 481
           YIGLPCRIARGC+YC ADHRSSCLVKI DD++SSREYVVDLVGEPGN+HGP+ SI GG L
Sbjct: 412 YIGLPCRIARGCKYCVADHRSSCLVKI-DDKQSSREYVVDLVGEPGNVHGPDSSITGGLL 470

Query: 482 SSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPK 541
           SSMPSP Q+S LKE+Q+PYMDN S CQ+ +S++   +PE P Y            +G  K
Sbjct: 471 SSMPSPLQISHLKEYQQPYMDNESCCQIQNSKNTCIYPEDPLY------------LGNEK 518

Query: 542 SSKDALVNQPRAEKESSLVPLKLQGNPKNS------------------DAAA-GAPIQEY 582
           ++     +Q     ESS++PL+  GN                      DA+A G  I E 
Sbjct: 519 NTLYTPTDQICERMESSVLPLEFNGNTDRCIIQSAMLQSVQSNVSEAVDASASGVSIHEC 578

Query: 583 SRLVEENVAIEAAYKEEIVVSESSVI---IKQPNATLPSQLD-KEDESKLEKQGKFPVGP 638
            R+  E + I+ A+K+EI +S S +    +KQP  +L S+ + KE E +LE +G+F    
Sbjct: 579 FRIAGEKIVIQQAHKKEIALSGSPITSKALKQPKVSLSSKSNIKEVEGRLENRGRFHTVT 638

Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
            PRYLN+EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEWHGSDVAVKVLTVQ+F DD
Sbjct: 639 IPRYLNLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEWHGSDVAVKVLTVQNFQDD 698

Query: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ 758
           QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP + E++DQ
Sbjct: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPTSAEILDQ 758

Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
           RRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF+SS
Sbjct: 759 RRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFLSS 818

Query: 819 KSVAGTVVFFA 829
           KSVAGT  + A
Sbjct: 819 KSVAGTPEWMA 829

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356510128|ref|XP_003523792.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  963 bits (2489), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 525/875 (60%), Positives = 624/875 (71%), Gaps = 91/875 (10%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEK----NTEKGTFGINENDRKS 56
           MPHRTTY FPRQFP+  G D S+        KQLL++ +K    + +  TF    +  K 
Sbjct: 1   MPHRTTYIFPRQFPERGGLDESS--------KQLLDHEKKKIVNSIKHDTFTAESDPPKK 52

Query: 57  AAATTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSAS- 115
           +  T         + K+SA    VS LF +GD KF+ K +Q AAF DWLT+KK     S 
Sbjct: 53  SPPTKDNDVVVLSSAKHSA----VSYLFAAGD-KFRTKHKQIAAFSDWLTDKKASSQCSP 107

Query: 116 RHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTG 175
           RH              DR+ LLPP            TV +   D+ FDRQVSLPRLSS G
Sbjct: 108 RH-------------HDRDLLLPPET----------TVKDAAVDQRFDRQVSLPRLSS-G 143

Query: 176 SSYAASSLFSGTTLDGNFSSDVKD------TSTRVSTSRQE---VEEEESKDTAAQRTKE 226
           SSYA S LFSGTTLD NFSSD+K+      T T +   R +    EEE+S    A+++KE
Sbjct: 144 SSYAGS-LFSGTTLDCNFSSDIKEETSSSRTLTTIPAPRHKNEEEEEEQSTKKLAKKSKE 202

Query: 227 SYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYN 286
           SY+LQLTLA+RLT  A + + P+L      E  D E+VSYRLWVSGCLSY DKISDGFYN
Sbjct: 203 SYILQLTLAKRLTCLATLVTEPVL--TPGTETWDAESVSYRLWVSGCLSYTDKISDGFYN 260

Query: 287 ILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQEL 346
           ILGMNPYLWVMCND+EEG+R+P+LM+LK ++ ++T MEVVL+DR  DSRLK L+DKAQEL
Sbjct: 261 ILGMNPYLWVMCNDVEEGRRIPTLMALKAVEPSDTCMEVVLVDRREDSRLKLLQDKAQEL 320

Query: 347 YCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSM 406
           YCASENTL+LVE+LGKLVAI MGG FP+EQGDLHKRWK+ SK+LR F KC+VLPIGSLS 
Sbjct: 321 YCASENTLLLVEQLGKLVAIYMGGMFPVEQGDLHKRWKLVSKKLRNFHKCVVLPIGSLSS 380

Query: 407 GLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEP 466
           GLCRHRA+LFK+LADYIGLPCRIARGC+YC ADHRSSCLVKI+DD++ SREYVVDLVGEP
Sbjct: 381 GLCRHRAVLFKRLADYIGLPCRIARGCKYCVADHRSSCLVKIKDDKQLSREYVVDLVGEP 440

Query: 467 GNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSG 526
           GN+HGP+ SING ++SSMPSPFQ+S LKE Q PYMD+T+     + R  +  PES PYSG
Sbjct: 441 GNVHGPDSSINGAYVSSMPSPFQISHLKESQSPYMDDTASSISSNHRPVN--PESLPYSG 498

Query: 527 IIRKGQKLKDIGLPKSSKDAL---VNQPRAEKESSLVPLKLQGN---------------- 567
             +  Q+L +  L KS K ++   V+Q     E SL+P  L+GN                
Sbjct: 499 SEQNDQQLNETDLLKSHKGSIYASVDQICEGTEPSLIPFGLEGNDEECAVLSSVLPTIHE 558

Query: 568 --PKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVI---IKQP--NATLPSQL 620
              K+   A  A + EY RL E+   ++     EI+V+ SSV+    +Q    ++  S+L
Sbjct: 559 DVSKSLHPAIEASLHEYPRLSED--VVQETSHNEIIVNGSSVVKSTFQQSMLGSSCQSEL 616

Query: 621 DKEDESKLEKQGKFP-VGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAE 679
            K+   ++E QG  P  G  PRY+N+EPSLAMDWLEISWD+L +KERVGAGSFGTV+RAE
Sbjct: 617 -KQVGIRIENQGCLPAAGNIPRYVNLEPSLAMDWLEISWDDLRIKERVGAGSFGTVYRAE 675

Query: 680 WHGSDVAVKVLTVQDFLDDQLKEFLR-----EVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734
           WHGSDVAVKVLTVQDF DDQLKEFLR     EVAIMKRVRHPNVVLFMG+VTKRPHLSIV
Sbjct: 676 WHGSDVAVKVLTVQDFHDDQLKEFLREVCIHEVAIMKRVRHPNVVLFMGSVTKRPHLSIV 735

Query: 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV 794
           TEYLPRGSLYRLIHRPA+GE++D+RRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLV
Sbjct: 736 TEYLPRGSLYRLIHRPASGEILDKRRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLV 795

Query: 795 DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           DKNWT KVCDFGLSRFKANTFI SKSVAGT  + A
Sbjct: 796 DKNWTAKVCDFGLSRFKANTFIPSKSVAGTPEWMA 830

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551777|ref|XP_003544250.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  952 bits (2462), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 521/876 (59%), Positives = 626/876 (71%), Gaps = 75/876 (8%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
           MPHR TYFFPRQFP+ RG D S S       K+ + N  K+ +        +  K    T
Sbjct: 1   MPHRATYFFPRQFPE-RGLDES-SKQRLDQEKRKIVNSIKSPDTNFAAFESDAPKKQTTT 58

Query: 61  TSTTTTTTKN--LKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRS-ASRH 117
             + T   KN  + +S    +VSD+FT GD KF+ K++Q AAFCDWL +KK+DR+  S H
Sbjct: 59  PQSPTPDVKNDVVFSSTKQNAVSDIFTGGD-KFRTKQKQIAAFCDWLIDKKKDRNRPSHH 117

Query: 118 VKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSS 177
            K + +      +++RE LL PP P+     V D V     DR+FDRQVSLPRLSS GSS
Sbjct: 118 FKPYPNEEEEEEEDERELLLRPPPPDAAAQVVKDAV-----DRSFDRQVSLPRLSS-GSS 171

Query: 178 YAASSLFSGTTLDGN--FSSDVKDTSTRVSTSRQEVEEEESKD-----------TAAQRT 224
           YA S LF   TLDG   FSSDV  T    S+ RQ   EE++               AQ+ 
Sbjct: 172 YAGS-LF---TLDGTATFSSDV--TKEETSSFRQVFTEEDATQKQQEEEEKEKRNTAQKY 225

Query: 225 KESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGF 284
           +ESY LQL   +RL+  A + S P+L  ++  E  D E+VSYRLWVSGCLSY DKISDGF
Sbjct: 226 RESYYLQLAFTKRLSCLASLGSEPVLTLDAGTETWDAESVSYRLWVSGCLSYTDKISDGF 285

Query: 285 YNILGMNPYLWVMCNDLEE-GKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKA 343
           YNILGMNPYLWVMCND+EE GKRLP+LM+LK  + ++TS+EVVL DRH DSRLKEL+DKA
Sbjct: 286 YNILGMNPYLWVMCNDVEEEGKRLPTLMALKAAEPSDTSIEVVLFDRHEDSRLKELQDKA 345

Query: 344 QELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGS 403
           QELY ASEN LVLVE+LGKLVAICMGG+FP+EQGDLHKRWK+ SKRLR F +C+VLP+GS
Sbjct: 346 QELYSASENALVLVEKLGKLVAICMGGSFPVEQGDLHKRWKLVSKRLRNFHQCVVLPVGS 405

Query: 404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLV 463
           LS GLCRHRAILFK+LADYIGLPCRIARGCRYC +DHRSSCLVKI+DDR+ SREYVVDLV
Sbjct: 406 LSSGLCRHRAILFKRLADYIGLPCRIARGCRYCVSDHRSSCLVKIKDDRQLSREYVVDLV 465

Query: 464 GEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPP 523
           GEPGNIHGP+ SING ++SS+PSPFQ+S LKE Q PY+D  +  Q   S  N++      
Sbjct: 466 GEPGNIHGPDSSINGAYVSSIPSPFQISHLKESQSPYVDVAACSQ---SLGNTSL----- 517

Query: 524 YSGIIRKGQKLKDIGLPKSSKDAL---VNQPRAEKESSLVPLKLQGNPKNS--------- 571
             G +++ Q+ ++  L K++  ++   ++Q R   E  L+P  L+GN K           
Sbjct: 518 --GCVQEDQQAEETDLQKNNNGSIYPAIDQTRGGAEPPLIPFGLKGNHKECAILGLLNFP 575

Query: 572 ----------DAAAGAPIQEYSRLVEENVAI-EAAYKE-EIVVSESSVI---IKQPNATL 616
                       A  A + EY RL +++V + EA+ KE EI+V  SS +    KQ   +L
Sbjct: 576 PVYEGVSEDLHPATEASLHEYPRLSKDSVVVLEASNKEIEIIVKGSSGVKSNYKQSTVSL 635

Query: 617 PSQLDKEDE---SKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFG 673
            S+  +E E   +K+E QG    G  PRYLN+EPSLAMDWLEI WD+L +KERVGAGSFG
Sbjct: 636 SSESKQEQEHVKNKVENQG---AGNIPRYLNLEPSLAMDWLEIPWDDLRIKERVGAGSFG 692

Query: 674 TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733
           TV+RAEWHGSDVAVKVLTVQDF DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI
Sbjct: 693 TVYRAEWHGSDVAVKVLTVQDFQDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 752

Query: 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLL 793
           VTEYLPRGSL+RLIH+PA+GE++D RRRLRMALDVAKGINYLH L PPI+HWDLK+PNLL
Sbjct: 753 VTEYLPRGSLFRLIHKPASGEILDPRRRLRMALDVAKGINYLHCLKPPIVHWDLKTPNLL 812

Query: 794 VDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           VD+NWTVKVCDFGLSRFKANTF+SSKSVAGT  + A
Sbjct: 813 VDRNWTVKVCDFGLSRFKANTFLSSKSVAGTPEWMA 848

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357465219|ref|XP_003602891.1| Serine/threonine protein kinase [Medicago truncatula] gi|355491939|gb|AES73142.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  919 bits (2375), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 498/860 (57%), Positives = 608/860 (70%), Gaps = 70/860 (8%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
           MPHR TYFFPRQFP+ RG D S+        K+LL+  +           END       
Sbjct: 1   MPHRATYFFPRQFPE-RGLDESS--------KKLLDQDKDKIVNSIKSPIEND------- 44

Query: 61  TSTTTTTTKNLKNSAAPLSVSD-LFTSGD-----EKFKVKKQQFAAFCDWLTEKKEDRSA 114
               T TTK+L +S  P   +D +F+SG      +K + +++Q +AFCDW  +KK  R +
Sbjct: 45  ----TPTTKSLSSSTPPTPKNDAVFSSGKHSVAGDKLRFRQKQISAFCDWFIDKK--RHS 98

Query: 115 SRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSST 174
                 F  RLS+ +D+D +     PE       V DT      DRNFDRQVSLPRLSS 
Sbjct: 99  GHLTHHFHRRLST-SDDDHDFFHSQPE-----TAVNDTAI----DRNFDRQVSLPRLSS- 147

Query: 175 GSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMLQLTL 234
            SSYA S LFS    +   SS V  ++   +T+R++ E++E+KD   ++ +ESY+LQLTL
Sbjct: 148 DSSYAGS-LFSSDIKEETQSSQV--STIPATTARRQKEDDENKDGLVKKCEESYILQLTL 204

Query: 235 ARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYL 294
           A+RL   A + S P+L      E  D E+VSYRLWVSGCLSY DKISDGFYNILGMNPYL
Sbjct: 205 AKRLASLASLVSEPVL--TPGTENWDAESVSYRLWVSGCLSYTDKISDGFYNILGMNPYL 262

Query: 295 WVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTL 354
           WVMCND EEGK++P+LM+LK ++ +E SMEVVL+DR  DSRLK L DKAQELY +SENTL
Sbjct: 263 WVMCNDEEEGKKIPTLMALKAVEPSEASMEVVLVDRQEDSRLKLLHDKAQELYRSSENTL 322

Query: 355 VLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAI 414
           V VE+LGKLVAI MGG FP+E+GDLHK+WK+ SKRLR F KC+VLPIG LS GLCRHRAI
Sbjct: 323 VFVEQLGKLVAINMGGIFPVERGDLHKQWKLVSKRLRNFHKCVVLPIGGLSSGLCRHRAI 382

Query: 415 LFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNF 474
           LFK+LAD+IGLPCRIARGC+YC ADHRSSCLVKI+DD++ SREYVVDLVGEPG +HGP+ 
Sbjct: 383 LFKRLADFIGLPCRIARGCKYCVADHRSSCLVKIKDDKQISREYVVDLVGEPGIVHGPDS 442

Query: 475 SINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAF-PESPPYSGIIRKGQK 533
           SING ++SS+PSPFQ+S  KE Q PYMD+ +  Q P     S+F PE+ PY G  +  Q+
Sbjct: 443 SINGAYVSSIPSPFQISHFKELQSPYMDDEASSQPPICFDQSSFDPETHPYLGCGQIDQQ 502

Query: 534 LKDIGLPK--SSKDALVNQPRAEKESSLVPLKLQGNPK------------NSDAAAGAPI 579
           +K+  L K   S  A ++      +  L PL L+ N +            + D +   P+
Sbjct: 503 VKETDLLKVQGSFCASIDHTCEGTKPLLTPLGLKENDEECAVLGSILPTIHEDVSKVFPV 562

Query: 580 -----QEYSRLVEENVAIEAAYKEEIVVSESSVI---IKQP--NATLPSQLDKEDESKLE 629
                 EY RL E+ V ++     EI+V+E SV+    KQ   +++  S+L K+ ++++E
Sbjct: 563 SEESLHEYPRLSEDAVVLQETSSNEIIVTEGSVVKSTFKQCILSSSCQSEL-KQVDNRIE 621

Query: 630 KQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKV 689
            Q   P G  PRY+N+EPSL+MDWLEISW++L +KERVGAGSFGTVH AEWHGSDVAVKV
Sbjct: 622 NQDYLPAGNIPRYVNLEPSLSMDWLEISWNDLRIKERVGAGSFGTVHHAEWHGSDVAVKV 681

Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR 749
           LTVQDF DDQLKEFLREVAIMKRVRHPNVVLFMGAVT  P+LSIVTEYLPRGSLY LIHR
Sbjct: 682 LTVQDFHDDQLKEFLREVAIMKRVRHPNVVLFMGAVTTCPNLSIVTEYLPRGSLYHLIHR 741

Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           PA+GE++D RRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLVDKNWTVKVCDFGLSR
Sbjct: 742 PASGEILDSRRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLVDKNWTVKVCDFGLSR 801

Query: 810 FKANTFISSKSVAGTVVFFA 829
           FKANTFI SKSVAGT  + A
Sbjct: 802 FKANTFIPSKSVAGTPEWMA 821

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334186877|ref|NP_194179.2| protein kinase family protein [Arabidopsis thaliana] gi|332659512|gb|AEE84912.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  899 bits (2323), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 484/878 (55%), Positives = 611/878 (69%), Gaps = 85/878 (9%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKG----TFGINENDRKS 56
           MPHRTTYFFPRQFPD RGFD+ +          L  +H+K         +FG   +++ +
Sbjct: 1   MPHRTTYFFPRQFPD-RGFDSFS----------LKNDHDKKKSSSNVGESFGFQRDNKSN 49

Query: 57  AAA------TTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKE 110
                      ST  ++   L  S+A   VSDLF+   +  K  +QQ AAF +WL EKK 
Sbjct: 50  GVGEDSNKEKESTVFSSNPLLSKSSA---VSDLFSDDRKSEKKHQQQLAAFYEWLAEKKA 106

Query: 111 D--------RSASRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPV---PDTV------ 153
           +         +  R VK  +  +SS ADE+RE LL  P  +P P+P    PD++      
Sbjct: 107 NLSRSSSTTTTHGRGVKPTRFSMSSDADEERELLLSSPA-DPAPLPATSSPDSIIDSART 165

Query: 154 TNIDN---DRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFS-----SDVKDTSTRVS 205
            NI     DR+FDR+VSLPR+SS  S   A S FSGTT+DGNFS     +D ++TST   
Sbjct: 166 VNIHERNIDRSFDREVSLPRMSSESS--FAGSFFSGTTVDGNFSNFSSHTDARETSTTTL 223

Query: 206 TSRQEVEE------EESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVS 259
            S  + EE      +  + + AQ+++E Y LQ+TLA+ L+ QA        L   ++ + 
Sbjct: 224 VSVNKEEEEVEVREQGKEQSLAQKSREGYYLQVTLAKWLSSQAN-------LACESVHIQ 276

Query: 260 DTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDST 319
            TE++SYR WVSGCLSY+DKISDGFY+ILGM+PYLW+MCN+ E+GKR+PSL+ LK+ +  
Sbjct: 277 STESISYRFWVSGCLSYSDKISDGFYSILGMDPYLWLMCNNSEDGKRIPSLLLLKETEPN 336

Query: 320 ETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDL 379
           +TSMEVVLIDR  DSRLKELEDKA ELYC+S+N LVLVE+LG+LVA+ MGG F +EQGDL
Sbjct: 337 DTSMEVVLIDRREDSRLKELEDKAHELYCSSDNMLVLVEKLGRLVAVYMGGNFQVEQGDL 396

Query: 380 HKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEAD 439
            KRWK+ S RL++FRKCI+LPIGSL+MGLCRHRAILFKKLADYIGLPCRIARGCRYC+  
Sbjct: 397 QKRWKLVSNRLKEFRKCIILPIGSLTMGLCRHRAILFKKLADYIGLPCRIARGCRYCKES 456

Query: 440 HRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKP 499
           H+SSCLVKI+DDR+ SREYVVDL+GEPGN+H P+ SING     +PSP Q+S L +F +P
Sbjct: 457 HQSSCLVKIDDDRKLSREYVVDLIGEPGNVHDPDSSINGETQCQIPSPLQMSHLTDFSRP 516

Query: 500 YMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKD---ALVNQPRAEKE 556
            + +TS CQ  +S+++    E+   SG   +GQ  K+  LP ++     A ++Q    K 
Sbjct: 517 CVHSTSPCQTVESKTSRTLSENIQRSG--SQGQVHKEFELPDNAGTVCCAHIDQTCCAKV 574

Query: 557 SSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATL 616
           SS+V          +++   A   +   L EE +A +   KEE V+ E    +KQPN ++
Sbjct: 575 SSMVL---------TESVLRALPLDIPNLSEEKIAPQETCKEETVLLEDPTAMKQPNLSV 625

Query: 617 PSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVH 676
             ++ + D  K +K+G+ PV     YL IEPSLA DWLE+SW+ELH+KERVGAGSFGTVH
Sbjct: 626 EPEIVEADTRK-DKKGRLPVDAISPYLTIEPSLASDWLEVSWNELHIKERVGAGSFGTVH 684

Query: 677 RAEWHGSDVAVKVLTVQDFLDDQLKEFLRE-----VAIMKRVRHPNVVLFMGAVTKRPHL 731
           RAEWHGSDVAVK+L++QDF DDQ +EFLRE     VAIMKRVRHPNVVLFMGAVT+RP L
Sbjct: 685 RAEWHGSDVAVKILSIQDFHDDQFREFLREVCKQAVAIMKRVRHPNVVLFMGAVTERPRL 744

Query: 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN 791
           SI+TEYLPRGSL+RLIHRPA+GE++DQRRRLRMALDVAKG+NYLH LNPP++HWDLKSPN
Sbjct: 745 SIITEYLPRGSLFRLIHRPASGELLDQRRRLRMALDVAKGLNYLHCLNPPVVHWDLKSPN 804

Query: 792 LLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LLVDKNWTVKVCDFGLSRFKANTFI SKSVAGT  + A
Sbjct: 805 LLVDKNWTVKVCDFGLSRFKANTFIPSKSVAGTPEWMA 842

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297803662|ref|XP_002869715.1| hypothetical protein ARALYDRAFT_492397 [Arabidopsis lyrata subsp. lyrata] gi|297315551|gb|EFH45974.1| hypothetical protein ARALYDRAFT_492397 [Arabidopsis lyrata subsp. lyrata]

 Score =  897 bits (2317), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 490/886 (55%), Positives = 606/886 (68%), Gaps = 91/886 (10%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGT---FGINENDRKSA 57
           MPHRTTYFFPRQFPD RGFD+ +          L  +HEK +       FG    ++ + 
Sbjct: 1   MPHRTTYFFPRQFPD-RGFDSLS----------LKNDHEKISSSNVSENFGFQRENKSNG 49

Query: 58  AATTSTT---TTTTKNLKNSAAPLSVSDLFTSGDEKFKVKK---QQFAAFCDWLTEKKED 111
            +  S     TT   +    +   +VSDLF+ G +  K +K   QQ AAF DWL EKK +
Sbjct: 50  VSEDSNKDKETTVFSSNSLLSKSSAVSDLFSGGVDDRKSEKKHQQQLAAFYDWLAEKKAN 109

Query: 112 RSAS-------RHVKSFQSRLSSGADEDREPLL-PPPEPEPVP-VPVPDTV--------- 153
            S S       R VK  +  +SS ADE+RE LL  P +P P+P    PD+V         
Sbjct: 110 LSRSSSTTAHGRAVKPTRFSMSSDADEEREHLLLSPADPAPLPATSSPDSVIAASSSSAR 169

Query: 154 -TNIDN---DRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQ 209
             NI+    DR FDR+VSLPR+SS  S   A S FSGTT+DGNFS+    T  R +++  
Sbjct: 170 TVNINERNIDRGFDREVSLPRMSSESS--FAGSFFSGTTVDGNFSNFSSHTDARETSTTT 227

Query: 210 EVEEEES-----------KDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEV 258
            V   +            + + AQ++KE Y LQ+TL +RL+ QA        L   ++ +
Sbjct: 228 RVSVTKDEEEVEVREEGKEQSLAQKSKEGYYLQVTLVKRLSSQAN-------LACESVHI 280

Query: 259 SDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDS 318
             TETVSYR WVSGCLSYNDKISDGFY+ILGM+PYLW+MCN+ EEGKR+PSL+ LK+ + 
Sbjct: 281 QSTETVSYRFWVSGCLSYNDKISDGFYSILGMDPYLWLMCNNSEEGKRIPSLLLLKETEP 340

Query: 319 TETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGD 378
            +TS+EVVLIDR  DSRLKELEDKA ELYC+S+N LVLVE+LG+LVA+ MGG F +EQGD
Sbjct: 341 NDTSLEVVLIDRREDSRLKELEDKAHELYCSSDNMLVLVEKLGRLVAVYMGGNFQVEQGD 400

Query: 379 LHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEA 438
           L KRWK+ S RL++FRKCI+LPIGSL+MGLCRHRAILFKKLADYIGLPCRIARGCRYC  
Sbjct: 401 LQKRWKLVSNRLKEFRKCIILPIGSLTMGLCRHRAILFKKLADYIGLPCRIARGCRYCRE 460

Query: 439 DHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQK 498
            H+SSCLVKI+DDR+ SREYVVDL+GEPGN+H P+ SING     +PSP Q+S L +F +
Sbjct: 461 SHQSSCLVKIDDDRKLSREYVVDLIGEPGNVHDPDSSINGETQCQIPSPLQMSHLTDFSR 520

Query: 499 PYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKD---ALVNQPRAEK 555
           P + +TS C   +S+++ A  E+   SG   +G   K+  LP ++     A V+Q    K
Sbjct: 521 PCVHSTSPCHTVESKASRALSENIQRSG--SQGHVHKEFELPDNAATICCAHVDQTCCAK 578

Query: 556 ESSLVPLK--LQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSE---SSVIIK 610
            SS+V  +  L+  P N              L E+ +  +   KEE V+ E     + IK
Sbjct: 579 ASSMVLPESVLRALPLN-----------IPNLSEDKIQPQETSKEETVLLEDPIEKIAIK 627

Query: 611 QPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAG 670
           QPN ++  ++ + D  K +K+G+ PV     YL IEPSLA DWLE+SW+ELH+KERVGAG
Sbjct: 628 QPNLSVEPEIVEADTRK-DKKGRLPVDAVSPYLTIEPSLASDWLEVSWNELHIKERVGAG 686

Query: 671 SFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730
           SFGTVHRAEWHGSDVAVK+L++QDF DDQ +EFLREVAIMKRVRHPNVVLFMGAVT+RP 
Sbjct: 687 SFGTVHRAEWHGSDVAVKILSIQDFHDDQFREFLREVAIMKRVRHPNVVLFMGAVTERPR 746

Query: 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV-------AKGINYLHNLNPPIL 783
           LSI+TEYLPRGSL+RLIHRPA+GE++DQRRRLRMALDV       AKG+NYLH LNPP++
Sbjct: 747 LSIITEYLPRGSLFRLIHRPASGELLDQRRRLRMALDVVCGLSHYAKGLNYLHCLNPPVV 806

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI SKSVAGT  + A
Sbjct: 807 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIPSKSVAGTPEWMA 852

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|5051790|emb|CAB45083.1| putative protein kinase [Arabidopsis thaliana] gi|7269298|emb|CAB79358.1| putative protein kinase [Arabidopsis thaliana]

 Score =  892 bits (2305), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 484/885 (54%), Positives = 611/885 (69%), Gaps = 92/885 (10%)

Query: 1   MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKG----TFGINENDRKS 56
           MPHRTTYFFPRQFPD RGFD+ +          L  +H+K         +FG   +++ +
Sbjct: 1   MPHRTTYFFPRQFPD-RGFDSFS----------LKNDHDKKKSSSNVGESFGFQRDNKSN 49

Query: 57  AAA------TTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKE 110
                      ST  ++   L  S+A   VSDLF+   +  K  +QQ AAF +WL EKK 
Sbjct: 50  GVGEDSNKEKESTVFSSNPLLSKSSA---VSDLFSDDRKSEKKHQQQLAAFYEWLAEKKA 106

Query: 111 D--------RSASRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPV---PDTV------ 153
           +         +  R VK  +  +SS ADE+RE LL  P  +P P+P    PD++      
Sbjct: 107 NLSRSSSTTTTHGRGVKPTRFSMSSDADEERELLLSSPA-DPAPLPATSSPDSIIDSART 165

Query: 154 TNIDN---DRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFS-----SDVKDTSTRVS 205
            NI     DR+FDR+VSLPR+SS  S   A S FSGTT+DGNFS     +D ++TST   
Sbjct: 166 VNIHERNIDRSFDREVSLPRMSSESS--FAGSFFSGTTVDGNFSNFSSHTDARETSTTTL 223

Query: 206 TSRQEVEE------EESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVS 259
            S  + EE      +  + + AQ+++E Y LQ+TLA+ L+ QA        L   ++ + 
Sbjct: 224 VSVNKEEEEVEVREQGKEQSLAQKSREGYYLQVTLAKWLSSQAN-------LACESVHIQ 276

Query: 260 DTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDST 319
            TE++SYR WVSGCLSY+DKISDGFY+ILGM+PYLW+MCN+ E+GKR+PSL+ LK+ +  
Sbjct: 277 STESISYRFWVSGCLSYSDKISDGFYSILGMDPYLWLMCNNSEDGKRIPSLLLLKETEPN 336

Query: 320 ETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDL 379
           +TSMEVVLIDR  DSRLKELEDKA ELYC+S+N LVLVE+LG+LVA+ MGG F +EQGDL
Sbjct: 337 DTSMEVVLIDRREDSRLKELEDKAHELYCSSDNMLVLVEKLGRLVAVYMGGNFQVEQGDL 396

Query: 380 HKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEAD 439
            KRWK+ S RL++FRKCI+LPIGSL+MGLCRHRAILFKKLADYIGLPCRIARGCRYC+  
Sbjct: 397 QKRWKLVSNRLKEFRKCIILPIGSLTMGLCRHRAILFKKLADYIGLPCRIARGCRYCKES 456

Query: 440 HRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKP 499
           H+SSCLVKI+DDR+ SREYVVDL+GEPGN+H P+ SING     +PSP Q+S L +F +P
Sbjct: 457 HQSSCLVKIDDDRKLSREYVVDLIGEPGNVHDPDSSINGETQCQIPSPLQMSHLTDFSRP 516

Query: 500 YMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKD---ALVNQPRAEKE 556
            + +TS CQ  +S+++    E+   SG   +GQ  K+  LP ++     A ++Q    K 
Sbjct: 517 CVHSTSPCQTVESKTSRTLSENIQRSG--SQGQVHKEFELPDNAGTVCCAHIDQTCCAKV 574

Query: 557 SSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATL 616
           SS+V          +++   A   +   L EE +A +   KEE V+ E    +KQPN ++
Sbjct: 575 SSMVL---------TESVLRALPLDIPNLSEEKIAPQETCKEETVLLEDPTAMKQPNLSV 625

Query: 617 PSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVH 676
             ++ + D  K +K+G+ PV     YL IEPSLA DWLE+SW+ELH+KERVGAGSFGTVH
Sbjct: 626 EPEIVEADTRK-DKKGRLPVDAISPYLTIEPSLASDWLEVSWNELHIKERVGAGSFGTVH 684

Query: 677 RAEWHGSDVAVKVLTVQDFLDDQLKEFLRE-----VAIMKRVRHPNVVLFMGAVTKRPHL 731
           RAEWHGSDVAVK+L++QDF DDQ +EFLRE     VAIMKRVRHPNVVLFMGAVT+RP L
Sbjct: 685 RAEWHGSDVAVKILSIQDFHDDQFREFLREVCKQAVAIMKRVRHPNVVLFMGAVTERPRL 744

Query: 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV-------AKGINYLHNLNPPILH 784
           SI+TEYLPRGSL+RLIHRPA+GE++DQRRRLRMALDV       AKG+NYLH LNPP++H
Sbjct: 745 SIITEYLPRGSLFRLIHRPASGELLDQRRRLRMALDVVCAIPHYAKGLNYLHCLNPPVVH 804

Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI SKSVAGT  + A
Sbjct: 805 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIPSKSVAGTPEWMA 849

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	867
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.251	0.265	0.633	8.8e-130
TAIR|locus:2027794	1030	AT1G73660 [Arabidopsis thalian	0.199	0.167	0.657	4e-92
TAIR|locus:2143009	880	AT5G11850 [Arabidopsis thalian	0.209	0.206	0.620	1.9e-91
TAIR|locus:2194055	992	AT1G18160 [Arabidopsis thalian	0.199	0.174	0.645	1.4e-90
TAIR|locus:2025515	933	EDR1 "ENHANCED DISEASE RESISTA	0.199	0.185	0.617	6.5e-80
TAIR|locus:2084304	671	AT3G06630 [Arabidopsis thalian	0.199	0.257	0.571	6.5e-53
TAIR|locus:2084314	773	AT3G06620 [Arabidopsis thalian	0.199	0.223	0.577	5.8e-49
TAIR|locus:2052786	775	AT2G31010 [Arabidopsis thalian	0.212	0.237	0.473	7.3e-48
TAIR|locus:2127228	736	AT4G23050 [Arabidopsis thalian	0.199	0.235	0.56	2.4e-46
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.201	0.228	0.536	3.9e-45

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 706 (253.6 bits), Expect = 8.8e-130, Sum P(2) = 8.8e-130
 Identities = 140/221 (63%), Positives = 171/221 (77%)

Query:   612 PNATLPSQLDKEDESKLEK--QGKFPVG-PGPRYLNIEPSLAMDWLEISWDELHVKERVG 668
             P+A +P Q      +++E       P+  P P   N E  L  D ++I W +L++KE++G
Sbjct:   499 PSANMPPQNMMRASNQIEAAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIG 558

Query:   669 AGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728
             AGSFGTVHRAEWHGSDVAVK+L  QDF  +++ EFLREVAIMKR+RHPN+VLFMGAVT+ 
Sbjct:   559 AGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 618

Query:   729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK 788
             P+LSIVTEYL RGSLYRL+H+  A E +D+RRRL MA DVAKG+NYLHN NPPI+H DLK
Sbjct:   619 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLK 678

Query:   789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             SPNLLVDK +TVKVCDFGLSR KA+TF+SSKS AGT  + A
Sbjct:   679 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 719

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)]

 Score = 612 (220.5 bits), Expect = 4.0e-92, Sum P(2) = 4.0e-92
 Identities = 115/175 (65%), Positives = 141/175 (80%)

Query:   655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
             EI W+E+ V ER+G GS+G V+R +WHG++VAVK    QD   + L+EF  EV IMK++R
Sbjct:   742 EILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLR 801

Query:   715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
             HPN+VLFMGAVT+ P+LSIVTE+LPRGSLYRLIHRP     +D+RRRLRMALD A+G+NY
Sbjct:   802 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRP--NNQLDERRRLRMALDAARGMNY 859

Query:   775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             LH+ NP I+H DLKSPNLLVDKNW VKVCDFGLSR K +T++SSKS AGT  + A
Sbjct:   860 LHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMA 914

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

GO:0009651 "response to salt stress" evidence=IMP

GO:0048573 "photoperiodism, flowering" evidence=RCA

TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 1.9e-91, Sum P(3) = 1.9e-91
 Identities = 116/187 (62%), Positives = 145/187 (77%)

Query:   645 IEPSL--AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKE 702
             I P L  A  W EI W++L + ER+G GS+G V+RAEW+G++VAVK    QDF  D L +
Sbjct:   592 INPLLGEAAKW-EIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQ 650

Query:   703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
             F  E+ IM R+RHPNVVLFMGAVT+ P+ SI+TE+LPRGSLYRL+HRP     +D++RR+
Sbjct:   651 FKSEIEIMLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRP--NHQLDEKRRM 708

Query:   763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
             RMALDVAKG+NYLH  +P ++H DLKSPNLLVDKNW VKVCDFGLSR K +T++SSKS A
Sbjct:   709 RMALDVAKGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTA 768

Query:   823 GTVVFFA 829
             GT  + A
Sbjct:   769 GTPEWMA 775

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)]

 Score = 605 (218.0 bits), Expect = 1.4e-90, Sum P(2) = 1.4e-90
 Identities = 113/175 (64%), Positives = 140/175 (80%)

Query:   655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
             EI W+E+ V ER+G GS+G V+R +WHG+ VAVK    QD   + L+EF  EV +M+R+R
Sbjct:   709 EILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRRLR 768

Query:   715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
             HPN+VLFMGAVT+ P+LSIVTE+LPRGSLYRLIHRP     +D+R+RLRMALD A+G+NY
Sbjct:   769 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRP--NNQLDERKRLRMALDAARGMNY 826

Query:   775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             LH+ NP I+H DLKSPNLLVDKNW VKVCDFGLSR K +T++SSKS AGT  + A
Sbjct:   827 LHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMA 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 6.5e-80, Sum P(2) = 6.5e-80
 Identities = 108/175 (61%), Positives = 135/175 (77%)

Query:   655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
             EI W++L + ER+G GS+G V+ A+WHG++VAVK    QDF    L EF  EV IM+R+R
Sbjct:   663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722

Query:   715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
             HPNVV F+GAVT+ P+LSIVTE+LPRGSLYR++HRP +   +D+RRR++MALDVA G+N 
Sbjct:   723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSH--IDERRRIKMALDVAMGMNC 780

Query:   775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             LH   P I+H DLK+PNLLVD NW VKV DFGLSR K NTF+SSKS AGT  + A
Sbjct:   781 LHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP;NAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IMP

GO:0009620 "response to fungus" evidence=IMP

GO:1900150 "regulation of defense response to fungus" evidence=IMP

GO:2000031 "regulation of salicylic acid mediated signaling pathway" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0008219 "cell death" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009617 "response to bacterium" evidence=IMP

GO:1900424 "regulation of defense response to bacterium" evidence=IMP

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005769 "early endosome" evidence=IDA

GO:0005783 "endoplasmic reticulum" evidence=IDA

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)]

 Score = 524 (189.5 bits), Expect = 6.5e-53, Sum P(2) = 6.5e-53
 Identities = 100/175 (57%), Positives = 133/175 (76%)

Query:   655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
             EI WD+L + E++G GS GTV+   W GSDVAVKV + Q++ +  +K F +EV++MKR+R
Sbjct:   428 EILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIKSFEKEVSLMKRLR 487

Query:   715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
             HPNV+LFMGAVT    L IV+E++PRGSL+RL+ R  +   +D RRR+ MALD+A+G+NY
Sbjct:   488 HPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMS--KLDWRRRINMALDIARGMNY 545

Query:   775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             LH  +PPI+H DLKS NLLVD+NWTVKV DFGLSR K  T+++SKS  GT  + A
Sbjct:   546 LHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMA 600

GO:0000155 "phosphorelay sensor kinase activity" evidence=IEA

GO:0000160 "phosphorelay signal transduction system" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)]

 Score = 525 (189.9 bits), Expect = 5.8e-49, Sum P(2) = 5.8e-49
 Identities = 101/175 (57%), Positives = 133/175 (76%)

Query:   655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
             EI WD+L + E+VG GS GTV+   W GSDVAVKV + Q++  + ++ F +EV +MKR+R
Sbjct:   488 EILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKRLR 547

Query:   715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
             HPNV+LFMGAVT    L IV+E+LPRGSL+RL+ +  +   +D RRR+ MALD+A+G+NY
Sbjct:   548 HPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTS--KLDWRRRIHMALDIARGMNY 605

Query:   775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             LH+ +PPI+H DLKS NLLVDKNWTVKV DFGLSR K  T+++SKS  GT  + A
Sbjct:   606 LHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMA 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0000956 "nuclear-transcribed mRNA catabolic process" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)]

 Score = 439 (159.6 bits), Expect = 7.3e-48, Sum P(2) = 7.3e-48
 Identities = 89/188 (47%), Positives = 121/188 (64%)

Query:   643 LNIEPSLA-MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK 701
             L  +P L   +W +I + EL V  RVG G FG V R  W+G+DVA+K+   QD   + ++
Sbjct:   501 LQNQPLLPYQEW-DIDFSELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENME 559

Query:   702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
             +F  E++I+ RVRHPNVVLF+GA TK P LS++TEY+  GSLY LIH     + +   RR
Sbjct:   560 DFCNEISILSRVRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRR 619

Query:   762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
             LRM  D+ +G+  +H +   I+H DLKS N LVDK+WTVK+CDFGLSR   +  +   S 
Sbjct:   620 LRMLRDICRGLMCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSS 677

Query:   822 AGTVVFFA 829
             AGT  + A
Sbjct:   678 AGTPEWMA 685

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)]

 Score = 505 (182.8 bits), Expect = 2.4e-46, Sum P(2) = 2.4e-46
 Identities = 98/175 (56%), Positives = 128/175 (73%)

Query:   655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
             EI W++L + E VG GSF  VHR  W+GSDVA+KV    D+    L E  +E+ IMK++R
Sbjct:   462 EIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKLR 521

Query:   715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
             HPNV+LFMGAV      +I+ EY+PRGSL++++H     + +D++RRLRMALDVA+G+NY
Sbjct:   522 HPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHN--TNQPLDKKRRLRMALDVARGMNY 579

Query:   775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             LH  NPPI+H DLKS NLLVDKNW VKV DFGLS++K  TF+S+KS  GT  + A
Sbjct:   580 LHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMA 634

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 497 (180.0 bits), Expect = 3.9e-45, P = 3.9e-45
 Identities = 96/179 (53%), Positives = 133/179 (74%)

Query:   651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIM 710
             +D+ EI W++L + E++G GS GTV+   W GSDVAVKV + Q++ ++ +  F +EV++M
Sbjct:   478 LDY-EILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLM 536

Query:   711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
             KR+RHPNV+LFMGAV     L IVTE+LPRGSL+RL+ R  +   +D RRR+ MA D+A+
Sbjct:   537 KRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKS--KLDLRRRIHMASDIAR 594

Query:   771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             G+NYLH+ +PPI+H DLKS NLLVD+NWTVKV DFGLSR K  T++++    GT  + A
Sbjct:   595 GMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNG-RGTPQWMA 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	867
pfam14381	203	pfam14381, EDR1, Ethylene-responsive protein kinas	2e-92
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-31
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-04
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-04
pfam03109	117	pfam03109, ABC1, ABC1 family	7e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.004

>gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1

 Score =  289 bits (742), Expect = 2e-92
 Identities = 104/213 (48%), Positives = 137/213 (64%), Gaps = 13/213 (6%)

Query: 259 SDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDS 318
           S  E +S+R WV GCLSY+DKI DGFY+I GM+      C+DL+E  R+PSL  L+ +  
Sbjct: 2   SSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMD-----PCSDLKEFGRIPSLEDLQAVPP 56

Query: 319 TETSMEVVLIDRHGDSRLKELEDKAQELYCASE-NTLVLVEELGKLVAICMGGTFPIEQG 377
            ++S EVVL+DR  D +LKELE  A+ L      NT  LV++L  LV+  MGG     + 
Sbjct: 57  GDSSFEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAES 116

Query: 378 DLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCE 437
            L  RWK  S  L+      V+P+GSL +GLCRHRA+LFK LAD IGLPCR+ +GC+YC 
Sbjct: 117 MLA-RWKECSNELK--ENSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCG 173

Query: 438 ADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIH 470
           +D  +S LVK +D     REY+VDL+G PG + 
Sbjct: 174 SDDDASNLVKFDDG----REYLVDLMGAPGTLI 202

EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  156 bits (396), Expect = 8e-43
 Identities = 61/160 (38%), Positives = 92/160 (57%), Gaps = 11/160 (6%)

Query: 661 LHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           L + +++G G+FG V++    G        VAVK L  +   +++ +EFL E +IMK++ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLS 59

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HPN+V  +G  T+   L IVTEY+P G L   + +   GE +  +  L+MAL +AKG+ Y
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEY 117

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
           L + N   +H DL + N LV +N  VK+ DFGLSR     
Sbjct: 118 LESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  146 bits (372), Expect = 4e-40
 Identities = 59/166 (35%), Positives = 90/166 (54%), Gaps = 8/166 (4%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G FGTV+ A    +   VA+K++  +D     L+E LRE+ I+K++ HPN+V   G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
                HL +V EY   GSL  L+        + +   LR+ L + +G+ YLH+    I+H
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNG--IIH 115

Query: 785 WDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            DLK  N+L+D  N  VK+ DFGLS+   +     K++ GT  + A
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMA 161

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  146 bits (371), Expect = 2e-39
 Identities = 57/167 (34%), Positives = 97/167 (58%), Gaps = 9/167 (5%)

Query: 661 LHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
             +  ++G+GSFGTV++A+  G+   VAVK+L  +     + +   RE+ I++R+ HPN+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHN 777
           V  + A   + HL +V EY   G L+  + R   G +  D+ +  ++AL + +G+ YLH+
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAK--KIALQILRGLEYLHS 116

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
               I+H DLK  N+L+D+N  VK+ DFGL++    +  S  +  GT
Sbjct: 117 NG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGT 161

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  146 bits (370), Expect = 3e-39
 Identities = 55/156 (35%), Positives = 85/156 (54%), Gaps = 14/156 (8%)

Query: 665 ERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           +++G G+FG V++ +  G      +VAVK L  +D  +++ K+FL+E  +MK++ HPNVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQR----RRLRMALDVAKGIN 773
             +G  T+   L +V EY+  G L  Y    RP               L  A+ +AKG+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + N LV ++  VK+ DFGLSR
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  144 bits (366), Expect = 9e-39
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 9/165 (5%)

Query: 662 HVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
            + E++G GSFG V+ A    +   VA+KV+  +  +    +  LRE+ I+K+++HPN+V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
                      L +V EY   G L+ L+ +   G + +   R      +   + YLH+  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEAR-FYLRQILSALEYLHSKG 117

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
             I+H DLK  N+L+D++  VK+ DFGL+R          +  GT
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (358), Expect = 1e-37
 Identities = 61/158 (38%), Positives = 90/158 (56%), Gaps = 14/158 (8%)

Query: 661 LHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           L + +++G G+FG V++    G       +VAVK L  +D  + Q++EFLRE  IM+++ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           HPN+V  +G  T+   L IV EY+P G L  Y   +RP     +     L  AL +A+G+
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGM 116

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            YL + N   +H DL + N LV +N  VK+ DFGLSR 
Sbjct: 117 EYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRD 152

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  140 bits (356), Expect = 2e-37
 Identities = 60/158 (37%), Positives = 88/158 (55%), Gaps = 15/158 (9%)

Query: 661 LHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           L + +++G G+FG V++ +  G       +VAVK L      + Q++EFLRE  IM+++ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLREARIMRKLD 59

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           HPNVV  +G  T+   L IV EY+  G L  Y   +RP     +     L  AL +A+G+
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGM 115

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            YL + N   +H DL + N LV +N  VK+ DFGLSR 
Sbjct: 116 EYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRD 151

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  122 bits (309), Expect = 4e-31
 Identities = 55/171 (32%), Positives = 90/171 (52%), Gaps = 11/171 (6%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E +G GSFG+V+ A     G  +AVK + +    +++L+   RE+ I+  ++HPN+V + 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 723 GAVTKRP--HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
           G+        L+I  EY+  GSL  L+ +         R+  R  L   +G+ YLH+   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL---EGLAYLHSNG- 121

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGTVVFFA 829
            I+H D+K  N+LVD +  VK+ DFG ++   +  T   + SV GT  + A
Sbjct: 122 -IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  112 bits (281), Expect = 2e-27
 Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 8/158 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+   ++ +K ++G G +G V+   W  +   VAVK L  +D +  +++EFL+E A+MK 
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTM--EVEEFLKEAAVMKE 58

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++  +
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAM 117

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            YL   N   +H DL + N LV +N  VKV DFGLSR 
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 153

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (276), Expect = 8e-27
 Identities = 56/150 (37%), Positives = 79/150 (52%), Gaps = 10/150 (6%)

Query: 665 ERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           +++G GSFG V R EW  S      VAVK L   D L D + +FL+E AIM  + H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
              G V   P L +VTE  P GSL   + + A G  +        A+ +A G+ YL +  
Sbjct: 60  RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESKR 117

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              +H DL + N+L+  +  VK+ DFGL R
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  109 bits (275), Expect = 1e-26
 Identities = 51/165 (30%), Positives = 98/165 (59%), Gaps = 11/165 (6%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           + E++G G FG V++A  H   G +VA+KV+ ++    ++ ++ + E+ I+K+ +HPN+V
Sbjct: 4   ILEKIGKGGFGEVYKA-RHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIV 60

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            + G+  K+  L IV E+   GSL  L+   +  + + + +   +  ++ KG+ YLH+  
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
             I+H D+K+ N+L+  +  VK+ DFGLS   ++T  +  ++ GT
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 9e-26
 Identities = 55/163 (33%), Positives = 88/163 (53%), Gaps = 18/163 (11%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVL-----TVQDFLDDQLKEFLRE 706
           W EI  + L ++ ++GAG FG V    W+G+  VAVK L     + + FL        +E
Sbjct: 1   W-EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFL--------QE 51

Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             IMK++RH  +V      ++   + IVTEY+ +GSL   +     G+ +   + + MA 
Sbjct: 52  AQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAA 110

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +A+G+ YL + N   +H DL + N+LV +N   K+ DFGL+R
Sbjct: 111 QIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (268), Expect = 1e-25
 Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 7/166 (4%)

Query: 663 VKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           + +++G GSFG V+      SD     +K + + +  + + ++ L EV I+K++ HPN++
Sbjct: 4   IIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            +  +  ++  L IV EY   G L + I  +   G+   + + L   + +   + YLH+ 
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
              ILH D+K  N+ +  N  VK+ DFG+S+  ++T   +K+V GT
Sbjct: 123 K--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-25
 Identities = 58/158 (36%), Positives = 86/158 (54%), Gaps = 10/158 (6%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMK 711
             I+  EL +   +G G FG V   ++ G  VAVK L      DD    + FL E ++M 
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-----DDSTAAQAFLAEASVMT 55

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            +RHPN+V  +G V +   L IVTEY+ +GSL   + R     ++   ++L  ALDV +G
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEG 114

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + YL   N   +H DL + N+LV ++   KV DFGL++
Sbjct: 115 MEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (257), Expect = 4e-24
 Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 17/154 (11%)

Query: 667 VGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V    +       G  VAVK L      +    +F RE+ I++ + H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 721 FMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           + G   K     L ++ EYLP GSL  Y   HR      ++ +R L  +  + KG++YL 
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDYLG 126

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +     +H DL + N+LV+    VK+ DFGL++ 
Sbjct: 127 SQR--YIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 5e-24
 Identities = 52/146 (35%), Positives = 84/146 (57%), Gaps = 6/146 (4%)

Query: 665 ERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           E++G G+FG V++    G+ +VAVK        D + K FL+E  I+K+  HPN+V  +G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
              ++  + IV E +P GSL   + +      +  ++ L+M+LD A G+ YL + N   +
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN--CI 115

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H DL + N LV +N  +K+ DFG+SR
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 8e-24
 Identities = 58/165 (35%), Positives = 83/165 (50%), Gaps = 9/165 (5%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           W EI    + +  ++GAG FG V    W+ +  VAVK L          K+FL E  IMK
Sbjct: 1   W-EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMK 56

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           ++RHP ++      T    + IVTE +  GSL   +    AG  +   + + MA  VA G
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASG 115

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTF 815
           + YL   N   +H DL + N+LV +N   KV DFGL+R  K + +
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (255), Expect = 1e-23
 Identities = 58/175 (33%), Positives = 86/175 (49%), Gaps = 29/175 (16%)

Query: 661 LHVKERVGAGSFGTVHRAEWHGSD------------------VAVKVLTVQDFLDDQLKE 702
           L+  E++G G FG VH  E  G                    VAVKVL   D  D+  ++
Sbjct: 7   LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRP-DASDNARED 65

Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR--------PAAGE 754
           FL+EV I+ R+  PN+   +G  T  P L ++ EY+  G L + + +            +
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +     L MA  +A G+ YL +LN   +H DL + N LV KN+T+K+ DFG+SR
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 8/152 (5%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH  +W G  DVA+K++      +D   +F+ E  +M ++ HPN+
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G  TK+  + IVTEY+  G L   +         +    L M  DV + + YL + 
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESN 119

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
               +H DL + N LV ++  VKV DFGL+R+
Sbjct: 120 G--FIHRDLAARNCLVGEDNVVKVSDFGLARY 149

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 19/173 (10%)

Query: 660 ELHVKERVGAGSFGTVHRAE-WHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
              + + +G G+FG V++       D VA+K ++++   ++ LK  ++E+ ++K ++HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-GEM-----MDQRRRLRMALDVAKG 771
           +V ++G++     L I+ EY   GSL ++I +     E      + Q         V +G
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ---------VLQG 111

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           + YLH     ++H D+K+ N+L  K+  VK+ DFG++    +      SV GT
Sbjct: 112 LAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 55/157 (35%), Positives = 82/157 (52%), Gaps = 10/157 (6%)

Query: 663 VKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +++ +G G FG V R           DVA+K L      D Q  +FL E +IM +  HPN
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPN 66

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++   G VTK   + I+TEY+  GSL + + R   G+     + + M   +A G+ YL  
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVG-QLVGMLRGIASGMKYLSE 124

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
           +N   +H DL + N+LV+ N   KV DFGLSR   ++
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 54/187 (28%), Positives = 99/187 (52%), Gaps = 13/187 (6%)

Query: 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           + E++G GS+G+V++A     G  VA+KV+ V    ++ L+E ++E++I+K+   P +V 
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIVK 62

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
           + G+  K   L IV EY   GS+  ++      + + +     +     KG+ YLH+   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNK- 119

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---QTACNS 837
             +H D+K+ N+L+++    K+ DFG+S    +T     +V GT  + A     +   N+
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 838 LALIFSL 844
            A I+SL
Sbjct: 179 KADIWSL 185

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 14/171 (8%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           ++  + +R+G+G++G V++A    +   VA+KV+ ++    D  +   +E++++K  RHP
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHP 60

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSL---YRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           N+V + G+  +R  L IV EY   GSL   Y++   P +   +    R     +  KG+ 
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLA 115

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           YLH      +H D+K  N+L+ ++  VK+ DFG+S     T    KS  GT
Sbjct: 116 YLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGT 164

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 52/163 (31%), Positives = 89/163 (54%), Gaps = 7/163 (4%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E  ++ ++G+G FG V    W     VA+K+L   D L  + ++F +EV  +KR+RH ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +      +    + I+TE + +GSL   + R   G+++     + MA  VA+G+ YL   
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKS 820
           N   +H DL + N+LV ++   KV DFGL+R  K + ++SS  
Sbjct: 124 N--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLR 705
           W E+  +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL 
Sbjct: 1   W-ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLN 58

Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA-----GEMMDQ 758
           E ++MK     +VV  +G V+      +V E + +G L  Y    RP A           
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++ ++MA ++A G+ YL       +H DL + N +V ++ TVK+ DFG++R
Sbjct: 119 QKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 53/152 (34%), Positives = 76/152 (50%), Gaps = 8/152 (5%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M ++ H  +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKL 61

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G  TK+  + IVTEY+  G L   +          Q   L M  DV +G+ YL + 
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ--LLEMCKDVCEGMAYLESK 119

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
               +H DL + N LVD    VKV DFGLSR+
Sbjct: 120 Q--FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 57/168 (33%), Positives = 93/168 (55%), Gaps = 17/168 (10%)

Query: 665 ERVGAGSFGTVHRAEWHGSD---VAVK-VLTVQDFLDDQ--LKEFLREVAIMKRVRHPNV 718
           E +G+GSFG+V+    +  D    AVK V    D    Q  +K+  +E+A++ +++HPN+
Sbjct: 6   ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL--RMALDVAKGINYLH 776
           V ++G   +  +L I  E +P GSL +L+ +   G   +   RL  R  L    G+ YLH
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILL---GLEYLH 119

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           + N   +H D+K  N+LVD N  VK+ DFG+++ +   F  +KS  G+
Sbjct: 120 DRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGS 164

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.4 bits (233), Expect = 6e-21
 Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 23/169 (13%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ G V++A     G +VA+K + ++       +  + E+ IMK  +HPN+V + 
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRK---QNKELIINEILIMKDCKHPNIVDYY 81

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA---LDVAKGINYLHNLN 779
            +      L +V EY+  GSL  +I       M +     ++A    +V +G+ YLH+ N
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEP----QIAYVCREVLQGLEYLHSQN 136

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFG----LSRFKANTFISSKSVAGT 824
             ++H D+KS N+L+ K+ +VK+ DFG    L++ K+       SV GT
Sbjct: 137 --VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 93.3 bits (233), Expect = 8e-21
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 17/154 (11%)

Query: 664 KERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHP 716
            E++G G++G V++A  +  G  VA+K + +     D  +E      LRE++++K ++HP
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRL-----DNEEEGIPSTALREISLLKELKHP 58

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V  +  +     L +V EY     L + + +      +       +   + +G+ Y H
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAYCH 115

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +    ILH DLK  N+L++++  +K+ DFGL+R 
Sbjct: 116 SHR--ILHRDLKPQNILINRDGVLKLADFGLARA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 8/157 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI  + L + +++G G FG V    W+G + VAVK L          + FL E  IMK++
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKL 58

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           RH  +V     V++ P + IVTEY+ +GSL   + +   G  +     + MA  VA G+ 
Sbjct: 59  RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           Y+  +N   +H DL+S N+LV      K+ DFGL+R 
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 90.3 bits (225), Expect = 2e-19
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 29/158 (18%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVV--- 719
           +G+G++G V  A  +  G  VA+K   + +  DD +  K  LRE+ +++ +RH N++   
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 720 -LFMGAVTKRP-------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            +       RP        + IVTE +    L+++I  P    + D   +  +   + +G
Sbjct: 66  DIL------RPPSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFL-YQILRG 115

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + YLH+ N  ++H DLK  N+LV+ N  +K+CDFGL+R
Sbjct: 116 LKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 25/178 (14%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLR 705
           W E+  D L + + +G G+FG V +AE  G D       VAVK+L   D  +  L + + 
Sbjct: 7   W-ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVS 64

Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP-----------A 751
           E+ +MK + +H N++  +G  T+   L +V EY   G+L  +    RP            
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             E + Q+  +  A  VA+G+ +L +     +H DL + N+LV ++  +K+ DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 26/159 (16%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDF--LDDQLKEFLREV-AIMKRVRHPN 717
           V +++G G+FG+V+ A     G  VA+K +  + F   ++ +   LREV ++ K   HPN
Sbjct: 3   VIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMN--LREVKSLRKLNEHPN 59

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL-------RMALDVAK 770
           +V       +   L  V EY+  G+LY+L        M D++ +         +   + +
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQL--------MKDRKGKPFSESVIRSIIYQILQ 110

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ ++H       H DLK  NLLV     VK+ DFGL+R
Sbjct: 111 GLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 59/181 (32%), Positives = 88/181 (48%), Gaps = 29/181 (16%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------------------VAVKVLTVQDFL 696
           E     L  KE++G G FG VH  E  G +                  VAVK+L  +D  
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59

Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR---PAAG 753
            +   +FL+E+ IM R++ PN++  +        L ++TEY+  G L + + R     A 
Sbjct: 60  KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119

Query: 754 EMMDQR-----RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           E  D         + MA  +A G+ YL +LN   +H DL + N LV KN+T+K+ DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 809 R 809
           R
Sbjct: 178 R 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 90.6 bits (223), Expect = 3e-19
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 6/163 (3%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHP-N 717
              +  ++G GSFG V+ A      VA+KVL  +     +  E FLRE+ I+  + HP N
Sbjct: 1   SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V           L +V EY+  GSL  L+ +      + +   L +   +   + YLH+
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 778 LNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSK 819
               I+H D+K  N+L+D++   VK+ DFGL++   +   +S 
Sbjct: 120 KG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160

Length = 384

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 55/167 (32%), Positives = 91/167 (54%), Gaps = 9/167 (5%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           WL ++  +L + E +G G FG V + E+ G  VAVK +      D   + FL E A+M +
Sbjct: 1   WL-LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC----DVTAQAFLEETAVMTK 55

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           + H N+V  +G +     L IV E + +G+L   + R     ++   + L+ +LDVA+G+
Sbjct: 56  LHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGM 113

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
            YL +    ++H DL + N+LV ++   KV DFGL+R  +    +SK
Sbjct: 114 EYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 28/180 (15%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD----------------VAVKVLTVQDFLDD 698
           E    +L +KE++G G FG VH  E  G                  VAVK+L   D    
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKT 59

Query: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM-- 755
              +FL+E+ IM R+++PN++  +G       L ++TEY+  G L + L  R        
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 756 ------MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                 +     L MA+ +A G+ YL +LN   +H DL + N LV  ++T+K+ DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 9/148 (6%)

Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
            R+G G+ G V +A+   +   VA+K + ++        + LRE+  ++  +HP VV  +
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                     +V EY+P   L  ++            +  +RM L   KG+ Y+H     
Sbjct: 66  DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHANG-- 119

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NLL+  +  +K+ DFGL+R
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLAR 147

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 11/169 (6%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+FG V+ A     G  +AVK + +QD     +KE   E+ +++ ++HPN+V + G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
              R  + I  EY   G+L  L+     G ++D+       L + +G+ YLH+    I+H
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG--IVH 122

Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS-RFKANT---FISSKSVAGTVVFFA 829
            D+K  N+ +D N  +K+ DFG + + K NT       +S+AGT  + A
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 53/157 (33%), Positives = 88/157 (56%), Gaps = 8/157 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI  + L ++ ++G G FG V    W+G+  VA+K L          + FL+E  +MK++
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKL 58

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  +A G+ 
Sbjct: 59  RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           Y+  +N   +H DL++ N+LV +N   KV DFGL+R 
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 43/166 (25%), Positives = 91/166 (54%), Gaps = 6/166 (3%)

Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVV 719
           +++++G G F  V++A     G  VA+K + + + +D + ++  L+E+ ++K++ HPNV+
Sbjct: 6   IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            ++ +  +   L+IV E    G L R+I H      ++ +R   +  + +   + ++H+ 
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
              I+H D+K  N+ +     VK+ D GL RF ++   ++ S+ GT
Sbjct: 126 R--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 17/177 (9%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLR--------EVAIMKRVR 714
           E +G G++G V+ A     G  +AVK + +   +  +     +        E+  +K + 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           H N+V ++G  T   +LSI  EY+P GS+   +      E    R      L   +G+ Y
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---EGLAY 123

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           LH+    ILH DLK+ NLLVD +   K+ DFG+S+   + + + +  S+ G+V + A
Sbjct: 124 LHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 67/196 (34%), Positives = 107/196 (54%), Gaps = 23/196 (11%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVL---TVQDFLDDQLKEFL----REVAIMKRVRHPN 717
           +G+GSFG+V+       G  +AVK +   +V     D+ +  L    RE+A++K ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V ++G+     HL+I  EY+P GS+  L++   A E    R  +R  L   KG+NYLHN
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLHN 124

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSK-----SVAGTVVFFA-- 829
               I+H D+K  N+LVD    +K+ DFG+S + +AN+  +       S+ G+V + A  
Sbjct: 125 RG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 830 -AHQTACNSLALIFSL 844
              QT+    A I+SL
Sbjct: 183 VVKQTSYTRKADIWSL 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 54/161 (33%), Positives = 89/161 (55%), Gaps = 8/161 (4%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M ++RH N+V
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 62

Query: 720 LFMGA-VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
             +G  V ++  L IVTEY+ +GSL   + R     ++     L+ +LDV + + YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
           N   +H DL + N+LV ++   KV DFGL++  ++T  + K
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 19/158 (12%)

Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVR 714
               ++G G++G V++A     G  VA+K + +     +  KE      +RE+ +++++R
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKLR 56

Query: 715 HPNVVLFMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           HPN+V     VT +   SI  V EY+    L  L+  P       Q +       + +G+
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQLLEGL 113

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            YLH+    ILH D+K  N+L++ +  +K+ DFGL+R 
Sbjct: 114 QYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARP 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 8/156 (5%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           I   EL + + +G+G FG V    W     VA+K +  +  + ++  +F+ E  +M ++ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEE--DFIEEAQVMMKLS 57

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP +V   G  T+R  + +V E++  G L   + R   G    Q   L M LDV +G+ Y
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRG-KFSQETLLGMCLDVCEGMAY 115

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           L + N  ++H DL + N LV +N  VKV DFG++RF
Sbjct: 116 LESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRF 149

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 52/157 (33%), Positives = 87/157 (55%), Gaps = 8/157 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI  + L +  ++G G FG V    W+G+  VA+K L     + +    FL+E  IMK++
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKL 58

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           RH  +V     V++ P + IVTE++ +GSL   + +   G+ +   + + MA  +A G+ 
Sbjct: 59  RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           Y+  +N   +H DL++ N+LV  N   K+ DFGL+R 
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 54/153 (35%), Positives = 82/153 (53%), Gaps = 10/153 (6%)

Query: 663 VKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           ++E +GAG FG V R            VA+K L    + + Q ++FL E +IM +  HPN
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPN 66

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++   G VTK   + I+TE++  G+L   + R   G+     + + M   +A G+ YL  
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFT-VIQLVGMLRGIAAGMKYLSE 124

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +N   +H DL + N+LV+ N   KV DFGLSRF
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRF 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 50/156 (32%), Positives = 86/156 (55%), Gaps = 8/156 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           E+  + L + +++GAG FG V    ++G + VA+K L          + FL E  +MK++
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQL 58

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           +HP +V     VT+ P + I+TEY+  GSL   +  P  G  +   + + MA  +A+G+ 
Sbjct: 59  QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMA 116

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++   N   +H DL++ N+LV +    K+ DFGL+R
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 16/157 (10%)

Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G G FG+V   +    D     VAVK + +      +++EFL E A MK   HPNV+  
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 722 MG------AVTKRPHLSIVTEYLPRGSL--YRLIHRPAAG-EMMDQRRRLRMALDVAKGI 772
           +G      ++ K P   ++  ++  G L  + L  R     E +  +  L+  +D+A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            YL N N   +H DL + N ++ ++ TV V DFGLS+
Sbjct: 127 EYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 52/185 (28%), Positives = 96/185 (51%), Gaps = 12/185 (6%)

Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E +G GSFG V++A    ++  VA+KV+ +++  +D++++  +E+  + + R P +  + 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G+  K   L I+ EY   GS   L+ +P     +D+     +  +V  G+ YLH      
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLL-KPGK---LDETYIAFILREVLLGLEYLHEEGK-- 119

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---QTACNSLA 839
           +H D+K+ N+L+ +   VK+ DFG+S    +T     +  GT  + A     Q+  +  A
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179

Query: 840 LIFSL 844
            I+SL
Sbjct: 180 DIWSL 184

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 21/173 (12%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAE-WHGSD------VAVKVLTVQDFLDDQLKEFLREV 707
            +  D + +K  +G G+FG V   E +H         VAVK L  +   +D  K+F RE 
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREA 59

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRR---- 761
            ++   +H N+V F G  T+     +V EY+  G L + +  H P A  +          
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 762 -----LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                L++A+ +A G+ YL + +   +H DL + N LV  +  VK+ DFG+SR
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.7 bits (213), Expect = 4e-18
 Identities = 42/155 (27%), Positives = 81/155 (52%), Gaps = 22/155 (14%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDF--LDDQL-KEFLREVAIMKRVRHPNVVLF 721
           +G G++  V++A    +   VA+K + + +     D +    LRE+ +++ ++HPN++  
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHR------PAAGEMMDQRRRLRMALDVAKGINYL 775
           +     + ++++V E++    L ++I        PA     D +  + M L   +G+ YL
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA-----DIKSYMLMTL---RGLEYL 118

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H+    ILH DLK  NLL+  +  +K+ DFGL+R 
Sbjct: 119 HSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 11/163 (6%)

Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           VG G+FG VH  R +     V +K + V+    D+      E  ++K + HPN++ +   
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
             +   L IV EY P G+L   I +     ++D+   L   + +   ++++H     ILH
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKL--ILH 124

Query: 785 WDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKSVAGTVV 826
            DLK+ N+L+DK+  V K+ DFG+S+      +SSKS A TVV
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISK-----ILSSKSKAYTVV 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 52/158 (32%), Positives = 83/158 (52%), Gaps = 28/158 (17%)

Query: 665 ERVGAGSFGTVHRAEW---HGS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           + +G G+FG+V +  +    G   +VAVK L  Q+ +    KEFLRE ++M ++ HP +V
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR-------LRMALDVAKGI 772
             +G V K   L +V E  P G L + +          ++RR         +A  VA G+
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYL----------KKRREIPVSDLKELAHQVAMGM 108

Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNWTVKVCDFGLSR 809
            YL + +   +H DL + N LLV+++   K+ DFG+SR
Sbjct: 109 AYLESKH--FVHRDLAARNVLLVNRHQ-AKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 23/175 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAE-------WHGSDVAVKVLTVQDFLDDQLKEFLREV 707
           EI    +   E +G G+FG V++ E          + VA+K L  ++      +EF +E 
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP-----------AAGE 754
            +M  ++HPN+V  +G  TK     ++ EYL  G L  + + + P               
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +D    L +A+ +A G+ YL + +   +H DL + N LV +  TVK+ DFGLSR
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 11/150 (7%)

Query: 665 ERVGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
             VG G++G V    ++A   G  VA+K     +  +D  K  LREV +++++RH N+V 
Sbjct: 7   GVVGEGAYGVVLKCRNKAT--GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
              A  ++  L +V EY+ R +L  L+     G   D  R     L   + I Y H+ N 
Sbjct: 65  LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSHN- 120

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I+H D+K  N+LV ++  +K+CDFG +R 
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARA 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 55/159 (34%), Positives = 86/159 (54%), Gaps = 8/159 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQ-DFLDDQLKEFLREVAIM 710
           EI    +  ++ +GAG FG V R         +VAV + T++  + + Q ++FL E +IM
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
            +  H N++   G VTK     I+TEY+  G+L + + R   GE     + + M   +A 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGE-FSSYQLVGMLRGIAA 118

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ YL ++N   +H DL + N+LV+ N   KV DFGLSR
Sbjct: 119 GMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 9/148 (6%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLF 721
            ++G G++G V++A     G  VA+K +    F  + + K  LRE+ ++K + HPN++  
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIK-LRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
           +     +  L +V E++    LY+LI     G  + +         + +G+ + H+    
Sbjct: 64  LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHG-- 118

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ILH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 16/157 (10%)

Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G G FG+V  A+    D     VAVK+L    F    ++EFLRE A MK   HPNV+  
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 722 MGAVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGE---MMDQRRRLRMALDVAKGI 772
           +G   +       P   ++  ++  G L+  +     GE    +  +  +R  +D+A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            YL + N   +H DL + N ++++N TV V DFGLS+
Sbjct: 127 EYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 56/151 (37%), Positives = 81/151 (53%), Gaps = 11/151 (7%)

Query: 665 ERV-GAGSFGTV--HRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E+V GAG FG V   R +  G     VA+K L    + + Q ++FL E +IM +  HPN+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +   G VTK   + IVTEY+  GSL   + +      + Q   + M   +A G+ YL ++
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDM 125

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +H DL + N+LV+ N   KV DFGLSR
Sbjct: 126 G--YVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 22/174 (12%)

Query: 665 ERV---GAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           ERV   G GS G V++   +  G   A+K + V    ++  K+ LRE+  ++    P VV
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYVV 62

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
              GA  K   +SIV EY+  GSL  L+        + +     +A  + KG++YLH   
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTVVF 827
             I+H D+K  NLL++    VK+ DFG+S+       + NTF+      GTV +
Sbjct: 120 -HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTY 166

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 8/147 (5%)

Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +  G++G V  A+    G   A+KV+   D    +Q+ + L E  I+ + + P VV    
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   + +L +V EYLP G L  L+     G + +   R+ +A ++   + YLH+    I+
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIA-EIVLALEYLHSNG--II 115

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H DLK  N+L+D N  +K+ DFGLS+ 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKV 142

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 12/156 (7%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EL   + +G+G+FGTV++  W          VA+KVL  ++      KE L E  +M  V
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASV 66

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HP+VV  +G +     + ++T+ +P G L   +        +  +  L   + +AKG++
Sbjct: 67  DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMS 123

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL      ++H DL + N+LV     VK+ DFGL++
Sbjct: 124 YLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 55/171 (32%), Positives = 90/171 (52%), Gaps = 16/171 (9%)

Query: 659 DELHVKERVGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRV 713
           D+L     +GAG+ G V    HR    G  +AVK + ++  +++ + K+ LRE+ I+ + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHR--PTGKIMAVKTIRLE--INEAIQKQILRELDILHKC 56

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             P +V F GA      +SI  EY+  GSL ++         + +R   ++A+ V KG+ 
Sbjct: 57  NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKI--LKEVQGRIPERILGKIAVAVLKGLT 114

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF----KANTFISSKS 820
           YLH     I+H D+K  N+LV+    +K+CDFG+S       A TF+ + S
Sbjct: 115 YLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS 164

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 59/175 (33%), Positives = 95/175 (54%), Gaps = 20/175 (11%)

Query: 660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           ++  +E +G G+ GTV++A +H      +AVKV+ +   ++ Q K+ + E+ I+ +   P
Sbjct: 2   DIQYQEILGHGNGGTVYKA-YHLLTRRILAVKVIPLDITVELQ-KQIMSELEILYKCDSP 59

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
            ++ F GA      +SI TE++  GSL  YR I     G         R+A+ V KG+ Y
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---------RIAVAVVKGLTY 110

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           L +L   ILH D+K  N+LV+    VK+CDFG+S    N+   +K+  GT  + A
Sbjct: 111 LWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMA 161

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 9/160 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  +++ +   +G G FG V++  +       +AV V T ++     ++E FL+E  IM
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + IV E  P G L   +        +D    +  +  ++ 
Sbjct: 62  RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLST 118

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            + YL +     +H D+ + N+LV     VK+ DFGLSR+
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 8/152 (5%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH  +W     VA+K +      ++   +F+ E  +M ++ HP +
Sbjct: 5   ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G  T++  L IVTE++  G L   + R   G+ + +   L M  DV +G+ YL   
Sbjct: 62  VQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGK-LSKDMLLSMCQDVCEGMEYLERN 119

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +   +H DL + N LV     VKV DFG++R+
Sbjct: 120 S--FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 8/156 (5%)

Query: 665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLFM 722
           E +G G+FG V +      + VAVK  T ++ L  +LK +FL E  I+K+  HPN+V  +
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G  T+R  + IV E +P G     + +    + +  ++ ++ ALD A G+ YL + N   
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN--C 114

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
           +H DL + N LV +N  +K+ DFG+SR + +   SS
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 59/164 (35%), Positives = 91/164 (55%), Gaps = 20/164 (12%)

Query: 658 WDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           ++E H+K  +++G G+FG+V    +       G  VAVK L  Q    + L++F RE+ I
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEI 58

Query: 710 MKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMA 765
           +K ++H N+V + G      R +L +V EYLP GSL  Y   HR    E +D R+ L  A
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYA 114

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             + KG+ YL +     +H DL + N+LV+    VK+ DFGL++
Sbjct: 115 SQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 19/171 (11%)

Query: 663 VKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           V +++G GS+G+V++ +   SD    A+K + +      + ++ + E+ I+  V HPN++
Sbjct: 4   VLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMALDVAKGIN 773
            +  A      L IV EY P G L + I +        +R+ +      R+ + + +G+ 
Sbjct: 63  SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQ 117

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
            LH     ILH DLKS N+L+  N  VK+ D G+S+        +K+  GT
Sbjct: 118 ALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKTQIGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 7/156 (4%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI  + + + +++GAG FG V    ++ S  VAVK L         ++ FL E  +MK +
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTL 58

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           +H  +V     VTK   + I+TEY+ +GSL   +     G+++   + +  +  +A+G+ 
Sbjct: 59  QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMA 117

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           Y+   N   +H DL++ N+LV ++   K+ DFGL+R
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 43/165 (26%), Positives = 84/165 (50%), Gaps = 5/165 (3%)

Query: 667 VGAGSFG--TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+FG  T++R     S V  K + +    + + ++ L E+ I+  ++HPN++ +   
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
                 L I  EY   G+LY  I R   G++ ++   L     +   ++Y+H     ILH
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILH 124

Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            D+K+ N+ + K   +K+ DFG+S+   + +  +++V GT  + +
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMS 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 37/183 (20%)

Query: 661 LHVKERVGAGSFGTVHRAE------------------WHGSDVAVKVLTVQDFLDDQLKE 702
           L  KE++G G FG VH  E                       VAVK+L   D   +   +
Sbjct: 7   LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PDANKNARND 65

Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL------YRLIHRPAAGEMM 756
           FL+EV I+ R++ PN++  +G       L ++TEY+  G L      + L  +   G   
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 757 DQRRR----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
                          L +AL +A G+ YL +LN   +H DL + N LV +N T+K+ DFG
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFG 183

Query: 807 LSR 809
           +SR
Sbjct: 184 MSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 17/159 (10%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
            +  ++G G+FG V++A     G  VA+K + + +  D      LRE+ I+K+++HPNVV
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV 70

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMA------LDVAK 770
             +    +RP  S       RGS+Y +   +    +G + +   +L  +      L + +
Sbjct: 71  PLIDMAVERPDKSKRK----RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           GINYLH  +  ILH D+K+ N+L+D    +K+ DFGL+R
Sbjct: 127 GINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 5/164 (3%)

Query: 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E +G G+   V+ A    +   VA+K + + +     + E  +EV  M +  HPNVV + 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V  YL  GSL  ++        +D+     +  +V KG+ YLH+ N  I
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQI 124

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            H D+K+ N+L+ ++ +VK+ DFG+S   A+    ++ V  T V
Sbjct: 125 -HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 10/171 (5%)

Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--LDDQLKEFL-REVAIMKRVRHPNVV 719
           V E +G GSFGTV +     SD  + V    D+  + ++ K+ L  EV I++ ++HPN+V
Sbjct: 4   VLETIGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 720 LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLH 776
            +   +  R +  L IV EY   G L +LI +     + +++    R+   +   +   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 777 NLNPP---ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           N + P   +LH DLK  N+ +D N  VK+ DFGL++   +    +K+  GT
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.3 bits (198), Expect = 5e-16
 Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 16/175 (9%)

Query: 657 SWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           S  EL    R+G+G+ GTV++     +    A+KV+   +  D   ++  RE+ I++ V 
Sbjct: 72  SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVN 130

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           HPNVV           + ++ E++  GSL    +       ++  Q         +  GI
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ---------ILSGI 181

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
            YLH  +  I+H D+K  NLL++    VK+ DFG+SR  A T     S  GT+ +
Sbjct: 182 AYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAY 234

Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.7 bits (195), Expect = 6e-16
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 24/162 (14%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V      GS    A+K+L+    +   Q++  L E  I++ +RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----- 770
           P +V   G+     +L +V EY+P G L+  +           R+  R    VA+     
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQ 109

Query: 771 ---GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               + YLH+L+  I++ DLK  NLL+D +  +K+ DFG ++
Sbjct: 110 VVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.9 bits (194), Expect = 8e-16
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 19/169 (11%)

Query: 658 WDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV- 713
           W+++  ++ +G G+FG V RA  +  G  +   +  +++F  ++  ++F  E+ ++ ++ 
Sbjct: 1   WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMDQRR 760
            HPN++  +GA   R +L I  EY P G+L   + +       PA          +  ++
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            L+ A DVA G+ YL       +H DL + N+LV +N   K+ DFGLSR
Sbjct: 121 LLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 5/155 (3%)

Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLFMG 723
           ER+G G+FG V        +  V V + ++ L   LK +FL+E  I+K+  HPN+V  +G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             T++  + IV E +  G     +     G  +  +  ++M  + A G+ YL + +   +
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
           H DL + N LV +   +K+ DFG+SR + +   +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.4 bits (193), Expect = 9e-16
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 8/154 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPN 717
           DE+ V + +G G++G+V++     + V + +  ++  LD+ +  + + E+ I+ +   P 
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL-- 775
           +V F GA      + +  EY+  GSL +L     A E + +    R+   V KG+ +L  
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 776 -HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            HN    I+H D+K  N+LV+ N  VK+CDFG+S
Sbjct: 121 EHN----IIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 30/169 (17%)

Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---PNV 718
           E +G G++G V+R   H   G  VA+K++ + D  DD + +  REVA++ ++R    PN+
Sbjct: 7   ELIGRGAYGAVYRG-KHVPTGRVVALKIINL-DTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRL-----IHRPAAGEMMDQRRRLRMALDVAKGIN 773
             + G+  K P L I+ EY   GS+  L     I       ++   R + +AL       
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII---REVLVAL------K 115

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           Y+H +   ++H D+K+ N+LV     VK+CDFG++        K +TF+
Sbjct: 116 YIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 21/172 (12%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + W+++  ++ +G G+FG V +A         D A+K +      DD  ++F  E+ ++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 62

Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMD 757
           ++  HPN++  +GA   R +L +  EY P G+L   + +       PA          + 
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            ++ L  A DVA+G++YL       +H DL + N+LV +N+  K+ DFGLSR
Sbjct: 123 SQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 33/177 (18%)

Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
            E +G G++G V++A  H   G  VA+K+    D ++D+ +E   E  I+++   HPN+ 
Sbjct: 11  VEVIGEGTYGKVYKAR-HKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIA 66

Query: 720 LFMGAVTKRPH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL------D 767
            F GA  K+        L +V E    GS+  L+       +  + +RL+         +
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG-----LRKKGKRLKEEWIAYILRE 121

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISS 818
             +G+ YLH     ++H D+K  N+L+ KN  VK+ DFG+S        + NTFI +
Sbjct: 122 TLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 8/149 (5%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
            R+G G+ G+V +      G   A+K +T  D   D  K+ LRE+ I K  + P +V + 
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITT-DPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 723 GAVT--KRPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           GA        + I  EY   GSL  +  +    G  + ++   ++A  V KG++YLH+  
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
             I+H D+K  N+L+ +   VK+CDFG+S
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 48/150 (32%), Positives = 82/150 (54%), Gaps = 11/150 (7%)

Query: 667 VGAGSFGTVH--RAEWHGSDVAVKV-LTVQDFLDDQLKEF-LREVAIMKRVRHPNVVLFM 722
           VG GS+G V   + +  G  VA+K  L  +D  D  +K+  +RE+ ++K++RH N+V  +
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
               ++  L +V E++    L  L   P     +D+ R  +    + +GI + H+ N  I
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN--I 121

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
           +H D+K  N+LV ++  VK+CDFG +R  A
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLA 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 69/234 (29%), Positives = 106/234 (45%), Gaps = 31/234 (13%)

Query: 639 GPRYLNIEPS-LAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG---SD----VAVK 688
           G  Y+ I+P+ L  D  W E   + L   + +GAG+FG V  A  +G   SD    VAVK
Sbjct: 13  GNEYVYIDPTQLPYDLKW-EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK 71

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L       ++ +  + E+ IM  +  H N+V  +GA T    + ++TEY   G L   +
Sbjct: 72  MLKPTAHSSER-EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL 130

Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
            R      +     L  +  VAKG+ +L + N   +H DL + N+L+     VK+CDFGL
Sbjct: 131 RRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGL 187

Query: 808 SR---------FKANTFISSKSVAGTVVFFAAHQTACNS------LALIFSLSG 846
           +R          K N  +  K +A   +F   +    +       L  IFSL  
Sbjct: 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 44/159 (27%), Positives = 85/159 (53%), Gaps = 14/159 (8%)

Query: 668 GAGSFGTVHRAEWHGSDV--AVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
           G G+FG V++A+   + +  A K++ ++   +++L++F+ E+ I+   +HPN+V    A 
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
                L I+ E+   G+L  ++     G    Q R +     + + +N+LH+    ++H 
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV--CRQMLEALNFLHSHK--VIHR 127

Query: 786 DLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISS 818
           DLK+ N+L+  +  VK+ DFG+S        K +TFI +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGT 166

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 49/178 (27%), Positives = 91/178 (51%), Gaps = 9/178 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           ++  + +R+G+G++G V++A     G   A+KV+ ++   D  + +  +E+ +MK  +H 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKDCKHS 66

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V + G+  +R  L I  E+   GSL  + H       + + +   ++ +  +G+ YLH
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLH 123

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
           +     +H D+K  N+L+  N  VK+ DFG+S     T    KS  GT  + A    A
Sbjct: 124 SKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 51/203 (25%), Positives = 104/203 (51%), Gaps = 15/203 (7%)

Query: 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVV 719
           +++++G G F  V+RA     G  VA+K + + D +D + + + ++E+ ++K++ HPNV+
Sbjct: 6   IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            +  +  +   L+IV E    G L R+I H      ++ ++   +  + +   + ++H+ 
Sbjct: 66  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA---HQTAC 835
              ++H D+K  N+ +     VK+ D GL RF ++   ++ S+ GT  + +    H+   
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 836 NSLALIFSLS------GWLQSSF 852
           N  + I+SL         LQS F
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 25/156 (16%)

Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V+      SD      AVK L  + D   +++++FL+E  IMK   HPNV+ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLS 60

Query: 721 FMGAVTKR---PHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVAKGIN 773
            +G        P   +V  Y+  G L   I    H P   +++         L VAKG+ 
Sbjct: 61  LLGICLPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIG------FGLQVAKGME 112

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL   +   +H DL + N ++D+++TVKV DFGL+R
Sbjct: 113 YL--ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 17/162 (10%)

Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE +        + V V T++D  D+  K+F RE  ++  ++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEM--------MDQRRRLRMALD 767
           +V F G   +   L +V EY+  G L + +  H P A  M        + Q + L +A  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +A G+ YL + +   +H DL + N LV +N  VK+ DFG+SR
Sbjct: 129 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 11/161 (6%)

Query: 665 ERVGAGSFGTVHRAEWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           + +G G FG V   E H     + V VK L      D+QL  FL+EV   + + HPNV+ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59

Query: 721 FMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            +G   +     +V E+ P G L  Y   +R    +M  +    RMA +VA G+ +LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGL--SRFKANTFIS 817
           +   +H DL   N  +  + +VK+ D+GL   ++  + +I+
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 52/167 (31%), Positives = 92/167 (55%), Gaps = 17/167 (10%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           ++L     +GAG+ G+V + + H   G+ +A KV+ +        K+ LRE+ IM   R 
Sbjct: 5   EDLETISDLGAGNGGSVSKVK-HIPTGTVMAKKVVHI-GAKSSVRKQILRELQIMHECRS 62

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGIN 773
           P +V F GA     ++ +  E++  GSL R+  +  P   E++      ++A+ V +G+ 
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLT 117

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFI 816
           YL+N++  I+H D+K  N+LV+    +K+CDFG+S       A+TF+
Sbjct: 118 YLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 59/192 (30%), Positives = 104/192 (54%), Gaps = 13/192 (6%)

Query: 659 DELHVK-ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K ER+G GSFG V +         VA+K++ +++  +D++++  +E+ ++ +   
Sbjct: 3   EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDS 61

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P V  + G+  K   L I+ EYL  GS   L+    AG   D+ +   M  ++ KG++YL
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR---AGPF-DEFQIATMLKEILKGLDYL 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA---HQ 832
           H+     +H D+K+ N+L+ +   VK+ DFG++    +T I   +  GT  + A     Q
Sbjct: 118 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175

Query: 833 TACNSLALIFSL 844
           +A +S A I+SL
Sbjct: 176 SAYDSKADIWSL 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 8/156 (5%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI  + L +++++GAG FG V  A ++  + VAVK +         ++ FL E  +MK +
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTL 58

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           +H  +V     VTK P + I+TE++ +GSL   + +   G      + +  +  +A+G+ 
Sbjct: 59  QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++   N   +H DL++ N+LV  +   K+ DFGL+R
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 43/162 (26%), Positives = 89/162 (54%), Gaps = 5/162 (3%)

Query: 665 ERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +++G GSFG   + +++  G    +K + +      + +E  +EVA++  ++HPN+V + 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +  +  +L IV +Y   G LY+ I+    G +  + + L   + +   + ++H+    I
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK--I 122

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           LH D+KS N+ + K+ T+K+ DFG++R   +T   +++  GT
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 72.9 bits (180), Expect = 3e-14
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 14/165 (8%)

Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEF-LREVAIMKRVRHPNVV-L 720
           +G GSFG V     +    G   A+KVL  +  +  +  E  L E  I+ R+ HP +V L
Sbjct: 1   LGKGSFGKVLLVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                T+   L +V EY P G L+  + +   G   ++R R   A ++   + YLH+L  
Sbjct: 59  HYAFQTEE-KLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAA-EIVLALEYLHSLG- 113

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
            I++ DLK  N+L+D +  +K+ DFGL++  ++    + +  GT 
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 38/167 (22%), Positives = 82/167 (49%), Gaps = 5/167 (2%)

Query: 660 ELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +  +  ++G GSFG V +   +      A+K + +      + +E + E  ++ ++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++ +  +   +  L+IV EY   G L++L+     G  + + +  R  + +  G+ +LH+
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
               ILH D+KS NL +D    VK+ D G+++  ++    + ++ GT
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 44/166 (26%), Positives = 88/166 (53%), Gaps = 6/166 (3%)

Query: 662 HVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
            + +++G GSFG ++  +A+       +K + +      + +   +EV ++ +++HPN+V
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            F  +  +   L IV EY   G L + I+R   G +  + + L   + ++ G+ ++H+  
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 780 PPILHWDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKSVAGT 824
             ILH D+KS N+ + KN  V K+ DFG++R   ++   + +  GT
Sbjct: 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 7/180 (3%)

Query: 654 LEISWDELHVKERV--GAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           LE  ++     ERV  G G++G V+ A    + V + +  + +     ++    E+A+  
Sbjct: 1   LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDVAK 770
            ++H N+V ++G+ ++     I  E +P GSL  L+ R   G + D  + +      + +
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIIFYTKQILE 119

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           G+ YLH+    I+H D+K  N+LV+  +  VK+ DFG S+  A     +++  GT+ + A
Sbjct: 120 GLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 41/147 (27%), Positives = 77/147 (52%), Gaps = 5/147 (3%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++      G  VA+K + ++   +      +RE++++K ++HPN+V   
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             + +   L ++ E+L    L + +     G+ MD          + +GI + H+    +
Sbjct: 66  DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--V 122

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           LH DLK  NLL+D    +K+ DFGL+R
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 56/192 (29%), Positives = 107/192 (55%), Gaps = 13/192 (6%)

Query: 659 DELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K E++G GSFG V +   + +   VA+K++ +++  +D++++  +E+ ++ +   
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDS 61

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P V  + G+  K   L I+ EYL  GS   L+  P     +D+ +   +  ++ KG++YL
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKGLDYL 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---Q 832
           H+     +H D+K+ N+L+ ++  VK+ DFG++    +T I   +  GT  + A     Q
Sbjct: 118 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 833 TACNSLALIFSL 844
           +A +S A I+SL
Sbjct: 176 SAYDSKADIWSL 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 57/192 (29%), Positives = 105/192 (54%), Gaps = 13/192 (6%)

Query: 659 DELHVK-ERVGAGSFGTVHRA-EWHGSDV-AVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K ER+G GSFG V++  +    +V A+K++ +++  +D++++  +E+ ++ +   
Sbjct: 3   EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDS 61

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +  + G+  K   L I+ EYL  GS   L+ +P   E       LR   ++ KG++YL
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILR---EILKGLDYL 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---Q 832
           H+     +H D+K+ N+L+ +   VK+ DFG++    +T I   +  GT  + A     Q
Sbjct: 118 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 833 TACNSLALIFSL 844
           +A +  A I+SL
Sbjct: 176 SAYDFKADIWSL 187

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 51/169 (30%), Positives = 75/169 (44%), Gaps = 29/169 (17%)

Query: 667 VGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           +G G+FG V +A   G       + VAVK+L  ++   D   +F RE A+M    HPN+V
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDHPNIV 71

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSL------------YRLIHRPAAGEMMDQRR------- 760
             +G       + ++ EY+  G L              L H  ++               
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +L +A  VA G+ YL       +H DL + N LV +N  VK+ DFGLSR
Sbjct: 132 QLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 41/177 (23%), Positives = 88/177 (49%), Gaps = 18/177 (10%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQ----DFLDDQLKEFLREVAIMKRVRHPNV 718
           +++G G+F + ++A     G+ +AVK +T         ++ ++   +E+ +M R+ HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +  +GA  +  H ++  E++  GS+  L+ +  A     +   +     + +G++YLH  
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN 122

Query: 779 NPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSK-----SVAGTVVFFA 829
              I+H D+K  NLL+D     +++ DFG +  +     +        + GT+ F A
Sbjct: 123 Q--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMA 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 8/148 (5%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A     G  VA+K + ++   +      +RE++++K + HPN+V  +
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLNPP 781
             V     L +V E+L    L    +  ++         ++  L  + +GI Y H+    
Sbjct: 65  DVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +LH DLK  NLL+D+   +K+ DFGL+R
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 21/161 (13%)

Query: 667 VGAGSFGTVHRA----EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
           +G G+FG V +A    +    D A+K +      DD  ++F  E+ ++ ++  HPN++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINL 61

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMDQRRRLRMALDV 768
           +GA   R +L +  EY P G+L   + +       PA          +  ++ L  A DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           A+G++YL       +H DL + N+LV +N+  K+ DFGLSR
Sbjct: 122 ARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 20/161 (12%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVR--- 714
                +G G++GTV++A     G  VA+K + V   L ++      LRE+A++K++    
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLREIALLKQLESFE 59

Query: 715 HPNVV----LFMGAVTKRP-HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDV 768
           HPN+V    +  G  T R   L++V E++ +  L   + + P  G  +       +   +
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG--LPPETIKDLMRQL 116

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +G+++LH+    I+H DLK  N+LV  +  VK+ DFGL+R
Sbjct: 117 LRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 41/150 (27%), Positives = 78/150 (52%), Gaps = 10/150 (6%)

Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTV----QDFLDDQLKEFLREVAIMKRVRHPNVV 719
           E +G G++GTV+      G  +AVK + +        + + ++   EV ++K ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            ++G       +SI  E++P GS+  +++R          +  +  LD   G+ YLHN  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNNC 122

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             ++H D+K  N+++  N  +K+ DFG +R
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 23/155 (14%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNVVL 720
           E++G G++GTV +A+       VA+K + + D  DD+      LRE+ ++K ++H N+V 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 63

Query: 721 FMGAVTKRPHLSIVTEYLPRG------SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
               +     L++V EY  +       S    I        M Q         + KG+ +
Sbjct: 64  LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ---------LLKGLAF 114

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+ N  +LH DLK  NLL++KN  +K+ DFGL+R
Sbjct: 115 CHSHN--VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.3 bits (174), Expect = 3e-13
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-----EFLREVAIMKRVR 714
           EL   + +G+G+FGTV++  W      VK+      L++        EF+ E  IM  + 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP++V  +G V   P + +VT+ +P G L   +H     + +  +  L   + +AKG+ Y
Sbjct: 68  HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMY 124

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           L      ++H DL + N+LV     VK+ DFGL+R 
Sbjct: 125 LEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 26/172 (15%)

Query: 662 HVKER-------VGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAI 709
           H+K R       +G G+FG V  AE H        + V V  +++  +   ++F RE  +
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAA-----GEM-----MD 757
           +  ++H ++V F G  T+   L +V EY+  G L R +  H P A     GE      + 
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             + L +A  +A G+ YL +L+   +H DL + N LV +   VK+ DFG+SR
Sbjct: 121 LGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 26/178 (14%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-SDATEKDLSDLIS 72

Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             E +  +  +  A  VA+G+ YL   +   +H DL + N+LV ++  +K+ DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 44/189 (23%), Positives = 100/189 (52%), Gaps = 9/189 (4%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVV 719
           +++++G G F  V+RA        VA+K + + + +D + ++  ++E+ ++K++ HPNV+
Sbjct: 6   IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVI 65

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            ++ +  +   L+IV E    G L ++I +      ++ +R   +  + +   + ++H+ 
Sbjct: 66  KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA---HQTAC 835
              ++H D+K  N+ +     VK+ D GL RF ++   ++ S+ GT  + +    H+   
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183

Query: 836 NSLALIFSL 844
           N  + I+SL
Sbjct: 184 NFKSDIWSL 192

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 9/172 (5%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +RVG+G++G V++A     G   AVK++ ++    D      +E+ ++K  +H N+V + 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G+   R  L I  EY   GSL  + H       + + +   +  +  +G+ YLH+     
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGK-- 127

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
           +H D+K  N+L+  N  VK+ DFG++     T    KS  GT  + A    A
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 25/176 (14%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQ-LKEFLREV 707
           E+    +   E +G  +FG +++         H   VA+K  T++D  + Q   EF +E 
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINNPQQWGEFQQEA 58

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM----------- 755
           ++M  + HPN+V  +G VT+   + ++ EYL +G L+  LI R    ++           
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 756 --MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             +D    L +A+ +A G+ YL   +   +H DL + N+L+ +   VK+ D GLSR
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.3 bits (170), Expect = 9e-13
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 11/150 (7%)

Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
            ++G GS+G V   R    G  VA+K     +  DD +  K  LRE+ ++K+++HPN+V 
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVN 64

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
            +    ++  L +V EY     L  L   P     + +    ++     + +N+ H  N 
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHN- 120

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             +H D+K  N+L+ K   +K+CDFG +R 
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 26/166 (15%)

Query: 657 SW--DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK 711
           SW   +  + E +G GSFG V  A+  G+    A+K L  ++ L   Q++   +E +I+ 
Sbjct: 14  SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK- 770
            + HP +V  M +      +  + E++  G L+   H   AG         R   DVAK 
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT--HLRKAG---------RFPNDVAKF 122

Query: 771 -------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                     YLH+ +  I++ DLK  NLL+D    VKV DFG ++
Sbjct: 123 YHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 17/168 (10%)

Query: 667 VGAGSFGTV---HRAEWHGSDVAVK-VLTVQD--FLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G+FG V   +  +  G ++AVK V    D      ++     E+ ++K ++H  +V 
Sbjct: 10  LGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
           + G +     LSI  EY+P GS+   +    A      R+  R  L+   G+ YLH+   
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE---GVEYLHSNM- 124

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS----KSVAGT 824
            I+H D+K  N+L D    VK+ DFG S+ +  T  SS    KSV GT
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVTGT 170

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 56/178 (31%), Positives = 88/178 (49%), Gaps = 26/178 (14%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E S D+L + + +G G FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 69

Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP-----------A 751
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             E M  +  +     VA+G+ YL   +   +H DL + N+LV +N  +K+ DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 20/160 (12%)

Query: 667 VGAGSFGTVHRAE-----WHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           +G+G+FG V+          GS    VAVK L  +   D + KEFL+E  +M    HPN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINY 774
           V  +G         I+ E +  G L   +           ++  +  L + LDVAKG  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 775 LHNLNPPILHWDLKSPNLLV-----DKNWTVKVCDFGLSR 809
           L  ++   +H DL + N LV     D +  VK+ DFGL+R
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 48/174 (27%), Positives = 86/174 (49%), Gaps = 21/174 (12%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAI 709
           EI+   +   E +G   FG V++    G+       AV + T++D  +  L+E  +  A+
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 710 MK-RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM--MDQRRRLRMA 765
           M+ R++HPN+V  +G VTK   LS++  Y     L+  L+ R    ++   D  + ++  
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 766 LD----------VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           L+          +A G+ +L + +  ++H DL + N+LV     VK+ D GL R
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 9/144 (6%)

Query: 670 GSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH-PNVVLFMGAV 725
           G+FG+V+ A+    G   A+KVL   D +  +Q+     E AIM      P V     + 
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
             + +L +V EYL  G    LI     G + +   +  +A +V  G+  LH     I+H 
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIA-EVVLGVEDLHQRG--IIHR 121

Query: 786 DLKSPNLLVDKNWTVKVCDFGLSR 809
           D+K  NLL+D+   +K+ DFGLSR
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.8 bits (166), Expect = 5e-12
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 12/146 (8%)

Query: 668 GAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK---RVRHPNVVLF 721
           G G FG V  AE+  +    A+K L   D +  D+++  + E  I +     RHP +V  
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                   H+  V EY   G L   IH     ++  + R +  A  V  G+ YLH     
Sbjct: 68  FACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK-- 121

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGL 807
           I++ DLK  NLL+D    VK+ DFGL
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 27/181 (14%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKE 702
            W E   D L + + +G G FG V RAE +G D         VAVK+L   +  D  L +
Sbjct: 6   KW-EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLAD 63

Query: 703 FLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP--------- 750
            + E+ +MK + +H N++  +G  T+   L ++ EY  +G+L  +    RP         
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 751 --AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
                E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 809 R 809
           R
Sbjct: 182 R 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 11/162 (6%)

Query: 665 ERVGAGSFGTVHRAE----WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           + +G G FG V   E    +  + V VK L V   + +Q+K FL E    + ++H N++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMM--DQRRRLRMALDVAKGINYLHNL 778
            +G  T+     +V E+ P G L   +      E+M  D     RMA ++A G+ +LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLS--RFKANTFISS 818
           N   +H DL   N L+  + TVK+ D+GLS  ++K + +++ 
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 9e-12
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 13/151 (8%)

Query: 667 VGAGSFGTVH------RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V         +  G  VAVK L  +    + + +  +E+ I++ + H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVK 70

Query: 721 FMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           + G  T+     I  + E+LP GSL   +  P     ++ +++L+ A+ + KG++YL + 
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +H DL + N+LV+    VK+ DFGL++
Sbjct: 129 Q--YVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 23/172 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
           E+  D + +   +G G+FG V+   + G D       VAVK L       D+  +FL E 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES-DFLMEA 60

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH-------RPAAGEMMDQRR 760
            IM +  H N+V  +G   +R    I+ E +  G L   +        RP++  M D   
Sbjct: 61  LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL-- 118

Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSR 809
            L  A DVAKG  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 119 -LFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 667 VGAGSFGTVHRAEWHGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +G G FG+V   + +  D    VAVK + +      ++++FL E   MK   HPNV+  +
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 723 GAVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGE---MMDQRRRLRMALDVAKGIN 773
           G   +       P   ++  ++  G L+  +     G+    +  +  ++   D+A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL + +   +H DL + N ++++N  V V DFGLS+
Sbjct: 127 YLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 52/166 (31%), Positives = 92/166 (55%), Gaps = 15/166 (9%)

Query: 665 ERVGAGSFGTVHR--AEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVVL 720
           E++G GS+ TV++  +  +G  VA+KV++++    ++   F  +RE +++K ++H N+VL
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKT---EEGVPFTAIREASLLKGLKHANIVL 67

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
               +  +  L+ V EY+       +I  P  G +     RL M   + +G+ Y+H  + 
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHP--GGLHPYNVRLFM-FQLLRGLAYIHGQH- 123

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            ILH DLK  NLL+     +K+ DFGL+R K+   I S++ +  VV
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKS---IPSQTYSSEVV 165

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)

Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE +        + V V  ++D      K+F RE  ++  ++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRR-----------LRM 764
           +V F G       L +V EY+  G L + +  H P A  ++D + R           L +
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           A  +A G+ YL + +   +H DL + N LV  N  VK+ DFG+SR
Sbjct: 129 ASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 46/152 (30%), Positives = 86/152 (56%), Gaps = 12/152 (7%)

Query: 665 ERVGAGSFGTVHR--AEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVVL 720
           E++G GS+ TV++  ++ +G  VA+KV+ +Q+   ++   F  +RE +++K ++H N+VL
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVL 67

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
               +  +  L++V EY+    L + + +   G   +  +     L   +G++Y+H    
Sbjct: 68  LHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQRY- 123

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
            ILH DLK  NLL+     +K+ DFGL+R K+
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 10/175 (5%)

Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+FG V++A+    G+  A KV+  +   +++L++++ E+ I+    HP +V  +GA
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL-RMALDVAKGINYLHNLNPPIL 783
                 L I+ E+ P G++  ++     G    Q + + R  L+    + YLH++   I+
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMK--II 132

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL 838
           H DLK+ N+L+  +  +K+ DFG+S     T     S  GT  + A     C ++
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 8/154 (5%)

Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+L   + VG G+FG VH  R        A+KV+ + + +   Q +    E  ++K V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P ++        +  L ++ EY+P G L+  +    +G   +       A ++   + YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLF-YASEIVCALEYL 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H+    I++ DLK  N+L+DK   +K+ DFG ++
Sbjct: 118 HSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 24/163 (14%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREV-AIMKRVR 714
           ++L     +G G+FGTV++   H   G+ +AVK +       +Q K  L ++  +M+   
Sbjct: 4   EDLKDLGEIGRGAFGTVNKM-LHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSD 61

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRL------RMAL 766
            P +V F GA+ +     I  E +       Y+ ++          +  +      ++A+
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-------EVLKSVIPEEILGKIAV 114

Query: 767 DVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
              K +NYL   L   I+H D+K  N+L+D+N  +K+CDFG+S
Sbjct: 115 ATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 9/148 (6%)

Query: 666 RVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           R+G G++G V+RA    S   VA+K + + +  D      LRE+ ++  +RHPN+V    
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 724 AVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
            V  +   SI  V EY  +  L  L+          Q + L   L + +G+ YLH     
Sbjct: 74  VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCL--MLQLLRGLQYLHE--NF 128

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NLL+     +K+ DFGL+R
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 42/145 (28%), Positives = 79/145 (54%), Gaps = 10/145 (6%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA+K + +Q     +L   + E+ +M+  +HPN+V ++
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYL 82

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH+    +
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--V 136

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 663 VKERVGAGSFGTVH-----RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +++R+G GSFGTV+     +A        +K + V +   ++  +  +E  ++ ++ HP 
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           +V F  +  +R    I+TEY     L  +L      G+ + + +     + +  G++Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
                ILH DLK+ N+ +  N  +K+ DFG+SR 
Sbjct: 124 QRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRL 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 40/167 (23%), Positives = 79/167 (47%), Gaps = 13/167 (7%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDD-QLKEFLREVA 708
           + IS D + + + +  G+FG +          G +  V V TV+D   + Q+   L+E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEM-----MDQRRRL 762
           ++  + H N++  +    +      V   Y+  G+L   + +   GE      +  ++ +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            MA+ +A G++YLH     ++H D+ + N ++D+   VK+ D  LSR
Sbjct: 121 HMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 26/158 (16%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVK-------VLTVQDFLDDQLKEFLREVAIMKRVRH 715
           E +G+G++G V  A     G  VA+K       V T+        K  LRE+ I++  +H
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA-------KRTLRELKILRHFKH 63

Query: 716 PNVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            N++    +          + +V + L    L+ +IH  +   + ++  R  +   + +G
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFL-YQLLRG 119

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + Y+H+ N  ++H DLK  NLLV+++  +++ DFG++R
Sbjct: 120 LKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 43/158 (27%), Positives = 66/158 (41%), Gaps = 13/158 (8%)

Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLT-VQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G FG V   + +      A+K +         Q +    E  I++   HP +V    
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
               + ++ ++ EY   G L+ ++     G   +   R  +A  V     YLHN    I+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIAC-VVLAFEYLHNRG--II 115

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL-----SRFKANTFI 816
           + DLK  NLL+D N  VK+ DFG      S  K  TF 
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 12/144 (8%)

Query: 666 RVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A +   G  VAVK +   D    Q +E L  EV IM+  +HPN+V   
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V K +++LH     +
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQG--V 136

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFG 806
           +H D+KS ++L+  +  VK+ DFG
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 26/192 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+S   L + + +G G FG V  AE  G D         VAVK+L   D  D  L + + 
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-DDATDKDLSDLVS 66

Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E +  +  +  A  VA+G+ YL   +   +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 185 HNIDYYKKTTNG 196

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 14/196 (7%)

Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLRE 706
           L ++ L    D   + E +G G++G V++   +  GS  AVK+L   D + D  +E   E
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAE 68

Query: 707 VAIMKRV-RHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIH-RPAAGEMMDQR 759
             I++ +  HPNVV F G   K   L      +V E    GS+  L+      G+ +D+ 
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
               +      G+ +LHN    I+H D+K  N+L+     VK+ DFG+S    +T +   
Sbjct: 129 MISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 820 SVAGTVVFFAAHQTAC 835
           +  GT  + A    AC
Sbjct: 187 TSVGTPFWMAPEVIAC 202

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 11/179 (6%)

Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723
           E VG G++G V++   H     +  + V D   D+ +E  +E+ ++K+   H N+  + G
Sbjct: 12  ELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 724 AVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           A  K+        L +V E+   GS+  LI +   G  + +     +  ++ +G+++LH 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN 836
               ++H D+K  N+L+ +N  VK+ DFG+S     T     +  GT  + A    AC+
Sbjct: 130 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 14/153 (9%)

Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLF 721
           +G G++GTV++A     G  VA+K + VQ   D      +REVA++KR+    HPN+V  
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 722 MGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           M         +   +++V E++ +     L   P  G   +  + L       +G+++LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFLH 125

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             N  I+H DLK  N+LV     VK+ DFGL+R
Sbjct: 126 -ANC-IVHRDLKPENILVTSGGQVKLADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 11/153 (7%)

Query: 664 KERV-GAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPN 717
           K +V G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+
Sbjct: 11  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           V   +G +     + ++T+ +P G L   +      + +  +  L   + +AKG+NYL  
Sbjct: 71  VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE 127

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
               ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 128 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 40/147 (27%), Positives = 76/147 (51%), Gaps = 6/147 (4%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A     G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             +     L +V E+L +     +   P +G  +   +     L   +G+ + H+    +
Sbjct: 66  DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSHR--V 121

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           LH DLK  NLL++    +K+ DFGL+R
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 17/169 (10%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREV 707
           E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 60

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ-----RR 760
           ++MK     +VV  +G V++     ++ E + RG L   +   RP       Q     ++
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 121 MIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVL--TVQDFLDDQ-LKEFLREVAIMKRVR 714
           EL   + +G+G FGTVH+  W   G  + + V   T+QD    Q  +E    +  M  + 
Sbjct: 8   ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           H  +V  +G +     L +VT+  P GSL  L H     + +D +R L   + +AKG+ Y
Sbjct: 68  HAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           L      ++H +L + N+L+  +  V++ DFG++
Sbjct: 125 LEEHR--MVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 32/173 (18%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ---LKEFL------------REVAIMK 711
           VG GSFG              + L VQ    DQ   +KE              +E  ++ 
Sbjct: 8   VGEGSFG--------------RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLA 53

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           +++HPN+V F  +     HL IV EY   G L + I +   G++  +   L+  + +  G
Sbjct: 54  KMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMCLG 112

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           + ++H     +LH D+KS N+ + +N  VK+ DFG +R   +    + +  GT
Sbjct: 113 VQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 46/150 (30%), Positives = 82/150 (54%), Gaps = 18/150 (12%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVV---- 719
           VG G+FG V  A  +  G +VA+K + ++ F    L K   RE+ ++K +RH N++    
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +F   ++    +  VTE L    L+RL+    +  +  Q  +      + +G+ Y+H+  
Sbjct: 77  IF---ISPLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQY-FLYQILRGLKYVHSAG 128

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             ++H DLK  N+L+++N  +K+CDFGL+R
Sbjct: 129 --VVHRDLKPSNILINENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 43/145 (29%), Positives = 78/145 (53%), Gaps = 10/145 (6%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV  A     G +VA+K + +Q     +L   + E+ +MK +++PN+V F+
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH     +
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECLQALEFLH--ANQV 136

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 10/163 (6%)

Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG GS+G V    HR +  G    +K L +++    + K   +E  ++ +++HPN+V + 
Sbjct: 8   VGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 723 GAVTKRP-HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
            +       L IV  +   G LY  + +   G+++ + + +   + +A  + YLH  +  
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           ILH DLK+ N+ + +   +KV D G++R   N    + ++ GT
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 61.7 bits (149), Expect = 4e-10
 Identities = 41/145 (28%), Positives = 80/145 (55%), Gaps = 10/145 (6%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA+K + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 82

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + +++LH  +  +
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLH--SNQV 136

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 10/174 (5%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726
           +G G+FG V++A+   + V      +    +++L++++ E+ I+    HPN+V  + A  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 727 KRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
              +L I+ E+   G++  +   + RP     +  R   +  L+    +NYLH     I+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTLE---ALNYLH--ENKII 125

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS 837
           H DLK+ N+L   +  +K+ DFG+S     T     S  GT  + A     C +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 660 ELHVKERVGAGSFGTVHRAEW--HGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EL   + +G+G+FGTV++  W   G +    VA+KVL  ++      KE L E  +M  V
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGV 66

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             P V   +G +     + +VT+ +P G L  L +     + +  +  L   + +AKG++
Sbjct: 67  GSPYVCRLLG-ICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           YL  +   ++H DL + N+LV     VK+ DFGL+R 
Sbjct: 124 YLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 21/171 (12%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+S +++ +   +G GSFG V+  E +  D         VAVK +     L +++ EFL 
Sbjct: 2   EVSREKITLLRELGQGSFGMVY--EGNARDIIKGEAETRVAVKTVNESASLRERI-EFLN 58

Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ----- 758
           E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +     
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118

Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +  ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 119 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 29/166 (17%)

Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++ TV+  R    G  VA+K + + D  +      +RE+++MK ++H N+V   
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIREISLMKELKHENIVRLH 64

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA----------KGI 772
             +     L +V EY+    L +          MD     R ALD            KGI
Sbjct: 65  DVIHTENKLMLVFEYM-DKDLKK---------YMDTHGV-RGALDPNTVKSFTYQLLKGI 113

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR---FKANTF 815
            + H     +LH DLK  NLL++K   +K+ DFGL+R      NTF
Sbjct: 114 AFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 60.3 bits (147), Expect = 8e-10
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 11/157 (7%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKE--FLREVAIMKRV- 713
           D+    + +G GSF TV  A+   ++   A+K+L  +  L  + K      E  ++ R+ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR-QLIKEKKVKYVKIEKEVLTRLN 59

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HP ++          +L  V EY P G L + I +   G + ++  R   A ++   + 
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAA-EILLALE 116

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           YLH+    I+H DLK  N+L+DK+  +K+ DFG ++ 
Sbjct: 117 YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKV 151

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 9/149 (6%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A        +A+K + ++   +      +RE++++K ++H N+V   
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLNPP 781
             V     L +V EYL    L    H  ++ +     R ++  L  + +GI Y H+    
Sbjct: 68  DVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-- 122

Query: 782 ILHWDLKSPNLLVDK-NWTVKVCDFGLSR 809
           +LH DLK  NLL+D+    +K+ DFGL+R
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 12/167 (7%)

Query: 666 RVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A E H G  VAVK +   D    Q +E L  EV IM+   H NVV   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMY 85

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++YLHN    +
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG--V 139

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  +K+ DFG     +      KS+ GT  + A
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 11/156 (7%)

Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH- 715
           D+L V E +G G++G V   R    G+ +AVK +       +Q K  L ++ I  R    
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDC 59

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           P  V F GA+ +   + I  E +       Y+ ++    G  + +    ++A+ + K + 
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALE 117

Query: 774 YLH-NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           YLH  L+  ++H D+K  N+L+++N  VK+CDFG+S
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 60.0 bits (146), Expect = 9e-10
 Identities = 40/170 (23%), Positives = 79/170 (46%), Gaps = 17/170 (10%)

Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLF 721
           +G G+FG V     R        A+K +  Q  ++   ++  L E  I++ + HP +V  
Sbjct: 8   IGKGAFGKVCIVQKRDT--KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 722 MGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
             +     ++ +V + L  G L Y L  +    +  +++ +  +  ++   + YLH+   
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWIC-EIVLALEYLHSKG- 120

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTVVFFA 829
            I+H D+K  N+L+D+   V + DF ++     +T  +S S  GT  + A
Sbjct: 121 -IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMA 167

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 9e-10
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 41/163 (25%)

Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
           +G G++G V    H+    G  VA+K   +  F + Q   +  LRE+ I++R +H N++ 
Sbjct: 13  IGEGAYGMVCSATHKP--TGVKVAIK--KISPF-EHQTFCQRTLREIKILRRFKHENIIG 67

Query: 721 FMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD------- 767
            +  + + P         IV E +    LY+LI            +   ++ D       
Sbjct: 68  IL-DIIRPPSFESFNDVYIVQELMET-DLYKLI------------KTQHLSNDHIQYFLY 113

Query: 768 -VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +G+ Y+H+ N  +LH DLK  NLL++ N  +K+CDFGL+R
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR 154

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 18/161 (11%)

Query: 667 VGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           +G G FG V  A+  G +       V VK L      ++   EF RE+ + +++ H NVV
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71

Query: 720 LFMGAV-TKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQ----RRRLRMALDVAKGI 772
             +G      PH  ++ EY   G L  +    +    ++       ++++ +   +A G+
Sbjct: 72  RLLGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           ++L N     +H DL + N LV     VKV    LS+   N
Sbjct: 131 DHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 46/176 (26%), Positives = 87/176 (49%), Gaps = 27/176 (15%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDV--AVKV--LTVQDFLDDQLKEFLREVAIMKRVR 714
           D+      +GAG+ G V +     S +  A K+  L ++  + +Q+   +RE+ ++    
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI---IRELKVLHECN 57

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMALDV 768
            P +V F GA      +SI  E++  GSL          +++ +  R+      ++++ V
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVLKKAGRIPENILGKISIAV 108

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFISSKS 820
            +G+ YL      I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 109 LRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 163

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 60.9 bits (148), Expect = 1e-09
 Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 18/164 (10%)

Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G+G+ G V  A     G +VA+K L+ + F +    K   RE+ +MK V H N++  + 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN 82

Query: 724 AVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
             T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+
Sbjct: 83  VFTPQKSLEEFQDVYLVME-LMDANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS 136

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
               I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V
Sbjct: 137 AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 178

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 40/170 (23%), Positives = 76/170 (44%), Gaps = 26/170 (15%)

Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF------------LREVAIMKR 712
           +G G++G V +A     G  VA+K + + +  +D  K+             LRE+ IM  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 713 VRHPNVVLFMGAV---TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           ++H N+   MG V    +   +++V + +    L +++ R     + + + +  + L + 
Sbjct: 77  IKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI--RLTESQVKCIL-LQIL 129

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
            G+N LH      +H DL   N+ ++     K+ DFGL+R       S  
Sbjct: 130 NGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Length = 335

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 40/145 (27%), Positives = 79/145 (54%), Gaps = 10/145 (6%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH  +  +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH--SNQV 137

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 31/177 (17%)

Query: 661 LHVKERVGAGSFGTVHRA---EWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           L + + +G G FG V +A      G    + VAVK+L  ++    +L++ L E  ++K+V
Sbjct: 2   LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQV 60

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI---------------HRPAAGEMMDQ 758
            HP+V+   GA ++   L ++ EY   GSL   +               +R ++      
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 759 RRRLRM------ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            R L M      A  +++G+ YL  +   ++H DL + N+LV +   +K+ DFGLSR
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 15/166 (9%)

Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVVL 720
           +++G GS+ TV++     +   VA+K + ++    ++   F  +RE +++K ++H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIREASLLKDLKHANIVT 67

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
               +  +  L++V EYL       +        M + R  L   L   +G+ Y H    
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCHQRR- 123

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +LH DLK  NLL+ +   +K+ DFGL+R K+   + SK+ +  VV
Sbjct: 124 -VLHRDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVV 165

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 8/166 (4%)

Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   R +  G   A+K+L  +  +  D++   L E  ++K  RHP +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   +  L  V EY+  G L+  + R     +  + R      ++   ++YLH+    I+
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHS--GKIV 117

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + DLK  NL++DK+  +K+ DFGL +       + K+  GT  + A
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 11/179 (6%)

Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723
           E VG G++G V++   H     +  + V D  +D+ +E   E+ ++K+   H N+  + G
Sbjct: 22  EVVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 724 AVTKRP------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           A  K+        L +V E+   GS+  L+ +   G  + +     +  ++ +G+ +LH 
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLAHLHA 139

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN 836
               ++H D+K  N+L+ +N  VK+ DFG+S     T     +  GT  + A    AC+
Sbjct: 140 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 31/159 (19%)

Query: 667 VGAGSFGTVHRAEW------HGSDVAVKVL--TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           +G G+FG V    W       G  VA+K +    Q+ +    K   RE+ ++   +H NV
Sbjct: 8   IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNV 61

Query: 719 VLFMGA--VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
              + A  + + PH+       +VTE L +  L+++I  P    +     ++     + +
Sbjct: 62  ---LSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQP--LSSDHVKV-FLYQILR 114

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ YLH+    ILH D+K  NLLV+ N  +K+CDFGL+R
Sbjct: 115 GLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 14/186 (7%)

Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-H 715
           D   + E +G G++G V +   + +GS  AVK+L   D + D  +E   E  I+K +  H
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDH 74

Query: 716 PNVVLFMGAVTKRP-----HLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVA 769
           PNVV F G   K+       L +V E    GS+  L+      GE M++     +  +  
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            G+ +LH  N  I H D+K  N+L+     VK+ DFG+S    +T +   +  GT  + A
Sbjct: 135 MGLQHLHV-NKTI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 830 AHQTAC 835
               AC
Sbjct: 193 PEVIAC 198

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 33/163 (20%)

Query: 666 RVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-F----LREVAIMKRVRHPNV 718
           ++G G+FG V +A        VA+K +     L +  KE F    LRE+ I++ ++H NV
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPITALREIKILQLLKHENV 73

Query: 719 V-LFMGAVTK-------RPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMAL 766
           V L     TK       +    +V E+     L  L+          E+   ++ ++M L
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEI---KKVMKMLL 129

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +   G+ Y+H     ILH D+K+ N+L+ K+  +K+ DFGL+R
Sbjct: 130 N---GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 48/170 (28%), Positives = 89/170 (52%), Gaps = 12/170 (7%)

Query: 660 ELHVK-ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           E +VK +++G G++ TV   R++   + VA+K + ++   +      +REV+++K ++H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHA 63

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V     +     L++V EYL       L +    G +M           + +G++Y H
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
                ILH DLK  NLL+++   +K+ DFGL+R K+   + +K+ +  VV
Sbjct: 121 KRK--ILHRDLKPQNLLINEKGELKLADFGLARAKS---VPTKTYSNEVV 165

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 43/178 (24%), Positives = 83/178 (46%), Gaps = 15/178 (8%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFL--------DDQLKEFLREVAIMK 711
           V E +G+G+FG V++        + +A+K + V +          D  + + + EV I+K
Sbjct: 4   VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63

Query: 712 -RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVA 769
            ++RHPN+V +     +   L IV + +    L    +      +   + R   + + + 
Sbjct: 64  EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
             + YLH     I+H DL   N+++ ++  V + DFGL++ K        SV GT+++
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTSVVGTILY 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 47/170 (27%), Positives = 89/170 (52%), Gaps = 12/170 (7%)

Query: 660 ELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           E ++K +++G G++ TV++     +D  VA+K + ++   +      +REV+++K ++H 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 64

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V     +     L++V EYL +     L      G  ++          + +G+NY H
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCH 121

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
                +LH DLK  NLL+++   +K+ DFGL+R K+   I +K+ +  VV
Sbjct: 122 RRK--VLHRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYSNEVV 166

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 30/165 (18%)

Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKE----FLREVAIMKRVRHPNVVL 720
           +G GSFG V+  R       VA+K ++   +   Q  E     ++EV  ++++RHPN + 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGIN 773
           + G   +     +V EY   GS         A ++++  ++    +++A       +G+ 
Sbjct: 80  YKGCYLREHTAWLVMEYC-LGS---------ASDILEVHKKPLQEVEIAAICHGALQGLA 129

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK--ANTFI 816
           YLH+     +H D+K+ N+L+ +  TVK+ DFG +     AN+F+
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 33/160 (20%)

Query: 666 RVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEF----LREVAIMKRVRHPNVV 719
           R+  G++G V+RA    +   VA+K L     ++ + + F    LRE+ I+ +++HPN+V
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLK----MEKEKEGFPITSLREINILLKLQHPNIV 67

Query: 720 ----LFMGAVTKRPHLSIVTEYLP---RGSLYRLIHRPAAGE---MMDQRRRLRMALDVA 769
               + +G  +    + +V EY+    +  +  +       E   +M Q         + 
Sbjct: 68  TVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ---------LL 116

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ +LH+    ILH DLK+ NLL++    +K+CDFGL+R
Sbjct: 117 SGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 50/174 (28%), Positives = 93/174 (53%), Gaps = 15/174 (8%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKV--LTVQDFLDDQLKEFLREVAIM 710
           E+  D+      +GAG+ G V +     S   +A K+  L ++  + +Q+   +RE+ ++
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI---IRELQVL 57

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
                P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V K
Sbjct: 58  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIK 114

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFISSKS 820
           G+ YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 115 GLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 49/151 (32%), Positives = 71/151 (47%), Gaps = 17/151 (11%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-----RHPNV 718
           +G GSFG V  AE  G+D   AVKVL     L DD ++  + E    KRV     +HP +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE----KRVLALAGKHPFL 58

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
                    +  L  V EY+  G L   I R       D+ R    A ++  G+ +LH  
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHER 115

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              I++ DLK  N+L+D    +K+ DFG+ +
Sbjct: 116 G--IIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 23/173 (13%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF----LREVA 708
           W +   D+  +  ++G G++G V++A    +   V +  V+  LD++ + F    +RE+ 
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIK 58

Query: 709 IMKRVRHPNVVLFMGAVT----------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ 758
           I++++ H N+V     VT           +    +V EY+    L  L+         D 
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDH 117

Query: 759 RRRL-RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            +   +  L+   G+NY H  N   LH D+K  N+L++    +K+ DFGL+R 
Sbjct: 118 IKSFMKQLLE---GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 43/177 (24%), Positives = 88/177 (49%), Gaps = 21/177 (11%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
           E+  D+      +GAG+ G V + +   S + +    +   +   ++ + +RE+ ++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMALD 767
             P +V F GA      +SI  E++  GSL          +++ + +R+      ++++ 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVLKEAKRIPEEILGKVSIA 111

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFISSKS 820
           V +G+ YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 112 VLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 21/171 (12%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREV-------AIMKRVRHPNVV 719
           +G G+FG V+    + +D   ++   Q   D   +E  +EV        ++K +RH  +V
Sbjct: 10  LGRGAFGEVYLC--YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 720 LFMGAVT--KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH- 776
            + G +   +   LSI  EY+P GS+   +   A G + +   R R    + +G++YLH 
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTR-RYTRQILQGVSYLHS 124

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS---KSVAGT 824
           N+   I+H D+K  N+L D    VK+ DFG S+      +S    KSV GT
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 11/168 (6%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQD-FLDDQLKEFLREVAIMKRVRHP 716
           +  +  +VG G +G V  A+   +   VA+K +     F  ++++  L E  I+   +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
            +V  + A     +L +  EY+P G    L++    G + +   R  MA ++ + ++ LH
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMA-EMFEAVDALH 118

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
            L    +H DLK  N L+D +  +K+ DFGLS         + SV G+
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGS 161

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 8/175 (4%)

Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRH 715
            +  VK  VG G FG V   R +  G   A+KV+     L  + +  F  E  I+     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +     A   + +L +V EY P G L  L++R    +  +   +  +A ++   I+ +
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR-YEDQFDEDMAQFYLA-ELVLAIHSV 118

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTVVFFA 829
           H +    +H D+K  N+L+D+   +K+ DFG + R  AN  ++SK   GT  + A
Sbjct: 119 HQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 13/169 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL---REVAIMKRVRHPNVVL 720
           +G GSFG V  A  H ++    AVKVL  +  L  + ++ +   R V ++K V+HP +V 
Sbjct: 3   IGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 60

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
              +      L  V +Y+  G L+  + R      ++ R R   A ++A  + YLH+LN 
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARF-YAAEIASALGYLHSLN- 116

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            I++ DLK  N+L+D    + + DFGL +       ++ +  GT  + A
Sbjct: 117 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 7/145 (4%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFL-DDQLKEF-LREVAIMKRVRHPNVVLFMGA 724
           VG G++G V +     +   V +   +D   ++++KE  LRE+ +++ ++  N+V    A
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
             +R  L +V EY+ +  L  L   P  G   ++ R     L   K I++ H  +  I+H
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPEKVRSYIYQL--IKAIHWCHKND--IVH 123

Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR 809
            D+K  NLL+  N  +K+CDFG +R
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 13/149 (8%)

Query: 667 VGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL---REVAIMKRVRHPNVVL 720
           +G GSFG V  A+   SD    AVKVL  +  L  + +  +   R V ++K ++HP +V 
Sbjct: 3   IGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
              +      L  V +Y+  G L+  + R      ++ R R   A +VA  I YLH+LN 
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARF-YAAEVASAIGYLHSLN- 116

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            I++ DLK  N+L+D    V + DFGL +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 47/170 (27%), Positives = 89/170 (52%), Gaps = 12/170 (7%)

Query: 660 ELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           E ++K E++G G++ TV +     ++  VA+K + ++   +      +REV+++K ++H 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 64

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V     V     L++V EYL +  L + +     G +M           + +G+ Y H
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
                +LH DLK  NLL+++   +K+ DFGL+R K+   + +K+ +  VV
Sbjct: 122 RRK--VLHRDLKPQNLLINERGELKLADFGLARAKS---VPTKTYSNEVV 166

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 45/154 (29%), Positives = 83/154 (53%), Gaps = 13/154 (8%)

Query: 663 VKERVGAGSFGTVHRA-EWH-GSDVAVK-VLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           ++E +G GS+G V  A + H G  VA+K +  V + + D  +  LRE+ +++ +RHP++V
Sbjct: 4   IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIV 62

Query: 720 ---LFMGAVTKRPHLSI-VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
                M   ++R    I V   L    L+++I   A  ++  +  +  +   + + + Y+
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHHQFFL-YQLLRALKYI 119

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H  N  + H DLK  N+L + +  +K+CDFGL+R
Sbjct: 120 HTAN--VFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)

Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++  RHP +     
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           A      L  V EY   G L+  + R       ++R R   A ++   + YLH+ +  ++
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSALEYLHSRD--VV 117

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + D+K  NL++DK+  +K+ DFGL +   +   + K+  GT  + A
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 44/188 (23%), Positives = 80/188 (42%), Gaps = 42/188 (22%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF--------------LREVAIMKR 712
           +G G++G V++A+        +           +K+F               RE+A+++ 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEY---------AIKKFKGDKEQYTGISQSACREIALLRE 58

Query: 713 VRHPNVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMAL 766
           ++H NVV    +F+    K   + ++ +Y     L+++I  HR A    +     ++  L
Sbjct: 59  LKHENVVSLVEVFLEHADKS--VYLLFDYAEH-DLWQIIKFHRQAKRVSI-PPSMVKSLL 114

Query: 767 -DVAKGINYLH-NLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRFKANTFISSKS 820
             +  G++YLH N    +LH DLK  N+LV     +   VK+ D GL+R           
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 821 VAGTVVFF 828
           +   VV  
Sbjct: 172 LDPVVVTI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 21/171 (12%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVA-------IMKRVRHPNVV 719
           +G G+FG V+    +  D   ++   Q   D +  E  +EV+       ++K ++H  +V
Sbjct: 10  LGQGAFGRVYLC--YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 720 LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH- 776
            + G +  R    L+I  EY+P GS+   +    A      R+  R  L+   G++YLH 
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE---GMSYLHS 124

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS---KSVAGT 824
           N+   I+H D+K  N+L D    VK+ DFG S+      +S    +SV GT
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +G+G+FG V    ++      DVA+KVL  ++    +  E +RE  IM ++ +P +V  +
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMI 61

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G V +   L +V E    G L + +      + +     + +   V+ G+ YL   N   
Sbjct: 62  G-VCEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--F 116

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR--------FKANTF 815
           +H DL + N+L+      K+ DFGLS+        +KA + 
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.1 bits (136), Expect = 3e-08
 Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 15/151 (9%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           VG+G++G V  A    +   VA+K L+         K   RE+ ++K + H NV+  +  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T    L       +VT  +    L  ++       + D   +  +   + +G+ Y+H+ 
Sbjct: 83  FTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQK---LSDDHIQF-LVYQILRGLKYIHSA 137

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              I+H DLK  N+ V+++  +K+ DFGL+R
Sbjct: 138 G--IIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 42/158 (26%), Positives = 81/158 (51%), Gaps = 12/158 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V+ A    +   VA+K ++      +++ ++ ++EV  ++++RHPN + + G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 724 AVTKRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
              +     +V EY L   S    +H+    E+        +     +G+ YLH+ N  +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGLAYLHSHN--M 136

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISS 818
           +H D+K+ N+L+ +   VK+ DFG +     AN F+ +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 17/158 (10%)

Query: 661 LHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRV 713
           L     +G G FG V    +       G  VAVK L  +     Q    + +E+ I+K +
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL 63

Query: 714 RHPNVVLFMGAVTKR--PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            H N+V + G  +++    L ++ EY+P GSL   + +          + L  A  + +G
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN----LAQLLLFAQQICEG 119

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + YLH+ +   +H DL + N+L+D +  VK+ DFGL++
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 20/159 (12%)

Query: 665 ERVGAGSFGTVHRAE-WHGSDVA---VKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           + +G G FG V  +E +  + VA   VK L       +Q  EFL++    + ++HPN++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59

Query: 721 FMG-AVTKRPHLSIVTEYLPRGSLYRLI-----HRPAAGEMMDQRRRLRMALDVAKGINY 774
            +G  V   P+L +V EY   G L   +     HR  +  ++ QR    MA ++A G+ +
Sbjct: 60  CLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----MACEIAAGVTH 114

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL--SRFK 811
           +H  N   LH DL   N  +  + TVKV D+G+  SR+K
Sbjct: 115 MHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 45/188 (23%)

Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL 696
           G RY+++ P                   +G GS G V  A     D  VAVK + + D  
Sbjct: 4   GSRYMDLRP-------------------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-- 42

Query: 697 DDQLKEFLREVAIMKRVRHPNVV-----LF---------MGAVTKRPHLSIVTEYLPRGS 742
              +K  LRE+ I++R+ H N+V     L          +G++T+   + IV EY+    
Sbjct: 43  PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETD 101

Query: 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-K 801
           L  ++ +   G + ++  RL M   + +G+ Y+H+ N  +LH DLK  N+ ++    V K
Sbjct: 102 LANVLEQ---GPLSEEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155

Query: 802 VCDFGLSR 809
           + DFGL+R
Sbjct: 156 IGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 12/167 (7%)

Query: 666 RVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V   R +  G  VAVK++   D    Q +E L  EV IM+  +H NVV   
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L ++ E+L  G+L  ++ +      +++ +   +   V + + YLH+    +
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG--V 138

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      KS+ GT  + A
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 27/209 (12%)

Query: 665 ER-VGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNV 718
           ER +G G FG + R          ++ V + T++    D Q + FL E   + +  H N+
Sbjct: 10  ERILGTGRFGELCRG-CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP----AAGEMMDQRRRLRMALDVAKGINY 774
           V   G +T+   + IVTEY+  G+L   + +      AG++M       M   +A G+ Y
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKY 122

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG-LSRFKANTFISSKSVAGTVVFFAA--- 830
           L  +    +H  L +  +LV+ +   K+  F  L   K+    ++ S   + V +AA   
Sbjct: 123 LSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS-GKSPVLWAAPEA 179

Query: 831 ---HQTACNSLALIFSLSGWLQSSFEESP 856
              H  +  S    F +  W   S+ E P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLD-DQLKEFLREVAIM-KRVRHPNVVLF 721
           +G GSFG V  A+ H +D    AVKVL  +  L   + K  + E  ++ K V+HP +V  
Sbjct: 3   IGKGSFGKVLLAK-HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
             +      L  V +Y+  G L+  + R  +    + R R   A ++A  + YLH+LN  
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARF-YAAEIASALGYLHSLN-- 116

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I++ DLK  N+L+D    V + DFGL +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 15/154 (9%)

Query: 667 VGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVL 720
           +G G++G V +A   +  G  VA+K + VQ   +      +REVA+++ +    HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 721 FMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
                T     +   L++V E++ +     L   P  G   +  +   M   + +G+++L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLRGLDFL 126

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H+    ++H DLK  N+LV  +  +K+ DFGL+R
Sbjct: 127 HSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 43/164 (26%), Positives = 88/164 (53%), Gaps = 24/164 (14%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V+ A    ++  VAVK ++      +++ ++ ++EV  +++++HPN + + G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGINYLH 776
              K     +V EY   GS         A ++++  ++    +++A       +G+ YLH
Sbjct: 89  CYLKEHTAWLVMEYC-LGS---------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK--ANTFISS 818
           + N  ++H D+K+ N+L+ +   VK+ DFG +     AN+F+ +
Sbjct: 139 SHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 19/170 (11%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVA-------IMKRVRHPNVV 719
           +G G+FG V+    + +D   ++   Q   D +  E  +EV        ++K + H  +V
Sbjct: 10  LGQGAFGRVYLC--YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 720 LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
            + G +       LSI  E++P GS+   +    A      R+  R  L+   G++YLH+
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE---GVSYLHS 124

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS---KSVAGT 824
               I+H D+K  N+L D    VK+ DFG S+      +S    KSV GT
Sbjct: 125 --NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 16/163 (9%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     G +VAVK L+         K   RE+ ++K V H N++  +  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++IH       +D  R   +   +  GI +LH+ 
Sbjct: 89  FTPQKSLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHSA 142

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
              I+H DLK  N++V  + T+K+ DFGL+R     F+ +  V
Sbjct: 143 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYV 183

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 25/167 (14%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFL-DDQLKEFLREVAIM 710
           ++ +++ +    +G GSFG V  A +   D   VA+K       +   Q+     E  I+
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV-- 768
             + HP  V   G+     +L +V E++  G  +  +           RR  R   DV  
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGC 134

Query: 769 --AKGI----NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             A  I     YL +LN  I++ DLK  NLL+DK+  +K+ DFG ++
Sbjct: 135 FYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAK 179

Length = 340

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 8/166 (4%)

Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   R +  G   A+K+L  +  +  D++   L E  +++  RHP +     
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +      L  V EY   G L+   H        + R R   A ++   + YLH+ +  ++
Sbjct: 63  SFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLHSCD--VV 117

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + DLK  NL++DK+  +K+ DFGL +   +   + K+  GT  + A
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 16/157 (10%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNVVL 720
           E++G G++G V++A     G  VA+K   ++  +D++      LRE+++++ +     ++
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLSESIYIV 64

Query: 721 FMGAV------TKRPHLSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            +  V        +P L +V EYL      +   +    G  +  +        + KG+ 
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + H     ++H DLK  NLLVDK   + K+ D GL R
Sbjct: 125 HCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.3 bits (129), Expect = 2e-07
 Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 26/160 (16%)

Query: 662 HVKERVGAGSFGTVHRAEWHGSD------VAVKVL--TVQDFLDDQLKEFLREVAIMKRV 713
            + +++G G++G V    W   D      VA+K +    ++  D Q + F RE+  ++ +
Sbjct: 10  EILQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDAFRNATDAQ-RTF-REIMFLQEL 63

Query: 714 R-HPNVV-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
             HPN+V L   + A   +  + +V EY+    L+ +I    A  + D  +R  M   + 
Sbjct: 64  GDHPNIVKLLNVIKAENDK-DIYLVFEYM-ETDLHAVIR---ANILEDVHKRYIM-YQLL 117

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           K + Y+H+ N  ++H DLK  N+L++ +  VK+ DFGL+R
Sbjct: 118 KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 12/167 (7%)

Query: 666 RVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A  +  G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V K ++ LH     +
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG--V 137

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      KS+ GT  + A
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 34/160 (21%), Positives = 75/160 (46%), Gaps = 14/160 (8%)

Query: 675 VHRAEWHGSDVAVKVLT-VQDFLDDQLKEFLREVAIMKRVRHPNVV----LFMGAVTKRP 729
           +++  ++  +V ++            +     E+  ++R+   N++      +  V   P
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLK 788
            LS++ EY  RG L  ++ +    + +  + +L MA+D  KG+  L+   N P  + +L 
Sbjct: 96  RLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           S + LV +N+ +K+   GL +  ++     K+V   +V+F
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYF 187

Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 21/162 (12%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-----RHPNVV 719
           +G GSFG V  AE  G++   A+K L     L+D   E      + +RV      HP + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC---TMVERRVLALAWEHPFLT 59

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
                   + HL  V EYL  G L  + H  ++G   + R R   A ++  G+ +LH   
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG 116

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTF 815
             I++ DLK  N+L+DK+  +K+ DFG+ +       KA+TF
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 7/147 (4%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLFMG 723
           VG+G++GTV  A     G+ VA+K L  + F  +   K   RE+ ++K ++H NV+  + 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 724 AVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             T    L    + YL    +   + +    E + + R   +   + KG+ Y+H     I
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG--I 139

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H DLK  NL V+++  +K+ DFGL+R
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 17/158 (10%)

Query: 662 HVKERVGAGSFGTVHRAEWHGSD----VAVKVLTVQDFLDDQL--KEFLREVAIMKRVR- 714
            + + +G G++G V  A    +     VA+K +T  +    ++  K  LRE+ +++  R 
Sbjct: 3   ELIKELGQGAYGIVCSARNAETSEEETVAIKKIT--NVFSKKILAKRALRELKLLRHFRG 60

Query: 715 HPNVV-LF-MGAVTKRPHLSI-VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           H N+  L+ M  V       + + E L    L+++I    +G+ +           +  G
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPLTDAHFQSFIYQILCG 117

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + Y+H+ N  +LH DLK  NLLV+ +  +K+CDFGL+R
Sbjct: 118 LKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 20/153 (13%)

Query: 666 RVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVR-HPNVVLF 721
           ++G G+F  V +A+    G   A+K +  + F   +Q+   LRE+  ++R+  HPN++  
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNN-LREIQALRRLSPHPNILRL 63

Query: 722 MGAVTKRPH--LSIVTEYLPRGSLYRLI---HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           +  +  R    L++V E L   +LY LI    RP     + ++R       + K ++++H
Sbjct: 64  IEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP-----LPEKRVKSYMYQLLKSLDHMH 117

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                I H D+K  N+L+  +  +K+ DFG  R
Sbjct: 118 RNG--IFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 11/148 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQD--FLDDQLKEFLREVAIMKRV-RHPNVVLF 721
           +G GSFG V  AE  G++   A+K L  +D   +DD ++  + E  ++     HP +   
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                 + +L  V EYL  G L   I    +    D  R    A ++  G+ +LH+    
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG-- 116

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I++ DLK  N+L+D +  +K+ DFG+ +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 14/177 (7%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRH 715
                 + +G G  G V      G+    A+KVL  ++ +  +++K  L E  I+  + H
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +     +     +L +V +Y P G L+RL+ R     + ++  R   A +V   + YL
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYL 119

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
           H L   I++ DLK  N+L+ ++  + + DF LS+           V    V  A  +
Sbjct: 120 HLLG--IVYRDLKPENILLHESGHIMLSDFDLSK--------QSDVEPPPVSKALRK 166

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 8/146 (5%)

Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +  G++G V+  R +      A+K +  Q+  L +Q+++   E  I+    +P VV    
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   + HL +V EY+  G    L+     G +     R+  A  V   + YLHN    I+
Sbjct: 69  SFETKRHLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVL-ALEYLHNYG--IV 123

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H DLK  NLL+     +K+ DFGLS+
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 22/172 (12%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAI-MK 711
               ++L     +G+G+ G V++  +   G  +AVK +       ++ K  L ++ + +K
Sbjct: 11  PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLK 69

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPR--GSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
               P +V   G       + I  E +      L + I  P     + +    +M + + 
Sbjct: 70  SHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP-----IPEDILGKMTVAIV 124

Query: 770 KGINYL---HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF----KANT 814
           K ++YL   H     ++H D+K  N+L+D +  VK+CDFG+S      KA T
Sbjct: 125 KALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 5e-07
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 19/153 (12%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVLFM 722
           +G G++G V  A        VA+K   + +  D+++  K  LRE+ +++ + H NV+  +
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIA-I 69

Query: 723 GAVTKRPH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
             +   PH      + IV E L    L+++I R +     D  +     L   +G+ Y+H
Sbjct: 70  KDIMPPPHREAFNDVYIVYE-LMDTDLHQII-RSSQTLSDDHCQYFLYQL--LRGLKYIH 125

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + N  +LH DLK  NLL++ N  +K+CDFGL+R
Sbjct: 126 SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 42/164 (25%), Positives = 88/164 (53%), Gaps = 24/164 (14%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V+ A    ++  VA+K ++      +++ ++ ++EV  ++R++HPN + + G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGINYLH 776
              +     +V EY   GS         A ++++  ++    +++A       +G+ YLH
Sbjct: 93  CYLREHTAWLVMEYC-LGS---------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISS 818
           + N  ++H D+K+ N+L+ +   VK+ DFG +     AN+F+ +
Sbjct: 143 SHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 12/148 (8%)

Query: 667 VGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV +  +        VAVK+L   D  D  LK E LRE  +M+++ +P +V  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILK-NDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
           +G + +     +V E    G L + + +    + + ++    +   V+ G+ YL   N  
Sbjct: 62  IG-ICEAESWMLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +H DL + N+L+      K+ DFGLS+
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 7/166 (4%)

Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   + +  G   A+K+L  +  +  D++   L E  +++  RHP +     
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +      L  V EY   G L+  + R       + R R   A ++   ++YLH+    ++
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIVSALDYLHS-EKNVV 118

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + DLK  NL++DK+  +K+ DFGL +       + K+  GT  + A
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 9/167 (5%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFM 722
           +G GSFG V  AE  G+D   A+KVL     L DD +   + E  I+     HP +    
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                +  L  V EY+  G L   I R       D+ R    A +V   + +LH     +
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG--V 117

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           ++ DLK  N+L+D     K+ DFG+ +      +++ +  GT  + A
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIA 164

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 11/168 (6%)

Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFL---REVAIMKRVRHPNVVLF 721
           +G GSFG V  A+    G   AVKVL  +  L+ + ++ +   R V ++K V+HP +V  
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
             +      L  V +++  G L+   H        + R R   A ++A  + YLH++N  
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHSIN-- 116

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           I++ DLK  N+L+D    V + DFGL +       ++ +  GT  + A
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 22/166 (13%)

Query: 667 VGAGSFGTVHRA-----EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G+G+ G V  A     E +   VA+K L+         K   RE+ +MK V H N++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 722 MGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           +   T +  L       IV E L   +L ++I        +D  R   +   +  GI +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
           H+    I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V
Sbjct: 143 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 24/175 (13%)

Query: 667 VGAGSFGTVH-----RAEWHGSDVAVKVL-----TVQDFLDDQLKEFLREVAIMKRVRHP 716
           +G GSFG V           G   A+KVL      V+D +  ++     E  I+  V HP
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-----ERDILAEVNHP 58

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMAL-DVAKGINY 774
            +V    A      L ++ ++L  G L+ RL     + E+M     ++  L ++A  +++
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDH 113

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LH+L   I++ DLK  N+L+D+   +K+ DFGLS+   +    + S  GTV + A
Sbjct: 114 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 41/156 (26%), Positives = 77/156 (49%), Gaps = 9/156 (5%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFL-REVAIM 710
           L++  ++  V + +G G+FG V       S    A+K+L+  + +      F   E  IM
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
                P VV    A     +L +V EY+P G L  L+   +  ++ ++  +   A +V  
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTA-EVVL 153

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
            ++ +H++   ++H D+K  N+L+DK+  +K+ DFG
Sbjct: 154 ALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 15/152 (9%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF----- 721
           +G GSFG V+ A     D + KV   +   D Q K   RE+ IMK + H N++       
Sbjct: 74  IGNGSFGVVYEAIC--IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYY 129

Query: 722 ---MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
                   K   L++V E++P+     + H       +        +  + + + Y+H+ 
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188

Query: 779 NPPILHWDLKSPNLLVDKN-WTVKVCDFGLSR 809
              I H DLK  NLL+D N  T+K+CDFG ++
Sbjct: 189 -KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 85  FTPQKSLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V
Sbjct: 139 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 11/169 (6%)

Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV---RHPNVVL 720
           +G G+FG V+  R +      A+KVL+ ++ +   ++   + E  I+ R      P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
              +      L +VT+Y+  G L+   H    G   + R +  +A ++   + +LH  + 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD- 116

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            I++ DLK  N+L+D    + +CDFGLS+       ++ +  GT  + A
Sbjct: 117 -IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 6/146 (4%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLFMG 723
           VG+G++G+V  A  +  G  VA+K L+ + F  +   K   RE+ ++K ++H NV+  + 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             T         ++       +   +   G  + + +   +   +  G+ Y+H+    I+
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--II 139

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H DLK  NL V+++  +K+ DFGL+R
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 18/179 (10%)

Query: 654 LEISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKE-----FLRE 706
           L +  ++  V + +G G+FG V   R +      A+K+L+      + +K      F  E
Sbjct: 38  LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK----FEMIKRSDSAFFWEE 93

Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             IM       +V    A     +L +V EY+P G L  L+   +  ++ ++  R   A 
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTA- 149

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGT 824
           +V   ++ +H++    +H D+K  N+L+DK+  +K+ DFG   +  AN  +   +  GT
Sbjct: 150 EVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGT 206

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 14/171 (8%)

Query: 667 VGAGSFGTVHRAE-WHGSD----VAVKVLTVQDFLDDQLKEFLREVA---IMKRVRHPNV 718
           +G G +G V +     G+D     A+KVL     + +Q K+     A   I++ V+HP +
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ-KDTAHTKAERNILEAVKHPFI 62

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V  + A      L ++ EYL  G L+  +H    G  M+      ++ +++  + +LH  
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS-EISLALEHLHQQ 119

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
              I++ DLK  N+L+D    VK+ DFGL +   +    + +  GT+ + A
Sbjct: 120 G--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 23/169 (13%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRV-----RH 715
           +G GSFG V  AE  G+D   A+K+L     +QD  DD     +    + KRV     + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD--DD-----VECTMVEKRVLALPGKP 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +            L  V EY+  G L  + H    G+  +       A ++A G+ +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVF-YAAEIAIGLFFL 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           H+    I++ DLK  N+++D    +K+ DFG+ +       ++++  GT
Sbjct: 118 HSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)

Query: 639 GPRYLNIEP-SLAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVK 688
           G  Y+ ++P  L  D  W E+  D L +   +G+G+FG V  A  HG         VAVK
Sbjct: 15  GHEYIYVDPMQLPYDSAW-EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVK 73

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L       ++ +  + E+ IM  +  H N+V  +GA TK   + I+TEY   G L   +
Sbjct: 74  MLKSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Query: 748 HR 749
           HR
Sbjct: 133 HR 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 23/159 (14%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 82

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG--------EMMDQRRRLRMALDVAKGINY 774
              T    L    +      +Y + H   A         ++ D   +  +   + +G+ Y
Sbjct: 83  DVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKY 135

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           +H+ +  I+H DLK  NL V+++  +K+ DFGL+R   +
Sbjct: 136 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 19/162 (11%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-----RHPNV 718
           +G GSFG V  AE  G     AVK L     L DD ++  + E    KRV      +P +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVE----KRVLALAWENPFL 58

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
                    + HL  V E+L  G L  + H    G   D  R    A ++  G+ +LH+ 
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRF-DLYRATFYAAEIVCGLQFLHSK 115

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820
              I++ DLK  N+++D++  +K+ DFG+   K N F  +++
Sbjct: 116 G--IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRA 153

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 9/156 (5%)

Query: 654 LEISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIM 710
           L +  ++  V + +G G+FG V   R +      A+K+L+  + +      F   E  IM
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
                P VV    A     +L +V EY+P G L  L+   +  ++ ++  R   A +V  
Sbjct: 98  AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTA-EVVL 153

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
            ++ +H++    +H D+K  N+L+DK+  +K+ DFG
Sbjct: 154 ALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.8 bits (107), Expect = 8e-05
 Identities = 32/129 (24%), Positives = 60/129 (46%), Gaps = 28/129 (21%)

Query: 709 IMKRVRHPNVV-LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR---- 763
           +MK   +PN + L+    T + H+ ++ +Y+  G L+ L+ +           +L     
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKK---------EGKLSEAEV 111

Query: 764 --MALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKS 820
             +   + + +N LH  N  I+H D+K  N+L D     + +CD+GL +      I + S
Sbjct: 112 KKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPS 164

Query: 821 VA-GTVVFF 828
              GT+ +F
Sbjct: 165 CYDGTLDYF 173

Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 9e-05
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 8/153 (5%)

Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G G+FG V   + +  G   A+K L   + L+ +Q+     E  I+    +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P VV    +     +L ++ EYLP G +  L+ +       ++  R  +A +    I+ +
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIA-ETILAIDSI 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H L    +H D+K  NLL+D    +K+ DFGL 
Sbjct: 118 HKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLC 148

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 16/172 (9%)

Query: 668 GAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRH-PNVV 719
           G G++G V           G   A+KVL     +      +    E  +++ VR  P +V
Sbjct: 9   GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
               A      L ++ +Y+  G L+  L  R       +   R+ +A ++   +++LH L
Sbjct: 69  TLHYAFQTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIA-EIVLALDHLHQL 124

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTVVFFA 829
              I++ D+K  N+L+D    V + DFGLS+ F A     + S  GT+ + A
Sbjct: 125 G--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V  AE  G+D   A+K+L     +QD  DD     + +  +    + P +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DDVECTMVEKRVLALSGKPPFLTQ 65

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                     L  V EY+  G L   I +        +   +  A ++A G+ +LH+   
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG- 121

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            I++ DLK  N+++D    +K+ DFG+ +      +++K+  GT  + A
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 8/144 (5%)

Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   +    G   A+K+L   D L+ +Q+     E  I+       VV    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   + +L ++ E+LP G +  L+ +     + ++  +  +A +    I+ +H L    +
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIA-ETVLAIDSIHQLG--FI 123

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL 807
           H D+K  NLL+D    VK+ DFGL
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 8/152 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G G+FG V   +    G   A+K+L   D L+ +Q+     E  I+     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
             VV    +   + +L ++ E+LP G +  L+ +     + ++  +  +A +    I+ +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIA-ETVLAIDAI 117

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
           H L    +H D+K  NLL+D    VK+ DFGL
Sbjct: 118 HQLG--FIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 30/128 (23%), Positives = 54/128 (42%), Gaps = 18/128 (14%)

Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP--RGSLYRLIHRPAAGEMMDQRRR 761
           L E  +++ V HP+V+     +       +V   LP     LY  +          +   
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL------TKRSRPLP 155

Query: 762 LRMAL----DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
           +  AL     + +G+ YLH     I+H D+K+ N+ ++    V + D G ++F      +
Sbjct: 156 IDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA 212

Query: 818 SKSVAGTV 825
              +AGTV
Sbjct: 213 FLGLAGTV 220

Length = 357

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 8/128 (6%)

Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRL 762
           L E  I+++V    +V    A   +  L +V   +  G L Y + +    G    + R +
Sbjct: 41  LNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAI 98

Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSV 821
             A  +  G+ +LH     I++ DLK  N+L+D +  V++ D GL+   K    I  K  
Sbjct: 99  FYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGR 154

Query: 822 AGTVVFFA 829
           AGT  + A
Sbjct: 155 AGTPGYMA 162

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 13/169 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V  AE  G+D   A+K+L     +QD  DD     + +  +  + + P +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DDVECTMVEKRVLALQDKPPFLTQ 65

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                     L  V EY+  G L   I +        + + +  A +++ G+ +LH    
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRG- 121

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            I++ DLK  N+++D    +K+ DFG+ +      +++++  GT  + A
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIA 169

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 31/142 (21%), Positives = 60/142 (42%), Gaps = 16/142 (11%)

Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK----------EFLREVAIMKRVR 714
           E +G G+F  +++           V   Q+ +   LK           F    ++M ++ 
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQE-VSVVLKVLGSDHRDSLAFFETASLMSQLS 59

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           H ++V   G V  R    +V EY+  G L   +HR      +    +L +A  +A  ++Y
Sbjct: 60  HKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHY 116

Query: 775 LHNLNPPILHWDLKSPNLLVDK 796
           L +    ++H ++   N+LV +
Sbjct: 117 LEDKK--LVHGNVCGKNILVAR 136

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 4e-04
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)

Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRH 715
           D+  V + +G G+FG V   R +  G   A+KVL   D +  +Q+     E  I+     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 716 PNVV-LFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           P +V L+     +  HL +V EY+P G L   LI +    E   +     + L     ++
Sbjct: 61  PWIVKLYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL----ALD 115

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            +H L    +H D+K  N+L+D +  +K+ DFGL 
Sbjct: 116 SVHKLG--FIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 4e-04
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 8/147 (5%)

Query: 670 GSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRHPNVVLFMGAVT 726
           G+FG V+  R + +    AVKV+   D ++  +   ++ E   +   + P +V    ++ 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWD 786
              ++ +V EYL  G +  L+H        D+   ++   +VA  ++YLH     I+H D
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG--IIHRD 129

Query: 787 LKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           LK  N+L+     +K+ DFGLS+   N
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLN 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 10/154 (6%)

Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQD-FLDDQLKEFLREVAIMKRVRH 715
           ++ H  + +G G+FG V   +    G   A+K L   + F  DQL     E  ++     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           P VV    +     +L ++ E+LP G L   LI      E +    R  MA +    I  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMA-ECVLAIEA 116

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +H L    +H D+K  N+L+D+   +K+ DFGLS
Sbjct: 117 VHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 9/167 (5%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFM 722
           +G GSFG V  A    S    AVKVL     L DD ++  + E  I+   R HP +    
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V E++  G L   I +       D+ R    A ++   + +LH+    I
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG--I 117

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           ++ DLK  N+L+D     K+ DFG+ +       ++ +  GT  + A
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.7 bits (103), Expect = 5e-04
 Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 10/132 (7%)

Query: 682 GSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVV-LFMGAVTKRPHLSIVTEYLP 739
           G +VA+K+L      ++ Q   F RE A+  R+ HPN+V L          L  V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DK 796
             +L  ++   AA   +      R+ L V   +   HN    I+H DLK  N++V     
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGV 117

Query: 797 NWTVKVCDFGLS 808
               KV DFG+ 
Sbjct: 118 RPHAKVLDFGIG 129

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A        VAVK L+   Q  +    +   RE+ ++K ++H NV+  +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI--HARRTYRELRLLKHMKHENVIGLL 80

Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    +    E YL    +   ++     + +       +   + +G+ Y+H+    
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  N+ V+++  +++ DFGL+R
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 5/109 (4%)

Query: 701 KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQR 759
           K  L E  I+++V  P +V    A   + HL +V   +  G L Y + +    G  ++  
Sbjct: 38  KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEME 95

Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           R +  +  +  GI +LH+++  I++ D+K  N+L+D     ++ D GL+
Sbjct: 96  RVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 15/35 (42%), Positives = 18/35 (51%), Gaps = 5/35 (14%)

Query: 657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVL 690
            +DE    E + A S   VHRA    G +VAVKV 
Sbjct: 13  EFDE----EPIAAASIAQVHRAVLKDGEEVAVKVQ 43

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 7e-04
 Identities = 37/144 (25%), Positives = 67/144 (46%), Gaps = 8/144 (5%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQD-FLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V       ++   A+K L   D  + +Q      E  I+    +  VV    
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   + +L  V +Y+P G +  L+ R   G   +   R  +A ++   I  +H +    +
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIA-ELTCAIESVHKMG--FI 123

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL 807
           H D+K  N+L+D++  +K+ DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 8/144 (5%)

Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQD-FLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   R     +  A+K L  +D  L +Q+     E  I+    +  VV    
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   + +L  V +Y+P G +  L+ R   G   +   R  +A ++   +  +H +    +
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIA-ELTCAVESVHKMG--FI 123

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL 807
           H D+K  N+L+D++  +K+ DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 14/158 (8%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V +     +    A+K +     +   ++   L E  ++ +V  P +V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +      L +V  ++  G L+  + R   G     R R   A ++   +  LH  N  ++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTA-ELLCALENLHKFN--VI 115

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTF 815
           + DLK  N+L+D    + +CDFGL +       K NTF
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 0.001
 Identities = 25/139 (17%), Positives = 61/139 (43%), Gaps = 9/139 (6%)

Query: 670 GSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729
                + + +   + VAVK + +     + LK   +E+   ++++HPN++ ++ +     
Sbjct: 13  LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72

Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL---DVAKGINYLHNLNPPILHWD 786
            L +V+  +  GS   L+         +    L +A    DV   ++Y+H+     +H  
Sbjct: 73  ELYVVSPLMAYGSCEDLLKT----HFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRS 126

Query: 787 LKSPNLLVDKNWTVKVCDF 805
           +K+ ++L+  +  V +   
Sbjct: 127 VKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 24/137 (17%)

Query: 729 PHLSIVTEYLP----RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
            + S   +YLP    R     LI+   A   MD    +  +  VA G+ +L + N   +H
Sbjct: 208 NYESPYDQYLPSAPERTRRDTLINESPALSYMDL---VGFSYQVANGMEFLASKN--CVH 262

Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR---------FKANTFISSKSVAGTVVFFAAHQTAC 835
            DL + N+L+ +   VK+CDFGL+R          K +TF+  K +A   +F   + T  
Sbjct: 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322

Query: 836 NSLAL------IFSLSG 846
           +  +       IF+L G
Sbjct: 323 DVWSFGILLWEIFTLGG 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 17/100 (17%)

Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR---------FKA 812
           L     VA+G+ +L + N   +H DL + N+L+ +   VK+CDFGL+R          K 
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 813 NTFISSKSVAGTVVFFAAHQTACNSLAL------IFSLSG 846
           +TF+  K +A   +F   + T  +  +       IFSL G
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 53/223 (23%), Positives = 80/223 (35%), Gaps = 71/223 (31%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
           E   D L + + +G G+FG V  A   G D       VAVK+L       +  K  + E+
Sbjct: 3   EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH-KALMSEL 61

Query: 708 AIMKRV-RHPNVVLFMGAV------------------------TKRPHLSIVTEYLPRG- 741
            I+  +  H NVV  +GA                          KR   S   E  P+  
Sbjct: 62  KILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQR 121

Query: 742 -------SLYRLIHRPAAGEMMDQRRRLRM----------------------------AL 766
                     R+  R  AG+      R +                             + 
Sbjct: 122 GRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSF 181

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            VA+G+ +L +     +H DL + N+L+ +N  VK+CDFGL+R
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.9 bits (94), Expect = 0.003
 Identities = 31/160 (19%), Positives = 62/160 (38%), Gaps = 39/160 (24%)

Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLR------EVAIMKRVRH----- 715
           +  G+   ++  ++ G    +K    + +   +L E +R      E  ++ R R      
Sbjct: 2   IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ---RRRLRMALDVAKGI 772
           P VV  +    K    +IV EY+              G+ +          +  ++ + +
Sbjct: 62  P-VVYDVDPDNK----TIVMEYIE-------------GKPLKDVIEEGNDELLREIGRLV 103

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVC--DFGLSRF 810
             LH     I+H DL + N++V  +   K+   DFGL ++
Sbjct: 104 GKLHKAG--IVHGDLTTSNIIVRDD---KLYLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 37/144 (25%), Positives = 67/144 (46%), Gaps = 8/144 (5%)

Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V         +  A+K L  +D L+ +Q+     E  I+    +  VV    
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +   + +L  V +Y+P G +  L+ R       +   R  +A ++   I  +H +    +
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIA-ELTLAIESVHKMG--FI 123

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL 807
           H D+K  N+L+D +  +K+ DFGL
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (93), Expect = 0.003
 Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 32/156 (20%)

Query: 670 GSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLR------EVAIMKRVRHPNVVLFMG 723
           G+   ++  ++ G    +K    + +   +L E +R      E  IM R R        G
Sbjct: 7   GAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK------AG 60

Query: 724 AVTKRPHL------SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
                 +        IV EY+    L  LI+             L ++ ++ + +  LH+
Sbjct: 61  VNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-------MEELELSREIGRLVGKLHS 113

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVC--DFGLSRFK 811
               I+H DL + N+++      K+   DFGL+ F 
Sbjct: 114 AG--IIHGDLTTSNMILSGG---KIYLIDFGLAEFS 144

Length = 211

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREV 707
           E   D L   + +GAG+FG V  A   G         VAVK+L      D++ +  + E+
Sbjct: 34  EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER-EALMSEL 92

Query: 708 AIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA 751
            I+  + +H N+V  +GA T    + ++TEY   G L   + + A
Sbjct: 93  KILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.004
 Identities = 20/54 (37%), Positives = 32/54 (59%), Gaps = 2/54 (3%)

Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +D    L  +  VAKG+++L + N   +H DL + N+L+      K+CDFGL+R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 36/147 (24%), Positives = 71/147 (48%), Gaps = 9/147 (6%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLR-EVAIMKRV-RHPNVVLFM 722
           +G GS+  V       ++   A+KV+  +   DD+  ++++ E  + ++   HP +V   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V EY+  G L  + H     ++ ++  R   A +++  +NYLH     I
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--I 117

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++ DLK  N+L+D    +K+ D+G+ +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	867
PF14381	204	EDR1: Ethylene-responsive protein kinase Le-CTR1	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.98
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.98
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.98
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.98
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.98
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.98
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.98
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.92
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.9
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.83
PLN00181	793	protein SPA1-RELATED; Provisional	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
PRK10345	210	hypothetical protein; Provisional	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.68
smart00090	237	RIO RIO-like kinase.	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.44
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.41
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.23
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.12
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.09
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
KOG3087	229	consensus Serine/threonine protein kinase [General	98.91
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.91
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.55
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.45
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.3
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.28
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.27
COG4248	637	Uncharacterized protein with protein kinase and he	98.25
PF01636	239	APH: Phosphotransferase enzyme family This family	98.24
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
PRK09902	216	hypothetical protein; Provisional	98.15
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.1
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.96
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.81
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.78
PLN02876	822	acyl-CoA dehydrogenase	97.73
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.66
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.59
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.49
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.49
PRK10593	297	hypothetical protein; Provisional	97.43
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.43
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.37
smart00460	68	TGc Transglutaminase/protease-like homologues. Tra	97.33
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.31
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.26
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.12
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.83
PRK05231	319	homoserine kinase; Provisional	96.82
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.73
COG5279	521	CYK3 Uncharacterized protein involved in cytokines	96.71
PF01841	113	Transglut_core: Transglutaminase-like superfamily;	96.54
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.15
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.08
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.04
PLN02236	344	choline kinase	96.02
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	95.99
KOG2270	520	consensus Serine/threonine protein kinase involved	95.75
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.65
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.65
PLN02756	418	S-methyl-5-thioribose kinase	95.6
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.4
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.05
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.97
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	93.42
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.39
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	92.68
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.48
PTZ00384	383	choline kinase; Provisional	92.42
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.83

>PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1

Probab=100.00  E-value=1.8e-68  Score=547.52  Aligned_cols=200  Identities=53%  Similarity=0.941  Sum_probs=188.7

Q ss_pred             CChHHHHHHHhhcccccCCCCccCceeeeccCcccceeecc-cc-ccCCCCCChhccccCCCCCcceeEEEecCCCChhH
Q 002910          259 SDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCN-DL-EEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRL  336 (867)
Q Consensus       259 ~~~e~~S~r~w~~g~Lsy~d~i~DGFYdi~~~~p~~~~~~~-d~-~~~~~~Psl~~l~~~~~~~~~~evilvd~~~D~~L  336 (867)
                      ++||++|||||++|+|||+|||+||||||+|++      |+ +. ++++||||+++|+++++.+.++|||||||..|+.|
T Consensus         1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~------~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L   74 (204)
T PF14381_consen    1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMD------CTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSL   74 (204)
T ss_pred             CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCC------CccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHH
Confidence            479999999999999999999999999999996      63 44 68999999999999998899999999999999999


Q ss_pred             HHHHHHHHHHhhcCC-ChHHHHHHHHHHHHhhhCCCccCCCchhhHHHHHHHHHHHhhcCCeeEEeeccccccchhhHHH
Q 002910          337 KELEDKAQELYCASE-NTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAIL  415 (867)
Q Consensus       337 ~~l~~~a~~~~~~~~-~~~~~v~~LA~lV~~~MGG~~~~~~~~l~~~w~~~~~~lk~~l~s~V~piG~l~~Gl~rHRALL  415 (867)
                      ++|+++|+++++++. +++++|++||+|||++|||++. +++.+..+|++++.+||.  +++++|||+|++|+|||||||
T Consensus        75 ~~L~~~a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~~~-~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALL  151 (204)
T PF14381_consen   75 KELEQRAHELSKGLSTNTKELVQKLAKLVADRMGGPVS-DAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALL  151 (204)
T ss_pred             HHHHHHHHHHHhccccCHHHHHHHHHHHHHHHhCCCCC-cchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHH
Confidence            999999999999987 7999999999999999999998 445555579998888998  999999999999999999999


Q ss_pred             HHhhhhhcCCCceeeccccccCC-CCcceEEEEecCCCCCCceEEEeccCCCCcccC
Q 002910          416 FKKLADYIGLPCRIARGCRYCEA-DHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHG  471 (867)
Q Consensus       416 FKvLAD~IglpcrLvrG~~y~~~-~~~a~n~V~l~~~~~~~~eyiVDLm~~PG~L~~  471 (867)
                      ||||||+|||||||||||+|||. +++|||+|++++++    |||||||++||+|+|
T Consensus       152 FKvLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~----eyiVDLm~~PG~L~P  204 (204)
T PF14381_consen  152 FKVLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDGR----EYIVDLMGAPGQLIP  204 (204)
T ss_pred             HHHHHHhcCCCceEEeeccCCccCCCCceEEEEcCCCc----EEEEEcCCCCCCcCC
Confidence            99999999999999999999999 99999999999988    999999999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=382.91  Aligned_cols=203  Identities=23%  Similarity=0.380  Sum_probs=186.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|++++.||+|+||+||.++.  +++.+|+|++++..+.. +..+....|..||.+++||+||.++..|++..++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            34568999999999999999999987  57779999999988775 4678899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |||+||+.||+|+.+|++.   +.+++.++..|+.+|+.||.|||++|  ||||||||+|||||.+|+|+|+|||||+..
T Consensus       101 ylVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999999873   45899999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ........++|||++|||||++....+   +|+||||+++|+|++|.+||....
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            665556678999999999999998776   799999999999999999998755

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=378.60  Aligned_cols=211  Identities=43%  Similarity=0.652  Sum_probs=191.8

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcCce-EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~-VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ...+.+.+.++.+.+.||.|+||+||+|.|+|+. ||||++..........+.|.+|+.+|.+++|||||+|+|++..++
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3556788888899999999999999999999999 999999988777666889999999999999999999999999988


Q ss_pred             -eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCc
Q 002910          730 -HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGL  807 (867)
Q Consensus       730 -~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGL  807 (867)
                       .++||||||++|+|.+++++. ....+++..++.||.||++||+|||++++ ||||||||+||||+.++ ++||||||+
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcc
Confidence             799999999999999999874 34569999999999999999999999886 99999999999999998 999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCC--C---hHHHHHHHHHHHHHhcCCCCccccch
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACN--S---LALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~--~---~SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ++....+........||+.|||||++++.  .   ++||||||+++|||+||..||..+..
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            99988765445568999999999999943  3   48999999999999999999998875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=370.70  Aligned_cols=200  Identities=24%  Similarity=0.468  Sum_probs=182.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ...+|.+.+.||.|+||+||+|++  ++..||||.+.+..+..+..+.+..|+.||+.++|||||.+++++...+.+|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            347899999999999999999998  577899999999888888888899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC------CcEEEEecCcc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN------WTVKVCDFGLS  808 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~------g~VKLsDFGLA  808 (867)
                      ||||.||+|..+|++.+   .+++..++.++.||+.||++||+++  ||||||||.||||+..      -.+||+|||+|
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999999744   5999999999999999999999999  9999999999999764      46899999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      |.+..... ..+.||+|-|||||+++...|   +|+||+|++||+|++|++||....
T Consensus       163 R~L~~~~~-a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQPGSM-AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCchhH-HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            99876543 468899999999999976554   899999999999999999998543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=356.60  Aligned_cols=200  Identities=26%  Similarity=0.429  Sum_probs=184.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ...++|++++.||.|+||+|.+++.  +|..+|+|++.++.+.. ++.+...+|..+|+.+.||+++++++.|.+..++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            3568999999999999999999987  57789999999987764 78889999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      |||||++||.|+.++++.+   .+++..++++|.||+.||+|||+++  |+||||||+|||||++|++||+|||+|+...
T Consensus       121 mvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            9999999999999999743   5899999999999999999999999  9999999999999999999999999999876


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ..   ..+.||||+|+|||+++..++   +|+|+||+++|||+.|.+||..-..
T Consensus       196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            65   358899999999999997666   7999999999999999999987654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-40  Score=372.43  Aligned_cols=198  Identities=28%  Similarity=0.398  Sum_probs=184.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ..|..++.||+|+|++||.++.  .|..||+|++.+..+.. ...+.+.+||+|.+.|+|||||+|+++|++..++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999987  68899999999876654 56778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |+|..++|..++++   .+.++|.+++++++||+.||.|||+++  |||||||..|+||+.+.+|||+|||||..+....
T Consensus        98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999999985   446999999999999999999999999  9999999999999999999999999999988777


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....+.||||.|+|||++.....   +||||+||++|.|+.|+|||+.-
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            77889999999999999996555   79999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-40  Score=359.63  Aligned_cols=199  Identities=24%  Similarity=0.375  Sum_probs=176.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-----HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-----~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ..+.|.+.+.||+|+||.|-+|..  +|+.||||++.++.....     ......+|++||++|+|||||+++++|+.+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            347789999999999999999977  688999999998776541     2233579999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC---CcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~---g~VKLsDFG  806 (867)
                      ..||||||+.||+|++.+-...   .+.+.....++.|++.|+.|||++|  |+||||||+|||+..+   -.+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999999998743   4888888999999999999999999  9999999999999766   789999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCCh------HHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSL------ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~------SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+.... ....++.||||.|.|||++.+...      .|||||||+||-+++|++||..-
T Consensus       325 lAK~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  325 LAKVSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             hhhcccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            9998864 334689999999999999996543      69999999999999999999753

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=371.54  Aligned_cols=201  Identities=28%  Similarity=0.405  Sum_probs=183.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP  729 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~  729 (867)
                      ..+..++|.++++||+|+||+|+++..+  ++.+|||++++..+. .+.++..+.|.+|+.... ||+++.++..|+++.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3567899999999999999999999884  567999999998876 467889999999998886 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ++|+||||+.||++..+++    ...+++.++..||.+|+.||.|||++|  |||||||.+|||||..|++||+|||||+
T Consensus       443 ~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             eEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999654443    235999999999999999999999999  9999999999999999999999999999


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..........++||||+|||||++.+..|   .|+|+||++||+|+.|..||..
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence            88777777889999999999999998877   6999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.5e-39  Score=361.49  Aligned_cols=203  Identities=26%  Similarity=0.380  Sum_probs=181.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|.+++.||+|+||.||+|+-  +|..+|+|++++..... .+++.++.|..||....+|+||++|.+|++..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            55789999999999999999999976  68889999999987664 6788999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ||||||++||++..+|.+.   ..+++..+.+|+.+++.|++-||++|  +|||||||+|+|||..|++||+|||||.-+
T Consensus       217 YLiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999999874   45999999999999999999999999  999999999999999999999999998532


Q ss_pred             cC-----------------------Ccc------------------------cccccCCCcccccccccCCCCh---HHH
Q 002910          812 AN-----------------------TFI------------------------SSKSVAGTVVFFAAHQTACNSL---ALI  841 (867)
Q Consensus       812 ~~-----------------------t~~------------------------s~~s~aGTp~YmAPEvl~~~~~---SDI  841 (867)
                      ..                       .+.                        ...+..|||.|||||++.+..+   +|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            10                       000                        1225689999999999998776   799


Q ss_pred             HHHHHHHHHHhcCCCCccccc
Q 002910          842 FSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       842 wSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ||||||+|||+.|.+||.+-.
T Consensus       372 WSLG~ImyEmLvGyPPF~s~t  392 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSET  392 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999998643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=347.65  Aligned_cols=197  Identities=30%  Similarity=0.438  Sum_probs=179.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe-EE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH-LS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~-l~  732 (867)
                      +..++++.+..||+|..|+||+++++  +..+|+|++. -.......+++.+|++|++.++||+||.+||+|..++. ++
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            45578888999999999999999984  7779999994 33445667889999999999999999999999999995 99


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+||||.+|+|..++...   +.++|....+++.+|++||.|||. ++  ||||||||+||||+..|.|||||||.++.+
T Consensus       155 I~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            999999999999999864   459999999999999999999995 88  999999999999999999999999999998


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .++  ...++.||..|||||.+++..|   +||||||++++|+++|+.||-.
T Consensus       230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~  279 (364)
T KOG0581|consen  230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP  279 (364)
T ss_pred             hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence            887  3578999999999999999887   6999999999999999999876

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-40  Score=344.31  Aligned_cols=205  Identities=22%  Similarity=0.398  Sum_probs=184.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe-EEeeCCe-EE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG-AVTKRPH-LS  732 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~g-a~~~~~~-l~  732 (867)
                      +..+|+++++||.|+||+||++..  +|..+|.|.+.-.....+..+.+..|+.+|++|+|||||++++ .|.+.+. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            347899999999999999999976  7888999999977777788889999999999999999999998 5555555 89


Q ss_pred             EEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--ccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          733 IVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPP--ILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~--IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ||||||.+|+|.++++... .+..++|+.+++++.|++.||.++|..-++  |+||||||.||+|+.+|.|||+||||+|
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999998632 345689999999999999999999984444  9999999999999999999999999999


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+.+......+..|||.||+||.+...++   +|||||||++|||+.-.+||..-
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            99887776788999999999999998776   89999999999999999999865

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=350.90  Aligned_cols=202  Identities=26%  Similarity=0.405  Sum_probs=180.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~  732 (867)
                      ..+||..++.||.|+|++|++|+.  .+++||||++.+..+.. +.++.+.+|..+|.+| .||.||+|+..|++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            458999999999999999999987  57889999998877665 3466788999999999 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +|+||+++|+|.++|++.+   .+++..+++|+.+|+.||+|||++|  ||||||||+|||||++|++||+|||.|+.+.
T Consensus       151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999999854   5999999999999999999999999  9999999999999999999999999998764


Q ss_pred             CCc-----------ccc--cccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          813 NTF-----------ISS--KSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       813 ~t~-----------~s~--~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ...           ...  .++.||.+|.+||++.+...   +|||+|||+||+|+.|.+||.....
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence            321           112  56899999999999998655   7999999999999999999987643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=341.91  Aligned_cols=202  Identities=25%  Similarity=0.394  Sum_probs=179.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc---hHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~---~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~  729 (867)
                      ...+.|.+++.||.|+||+|++|.+  ++..||+|++......   ....+.+.+|+.+|++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4568999999999999999999987  5788999987775332   123455678999999999 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCcc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLA  808 (867)
                      .++|||||+.||+|++++..   .+.+.|..+.+++.|++.|++|||++|  |+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999987   345889999999999999999999999  9999999999999999 99999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCC-h----HHHHHHHHHHHHHhcCCCCccccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNS-L----ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~-~----SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...........+.|||+.|+|||++.+.. +    +||||+|++||.|++|..||....
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~  227 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN  227 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence            98743344567899999999999999866 5    799999999999999999998643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-38  Score=351.25  Aligned_cols=199  Identities=29%  Similarity=0.491  Sum_probs=183.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|.+.+.||+|+||.||+|+.+  .+.||||.+.+....+++++.+.+|++|++.++|||||.++++|++..++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999874  5679999999998888999999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+.| +|+.+|....   .++|+.+..++.+++.||.|||+++  |+|||+||.|||++++|++|+||||++|.+.....
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            9966 9999998743   5999999999999999999999999  99999999999999999999999999998876555


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      -..++.|||-|||||++.+.++   +|.|||||++|||+.|.|||.....
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si  205 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI  205 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH
Confidence            5578899999999999998888   7999999999999999999986543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-37  Score=345.04  Aligned_cols=204  Identities=35%  Similarity=0.594  Sum_probs=182.9

Q ss_pred             cccccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       650 ~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ....|+|..+++.++++||+|+||+||+|+|.| +||||++.......++++.|++|+..+++-||-||+.|+|+|..++
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            347899999999999999999999999999987 5899999999999999999999999999999999999999999888


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      . .||+.+|+|.+|+.+||...  ..++-.+.+.||.||++||.|||.++  |||||||..||+|.++++|||+||||+.
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEeccccee
Confidence            7 99999999999999999754  35788889999999999999999999  9999999999999999999999999986


Q ss_pred             cccC--CcccccccCCCcccccccccCC---CCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          810 FKAN--TFISSKSVAGTVVFFAAHQTAC---NSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       810 ~~~~--t~~s~~s~aGTp~YmAPEvl~~---~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      .+..  .........|...|||||+++-   +++   +||||||+++|||++|..||.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            5432  1222234567889999999983   333   899999999999999999997

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-35  Score=326.75  Aligned_cols=198  Identities=23%  Similarity=0.337  Sum_probs=172.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+|+.  +++.||||++.+.... ......+.+|+.++.+++||||+++++.+.+...+||||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999987  4778999999865433 344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++.+.   ..+++..+..++.||+.||+|||++|  |+||||||+||||+.++++||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999763   35899999999999999999999999  9999999999999999999999999987543210


Q ss_pred             -----------------------------------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCC
Q 002910          816 -----------------------------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQ  857 (867)
Q Consensus       816 -----------------------------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~P  857 (867)
                                                         ......+||+.|+|||++.+..+   +|||||||++|+|++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               00124589999999999987554   8999999999999999999


Q ss_pred             cccc
Q 002910          858 MRSL  861 (867)
Q Consensus       858 f~sl  861 (867)
                      |...
T Consensus       236 f~~~  239 (363)
T cd05628         236 FCSE  239 (363)
T ss_pred             CCCC
Confidence            9754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=339.12  Aligned_cols=207  Identities=32%  Similarity=0.532  Sum_probs=180.6

Q ss_pred             cccccccCCCCeEEEEEeccCCceEEEEEEEcCc-eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       650 ~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~-~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ..+.|++..+.+++++.||+|-||+||+|.|+++ .||+|.++......   +.|.+|+.||++|+|+|||+++++|+.+
T Consensus       197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  197 ARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             ccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            3677889999999999999999999999999887 89999998765443   4678999999999999999999999998


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+|||||||+.|+|.++|+.. .+..+.-.+.+.|+.|||+||+||++++  +|||||..+||||+.+..|||+||||+
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccc
Confidence            8999999999999999999873 3556888999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCccccc-ccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          809 RFKANTFISSK-SVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~~-s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      |...+.....+ ..--..-|.|||.+....+   |||||||++|||||| |..||..+.
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms  409 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS  409 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence            97665544333 3333568999999998776   799999999999987 567766543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=327.46  Aligned_cols=202  Identities=23%  Similarity=0.353  Sum_probs=186.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      -.+..++|..+++||+|.||+|-+++.  .++.+|||++++..+.. +.+...+.|-++|+..+||++..+...|++..+
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            345668999999999999999999987  57889999999887764 677888999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+.||.|+.+|.+   ...+++.+.+++..+|+.||.|||+++  ||+||||.+|+|||++|++||+|||||+.
T Consensus       243 lCFVMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchh
Confidence            9999999999999998876   345899999999999999999999999  99999999999999999999999999998


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ........+++||||+|+|||++..+.+   .|+|.+|+++|+|++|+.||..
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            8877777899999999999999998877   6999999999999999999864

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=331.46  Aligned_cols=209  Identities=32%  Similarity=0.517  Sum_probs=176.9

Q ss_pred             ccccccccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       649 l~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      +...++.-.+++|.-...||+|+||.||+|...+ +.||||.+.......  .++|.+|+.++.+++|||||+|+|+|.+
T Consensus        65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            3445555667889888999999999999999854 889999776544322  4569999999999999999999999999


Q ss_pred             CC-eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEec
Q 002910          728 RP-HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDF  805 (867)
Q Consensus       728 ~~-~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDF  805 (867)
                      .+ +.+||+|||++|+|.++|+..... .++|..+++||.++|+||+|||. ..|+|||||||++|||||.++++||+||
T Consensus       143 ~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  143 GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            88 599999999999999999985433 78999999999999999999998 4458999999999999999999999999


Q ss_pred             CccccccCCccccccc-CCCcccccccccCC---CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          806 GLSRFKANTFISSKSV-AGTVVFFAAHQTAC---NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       806 GLAr~~~~t~~s~~s~-aGTp~YmAPEvl~~---~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      |||+..........+. .||.+|+|||.+..   ..++||||||++|.|+++|+.+...
T Consensus       222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence            9997654311111222 89999999999975   4458999999999999999976653

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=322.10  Aligned_cols=198  Identities=24%  Similarity=0.336  Sum_probs=172.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+|++  +++.||||++...... ......+.+|+.+|+.++||||++++++|.....+||||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999988  4778999999865433 244567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999999763   35899999999999999999999999  9999999999999999999999999987542211


Q ss_pred             c--------------------------------------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcC
Q 002910          816 I--------------------------------------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE  854 (867)
Q Consensus       816 ~--------------------------------------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG  854 (867)
                      .                                      ...+.+||+.|+|||++....+   +|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            0                                      1123579999999999887554   7999999999999999


Q ss_pred             CCCcccc
Q 002910          855 SPQMRSL  861 (867)
Q Consensus       855 ~~Pf~sl  861 (867)
                      .+||...
T Consensus       236 ~~Pf~~~  242 (364)
T cd05599         236 YPPFCSD  242 (364)
T ss_pred             CCCCCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-35  Score=318.28  Aligned_cols=198  Identities=23%  Similarity=0.366  Sum_probs=175.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ...++|.+.+.||+|+||+||+|++  +++.||||++....... ...+.+.+|+.+|++++||||+++++++...+.++
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            3458999999999999999999998  46789999998654332 45667899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++...
T Consensus        95 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999999763   35788999999999999999999999  9999999999999999999999999998764


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...   ...+||+.|+|||++.+...   +|||||||++|+|++|..||...
T Consensus       170 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  218 (329)
T PTZ00263        170 DRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD  218 (329)
T ss_pred             CCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence            432   35689999999999986554   89999999999999999999654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-36  Score=326.49  Aligned_cols=199  Identities=24%  Similarity=0.420  Sum_probs=183.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .+|.+.+.||+|.||+|-+|..  -|+.||||.|+++.+.. ..+..+.+|++||..|+||||+.+|.+|+....+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            6788999999999999999976  58899999999988775 56888999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||..+|.|++|+.+..   .++++.++.+++||+.|+.|+|+++  ++|||||.+|||||.++++||+||||+.......
T Consensus       133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            9999999999998744   5999999999999999999999999  9999999999999999999999999998776543


Q ss_pred             ccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      . .+++||+|-|.+||++.+.+|    .|.||||++||.++.|..||.+...
T Consensus       208 f-LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh  258 (668)
T KOG0611|consen  208 F-LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH  258 (668)
T ss_pred             H-HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence            2 478999999999999999888    6999999999999999999987543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.7e-35  Score=323.68  Aligned_cols=197  Identities=23%  Similarity=0.289  Sum_probs=170.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .|.+++.||+|+||+||+|++  ++..||||++...... ......+.+|+.+|++++|||||++++++.+...+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            688999999999999999988  5678999999876543 3456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--  814 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--  814 (867)
                      |+++|+|.+++.+.   ..+++..+..++.||+.||+|||+++  |+||||||+||||+.++++||+|||+++.....  
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999763   34889999999999999999999999  999999999999999999999999998643110  


Q ss_pred             ---------------------------------------------cccccccCCCcccccccccCCCCh---HHHHHHHH
Q 002910          815 ---------------------------------------------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSG  846 (867)
Q Consensus       815 ---------------------------------------------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~  846 (867)
                                                                   .....+.+||+.|+|||++.+..+   +|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         001124579999999999886554   79999999


Q ss_pred             HHHHHhcCCCCcccc
Q 002910          847 WLQSSFEESPQMRSL  861 (867)
Q Consensus       847 lLyeM~tG~~Pf~sl  861 (867)
                      ++|+|++|.+||...
T Consensus       237 il~elltG~~Pf~~~  251 (381)
T cd05626         237 ILFEMLVGQPPFLAP  251 (381)
T ss_pred             HHHHHHhCCCCCcCC
Confidence            999999999999653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.7e-35  Score=323.69  Aligned_cols=197  Identities=22%  Similarity=0.299  Sum_probs=170.6

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .|.+++.||+|+||+||+|+.  .++.||||++.+.... ......+.+|+.++++++|||||++++.|.....+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588999999999999999987  5677999999865433 3456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--  814 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--  814 (867)
                      ||++|+|.+++.+.   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+|++||+|||+++.....  
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999763   35889999999999999999999999  999999999999999999999999997532100  


Q ss_pred             ---------------------------------------------cccccccCCCcccccccccCCCCh---HHHHHHHH
Q 002910          815 ---------------------------------------------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSG  846 (867)
Q Consensus       815 ---------------------------------------------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~  846 (867)
                                                                   .....+.+||+.|+|||++.+..+   +|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         001124579999999999987655   79999999


Q ss_pred             HHHHHhcCCCCcccc
Q 002910          847 WLQSSFEESPQMRSL  861 (867)
Q Consensus       847 lLyeM~tG~~Pf~sl  861 (867)
                      ++|+|++|.+||...
T Consensus       237 il~elltG~~Pf~~~  251 (382)
T cd05625         237 ILYEMLVGQPPFLAQ  251 (382)
T ss_pred             HHHHHHhCCCCCCCC
Confidence            999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-35  Score=331.01  Aligned_cols=208  Identities=25%  Similarity=0.399  Sum_probs=182.0

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-  728 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-  728 (867)
                      .|.....+.|+.+++||+|.||.||+|+.  +|+.||+|.++.+........-..+||.||++|.||||+++.+.++.. 
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            56666778999999999999999999998  678899999998876666667778999999999999999999999877 


Q ss_pred             -CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          729 -PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       729 -~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                       ..+|||+|||+. +|.-++...  +-.+++.++..|+.|++.||+|||.+|  |+|||||.+|||||.+|.+||+||||
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccc
Confidence             689999999966 787777753  346999999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCc-ccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccchh
Q 002910          808 SRFKANTF-ISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMFI  864 (867)
Q Consensus       808 Ar~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~L  864 (867)
                      |++..... ....+..-|.=|.|||++.+...    .|+||.||||.|||+|++.|+.-..+
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv  326 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV  326 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence            99764432 23456678999999999997443    69999999999999999999876543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=310.87  Aligned_cols=195  Identities=24%  Similarity=0.389  Sum_probs=172.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++....... ...+.+.+|+.++++++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999884  7889999997654332 44567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999999999763   35889999999999999999999999  9999999999999999999999999998764432


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                         ...+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  201 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD  201 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence               35689999999999886544   79999999999999999999754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=323.17  Aligned_cols=197  Identities=23%  Similarity=0.355  Sum_probs=170.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|.+++.||.|+||+||++..  +++.||||++.+.... ....+.+.+|+.+|++++|||||+++++|.....+||||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4789999999999999999987  5778999998765432 345677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999753   35889999999999999999999999  9999999999999999999999999996322100


Q ss_pred             -----------------------------------------------ccccccCCCcccccccccCCCCh---HHHHHHH
Q 002910          816 -----------------------------------------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLS  845 (867)
Q Consensus       816 -----------------------------------------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG  845 (867)
                                                                     ....+.+||+.|+|||++.+..+   +||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                           00013579999999999986554   7999999


Q ss_pred             HHHHHHhcCCCCccc
Q 002910          846 GWLQSSFEESPQMRS  860 (867)
Q Consensus       846 ~lLyeM~tG~~Pf~s  860 (867)
                      |++|+|++|.+||..
T Consensus       236 vil~elltG~~Pf~~  250 (377)
T cd05629         236 AIMFECLIGWPPFCS  250 (377)
T ss_pred             hhhhhhhcCCCCCCC
Confidence            999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.2e-35  Score=316.37  Aligned_cols=192  Identities=23%  Similarity=0.356  Sum_probs=168.5

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      +.||+|+||+||+|+.  +++.||||++...... ......+.+|+.++++++||||+++++++.....+||||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999987  5778999999865433 345567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV  821 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~  821 (867)
                      +|..++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            999998763   35889999999999999999999999  9999999999999999999999999998654433334567


Q ss_pred             CCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          822 AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       822 aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  198 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence            89999999999987554   89999999999999999999654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9e-35  Score=319.19  Aligned_cols=201  Identities=23%  Similarity=0.383  Sum_probs=176.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC---ceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG---SDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g---~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      .+..++|++.+.||.|+||.||+|.+.+   ..||+|++...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence            4567899999999999999999998742   46999998765433 3456678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+++|+|.+++.+.   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999999763   34889999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ....   ....+||+.|||||++.+..+   +|||||||++|+|++|.+||.....
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~  233 (340)
T PTZ00426        181 VDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP  233 (340)
T ss_pred             cCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence            5432   245689999999999886544   8999999999999999999987543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.4e-35  Score=322.82  Aligned_cols=199  Identities=22%  Similarity=0.288  Sum_probs=170.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++++.||+|+||+||+|+.  +++.||||++.+..... .....+.+|+.+|++++||||+++++.|...+.+||||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4799999999999999999987  47789999987654332 34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t-  814 (867)
                      ||+++|+|.+++.+.   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|...... 
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999999763   35889999999999999999999999  999999999999999999999999997532100 


Q ss_pred             ------------------------------------------cccccccCCCcccccccccCCCCh---HHHHHHHHHHH
Q 002910          815 ------------------------------------------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQ  849 (867)
Q Consensus       815 ------------------------------------------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLy  849 (867)
                                                                .......+||+.|||||++.+..+   +|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      011124579999999999987554   79999999999


Q ss_pred             HHhcCCCCccccc
Q 002910          850 SSFEESPQMRSLM  862 (867)
Q Consensus       850 eM~tG~~Pf~sl~  862 (867)
                      +|++|+.||....
T Consensus       236 ell~G~~Pf~~~~  248 (376)
T cd05598         236 EMLVGQPPFLADT  248 (376)
T ss_pred             ehhhCCCCCCCCC
Confidence            9999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=318.67  Aligned_cols=206  Identities=23%  Similarity=0.319  Sum_probs=183.5

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      .+.+..++|++.+.||.|.-++||+|+.  .+..||||++.......+ ++.+.+|+..|+.++||||+.++..|.....
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            3456679999999999999999999988  578899999998876666 8899999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||.||.+|++.++++..-.. .++|..+..+.+++++||.|||.+|  .||||||+.||||+.+|.|||+|||.+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999999999999875433 3899999999999999999999999  99999999999999999999999998876


Q ss_pred             ccCCccc----ccccCCCcccccccccC-----CCChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFIS----SKSVAGTVVFFAAHQTA-----CNSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s----~~s~aGTp~YmAPEvl~-----~~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +.+...+    .+++.|||+|||||+++     .+.++||||||++..||.+|+.||..+-
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            6544322    25679999999999955     2445999999999999999999998764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=314.42  Aligned_cols=195  Identities=23%  Similarity=0.364  Sum_probs=173.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||+|++  .++.||||++....... .....+.+|+.++..++||||+++++++.....+||||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4789999999999999999998  47789999998654332 34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999753   35889999999999999999999999  99999999999999999999999999986544  


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       .....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence             2346689999999999987654   79999999999999999999653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=320.82  Aligned_cols=196  Identities=31%  Similarity=0.459  Sum_probs=170.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--eEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HLSIV  734 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~--~l~LV  734 (867)
                      .++..++.||+|+||.||++...  |...|||.+.....  ...+.+.+|+.+|.+++|||||+++|......  .++|+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            45778899999999999999884  68899999877632  22677899999999999999999999855444  69999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCccccccC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~~~  813 (867)
                      |||+++|+|.+++.+.+.  .+++..+.++++||++||+|||++|  ||||||||+||||+. +|.+||+|||+++....
T Consensus        95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999987542  5999999999999999999999999  999999999999999 79999999999987663


Q ss_pred             ---CcccccccCCCcccccccccCCC--C--hHHHHHHHHHHHHHhcCCCCccc
Q 002910          814 ---TFISSKSVAGTVVFFAAHQTACN--S--LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       814 ---t~~s~~s~aGTp~YmAPEvl~~~--~--~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                         .........|||.|||||++.++  .  .+|||||||++.||+||.+||..
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence               22334568999999999999942  2  58999999999999999999887

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-35  Score=336.16  Aligned_cols=197  Identities=25%  Similarity=0.426  Sum_probs=180.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeec-ccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~-~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +.-|++++.||.|+.|.|.+|++  +|+.+|||++.+. .........+.+|+-||+.+.||||+++|++|+...++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            46689999999999999999998  7999999999887 44556677889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      .||+++|.|++++.+.   +.+.++.+.+++.||+.|+.|||..+  |+||||||+|+|||..++|||+|||+|......
T Consensus        91 lEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999999874   45899999999999999999999999  999999999999999999999999999876544


Q ss_pred             cccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .+ ..+.||.|.|.|||++++.+|    +||||.|++||.+++|+.||..
T Consensus       166 kl-LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  166 KL-LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             cc-ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence            33 467899999999999999887    8999999999999999999974

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-36  Score=333.57  Aligned_cols=196  Identities=29%  Similarity=0.478  Sum_probs=175.8

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      +.|+|.++.+.-++-||.|+-|-||+|++++..||||+++..       +  ..+|+-|++|+||||+.|.|+|+..+.+
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el-------k--ETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------K--ETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh-------h--hhhHHHHHhccCcceeeEeeeecCCcee
Confidence            568888888888999999999999999999999999976422       1  2457789999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |||||||+.|-|+.+|+.   +..+.......|..+|+.||+|||.+.  |||||||..||||..+-.|||+|||-++..
T Consensus       188 CIiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             EEeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhh
Confidence            999999999999999986   446889999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..-.. .-++|||..|||||++++.+   +.||||||++||||+||..||....
T Consensus       263 ~~~ST-kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd  315 (904)
T KOG4721|consen  263 SDKST-KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD  315 (904)
T ss_pred             hhhhh-hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence            55432 35889999999999999865   4799999999999999999997643

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-34  Score=318.35  Aligned_cols=198  Identities=24%  Similarity=0.344  Sum_probs=171.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+|..  .++.||||++...... ......+.+|+.++..++||||+++++.+.....+||||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4789999999999999999988  4778999999865433 345667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++.+.   ..+++..+..++.||+.||+|||++|  |+||||||+||||+.+|.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999763   35889999999999999999999999  9999999999999999999999999987542110


Q ss_pred             -----------------------------------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCC
Q 002910          816 -----------------------------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQ  857 (867)
Q Consensus       816 -----------------------------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~P  857 (867)
                                                         ....+.+||+.|+|||++.+..+   +|||||||++|+|++|.+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                               00124589999999999987554   7999999999999999999


Q ss_pred             cccc
Q 002910          858 MRSL  861 (867)
Q Consensus       858 f~sl  861 (867)
                      |...
T Consensus       236 f~~~  239 (360)
T cd05627         236 FCSE  239 (360)
T ss_pred             CCCC
Confidence            9654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-35  Score=318.76  Aligned_cols=205  Identities=24%  Similarity=0.325  Sum_probs=181.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC--ceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g--~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|++++.||.|.-|+||+++..+  ..+|+|++.+..+. .+.+.+...|.+||..+.||+++.+|..|++....
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            3456889999999999999999999976  56999999988766 46678889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+|||||+||+|+.+++++. ++.+++..+++|+.+|+.||+|||-.|  ||||||||+||||.++|+|-|+||.|+...
T Consensus       153 cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999999988765 566899999999999999999999999  999999999999999999999999986321


Q ss_pred             c--------------------------------------------------------CCcccccccCCCcccccccccCC
Q 002910          812 A--------------------------------------------------------NTFISSKSVAGTVVFFAAHQTAC  835 (867)
Q Consensus       812 ~--------------------------------------------------------~t~~s~~s~aGTp~YmAPEvl~~  835 (867)
                      .                                                        .+...+.++.||-+|+|||++++
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            0                                                        00123456789999999999998


Q ss_pred             CCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          836 NSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       836 ~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...   .|||.||++||||+.|..||.+-+
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~  339 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSN  339 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence            665   799999999999999999998654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-34  Score=311.40  Aligned_cols=205  Identities=25%  Similarity=0.403  Sum_probs=169.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV  725 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~  725 (867)
                      |.+..++|++.+.||.|+||.||+|.+.       +..||||++.... .......+.+|+.+|..+ +|||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            5677899999999999999999999752       3569999987432 334456789999999999 899999999988


Q ss_pred             eeC-CeEEEEEeccCCCCHHHHHhcCCC----------------------------------------------------
Q 002910          726 TKR-PHLSIVTEYLPRGSLYRLIHRPAA----------------------------------------------------  752 (867)
Q Consensus       726 ~~~-~~l~LVmEy~~gGSL~~~L~~~~~----------------------------------------------------  752 (867)
                      ... ..+++||||+++|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            764 458999999999999999875321                                                    


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--cccccccCC
Q 002910          753 -------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAG  823 (867)
Q Consensus       753 -------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aG  823 (867)
                             ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  ........+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                   124778888999999999999999999  999999999999999999999999999865321  122234456


Q ss_pred             CcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          824 TVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       824 Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ++.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~  280 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  280 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence            789999999876544   899999999999996 99998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-34  Score=321.11  Aligned_cols=202  Identities=21%  Similarity=0.314  Sum_probs=174.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|++.+.||+|+||.||++++  +++.+|+|++.+.... ......+.+|+.+++.++||||+++++++.....+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            44568999999999999999999998  4678999999764333 23445678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+||||+++|+|.+++...    .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            9999999999999999642    3788999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCc-ccccccCCCcccccccccCCC-------ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTF-ISSKSVAGTVVFFAAHQTACN-------SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~-~s~~s~aGTp~YmAPEvl~~~-------~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .... ....+.+||+.|||||++.+.       ..+|||||||++|+|++|..||....
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            4332 223467899999999998753       34899999999999999999997543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.1e-34  Score=311.22  Aligned_cols=192  Identities=22%  Similarity=0.351  Sum_probs=167.7

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      +.||+|+||.||+++.  +|..||+|++...... ......+.+|+.+++.++||||++++++|.....+||||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999987  5788999999865432 345567789999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV  821 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~  821 (867)
                      +|..++...   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            999988763   35899999999999999999999999  9999999999999999999999999987643333333456


Q ss_pred             CCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          822 AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       822 aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            89999999999986554   89999999999999999999654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-34  Score=318.41  Aligned_cols=203  Identities=20%  Similarity=0.300  Sum_probs=175.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +.+..++|++.+.||+|+||+||+|+.  ++..||+|++.+..... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            345678999999999999999999988  47789999997654332 334557899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+++|+|.+++...    .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999998652    3788899999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCc-ccccccCCCcccccccccCCC-------ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTF-ISSKSVAGTVVFFAAHQTACN-------SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~-~s~~s~aGTp~YmAPEvl~~~-------~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..... ......+||+.|+|||++.+.       ..+|||||||++|+|++|..||....
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            64332 223456899999999998753       34899999999999999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.3e-34  Score=301.23  Aligned_cols=198  Identities=21%  Similarity=0.259  Sum_probs=170.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .|++.+.||+|+||+||+|.+  +++.||||++....... .....+.+|+.+|++++|+||+.+++++.....+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            378899999999999999987  57889999987655433 334567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++|+|..++.... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999998876432 235889999999999999999999999  9999999999999999999999999998654322 


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  204 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR  204 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence            1235579999999999987555   79999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-34  Score=318.30  Aligned_cols=203  Identities=21%  Similarity=0.301  Sum_probs=175.4

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      .+.+..++|++.+.||+|+||.||+|++  .+..+|+|++.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3455678999999999999999999998  4677999998764433 234456789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++|+|..++...    .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            999999999999999998652    3788899999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCC-------ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACN-------SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~-------~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... ......+||+.|||||++.+.       ..+|||||||++|+|++|.+||...
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            764332 223466899999999998753       3489999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-35  Score=310.91  Aligned_cols=200  Identities=23%  Similarity=0.315  Sum_probs=170.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|+.+.++|+|+||+||+|++  +|+.||||++....-...-.+-.++|+++|++|+|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3577788899999999999987  68889999987665333334456899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||...-|..+-+-+   ..++......++.|++.|+.|+|+++  ||||||||+||||+.+|.+||||||+||.+..+..
T Consensus        82 ~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   82 YCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             ecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            99876665543332   23889999999999999999999999  99999999999999999999999999998875444


Q ss_pred             cccccCCCcccccccccCC-CCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          817 SSKSVAGTVVFFAAHQTAC-NSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~-~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      .......|--|.|||++.+ .++   .|||++||++.||++|.+.|.+-..
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD  207 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD  207 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence            4455577888999999997 444   7999999999999999998876543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=313.76  Aligned_cols=199  Identities=25%  Similarity=0.392  Sum_probs=175.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|.+.+.||+|+||+||+|++.  ++.||||++....... .....+.+|+.++..++||||+++++++.....+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999985  8889999998765443 45667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++.+.   ..+++..++.++.||+.||+|||++|  |+||||||+||||+.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999864   35899999999999999999999999  9999999999999999999999999998654432


Q ss_pred             -----------------------------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 -----------------------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 -----------------------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                                                   .......||+.|+|||++.+..+   +|||||||++|+|++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                         22345679999999999987654   799999999999999999997543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.9e-34  Score=311.51  Aligned_cols=191  Identities=24%  Similarity=0.368  Sum_probs=167.5

Q ss_pred             EeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCC
Q 002910          666 RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS  742 (867)
Q Consensus       666 ~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGS  742 (867)
                      .||+|+||.||+++.  +++.||||++...... ......+.+|+.+|+.++||||+++++++.....+++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            689999999999987  5778999999865433 3456778899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccC
Q 002910          743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA  822 (867)
Q Consensus       743 L~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~a  822 (867)
                      |..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++............+
T Consensus        82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          82 LFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence            99888753   35889999999999999999999999  99999999999999999999999999986443333335668


Q ss_pred             CCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          823 GTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       823 GTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence            9999999999986544   89999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.5e-34  Score=308.72  Aligned_cols=195  Identities=28%  Similarity=0.388  Sum_probs=168.2

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHH---HhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIM---KRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~IL---k~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      |++.+.||+|+||.||+|.+  +++.||||++...... ....+.+.+|++++   +.++||||+++++++.....+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67899999999999999988  4778999999865433 23456677777765   456799999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++|+|..+++.    ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988864    34899999999999999999999999  999999999999999999999999998764443


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+||+.|||||.+.+..+   +|||||||++|+|++|..||...
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            333456789999999999987554   79999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.3e-34  Score=307.33  Aligned_cols=197  Identities=22%  Similarity=0.320  Sum_probs=170.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCC-CeeeEEeEEeeCCeEEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHP-NVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHP-NIVkl~ga~~~~~~l~LVm  735 (867)
                      +|++++.||+|+||.||+|++.  ++.||||++.+.... ....+.+..|+.++..+.|+ +|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999884  567999999865432 34566788999999999765 6888999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|..++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999998753   34889999999999999999999999  9999999999999999999999999987543333


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  204 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            33456689999999999987654   79999999999999999999643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.5e-34  Score=307.54  Aligned_cols=197  Identities=22%  Similarity=0.324  Sum_probs=170.5

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +|.+.+.||+|+||+||+|++.  +..||||++.+.... ....+.+..|..++..+ +|++|+.+++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999884  567999999875433 23455677888888877 4899999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999988753   34889999999999999999999999  9999999999999999999999999998654333


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~  204 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  204 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence            33456789999999999987654   79999999999999999999754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=307.76  Aligned_cols=190  Identities=21%  Similarity=0.345  Sum_probs=166.4

Q ss_pred             eccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||+|+||+||+|++  ++..||+|++...... ......+.+|+.++++++||||+++++++...+.+++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999988  4677999999765432 34567788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCC
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG  823 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aG  823 (867)
                      .+++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++............+|
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            9999763   34889999999999999999999999  999999999999999999999999999864333333345689


Q ss_pred             CcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          824 TVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       824 Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~  196 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE  196 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence            999999999987554   79999999999999999999753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.8e-34  Score=302.79  Aligned_cols=198  Identities=23%  Similarity=0.361  Sum_probs=168.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||.|+||+||+|+.  +++.||||++...... .....+.+|+.+++.++||||+++++++.....+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            37899999999999999999988  5778999998755322 22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. ++|.+++...  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          83 EYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             ECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9995 6777777653  234788899999999999999999999  9999999999999999999999999998654433


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+|+.|+|||++.+.    ..+|||||||++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            333456789999999998653    2479999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=327.75  Aligned_cols=195  Identities=24%  Similarity=0.390  Sum_probs=176.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ...|...+.||+|+.|.||.|+.  +++.||||.+.......+  +-+++|+.+|+..+|+|||.+++.|.....+|+||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            35677788999999999999987  577799999987653333  34689999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |||+||+|.+++..    ..++|.++..|+++++.||+|||.+|  |+|||||.+|||++.+|.+||+|||+|..+....
T Consensus       350 Eym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999999864    34999999999999999999999999  9999999999999999999999999999888777


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....+..|||.|||||++....+   .||||||+|++||+.|.+||.-
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence            77789999999999999998554   8999999999999999999974

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-33  Score=299.95  Aligned_cols=197  Identities=22%  Similarity=0.354  Sum_probs=168.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||.|+||+||+|..  ++..||+|++...... .....+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            47899999999999999999987  4678999998754321 22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+.+ +|.+++...  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          83 EYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             eCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            99974 898888653  234788999999999999999999999  9999999999999999999999999998655443


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .......+|+.|+|||++.+.    ..+|||||||++|+|++|.+||..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            333456789999999998753    338999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.1e-34  Score=308.10  Aligned_cols=192  Identities=23%  Similarity=0.352  Sum_probs=166.3

Q ss_pred             EEeccCCceEEEEEEE-----cCceEEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          665 ERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       665 e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +.||+|+||.||+++.     .++.||||++.......  .....+.+|+.+|+.++||||++++++|...+.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975     46779999998654322  3345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++|+|.+++.+.   ..+.+..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            9999999999763   34788889999999999999999999  999999999999999999999999999764433333


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~  203 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE  203 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence            345689999999999886544   89999999999999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=308.25  Aligned_cols=199  Identities=20%  Similarity=0.268  Sum_probs=171.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+++.  .++.||||++.+.... ....+.+.+|+.++..++|+||+.+++++....++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999987  4778999999764332 234566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999752  235889999999999999999999999  9999999999999999999999999987654332


Q ss_pred             c-cccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 I-SSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~-s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      . .....+||+.|||||++..        ...+|||||||++|+|++|..||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            2 2233579999999999863        23489999999999999999999754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.2e-34  Score=309.77  Aligned_cols=192  Identities=23%  Similarity=0.356  Sum_probs=166.9

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      +.||+|+||+||+++.  ++..||+|++.+.... ......+.+|+.+++.++||||+++++++.....+||||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999987  5778999999865433 234567789999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      +|..++...   ..+++..+..++.||+.||.|||+ ++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            999988753   358999999999999999999997 78  999999999999999999999999999864433333346


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            689999999999986554   79999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-33  Score=297.33  Aligned_cols=198  Identities=22%  Similarity=0.321  Sum_probs=170.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||+||+|+++  +..||||++..........+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999984  6779999998665444556678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~-  815 (867)
                      |++++.+..+...   ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998877655443   235889999999999999999999999  9999999999999999999999999998764322 


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            22234578999999999886554   89999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-33  Score=305.85  Aligned_cols=196  Identities=20%  Similarity=0.302  Sum_probs=168.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccch--HHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l  731 (867)
                      +|++++.||+|+||+||+++.     .+..||+|++.+.....  ...+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588999999999999999876     46789999997654322  33566789999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999998753   34889999999999999999999999  999999999999999999999999999864


Q ss_pred             cCC-cccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANT-FISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t-~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ... .......+||+.|||||++.+..    .+|||||||++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            332 22233568999999999987543    48999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.3e-33  Score=307.25  Aligned_cols=191  Identities=19%  Similarity=0.277  Sum_probs=166.6

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++  ++..||||+++...... .....+.+|+.++..+ +||||++++++|.....+||||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999988  47789999998765433 3456788999999998 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++.+.   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9999888753   35899999999999999999999999  999999999999999999999999999754333333356


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            789999999999987654   7999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-33  Score=307.62  Aligned_cols=199  Identities=19%  Similarity=0.246  Sum_probs=171.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||++++  +++.||+|++.+.... ......+.+|+.++..++|+||+++++++...+.+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            5799999999999999999988  4667999998764322 234556788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|..++.+.  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999763  235889999999999999999999999  9999999999999999999999999998664432


Q ss_pred             c-cccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 I-SSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~-s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      . .....+||+.|+|||++.+        ...+|||||||++|+|++|..||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            2 2234579999999999864        23479999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=314.96  Aligned_cols=201  Identities=26%  Similarity=0.393  Sum_probs=169.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH------------HHHHHHHHHHHHHhcCCCCeeeE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD------------QLKEFLREVAIMKRVRHPNVVLF  721 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~------------~~k~f~~Ei~ILk~LrHPNIVkl  721 (867)
                      ..+++|++++.||+|.||+|-+|+.  .++.||||++.+......            ..+...+||.||++|+|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            4568999999999999999999988  578899999987543221            23578999999999999999999


Q ss_pred             EeEEeeC--CeEEEEEeccCCCCHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC
Q 002910          722 MGAVTKR--PHLSIVTEYLPRGSLYRLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW  798 (867)
Q Consensus       722 ~ga~~~~--~~l~LVmEy~~gGSL~~~L~~~~~~~~-l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g  798 (867)
                      +.+..++  ..+|||+|||..|.+...-    ..+. +.+.++++|+++++.||+|||.+|  ||||||||+|+||+.+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCC
Confidence            9998765  5799999999998875321    2233 899999999999999999999999  99999999999999999


Q ss_pred             cEEEEecCccccc-----cCCcccccccCCCcccccccccCCCC-------hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          799 TVKVCDFGLSRFK-----ANTFISSKSVAGTVVFFAAHQTACNS-------LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       799 ~VKLsDFGLAr~~-----~~t~~s~~s~aGTp~YmAPEvl~~~~-------~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +|||+|||.+...     .+........+|||-|||||...++.       ..||||||++||.|+.|..||..-.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999998765     22222233479999999999988733       2599999999999999999998654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-33  Score=304.04  Aligned_cols=197  Identities=21%  Similarity=0.324  Sum_probs=170.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +|+..+.||+|+||+||+|+.  +++.||||++.+.... ....+.+..|+.++..+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999987  4778999999865432 344567888999998886 577888999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999998763   34899999999999999999999999  9999999999999999999999999998654333


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence            33456789999999999987554   79999999999999999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-33  Score=304.47  Aligned_cols=192  Identities=26%  Similarity=0.357  Sum_probs=164.5

Q ss_pred             EEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++.  ++.||||+++..... ....+.+..|..++..+ +||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999884  567999999865432 23455667777777654 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999998753   34889999999999999999999999  999999999999999999999999999865443333456


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            789999999999987554   79999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-33  Score=305.46  Aligned_cols=192  Identities=28%  Similarity=0.399  Sum_probs=164.4

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~-ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++  +++.||||++.+..... ...+.+..|.. +++.++||||+++++.+.....+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3689999999999998  57889999998654332 33455666655 56789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++.+.   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9999998763   35889999999999999999999999  999999999999999999999999999764433333456


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  199 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence            689999999999987654   89999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-33  Score=304.69  Aligned_cols=192  Identities=29%  Similarity=0.392  Sum_probs=163.5

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~-ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++  .+..||+|++.+..... .....+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999988  47789999998654332 33445666655 67889999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|...+...   ..+.+..+..++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++...........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9999888753   34788899999999999999999999  999999999999999999999999999864333333456


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            689999999999887554   79999999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-33  Score=300.36  Aligned_cols=196  Identities=23%  Similarity=0.379  Sum_probs=165.1

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----CeEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHLS  732 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~l~  732 (867)
                      +|++.+.||.|+||.||+|+.  ++..||||++............+.+|+.++++++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999987  577899999875433334456788999999999999999999988543     3589


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||| +++|.+++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecC-CCCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999999 56898888753   34899999999999999999999999  9999999999999999999999999998643


Q ss_pred             CCc---ccccccCCCcccccccccCC-----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTF---ISSKSVAGTVVFFAAHQTAC-----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~---~s~~s~aGTp~YmAPEvl~~-----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...   .......||+.|+|||++.+     ...+|||||||++|+|++|.+||...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            221   12234579999999999764     33489999999999999999999653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.9e-33  Score=304.80  Aligned_cols=191  Identities=24%  Similarity=0.313  Sum_probs=165.7

Q ss_pred             EeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||+|+||+||+|+.  +++.||||++.+.... ......+..|+.++..+ +||||+++++++.....+|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            689999999999988  4678999999865432 34556778899998876 6999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV  821 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~  821 (867)
                      +|..++.+.   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++............
T Consensus        82 ~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (320)
T cd05590          82 DLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF  156 (320)
T ss_pred             hHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence            999988763   35889999999999999999999999  9999999999999999999999999988643333334566


Q ss_pred             CCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          822 AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       822 aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  199 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE  199 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            89999999999987554   79999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-33  Score=304.43  Aligned_cols=191  Identities=25%  Similarity=0.347  Sum_probs=165.7

Q ss_pred             EeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||+|+||+||+|++.  ++.||||++...... ......+..|..++..+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5899999999999884  568999999865432 34556778899999876 7999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV  821 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~  821 (867)
                      +|..++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++............
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05591          82 DLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF  156 (321)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence            999988753   34889999999999999999999999  9999999999999999999999999998654433334566


Q ss_pred             CCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          822 AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       822 aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~  199 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD  199 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence            89999999999886544   79999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.5e-34  Score=306.53  Aligned_cols=192  Identities=25%  Similarity=0.322  Sum_probs=168.6

Q ss_pred             EEeccCCceEEEEEEE-----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          665 ERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       665 e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      +.||+|+||.||+++.     .|+.||+|++............+.+|+.+|++++||||+++++++...+.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875     46789999998765444455667889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccc
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK  819 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~  819 (867)
                      +|+|.+++.+.   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..........
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            99999999753   35899999999999999999999999  99999999999999999999999999987654433345


Q ss_pred             ccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          820 SVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       820 s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..+||+.|+|||.+.+..   .+|||||||++|+|++|..||...
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence            678999999999987644   389999999999999999999754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.3e-33  Score=305.52  Aligned_cols=191  Identities=19%  Similarity=0.280  Sum_probs=165.9

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|+.  +++.||+|++.+..... .....+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3699999999999987  46779999998764432 4456678899998876 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9999888753   35899999999999999999999999  999999999999999999999999999864433333456


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            789999999999987654   8999999999999999999953

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.5e-33  Score=294.19  Aligned_cols=193  Identities=23%  Similarity=0.280  Sum_probs=166.9

Q ss_pred             eccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||+|+||+||++.+  +++.||+|++....... ...+.+..|+.+++.++||||+++++++.....+++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999987  57789999987654332 3456778999999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccC
Q 002910          744 YRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA  822 (867)
Q Consensus       744 ~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~a  822 (867)
                      ..++.... ....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            98875422 2345899999999999999999999999  99999999999999999999999999986654333344568


Q ss_pred             CCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          823 GTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       823 GTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+.|+|||++.+..+   +|+|||||++|+|++|..||...
T Consensus       159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999987654   79999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.7e-33  Score=304.67  Aligned_cols=199  Identities=18%  Similarity=0.271  Sum_probs=170.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+++++  +..+|+|++.+.... ......+.+|+.++..++|+||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999884  567999998754332 233455788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t-  814 (867)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999763  235889999999999999999999999  999999999999999999999999998754332 


Q ss_pred             cccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+||+.|+|||++..        ...+|||||||++|+|++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            222234689999999999862        23489999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-32  Score=299.84  Aligned_cols=197  Identities=23%  Similarity=0.377  Sum_probs=172.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +..++|++.+.||+|+||.||++++.  +..+|+|++.... .......+.+|+++|++++||||+++++++...+.+++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            34589999999999999999999984  6779999987542 23445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||+++...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999999763   3488999999999999999999974 6  9999999999999999999999999997654


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ...  .....||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       156 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            432  245679999999999986544   8999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-33  Score=305.08  Aligned_cols=192  Identities=27%  Similarity=0.376  Sum_probs=164.4

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~-ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|+.  +|+.||||++.+.... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3589999999999987  5788999999865432 233455666665 46779999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9999888753   35899999999999999999999999  999999999999999999999999999864433333456


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence            789999999999987654   89999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.4e-33  Score=303.64  Aligned_cols=191  Identities=19%  Similarity=0.277  Sum_probs=166.5

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|+.  +++.||+|++.+..... ...+.+.+|+.++.++ +||||+.+++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999987  46789999998764433 4566788999999888 599999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9999888753   35899999999999999999999999  999999999999999999999999999764333333356


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            789999999999987554   8999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.3e-33  Score=294.97  Aligned_cols=202  Identities=28%  Similarity=0.427  Sum_probs=167.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc------------------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH------------------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV  718 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~------------------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI  718 (867)
                      ..++|++.+.||+|+||.||+|.+.                  +..||+|++.... .......+.+|+.+|.+++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4578999999999999999999752                  2359999887543 34456779999999999999999


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA----------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPI  782 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~----------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~I  782 (867)
                      +++++++......++||||+++|+|.+++....                ....+++..++.++.||+.||.|||+++  |
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i  159 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F  159 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence            999999999999999999999999999986421                1124677888999999999999999999  9


Q ss_pred             cccCCCCCcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc--CC
Q 002910          783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE--ES  855 (867)
Q Consensus       783 VHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t--G~  855 (867)
                      +||||||+|||++.++.+||+|||+++......  .......+++.|||||++.+..+   +||||||+++|+|++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            999999999999999999999999998653322  11233456789999999876544   899999999999986  56


Q ss_pred             CCcccc
Q 002910          856 PQMRSL  861 (867)
Q Consensus       856 ~Pf~sl  861 (867)
                      .||..+
T Consensus       240 ~p~~~~  245 (304)
T cd05096         240 QPYGEL  245 (304)
T ss_pred             CCCCcC
Confidence            777654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=312.56  Aligned_cols=198  Identities=25%  Similarity=0.401  Sum_probs=179.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~L  733 (867)
                      ...|.+.+.||.|.||.||+++.  +|+.+|+|++.+.....+ ....+.+|+.||+++. |||||.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            36799999999999999999988  578899999998776543 4667899999999999 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC----CCcEEEEecCccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK----NWTVKVCDFGLSR  809 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~----~g~VKLsDFGLAr  809 (867)
                      |||+|.||.|++.+...    .+++..+..++.||+.+++|||+.|  |+||||||+|+|+..    ++.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999874    2899999999999999999999999  999999999999953    3579999999999


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .... .......+|||+|+|||++....+   +||||+|+++|.|++|.+||+...
T Consensus       188 ~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  188 FIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             EccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            8777 445678899999999999997666   799999999999999999999876

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=314.87  Aligned_cols=206  Identities=23%  Similarity=0.271  Sum_probs=180.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +.+.-+.|..-++||+|+||.||-++.  +|+.+|+|.+.+..+... ...-.++|..||.+++.++||.+-.+|++...
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            445668899999999999999997765  788999999877665543 23345899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||..|+||+|..+|...+. ..+++.++++||.+|+.||++||+.+  ||||||||+|||||++|+|+|+|+|||..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEe
Confidence            9999999999999999887553 45899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      +.... .....+||.+|||||++.+..+   .|+|||||+||+|+.|+.||+....
T Consensus       337 i~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  337 IPEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             cCCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            65432 2245599999999999999888   5999999999999999999987543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-33  Score=303.35  Aligned_cols=192  Identities=27%  Similarity=0.377  Sum_probs=162.4

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~-ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++  ++..||+|++....... .....+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            3699999999999988  45679999998654322 23344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+.+..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9999999763   34778888899999999999999999  999999999999999999999999999864433333456


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence            789999999999987654   79999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=321.35  Aligned_cols=210  Identities=28%  Similarity=0.465  Sum_probs=181.6

Q ss_pred             ccccccccCCCCeEEEEEeccCCceEEEEEEEc---C--ce-EEEEEEeec-ccchHHHHHHHHHHHHHHhcCCCCeeeE
Q 002910          649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWH---G--SD-VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLF  721 (867)
Q Consensus       649 l~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~---g--~~-VAVKvi~~~-~~~~~~~k~f~~Ei~ILk~LrHPNIVkl  721 (867)
                      .....|++..++..+.++||+|+||.||+|++.   +  .. ||||..+.. .......+++++|+++|++++|||||+|
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            345668899999999999999999999999873   1  13 899988863 3667889999999999999999999999


Q ss_pred             EeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEE
Q 002910          722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVK  801 (867)
Q Consensus       722 ~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VK  801 (867)
                      ||+......++||||+|+||+|.++|++...  .++..++..++.++++||+|||+++  +|||||..+|+|++.++.+|
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEE
Confidence            9999999999999999999999999997442  5889999999999999999999999  99999999999999999999


Q ss_pred             EEecCccccccCCccccc-ccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccch
Q 002910          802 VCDFGLSRFKANTFISSK-SVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLMF  863 (867)
Q Consensus       802 LsDFGLAr~~~~t~~s~~-s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~~  863 (867)
                      |+||||++....... .. ..--...|+|||.+...-+   +||||||+++||+|+ |..||..+..
T Consensus       303 ISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             eCccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence            999999987652221 22 2234579999999997655   899999999999999 6789988763

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-33  Score=306.43  Aligned_cols=193  Identities=29%  Similarity=0.423  Sum_probs=166.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..++|++++.||.|+||+||+|++  +++.||||++.... .......+.+|+++++.++|+||+++++++...+.+++|
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            447788899999999999999988  47889999986543 234456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+.+|+|....       ...+..+..++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++.....
T Consensus       151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            9999999986432       3567788899999999999999999  999999999999999999999999999876554


Q ss_pred             cccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcc
Q 002910          815 FISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      ........||+.|+|||++..        ...+|||||||++|+|++|..||.
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            433456689999999998743        124899999999999999999996

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.9e-33  Score=292.23  Aligned_cols=198  Identities=26%  Similarity=0.405  Sum_probs=164.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE---cCceEEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeEEe-----e
Q 002910          659 DELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVT-----K  727 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~---~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~-----~  727 (867)
                      .+|++.+.||+|+||+||+|++   .+..||+|++............+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688999999999999999987   356799999876544433344566788877766   6999999999885     3


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ...+++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 68988887533 234889999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++..... .......||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence            9865443 22345679999999999876554   79999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-33  Score=303.93  Aligned_cols=199  Identities=24%  Similarity=0.318  Sum_probs=172.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|.+.+.||+|+||+||+|+.  +++.||||++...... ....+.+.+|+.+++.++||||+++++++.....++|||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4789999999999999999987  5778999999876542 234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999999764  235899999999999999999999999  9999999999999999999999999998654322


Q ss_pred             -ccccccCCCcccccccccCC---------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 -ISSKSVAGTVVFFAAHQTAC---------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 -~s~~s~aGTp~YmAPEvl~~---------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       .......||+.|+|||++..         ...+|||||||++|+|++|..||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence             22234579999999999873         23479999999999999999999653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-33  Score=300.94  Aligned_cols=192  Identities=24%  Similarity=0.327  Sum_probs=164.5

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++  ++..||+|++...... ......+..|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            3699999999999988  4678999999865432 23455677888888764 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9999988753   34889999999999999999999999  999999999999999999999999998754322223346


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            789999999999987654   79999999999999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-34  Score=294.80  Aligned_cols=203  Identities=26%  Similarity=0.392  Sum_probs=181.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHH-HHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~-~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+.+++|.+++.||+|.||.||+|+.+  +-.||+|++.+..+.... .+.+.+|++|-..|+||||+++|++|.+...+
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            456799999999999999999999985  456999999988766544 35678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+++||.++|+|+..|.... ...+++.....++.|++.||.|+|..+  ||||||||+|+|++..+.+||+|||-+-..
T Consensus        98 yLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999998533 456899999999999999999999988  999999999999999999999999987543


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .  .....+.|||..|++||...+...   .|+|++|++.|+++.|.+||.+..
T Consensus       175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            3  455678999999999999998665   799999999999999999998753

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-34  Score=318.65  Aligned_cols=199  Identities=25%  Similarity=0.435  Sum_probs=184.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe-EEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH-LSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~-l~LVm  735 (867)
                      ++|..+++||+|+||.++.+++  .++.+++|.+..............+|+.++++++|||||.+++.|...+. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            6788999999999999998877  46679999999988887777788999999999999999999999998888 99999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      +||+||+|.+.|.+.. +..+++++++.|+.||+.|++|||+++  |+|||||+.||++++++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998865 567999999999999999999999988  9999999999999999999999999999988775


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....+..|||.||+||++.+.++   +|||||||++|+|++-+++|..
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a  208 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA  208 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence            45678999999999999998776   8999999999999999999875

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.1e-33  Score=299.26  Aligned_cols=192  Identities=24%  Similarity=0.321  Sum_probs=164.1

Q ss_pred             EEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHh-cCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR-VRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~-LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||+|+||+||+|++.  +..||||++...... ......+..|..++.. ++||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999984  567999999875432 2345567778888876 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9999999753   34889999999999999999999999  999999999999999999999999999754333223345


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            689999999999987554   89999999999999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-33  Score=292.39  Aligned_cols=200  Identities=25%  Similarity=0.371  Sum_probs=175.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|...+.||+|.||.||+|++  +|+.||||.++.....+.--...++|++.|+.++|+||+.++++|.....+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999998  68889999999876555444567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||+ .+|+..|+..  ...+...++..|+.++++||+|||.+.  |+||||||.|+||+.+|.+||+||||+|.......
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            994 5999999874  346899999999999999999999999  99999999999999999999999999998876654


Q ss_pred             cccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ......-|-=|.|||++.+...    .|+||.||++.||+-+.|.|.+-..
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD  207 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD  207 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence            4444467888999999997554    6999999999999999888876543

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.7e-33  Score=298.63  Aligned_cols=192  Identities=26%  Similarity=0.367  Sum_probs=166.2

Q ss_pred             EEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||.|+||+||+|++.  +..||||++.+.... ......+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999884  667999999875433 24456778899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++.+.   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9999988763   35899999999999999999999999  999999999999999999999999999764333333345


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            689999999999987554   89999999999999999999643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=290.10  Aligned_cols=198  Identities=22%  Similarity=0.263  Sum_probs=170.7

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .|++.+.||+|+||+||++.+  +++.||||++........ ....+.+|+.++++++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478899999999999999987  477899999976544332 33457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++|+|..++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886532 235899999999999999999999999  9999999999999999999999999998754322 


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......|++.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence            1234578999999999986544   79999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-32  Score=286.45  Aligned_cols=202  Identities=20%  Similarity=0.326  Sum_probs=170.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +..++|++.+.||+|+||.||+|.++     +..||+|+++... .......+.+|+.++++++||||+++++++.....
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            45678999999999999999999763     4569999987643 23445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+++|+|.+++....  ..+++..++.++.||+.||+|||+++  ++||||||+|||++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999999997632  35889999999999999999999999  99999999999999999999999998765


Q ss_pred             ccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHh-cCCCCccccc
Q 002910          811 KANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSF-EESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~-tG~~Pf~sl~  862 (867)
                      ..... .......+++.|+|||.+.+..+   +|||||||++|+++ +|..||+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~  213 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            43322 11223345678999999886554   79999999999976 4999998643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.2e-32  Score=297.12  Aligned_cols=197  Identities=23%  Similarity=0.382  Sum_probs=171.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +..++|++.+.||.|+||.||++.+.  +..+|+|++.... .......+.+|+++++.++||||++++++|...+.+++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            45589999999999999999999984  6679999887542 33445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||. ++  |+||||||+|||++.++.+||+|||+++...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999999763   348899999999999999999997 47  9999999999999999999999999987654


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ...  .....||+.|+|||++.+..+   +|+|||||++|+|++|..||..
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            322  235579999999999987544   8999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-34  Score=313.13  Aligned_cols=198  Identities=27%  Similarity=0.428  Sum_probs=179.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ..|..+++||+|+||.||+|.+  .++.||+|++..... ....+.+.+|+.+|..++++||.++|+.|.....+|++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4567778999999999999988  477799999986543 3457788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||.||++.+.|..   +..+.+..+..++++++.||.|||.++  .+|||||+.|||+..+|.|||+|||.+..+.++..
T Consensus        92 y~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999999975   334588888889999999999999999  99999999999999999999999999999888877


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...++.|||.|||||++....|   +||||||++++||.+|.||+-.++
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h  215 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH  215 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence            7789999999999999997665   899999999999999999998765

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-32  Score=279.88  Aligned_cols=196  Identities=29%  Similarity=0.474  Sum_probs=173.4

Q ss_pred             eEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |++++.||+|+||+||+++..  +..+|+|++..............+|+.++++++||||+++++++.....+++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            789999999999999999994  456999999988766555556677999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      .+++|.+++..   ...+++..++.++.||+.||.|||+++  |+|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccc---ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            99999999983   235899999999999999999999999  9999999999999999999999999997643333344


Q ss_pred             cccCCCcccccccccC-C---CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTA-C---NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~-~---~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....+|+.|+|||++. +   ...+||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            5678999999999988 3   33489999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.8e-32  Score=278.15  Aligned_cols=200  Identities=20%  Similarity=0.362  Sum_probs=177.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|.+.+.||+|+||.||+|.+  ++..|++|.+............+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            578899999999999999988  578899999987666666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.++++... ...+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999999998642 346889999999999999999999999  999999999999999999999999999876554443


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .....|++.|+|||++.+..+   +|+||||+++|+|++|..||....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            455688999999999887654   899999999999999999987543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.3e-32  Score=297.98  Aligned_cols=195  Identities=26%  Similarity=0.339  Sum_probs=166.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      .++|++.+.||+|+||.||++..  .+..||||++............+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            48999999999999999999987  5778999999765444455677889999999999999999999986543      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|+||||+.+ +|...++.     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            57999999965 56666643     3788889999999999999999999  9999999999999999999999999997


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... ......||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       172 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         172 TACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            654332 2245678999999999987554   89999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-32  Score=291.08  Aligned_cols=190  Identities=19%  Similarity=0.284  Sum_probs=165.0

Q ss_pred             EEeccCCceEEEEEEEcCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCeEEEEEeccC
Q 002910          665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLSIVTEYLP  739 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----~~~l~LVmEy~~  739 (867)
                      ..||+|++|.||+|.++|+.||||++....... ...+.+.+|+.+|++++|||||++++++.+    ...+++||||++
T Consensus        26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            568999999999999999999999997654433 335778899999999999999999999876    457899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      +|+|.+++...   ..+++.....++.+++.||.|||+. +  ++||||||+|||+++++.+||+|||+++......   
T Consensus       106 ~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        106 RGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            99999999763   3588999999999999999999984 7  8899999999999999999999999998654432   


Q ss_pred             cccCCCcccccccccCC--CC---hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          819 KSVAGTVVFFAAHQTAC--NS---LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~--~~---~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....||+.|+|||++.+  ..   .+|||||||++|+|++|..||....
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence            24578999999999875  23   4899999999999999999998653

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.2e-32  Score=284.36  Aligned_cols=198  Identities=23%  Similarity=0.380  Sum_probs=170.2

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|.+.+.||.|+||.||+|+.  ++..||||++............+.+|+.++++++||||+++++++..+..+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            588999999999999999987  577899999876543334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      ++ ++|.+++........+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            97 688888876444456899999999999999999999999  999999999999999999999999999765443322


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....+++.|+|||++.+.    ..+|+|||||++|+|++|.+||..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            3344678999999998753    348999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-33  Score=299.09  Aligned_cols=202  Identities=25%  Similarity=0.330  Sum_probs=173.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLS  732 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l~  732 (867)
                      ++++|+++.+|+.|+||.||+|+++  ++.||+|.++...-....--.-++||.+|.+++|||||.+-.++.-  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            4588999999999999999999984  5669999998765322222335799999999999999999988753  45699


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||||||+. +|..+++.-.  ..+.......++.|+++|++|||.+.  |+|||||++|+|++..|.+||+||||||...
T Consensus       154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhc
Confidence            99999965 8888887633  35888889999999999999999999  9999999999999999999999999999998


Q ss_pred             CCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      +.........-|.=|.|||++.+...    .|+||+||++.||+.+++-|.+-+.
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE  283 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE  283 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence            87666677788999999999998554    6999999999999999998876543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.8e-32  Score=309.36  Aligned_cols=200  Identities=18%  Similarity=0.208  Sum_probs=170.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc---CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~---g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ...|.+.+.||+|+||.||+|...   +..||+|.+....  ......+.+|+.+|+.++|||||+++++|...+.+|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            345999999999999999999873   4568888765433  23445678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          735 TEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||+++|+|.++++.. .....+++..+..++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999999999988642 22345889999999999999999999999  99999999999999999999999999987644


Q ss_pred             Cc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..  ......+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            32  12345689999999999886554   79999999999999999998754

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.9e-32  Score=289.88  Aligned_cols=198  Identities=22%  Similarity=0.341  Sum_probs=168.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|.+.+.||+|+||.||+|+.  .+..||+|.+...... .....+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            47899999999999999999987  4677999998754322 22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+.+ +|..++...  ...+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        84 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          84 EYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             eCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            99965 788877653  234788899999999999999999999  9999999999999999999999999998654433


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+|+.|+|||.+.+.    ..+|||||||++|+|++|.+||...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            333455789999999998653    3489999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=300.37  Aligned_cols=190  Identities=22%  Similarity=0.336  Sum_probs=162.5

Q ss_pred             eccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhc---CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV---RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       667 LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      ||+|+||+||+|++  .++.||||++.+..... .....+..|..++.++   .||||+.+++.+.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999987  47889999997654332 3445566788887766   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|..++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9999988753   35899999999999999999999999  999999999999999999999999999764433333456


Q ss_pred             cCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+.|+|||++.+.    ..+|||||||++|+|++|..||...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~  200 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE  200 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence            7899999999998643    3389999999999999999998653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-32  Score=311.70  Aligned_cols=204  Identities=23%  Similarity=0.286  Sum_probs=175.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~----  729 (867)
                      ...++|++.+.||+|+||+||+|++  +++.||||++............+.+|+.++..++|+||++++..+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457999999999999999999987  6888999999887766677778899999999999999999988775432    


Q ss_pred             ----eEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          730 ----HLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       730 ----~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                          .+++||||+++|+|.++++... ....+++..+..++.|++.||+|||+++  |+||||||+||||+.++.+||+|
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEe
Confidence                3789999999999999987522 2346899999999999999999999999  99999999999999999999999


Q ss_pred             cCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          805 FGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       805 FGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+++.....  .......+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~  248 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE  248 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            9999875432  122346689999999999987654   89999999999999999999653

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-32  Score=302.36  Aligned_cols=191  Identities=20%  Similarity=0.230  Sum_probs=164.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +....|.+.+.||.|+||.||+|..  +++.||+|...        ...+.+|+.+|++++|||||+++++|......++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            4457899999999999999999988  57789999643        2346789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||++ +++|..++...   ..+++..++.++.||+.||.|||+++  ||||||||+||||+.++.+||+|||+++....
T Consensus       161 v~e~~-~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EEecC-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99999 47888888653   34789999999999999999999999  99999999999999999999999999975432


Q ss_pred             C-cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          814 T-FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       814 t-~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      . .......+||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            2 122345689999999999987554   7999999999999999987753

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=8.2e-32  Score=279.80  Aligned_cols=202  Identities=25%  Similarity=0.440  Sum_probs=172.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |+|..++|++.++||.|+||.||+|.. .+..||+|.+....   ...+.+.+|+.++++++|+||+++++.+......+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            467889999999999999999999987 45679999876543   23567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ++|||+++++|.+++++.. ...+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++...
T Consensus        78 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecC
Confidence            9999999999999997642 345788899999999999999999999  9999999999999999999999999998765


Q ss_pred             CCcc-cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTFI-SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~~-s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .... ......++..|+|||.+....+   +|||||||++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            4322 1223345678999999876554   799999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.98  E-value=3.2e-32  Score=302.73  Aligned_cols=207  Identities=27%  Similarity=0.397  Sum_probs=172.0

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG  723 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~g  723 (867)
                      +.|.+..++|++.+.||+|+||.||+|.+.       +..||||++..... ......+.+|+.+++.+ +|+|||++++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence            445677889999999999999999999862       23699999976532 34456788999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCC---------------------------------------------------
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------  752 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~---------------------------------------------------  752 (867)
                      +|...+.+++||||+++|+|.++++....                                                   
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            99999999999999999999999864210                                                   


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          753 ----------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       753 ----------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                                      ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++++||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                            123678889999999999999999999  99999999999999999999999999986543211


Q ss_pred             --cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          817 --SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       817 --s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                        ......+++.|||||++.+..+   +|||||||++|+|++ |..||...
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~  318 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI  318 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence              1123345678999999876544   799999999999996 99998654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.98  E-value=3.9e-32  Score=301.88  Aligned_cols=206  Identities=26%  Similarity=0.366  Sum_probs=171.3

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA  724 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga  724 (867)
                      .+.+..++|++.+.||+|+||+||+|.+.       +..||||+++.... ....+.+.+|+.+|..+ +|||||+++++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            45667789999999999999999999752       34699999875432 23456788999999999 89999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCC----------------------------------------------------
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA----------------------------------------------------  752 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~----------------------------------------------------  752 (867)
                      |......++|||||++|+|.++++....                                                    
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            9999999999999999999999875321                                                    


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          753 --------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       753 --------------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                                          ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                124678889999999999999999999  9999999999999999999999999998654


Q ss_pred             CCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....  ......+++.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            3221  1122345678999999986554   799999999999997 88888654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-34  Score=337.26  Aligned_cols=205  Identities=20%  Similarity=0.287  Sum_probs=181.5

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ..+....++|.+++.||+|+||.|..++++  ++.||+|++.+.... .....-|..|..||.....+-||.++.+|+++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344566799999999999999999999984  667999999886554 35566788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .++|+|||||+||+|-.++.+..   .+++..+++|+.+|+.||+-||+.|  +|||||||+|||||..|+|||+|||.|
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999998743   5999999999999999999999999  999999999999999999999999998


Q ss_pred             cccc-CCcccccccCCCcccccccccCC-----CCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKA-NTFISSKSVAGTVVFFAAHQTAC-----NSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~-~t~~s~~s~aGTp~YmAPEvl~~-----~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      -.+. +....+....|||.|++||+++.     +.|   +|+||+|+++|||+.|..||..-
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            7665 44455677899999999999983     233   79999999999999999999753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-33  Score=305.93  Aligned_cols=202  Identities=23%  Similarity=0.353  Sum_probs=181.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCce--EEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~--VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~  730 (867)
                      .|...+|..+.+||+|+||+|-+|..+|+.  +|||+++++.+.. +.++-.+.|.++|... +-|++++++..|++.++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            567789999999999999999999987765  9999999887664 5667778899998876 47899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+.||+|..+|++.+   .+.+..+..||.+|+-||-+||++|  ||+||||..||+||.+|+|||+|||+|+.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999999998743   4788899999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      -.-.....+++||||.|+|||++...++   .|+||+|++||||+.|.+||.+.
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            6555555689999999999999998777   69999999999999999999764

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=1.5e-31  Score=278.27  Aligned_cols=201  Identities=21%  Similarity=0.409  Sum_probs=173.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||.|+||.||+|++  +++.||||.+...... ......+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            6899999999999999999987  6788999988764433 345567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          736 EYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      ||+++|+|.+++.... ....+++..+..++.||+.||+|||+++  |+|+||||+|||++.++.++|+|||+++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999998886422 2345788999999999999999999999  999999999999999999999999999876544


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........|++.|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            333345678899999999876544   89999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=8e-32  Score=295.03  Aligned_cols=196  Identities=24%  Similarity=0.323  Sum_probs=167.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------  728 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------  728 (867)
                      ..++|++.+.||+|+||.||+|..  .+..||||++............+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            347999999999999999999987  577899999876554455567788999999999999999999988643      


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+++||||+.+ +|...+..     .+++..+..++.||+.||.|||++|  |+||||||+||||+.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccc
Confidence            357999999965 56666643     3788899999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +....... .....||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       167 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         167 RTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             ccCCCccc-cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            87544322 345689999999999987554   89999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=304.22  Aligned_cols=199  Identities=25%  Similarity=0.345  Sum_probs=179.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .=|.+.+.||+|.|++|-+|++  +|..||||++.+..+.......+.+|++.|+.++|||||++|.+..+...+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4477888999999999999987  89999999999988877777789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE-cCCCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-DKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL-d~~g~VKLsDFGLAr~~~~t~  815 (867)
                      +=.+|+|++||-+...  .+.+..+.+|+.||+.|+.|+|+..  +|||||||+|+.+ .+-|-|||+|||++..+.. .
T Consensus        98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-G  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-G  172 (864)
T ss_pred             ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCC-c
Confidence            9999999999987543  4899999999999999999999999  9999999999975 6789999999999865533 2


Q ss_pred             ccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....+.||...|-|||++.+..|    .||||||++||.+++|.+||+...
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN  223 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN  223 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence            33468899999999999999877    799999999999999999999754

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=1.6e-31  Score=280.83  Aligned_cols=205  Identities=23%  Similarity=0.347  Sum_probs=169.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      |++..++|++.+.||+|+||.||+|.+.+       ..||||++.... ......++.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            45567899999999999999999998643       459999876432 2234567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT  799 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~-------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~  799 (867)
                      .....++||||+++|+|.+++.....       ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence            99999999999999999999875221       123577888999999999999999999  999999999999999999


Q ss_pred             EEEEecCccccccCCcc--cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          800 VKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       800 VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +||+|||+++.......  ......+++.|+|||.+.+..   .+||||||+++|+|++ |..||...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999976543222  112335578999999987644   3899999999999998 68888654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.98  E-value=1.9e-31  Score=281.29  Aligned_cols=204  Identities=24%  Similarity=0.387  Sum_probs=170.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      +.+++|++.+.||+|+||+||+|.+      .+..+|+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4568899999999999999999985      34568999887432 2345577889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAA--------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~--------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd  795 (867)
                      ..|+||||+++++|.+++.....              ...+++...+.++.||+.||.|||+++  |+||||||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~  158 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence            99999999999999999864221              234788899999999999999999999  99999999999999


Q ss_pred             CCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       796 ~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      .++.+||+|||+++......  .......++..|+|||.+.+...   +|+||||+++|+|++ |..||....
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999998653321  12234456778999999875544   899999999999998 999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.98  E-value=2e-32  Score=296.19  Aligned_cols=201  Identities=24%  Similarity=0.347  Sum_probs=170.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCC------
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRP------  729 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN-IVkl~ga~~~~~------  729 (867)
                      ..|..+++||.|+||+||+|+.  +|+.||+|+++...-.+..-....+|+.+|+.|+|+| ||.+++++.+..      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            5577778899999999999987  6888999999876532222345689999999999999 999999998877      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~-~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .+++|+||+ ..+|..++...... ..++...+..++.||+.||+|||+++  |+||||||.||||++.|.+||+|||+|
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchH
Confidence            899999999 55899999874421 34777889999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCC-h---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNS-L---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~-~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +...-.........+|.-|.|||++.+.. +   .||||+||++.||+++.+-|....
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s  225 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS  225 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence            97654333345668899999999999864 3   599999999999999998887654

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.98  E-value=1.3e-31  Score=294.60  Aligned_cols=195  Identities=25%  Similarity=0.327  Sum_probs=166.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------C
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~  729 (867)
                      .++|++.+.||+|+||.||+|..  .++.||||++..........+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            47899999999999999999987  577899999876544445567788999999999999999999987543      3


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|+||||+.+ +|...+..     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            57999999965 67776643     3788899999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....... .....||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       175 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         175 TAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             ccCCCCc-ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            7644322 245678999999999987554   89999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.98  E-value=9.6e-32  Score=296.92  Aligned_cols=196  Identities=24%  Similarity=0.346  Sum_probs=166.3

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----eEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLS  732 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-----~l~  732 (867)
                      +|++++.||+|+||+||++..  +++.||||++..........+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999986  5888999998654333345667889999999999999999999998776     799


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+. ++|...+...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999995 5788877652   35899999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCc-ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTF-ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~-~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ... .......+|+.|+|||++.+.    ..+|||||||++|+|++|++||...
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            321 122344688999999998763    3489999999999999999999654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.98  E-value=1.8e-31  Score=282.27  Aligned_cols=190  Identities=22%  Similarity=0.295  Sum_probs=163.0

Q ss_pred             eccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||+|+||+||+++.  .|+.||+|.+........ ....+..|++++++++||||+++++++.....+++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999987  478899999876543322 234456799999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCC
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG  823 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aG  823 (867)
                      ..++.... ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++....... ......|
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~  156 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG  156 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence            98886533 234788999999999999999999999  9999999999999999999999999987664432 2234578


Q ss_pred             CcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          824 TVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       824 Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      |+.|+|||++.+..+   +|+|||||++|+|++|..||..
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999887655   7999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.98  E-value=2.3e-31  Score=282.98  Aligned_cols=198  Identities=22%  Similarity=0.267  Sum_probs=169.9

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .|++.+.||+|+||.||++.+  .++.||||.+....... .....+.+|+.++++++|+||+.+++.+.....+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367888999999999999988  46789999987654433 234557889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999999886532 234889999999999999999999999  9999999999999999999999999987654322 


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            2234589999999999987554   79999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.98  E-value=2.8e-31  Score=275.55  Aligned_cols=198  Identities=26%  Similarity=0.444  Sum_probs=168.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.++|++.+.||.|+||.||++.++ +..+|+|.+......   ...+.+|+.+|++++||||+++++++.....+++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            3468999999999999999999985 457999987754432   346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.++++...  ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999999987532  24889999999999999999999999  9999999999999999999999999998654332


Q ss_pred             c-cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          816 I-SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       816 ~-s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      . ......++..|+|||.+.+..+   +|+||||+++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            2 1223345678999999886544   899999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=4.3e-32  Score=308.68  Aligned_cols=198  Identities=27%  Similarity=0.430  Sum_probs=182.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ....|.+...||+|.|++|.+|++  ++.+||||++.+.......++.+.+|+.||+.|.|||||+++.+...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            457899999999999999999988  688999999999888877777899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+.+|.+++++.+..   .+.+..+..++.|++.+++|||+++  |||||||.+||||+.+.++||+|||++..+.. 
T Consensus       134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY-  207 (596)
T ss_pred             EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc-
Confidence            99999999999999754   3666888899999999999999999  99999999999999999999999999988764 


Q ss_pred             cccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....++.||+|.|.|||++.+.++    +|+||||++||.|+.|..||..
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence            344678999999999999998666    7999999999999999999973

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.98  E-value=1.6e-31  Score=280.89  Aligned_cols=202  Identities=28%  Similarity=0.430  Sum_probs=169.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +..++|++.+.||.|+||.||+|.+.+       ..||+|.+.... .......+.+|+.++.+++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            345789999999999999999998743       358999886443 334456789999999999999999999999998


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd  795 (867)
                      ...+++|||+++|+|.+++.....             ...+++..++.++.|++.||.|||+++  |+||||||+|||++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~  158 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG  158 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence            999999999999999999976321             145788899999999999999999999  99999999999999


Q ss_pred             CCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       796 ~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +++.+||+|||+++......  .......+++.|+|||.+.+..+   +|||||||++|+|++ |..||..
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~  229 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG  229 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999998653321  11234466889999999876544   899999999999997 9989865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.98  E-value=3.2e-31  Score=279.80  Aligned_cols=190  Identities=29%  Similarity=0.415  Sum_probs=167.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||.||+|.+  ++..||+|++.... ......++.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4688899999999999999987  57789999987543 33445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|..+.       .+++..+..++.|++.||.|||+++  |+|+||||+|||++.++.+||+|||++....... 
T Consensus        80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            99999997542       3678889999999999999999999  9999999999999999999999999998654432 


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                       .....||+.|+|||.+.+..+   +|+||||+++|+|++|..||..
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence             245689999999999987655   7999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=3.1e-31  Score=281.54  Aligned_cols=197  Identities=23%  Similarity=0.262  Sum_probs=169.9

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      |+..+.||.|+||+||+|.+  +++.+|+|++........ ....+.+|+.+|++++|+||+.+++++...+.+++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67788999999999999988  477899999876554432 345578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|..++.... ...+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++...... .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  157 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-S  157 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-c
Confidence            99999998886532 235899999999999999999999999  9999999999999999999999999987653321 1


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....|++.|+|||.+.+..+   +|+||||+++|+|++|..||...
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            235579999999999986554   79999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=1.8e-31  Score=303.48  Aligned_cols=195  Identities=23%  Similarity=0.314  Sum_probs=159.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------  728 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------  728 (867)
                      ...+|++++.||+|+||+||+|.+  ++..||||++....      ....+|+.+|+.++|||||+++++|...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            346899999999999999999987  57789999886432      1234799999999999999999887432      


Q ss_pred             --CeEEEEEeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEe
Q 002910          729 --PHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCD  804 (867)
Q Consensus       729 --~~l~LVmEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsD  804 (867)
                        ..+++||||+++ +|.+++... .....+++..++.++.||+.||.|||+++  |+||||||+||||+.++ .+||+|
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence              247799999975 676666431 22345889999999999999999999999  99999999999998665 799999


Q ss_pred             cCccccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          805 FGLSRFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       805 FGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+++...... ......||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99998664322 22356789999999998653    3489999999999999999999754

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=3.2e-31  Score=281.33  Aligned_cols=196  Identities=26%  Similarity=0.426  Sum_probs=173.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||++.+  .++.+|+|++...... ......+.+|+++++++.||||+++++.+.....+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4789999999999999999988  4788999999765443 245677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+  |+||||+|.||||+.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999999764   35889999999999999999999999  999999999999999999999999999876554 


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                        ....++++.|+|||.+.+...   +|+||||+++|+|++|..||....
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence              245578999999999876543   799999999999999999987543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=2.5e-31  Score=277.08  Aligned_cols=197  Identities=28%  Similarity=0.433  Sum_probs=170.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||.||+|+.  ++..||+|++....  ......+.+|+.++++++||||+++++.+.....+++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46899999999999999999987  56789999987543  223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.++++..   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          86 EYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999998753   35889999999999999999999999  9999999999999999999999999998765443


Q ss_pred             ccccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......|++.|+|||.+..      ...+|+|||||++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            33345678999999998752      23489999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-33  Score=308.14  Aligned_cols=200  Identities=22%  Similarity=0.342  Sum_probs=171.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC-eEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP-HLS  732 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~-~l~  732 (867)
                      .-++|+++++||.|+||.||+|+.  .+..||||.+++....-++. --+||+..|++|. |||||++.+++.+.. .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            347899999999999999999986  67889999988766543322 2368999999999 999999999998887 899


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||| ..+|+++++.+  ...+++..++.|+.||++||+|+|++|  +.||||||+|||+.....|||+||||||...
T Consensus        87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccc
Confidence            999999 56999999885  567999999999999999999999999  9999999999999988899999999999876


Q ss_pred             CCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      +..- .....-|-=|.|||++....+    .|+|++||+++|++.-++-|.+...
T Consensus       162 SkpP-YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE  215 (538)
T KOG0661|consen  162 SKPP-YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE  215 (538)
T ss_pred             cCCC-cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence            5321 123466778999999885333    7999999999999998888876543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=2.8e-31  Score=277.06  Aligned_cols=201  Identities=28%  Similarity=0.481  Sum_probs=171.7

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      |++...+|.+.+.||.|+||.||+|.+  .++.||+|++....   .....+.+|+.++++++||||+++++++.....+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            456778999999999999999999988  47789999987543   3356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            99999999999999987533 335889999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCccc-ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          812 ANTFIS-SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       812 ~~t~~s-~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      ...... .....+++.|+|||.+.+...   +|||||||++|+|++ |..||..
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            543221 112234678999999886554   799999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=4.5e-31  Score=273.69  Aligned_cols=200  Identities=24%  Similarity=0.442  Sum_probs=174.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||+|..  +++.||+|.++...... ...+.+.+|+.++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            6899999999999999999988  58889999987654433 44678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          736 EYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      ||+++++|..++.... ....+++..++.++.+++.||+|||+.+  |+||||+|+||+++.++.++|+|||+++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999986522 2345789999999999999999999999  999999999999999999999999999876544


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ........+++.|+|||.+.+..+   +|+||||+++|+|++|..||..
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            333345678999999999887654   7999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1e-32  Score=314.03  Aligned_cols=196  Identities=26%  Similarity=0.434  Sum_probs=171.9

Q ss_pred             EEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe--EEEEE
Q 002910          662 HVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH--LSIVT  735 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~--l~LVm  735 (867)
                      +..+.||+|+|-+||+|.+  .|-+||.-.++..++..  ..+++|..|+.+|+.|+|||||+||.+|.+...  +-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4456799999999999987  46667766666555543  557899999999999999999999999987655  88999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEEEecCccccccCC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr~~~~t  814 (867)
                      |.+..|+|..|+++..   .++.+....|++||++||.|||++.|||||||||.+||+|+ ..|.|||+|+|||..+...
T Consensus       123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999998743   58899999999999999999999999999999999999997 4689999999999998877


Q ss_pred             cccccccCCCcccccccccCC--CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 FISSKSVAGTVVFFAAHQTAC--NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~--~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +.  +++.|||+|||||++..  ++..||||||+++.||+|+..||..+.
T Consensus       200 ~a--ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~  247 (632)
T KOG0584|consen  200 HA--KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECT  247 (632)
T ss_pred             cc--ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence            65  55899999999999983  455899999999999999999998765

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-34  Score=294.70  Aligned_cols=197  Identities=24%  Similarity=0.368  Sum_probs=178.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|.+.+.||+|.|+.||++.+  +|+.+|+|++....+.....+++.+|++|.+.|+|||||++.+.+......|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            36888899999999999999977  6888999999988888778889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGLAr~~~  812 (867)
                      |+|.|++|..-|-..   ..++|..+-.+++||+.+|+|+|.++  |||||+||+|+|+-   +..-+||+|||++....
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998766653   35789999999999999999999999  99999999999994   44569999999999887


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                       .......++|||+|||||+++..++   +|||+-|++||-++.|.+|||.
T Consensus       165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence             4444667899999999999998777   6999999999999999999998

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.5e-31  Score=271.75  Aligned_cols=198  Identities=29%  Similarity=0.454  Sum_probs=173.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||.|+||.||+|.+  .++.+++|++.....  ...+.+.+|+.++++++||||+++++++.....++++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            37899999999999999999987  467799999986542  25678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+++  |+|+||||+||+++.++.+||+|||++.......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999999987631  35889999999999999999999999  9999999999999999999999999998765543


Q ss_pred             ccccccCCCcccccccccCCC---C---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN---S---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~---~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......++..|+|||.+.+.   .   .+|+||||+++|+|++|.+||...
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~  207 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL  207 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            334456789999999998654   3   389999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=6.9e-31  Score=271.29  Aligned_cols=198  Identities=21%  Similarity=0.380  Sum_probs=172.7

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-~~~l~LVmE  736 (867)
                      +|++.+.||.|+||.||++..  .++.||+|.+..........+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            488999999999999999987  46779999998766555666778999999999999999999998864 456899999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++.... ...+++..++.++.+++.||+|||+.+  |+||||||+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999987532 345899999999999999999999999  99999999999999999999999999987655444


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ......+++.|+|||++.+..+   +|+||||+++|+|++|..||..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            4456678999999999887654   7999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=4.6e-31  Score=273.31  Aligned_cols=198  Identities=24%  Similarity=0.360  Sum_probs=172.5

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||.|+||.||++.+  ++..+|+|.+..... ....+.+.+|+.++++++||||+++++.+.....+++||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            588999999999999999987  577899999875432 34566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++|+|.+++.... ...+++..++.++.||+.||.|||+++  |+|+||||+||+++.++.++|+|||+++........
T Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99999999886532 345789999999999999999999999  999999999999999999999999999876554333


Q ss_pred             ccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....|++.|+|||++.+..   .+|+||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  203 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN  203 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence            34567899999999987654   489999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.7e-31  Score=272.85  Aligned_cols=198  Identities=25%  Similarity=0.383  Sum_probs=171.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch---HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~---~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ++|.+.+.||.|+||.||+|..  .+..+|+|.+.......   ...+.+.+|+.++++++||||+++++++.....+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999986  57889999987654332   345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999998763   34788999999999999999999999  99999999999999999999999999876533


Q ss_pred             Cccc---ccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFIS---SKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s---~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....   .....+++.|+|||.+.+..   .+||||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence            2111   13456889999999998764   489999999999999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=2.5e-31  Score=280.03  Aligned_cols=196  Identities=26%  Similarity=0.378  Sum_probs=161.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeEEee-----CC
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVTK-----RP  729 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~~-----~~  729 (867)
                      +|++.+.||+|+||+||+|++  +++.||+|.+............+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            488999999999999999988  577899999876543332233456677777665   69999999998864     34


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+. ++|..++.... ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence            5899999997 48888887533 234889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....... .....||+.|+|||++.+..+   +|||||||++|+|++|.+||..
T Consensus       157 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~  209 (288)
T cd07863         157 IYSCQMA-LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  209 (288)
T ss_pred             cccCccc-CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence            7644322 234578999999999976554   7999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=4.7e-31  Score=276.72  Aligned_cols=198  Identities=22%  Similarity=0.352  Sum_probs=170.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++..........+.+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4789999999999999999988  47789999987654333334567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |++++.|..++...   ..+++..++.++.||+.||.|||+++  |+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99999988877642   24899999999999999999999999  99999999999999999999999999987655432


Q ss_pred             cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......++..|+|||.+.+.    ..+||||||+++|+|++|.+||...
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            33345688999999998753    3489999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=5e-31  Score=275.13  Aligned_cols=201  Identities=28%  Similarity=0.439  Sum_probs=170.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ..++|++.+.||+|+||+||+|.+.     ...||||++.... .......+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            4578999999999999999999884     2368999886543 334456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999997633  35889999999999999999999999  999999999999999999999999999876


Q ss_pred             cC--CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          812 AN--TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       812 ~~--t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ..  .........+++.|+|||.+.+..+   +||||||+++|+|++ |..||+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~  213 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence            42  1111223345678999999886544   799999999999997 999986543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.4e-31  Score=274.16  Aligned_cols=203  Identities=30%  Similarity=0.457  Sum_probs=171.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |++..++|++.+.||+|+||.||+|.+ .++.||+|.++....   ..+.+.+|+.++++++||||+++++++...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            356778999999999999999999987 455799999875442   2456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++...
T Consensus        78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            9999999999999997643 345889999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCccc-ccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCccccc
Q 002910          813 NTFIS-SKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       813 ~t~~s-~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ..... ......+..|+|||.+.+..   .+|+||||+++|+|++ |+.||....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            33211 11222345899999988654   4899999999999998 999987644

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=3.3e-31  Score=285.32  Aligned_cols=199  Identities=24%  Similarity=0.391  Sum_probs=166.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ...+|++.+.||+|+||+||+|.+  ++.    .||+|++.... .....+++.+|+.+++.++||||+++++++... .
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            347899999999999999999987  333    38999886432 234556788999999999999999999998764 5


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++|+||+++|+|.+++....  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccc
Confidence            789999999999999998632  34788899999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......  ......+++.|+|||.+.+..+   +||||||+++|+|++ |..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            643221  1223345678999999886554   799999999999987 99998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=3.1e-31  Score=298.65  Aligned_cols=207  Identities=29%  Similarity=0.423  Sum_probs=172.2

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMG  723 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~g  723 (867)
                      ..+++..++|++++.||.|+||.||+|.+.+       ..||||++.... .....+.+.+|+.+|+++. |||||++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            4566778899999999999999999998632       359999986542 2344567899999999996 999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCC---------------------------------------------------
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------  752 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~---------------------------------------------------  752 (867)
                      ++...+.+|||||||++|+|.++|+....                                                   
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            99999999999999999999999875310                                                   


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          753 ------------------------------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       753 ------------------------------------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                                                                ...+++..+..++.||+.||+|||+.+  |+||||||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~  266 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR  266 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence                                                      123677888999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |||++.++.+||+|||+++.....  ........+++.|+|||.+.+..   .+|||||||++|+|++ |..||...
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            999999999999999999865332  12223446778999999987654   4899999999999996 88888653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-31  Score=291.48  Aligned_cols=192  Identities=21%  Similarity=0.319  Sum_probs=165.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Ce
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~~  730 (867)
                      ++|++++.||.|+||+||+|..  .+..||||++..........+.+.+|+.+|++++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            6899999999999999999987  467799999876543334556778999999999999999999988543      35


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .|++||++ +++|..++..    ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence            79999998 8899888753    24899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....   .....||+.|+|||++.+.    ..+|||||||++|+|++|..||..
T Consensus       168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            5443   2355789999999998762    348999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.8e-31  Score=278.10  Aligned_cols=196  Identities=28%  Similarity=0.454  Sum_probs=170.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||.||+|.+  +++.||+|+++...  ......+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            5788889999999999999987  57789999987553  2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++...   ..+++..++.++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||++........
T Consensus        87 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          87 FCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999998753   35899999999999999999999999  99999999999999999999999999876654433


Q ss_pred             cccccCCCcccccccccC---C---CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTA---C---NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~---~---~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......|++.|+|||.+.   .   ...+|+|||||++|+|++|.+||...
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence            344568999999999974   2   23489999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-33  Score=310.18  Aligned_cols=203  Identities=21%  Similarity=0.296  Sum_probs=183.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCce--EEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~--VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+.+.+++++..||-|+||.|-+++.+++.  +|+|++++..+.+ ++.+.+..|.+||..++.|+||++|..|.+..++
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            445678889999999999999999987666  8999998877654 6778889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ||+||-|-||.|+.+|+..+   .+++..+.+++..+++|++|||++|  ||||||||+|++|+.+|-+||.|||+|+.+
T Consensus       496 YmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHh
Confidence            99999999999999998744   5889999999999999999999999  999999999999999999999999999987


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccch
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      .... ...++||||+|.|||++.+...   +|+|+||+++||+++|.+||.+...
T Consensus       571 ~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  571 GSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             ccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            6643 3468999999999999998665   7999999999999999999987643

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1e-30  Score=270.42  Aligned_cols=198  Identities=22%  Similarity=0.397  Sum_probs=175.2

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|+..+.||.|+||.||.++.  ++..+++|.+............+.+|+.++++++|+||+++++++.....++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999999998877  577899999987776667777899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++.+.. ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            99999999997643 345889999999999999999999999  999999999999999999999999999876544323


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....+++.|+|||.+.+..+   +|+||||+++|+|++|..||..
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence            345678999999999876544   7999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.5e-31  Score=276.13  Aligned_cols=205  Identities=24%  Similarity=0.333  Sum_probs=172.1

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      |++..++|++.+.||+|+||.||+|.+.+       ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            35677899999999999999999998743       469999976443 2344567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT  799 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~-------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~  799 (867)
                      .....++||||+++|+|.+++.....       ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence            99999999999999999999975321       224678899999999999999999999  999999999999999999


Q ss_pred             EEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          800 VKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       800 VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +||+|||+++.......  ......++..|+|||.+.+...   +|||||||++|+|++ |..||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  225 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL  225 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence            99999999986544321  2234467889999999875444   799999999999998 88888643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=5.6e-31  Score=280.91  Aligned_cols=198  Identities=21%  Similarity=0.333  Sum_probs=168.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|.+.+.||.|+||.||+|++  .+..||+|.+...... .....+.+|+.++++++||||+++++++.....+++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            57899999999999999999987  4678999998754322 22345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. ++|..++...  ...+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        84 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          84 EYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             eccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9996 5888888753  235788999999999999999999999  9999999999999999999999999997654333


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+.    ..+||||||+++|+|++|.+||...
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            223345678999999998653    3489999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=313.77  Aligned_cols=210  Identities=23%  Similarity=0.330  Sum_probs=175.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeE-Eee
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA-VTK  727 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga-~~~  727 (867)
                      ..+.|...++++.+.|.+|||+.||+|...  |..||+|.+...  .+..++.+.+||.+|+.|+ |+|||.+++. ...
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            345677788999999999999999999983  378999988765  4677889999999999998 9999999993 221


Q ss_pred             ---C---CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEE
Q 002910          728 ---R---PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVK  801 (867)
Q Consensus       728 ---~---~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VK  801 (867)
                         .   -.++|+||||.||.|-+++..+.... |++..+++|+.|+|+|+.+||...|||||||||.|||||+.+|+.|
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence               1   24789999999999999998655444 9999999999999999999999999999999999999999999999


Q ss_pred             EEecCccccccCCccccc---------ccCCCcccccccccC------CCChHHHHHHHHHHHHHhcCCCCccccchh
Q 002910          802 VCDFGLSRFKANTFISSK---------SVAGTVVFFAAHQTA------CNSLALIFSLSGWLQSSFEESPQMRSLMFI  864 (867)
Q Consensus       802 LsDFGLAr~~~~t~~s~~---------s~aGTp~YmAPEvl~------~~~~SDIwSLG~lLyeM~tG~~Pf~sl~~L  864 (867)
                      |||||.+.-.........         ..--|+.|.|||.+.      -++++|||+|||+||.++....||..-+.+
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l  264 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL  264 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence            999999865332211111         123489999999976      255699999999999999999999987654

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=8.1e-31  Score=275.94  Aligned_cols=209  Identities=28%  Similarity=0.375  Sum_probs=174.0

Q ss_pred             ccccccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 002910          649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV  725 (867)
Q Consensus       649 l~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~  725 (867)
                      ...+++...+++|++.+.||+|+||+||++..  .++.+|+|++....   .....+.+|+.+++++ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            34566667789999999999999999999987  57789999876432   2234577899999999 699999999987


Q ss_pred             e-----eCCeEEEEEeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc
Q 002910          726 T-----KRPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT  799 (867)
Q Consensus       726 ~-----~~~~l~LVmEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~  799 (867)
                      .     ..+.+++||||+++++|.+++... .....+++..+..++.|++.||.|||+++  |+||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~  162 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCC
Confidence            4     345789999999999999987632 12345788999999999999999999999  999999999999999999


Q ss_pred             EEEEecCccccccCCcccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          800 VKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       800 VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +||+|||+++.............|++.|+|||++..        ...+|||||||++|+|++|..||....
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999999876544333445679999999999863        234899999999999999999987653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=6.1e-31  Score=281.77  Aligned_cols=205  Identities=26%  Similarity=0.408  Sum_probs=170.7

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC---------ceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g---------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      .+++..++|.+++.||+|+||.||+|++.+         ..+|+|++.... .......+.+|+.+++++ +||||++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            456677999999999999999999998632         359999987542 334556788999999999 799999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      +++.....+++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++  |+||||||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp  168 (307)
T cd05098          91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA  168 (307)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence            999999999999999999999999976321             124788999999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCcccc--cccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTFISS--KSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~~s~--~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +|||++.++.+||+|||+++.........  ....+++.|+|||.+.+..+   +|+|||||++|+|++ |..||..
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            99999999999999999997654322111  12234578999999876544   899999999999998 7888754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=3e-31  Score=276.05  Aligned_cols=201  Identities=22%  Similarity=0.423  Sum_probs=174.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||+|.+  ++..+|||.+...... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            6788999999999999999986  6788999988765433 345578899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||+++  |+|+||||+||+++.++.++|+|||+++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            999999999988742 22345899999999999999999999999  999999999999999999999999998876544


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........+++.|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            333345678999999999876554   79999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=7.5e-31  Score=278.32  Aligned_cols=198  Identities=26%  Similarity=0.433  Sum_probs=171.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      -+.|++++.||.|+||.||+|+.  .+..+++|++....  ....+.+.+|+.+++.++||||+++++.+.....+++||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            36799999999999999999988  46789999987542  455677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|..++.+..  ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++......
T Consensus        89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            9999999988876532  35899999999999999999999999  9999999999999999999999999987654443


Q ss_pred             ccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+        ...+|+|||||++|+|++|.+||+..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence            33345678999999999853        22489999999999999999998754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=2e-33  Score=296.64  Aligned_cols=196  Identities=28%  Similarity=0.451  Sum_probs=178.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +-|.++++||.|+||.||+|.+  .|..+|||.+...    ..++++.+|+.||.++..|++|++||.|.....+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3466788999999999999987  5888999987654    467889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||..|++.++++.+  .+.+.+..+..+++..++||+|||...  -||||||..||||+.+|+.||+|||.+..+.++-.
T Consensus       109 YCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999999864  457999999999999999999999988  89999999999999999999999999999988888


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..+++.|||.|||||++..-.   .+||||||++..+|..|++||...+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH  233 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH  233 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence            889999999999999998544   4899999999999999999998765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=3.7e-31  Score=277.22  Aligned_cols=202  Identities=26%  Similarity=0.380  Sum_probs=170.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ..++|.+.+.||+|+||.||+|.+.       +..||||++.... ..+..+.+.+|+++|++++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            4578899999999999999999863       3569999986543 2334578999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPA-----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW  798 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~-----------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g  798 (867)
                      ..++||||+++++|.+++....           ....+++..+..++.||+.||.|||+++  |+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~  159 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence            9999999999999999997532           1234788899999999999999999999  99999999999999999


Q ss_pred             cEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          799 TVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       799 ~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .+||+|||+++......  .......+++.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999997643221  11233456789999999887555   799999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.2e-30  Score=272.04  Aligned_cols=198  Identities=24%  Similarity=0.372  Sum_probs=168.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~---~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l  731 (867)
                      ++|.+.+.||+|+||.||++.+  ++..||||.+......   ....+.+.+|+.++++++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5789999999999999999987  4778999988643321   24567889999999999999999999988763  468


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++...   ..+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999998753   24788899999999999999999999  999999999999999999999999998765


Q ss_pred             cCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....   .......|+..|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            3211   12234578999999999876544   89999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=1.6e-31  Score=306.20  Aligned_cols=192  Identities=28%  Similarity=0.369  Sum_probs=169.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-C-----CCeeeEEeEEeeCCeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-H-----PNVVLFMGAVTKRPHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-H-----PNIVkl~ga~~~~~~l  731 (867)
                      +|.+.+.||+|+||+|.+|..  +++.||||+++...   ....+-..|+.||..|+ |     -|||+++++|...+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            899999999999999999987  57789999998764   45556778999999997 4     3899999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC--CcEEEEecCccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN--WTVKVCDFGLSR  809 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~--g~VKLsDFGLAr  809 (867)
                      |||+|.+ ..+|+++|+.+. ...++...++.|+.||+.||.+||+.+  |||+|||||||||..-  ..|||+|||.++
T Consensus       264 ciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999999 679999999865 445899999999999999999999999  9999999999999543  379999999999


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+   +-+.+..|.|||++.+.++   .|+|||||++.||++|.+.|.+-
T Consensus       340 ~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  340 FESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             ccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            8766544   5577889999999999888   59999999999999998888654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=6.9e-31  Score=272.59  Aligned_cols=196  Identities=28%  Similarity=0.469  Sum_probs=168.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCeEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT-KRPHLSI  733 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~-~~~~l~L  733 (867)
                      .+..++|++.+.||+|+||.||++...+..+|+|.+....    ..+.+.+|+.++++++|+||+++++++. .....++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            4567899999999999999999999999999999986432    3456889999999999999999999764 5567999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++++|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+||+++.++.+||+|||+++....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999999997643 234789999999999999999999999  99999999999999999999999999976543


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      ..   ....++..|+|||++.+...   +|||||||++|+|++ |..||..
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            32   23455678999999876544   899999999999997 8988864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=6.8e-31  Score=299.94  Aligned_cols=196  Identities=18%  Similarity=0.284  Sum_probs=161.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC------CCeeeEEeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH------PNVVLFMGAV  725 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH------PNIVkl~ga~  725 (867)
                      +++..++|++.+.||+|+||+||+|.+  .+..||||+++...   ........|+.+++.++|      .+|++++++|
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            445668999999999999999999987  46779999986432   223445667777777655      4588899888


Q ss_pred             eeC-CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCC-----
Q 002910          726 TKR-PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNW-----  798 (867)
Q Consensus       726 ~~~-~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g-----  798 (867)
                      ... .++|||||++ +++|.+++.+.   ..+++..+..++.||+.||+|||. .|  ||||||||+|||++.++     
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccc
Confidence            764 5789999998 77888888753   358999999999999999999997 58  99999999999998765     


Q ss_pred             -----------cEEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          799 -----------TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       799 -----------~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                                 .+||+|||++......   ....+||+.|+|||++.+..+   +|||||||++|+|++|++||...
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                       4999999998653322   346789999999999987665   79999999999999999999653

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=4.8e-31  Score=283.01  Aligned_cols=190  Identities=22%  Similarity=0.352  Sum_probs=155.3

Q ss_pred             EEEeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeEEEEEec
Q 002910          664 KERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEY  737 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l~LVmEy  737 (867)
                      +++||+|+||+||+|++.    +..||+|.+.....    ...+.+|+.+|++++||||+++++++..  ...+++||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            457999999999999863    45699998865432    2346789999999999999999999854  4568999999


Q ss_pred             cCCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE----cCCCcEEEEecCc
Q 002910          738 LPRGSLYRLIHRPA------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL  807 (867)
Q Consensus       738 ~~gGSL~~~L~~~~------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL----d~~g~VKLsDFGL  807 (867)
                      +. ++|..++....      ....+++..+..++.||+.||.|||+++  |+||||||+|||+    +..+.+||+|||+
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            84 58888775321      1224888999999999999999999999  9999999999999    4668999999999


Q ss_pred             cccccCCc---ccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCccc
Q 002910          808 SRFKANTF---ISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       808 Ar~~~~t~---~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++......   .......||+.|+|||++.+..    .+|||||||++|+|++|.+||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            98764332   1223568899999999987633    38999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.1e-30  Score=280.77  Aligned_cols=193  Identities=24%  Similarity=0.385  Sum_probs=168.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||.||++.+  ++..+|+|.+.... .......+.+|++++++++||||+++++.|...+.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            4789999999999999999988  46678888876432 33445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |+++++|.++++..   ..+++..+..++.||+.||.|||+ ++  |+||||||+|||++.++.+||+|||+++......
T Consensus        80 y~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          80 HMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            99999999999763   358899999999999999999997 57  9999999999999999999999999987654432


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                        .....|++.|+|||.+.+...   +|+||||+++|+|++|..||.
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence              245688999999999876544   899999999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=8.8e-31  Score=316.96  Aligned_cols=200  Identities=23%  Similarity=0.248  Sum_probs=169.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||+|.+  .++.||||++...... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            6899999999999999999987  4788999998764333 234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          736 EYLPRGSLYRLIHRPAA--------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~--------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ||++||+|.+++.....        ...++...++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999864211        123456678889999999999999999  99999999999999999999999999


Q ss_pred             cccccCC------------------cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          808 SRFKANT------------------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       808 Ar~~~~t------------------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++.....                  .......+||+.|||||.+.+..+   +|||||||++|+|++|..||..
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9865110                  011123579999999999987554   7999999999999999999965

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=3.7e-31  Score=278.93  Aligned_cols=197  Identities=26%  Similarity=0.423  Sum_probs=170.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++++.||+|+||.||++.+.  +..||+|.+... ........+.+|+.++++++||||+++++.+...+.+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            46889999999999999999984  788999988753 234456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |+++++|..++........+++..+..++.||+.||.|||. .+  |+||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999998764323468999999999999999999996 58  9999999999999999999999999997654332


Q ss_pred             ccccccCCCcccccccccCCC---------ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN---------SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~---------~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                        .....+++.|+|||.+.+.         ..+|+|||||++|+|++|..||..
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence              2445788999999998642         348999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.2e-30  Score=270.37  Aligned_cols=198  Identities=30%  Similarity=0.478  Sum_probs=172.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .+..++|++.+.||.|+||.||+|...++.||+|.+.....   ..+++.+|+.++++++|+||+++++++......++|
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            35668999999999999999999999999999999875532   567789999999999999999999999989999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++.... ...+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999997643 235899999999999999999999999  999999999999999999999999999876332


Q ss_pred             cccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .   .....+..|+|||.+....   .+|+||||+++|+|++ |..||...
T Consensus       156 ~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         156 Q---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             c---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            2   1334567899999987654   4899999999999997 88888654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-32  Score=311.51  Aligned_cols=198  Identities=24%  Similarity=0.336  Sum_probs=171.7

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------eEE
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------HLS  732 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------~l~  732 (867)
                      +...+.||+|+||.||++++  .|..||||.++... .....+.+.+|++||++++|||||++++.-.+..      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34567899999999999987  68899999987643 3456778999999999999999999998765443      357


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC--CC--cEEEEecCcc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NW--TVKVCDFGLS  808 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~--~g--~VKLsDFGLA  808 (867)
                      +|||||.||+|...|.++.....+++...+.++.+++.||.|||++|  ||||||||.||++-.  +|  .-||+|||.|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999999887888999999999999999999999999  999999999999832  23  4599999999


Q ss_pred             ccccCCcccccccCCCcccccccccCC-CCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTAC-NSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~-~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      |...+.. ...++.||++|++||++.. ..+   .|.|||||++|+..||..||...+
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9887654 4578999999999999995 444   699999999999999999997654

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=1.1e-30  Score=276.89  Aligned_cols=205  Identities=25%  Similarity=0.332  Sum_probs=168.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      |++..++|++.+.||+|+||.||+|.++       +..||+|.+.... .......+.+|+.++++++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            5677899999999999999999999753       3369999876443 2233456889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT  799 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~-------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~  799 (867)
                      .....++||||+++|+|.+++.....       ........+..++.|++.||.|||+++  |+||||||+|||++.++.
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence            99999999999999999999975221       123467788899999999999999999  999999999999999999


Q ss_pred             EEEEecCccccccCCcc--cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          800 VKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       800 VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +||+|||+++.......  ......++..|+|||.+.+..   .+|+|||||++|+|++ |..||...
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999986543221  112234577899999987644   4899999999999998 78888653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=3.6e-32  Score=284.69  Aligned_cols=202  Identities=22%  Similarity=0.401  Sum_probs=174.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc------hHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL------DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP  729 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~------~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~  729 (867)
                      ..|.-.+.||.|..++|.++.+  ++.++|+|++......      ....++..+|+.||+++. ||+|+.+.++|+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4455567799999999999977  5788999998753221      233566789999999985 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++|+|.|+.|.|+++|..   ...++++....+++|+..|+.|||.++  ||||||||+|||+|++.++||+|||+++
T Consensus        97 F~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence            99999999999999999976   445999999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---------HHHHHHHHHHHHHhcCCCCccccchhhc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---------ALIFSLSGWLQSSFEESPQMRSLMFIVL  866 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---------SDIwSLG~lLyeM~tG~~Pf~sl~~LV~  866 (867)
                      .+... ......||||+|+|||.+.+..+         .|+|++|+++|.++.|-+|||.-..+++
T Consensus       172 ~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM  236 (411)
T KOG0599|consen  172 QLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM  236 (411)
T ss_pred             ccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH
Confidence            76543 23467899999999999996433         6999999999999999999998776653

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=5e-31  Score=276.61  Aligned_cols=196  Identities=32%  Similarity=0.535  Sum_probs=163.7

Q ss_pred             EEEEEeccCCceEEEEEEEc------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          662 HVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~~------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .+.+.||.|.||.||+|.++      +..|+||+++. .......+.+.+|++++++++||||++++|++...+..++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            57889999999999999997      56799999954 333455788999999999999999999999999888899999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC--
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~--  813 (867)
                      ||+++|+|.++|+... ...+++..++.|+.||+.||.|||+++  |+|++|+++|||++.++.+||+|||+++....  
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccc-ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence            9999999999998752 345899999999999999999999999  99999999999999999999999999987622  


Q ss_pred             CcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .............|+|||.+.+..   .+||||||+++|+|++ |..||...
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            122233446778999999987654   4899999999999999 67888654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.5e-31  Score=293.48  Aligned_cols=192  Identities=19%  Similarity=0.217  Sum_probs=164.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ...+|.+++.||.|+||.||+|...    +..||+|.+....       ...+|+.+|++++|||||++++++.....++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3468999999999999999999763    3568888876432       3467999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+. ++|..++..   ...+++..++.++.||+.||.|||+++  ||||||||+|||++.++.+||+|||+++...
T Consensus       163 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             EEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            9999995 688888854   345899999999999999999999999  9999999999999999999999999997654


Q ss_pred             CCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  .......||+.|+|||++.+..+   +|||||||++|+|++|..||+..
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            322  12235679999999999987654   89999999999999999999764

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=7e-31  Score=277.79  Aligned_cols=206  Identities=27%  Similarity=0.428  Sum_probs=172.6

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA  724 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga  724 (867)
                      .+++..++|++.+.||+|+||.||++.+.+       ..+|+|++.... .......+.+|+.+++++ +|+||++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            356777899999999999999999998742       458999887543 334556789999999999 79999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCc
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRP-------------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN  791 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~-------------~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeN  791 (867)
                      +...+.++++|||+++|+|..+++..             .....+++..++.++.||+.||+|||+++  |+||||||+|
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N  162 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN  162 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence            99999999999999999999999742             12345889999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEEecCccccccCCccc--ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          792 LLVDKNWTVKVCDFGLSRFKANTFIS--SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       792 ILLd~~g~VKLsDFGLAr~~~~t~~s--~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ||++.++.+||+|||+++........  .....+++.|+|||.+.+..+   +|||||||++|+|++ |..||...
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999999876543211  122345678999999876544   799999999999997 88887653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=9.4e-31  Score=272.86  Aligned_cols=198  Identities=27%  Similarity=0.455  Sum_probs=168.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCc-eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~g~-~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.++|++++.||.|+||+||+|++.+. .+|||.+......   ...+.+|+.++++++||||+++++++.....+++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            447899999999999999999998654 5999988754432   346889999999999999999999999888999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+.+|+|.+++....  ..+++..++.++.||+.||.|||+++  |+|+||||+|||++.++.+||+|||+++......
T Consensus        79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999997632  25899999999999999999999999  9999999999999999999999999988654332


Q ss_pred             c-cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          816 I-SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       816 ~-s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      . ......++..|+|||.+.+..   .+||||||+++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            1 112234567899999998644   4899999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=4.1e-31  Score=277.87  Aligned_cols=196  Identities=23%  Similarity=0.330  Sum_probs=166.6

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||.|+||.||+|++  +|..||+|.+............+.+|+.++++++||||+++++++.....+++||||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            478899999999999999998  578899999976543333445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +. ++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            96 5787777643  235899999999999999999999999  999999999999999999999999999865443322


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....+++.|+|||.+.+.    ..+|||||||++|+|++|..|+..
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            3345678999999998763    348999999999999999888643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-31  Score=277.37  Aligned_cols=199  Identities=26%  Similarity=0.415  Sum_probs=173.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||.|+||+||++.+  .+..+|+|++....  ....+.+.+|+.++++++||||+++++.+.....+++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            36789999999999999999988  46789999987542  345677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++...  ...+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          82 EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999999998753  235899999999999999999999999  9999999999999999999999999987655444


Q ss_pred             ccccccCCCcccccccccCCC--------ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN--------SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~--------~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .......+|+.|+|||.+...        ..+|+||||+++|+|++|..||....
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~  212 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN  212 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence            334456789999999997532        23899999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=3.9e-31  Score=274.25  Aligned_cols=201  Identities=26%  Similarity=0.476  Sum_probs=172.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ....+|++++.||.|+||.||+|.+. +..+|+|++.....  .....+.+|+.+++.++||||+++++++......++|
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            34578999999999999999999984 56799999876542  2345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.++++... ...+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            99999999999998643 345889999999999999999999999  999999999999999999999999999876544


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ........+++.|+|||.+....+   +||||||+++|+|++ |..||...
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence            333334456788999999876544   799999999999998 88998654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=4.7e-31  Score=288.96  Aligned_cols=204  Identities=26%  Similarity=0.412  Sum_probs=169.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV  725 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~  725 (867)
                      |.++.++|++.+.||+|+||.||+|.+.       ++.||+|++.... .....+.+.+|+.++.++ +|+||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            5677789999999999999999999752       3569999887432 334566788999999999 799999999988


Q ss_pred             ee-CCeEEEEEeccCCCCHHHHHhcCCC----------------------------------------------------
Q 002910          726 TK-RPHLSIVTEYLPRGSLYRLIHRPAA----------------------------------------------------  752 (867)
Q Consensus       726 ~~-~~~l~LVmEy~~gGSL~~~L~~~~~----------------------------------------------------  752 (867)
                      .. ...++++|||+++++|.+++.....                                                    
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            64 4568999999999999999864211                                                    


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--cccccccCCC
Q 002910          753 ------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGT  824 (867)
Q Consensus       753 ------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGT  824 (867)
                            ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  ........++
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                  125788999999999999999999999  999999999999999999999999999865321  1122344567


Q ss_pred             cccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          825 VVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       825 p~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +.|+|||++.+..+   +|||||||++|+|++ |..||..
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~  278 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  278 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence            78999999887655   799999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-30  Score=271.78  Aligned_cols=199  Identities=24%  Similarity=0.363  Sum_probs=165.9

Q ss_pred             eEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe-----
Q 002910          661 LHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH-----  730 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~-----  730 (867)
                      |++.+.||+|+||.||+|.+.     +..||+|+++...........+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999873     2569999998765556667789999999999999999999998865544     


Q ss_pred             -EEEEEeccCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          731 -LSIVTEYLPRGSLYRLIHRPA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       731 -l~LVmEy~~gGSL~~~L~~~~---~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                       .++||||+++|+|..++....   ....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence             799999999999999885422   1235889999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          807 LSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +++......  .......++..|+|||.+.+..+   +|||||||++|+|++ |.+||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            998654322  11222345678999999876544   899999999999998 88888654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1e-30  Score=271.84  Aligned_cols=201  Identities=25%  Similarity=0.457  Sum_probs=170.1

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |+|..++|+++++||+|+||.||+|.. .++.||+|.+......   ...+.+|+.++++++|+||+++++++. ....+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            456778999999999999999999987 5678999998755432   346889999999999999999999874 45789


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||+++...
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999999999987543 345889999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ... .......++..|+|||.+....   .+||||||+++|+|++ |++||...
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  207 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM  207 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            322 2222345677899999987654   3799999999999998 99998644

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=8.6e-31  Score=273.30  Aligned_cols=197  Identities=27%  Similarity=0.449  Sum_probs=167.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC------C
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR------P  729 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~------~  729 (867)
                      +.|.+.+.||+|+||.||+|.+  .++.||+|++....   .....+.+|+.+++++ +||||+++++++...      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5688888999999999999988  46779999987543   2234678899999998 699999999998753      4


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6899999999999999987632 345889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCC--------ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACN--------SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~--------~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .............|++.|+|||++.+.        ..+|+|||||++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            765443344567899999999998632        2489999999999999999998654

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=1e-30  Score=280.27  Aligned_cols=202  Identities=25%  Similarity=0.482  Sum_probs=166.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--Cce--EEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCe
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~--VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~  730 (867)
                      +.+++|++.+.||+|+||.||+|.+.  +..  +|+|.+... ........+.+|+.++.++ +||||+++++++...+.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            46789999999999999999999873  444  466655432 2344566788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      +++||||+++|+|.++++....             ...+++..++.++.||+.||+|||+++  |+||||||+|||++.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence            9999999999999999975321             235789999999999999999999999  9999999999999999


Q ss_pred             CcEEEEecCccccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          798 WTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +.+||+|||+++..... .......+++.|+|||.+.+..   .+|||||||++|+|++ |..||...
T Consensus       161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            99999999998643221 1112233467899999987644   3799999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.2e-30  Score=317.25  Aligned_cols=206  Identities=20%  Similarity=0.341  Sum_probs=172.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RP  729 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~  729 (867)
                      .++..++|.+++.||.|+||+||+|++  .+..||+|++............+..|+.+|+.|+|||||+++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            345668999999999999999999988  45679999998776666667789999999999999999999998854  45


Q ss_pred             eEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCccccCCCCCcEEEcC-------
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLN-----PPILHWDLKSPNLLVDK-------  796 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~g-----p~IVHRDLKPeNILLd~-------  796 (867)
                      .+||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||..+     ..||||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            6999999999999999997522 2245899999999999999999999843     23999999999999964       


Q ss_pred             ----------CCcEEEEecCccccccCCcccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          797 ----------NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       797 ----------~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                                .+.+||+|||+++....... .....||+.|+|||++.+.     ..+|||||||+||+|++|..||..
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      34599999999986643322 2456899999999998642     348999999999999999999974

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.4e-30  Score=278.21  Aligned_cols=205  Identities=27%  Similarity=0.411  Sum_probs=171.2

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG  723 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~g  723 (867)
                      +++..++|.+.+.||+|+||.||+|++.         +..||+|++... ........+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            4567799999999999999999999752         235899987643 2345567889999999999 7999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                      ++......++||||+++|+|.+++.....             ...+++..+..++.||+.||.|||++|  |+||||||+
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~  166 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAAR  166 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccc
Confidence            99999999999999999999999976321             234778889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |||++.++.+||+|||+++.......  ......+++.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999987643221  1223456788999999886544   899999999999998 77877543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=1.3e-30  Score=271.84  Aligned_cols=198  Identities=23%  Similarity=0.384  Sum_probs=163.1

Q ss_pred             EEEEEeccCCceEEEEEEEcC--c--eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------CeE
Q 002910          662 HVKERVGAGSFGTVHRAEWHG--S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PHL  731 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~~g--~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~~l  731 (867)
                      .+++.||+|+||.||+|.+..  .  .+|+|.++.........+.+.+|+.+++.++||||+++++.+...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999998843  2  489998877655566678899999999999999999999987432      347


Q ss_pred             EEEEeccCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          732 SIVTEYLPRGSLYRLIHRP---AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~---~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      +++|||+.+|+|..++...   .....+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcc
Confidence            8999999999999887421   12234789999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          809 RFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +.......  ......+++.|+|||.+.+..+   +||||||+++|+|++ |..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            87643221  1223356789999999886544   899999999999998 78888653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.9e-30  Score=276.65  Aligned_cols=200  Identities=27%  Similarity=0.477  Sum_probs=164.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--Cc--eEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~  732 (867)
                      |++|++.+.||+|+||+||+|...  +.  .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.....++
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            578999999999999999999873  32  3678776632 2234456789999999999 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc
Q 002910          733 IVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT  799 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~-------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~  799 (867)
                      +||||+++|+|.++++...             ....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence            9999999999999997532             1234788999999999999999999999  999999999999999999


Q ss_pred             EEEEecCccccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          800 VKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       800 VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +||+|||+++..... ........+..|+|||.+.+..   .+|||||||++|+|++ |..||...
T Consensus       158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999998643321 1112223356799999987654   4899999999999997 99998654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=1.1e-30  Score=273.04  Aligned_cols=193  Identities=27%  Similarity=0.403  Sum_probs=156.6

Q ss_pred             EeccCCceEEEEEEEc-C---ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEWH-G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~-g---~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||+|+||+||+|... +   ..+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            5899999999999752 2   347777665332 2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--ccc
Q 002910          742 SLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FIS  817 (867)
Q Consensus       742 SL~~~L~~~~~--~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~~s  817 (867)
                      +|.+++.....  ....++.....++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999976432  223467788899999999999999999  999999999999999999999999998754322  112


Q ss_pred             ccccCCCcccccccccCC----------CChHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTAC----------NSLALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~----------~~~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .....+++.|+|||++..          ...+|||||||++|+|++ |..||...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            234456788999999753          234899999999999998 77887654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1.3e-30  Score=293.79  Aligned_cols=205  Identities=29%  Similarity=0.418  Sum_probs=172.0

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA  724 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga  724 (867)
                      .+++..++|.+.+.||+|+||.||+|++.+       ..||||++.... .....+.+.+|+.+|.++. |||||+++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            477888999999999999999999998743       469999997543 2334567899999999997 9999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCC----------------------------------------------------
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA----------------------------------------------------  752 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~----------------------------------------------------  752 (867)
                      +.....++|||||+++|+|.+++++...                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999975321                                                    


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          753 -------------------------------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       753 -------------------------------------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                                                                 ...+++..++.++.||+.||+|||+.+  |+||||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp  267 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA  267 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence                                                       123567778899999999999999998  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +|||++.++.+||+|||+++......  .......+++.|+|||.+.+..+   +||||||+++|+|++ |..||..
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999998643221  12234467889999999886544   799999999999998 8888754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=270.97  Aligned_cols=198  Identities=27%  Similarity=0.470  Sum_probs=166.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +..+|++.+.||+|+||.||++.+. +..+|+|++.......   ..+.+|+.++++++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            3467899999999999999999885 4469999987544322   35778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++....  ..+++..++.++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++...+..
T Consensus        79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999997533  25889999999999999999999999  9999999999999999999999999998654432


Q ss_pred             cc-ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          816 IS-SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       816 ~s-~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .. .....++..|+|||.+.+..+   +|+||||+++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence            21 112233457999999876544   899999999999998 78888643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=1.8e-30  Score=268.35  Aligned_cols=192  Identities=27%  Similarity=0.438  Sum_probs=161.2

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS  742 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGS  742 (867)
                      +.||+|+||.||+|.+  +++.+|+|.+... ...+....+.+|++++++++||||+++++++.....+++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            3589999999999987  5788999987643 234455678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc--cc
Q 002910          743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS--KS  820 (867)
Q Consensus       743 L~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~--~s  820 (867)
                      |.+++...  ...+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++.........  ..
T Consensus        80 L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          80 FLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99999753  235889999999999999999999999  9999999999999999999999999987654321111  11


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...+..|+|||.+.+..+   +||||||+++|+|++ |..||..+
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~  200 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL  200 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            133467999999876554   899999999999997 88888644

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.7e-30  Score=279.67  Aligned_cols=206  Identities=26%  Similarity=0.399  Sum_probs=171.0

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      .+.+..++|.+.+.||+|+||.||+|++.         ...+|+|++.... .......+.+|+.+++++ +||||++++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            45667799999999999999999999752         3358999877532 345567789999999999 599999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      +++.....+++||||+++|+|.+++.....             ...+++..+..++.||+.||.|||++|  |+||||||
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp  162 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA  162 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence            999999999999999999999999975321             234788999999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCccc--ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTFIS--SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~~s--~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||++.++.+||+|||+++........  .....+++.|+|||.+.+..+   +||||||+++|+|++ |..||...
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999865432211  122234568999999886554   799999999999998 88887653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=9.1e-31  Score=275.06  Aligned_cols=197  Identities=25%  Similarity=0.381  Sum_probs=170.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||.||+|.+  .++.||+|++..........+.+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            4789999999999999999998  47789999887654333445668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |++++.|..+....   ..+++..++.++.||+.||.|||+.+  |+||||+|+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            99999998877653   23889999999999999999999999  99999999999999999999999999987654433


Q ss_pred             cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          817 SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ......++..|+|||.+.+.    ..+||||||+++|+|++|.+||..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            33445688999999998753    348999999999999999988853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=2.6e-30  Score=276.30  Aligned_cols=195  Identities=24%  Similarity=0.382  Sum_probs=170.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .+|++.+.||+|+||.||+|..  .+..||+|.+......  ....+.+|+.+++.++||||+++++.+......++|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            6899999999999999999987  5778999998765433  34568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++..    ..+++..+..++.|++.||+|||..+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999999864    23788899999999999999999999  99999999999999999999999999876543332


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+++.|+|||.+.+...   +|||||||++|+|++|..||...
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            2344578999999999876543   89999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=274.20  Aligned_cols=198  Identities=21%  Similarity=0.317  Sum_probs=167.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||.|+||.||+|..  +++.||||.+...... .....+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            47899999999999999999987  5788999998754322 22234678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. ++|.+++.+..  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          83 EYLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             ecCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9997 48999887643  35889999999999999999999999  9999999999999999999999999987654322


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+.    ..+||||||+++|+|++|.+||...
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            222334578899999998642    3489999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=5.4e-31  Score=277.33  Aligned_cols=203  Identities=22%  Similarity=0.331  Sum_probs=168.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +...+|.+.+.||.|+||+||+|.+.       +..||||++.... .......+.+|+.++..++||||+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            45567888999999999999999873       3569999987543 233456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~-------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd  795 (867)
                      ..+++++||+.+++|..++....             ....+++..+..++.|++.||.|||+++  |+||||||+|||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~  158 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence            99999999999999999985311             1234788889999999999999999999  99999999999999


Q ss_pred             CCCcEEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          796 KNWTVKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       796 ~~g~VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .++.+||+|||+++.......  ......+++.|+|||.+.++.+   +|||||||++|+|++ |..||...
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999886543221  1223456789999999876554   799999999999998 77887653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.7e-30  Score=274.87  Aligned_cols=202  Identities=30%  Similarity=0.477  Sum_probs=168.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC------------------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWHG------------------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV  718 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~g------------------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI  718 (867)
                      ...+|++.+.||+|+||.||+|.+..                  ..||+|++.... .....+.+.+|+.++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            45789999999999999999997632                  348999887543 23556788999999999999999


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA--------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~--------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                      +++++++...+..++||||+++++|..++....        ....+++..++.++.|++.||.|||+++  |+||||||+
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~  159 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR  159 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence            999999999999999999999999999997633        1125889999999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc--CCCCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE--ESPQMRSL  861 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t--G~~Pf~sl  861 (867)
                      ||+++.++.+||+|||+++......  .......+++.|+|||.+.+..   .+|||||||++|+|++  +..||...
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999998653322  1223445678999999987644   4899999999999987  66777543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.2e-31  Score=314.05  Aligned_cols=209  Identities=27%  Similarity=0.433  Sum_probs=176.9

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG  723 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~g  723 (867)
                      ....++...+....+.||+|.||+||+|+..       ...||||.++... ..+..++|.+|+++|..++|||||+|+|
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            3456788899999999999999999999863       2349999987654 3446788999999999999999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcE
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPA-------A----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL  792 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~-------~----~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNI  792 (867)
                      +|...+.+|||+|||..|+|.++|....       .    ...++..+.+.||.||+.||+||-++.  +|||||..+|+
T Consensus       557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC  634 (774)
T KOG1026|consen  557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC  634 (774)
T ss_pred             EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence            9999999999999999999999998522       1    123888999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEEecCccccccCC-ccccc-ccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          793 LVDKNWTVKVCDFGLSRFKANT-FISSK-SVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       793 LLd~~g~VKLsDFGLAr~~~~t-~~s~~-s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ||..+..|||+||||+|..=.+ ++... ...-...||+||.+..+++   +||||+|++|||+|+ |+-||..+.
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            9999999999999999965332 22211 2234579999999999888   799999999999986 567777654

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.2e-30  Score=267.47  Aligned_cols=202  Identities=28%  Similarity=0.479  Sum_probs=171.2

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |++..++|++.+.||.|+||.||+|.+. +..+|||.+......   .+.+.+|+.++++++|+||+++++++......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            4567789999999999999999999874 456999988755432   356889999999999999999999999889999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++++|.+++.... ...+++..+..++.+|+.||.|||+++  |+|+||||+||+++.++.+||+|||+++...
T Consensus        78 ~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceecc
Confidence            9999999999999997643 345889999999999999999999999  9999999999999999999999999987654


Q ss_pred             CCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ... .......++..|+|||.+.+..   .+|+||||+++|+|++ |+.||...
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            321 1112333467899999988643   4799999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=2e-30  Score=271.26  Aligned_cols=200  Identities=28%  Similarity=0.434  Sum_probs=168.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--C---ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g---~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ...+|++.+.||+|+||.||+|.+.  +   ..+|+|.+.... .....+.+.+|+.++++++||||+++++++.....+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3468999999999999999999873  2   258999886543 344567889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999997632  35788999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCccc---ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          812 ANTFIS---SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s---~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......   .....+++.|+|||.+.+..+   +|+||||+++|++++ |..||+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            442211   112233568999999987544   899999999999886 99998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=3.3e-30  Score=270.39  Aligned_cols=196  Identities=22%  Similarity=0.350  Sum_probs=171.0

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||.|+||.||+|.+  .++.||+|++............+.+|+.++++++||||+++++++.....+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            588999999999999999987  578899999987665555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc-c
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-I  816 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~-~  816 (867)
                      + +++|.+++....  ..+++..++.++.||+.||+|||+++  |+|+||||+||+++.++.++|+|||+++...... .
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999987533  45899999999999999999999999  9999999999999999999999999998664432 1


Q ss_pred             cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          817 SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ......++..|+|||.+.+.    ..+|||||||++|+|++|.+||.+
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            12345789999999998643    348999999999999999887754

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.8e-30  Score=271.89  Aligned_cols=193  Identities=27%  Similarity=0.345  Sum_probs=159.4

Q ss_pred             EeccCCceEEEEEEEcC----ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~g----~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||+|+||.||+|.+.+    ..+|+|.+..... ......+.+|+.++++++||||+++++++.....+++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            58999999999998742    3589998765542 233456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc--cc
Q 002910          742 SLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--IS  817 (867)
Q Consensus       742 SL~~~L~~~~~--~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s  817 (867)
                      +|.++++....  ....++..+..++.|++.||+|||+.+  |+||||||+||+++.++++||+|||+++......  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            99999975321  223567778889999999999999999  9999999999999999999999999997654332  12


Q ss_pred             ccccCCCcccccccccCC----------CChHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTAC----------NSLALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~----------~~~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .....+++.|+|||++.+          ...+||||||+++|+|++ |..||...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence            234567889999999864          235899999999999996 99998653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=3.1e-30  Score=273.48  Aligned_cols=202  Identities=28%  Similarity=0.406  Sum_probs=169.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~-------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      |.+++|.+.+.||.|+||+||++..       .+..+|+|.+....  ....+.+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4678999999999999999999975       12348888876432  34566789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPA----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW  798 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~----------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g  798 (867)
                      ..+++||||+++++|.+++....          ....+++..++.++.|++.||+|||+++  |+||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence            99999999999999999997432          1234899999999999999999999999  99999999999999999


Q ss_pred             cEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          799 TVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       799 ~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .+||+|||+++......  .......+++.|+|||.+.+..+   +|||||||++|+|++ |.+||...
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999998653321  11123345788999999886544   899999999999998 89998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=2.6e-30  Score=276.41  Aligned_cols=190  Identities=22%  Similarity=0.348  Sum_probs=154.6

Q ss_pred             EEEeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeEEEEEec
Q 002910          664 KERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEY  737 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l~LVmEy  737 (867)
                      +.+||+|+||+||+|+..    +..||+|.+.....    ...+.+|+.++++++||||+++++++..  ...+++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            467999999999999863    35699998865432    2346789999999999999999998853  5678999999


Q ss_pred             cCCCCHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE----cCCCcEEEEecCc
Q 002910          738 LPRGSLYRLIHRP------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL  807 (867)
Q Consensus       738 ~~gGSL~~~L~~~------~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL----d~~g~VKLsDFGL  807 (867)
                      +. ++|.+++...      .....+++..+..++.||+.||.|||+++  |+||||||+|||+    +.++.+||+|||+
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            85 5777776421      11234788999999999999999999999  9999999999999    5678999999999


Q ss_pred             cccccCCcc---cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          808 SRFKANTFI---SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       808 Ar~~~~t~~---s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++.......   ......||+.|+|||++.+.    ..+|||||||++|+|++|.+||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            987644321   22345789999999998753    348999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=2.8e-30  Score=270.16  Aligned_cols=200  Identities=28%  Similarity=0.495  Sum_probs=166.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ++..++|++.+.||+|+||.||+|++.+ ..||+|++......   .+.+.+|+.++++++||||+++++.+. ....++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            4566889999999999999999998844 46999998754432   246889999999999999999999875 456899


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            999999999999997532 335788999999999999999999999  99999999999999999999999999986543


Q ss_pred             Ccc-cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          814 TFI-SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       814 t~~-s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ... ......++..|+|||.+.+..   .+|+|||||++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            322 122345677899999987644   4899999999999999 88887643

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=2.2e-30  Score=269.43  Aligned_cols=201  Identities=28%  Similarity=0.482  Sum_probs=168.4

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |++..++|++.+.||+|+||.||+|.+. +..+|+|.+......   .+.+.+|+.++++++|+||+++++++. ....+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            4566789999999999999999999874 567999998765433   246889999999999999999999875 45689


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ++|||+++++|.++++... ...+++..+..++.+++.||.|||+++  |+||||||+||+++.++.+||+|||+++...
T Consensus        77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999999997632 234789999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCcc-cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTFI-SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~~-s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .... ......++..|+|||.+.+..   .+||||||+++|+|++ |.+||...
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            4321 112234566899999987654   4899999999999998 88988654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=3.5e-30  Score=266.50  Aligned_cols=200  Identities=26%  Similarity=0.340  Sum_probs=173.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||.|+||+||+|.+  ++..+|+|++....... ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4789999999999999999987  56789999987654433 56788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++........+++..+..++.|++.||.|||+++  |+||||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999976433345899999999999999999999999  99999999999999999999999999876544321


Q ss_pred             ----cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 ----SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 ----s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                          ......|++.|+|||.+...    ..+|+||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence                12345789999999998654    2389999999999999999998654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=285.70  Aligned_cols=204  Identities=17%  Similarity=0.258  Sum_probs=182.1

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP  729 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~  729 (867)
                      +.+...+|.++++||+|+|++|.++++.  .+.+|+|++++..+.+ +.+.-...|..+..+. +||++|.+...|+++.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            4456789999999999999999999884  5569999999876664 3455566788888776 5999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++|.||++||+|..++++.   ..+++++++++..+|+.||+|||++|  ||+||||..|+|||..|++||+|+|+|+
T Consensus       325 rlffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             eEEEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhh
Confidence            999999999999998888763   35999999999999999999999999  9999999999999999999999999999


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .-........++||||.|+|||++++..+   .|+|+||+++++|+.|+.||...+
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            87666666789999999999999999888   699999999999999999997654

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=2.8e-30  Score=272.17  Aligned_cols=195  Identities=26%  Similarity=0.416  Sum_probs=168.2

Q ss_pred             eEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |++.+.||+|+||.||++.+.  +..+++|.+....  ....+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            577889999999999999984  5567888875432  345677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      ++++|..++.+.  ...+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus        85 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          85 AGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999999887652  235899999999999999999999999  9999999999999999999999999997665443334


Q ss_pred             cccCCCcccccccccCC-----C---ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTAC-----N---SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~-----~---~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....+|+.|+|||++..     .   ..+|+|||||++|+|++|.+||...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  211 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL  211 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence            55689999999999852     1   2489999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=4e-30  Score=272.19  Aligned_cols=198  Identities=24%  Similarity=0.339  Sum_probs=165.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||.||+|..  .+..||+|++..... ......+.+|+.+++.++|+||+++++++......|+||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            36899999999999999999987  578899999875432 222335678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. ++|...+....  ..+.+..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 67766665422  34678888899999999999999999  9999999999999999999999999998654433


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+.    ..+||||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            333445679999999998653    3489999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=3.8e-30  Score=264.95  Aligned_cols=200  Identities=27%  Similarity=0.427  Sum_probs=172.5

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeEEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVT  735 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l~LVm  735 (867)
                      +|++.+.||.|+||.||++.+  ++..+|+|++..........+.+.+|+.++++++||||+++++.+..  ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            578899999999999999987  56789999998776666667789999999999999999999998754  45689999


Q ss_pred             eccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLH-----NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLH-----s~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ||+++++|.+++... .....+++..++.++.||+.||+|||     +.+  |+|+||||+||+++.++.+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence            999999999998753 12346899999999999999999999     777  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .............+++.|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            76554332345578999999999886543   79999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=2.3e-30  Score=269.22  Aligned_cols=190  Identities=23%  Similarity=0.387  Sum_probs=160.7

Q ss_pred             EeccCCceEEEEEEE----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||+|+||.||+|.+    ++..+|+|++..........+.+.+|+.+++++.||||+++++++. ....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999976    3567999998766544556678999999999999999999999875 45679999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc---cc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI---SS  818 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~---s~  818 (867)
                      +|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||.|||++.++.+||+|||+++.......   ..
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999753   35889999999999999999999999  99999999999999999999999999987644321   11


Q ss_pred             cccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....+++.|+|||.+.+..   .+|+|||||++|+|++ |..||...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2234468999999987644   4899999999999997 99998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=2.8e-30  Score=277.19  Aligned_cols=204  Identities=27%  Similarity=0.394  Sum_probs=171.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV  725 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~  725 (867)
                      +.+..++|.+.+.||+|+||.||++.+.       +..+|||++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            4567789999999999999999999752       2368999886543 234456789999999999 799999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEec
Q 002910          726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF  805 (867)
Q Consensus       726 ~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDF  805 (867)
                      ...+.+++||||+++|+|..+++... ...+++..+..++.||+.||.|||+++  |+|+||||+|||++.++.+||+||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999997533 234899999999999999999999999  999999999999999999999999


Q ss_pred             CccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          806 GLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       806 GLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |+++......  .......+++.|+|||.+.+..   .+|||||||++|+|++ |..||...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            9998654321  1122335678899999987654   4899999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=3.6e-30  Score=270.19  Aligned_cols=197  Identities=26%  Similarity=0.420  Sum_probs=163.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHH-HHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~I-Lk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||++.+  +|..||||.+........ ...+..|+.+ ++.+.||||+++++++...+.+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            4789999999999999999988  478899999876543333 3345556665 66678999999999999999999999


Q ss_pred             eccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||++ |+|.+++... .....+++..++.++.||+.||+|||++ +  |+||||||+|||++.++.+||+|||+++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9996 6888777642 2234689999999999999999999986 8  99999999999999999999999999986644


Q ss_pred             CcccccccCCCcccccccccCC-------CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTAC-------NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~-------~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ... .....++..|+|||.+.+       ...+|+|||||++|+|++|..||..
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         157 SVA-KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             ccc-cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            322 233578899999998864       2348999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=4.1e-30  Score=267.68  Aligned_cols=197  Identities=25%  Similarity=0.386  Sum_probs=169.1

Q ss_pred             CeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccc----hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL----DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~----~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +|++.+.||+|+||+||+|.. ++..+|+|.+......    ......+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999987 6778999998754322    23456688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++.+.   ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999999763   34789999999999999999999999  999999999999999999999999998764211


Q ss_pred             ------cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 ------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                            ........|++.|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  211 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM  211 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence                  111234578999999999886544   89999999999999999999754

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=3.4e-30  Score=268.14  Aligned_cols=196  Identities=29%  Similarity=0.455  Sum_probs=168.2

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-------hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-------DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-------~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      |.+...||+|+||.||+|..  .++.+|+|.+......       ....+.+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            67788999999999999987  4678999988754332       12346688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|..++...   ..+++..+..++.|++.||.|||+++  ++||||+|+||+++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999763   34788999999999999999999999  999999999999999999999999999866


Q ss_pred             cCCc------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTF------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....      .......|++.|+|||.+.+..+   +|+|||||++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            4211      11123468899999999887554   89999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=4.2e-30  Score=274.83  Aligned_cols=195  Identities=25%  Similarity=0.382  Sum_probs=171.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .+|++.+.||+|+||.||++..  ++..||+|.+......  ..+.+.+|+.+++.++||||+++++.+......++|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            7899999999999999999986  5788999998765432  33567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++.+    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++........
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999999864    23788899999999999999999999  99999999999999999999999999876544333


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+++.|+|||.+.+..+   +|+||||+++|+|++|..||...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3345578999999999887544   89999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=4.3e-30  Score=270.39  Aligned_cols=199  Identities=25%  Similarity=0.407  Sum_probs=165.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ..++|++.+.||+|+||+||+|++  ++.    .||+|++.... .......+.+|+.+++.+.||||+.+++++.. ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            457899999999999999999987  344    37999886543 23445678899999999999999999998875 45


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .+++|||+++|+|.++++...  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceee
Confidence            789999999999999997632  35889999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......  ......+++.|+|||.+.+..+   +|||||||++|+|++ |..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  215 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI  215 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            643221  1122345678999999876544   799999999999998 88998654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=270.81  Aligned_cols=196  Identities=27%  Similarity=0.421  Sum_probs=173.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||.|+||.||+|.+  +++.||+|++.... .......+.+|+.+++.++|+||+++++.+.....+++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            3678889999999999999987  57789999987543 23445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++...    .+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||+++.......
T Consensus        80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999999999753    5899999999999999999999999  99999999999999999999999999988765433


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+++.|+|||.+.+..+   +|+||||+++|+|++|..||...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~  201 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL  201 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            3455678999999999987554   89999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=4e-30  Score=265.93  Aligned_cols=198  Identities=23%  Similarity=0.416  Sum_probs=173.1

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||+|+||.||++..  .+..||+|.+..........+++.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            488999999999999999987  577899999987655555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+++  ++|+||+|+|||++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999987532 234789999999999999999999999  999999999999999999999999999766544333


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....|++.|+|||.+.+...   +|+||||+++|+|++|..||..
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            344568899999999876554   7999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=2.9e-30  Score=264.83  Aligned_cols=194  Identities=28%  Similarity=0.467  Sum_probs=167.6

Q ss_pred             EEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          665 ERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      +.||.|+||.||+|.+.     +..|++|++....... ..+.+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            36899999999999885     6679999987654333 56788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          740 RGSLYRLIHRPAA------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       740 gGSL~~~L~~~~~------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      +++|.+++.....      ...+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999987421      256899999999999999999999999  99999999999999999999999999987654


Q ss_pred             Cc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          814 TF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       814 t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ..  .......+++.|+|||.+....+   +||||||+++|+|++ |..||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            32  23345678899999999876443   899999999999998 58888654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=2.9e-30  Score=272.61  Aligned_cols=203  Identities=27%  Similarity=0.383  Sum_probs=169.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~-------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +.+.+|.+.++||+|+||.||++..       .+..+|+|.+...  .......+.+|++++++++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4568899999999999999999964       2446888877643  244566889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAA------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~  796 (867)
                      ...+++|||+++++|.+++.....            ...+++..++.++.||+.||.|||+++  |+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence            999999999999999999975321            124788999999999999999999999  999999999999999


Q ss_pred             CCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          797 NWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ++.+||+|||+++......  .......+++.|+|||.+.+...   +|||||||++|+|++ |.+||....
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence            9999999999997553321  11123345788999999876544   899999999999998 899986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=3.8e-30  Score=273.18  Aligned_cols=202  Identities=26%  Similarity=0.369  Sum_probs=168.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +...+|.+.+.||+|+||.||+|++.       +..+++|.+....  ....+.+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34578999999999999999999863       2347888775433  33446788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd  795 (867)
                      ...++||||+++++|.+++.....             ...+++..++.++.||+.||+|||+++  |+||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~  157 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG  157 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence            999999999999999999975321             234789999999999999999999999  99999999999999


Q ss_pred             CCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       796 ~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .++.+||+|||+++......  .......+++.|+|||.+.+..+   +||||||+++|+|++ |..||...
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999997654322  11233456789999999886554   899999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.7e-30  Score=274.54  Aligned_cols=200  Identities=24%  Similarity=0.385  Sum_probs=172.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||+|..  .+..||+|.+....... ...+.+.+|++++++++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4789999999999999999988  46789999998765543 45677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+.+++|.+++.+.. ...+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987532 345899999999999999999999999  9999999999999999999999999986542211


Q ss_pred             -----------------------------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 -----------------------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 -----------------------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                                                   .......||..|+|||++.+...   +||||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                         01123468899999999886543   79999999999999999998654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=2.4e-30  Score=280.29  Aligned_cols=196  Identities=18%  Similarity=0.238  Sum_probs=164.1

Q ss_pred             EEEEeccC--CceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          663 VKERVGAG--SFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       663 i~e~LG~G--sFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      +++.||+|  +|++||++..  ++..||+|.+............+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  7899999987  5778999999766554555667788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc--
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI--  816 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~--  816 (867)
                      ++|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.++++||+.+........  
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986532 234889999999999999999999999  99999999999999999999999987543322111  


Q ss_pred             -----cccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 -----SSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 -----s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                           ......++..|+|||++.+.     ..+|||||||++|+|++|..||..+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                 11233567889999998753     3489999999999999999999653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=3.1e-30  Score=265.84  Aligned_cols=196  Identities=28%  Similarity=0.455  Sum_probs=172.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|.+.+.||.|+||.||+|++.  +..+++|.+....    ..+.+.+|+.++++++||||+++++.+.....+|++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            368999999999999999999984  6789999986542    2678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||..+  |+||||+|.||+++.++.+||+|||++.......
T Consensus        78 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          78 EYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             ecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            999999999998753  345899999999999999999999999  9999999999999999999999999998766544


Q ss_pred             ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+..   .+||||||+++|+|++|..||...
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            3344567899999999987654   489999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=2.2e-31  Score=288.67  Aligned_cols=192  Identities=27%  Similarity=0.397  Sum_probs=156.9

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----eEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLS  732 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-----~l~  732 (867)
                      .|.-.+++|.|+||.||+|..  ++..||||..-.+..      .-.+|+.||+.+.|||||++..+|....     .+.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            466788999999999999988  466799998754431      2247899999999999999998886432     356


Q ss_pred             EEEeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCcccc
Q 002910          733 IVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF  810 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLAr~  810 (867)
                      +|||||+. +|++.++.. ..+..++.-.+..+..||.+||+|||..|  |+||||||.|||+|.+ |.+||||||.|+.
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            89999966 888888742 11234777778889999999999999999  9999999999999976 8999999999998


Q ss_pred             ccCCcccccccCCCcccccccccCCCC-h---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNS-L---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~-~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +....-+ .+-..|-.|.|||++.+.. +   .||||.||++.||+.|.+-|.+-
T Consensus       176 L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  176 LVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             eccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            7554332 4456678999999999743 3   59999999999999999988763

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=6.3e-30  Score=273.73  Aligned_cols=197  Identities=22%  Similarity=0.326  Sum_probs=168.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||.||++.+  .++.||+|.+...... ......+.+|+.+++.++||||+++++.+.....+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4789999999999999999988  4677999998766433 234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t-  814 (867)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++..... 
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999753   35889999999999999999999999  999999999999999999999999998742110 


Q ss_pred             --------------cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          815 --------------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       815 --------------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                                    ........+++.|+|||.+.+...   +|+|||||++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~  218 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  218 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                          001123467889999999876444   8999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=3.9e-30  Score=268.83  Aligned_cols=200  Identities=29%  Similarity=0.470  Sum_probs=167.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--C---ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g---~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ...+|++.+.||+|+||.||+|.+.  +   ..||||++... .......++..|+.++++++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            3467899999999999999999873  3   24999988653 2345567899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++  ++||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          81 MIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999998763  235789999999999999999999999  999999999999999999999999998765


Q ss_pred             cCCccc---ccccC--CCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          812 ANTFIS---SKSVA--GTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s---~~s~a--GTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......   .....  .+..|+|||.+.+..+   +|||||||++|+|++ |..||+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            432211   11111  2457999999886554   899999999999886 99998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=6e-30  Score=264.87  Aligned_cols=197  Identities=28%  Similarity=0.433  Sum_probs=172.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||+|+||.||+|..  ++..|++|++..........+.+.+|+.++++++|+||+++++.+.....+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            478899999999999999987  577899999987765556778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++...   ..+++..+..++.+++.||.|||+.+  |+|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999763   34788899999999999999999999  999999999999999999999999998875433221


Q ss_pred             ----ccccCCCcccccccccCCCC------hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 ----SKSVAGTVVFFAAHQTACNS------LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ----~~s~aGTp~YmAPEvl~~~~------~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                          .....+++.|+|||.+.+..      .+||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence                12357889999999988654      389999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.5e-31  Score=298.20  Aligned_cols=201  Identities=22%  Similarity=0.318  Sum_probs=175.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ..+-.-|..++.||-|+||+|.+++-  +...||+|.+++.+... .++...+.|..||....++-||+||..|++...+
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            34557789999999999999999976  45569999999887664 5677889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+||+|++||++..+|-+   .+.+.|..+++|+.++.+|+++.|+.|  +|||||||+|||||.+|+|||+|||||.-+
T Consensus       705 YFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccc
Confidence            999999999999999987   446899999999999999999999999  999999999999999999999999998421


Q ss_pred             ---cCC---------------------------------------cccccccCCCcccccccccCCCCh---HHHHHHHH
Q 002910          812 ---ANT---------------------------------------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSG  846 (867)
Q Consensus       812 ---~~t---------------------------------------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~  846 (867)
                         ++.                                       .+...+..||+.|+|||++....+   +|+||.|+
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence               110                                       111235589999999999997666   79999999


Q ss_pred             HHHHHhcCCCCccc
Q 002910          847 WLQSSFEESPQMRS  860 (867)
Q Consensus       847 lLyeM~tG~~Pf~s  860 (867)
                      +||+|+.|.+||-.
T Consensus       860 il~em~~g~~pf~~  873 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLA  873 (1034)
T ss_pred             HHHHHhhCCCCccC
Confidence            99999999999964

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=6e-30  Score=273.85  Aligned_cols=196  Identities=26%  Similarity=0.391  Sum_probs=171.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.+|++.+.||.|+||.||+|..  .++.||+|.+.....  ...+.+.+|+.+++.++||||+++++.+.....+++||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            46799999999999999999986  578899999875532  23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|..++...    .+++..+..++.+++.||+|||+++  |+||||||+||+++.++.+||+|||+++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999999988642    4789999999999999999999999  9999999999999999999999999988654433


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+..+   +|+|||||++|+|++|..||...
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~  218 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            22345578999999999886544   89999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.9e-30  Score=266.78  Aligned_cols=200  Identities=27%  Similarity=0.453  Sum_probs=171.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC----
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP----  729 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~----  729 (867)
                      .+++|++.+.||+|+||.||+|.+  .+..+++|++....   .....+.+|+.+++++ .|+||+++++++....    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            458999999999999999999998  45679999987654   2345788999999999 6999999999997654    


Q ss_pred             --eEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          730 --HLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       730 --~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                        .+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++  |+|+||+|+||+++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence              4899999999999999887522 2345899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCC--------ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACN--------SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~--------~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++..............|++.|+|||.+...        ..+||||||+++|+|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            998765544444566789999999987642        2389999999999999999999754

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=2.4e-30  Score=272.06  Aligned_cols=197  Identities=22%  Similarity=0.347  Sum_probs=168.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||.|+||.||+|+.  ++..||||.+............+.+|++++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            488999999999999999988  577899999876544444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +. ++|..++.... ...+++..+..++.||+.||+|||+++  ++||||+|+||+++.++.+||+|||+++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            95 68888886533 345889999999999999999999999  999999999999999999999999998765443322


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....+++.|+|||.+.+.    ..+||||||+++|+|++|..||..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            3344678899999988753    348999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-30  Score=274.99  Aligned_cols=203  Identities=28%  Similarity=0.472  Sum_probs=167.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC----------------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHG----------------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV  719 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g----------------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIV  719 (867)
                      +..++|++.+.||+|+||.||++...+                ..||+|++... ........+.+|+++|++++||||+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence            456799999999999999999987632                23899988754 2344556789999999999999999


Q ss_pred             eEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA---------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       720 kl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~---------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                      ++++++......++||||+++++|.+++.....         ...+++..++.++.|++.||.|||+++  |+||||||+
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~  158 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR  158 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence            999999999999999999999999999865321         123678889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc--CCCCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE--ESPQMRSL  861 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t--G~~Pf~sl  861 (867)
                      |||++.++.+||+|||+++.......  ......+++.|+|||.+.+..+   +||||||+++|+|++  +..||...
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999999999999976533211  1122345679999999876544   899999999999987  66777643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=3.6e-30  Score=273.06  Aligned_cols=196  Identities=22%  Similarity=0.330  Sum_probs=168.5

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~---~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +|.+.+.||.|+||.||+|.+  .++.||||.+......   ......+..|+.++++++|+||+++++++...+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999987  4778999999876544   23345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+ +|+|..++....  ..+++..++.++.||+.||.|||+++  |+|+||||+|||++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 999999997633  35899999999999999999999999  999999999999999999999999999876554


Q ss_pred             cccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          815 FISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ........+++.|+|||.+.+    ...+|+|||||++|+|++|.+||..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            333334467889999998864    2348999999999999999877753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=3.4e-30  Score=272.40  Aligned_cols=200  Identities=22%  Similarity=0.373  Sum_probs=164.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCce----EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~----VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ..++|++.+.||.|+||+||+|.+  ++..    +++|.+... .......++..|+.++.++.||||+++++++. ...
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            346889999999999999999998  4443    667766432 22344567888999999999999999999875 456


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .+++|||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  ++||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcccee
Confidence            78999999999999999753  235899999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          811 KANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      .....  .......++..|+|||.+.+..+   +||||||+++|+|++ |..||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            53221  11234467789999999886555   799999999999998 999987653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.8e-30  Score=266.69  Aligned_cols=201  Identities=25%  Similarity=0.443  Sum_probs=169.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |++..++|++.+.||+|+||.||++.+ .+..+|+|.+....   ...+.+.+|+.++++++|+||+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            466778999999999999999999987 45669999876542   234678899999999999999999999887 7789


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||+++...
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            9999999999999997643 345788889999999999999999999  9999999999999999999999999997654


Q ss_pred             CCcc-cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTFI-SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~~-s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .... ......++..|+|||.+.....   +|+||||+++|+|++ |++||...
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            3221 1122345678999999876543   799999999999998 99998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=2.4e-30  Score=274.20  Aligned_cols=198  Identities=26%  Similarity=0.369  Sum_probs=169.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSI  733 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~L  733 (867)
                      .++|++.+.||.|+||.||+|.+.  ++.+|+|.++...........+.+|+.++++++||||+++++++...  ..+|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            368899999999999999999984  77899999986654444445677899999999999999999998877  88999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+. ++|.+++....  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus        84 v~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          84 VMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999996 58988887533  25899999999999999999999999  99999999999999999999999999987655


Q ss_pred             CcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .........+++.|+|||.+.+.    ..+||||||+++|+|++|.+||..
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            43333445678999999998753    348999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=7.5e-30  Score=266.58  Aligned_cols=202  Identities=25%  Similarity=0.380  Sum_probs=167.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +..+.+.....||+|+||.||+|++  ++..||+|.+....  ....+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3445555567899999999999987  45679999876543  3445678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~~  812 (867)
                      ||||+++++|.+++.........++..+..++.||+.||+|||+.+  |+||||||+||+++. .+.+||+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            9999999999999975322112278888899999999999999999  999999999999976 6799999999987654


Q ss_pred             CCcccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..........|++.|+|||.+.+.     ..+|+||||+++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence            433323445689999999998653     3489999999999999999998754

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=285.38  Aligned_cols=197  Identities=23%  Similarity=0.355  Sum_probs=168.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-----CCeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-----RPHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-----~~~l  731 (867)
                      ..|..++.||.|+||.|+.|..  +|..||||.+....-..-..++..+|+++|+.++|+||+.+++.+..     -..+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4555689999999999999987  57889999987555445567889999999999999999999999865     3458


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+|+|+| +.+|.++|+..   ..+.+.++..++.||++||.|+|+.+  |+||||||.|+|++.+..+|||||||||..
T Consensus       102 YiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             EEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeec
Confidence            9999999 77999999863   34999999999999999999999999  999999999999999999999999999987


Q ss_pred             cCC--cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANT--FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t--~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  ....+....|--|.|||++.+.    ...||||.||++.||++|++-|.+-
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~  231 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK  231 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence            531  1112344678889999998753    2369999999999999999988764

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.7e-30  Score=284.79  Aligned_cols=187  Identities=22%  Similarity=0.263  Sum_probs=159.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ..+|.+.+.||+|+||.||+|++.  +..||+|+....        ....|+.++++++||||+++++++......++||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            357999999999999999999984  557999975432        2346899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+ .++|..++...  ...+++..++.++.||+.||.|||+++  ||||||||+|||++.++.+||+|||+++......
T Consensus       137 e~~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        137 PHY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             Ecc-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            999 46888887653  345899999999999999999999999  9999999999999999999999999997543321


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQM  858 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf  858 (867)
                       ......||+.|+|||++.+..+   +|||||||++|+|+++..++
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             2245679999999999987554   89999999999999865444

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=5.8e-30  Score=267.56  Aligned_cols=198  Identities=23%  Similarity=0.366  Sum_probs=168.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~---~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l  731 (867)
                      .+|+..+.||+|+||.||+|..  .+..||+|++......   .+....+.+|+.++++++||||+++++.+..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999987  5778999988755332   2455678899999999999999999998875  3678


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +++|||+++++|.+++...   ..+++...+.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            9999999999999999753   34788999999999999999999999  999999999999999999999999999765


Q ss_pred             cCC---cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANT---FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t---~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...   ........++..|+|||.+.+..+   +|+|||||++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            331   111233568899999999987654   79999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=303.36  Aligned_cols=193  Identities=25%  Similarity=0.402  Sum_probs=168.7

Q ss_pred             EEeccCCceEEEEEEEcCce--EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCC
Q 002910          665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS  742 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~~--VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGS  742 (867)
                      -+||+|.||+||-|++..+.  +|||-+...+  ....+-+..|+.+.++|+|.|||+++|.+...+.+-|.||-++||+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            36999999999999985554  6778775443  3445668899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCccccccCCccccc
Q 002910          743 LYRLIHRPAAGEMM--DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSK  819 (867)
Q Consensus       743 L~~~L~~~~~~~~l--~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~~~t~~s~~  819 (867)
                      |..+|+.  ..+++  ++...-+|.+||++||.|||.+.  |||||||-+|+||+. .|.+||+|||-++.+..-.-...
T Consensus       659 LSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  659 LSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             HHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            9999986  23455  88999999999999999999999  999999999999974 78999999999998876555567


Q ss_pred             ccCCCcccccccccCCCC-----hHHHHHHHHHHHHHhcCCCCccccch
Q 002910          820 SVAGTVVFFAAHQTACNS-----LALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       820 s~aGTp~YmAPEvl~~~~-----~SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ++-||..|||||++..++     .+|||||||++.||.||+|||..++.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs  783 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS  783 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence            889999999999998544     48999999999999999999998864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=4.1e-30  Score=271.74  Aligned_cols=200  Identities=23%  Similarity=0.298  Sum_probs=166.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCe-----
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPH-----  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~-----  730 (867)
                      ++|++.+.||.|+||.||+|.+  +++.||||++............+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4789999999999999999988  5778999998765433334457888999999996 6999999999887665     


Q ss_pred             EEEEEeccCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGL  807 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~--~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGL  807 (867)
                      .|+||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+++  |+||||||+||+++. ++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence            8999999975 78888765322  245899999999999999999999999  999999999999998 89999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.............+++.|+|||.+.+    ...+||||||+++|+|++|.+||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9865443332334467899999998864    33489999999999999999998643

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=5.5e-30  Score=270.13  Aligned_cols=193  Identities=26%  Similarity=0.415  Sum_probs=161.7

Q ss_pred             eEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEE
Q 002910          661 LHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLS  732 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~  732 (867)
                      |++.+.||+|+||+||++.+      .+..||+|++.... .......+.+|+.++++++||||+++++++...  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            48899999999999988754      35679999987543 223456788999999999999999999988653  4589


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++++|.+++...    .+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999999752    3899999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCcc---cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFI---SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~---s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....   ......++..|+|||.+.+..   .+||||||+++|+|++|..|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            3221   112234567899999987654   38999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=269.84  Aligned_cols=197  Identities=25%  Similarity=0.370  Sum_probs=170.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||.||+|.+  ++..||+|++..........+.+.+|++++++++|+||+++++.+...+.+++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4689999999999999999988  46789999987655444556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |++++.+..++...   ..+++..+..++.||+.||.|||.++  |+||||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99988777666542   34889999999999999999999999  99999999999999999999999999887654332


Q ss_pred             -cccccCCCcccccccccCCC-C---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          817 -SSKSVAGTVVFFAAHQTACN-S---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 -s~~s~aGTp~YmAPEvl~~~-~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                       ......++..|+|||++... .   .+|+||||+++|+|++|.+||..
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence             23345788999999998766 3   38999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=4.1e-30  Score=279.34  Aligned_cols=206  Identities=27%  Similarity=0.392  Sum_probs=171.2

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      .|++...+|++++.||+|+||.||+|++.         +..||+|++... ......+.+.+|+.+++++ +||||++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            46677789999999999999999999762         125899987643 3345567899999999999 799999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~-------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      +++...+.++++|||+++|+|.+++.+..             ....+.+..+..++.||+.||+|||+++  |+||||||
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp  162 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA  162 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence            99999999999999999999999997532             1234778889999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||++.++.+||+|||+++.......  ......+++.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999986544221  1122344578999999987554   899999999999998 88888654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=4.4e-30  Score=273.35  Aligned_cols=202  Identities=27%  Similarity=0.439  Sum_probs=166.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc------------------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH------------------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV  718 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~------------------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI  718 (867)
                      ..++|++.+.||.|+||.||++.+.                  +..+|+|++.... .......+.+|+.+|+.++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998653                  2258999887542 23445678999999999999999


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA--------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~--------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                      +++++++......++||||+++|+|.+++.....        ...+++..+..++.||+.||+|||+++  |+||||||+
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~  159 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR  159 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence            9999999999999999999999999999876321        124677889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc--CCCCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE--ESPQMRSL  861 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t--G~~Pf~sl  861 (867)
                      |||++.++.+||+|||+++.......  ......+++.|+|||...+..+   +|+|||||++|+|++  |..||...
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999986543221  1122344678999998776554   799999999999998  67887643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=9.9e-30  Score=269.21  Aligned_cols=206  Identities=28%  Similarity=0.379  Sum_probs=171.5

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR  728 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~  728 (867)
                      ..+.-..++|.+.+.||+|+||.||++..  .++.+|+|++....   .....+.+|+.+++++ +||||+++++++...
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34444568999999999999999999987  57789999986542   2234567899999998 799999999998754


Q ss_pred             -----CeEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEE
Q 002910          729 -----PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       729 -----~~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                           ...++||||+++++|.++++... ....+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEE
Confidence                 35899999999999999886421 2345889999999999999999999999  999999999999999999999


Q ss_pred             EecCccccccCCcccccccCCCcccccccccCCC--------ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          803 CDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN--------SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       803 sDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~--------~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +|||+++.............|++.|+|||.+...        ..+|||||||++|+|++|.+||....
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            9999998765443333456789999999997642        34899999999999999999987653

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=4.6e-30  Score=272.04  Aligned_cols=199  Identities=25%  Similarity=0.405  Sum_probs=165.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +|++.+.||+|+||.||+|....       ..+|+|.+.... .......+.+|+.+++.++||||+++++.+......+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47888999999999999998632       458888876443 2344577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCc
Q 002910          733 IVTEYLPRGSLYRLIHRPA---------------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN  791 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~---------------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeN  791 (867)
                      +||||+.+|+|.+++....                     ....+++..++.++.|++.||.|||+++  |+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence            9999999999999986421                     1234788999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          792 LLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       792 ILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ||++.++.+||+|||+++......  .......++..|+|||.+.+...   +||||||+++|+|++ |..||...
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999998653321  12233456789999999875443   899999999999998 88888643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=4.3e-30  Score=266.34  Aligned_cols=195  Identities=28%  Similarity=0.481  Sum_probs=166.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +..++|++.+.||+|+||.||++...++.||+|++....    ....+.+|+.++++++||||+++++++... ..++||
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            455789999999999999999999999999999986432    235688999999999999999999998654 479999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++.... ...+++..++.++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||+++......
T Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             ECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999999997643 335789999999999999999999999  9999999999999999999999999987644321


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                         .....+..|+|||.+.+..+   +|+||||+++|+|++ |.+||...
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence               23344678999999876554   799999999999997 89998654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.1e-30  Score=273.87  Aligned_cols=198  Identities=26%  Similarity=0.411  Sum_probs=172.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +..++|++.+.||+|+||+||++.+.  ++.||+|++.... .....+.+.+|+++++.++||||+++++.+.....+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            34578999999999999999999984  7889999887543 23445778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||||+++++|..++...   ..+++..+..++.+++.||.|||+ ++  |+||||||+||+++.++.++|+|||+++...
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          81 CMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            99999999999998763   358899999999999999999996 67  9999999999999999999999999987653


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  .....|+..|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       156 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~  205 (284)
T cd06620         156 NSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS  205 (284)
T ss_pred             hhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            322  235678999999999876544   79999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=4.7e-30  Score=270.22  Aligned_cols=203  Identities=23%  Similarity=0.320  Sum_probs=166.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +..++|.+.+.||+|+||.||+|.+.+       ..||+|.+.... .......+.+|+.++++++|+||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456889999999999999999998854       457888765432 233345688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC---cEE
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVK  801 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~----~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g---~VK  801 (867)
                      ...++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+++  ++||||||+|||++.++   .+|
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence            999999999999999999976431    124889999999999999999999999  99999999999998754   699


Q ss_pred             EEecCccccccCCccc--ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          802 VCDFGLSRFKANTFIS--SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       802 LsDFGLAr~~~~t~~s--~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |+|||+++........  ......++.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999876332211  112234568999999876544   899999999999996 89998653

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=2.9e-30  Score=282.54  Aligned_cols=205  Identities=25%  Similarity=0.408  Sum_probs=167.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-------cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV  725 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~  725 (867)
                      |+...++|++.+.||+|+||+||+|.+       .++.||||+++... .......+.+|+.+|.++ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            556778999999999999999999974       35679999987543 234456788999999999 689999999988


Q ss_pred             eeC-CeEEEEEeccCCCCHHHHHhcCCC----------------------------------------------------
Q 002910          726 TKR-PHLSIVTEYLPRGSLYRLIHRPAA----------------------------------------------------  752 (867)
Q Consensus       726 ~~~-~~l~LVmEy~~gGSL~~~L~~~~~----------------------------------------------------  752 (867)
                      ... ..+++||||+++|+|.++++....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            654 468999999999999999875210                                                    


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--cccc
Q 002910          753 ------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISS  818 (867)
Q Consensus       753 ------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~~s~  818 (867)
                                  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        123677888899999999999999999  999999999999999999999999999764322  1122


Q ss_pred             cccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....+++.|+|||.+.+..+   +||||||+++|+|++ |..||...
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            23345678999999876543   799999999999996 88888653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=7.1e-30  Score=262.92  Aligned_cols=196  Identities=29%  Similarity=0.436  Sum_probs=170.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~---~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +|+..+.||+|+||+||+|..  ++..|++|.+......   .+..+.+.+|+.+++.++|+||+++++++.....+++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            366778999999999999988  4788999998765422   34567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++.+.   ..+++..+..++.||+.||+|||+.+  |+|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999999763   34789999999999999999999999  999999999999999999999999998865443


Q ss_pred             cccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      . ......|++.|+|||.+....    .+|+||||+++|+|++|..||...
T Consensus       156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            3 234567899999999987654    389999999999999999998654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=6.2e-30  Score=268.85  Aligned_cols=204  Identities=19%  Similarity=0.294  Sum_probs=170.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-  727 (867)
                      .+..++|++.+.||+|+||.||+|.+..      ..|++|++... ........+.+|+.+|++++||||+++++++.. 
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3567899999999999999999998843      66889887633 344556778999999999999999999998765 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEE
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAG-----EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~-----~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                      ....++++||+++|+|..++......     ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence            46789999999999999998764322     45889999999999999999999999  999999999999999999999


Q ss_pred             EecCccccccCCcc--cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          803 CDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       803 sDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||+++.+.....  ......++..|+|||.+.+..   .+|||||||++|++++ |..||...
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            99999986532211  112345677899999987654   3899999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=8.8e-30  Score=262.43  Aligned_cols=198  Identities=25%  Similarity=0.399  Sum_probs=172.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||+|+||.||+|..  ++..+|||.+............+.+|+.++++++||||+++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999987  577899999987766666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCccccccCCcc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLAr~~~~t~~  816 (867)
                      +++++|.+++.... ...+++..+..++.+++.||+|||+++  |+|+||||+||+++.+ +.+||+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997632 335889999999999999999999999  9999999999999854 4689999999987654322


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       .....+++.|+|||.+....   .+|+||||+++|+|++|+.||...
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence             23457899999999988654   489999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=6.5e-30  Score=268.35  Aligned_cols=197  Identities=23%  Similarity=0.372  Sum_probs=168.1

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||.|++|+||+|++  ++..||||++..... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            588999999999999999998  477899999876542 22345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++ +|.+++........+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            975 88888876443456899999999999999999999999  999999999999999999999999999765443322


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....+++.|++||++.+.    ..+|+||||+++|+|++|.+||..
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  203 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG  203 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3345678999999998653    348999999999999999999863

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=8.5e-30  Score=263.24  Aligned_cols=198  Identities=30%  Similarity=0.411  Sum_probs=175.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||.|+||.||+|...  +..|+||++...... .....+.+|+.++.+++|+||+++++++.....+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            47889999999999999999884  778999998765432 456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |+++++|.+++...   ..+++..++.++.|++.||+|||+ .+  ++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999999763   458999999999999999999999 99  9999999999999999999999999998765443


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .......++..|+|||.+.+...   +|+||||+++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            33335578899999999887643   899999999999999999998774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=7.2e-30  Score=265.98  Aligned_cols=200  Identities=27%  Similarity=0.504  Sum_probs=166.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ++..++|.+.+.||.|+||.||+|.+.+ ..+|+|.+.....   ..+.+.+|+.++++++||||+++++++. ....++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            4556789999999999999999998854 4699998765432   2346788999999999999999998875 456899


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+.+++|.++++... ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999999999999997632 335789999999999999999999999  99999999999999999999999999986543


Q ss_pred             Ccc-cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          814 TFI-SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       814 t~~-s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ... ......++..|+|||.+.+...   +||||||+++|+|++ |..||...
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            321 1223356678999999876443   799999999999998 89998754

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=8.4e-30  Score=270.13  Aligned_cols=198  Identities=24%  Similarity=0.356  Sum_probs=166.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||.|+||+||+|.+  +++.||+|.+............+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            6899999999999999999987  46789999987654434445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~~~t~  815 (867)
                      |++ ++|.+++.... ...+++..+..++.||+.||+|||+++  |+||||+|+||+++. ++.+||+|||+++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 57877775433 233678888899999999999999999  999999999999985 5679999999997654432


Q ss_pred             ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .......+++.|+|||.+.+.    ..+||||||+++|+|++|.+||..
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            222344678999999998653    348999999999999999999854

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=9.6e-30  Score=267.97  Aligned_cols=196  Identities=30%  Similarity=0.492  Sum_probs=162.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CC
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RP  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~  729 (867)
                      ..+|++.+.||.|+||.||++.+      .+..||+|.+....  ....+.+.+|+.++++++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            35789999999999999999975      36679999986543  3456788999999999999999999998754  34


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++|+|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            689999999999999999753  234889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcc---cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          810 FKANTFI---SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       810 ~~~~t~~---s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      .......   ......++..|+|||.+.+..+   +||||||+++|+|++|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            6543211   1112234456999999876544   899999999999999866544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=9e-30  Score=265.53  Aligned_cols=201  Identities=27%  Similarity=0.406  Sum_probs=168.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--Cc---eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~---~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      |..++|+..+.||+|+||.||+|...  +.   .+|+|.+.... .....+.+.+|++++++++||||+++++++.....
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45578999999999999999999873  33   58899876442 23445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999999997532  35889999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcccc---cccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTFISS---KSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~---~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ........   .....++.|+|||.+.+..   .+|||||||++|+|++ |..||+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            64322111   1123346799999987654   4899999999999997 99999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1.1e-29  Score=262.80  Aligned_cols=197  Identities=27%  Similarity=0.473  Sum_probs=167.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ...+|++.+.||+|+||.||++.+. +..+|+|++.......   ..+.+|++++++++||||+++++++......++||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3468999999999999999999884 7789999887654432   35788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++....  ..+++..++.++.+++.||+|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999999987532  34788999999999999999999999  9999999999999999999999999987654332


Q ss_pred             c-cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          816 I-SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       816 ~-s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      . ......++..|+|||.+.+..+   +||||||+++|+|++ |..||..
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            2 1123345678999999886554   899999999999998 8999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-29  Score=265.21  Aligned_cols=198  Identities=25%  Similarity=0.401  Sum_probs=168.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecc---cchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQD---FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~---~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l  731 (867)
                      .+|.+.+.||+|+||.||+|..  ++..||+|++....   ........+.+|+.++++++|+||+++++.+...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999987  57789999886432   1234567789999999999999999999998764  468


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +++|||+++++|.+++...   ..+++.....++.||+.||.|||+++  |+|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            9999999999999998753   24788999999999999999999999  999999999999999999999999999865


Q ss_pred             cCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....   .......+++.|+|||.+.+..+   +|+|||||++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            4321   11234568999999999887544   79999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.8e-30  Score=267.86  Aligned_cols=197  Identities=19%  Similarity=0.293  Sum_probs=173.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +|++.+.||.|+||.||+|.+.  +..||+|++....... ...+.+.+|+.++++++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999884  7889999998765443 556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+.+++|..++...   ..+++..+..++.||+.||.|||+++  |+|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999763   35889999999999999999999999  9999999999999999999999999987654432 


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ......|+..|+|||.+.+..   .+|+||||+++|+|++|..||....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            234567899999999988644   4899999999999999999987653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=8.3e-30  Score=268.37  Aligned_cols=196  Identities=27%  Similarity=0.436  Sum_probs=170.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ..|+..+.||.|+||.||+|.+  .+..||+|++..... ......+.+|+.+++++.||||+++++.+.....+++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            4577788999999999999987  467899999875432 3446788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++|+|.+++..    ..+++.....++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999999864    24788899999999999999999999  99999999999999999999999999977654433


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......++..|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            3345578899999999876544   89999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-32  Score=303.34  Aligned_cols=198  Identities=26%  Similarity=0.432  Sum_probs=173.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCce--EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~g~~--VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.+.|+..||.|+||+||+|..+.+.  .|.|+|..+.  .+.++.++-||.||..+.||+||+++++|...+.+||+.|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            34556778999999999999875443  5677776543  5678899999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||.||-+..++-..  +..+.+.++..+++|++.||+|||+++  |||||||..|||++-+|.|+|+|||.+.....+.-
T Consensus       110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            99999999888763  446999999999999999999999999  99999999999999999999999999877666666


Q ss_pred             cccccCCCcccccccccCCCC-----h---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS-----L---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~-----~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...++.|||.|||||++.+..     |   +||||||++|.+|..+.||...+.
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln  239 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN  239 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence            667899999999999998633     3   899999999999999999988765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=295.31  Aligned_cols=192  Identities=28%  Similarity=0.400  Sum_probs=171.0

Q ss_pred             EEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .+.||.|.||+||-|++  +|+.||||+|.+-.+..++...+.+|+.||..++||.||.+...|++.+.+++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            57899999999999987  6899999999999888887788999999999999999999999999999999999999655


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecCccccccCCcccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      -|.-+|.. . .+.++++...+++.||+.||.|||-++  |||+||||+|||+..   --.+||||||++|.+..... .
T Consensus       649 MLEMILSs-E-kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-R  723 (888)
T KOG4236|consen  649 MLEMILSS-E-KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-R  723 (888)
T ss_pred             HHHHHHHh-h-cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh-h
Confidence            55544443 2 446999999999999999999999999  999999999999964   35799999999999876543 4


Q ss_pred             cccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          819 KSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +++.|||.|+|||++++..+   -|+||.|+++|.-+.|..||..
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            68899999999999999887   4999999999999999999975

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=6.9e-30  Score=270.01  Aligned_cols=203  Identities=26%  Similarity=0.381  Sum_probs=168.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +..++|++.+.||+|+||.||+|.+.       +..||+|++.... .......+.+|+.+++++.||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            45688999999999999999999863       4579999886543 234456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPA-------------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~-------------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      ..+++||||+++|+|.+++....                   ....+++..++.++.||+.||.|||.++  ++||||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p  158 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT  158 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence            99999999999999999997421                   1124678889999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||++.++.+||+|||+++......  ........++.|+|||.+.+..+   +|||||||++|+|++ |..||..+
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999987543221  11223345678999999876544   899999999999997 88888654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=6.5e-30  Score=265.64  Aligned_cols=196  Identities=22%  Similarity=0.411  Sum_probs=167.5

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc----hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL----DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~----~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +|+..+.||+|+||.||++..  +++.+|+|++......    ....+.+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986  6788999998754322    2345778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~~  812 (867)
                      ||||+++++|.+++.+.   ..+++..+..++.||+.||+|||+++  ++|+||+|+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999763   35889999999999999999999999  99999999999998776 59999999987664


Q ss_pred             CCcc----cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFI----SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~----s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....    ......++..|+|||.+.+..+   +|+||||+++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            4311    1223468899999999876444   7999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=8.5e-30  Score=268.09  Aligned_cols=199  Identities=27%  Similarity=0.429  Sum_probs=167.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEee------
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK------  727 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~------  727 (867)
                      ..+.|++.+.||.|+||.||+|.+  .++.+|+|++....   .....+..|+.+++++ +|+||+++++++..      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            447889999999999999999998  46789999986542   3445678899999998 69999999999853      


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ...++++|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+||+++.++.++|+|||+
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence            457899999999999999987533 334788889999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.............|++.|+|||.+..        ...+|+||||+++|+|++|..||...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            8866543333455679999999999763        22489999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.2e-30  Score=293.43  Aligned_cols=190  Identities=21%  Similarity=0.251  Sum_probs=162.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ...|.+.+.||+|+||.||+|.+.  +..||||....        ..+.+|+.+|++++|+|||++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            457999999999999999999984  66799996322        24568999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+ .++|..++...  ...+++..++.++.||+.||.|||++|  ||||||||+||||+.++.+||+|||+++......
T Consensus       240 e~~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        240 PKY-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             Ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            999 46888887653  235899999999999999999999999  9999999999999999999999999998654321


Q ss_pred             c--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          816 I--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .  .....+||+.|+|||++.+..+   +|||||||+||+|++|..++..
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            1  1234679999999999987554   7999999999999988776654

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=7e-30  Score=264.29  Aligned_cols=192  Identities=29%  Similarity=0.461  Sum_probs=163.5

Q ss_pred             EEeccCCceEEEEEEEc---Cc--eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          665 ERVGAGSFGTVHRAEWH---GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~---g~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      +.||+|+||.||+|.+.   ++  .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            36899999999999873   22  5899998876544 567789999999999999999999999988 88999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc---c
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF---I  816 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~---~  816 (867)
                      +++|.+++..... ..+++..++.++.|++.||.|||+++  ++||||||+||+++.++.+||+|||+++......   .
T Consensus        79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            9999999986432 45899999999999999999999999  9999999999999999999999999998764321   1


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......++..|+|||.+.+..   .+|||||||++|+|++ |..||...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            112346778999999987544   4899999999999998 99998543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.2e-29  Score=261.45  Aligned_cols=191  Identities=28%  Similarity=0.443  Sum_probs=161.4

Q ss_pred             EeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHH
Q 002910          666 RVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY  744 (867)
Q Consensus       666 ~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~  744 (867)
                      .||+|+||.||+|.. .++.+|+|++.... .......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            689999999999987 46679999876543 3344456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc-cccCC
Q 002910          745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS-KSVAG  823 (867)
Q Consensus       745 ~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~-~s~aG  823 (867)
                      +++....  ..+++..+..++.|++.+|.|||+++  ++||||||+||+++.++.+||+|||+++......... ....+
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9987532  34789999999999999999999999  9999999999999999999999999997654332211 12344


Q ss_pred             CcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          824 TVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       824 Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ++.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            678999999876554   899999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=9.5e-30  Score=272.41  Aligned_cols=199  Identities=26%  Similarity=0.363  Sum_probs=166.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLS  732 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~  732 (867)
                      +.++|++.+.||.|+||.||+|.+  +++.||+|++............+.+|+.++++++|+||+++++++...  ..++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            458899999999999999999988  478899999876543333334567899999999999999999998755  5689


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+. ++|.+++....  ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++...
T Consensus        85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999996 47888876532  45899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..........+++.|+|||.+.+.    ..+||||||+++|+|++|.+||..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            432222334567889999998652    348999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=8.2e-30  Score=271.60  Aligned_cols=199  Identities=21%  Similarity=0.335  Sum_probs=165.0

Q ss_pred             CeEEEEEeccCCceEEEEEEE----cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLS  732 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~----~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~  732 (867)
                      .|.+.+.||+|+||.||+|.+    .+..||+|++...... ......+.+|+.++++++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            478899999999999999998    4578999999874322 22345678899999999999999999999988  7899


Q ss_pred             EEEeccCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC----CCcEEEEecC
Q 002910          733 IVTEYLPRGSLYRLIHRPA--AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK----NWTVKVCDFG  806 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~--~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~----~g~VKLsDFG  806 (867)
                      +||||+++ +|..++....  ....+++..++.++.||+.||+|||+.+  |+||||||+|||++.    ++.+||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999965 6666664321  1235889999999999999999999999  999999999999999    9999999999


Q ss_pred             ccccccCCc---ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTF---ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~---~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++......   ......++|+.|+|||++.+.    ..+||||||+++|+|++|.+||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            998654332   223455789999999988753    3489999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-29  Score=266.32  Aligned_cols=199  Identities=25%  Similarity=0.410  Sum_probs=166.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--Cc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ...+|++.+.||+|+||+||+|.+.  +.    .+|+|.+..... .....++.+|+.++++++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            4578999999999999999999873  33    488888765432 3455678899999999999999999999887 78


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++||||+++|+|.+++....  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999997642  24899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......  ......+++.|+|||.+....+   +|+||||+++|++++ |..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  215 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI  215 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            543221  1112234578999999876544   899999999999998 99998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.2e-29  Score=265.15  Aligned_cols=190  Identities=23%  Similarity=0.387  Sum_probs=157.2

Q ss_pred             EeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||.|+||.||+|.+.    +..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            3899999999999773    3458999886542 3344567899999999999999999999885 45789999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc---cc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI---SS  818 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~---s~  818 (867)
                      +|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.......   ..
T Consensus        80 ~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          80 PLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999998753  235899999999999999999999999  99999999999999999999999999975433211   11


Q ss_pred             cccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....+++.|+|||.+.+..   .+||||||+++|+|++ |..||..+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence            1223467899999987644   4899999999999996 99999754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=2.5e-30  Score=271.83  Aligned_cols=195  Identities=26%  Similarity=0.425  Sum_probs=168.9

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .|+..+.||+|+||.||+|.+  .+..||+|++..... ....+.+.+|+.++++++||||+++++.+......++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            455667799999999999987  467899998875432 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++..    ..+++..+..++.||+.||.|||+++  |+|+||+|+||+++.++.+||+|||+++........
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            999999998864    34789999999999999999999999  999999999999999999999999999876554433


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....++..|+|||.+.+..+   +|+||||+++|+|++|..|+...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence            345578999999999987554   89999999999999999998643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1.3e-29  Score=265.36  Aligned_cols=201  Identities=21%  Similarity=0.333  Sum_probs=168.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ..++|++.+.||.|+||+||+|++.       ...+++|.+.... .....+.+.+|+.++++++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            3478999999999999999999873       3458899876433 2234677899999999999999999999999989


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAG------EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~------~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                      ..++||||+++|+|.+++......      ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++.++|+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence            999999999999999999764321      15899999999999999999999999  9999999999999999999999


Q ss_pred             ecCccccccCC-cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          804 DFGLSRFKANT-FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       804 DFGLAr~~~~t-~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      |||+++..... ........+++.|+|||.+.+..+   +||||||+++|+|++ |..||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            99998754322 223344567788999999876544   899999999999998 7788854

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.6e-29  Score=264.32  Aligned_cols=202  Identities=22%  Similarity=0.354  Sum_probs=167.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC-----ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g-----~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ++..++|.+.+.||+|+||.||+|.+..     ..||||...... .....+.+.+|+.+++++.||||+++++++.. .
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            3456789999999999999999998732     258888875442 23456688999999999999999999998875 4


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+++  ++||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceee
Confidence            5789999999999999997632  34789999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ...... .......+++.|+|||.+....+   +||||||+++|+|++ |..||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            654432 11223345578999999876544   799999999999985 999986653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=2e-29  Score=265.48  Aligned_cols=196  Identities=26%  Similarity=0.437  Sum_probs=170.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +-|++.+.||.|+||.||+|.+  .+..+|||++..... ......+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            3467888999999999999987  467899998865432 2445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|..++..    ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++.......
T Consensus        83 ~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          83 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999999999864    24789999999999999999999999  99999999999999999999999999987655433


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......++..|+|||.+.+..   .+|+|||||++|+|++|..||...
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            334567899999999987644   389999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-29  Score=256.83  Aligned_cols=198  Identities=26%  Similarity=0.465  Sum_probs=175.5

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|.+.+.||+|++|.||++..  .+..|++|.+............+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            478899999999999999987  467899999988766556778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998764   35899999999999999999999999  999999999999999999999999999876554333


Q ss_pred             ccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          818 SKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .....+++.|+|||.+.+..   .+|+|+||+++|+|++|..||+...
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            34567899999999987654   3899999999999999999987643

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=265.54  Aligned_cols=195  Identities=27%  Similarity=0.466  Sum_probs=169.6

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCeEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr---HPNIVkl~ga~~~~~~l~LV  734 (867)
                      .|++.+.||.|+||.||+|.+  .+..||+|.+.... .......+.+|+.++++++   ||||+++++++......++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            467788999999999999997  57789999987542 2345567889999999997   99999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++...    .+++..++.++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999998652    5889999999999999999999999  999999999999999999999999999876554


Q ss_pred             cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........|++.|+|||.+.++    ..+|+||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  205 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV  205 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence            3334456799999999998753    3489999999999999999998654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.4e-29  Score=261.16  Aligned_cols=199  Identities=24%  Similarity=0.403  Sum_probs=171.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|.+.+.||.|+||.||++.+  .+..+|+|.+..........+.+.+|+.++++++|+||+++++.+......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            478899999999999999988  467899999877654445566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCccccccCCcc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~~~t~~  816 (867)
                      +++++|.+++.+.. ...+++..+..++.|++.||.|||+++  |+|+||||+||+++.++ .+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987633 234789999999999999999999999  99999999999998885 469999999987654433


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......|++.|+|||.+.+..   .+|+||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            333457899999999987654   489999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1.4e-29  Score=266.61  Aligned_cols=191  Identities=24%  Similarity=0.270  Sum_probs=164.6

Q ss_pred             eccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||+|+||+||+|..  +++.||+|++....... .....+.+|+.+|++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999987  57889999987654332 3345667899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCC
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG  823 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aG  823 (867)
                      .+++..... ..+++..++.++.|++.||.|||+.+  |+||||+|+||+++.++.+||+|||+++...... ......+
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  156 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAG  156 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-ccccccC
Confidence            999876432 35889999999999999999999999  9999999999999999999999999987654322 2234578


Q ss_pred             CcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          824 TVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       824 Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +..|+|||.+.+..+   +|+||||+++|+|++|..||...
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence            899999999887554   79999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-30  Score=309.93  Aligned_cols=206  Identities=28%  Similarity=0.448  Sum_probs=172.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE---cCc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW---HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~---~g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ..+.....++.+.||+|.||.||+|..   .+.    .||||.++... ......+|++|..+|+.++|||||+++|++.
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            346788999999999999999999987   233    27777776542 3466788999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEE
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~----~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                      +....+|++|||++|+|..+|+....    ...+.-++.+.++.|||+|++||++++  .|||||..+|+||+....|||
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEE
Confidence            99999999999999999999997521    345888999999999999999999999  999999999999999999999


Q ss_pred             EecCccccc-cCCccccccc-CCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          803 CDFGLSRFK-ANTFISSKSV-AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       803 sDFGLAr~~-~~t~~s~~s~-aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +||||||.+ ...+++.... .-...|||||.+....+   +||||||++|||+|+ |..||....
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~  909 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS  909 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence            999999954 3333333333 23469999999997554   799999999999998 467776543

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.1e-29  Score=266.57  Aligned_cols=196  Identities=20%  Similarity=0.312  Sum_probs=167.4

Q ss_pred             CeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccch--HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l  731 (867)
                      +|++.+.||.|+||.||+|+.     +|..||+|++.......  ...+.+.+|+.+++++ +|+||+.+++.++....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999986     56789999987644322  2346678999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+  ++||||+|+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999999763   35788999999999999999999999  999999999999999999999999999765


Q ss_pred             cCCc-ccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTF-ISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~-~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .... .......|+..|+|||.+.+.     ..+||||||+++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            4322 122345789999999998753     348999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.1e-29  Score=262.09  Aligned_cols=185  Identities=21%  Similarity=0.323  Sum_probs=155.7

Q ss_pred             EEeccCCceEEEEEEEcCc------------eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          665 ERVGAGSFGTVHRAEWHGS------------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~------------~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +.||+|+||.||+|.+...            .+++|++....   .....+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            3689999999999998533            26777765433   115678899999999999999999999988 7789


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-------cEEEEec
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-------TVKVCDF  805 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-------~VKLsDF  805 (867)
                      +||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++       .+||+||
T Consensus        77 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999999998633  25889999999999999999999999  99999999999999888       8999999


Q ss_pred             CccccccCCcccccccCCCcccccccccCCC--C---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          806 GLSRFKANTFISSKSVAGTVVFFAAHQTACN--S---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       806 GLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~--~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |+++....    .....++..|+|||.+...  .   .+||||||+++|+|++ |..||...
T Consensus       153 g~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         153 GIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             Cccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            99976544    2344677889999998765  2   3899999999999998 57777655

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.6e-29  Score=265.36  Aligned_cols=187  Identities=19%  Similarity=0.310  Sum_probs=155.1

Q ss_pred             EEeccCCceEEEEEEEcC--------------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          665 ERVGAGSFGTVHRAEWHG--------------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g--------------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +.||+|+||+||+|++..              ..+++|++....  ......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999998632              237888765432  3345578889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc-------EEEE
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-------VKVC  803 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~-------VKLs  803 (867)
                      .++||||+++|+|..+++..  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.       +|++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999999888753  235899999999999999999999999  999999999999987664       8999


Q ss_pred             ecCccccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHh-cCCCCcccc
Q 002910          804 DFGLSRFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSF-EESPQMRSL  861 (867)
Q Consensus       804 DFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~-tG~~Pf~sl  861 (867)
                      |||++......    ....+++.|+|||.+.+.    ..+|||||||++|+|+ +|..||...
T Consensus       155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            99998654322    345688899999988632    2379999999999996 688887653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=2.2e-29  Score=267.20  Aligned_cols=200  Identities=22%  Similarity=0.302  Sum_probs=165.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----  729 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-----  729 (867)
                      ..++|++.+.||+|+||.||+|..  ++..||||++............+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            347899999999999999999988  5778999998765433333445678999999999999999999987654     


Q ss_pred             ---eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          730 ---HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       730 ---~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                         ..++||||+. ++|.+++....  ..+++..++.++.||+.||+|||+++  |+|+||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCC
Confidence               3599999995 57888776532  35899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCccc----ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFIS----SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s----~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.........    .....+++.|+|||.+.+.    ..+||||||+++|+|++|.+||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99865432211    1234678899999987653    3489999999999999999988643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=5.2e-30  Score=273.80  Aligned_cols=195  Identities=26%  Similarity=0.385  Sum_probs=167.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|.....||+|+||.||++..  ++..||||.+....  ....+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            3444456799999999999987  57789999886543  3445668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+++++|.+++..    ..+++..+..++.||+.||+|||+++  |+||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999998854    24788999999999999999999999  99999999999999999999999999876544333


Q ss_pred             cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......|++.|+|||.+.+..   .+|+||||+++|+|++|..||...
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  221 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE  221 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            334567899999999987643   489999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=6.4e-30  Score=265.26  Aligned_cols=196  Identities=30%  Similarity=0.458  Sum_probs=171.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||.|+||.||++.+.  ++.+|+|.+..... ....+.+.+|++++++++||||+++++.+.....++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            36778889999999999999985  77899999876543 3455678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||+ .+  ++|+||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            999999999997632  458899999999999999999999 88  9999999999999999999999999987654332


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .  ....+++.|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       156 ~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         156 A--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             h--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            2  22678999999999876544   89999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-29  Score=261.44  Aligned_cols=190  Identities=25%  Similarity=0.404  Sum_probs=158.8

Q ss_pred             EEeccCCceEEEEEEEcC-----ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          665 ERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g-----~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      +.||+|+||.||+|.+..     ..+|+|.+...... ...+.+.+|+.+++++.|||||++++++. ....++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            368999999999998732     46999998765543 44567899999999999999999999876 456899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc--
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS--  817 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s--  817 (867)
                      +|+|.+++....   .+++..+..++.|++.||+|||..+  |+||||||+|||++.++.+||+|||+++........  
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999998633   5889999999999999999999999  999999999999999999999999999865432211  


Q ss_pred             -ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          818 -SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       818 -~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                       .....++..|+|||.+.+..+   +||||||+++|+|++ |.+||...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence             112233568999999876554   899999999999997 99998654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2e-29  Score=276.25  Aligned_cols=195  Identities=25%  Similarity=0.335  Sum_probs=166.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------C
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~  729 (867)
                      .++|++.+.||+|+||+||+|..  +++.||||++............+.+|+.++++++||||++++++|...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999987  578899999875443444556788999999999999999999988644      3


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|+||||+. ++|.+.+..     .+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccce
Confidence            5799999995 588887754     2788899999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....... .....+++.|+|||.+.+..+   +|||||||++|+|++|..||...
T Consensus       167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         167 TAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             eCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            7654332 344578899999999987554   79999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.6e-29  Score=259.10  Aligned_cols=193  Identities=28%  Similarity=0.463  Sum_probs=163.3

Q ss_pred             EEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      +.||+|+||.||++.+. ++.||+|++...... .....+.+|+.+++++.||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            36899999999999885 788999988765433 4567789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc--ccccc
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSV  821 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~--s~~s~  821 (867)
                      .+++....  ..+++..+..++.+++.||.|||+++  |+||||||+|||++.++.+||+|||+++.......  .....
T Consensus        80 ~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99997532  35788999999999999999999999  99999999999999999999999999976542211  11223


Q ss_pred             CCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          822 AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       822 aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ..+..|+|||.+.+..+   +|+||||+++|+|++ |..||....
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            44678999999876554   799999999999998 888886543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.6e-29  Score=264.52  Aligned_cols=197  Identities=27%  Similarity=0.471  Sum_probs=167.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~  730 (867)
                      ++|++.+.||+|+||.||+|++.      +..+|||++...... ...+.+.+|+++++.+.||||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            57888899999999999999874      567999998765433 456789999999999999999999999877  557


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999997633  24889999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....   .......++..|+|||.+.+...   +||||||+++|+|++|..|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            65321   11122345667999999876554   7999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-29  Score=265.22  Aligned_cols=196  Identities=24%  Similarity=0.365  Sum_probs=167.0

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |++.+.||.|++|.||+|.+  +|+.||+|++............+.+|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56788999999999999987  5888999999866544444566888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      + ++|.+++.... ...+++..++.++.||+.||+|||+++  ++||||+|+||+++.++.++|+|||+++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            4 68999887633 235899999999999999999999999  9999999999999999999999999997654332222


Q ss_pred             cccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          819 KSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....+++.|+|||++.+.    ..+|+||||+++|+|++|.+||..
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            334668999999987643    348999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=2.7e-29  Score=261.14  Aligned_cols=190  Identities=23%  Similarity=0.347  Sum_probs=166.4

Q ss_pred             eccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||.|+||.||+|+..  ++.+|+|++....... ...+.+.+|+.++++++||||+++++.+.....+++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999986  7889999998665432 3456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCC
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG  823 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aG  823 (867)
                      .+++.+.   ..+++..+..++.||+.||+|||+++  ++|+||+|+||+++.++.+||+|||+++...... ......+
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~  154 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG  154 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence            9999763   24789999999999999999999999  9999999999999999999999999998765432 2234578


Q ss_pred             CcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          824 TVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       824 Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ++.|++||.+.+..+   +|+||||+++|+|++|..||....
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            999999999876544   899999999999999999997553

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=281.70  Aligned_cols=185  Identities=34%  Similarity=0.528  Sum_probs=158.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHh--cCCCCeeeEEeEEeeC----CeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--VRHPNVVLFMGAVTKR----PHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~--LrHPNIVkl~ga~~~~----~~l~  732 (867)
                      .+.++.+.||+|.||+||+|+|+|..||||++...+     ...+.+|.+|.+.  |+|+||+.|+++=...    ..+|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            688999999999999999999999999999986432     4578899999886  6999999999875433    2589


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN------LNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs------~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ||++|-+.|||+++|.+.    .++....++++.-++.||+|||.      ..|.|.|||||+.||||.++|.+.|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            999999999999999863    48999999999999999999993      33569999999999999999999999999


Q ss_pred             ccccccCC----cccccccCCCcccccccccCCCC---------hHHHHHHHHHHHHHh
Q 002910          807 LSRFKANT----FISSKSVAGTVVFFAAHQTACNS---------LALIFSLSGWLQSSF  852 (867)
Q Consensus       807 LAr~~~~t----~~s~~s~aGTp~YmAPEvl~~~~---------~SDIwSLG~lLyeM~  852 (867)
                      ||-.....    ....+..+||..|||||++...-         .+||||||+++||+.
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            98653321    23456779999999999988532         279999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=9.6e-30  Score=294.15  Aligned_cols=200  Identities=16%  Similarity=0.169  Sum_probs=155.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCc---eEEEEEE--------------ee-cccchHHHHHHHHHHHHHHhcCCCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWHGS---DVAVKVL--------------TV-QDFLDDQLKEFLREVAIMKRVRHPNV  718 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~g~---~VAVKvi--------------~~-~~~~~~~~k~f~~Ei~ILk~LrHPNI  718 (867)
                      ..++|++++.||+|+||+||+|.++..   ..++|.+              .+ ..........+.+|+.+|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            357899999999999999999876321   1222211              00 01112234567899999999999999


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~--~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~  796 (867)
                      |++++++......|+|||++ +++|..++.....  ........+..++.||+.||.|||+++  ||||||||+||||+.
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~  302 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC  302 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence            99999999999999999999 4577777654221  112335667789999999999999999  999999999999999


Q ss_pred             CCcEEEEecCccccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          797 NWTVKVCDFGLSRFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      ++.+||+|||+++...... .......||+.|+|||++.+..+   +|||||||++|+|++|..+++
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            9999999999998765432 22235689999999999987655   799999999999999875443

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=2.2e-29  Score=264.28  Aligned_cols=193  Identities=24%  Similarity=0.331  Sum_probs=154.7

Q ss_pred             EeccCCceEEEEEEE-cCce---EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFGTVHRAEW-HGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG~VykA~~-~g~~---VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .||+|+||+||++++ .+..   +++|.+.... .....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            589999999999976 3333   4555544332 2344578999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--cccc
Q 002910          742 SLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISS  818 (867)
Q Consensus       742 SL~~~L~~~~~-~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~~s~  818 (867)
                      +|.+++++... ....++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999976321 234667778899999999999999999  999999999999999999999999998643221  1122


Q ss_pred             cccCCCcccccccccCC----------CChHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTAC----------NSLALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~----------~~~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...++++.|+|||++..          ...+||||||+++|+|++ +..||...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            35678899999999753          234899999999999986 46677543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=2.7e-29  Score=268.05  Aligned_cols=196  Identities=25%  Similarity=0.389  Sum_probs=170.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|.+.+.||+|+||.||++..  ++..||+|.+....  ....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            47899999999999999999976  57789999986443  233466889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++.+.    .+++..+..++.|++.||.|||+++  ++||||||+||+++.++.+||+|||++.......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999999998752    3788899999999999999999999  9999999999999999999999999987655443


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+++.|+|||.+.+..+   +|+||||+++|+|++|..||...
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            33345578999999999876544   89999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=2.8e-29  Score=260.50  Aligned_cols=190  Identities=27%  Similarity=0.400  Sum_probs=154.3

Q ss_pred             EeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCeEEEEEeccC
Q 002910          666 RVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT-KRPHLSIVTEYLP  739 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~-~~~~l~LVmEy~~  739 (867)
                      .||+|+||.||+|.+.     +..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+..++||||+.
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            5899999999999862     2358999875322 2345677889999999999999999999775 4556899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc----
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF----  815 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~----  815 (867)
                      +|+|.+++.+..  ....+..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......    
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999997532  23677788899999999999999999  9999999999999999999999999997553321    


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcC-CCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE-SPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG-~~Pf~s  860 (867)
                      .......+++.|+|||.+.+..+   +|||||||++|+|++| .+||..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            11123456789999999876554   7999999999999995 566543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=2.2e-29  Score=267.09  Aligned_cols=201  Identities=22%  Similarity=0.353  Sum_probs=167.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC---
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP---  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~---  729 (867)
                      +...++|++.+.||.|+||.||+|.+  +++.||+|++............+.+|+.++++++||||+++++++....   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            44568999999999999999999998  4778999999765433334456788999999999999999999987654   


Q ss_pred             -------eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEE
Q 002910          730 -------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       730 -------~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                             .+++||||+++ +|...+...  ...+++..++.++.||+.||.|||+.+  |+||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEe
Confidence                   79999999976 677776643  235899999999999999999999999  999999999999999999999


Q ss_pred             EecCccccccCCcc-cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          803 CDFGLSRFKANTFI-SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       803 sDFGLAr~~~~t~~-s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +|||+++....... ......+++.|+|||.+.+.    ..+|||||||++|+|++|++||..
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999986543321 11233567889999988643    348999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=8.6e-30  Score=272.76  Aligned_cols=191  Identities=25%  Similarity=0.366  Sum_probs=165.5

Q ss_pred             EEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      ....||.|+||.||+|..  .++.||+|++.....  ...+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344699999999999987  578899999865432  2345678999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      ++|..++..    ..+++..++.++.||+.||+|||+++  |+||||||+||+++.++.+||+|||+++...........
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            999998754    24789999999999999999999999  999999999999999999999999999765544433455


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..|++.|+|||.+.+...   +|+|||||++|+|++|..||...
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  220 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD  220 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            689999999999886444   89999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=2e-29  Score=266.44  Aligned_cols=196  Identities=24%  Similarity=0.445  Sum_probs=164.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ce
Q 002910          659 DELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~  730 (867)
                      ..|++.+.||+|+||.||+|++      .+..||+|.+.... .......+.+|+.++++++||||+++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            4578899999999999999975      35679999986542 234456789999999999999999999998775  56


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++||||+++++|.+++.+..  ..+++..++.++.||+.||+|||+++  |+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999999986532  24789999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcc---cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          811 KANTFI---SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       811 ~~~t~~---s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      ......   ......++..|+|||.+.+..+   +||||||+++|+|+++..|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence            543221   1124467778999999886544   899999999999999766543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-31  Score=296.84  Aligned_cols=193  Identities=25%  Similarity=0.378  Sum_probs=167.1

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~-~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      |.-++.||.|+||-||-|++  +...||||.+....- ..+.++.+++|++.|++++|||+|.+.|+|..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44456799999999999987  566799998875432 345678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      | -|+-.+++.-.  .+++.+..+..|..+.+.||.|||+++  .||||||..||||...|.|||+|||.+..+...   
T Consensus       108 C-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  108 C-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             H-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            9 55666666532  246889999999999999999999999  999999999999999999999999998776443   


Q ss_pred             ccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          818 SKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                       +++.|||.|||||++..      ...+||||||++..++...+||++.+.
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN  229 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  229 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence             68899999999999884      334899999999999999999998875

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=3.5e-29  Score=265.44  Aligned_cols=189  Identities=22%  Similarity=0.257  Sum_probs=156.2

Q ss_pred             EeccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHHHHHHHHH---hcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          666 RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMK---RVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       666 ~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk---~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      .||+|+||.||++..  +++.+|+|++........ ....+.+|..+++   ...||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999987  477899999876544322 2223344544433   4479999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccc
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK  819 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~  819 (867)
                      +|+|..++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  153 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--cc
Confidence            99999988753   35899999999999999999999999  9999999999999999999999999987654322  23


Q ss_pred             ccCCCcccccccccCC-C---ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          820 SVAGTVVFFAAHQTAC-N---SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       820 s~aGTp~YmAPEvl~~-~---~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...||+.|+|||.+.+ .   ..+|||||||++|+|++|..||...
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            4579999999999863 2   3489999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=3e-29  Score=263.21  Aligned_cols=192  Identities=26%  Similarity=0.457  Sum_probs=157.3

Q ss_pred             EeccCCceEEEEEEEcC--c--eEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          666 RVGAGSFGTVHRAEWHG--S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~g--~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      .||+|+||.||+|.+.+  .  .+++|.+... ........+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            58999999999998743  3  3677776532 2234556788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          741 GSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       741 GSL~~~L~~~~-------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      |+|.+++....             ....+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence            99999997532             1224788999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ++..... ........++.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            8643221 11122344678999999876544   799999999999996 99998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=3.6e-29  Score=264.79  Aligned_cols=189  Identities=22%  Similarity=0.256  Sum_probs=156.9

Q ss_pred             EeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHH---HHHHhcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          666 RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREV---AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       666 ~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei---~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      .||+|+||.||+|..  .++.||+|++....... .....+..|.   .+++...||||+.+++.+...+.+++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            379999999999987  47789999987654332 1122233343   34555679999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccc
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK  819 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~  819 (867)
                      ||+|..++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~  153 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--Cc
Confidence            99999988653   35899999999999999999999999  9999999999999999999999999987654332  23


Q ss_pred             ccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          820 SVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       820 s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...|++.|+|||.+.+.    ..+||||+|+++|+|++|..||...
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            55799999999998743    3379999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=4.1e-29  Score=261.15  Aligned_cols=197  Identities=29%  Similarity=0.409  Sum_probs=167.5

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc--------hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL--------DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~--------~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      +|.+.+.||.|+||.||+|..  ++..+|+|.+......        ....+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999976  5788999988643221        122456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++++|.+++.+.   ..+++..+..++.||+.||.|||+++  ++||||+|+||+++.++.+||+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999764   35889999999999999999999999  9999999999999999999999999997


Q ss_pred             cccCCc--ccccccCCCcccccccccCCCC-----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTF--ISSKSVAGTVVFFAAHQTACNS-----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~--~s~~s~aGTp~YmAPEvl~~~~-----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......  .......|+..|+|||.+....     .+|+||||+++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  215 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE  215 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence            654321  1123457889999999987543     389999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=4.1e-29  Score=256.77  Aligned_cols=196  Identities=32%  Similarity=0.504  Sum_probs=165.2

Q ss_pred             eEEEEEeccCCceEEEEEEEcC------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          661 LHVKERVGAGSFGTVHRAEWHG------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~g------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +++.+.||.|+||.||++.+..      ..||+|++.... .....+.+..|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3567889999999999999854      679999986543 223567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++..... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||+++.....
T Consensus        80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999976332 12899999999999999999999999  999999999999999999999999999876543


Q ss_pred             cc-cccccCCCcccccccccCCC---ChHHHHHHHHHHHHHhc-CCCCccc
Q 002910          815 FI-SSKSVAGTVVFFAAHQTACN---SLALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       815 ~~-s~~s~aGTp~YmAPEvl~~~---~~SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      .. ......+++.|+|||.+.+.   ..+|+||||+++|+|++ |.+||..
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            11 11123367899999998653   34899999999999998 7888864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=9e-29  Score=262.21  Aligned_cols=198  Identities=27%  Similarity=0.430  Sum_probs=168.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSIV  734 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~LV  734 (867)
                      ++|...+.||.|++|.||++..  +++.+|+|.+..... ......+.+|++++++++||||++++++|...  ..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            4688999999999999999998  467899999875432 24556789999999999999999999988653  478999


Q ss_pred             EeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          735 TEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||+++++|.+++... .....+++..+..++.||+.||.|||+.+  ++|+||+|.||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999887642 12345788999999999999999999999  99999999999999999999999999876544


Q ss_pred             CcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  ....++..|+|||.+.+..   .+|+|||||++|+|++|..||...
T Consensus       158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            322  2456788999999987654   389999999999999999998754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=1.1e-28  Score=251.79  Aligned_cols=198  Identities=29%  Similarity=0.420  Sum_probs=174.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSIVT  735 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~LVm  735 (867)
                      +|.+.+.||+|++|.||+|...  ++.|++|++..........+.+.+|+.++++++||||+++++.+...  ..+++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999985  78899999987765556678899999999999999999999999888  8899999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999997643   6899999999999999999999999  9999999999999999999999999988765543


Q ss_pred             c--cccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 I--SSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~--s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .  ......++..|++||.+....   .+|+||||+++|+|++|..||....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2  134567899999999988653   3899999999999999999987653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=7.3e-29  Score=253.89  Aligned_cols=200  Identities=26%  Similarity=0.431  Sum_probs=175.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|.+.+.||.|+||.||++.+.  +..+++|++............+.+|+++++.++|||++++++.+......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788999999999999999985  78899999987665556677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          738 LPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       738 ~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+++  ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            99999999997632 1346899999999999999999999999  99999999999999999999999999987655443


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......|++.|+|||.+.+...   +|+||||+++|+|++|..||...
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence            3445688999999999776543   89999999999999999998553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=1.5e-29  Score=263.70  Aligned_cols=186  Identities=19%  Similarity=0.302  Sum_probs=155.5

Q ss_pred             EEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          665 ERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.||.|+||.||+|.+.         ...+|+|.+....  ....+.+..|+.+++.+.||||+++++++......++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            36899999999999763         2237888775432  234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc--------EEEEecCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--------VKVCDFGL  807 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~--------VKLsDFGL  807 (867)
                      ||+++|+|..+++...  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.        +|++|||+
T Consensus        79 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999997643  25789999999999999999999999  999999999999987765        69999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCC-CCccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEES-PQMRS  860 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~-~Pf~s  860 (867)
                      +......    ....+++.|+|||++.+..    .+||||||+++|+|++|. +|+..
T Consensus       155 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         155 SITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             ccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            8654332    3457889999999998633    489999999999999994 66544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-31  Score=318.69  Aligned_cols=197  Identities=28%  Similarity=0.382  Sum_probs=174.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +++-...||.|.||+||.|..  +|...|+|-++.++........+.+|..++..++|||||++||+=.+...++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            345577899999999999986  688899999998887766777889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc--
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--  815 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--  815 (867)
                      |.+|+|.+++..   +...++.....+..|++.|++|||++|  ||||||||+||||+.+|.+|++|||.|....+..  
T Consensus      1316 C~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             hccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999999986   334777788889999999999999999  9999999999999999999999999998765542  


Q ss_pred             --ccccccCCCcccccccccCCCC------hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 --ISSKSVAGTVVFFAAHQTACNS------LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 --~s~~s~aGTp~YmAPEvl~~~~------~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                        ...+...|||.|||||++.+..      ..|||||||++.||.||+-||..+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence              2234669999999999999754      379999999999999999999765

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=4.7e-29  Score=260.37  Aligned_cols=199  Identities=26%  Similarity=0.392  Sum_probs=163.3

Q ss_pred             eEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          661 LHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      |.+.+.||+|+||.||+|.+.     +..||||++..........+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567788999999999999862     567999999876655666788999999999999999999999886432      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~---~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ..++++||+.+|+|..++....   ....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence            2478999999999998875321   1124788899999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          807 LSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +++......  .......+++.|++||.+.....   +|||||||++|+|++ |.+||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            998653321  11223355688999999876544   899999999999998 88888654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=5e-29  Score=266.90  Aligned_cols=199  Identities=25%  Similarity=0.424  Sum_probs=163.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ..++|++.+.||+|+||.||+|.+  .+.    .+|+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            457889999999999999999987  344    36888776433 233345688999999999999999999998654 5


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++++||+++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccc
Confidence            779999999999999987632  34788899999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......  ......++..|+|||.+.+..+   +||||||+++|+|++ |..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            543211  1223455779999999876544   899999999999987 88888653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1.3e-28  Score=250.31  Aligned_cols=195  Identities=30%  Similarity=0.504  Sum_probs=171.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|.+.+.||+|++|.||++.+.  +..+++|++.....  .....+.+|+.++++++|+||+++++.+......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            5788899999999999999984  77899999876543  4567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++....  ..+++..+..++.|++.||.|||..+  ++||||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999999987642  35899999999999999999999999  99999999999999999999999999876654321 


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....++..|++||.+.....   +|+||||+++|+|++|..||...
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            345678999999999875443   89999999999999999998765

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=8.2e-29  Score=259.29  Aligned_cols=193  Identities=22%  Similarity=0.304  Sum_probs=160.3

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeC--CeEEEEE
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKR--PHLSIVT  735 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~--~~l~LVm  735 (867)
                      |++.+.||+|+||.||+|..  +++.||+|++......... ....+|+.++.++. |+||+++++++...  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            57889999999999999987  5778999998754322222 23457899999886 99999999999887  8899999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. |+|.+.+...  ...+++..++.++.||+.||.|||+.+  |+||||||+||+++. +.+||+|||+++......
T Consensus        80 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          80 ELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             ecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9996 5777777653  235899999999999999999999999  999999999999999 999999999998764432


Q ss_pred             ccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      . .....+++.|+|||.+..    ...+|||||||++|+|++|.+||...
T Consensus       154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            2 233467899999998653    23489999999999999999999653

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=1.1e-28  Score=264.43  Aligned_cols=194  Identities=23%  Similarity=0.367  Sum_probs=166.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ..|.+.+.||+|+||+||+|..  .++.||+|++...... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            5688899999999999999987  5788999998754332 345677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. |+|.+++...  ...+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.+||+|||+++..... 
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9996 5676666542  235899999999999999999999999  999999999999999999999999998765332 


Q ss_pred             ccccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                         ....+++.|+|||++..      ...+||||||+++|+|++|.+||...
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~  217 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence               34578899999998742      23489999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=6.6e-29  Score=262.63  Aligned_cols=186  Identities=18%  Similarity=0.280  Sum_probs=153.6

Q ss_pred             EeccCCceEEEEEEEc--------------------------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee
Q 002910          666 RVGAGSFGTVHRAEWH--------------------------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV  719 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~--------------------------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIV  719 (867)
                      .||+|+||.||+|.+.                          ...||+|++....  .....++.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            5899999999999752                          1237888875432  23446788899999999999999


Q ss_pred             eEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-
Q 002910          720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-  798 (867)
Q Consensus       720 kl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-  798 (867)
                      ++++++......++||||+++|+|..++.+.  ...+++..+..++.||+.||+|||+++  |+||||||+|||+++.+ 
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence            9999999999999999999999999998753  235789999999999999999999999  99999999999997654 


Q ss_pred             ------cEEEEecCccccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHH-hcCCCCcccc
Q 002910          799 ------TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSS-FEESPQMRSL  861 (867)
Q Consensus       799 ------~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM-~tG~~Pf~sl  861 (867)
                            .+||+|||++......    ....+++.|+|||.+.+.    ..+||||||+++|+| ++|..||...
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                  4899999997643222    234678899999988753    348999999999998 5789998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-30  Score=273.70  Aligned_cols=191  Identities=24%  Similarity=0.382  Sum_probs=162.9

Q ss_pred             EEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      .+.||.|+|+.|--+..  +|.+||||++.++.  .....++.+|++++.+++ |+||++++++|+++.+.|||||-|.|
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            46799999999998865  78999999998874  344568899999999997 99999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC---cEEEEecCcccccc-CCcc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSRFKA-NTFI  816 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g---~VKLsDFGLAr~~~-~t~~  816 (867)
                      |.|..+|++.   ..+++..+.++..+|+.||.|||.+|  |.||||||+|||-.+-.   -||||||.|..-+. +..+
T Consensus       161 GplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  161 GPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             chHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999873   45999999999999999999999999  99999999999986543   47999999865432 1111


Q ss_pred             ------cccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 ------SSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 ------s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                            ..-+.+|+.+|||||+..-        .+..|.||||++||-|+.|++||.+.
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence                  1235688999999999662        33489999999999999999999764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=288.43  Aligned_cols=205  Identities=28%  Similarity=0.506  Sum_probs=173.7

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      .++..+.+.++++||+|-||+|.++...+ ..||||+++... ......+|.+|+++|.+|+|||||+++|+|..++.++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            46677889999999999999999999876 889999998654 3344688999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +|||||++|+|.+++.+..... +.......|+.||+.||+||.+.+  +|||||.+.|+|++.++++||+|||++|-+-
T Consensus       612 mI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999998753222 456677789999999999999999  9999999999999999999999999998432


Q ss_pred             -CCccccc-ccCCCcccccccccCCCCh---HHHHHHHHHHHHHh--cCCCCccccc
Q 002910          813 -NTFISSK-SVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSF--EESPQMRSLM  862 (867)
Q Consensus       813 -~t~~s~~-s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~--tG~~Pf~sl~  862 (867)
                       ..+...+ ...-...|||+|.+..+++   +|+|+||+++||||  +..-||..++
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt  745 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT  745 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence             2222222 3344679999999998777   79999999999875  4567777664

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=5.5e-29  Score=262.92  Aligned_cols=198  Identities=28%  Similarity=0.402  Sum_probs=172.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..+.|...+.||+|+||.||++.+.  +..+++|++.....   ..+.+.+|+.++++++|+||+++++.+......++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3467888899999999999999985  78899999876543   456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++....  ..+++..+..++.|++.||+|||+.|  |+|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999998643  35899999999999999999999999  999999999999999999999999998765443


Q ss_pred             cccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........+++.|++||.+.+..   .+|+||||+++|+|++|..||...
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            32334556889999999987654   489999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=4.5e-29  Score=260.02  Aligned_cols=199  Identities=24%  Similarity=0.420  Sum_probs=172.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LV  734 (867)
                      ++|.+.+.||+|+||.||+|..  ++..||+|++...... ......+.+|+.++++++ ||||+++++.+......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4789999999999999999988  5788999998775443 344567889999999999 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++.+..   .+++..++.++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999998643   5899999999999999999999999  999999999999999999999999998765432


Q ss_pred             c--------------------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 F--------------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~--------------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .                    .......++..|+|||.+.+...   +|+||||+++|++++|..||....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            2                    22234567899999999876543   899999999999999999987553

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=7.7e-29  Score=254.96  Aligned_cols=198  Identities=26%  Similarity=0.433  Sum_probs=173.3

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      +|++.+.||.|+||.||++++  ++..+|+|.+............+.+|+.++++++|+||+++++.+......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588999999999999999987  467799999987665556667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          738 LPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       738 ~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      +++++|..++.+.. ....+++..++.++.|++.||+|||+.|  ++|+||+|.||+++.++.+||+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            99999999886522 1245889999999999999999999999  9999999999999999999999999998765542 


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       .....+++.|++||.+.+...   +|+||||+++|+|++|..||...
T Consensus       158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  204 (256)
T cd08530         158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR  204 (256)
T ss_pred             -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence             234578999999999887544   89999999999999999998754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=1e-28  Score=258.17  Aligned_cols=196  Identities=23%  Similarity=0.374  Sum_probs=166.5

Q ss_pred             eEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeEEEEEe
Q 002910          661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSIVTE  736 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l~LVmE  736 (867)
                      |++.+.||.|+||.||+|.+.  ++.+|+|++............+.+|+.++++++||||+++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999884  67899999987653334456788999999999999999999999888  88999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |++ ++|..++....  ..+++..++.++.||+.||+|||..+  ++|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            996 48888886532  35899999999999999999999999  99999999999999999999999999986654321


Q ss_pred             -cccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 -SSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 -s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       ......++..|+|||.+.+    ...+||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~  205 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS  205 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             1223466889999998764    34589999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=5.9e-29  Score=263.96  Aligned_cols=198  Identities=27%  Similarity=0.433  Sum_probs=162.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-------  728 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-------  728 (867)
                      .++|.+.+.||.|+||.||+|.+  +++.+|||++............+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            58999999999999999999998  477899999876543333334567899999999999999999887543       


Q ss_pred             -CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          729 -PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       729 -~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                       ..+++||||+.+ +|...+...  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCcc
Confidence             347999999964 677666542  335899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcc-----------cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          808 SRFKANTFI-----------SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       808 Ar~~~~t~~-----------s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++.......           ......+++.|+|||.+.+.    ..+||||||+++|+|++|.+||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            976533211           11233568889999987653    348999999999999999999853

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=7.1e-29  Score=269.81  Aligned_cols=194  Identities=25%  Similarity=0.434  Sum_probs=162.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----CeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~l  731 (867)
                      ++|++.+.||+|+||.||+|.+  +++.||||++.... .......+.+|+.++++++||||+++++++...     ..+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            6899999999999999999987  57889999986422 123456678899999999999999999887543     358


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+. ++|..++..    ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999995 588887754    34899999999999999999999999  999999999999999999999999998765


Q ss_pred             cCCcc---cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFI---SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~---s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....   ......||+.|+|||.+.+.    ..+||||||+++|+|++|++||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            43211   12335789999999987542    348999999999999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-28  Score=256.01  Aligned_cols=188  Identities=28%  Similarity=0.368  Sum_probs=159.4

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHH-HhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIM-KRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~IL-k~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.||.|+||.||+|..  .++.||||++.+..... .....+..|..++ ....|+||+++++++.....+++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999988  57789999987654332 3334455565554 455899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      ++|.+++...   ..+++..+..++.||+.||.|||+.+  |+||||+|+||+++.++.+||+|||+++....    ...
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~  152 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK  152 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence            9999999753   34889999999999999999999999  99999999999999999999999999876433    235


Q ss_pred             cCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..+++.|+|||.+.+..   .+||||||+++|+|++|..||...
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            57889999999988754   489999999999999999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=5.7e-29  Score=266.22  Aligned_cols=198  Identities=15%  Similarity=0.180  Sum_probs=167.2

Q ss_pred             eEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.+++.+|.|+++.|+++..+++.||||++..........+.+.+|+.++++++||||+++++++......+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34555667777777777777899999999987655566778899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc-----
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-----  815 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~-----  815 (867)
                      |+|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++.......     
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999998643 234889999999999999999999999  9999999999999999999999999987543221     


Q ss_pred             --ccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 --ISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 --~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                        .......++..|+|||++...     ..+|+|||||++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence              112344677899999998653     3489999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.6e-28  Score=262.54  Aligned_cols=201  Identities=15%  Similarity=0.193  Sum_probs=152.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCc-----eEEEEEEeecccch--HH--H-----HHHHHHHHHHHhcCCCCeee
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLD--DQ--L-----KEFLREVAIMKRVRHPNVVL  720 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~-----~VAVKvi~~~~~~~--~~--~-----k~f~~Ei~ILk~LrHPNIVk  720 (867)
                      ++.-++|++.+.||+|+||+||+|.+.+.     .+|+|+........  +.  .     .....+...+..+.|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            34557899999999999999999998543     56676543322111  10  0     11223344556678999999


Q ss_pred             EEeEEeeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC
Q 002910          721 FMGAVTKRP----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       721 l~ga~~~~~----~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~  796 (867)
                      +++.+....    ..+++||++ ..++.+.+...   ...++..++.++.|++.||+|||+++  |+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~  161 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence            998765443    357888887 44666666542   23578888999999999999999999  999999999999999


Q ss_pred             CCcEEEEecCccccccCCc-------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          797 NWTVKVCDFGLSRFKANTF-------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~t~-------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.+||+|||+++......       .......||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999998653211       11234579999999999887654   79999999999999999999766

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=6.1e-29  Score=256.00  Aligned_cols=189  Identities=28%  Similarity=0.423  Sum_probs=164.1

Q ss_pred             eccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||.|+||.||++.+.  +..+++|++...... ....+.+.+|+.++++++||||+++++.+......|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999984  788999998765443 24567789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc--------
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--------  815 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--------  815 (867)
                      .+++.+..   .+++..+..++.||+.||.|||+++  |+||||+|+||+++.++.+||+|||++.......        
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99998633   5899999999999999999999999  9999999999999999999999999987543321        


Q ss_pred             ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .......+++.|+|||.+....   .+|+||||+++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            1223457889999999987654   38999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=4.3e-29  Score=263.55  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=163.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|...+.||+|+||.||++.+  +++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            45677788999999999999988  4678999998755433 44567889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHH---hcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          735 TEYLPRGSLYRLI---HRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       735 mEy~~gGSL~~~L---~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      |||+. +++.++.   ... ....+++..+..++.+++.||+|||+ .+  |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~e~~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            99985 4554433   221 12458999999999999999999997 48  99999999999999999999999999986


Q ss_pred             ccCCcccccccCCCcccccccccCCC------ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACN------SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~------~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... .....|++.|+|||.+.+.      ..+||||||+++|+|++|..||...
T Consensus       158 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         158 LVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             hccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            554322 2344789999999998765      2389999999999999999998653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=262.26  Aligned_cols=206  Identities=21%  Similarity=0.303  Sum_probs=175.0

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--  728 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--  728 (867)
                      ..-|+-++|++.++||.|+|+.||+++.  ++..+|+|.+....  .+..+..++|++..++++||||++++++....  
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            3456778999999999999999999985  67889999998765  46678899999999999999999999876433  


Q ss_pred             ---CeEEEEEeccCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          729 ---PHLSIVTEYLPRGSLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       729 ---~~l~LVmEy~~gGSL~~~L~~~~~-~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                         ...||++.|...|+|.+.+.+... +..+++.+++.|+.+|++||++||...+++.||||||.|||+...+.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence               348999999999999999986443 4479999999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCCc---------ccccccCCCcccccccccCCC------ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          805 FGLSRFKANTF---------ISSKSVAGTVVFFAAHQTACN------SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       805 FGLAr~~~~t~---------~s~~s~aGTp~YmAPEvl~~~------~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ||.++...-.-         -.......|..|.|||++...      ..+|||||||+||.|+.|..||.-
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            99987542210         011233568999999998854      447999999999999999999963

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=1.2e-28  Score=257.31  Aligned_cols=199  Identities=24%  Similarity=0.392  Sum_probs=167.9

Q ss_pred             CeEEEEEeccCCceEEEEEEEc---CceEEEEEEeecc--------cchHHHHHHHHHHHHHHh-cCCCCeeeEEeEEee
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQD--------FLDDQLKEFLREVAIMKR-VRHPNVVLFMGAVTK  727 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~---g~~VAVKvi~~~~--------~~~~~~k~f~~Ei~ILk~-LrHPNIVkl~ga~~~  727 (867)
                      +|++.+.||+|+||.||++.+.   +..+|+|.+....        .......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4778889999999999999984   4679999886432        223455677889998875 799999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEec
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDF  805 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDF  805 (867)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.||.|||. .+  |+|+||+|+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887541 123458899999999999999999995 67  999999999999999999999999


Q ss_pred             CccccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          806 GLSRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       806 GLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |++....... ......|+..|+|||.+.+..   .+|+||||+++|+|++|.+||...
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~  216 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST  216 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence            9998755443 334567899999999998754   489999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=8.1e-29  Score=268.51  Aligned_cols=194  Identities=17%  Similarity=0.250  Sum_probs=162.3

Q ss_pred             EEeccC--CceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          665 ERVGAG--SFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       665 e~LG~G--sFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      ..||.|  +||+||+|++  .++.||+|++.......+..+.+.+|+.+++.++||||++++++|......++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999988  688999999987665556678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc---
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS---  817 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s---  817 (867)
                      ++|.+++.+.. ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+|++||+.+.........   
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 234889999999999999999999999  999999999999999999999999865433221111   


Q ss_pred             ----ccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 ----SKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ----~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                          .....++..|+|||++.+.     ..+|||||||++|+|++|.+||...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                0112345679999998763     3489999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.9e-28  Score=260.18  Aligned_cols=194  Identities=26%  Similarity=0.387  Sum_probs=166.6

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .|...+.||.|++|.||++.+  .++.+++|++....  ....+.+.+|+.+++.+.||||+++++++...+..++|+||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            344457899999999999987  46779999886433  23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +.+++|.+++..    ..+++..+..++.|++.||+|||+++  |+||||+|+||+++.++.++|+|||+++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            999999999875    24788999999999999999999999  999999999999999999999999998765443333


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....|++.|+|||.+.+..+   +|+||||+++|+|++|..||...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~  218 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE  218 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence            345678999999999876544   89999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=5.8e-29  Score=270.32  Aligned_cols=196  Identities=20%  Similarity=0.338  Sum_probs=165.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----~~~l~  732 (867)
                      ++|.+.+.||.|+||.||+|..  ++..||+|++..........+.+.+|+.+|++++||||+++++++..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6899999999999999999987  57889999987654333455678889999999999999999988753    35689


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+. ++|.+++...   ..+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++...
T Consensus        85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            9999995 6898888753   34899999999999999999999999  9999999999999999999999999997654


Q ss_pred             CCccc----ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFIS----SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s----~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....    .....|+..|+|||.+.+.    ..+||||||+++|+|++|.+||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            32211    1244789999999997652    348999999999999999999954

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=6.4e-29  Score=258.83  Aligned_cols=193  Identities=27%  Similarity=0.388  Sum_probs=160.0

Q ss_pred             EeccCCceEEEEEEEcC--------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          666 RVGAGSFGTVHRAEWHG--------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~g--------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .||+|+||.||+|++..        ..+|||.+.... .......+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            58999999999998742        458999876432 234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-----cEEEEecCcc
Q 002910          738 LPRGSLYRLIHRPA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-----TVKVCDFGLS  808 (867)
Q Consensus       738 ~~gGSL~~~L~~~~----~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-----~VKLsDFGLA  808 (867)
                      +++++|.+++....    ....+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++     .+||+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999997532    1234788999999999999999999999  99999999999999887     8999999999


Q ss_pred             ccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          809 RFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +.......  ......++..|+|||.+.+...   +||||||+++|+|++ |..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            76543221  1123355788999999886554   799999999999997 99988643

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-30  Score=294.69  Aligned_cols=204  Identities=28%  Similarity=0.459  Sum_probs=178.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--C---ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g---~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+|+.....|.+.||.|.||+|++|+++  +   ..||||.++.. ..+++..+|+.|+.||-+..||||++|.|+++..
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            4788899999999999999999999883  3   34999998754 4567788999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..++||+|||++|+|+.+|+.+.  +.+..-+...|++.|+.||+||-+.+  +|||||..+||||+.+-.+||+||||+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999999999855  34888889999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccc-cccCC--CcccccccccCCCCh---HHHHHHHHHHHH-HhcCCCCccccc
Q 002910          809 RFKANTFISS-KSVAG--TVVFFAAHQTACNSL---ALIFSLSGWLQS-SFEESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~-~s~aG--Tp~YmAPEvl~~~~~---SDIwSLG~lLye-M~tG~~Pf~sl~  862 (867)
                      |.+.+..... .+..|  ...|.|||.+...++   +|+||+|+++|| |-.|+-|||.+.
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS  839 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  839 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence            9875533211 22223  369999999998766   799999999996 557899999875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-29  Score=290.78  Aligned_cols=206  Identities=27%  Similarity=0.412  Sum_probs=181.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEee-
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTK-  727 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~-  727 (867)
                      +.+....+.|++.+.||.|.+|+||+++.  +++..|+|++....   +.-+++..|.+||+.+. |||++.+||+|.. 
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            33444567899999999999999999876  68889999987654   33345667888988874 9999999999853 


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          728 ----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       728 ----~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                          .+.+|||||||.+|+.-++++... +..+.|..+.+|++.++.||.+||.+.  ++|||||-.|||++.++.|||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEe
Confidence                457999999999999999998755 667999999999999999999999998  9999999999999999999999


Q ss_pred             ecCccccccCCcccccccCCCcccccccccCCCCh--------HHHHHHHHHHHHHhcCCCCccccch
Q 002910          804 DFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL--------ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       804 DFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~--------SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      |||++..+..+.....+..|||.|||||++.+.+.        +|+||||++..||..|.+|+..++.
T Consensus       166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            99999999998888899999999999999997654        6999999999999999999988764

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=1.6e-28  Score=259.54  Aligned_cols=196  Identities=21%  Similarity=0.296  Sum_probs=166.6

Q ss_pred             CeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccch--HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l  731 (867)
                      +|++.+.||+|+||.||++++     +++.||||++.+.....  ...+.+.+|+.++.++ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999975     35679999987644322  3346688999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++|+|..++...   ..+++..+..++.|++.||.|||+.+  ++||||||.||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999998753   35888999999999999999999999  999999999999999999999999998765


Q ss_pred             cCCc-ccccccCCCcccccccccCCCC-----hHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTF-ISSKSVAGTVVFFAAHQTACNS-----LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~-~s~~s~aGTp~YmAPEvl~~~~-----~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .... .......|++.|+|||.+.+..     .+|+||||+++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            4322 1123457899999999987543     48999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.3e-28  Score=267.76  Aligned_cols=194  Identities=23%  Similarity=0.336  Sum_probs=164.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------  728 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------  728 (867)
                      ..++|.+.+.||+|+||.||+|..  ++..||+|++..........+.+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            348899999999999999999986  577899999876443334456788999999999999999999988643      


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ...+++++++ +++|.+++..    ..+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccc
Confidence            3478888887 8899888764    24889999999999999999999999  999999999999999999999999998


Q ss_pred             ccccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +.....   .....+++.|+|||.+.+    ...+|||||||++|+|++|.+||..
T Consensus       168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         168 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             cccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            765432   234578899999999765    3348999999999999999999853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=1.2e-28  Score=268.57  Aligned_cols=196  Identities=22%  Similarity=0.337  Sum_probs=165.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----CeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~l  731 (867)
                      ++|.+.+.||.|+||+||+|+.  ++..||||.+............+.+|+.+++.++|+||+++++++...     ..+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            5799999999999999999987  577899999876433334456778999999999999999999988654     358


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+. ++|.+++...   ..+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            99999995 6898888753   35899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ...........++..|+|||.+.+.    ..+|||||||++|+|++|.+||..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            4432223445688999999987642    348999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.5e-28  Score=267.28  Aligned_cols=194  Identities=25%  Similarity=0.358  Sum_probs=165.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      .++|++.+.||+|+||.||+|..  .+..||||++............+.+|+.+|++++||||+++++++....      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            36799999999999999999987  5778999998654333344567889999999999999999999987654      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ..++||||+ +++|..++..    ..+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            358999999 7899888864    24889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......   ....+++.|+|||.+.+.    ..+|+||||+++|+|++|.+||...
T Consensus       167 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         167 QTDSEM---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             ccccCc---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            654332   345678999999997652    3489999999999999999999643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=279.75  Aligned_cols=188  Identities=29%  Similarity=0.430  Sum_probs=160.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHh--cCCCCeeeEEeEEeeCC----eE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--VRHPNVVLFMGAVTKRP----HL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~--LrHPNIVkl~ga~~~~~----~l  731 (867)
                      ...+++.+.||+|+||.||+|.++++.||||++..     ...+.|.+|.+|.+.  |+|+||++|+++-....    .+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            45667888999999999999999999999999864     456789999999775  68999999998866544    79


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-------cCCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-------LNPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-------~gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                      +||+||.+.|+|.++|..    ..++|....+|+.-+++||+|||+       +.|+|+|||||+.||||-.++++.|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999985    348999999999999999999995       346899999999999999999999999


Q ss_pred             cCccccccCCcc--cccccCCCcccccccccCCC-----C----hHHHHHHHHHHHHHhcC
Q 002910          805 FGLSRFKANTFI--SSKSVAGTVVFFAAHQTACN-----S----LALIFSLSGWLQSSFEE  854 (867)
Q Consensus       805 FGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~-----~----~SDIwSLG~lLyeM~tG  854 (867)
                      ||||..+....-  ..-.-+||..|||||++.+.     .    ..||||+|++||||+..
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR  420 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR  420 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence            999987653211  11235899999999998852     1    27999999999999764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=2.8e-28  Score=259.54  Aligned_cols=201  Identities=21%  Similarity=0.332  Sum_probs=167.8

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP  729 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~  729 (867)
                      .+.+.+++|.+.+.||+|+||+||+|.+.  ++.||||.+...... .....+.+|+.++.++. ||||+++++++....
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            34567799999999999999999999995  788999999765432 33456677887777765 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .+++||||+. +.|..++....  ..+++..+..++.||+.||.|||+ ++  |+||||+|+||+++.++.+||+|||++
T Consensus        88 ~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          88 DVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             eEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccc
Confidence            9999999984 57777665422  368899999999999999999997 58  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCC-------hHHHHHHHHHHHHHhcCCCCccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNS-------LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~-------~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +...+.... ....+++.|+|||.+.+..       .+||||||+++|+|++|+.||..
T Consensus       163 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         163 GRLVDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             hhccCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            766443221 2346788999999987553       48999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.2e-28  Score=265.81  Aligned_cols=196  Identities=24%  Similarity=0.371  Sum_probs=168.2

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----eEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLS  732 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-----~l~  732 (867)
                      +|++.+.||.|+||.||+|+.  .+..||||++..........+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            488999999999999999997  4678999998765433455677899999999999999999999988775     789


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||++ ++|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||.|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 5898888753   26899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCc---ccccccCCCcccccccccCCC-C---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTF---ISSKSVAGTVVFFAAHQTACN-S---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~---~s~~s~aGTp~YmAPEvl~~~-~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...   .......+++.|+|||.+.+. .   .+|+||||+++|+|++|.+||...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            432   112345678999999998765 2   389999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=1.1e-28  Score=268.19  Aligned_cols=196  Identities=21%  Similarity=0.336  Sum_probs=164.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC--CeEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR--PHLS  732 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~--~~l~  732 (867)
                      .++|++.+.||+|+||.||+|.+  .++.+|||.+............+.+|+.+++++ +||||++++++|...  ..++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46889999999999999999987  477899998865433344556678899999999 999999999998653  4689


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+. ++|..++...    .+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++...
T Consensus        86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            9999996 5999888652    5788899999999999999999999  9999999999999999999999999998654


Q ss_pred             CCcc-----cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFI-----SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~-----s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....     ......||+.|+|||.+.+.    ..+|+||||+++|+|++|.+||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            3221     12234688999999987653    348999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=282.99  Aligned_cols=205  Identities=29%  Similarity=0.483  Sum_probs=177.9

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcC--ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g--~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+.|++...++...++||-|.||.||.|.|+.  -.||||.++.+.   -.+++|+.|..+|+.++|||+|+++|+|+.+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            37789999999999999999999999999964  458999887553   4577899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ...|||+|||..|+|.+||++.+. ..++.-..++||.||..||+||..++  +|||||..+|+||..+..|||+||||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchh
Confidence            999999999999999999998653 35778888999999999999999999  999999999999999999999999999


Q ss_pred             ccccC-CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          809 RFKAN-TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       809 r~~~~-t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |++.. ++......--.+-|.|||-+..+.+   +|||+||++|||+.| |-.||.++
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi  470 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI  470 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence            98764 3332222222468999999998776   799999999999965 55777654

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=3.9e-28  Score=254.32  Aligned_cols=196  Identities=26%  Similarity=0.369  Sum_probs=163.7

Q ss_pred             eEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeEEeeCCe-----
Q 002910          661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVTKRPH-----  730 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~~~~~-----  730 (867)
                      |++.+.||.|+||.||+|+++  ++.||+|++............+.+|+.+++++   .||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999984  78899999976543333345567788887776   59999999999988776     


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++++|||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+  |+|+||+|+||+++.++.+||+|||+++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence            999999996 48988887533 234899999999999999999999999  99999999999999999999999999977


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... .....+++.|+|||.+.+...   +|+|||||++|+|++|.+||...
T Consensus       157 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~  209 (287)
T cd07838         157 YSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT  209 (287)
T ss_pred             ccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence            543321 123457889999999887554   89999999999999999988653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=3e-28  Score=256.74  Aligned_cols=187  Identities=18%  Similarity=0.339  Sum_probs=155.9

Q ss_pred             CCeEEEEE--eccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEE
Q 002910          659 DELHVKER--VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       659 ~dy~i~e~--LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~L  733 (867)
                      ++|.+.+.  ||.|+||.||++..  ++..+|+|++........       |+.+...+ +||||+++++.|...+.+++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            34555555  49999999999987  567799999876533221       22222222 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~~  812 (867)
                      ||||+++++|.+++....   .+++..+..++.||+.||.|||+.+  |+||||||+||+++.++ .++|+|||+++...
T Consensus        87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999997632   6899999999999999999999999  99999999999999998 99999999987664


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..    ....+++.|+|||++.+..+   +|+||||+++|+|++|..||...
T Consensus       162 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        162 TP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             CC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            43    34578999999999876544   79999999999999999999743

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=4.8e-28  Score=261.27  Aligned_cols=194  Identities=24%  Similarity=0.382  Sum_probs=165.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.|...+.||+|+||.||++++  ++..+|+|++...... .+....+.+|+.++++++||||+++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4577888999999999999987  5778999998765333 345667899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. |+|.+++...  ...+++..+..++.+|+.||.|||+++  |+||||+|+||+++.++.+||+|||++...... 
T Consensus       105 e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         105 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             eCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9996 4777776542  335889999999999999999999999  999999999999999999999999998754332 


Q ss_pred             ccccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                         ....|++.|+|||.+..      ...+|+|||||++|+|++|..||...
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence               34578899999999742      23489999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=2.5e-28  Score=264.77  Aligned_cols=197  Identities=20%  Similarity=0.329  Sum_probs=162.7

Q ss_pred             CCe-EEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH------H------HHHHHHHHHHHHhcCCCCeeeEEe
Q 002910          659 DEL-HVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD------Q------LKEFLREVAIMKRVRHPNVVLFMG  723 (867)
Q Consensus       659 ~dy-~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~------~------~k~f~~Ei~ILk~LrHPNIVkl~g  723 (867)
                      ++| .+.+.||.|+||+||+|..  .++.||||++........      .      ...+.+|+.++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            344 4567899999999999986  577899999876543221      0      124678999999999999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                      ++......++||||+. |+|.+++...   ..+++.....++.|++.||.|||+++  |+||||+|+|||++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 6898888652   34889999999999999999999999  9999999999999999999999


Q ss_pred             ecCccccccC--------------CcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          804 DFGLSRFKAN--------------TFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       804 DFGLAr~~~~--------------t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |||+++....              .........+++.|+|||.+.+.    ..+|+|||||++|+|++|.+||...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999976541              11112234568899999998753    3489999999999999999998643

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.6e-29  Score=281.13  Aligned_cols=205  Identities=18%  Similarity=0.238  Sum_probs=174.2

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP  729 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~  729 (867)
                      .-+.+.-..|+++++||.||-++||++... .+.+|+|.+........-+..+.+|+.+|.+|+ |.+||++|++-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            445677889999999999999999999884 456888877666666677888999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+||||||= ..+|..+|.+...  .++...+..|..||+.+++++|++|  |||.||||.|+|+- .|.+||+|||+|.
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhc
Confidence            999999964 6699999987432  3443377889999999999999999  99999999999984 5699999999998


Q ss_pred             cccC--CcccccccCCCcccccccccCCCC--------------hHHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKAN--TFISSKSVAGTVVFFAAHQTACNS--------------LALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~--t~~s~~s~aGTp~YmAPEvl~~~~--------------~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .+..  +.....+-+||+.||+||.+..+.              .+|||||||+||+|+.|++||....
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            7643  344455679999999999998532              2799999999999999999998765

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=6.5e-28  Score=262.70  Aligned_cols=194  Identities=25%  Similarity=0.384  Sum_probs=164.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-~~~l~L  733 (867)
                      ..++|++.+.||.|+||.||+|..  ++..||||++.+........+.+.+|+.+++.++||||++++++|.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            347899999999999999999986  57789999887544334455678899999999999999999999865 567899


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+ +++|..++..    ..+++..+..++.||+.||+|||+.+  |+||||+|.|||++.++.+||+|||+++....
T Consensus        88 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          88 VTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             Eeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            99998 6789888864    24778888899999999999999999  99999999999999999999999999976533


Q ss_pred             CcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..   ....+++.|+|||.+.+    ...+|+||||+++|+|++|.+||..
T Consensus       161 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         161 QM---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             Cc---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            22   34467889999998754    3348999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=7e-28  Score=261.65  Aligned_cols=196  Identities=23%  Similarity=0.336  Sum_probs=161.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeC----Ce
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKR----PH  730 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~----~~  730 (867)
                      +|.+.+.||+|+||.||++...    +..||+|++..........+.+.+|+.++++++ ||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788999999999999999984    557999998754333334567889999999995 99999999875432    45


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++++|||+. ++|..++..   ...+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            789999985 689888865   335899999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcc----cccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFI----SSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~----s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......    ......||+.|+|||.+.+    ...+||||||+++|+|++|.+||...
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            543211    1234578999999998765    23489999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=3.5e-28  Score=254.18  Aligned_cols=195  Identities=24%  Similarity=0.374  Sum_probs=166.6

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |.+.+.||.|++|.||+|..  ++..+++|.+............+.+|+.++++++|+||+++++++.....+++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56678999999999999987  4778999998766544445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      ++ +|..++....  ..+++..+..++.||+.||.|||+++  |+|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            65 8888776532  35899999999999999999999999  9999999999999999999999999987765543222


Q ss_pred             cccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          819 KSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....++..|+|||.+.+.    ..+|+||||+++|+|++|..||..
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            345678899999998754    348999999999999999988854

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-28  Score=247.91  Aligned_cols=190  Identities=27%  Similarity=0.417  Sum_probs=166.8

Q ss_pred             eccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       667 LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      ||.|+||.||++.+.  ++.+|+|++....... .....+.+|+.++++++||||+++++.+.....+++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999884  7889999988765443 3567789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCC
Q 002910          744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG  823 (867)
Q Consensus       744 ~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aG  823 (867)
                      .+++....   .+++..+..++.|++.||.|||+.+  ++|+||+|.||+++.++.++|+|||++..............+
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            99997632   4889999999999999999999999  999999999999999999999999999876554333456678


Q ss_pred             CcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          824 TVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       824 Tp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +..|++||.+.+..   .+|+||||+++|+|++|..||...
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  196 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE  196 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999987654   489999999999999999998543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=3.4e-28  Score=254.13  Aligned_cols=196  Identities=23%  Similarity=0.369  Sum_probs=168.0

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |++.+.||.|.||.||+|+.  +++.+|+|++..........+.+.+|+.++++++|+||+++++++.....+++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56678899999999999988  4788999999876533444567789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS  818 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~  818 (867)
                      + ++|.+++.+..  ..+++..+..++.+++.||.|||+++  |+||||+|+||+++.++.+||+|||+++.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            7 58999998642  35899999999999999999999999  9999999999999999999999999998765433233


Q ss_pred             cccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....++..|+|||.+.+.    ..+|+||||+++|+|++|.+||...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            344667889999998654    2489999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.4e-28  Score=263.62  Aligned_cols=191  Identities=23%  Similarity=0.349  Sum_probs=161.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------e
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------H  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------~  730 (867)
                      ++|.+.+.||+|+||.||+|.+  +++.||||++............+.+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            6899999999999999999987  5788999998764433344556889999999999999999999987543      4


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+. .+|..++.     ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             EEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            699999995 47776653     24788999999999999999999999  99999999999999999999999999876


Q ss_pred             ccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....   .....+++.|+|||.+.+.    ..+|+|||||++|+|++|..||..
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         167 ADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            5332   2345678999999998653    348999999999999999999975

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=7.8e-28  Score=257.42  Aligned_cols=189  Identities=26%  Similarity=0.370  Sum_probs=163.1

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCC
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS  742 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGS  742 (867)
                      ..||+|+||.||++..  ++..||||.+....  ......+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            5699999999999987  57789999875432  2345568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccC
Q 002910          743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA  822 (867)
Q Consensus       743 L~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~a  822 (867)
                      |.+++..    ..+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|||++..............
T Consensus       104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            9998754    24788999999999999999999999  99999999999999999999999999876544333334567


Q ss_pred             CCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          823 GTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       823 GTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |++.|+|||.+.+..   .+|+||||+++|+|++|..||...
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            899999999987644   489999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-29  Score=285.43  Aligned_cols=204  Identities=27%  Similarity=0.428  Sum_probs=172.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc---Cc--eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH---GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~---g~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .-|..+++.+.++||+|+||.|++|.|+   |+  .||||+++...... .+..|++|+.+|.+|+|||+|++||++.+ 
T Consensus       105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            4566788889999999999999999994   33  38999998776544 67899999999999999999999999987 


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+.||||+++.|+|.+.|++ .....+.-.....|+.||+.||.||..++  +|||||..+||||-..-.||||||||.
T Consensus       183 qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccce
Confidence            678999999999999999998 33445777888899999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcC-CCCccccc
Q 002910          809 RFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE-SPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG-~~Pf~sl~  862 (867)
                      |-+....   ......--..-|+|||.++...+   +|+|++|++|||||++ ..||-++.
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            9764321   11112223468999999998777   7999999999999985 56766554

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.8e-29  Score=264.19  Aligned_cols=196  Identities=24%  Similarity=0.308  Sum_probs=166.3

Q ss_pred             CCeEE-EEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEee----CCe
Q 002910          659 DELHV-KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK----RPH  730 (867)
Q Consensus       659 ~dy~i-~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~----~~~  730 (867)
                      ++|.+ .++||-|--|+|-.+.+  ++..+|+|++...       ....+|+++.-+. .|||||.++++|..    ...
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            56665 46799999999999977  5778999998643       3467888886555 59999999998853    456


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGL  807 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGL  807 (867)
                      +.||||.|+||+|+..++..+ ...+.|+.+..|+.||+.|+.|||+.+  |.||||||+|+|..   .+..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence            889999999999999998755 345899999999999999999999999  99999999999985   456799999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccchhh
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLMFIV  865 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~~LV  865 (867)
                      ++...... ...+.|-||.|.|||++....+   .|+||||+++|-|++|.+||.+.+-+.
T Consensus       211 AK~t~~~~-~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a  270 (400)
T KOG0604|consen  211 AKETQEPG-DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_pred             ccccCCCc-cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence            98765433 3468899999999999987666   699999999999999999999987643

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=2.5e-27  Score=255.63  Aligned_cols=192  Identities=24%  Similarity=0.378  Sum_probs=163.3

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      |...+.||+|+||+||+|+.  .+..|++|++...... ......+.+|+.+++.++||||+++++++......|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56677899999999999987  5778999998765433 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +. |+|.+++...  ...+++..+..++.||+.||.|||++|  |+||||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            95 5777777542  235889999999999999999999999  99999999999999999999999999864322    


Q ss_pred             ccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....|+..|+|||.+..      ...+|+||||+++|+|++|..||...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            235678999999999852      22379999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=251.12  Aligned_cols=204  Identities=24%  Similarity=0.378  Sum_probs=168.9

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHh-cCCCCeeeEEeEEeeCC
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR-VRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~-LrHPNIVkl~ga~~~~~  729 (867)
                      .+++..+++.-+..||+|+||.|-+.++  +|+..|+|.+.... ..+..++.++|+.+..+ ..+|++|.|||++..++
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            3667778888899999999999977776  78899999987653 34566788899997655 56999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          730 HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~-~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .+||.||.| ..+|..+-.+ ...+..++|.-.-+||..|+.||.|||++ ..|||||+||+||||+.+|+|||||||++
T Consensus       119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccc
Confidence            999999999 4577655432 22355689999999999999999999974 23999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCC----Ch---HHHHHHHHHHHHHhcCCCCccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACN----SL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..+.++-.. ...+|...|||||.+...    .+   +||||||+++.||.+++.||.+
T Consensus       197 G~L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  197 GYLVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eeehhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            988776531 235788899999998732    23   7999999999999999888754

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=9.9e-28  Score=251.69  Aligned_cols=194  Identities=26%  Similarity=0.369  Sum_probs=163.6

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEec
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      |++.+.||.|+||+||+|..  .+..|+||.+...... .......+|+..+++++ ||||+++++.+......++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            67889999999999999998  4677999988654322 22233457899999999 99999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      + +|+|.+++.... ...+++..+..++.|++.+|.|||+++  |+|+||+|.||+++.++.++|+|||+++....... 
T Consensus        80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence            9 889998887643 235899999999999999999999999  99999999999999999999999999976544321 


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....++..|+|||++...    ..+|+||||+++|+|++|.+||..
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~  201 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG  201 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence            2345688899999988643    348999999999999999998854

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=7.9e-28  Score=249.85  Aligned_cols=198  Identities=23%  Similarity=0.358  Sum_probs=164.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecc---cchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQD---FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~---~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +|.+.+.||+|+||+||++++.  +..+++|+++.-.   ........+.+|+.++++++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788999999999999999884  3446666655422   2233445577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          735 TEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||+++++|..++... .....+++..++.++.|++.||.|||+++  |+|+||||+||+++. +.+||+|||+++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence            9999999999988642 22346899999999999999999999999  999999999999975 5799999999987654


Q ss_pred             CcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .........|++.|+|||.+.+..   .+|+||||+++|+|++|..||..
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            433334567899999999987644   38999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=9.1e-28  Score=262.51  Aligned_cols=193  Identities=23%  Similarity=0.345  Sum_probs=165.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe-----
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH-----  730 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~-----  730 (867)
                      .++|++.+.||.|+||.||+|++  .+..||||++..........+.+.+|+.+++.++||||+++++++.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            47899999999999999999998  46789999987654334455678899999999999999999988866554     


Q ss_pred             -EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          731 -LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       731 -l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                       +++||||+ +++|.+++..    ..+++..+..++.||+.||+|||+.|  |+||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccc
Confidence             89999999 7799998864    34899999999999999999999999  9999999999999999999999999997


Q ss_pred             cccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....   .....+++.|+|||.+.+    ...+||||||+++|+|++|..||..
T Consensus       167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            65432   244578899999999764    3458999999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=1.4e-27  Score=260.92  Aligned_cols=194  Identities=22%  Similarity=0.347  Sum_probs=160.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--------
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--------  728 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--------  728 (867)
                      .+|.+.+.||.|+||.||+|..  ++..||+|++.....  ...+.+.+|+.++++++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            6899999999999999999987  477899999876543  4456788999999999999999999776543        


Q ss_pred             ------CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEE
Q 002910          729 ------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVK  801 (867)
Q Consensus       729 ------~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VK  801 (867)
                            ..+++||||+. ++|.+++..    ..+++..+..++.||+.||+|||++|  |+||||||+||+++ .++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence                  35799999996 589888754    24889999999999999999999999  99999999999997 456789


Q ss_pred             EEecCccccccCCcc---cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          802 VCDFGLSRFKANTFI---SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       802 LsDFGLAr~~~~t~~---s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |+|||+++.......   ......++..|+|||.+...    ..+|||||||++|+|++|..||...
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999976533211   11233678899999987542    3489999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=1.5e-27  Score=256.54  Aligned_cols=194  Identities=24%  Similarity=0.373  Sum_probs=164.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~-~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.|...+.||.|+||.||+|+.  ++..+|+|.+..... ......++.+|+.+++.++|+||+++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4577778899999999999988  567799999875432 2345567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. |+|.+++...  ...+++..+..++.|++.||.|||+++  ++||||||+|||++.++.+||+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9996 5787776542  234789999999999999999999999  999999999999999999999999998765432 


Q ss_pred             ccccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                         ....+++.|+|||.+.+      ...+|||||||++|+|++|..||+..
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  217 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence               34578899999999742      33489999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=8.7e-29  Score=263.11  Aligned_cols=199  Identities=21%  Similarity=0.339  Sum_probs=166.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-~~~l  731 (867)
                      ..|++...||+|.||.||+|...      ...+|||.++-..-...-.....+|+.+++.++|||||.+..+|.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57888999999999999999552      2258999987663323333457899999999999999999998876 7889


Q ss_pred             EEEEeccCCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC----CcEEEEec
Q 002910          732 SIVTEYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN----WTVKVCDF  805 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~--~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~----g~VKLsDF  805 (867)
                      +|++||.+. +|+.+|+-  ......++......++.||+.|+.|||++.  |+||||||.||||..+    |.|||+||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence            999999965 88888863  333456889999999999999999999999  9999999999999877    99999999


Q ss_pred             CccccccCC---cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          806 GLSRFKANT---FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       806 GLAr~~~~t---~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ||+|...+.   ..+...+.-|.-|.|||++.+.    +..|+|+.||+..||++-.+-|..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999988764   3344566789999999999974    447999999999999998887764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=274.91  Aligned_cols=196  Identities=22%  Similarity=0.316  Sum_probs=172.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHH-H-----HHHHHHHHHHhcC---CCCeeeEEeEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQL-K-----EFLREVAIMKRVR---HPNVVLFMGAV  725 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~-k-----~f~~Ei~ILk~Lr---HPNIVkl~ga~  725 (867)
                      .+.+|..++.+|.|+||+|++|.++  ...|+||.|.+..+..+.+ +     .+-.|+.||.+|+   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4578999999999999999999984  4569999998876654322 1     2457999999998   99999999999


Q ss_pred             eeCCeEEEEEecc-CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          726 TKRPHLSIVTEYL-PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       726 ~~~~~l~LVmEy~-~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                      ++.+++||+||-- +|.+|+++|...   ..++|..+..|++||+.|+++||+.|  |||||||-+|+.++.+|.+||+|
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEee
Confidence            9999999999975 466999999863   35999999999999999999999999  99999999999999999999999


Q ss_pred             cCccccccCCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCcc
Q 002910          805 FGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       805 FGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      ||.+.+..+..  ...+.||..|.|||++.+.++    -|||+||++||.+...++||.
T Consensus       714 fgsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998765533  257899999999999999888    599999999999999999986

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=8.5e-28  Score=271.80  Aligned_cols=204  Identities=22%  Similarity=0.416  Sum_probs=172.6

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc----Cce--EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH----GSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~----g~~--VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ..++..+...+.+.||.|-||.||.|.++    |..  ||||.-+.+.. .+..+.|+.|..||+.++|||||+++|+|.
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            34566677788899999999999999873    332  78888776543 344788999999999999999999999997


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      +.+ .|||||.++-|.|..+|+.+.  ..++......++.||+.+|.|||+.+  .|||||..+|||+...-.|||+|||
T Consensus       462 e~P-~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  462 EQP-MWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             ccc-eeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence            654 899999999999999999754  35888899999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCC-cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHh-cCCCCccccc
Q 002910          807 LSRFKANT-FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSF-EESPQMRSLM  862 (867)
Q Consensus       807 LAr~~~~t-~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~-tG~~Pf~sl~  862 (867)
                      |+|++.+. ++......-..-|||||.+....+   +|||.||+++||++ .|.-||+.+.
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk  597 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK  597 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence            99998764 333344455679999999886655   79999999999875 5778888764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-28  Score=254.91  Aligned_cols=197  Identities=21%  Similarity=0.351  Sum_probs=166.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~L  733 (867)
                      .+++++.+..||.|+.|+||++++.  |...|||.+.... ..++.++++..+.++.... .|+||+++|+|.....++|
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            4577888889999999999999985  5789999987654 3456788888888877765 8999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      .||.| ..-+..++.+  ...+++|+-+-++..-++.||.||.+ ++  |||||+||+|||+|..|+|||||||++..+.
T Consensus       169 cMelM-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  169 CMELM-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHH-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee
Confidence            99998 3345566655  23468999999999999999999996 67  9999999999999999999999999998877


Q ss_pred             CCcccccccCCCcccccccccCCCCh------HHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL------ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~------SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++... ...+|.+.|||||.+.-..+      +||||||++|+|+.||..||..
T Consensus       244 dSkAh-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  244 DSKAH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             ccccc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence            65442 34489999999999985422      8999999999999999999976

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=6.9e-27  Score=241.84  Aligned_cols=176  Identities=17%  Similarity=0.158  Sum_probs=149.8

Q ss_pred             CCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHHHHH
Q 002910          670 GSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI  747 (867)
Q Consensus       670 GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L  747 (867)
                      |.||+||++++  +++.||+|.+....       .+.+|...+....||||+++++++......++||||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            89999999988  57789999987643       2234455555667999999999999999999999999999999998


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCccc
Q 002910          748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF  827 (867)
Q Consensus       748 ~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~Y  827 (867)
                      .+.   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||+++......   ....++..|
T Consensus        77 ~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y  148 (237)
T cd05576          77 SKF---LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMY  148 (237)
T ss_pred             HHh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccc
Confidence            763   24889999999999999999999999  9999999999999999999999999887655432   344667889


Q ss_pred             ccccccCCCC---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          828 FAAHQTACNS---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       828 mAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +|||.+....   .+|+||+|+++|+|++|..|+..
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            9999987544   48999999999999999987653

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=268.27  Aligned_cols=200  Identities=22%  Similarity=0.332  Sum_probs=170.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-----HHHHHHHHHHHHHHhcCCCCeeeEEeEEee-CC
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-----DQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RP  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-----~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-~~  729 (867)
                      -++|.++.+||+|+|+.||+|.+  ..+.||||+-....-..     ...+..++|..|.+.|.||.||++|++|.- ..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            47888899999999999999976  56779999876543322     234567899999999999999999999974 45


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFG  806 (867)
                      ..|-|+|||+|.+|..+|+.   .+.++++.++.|+.||+.||.||....+||||.||||.||||-   ..|.+||+|||
T Consensus       542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            68999999999999999987   3469999999999999999999999999999999999999994   46889999999


Q ss_pred             ccccccCCcc-------cccccCCCcccccccccCCC--C-----hHHHHHHHHHHHHHhcCCCCccc
Q 002910          807 LSRFKANTFI-------SSKSVAGTVVFFAAHQTACN--S-----LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       807 LAr~~~~t~~-------s~~s~aGTp~YmAPEvl~~~--~-----~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      |++.+.+...       .....+||.-|++||.+.-+  +     +.||||+|+++|..+.|+-||..
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            9998865322       23456999999999998854  1     26999999999999999999964

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.94  E-value=5.9e-29  Score=260.17  Aligned_cols=204  Identities=25%  Similarity=0.353  Sum_probs=167.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHH-HHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~I-Lk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +++..++++-+..||.|+||+|++-.+  .|+..|||.++.... .+..++++.|... |+.-..||||+|||++..++.
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence            345557777788899999999999988  477899999987654 4556788888886 555579999999999999999


Q ss_pred             EEEEEeccCCCCHHHH---HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          731 LSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~---L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      .||.||+| ..+|..+   ++.- ....++|.-.-.++..++.||+||.+ .+  |||||+||+|||||..|.|||||||
T Consensus       138 cWiCMELM-d~SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFG  213 (361)
T KOG1006|consen  138 CWICMELM-DISLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFG  213 (361)
T ss_pred             eeeeHHHH-hhhHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeeccc
Confidence            99999999 4455443   3321 13358888888898899999999986 55  9999999999999999999999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCCh-----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSL-----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~-----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      +|..+.++... ...+|...|||||.+.....     +|+||||++|||+.||..||+.-.-
T Consensus       214 IcGqLv~SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  214 ICGQLVDSIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             chHhHHHHHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence            99888776543 34588899999999985443     8999999999999999999986543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=1.7e-26  Score=285.00  Aligned_cols=184  Identities=17%  Similarity=0.307  Sum_probs=154.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ..+...+.||+|+||.||+|++  .+..||||.+......      ...|+++|++++|||||+++++|......++|||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            3456677899999999999986  5788999988643311      1245889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |+++|+|.++++.      +++..+..++.||+.||+|||.. .+.|+||||||+||+++.++..++. ||+....... 
T Consensus       764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            9999999999963      78999999999999999999943 2339999999999999999888876 7765443221 


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                         ....+|+.|||||++.+..+   +|||||||++|||++|+.||.
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence               23478999999999887554   799999999999999999974

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=3.4e-27  Score=282.94  Aligned_cols=192  Identities=28%  Similarity=0.412  Sum_probs=160.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--------  727 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--------  727 (867)
                      ..+|+.++.||+|+||.||+++.  +|+.||||.|.... .......+.+|+..|.+|+|||||+++.+|.+        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            36788889999999999999987  79999999998776 66677889999999999999999999854410        


Q ss_pred             --------------------------------------------------------------------------------
Q 002910          728 --------------------------------------------------------------------------------  727 (867)
Q Consensus       728 --------------------------------------------------------------------------------  727 (867)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 002910          728 -----------------------R--------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH  776 (867)
Q Consensus       728 -----------------------~--------~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLH  776 (867)
                                             +        -.+||-||||+...|.++++++....  .....++++++|++||.|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                   0        12689999999999999988744211  56788999999999999999


Q ss_pred             hcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc---------C--------C-cccccccCCCcccccccccCCCC-
Q 002910          777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---------N--------T-FISSKSVAGTVVFFAAHQTACNS-  837 (867)
Q Consensus       777 s~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~---------~--------t-~~s~~s~aGTp~YmAPEvl~~~~-  837 (867)
                      +.|  ||||||||.||+|+.++.|||+|||++....         .        . .....+.+||.-|+|||++.+.. 
T Consensus       715 ~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 DQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             hCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            999  9999999999999999999999999998611         0        0 11234569999999999988654 


Q ss_pred             -----hHHHHHHHHHHHHHhcC
Q 002910          838 -----LALIFSLSGWLQSSFEE  854 (867)
Q Consensus       838 -----~SDIwSLG~lLyeM~tG  854 (867)
                           ++|+||||++++||+..
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~yP  814 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLYP  814 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhcc
Confidence                 38999999999999974

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-26  Score=269.91  Aligned_cols=205  Identities=28%  Similarity=0.471  Sum_probs=173.2

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~  722 (867)
                      .|++..+++.+.+.||.|.||+|++|...         ...||||.++..... .+.+.+..|+++|+.+. |+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            68889999999999999999999999752         235999998866544 67788999999999985 99999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPA-------A----G--EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~-------~----~--~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      |+|+..+.+++|+||+..|+|..+|+...       .    .  ..+.....+.++.||+.||+||++..  +|||||..
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa  446 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA  446 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence            99999999999999999999999998744       0    0  13788899999999999999999988  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCC-cccccccCC--CcccccccccCCCCh---HHHHHHHHHHHHHhcC-CCCccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANT-FISSKSVAG--TVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE-SPQMRS  860 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t-~~s~~s~aG--Tp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG-~~Pf~s  860 (867)
                      +||||.++..+||+||||+|...+. ....+...|  ...|||||.+....+   +||||+|++|||||+- ..||..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999999964432 232233343  345999999998555   7999999999999985 467664

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=4e-25  Score=221.75  Aligned_cols=195  Identities=31%  Similarity=0.478  Sum_probs=167.1

Q ss_pred             eEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |.+.+.||.|++|.||++...  +..+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            567889999999999999984  578999998865433 24677889999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc-cc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-IS  817 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~-~s  817 (867)
                      ++++|.+++.....  .+++.....++.+++.+|.|||+++  ++|+||+|.||+++.++.++|+|||++....... ..
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            99999999976331  1788999999999999999999998  9999999999999999999999999988765432 12


Q ss_pred             ccccCCCcccccccccC-C---CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          818 SKSVAGTVVFFAAHQTA-C---NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~-~---~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....++..|++||.+. .   ...+|+|+||+++++|++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            23457888999999983 2   2248999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.4e-25  Score=257.72  Aligned_cols=203  Identities=17%  Similarity=0.204  Sum_probs=152.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE------------------cCceEEEEEEeecccch--H----------HHHHHHH
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW------------------HGSDVAVKVLTVQDFLD--D----------QLKEFLR  705 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~------------------~g~~VAVKvi~~~~~~~--~----------~~k~f~~  705 (867)
                      +..++|.+.++||+|+||+||+|.+                  .++.||||.+.......  +          ..+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            4678999999999999999999964                  24569999986532110  0          0122345


Q ss_pred             HHHHHHhcCCCCe-----eeEEeEEee--------CCeEEEEEeccCCCCHHHHHhcCCC--------------------
Q 002910          706 EVAIMKRVRHPNV-----VLFMGAVTK--------RPHLSIVTEYLPRGSLYRLIHRPAA--------------------  752 (867)
Q Consensus       706 Ei~ILk~LrHPNI-----Vkl~ga~~~--------~~~l~LVmEy~~gGSL~~~L~~~~~--------------------  752 (867)
                      |+.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777776654     667777653        3568999999999999999874210                    


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc-cccccCCCcccccc
Q 002910          753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI-SSKSVAGTVVFFAA  830 (867)
Q Consensus       753 -~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~-s~~s~aGTp~YmAP  830 (867)
                       ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++....... ......+|+.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             112456778889999999999999999  99999999999999999999999999976533211 11223458999999


Q ss_pred             cccCCCC-------------------------hHHHHHHHHHHHHHhcCCC-Cccc
Q 002910          831 HQTACNS-------------------------LALIFSLSGWLQSSFEESP-QMRS  860 (867)
Q Consensus       831 Evl~~~~-------------------------~SDIwSLG~lLyeM~tG~~-Pf~s  860 (867)
                      |.+....                         ..|+||+||++|+|+++.. |+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            9976321                         2599999999999999875 6643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=1.6e-25  Score=267.70  Aligned_cols=185  Identities=24%  Similarity=0.358  Sum_probs=161.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +++|.+.+.||.|+||+||+|.+.  ++.||||++...... ......+.+|+.++..++||||+++++++.....+|||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            578999999999999999999985  788999999865543 34456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+.+++|..++...   ..+++..++.++.||+.||.|||.++  ||||||||+||||+.++.+||+|||+++.....
T Consensus        83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~  157 (669)
T cd05610          83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR  157 (669)
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence            9999999999999763   34788999999999999999999999  999999999999999999999999999987665


Q ss_pred             cccccccCCCcccccccccCCCCh----HHHHHHHHH
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGW  847 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~l  847 (867)
                      ........+|+.|++||.......    +++|++|..
T Consensus       158 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~  194 (669)
T cd05610         158 ELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN  194 (669)
T ss_pred             cccccccccCccccCccccccCCCCceeeeeeecCcC
Confidence            555566789999999998765443    677888743

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=229.91  Aligned_cols=194  Identities=23%  Similarity=0.345  Sum_probs=166.0

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .|...++||+|.||+||+|+.  ++..||+|.++.++-.+..-...++|+-+++.++|.|||+++++......+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455677899999999999987  466799999988765554456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      | ..+|..+....  .+.++...+..++.|+++||.|+|+++  +.||||||.|+||+.+|.+|++||||+|.+.-....
T Consensus        83 c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   83 C-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             h-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            9 55788887653  346899999999999999999999999  999999999999999999999999999987765433


Q ss_pred             ccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQM  858 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf  858 (867)
                      .....-|.-|.+|.++.+...    .|+||-||++.|+....-|.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence            445577889999999987654    59999999999998654443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=1.2e-25  Score=263.90  Aligned_cols=197  Identities=16%  Similarity=0.159  Sum_probs=141.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeE----
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA----  724 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga----  724 (867)
                      ....++|.+.+.||+|+||+||+|.+.      +..||||.+......    +.+..|  .++...+.+++.++..    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            346689999999999999999999884      567999987643211    111111  1222222333322222    


Q ss_pred             --EeeCCeEEEEEeccCCCCHHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcccc
Q 002910          725 --VTKRPHLSIVTEYLPRGSLYRLIHRPAAG-----------------EMMDQRRRLRMALDVAKGINYLHNLNPPILHW  785 (867)
Q Consensus       725 --~~~~~~l~LVmEy~~gGSL~~~L~~~~~~-----------------~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHR  785 (867)
                        ......++|||||+.+++|.++++.....                 ....+..+..++.||+.||.|||+++  |+||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR  279 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR  279 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence              24556799999999999999998753210                 01123345678999999999999999  9999


Q ss_pred             CCCCCcEEEcC-CCcEEEEecCccccccCC-cccccccCCCcccccccccCCCC-------------------------h
Q 002910          786 DLKSPNLLVDK-NWTVKVCDFGLSRFKANT-FISSKSVAGTVVFFAAHQTACNS-------------------------L  838 (867)
Q Consensus       786 DLKPeNILLd~-~g~VKLsDFGLAr~~~~t-~~s~~s~aGTp~YmAPEvl~~~~-------------------------~  838 (867)
                      ||||+|||++. ++.+||+|||+++..... .......++|+.|||||.+....                         .
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999985 689999999999865322 22335678999999999764321                         2


Q ss_pred             HHHHHHHHHHHHHhcCCCCcc
Q 002910          839 ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       839 SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      +|||||||+||+|+++..++.
T Consensus       360 ~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCc
Confidence            499999999999998766543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.2e-26  Score=260.35  Aligned_cols=190  Identities=23%  Similarity=0.298  Sum_probs=161.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..+.|.+...+|.|+|+.|..+.+  +++..++|++.+..      ....+|+.++... .||||+++.+.+....+.|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence            357888888999999999999987  57789999998762      1234567666665 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE-cCCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-DKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL-d~~g~VKLsDFGLAr~~~  812 (867)
                      |||++.|+.+.+-+....    .....+..|+++|+.++.|||.+|  ||||||||+|||+ +..|+++|+|||.++...
T Consensus       394 v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999998887776532    223677789999999999999999  9999999999999 699999999999998776


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..   ..+.|-|..|.|||++...++   +||||||++||+|++|..||...
T Consensus       468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~  516 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH  516 (612)
T ss_pred             hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence            65   245688999999999996555   79999999999999999999753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.92  E-value=1.1e-24  Score=219.34  Aligned_cols=183  Identities=28%  Similarity=0.439  Sum_probs=159.5

Q ss_pred             CceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHHHHHh
Q 002910          671 SFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH  748 (867)
Q Consensus       671 sFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~  748 (867)
                      +||.||+|.+.  +..+|+|++........ .+.+.+|+.++++++|+||+++++.+......+++|||+.+++|..++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999984  58899999876543322 5788999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCcccc
Q 002910          749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFF  828 (867)
Q Consensus       749 ~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~Ym  828 (867)
                      ...   .+++..++.++.+++.+|.|||+.+  |+|+||+|.||+++.++.++|+|||++....... ......+++.|+
T Consensus        80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  153 (244)
T smart00220       80 KRG---RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM  153 (244)
T ss_pred             hcc---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence            633   2789999999999999999999999  9999999999999999999999999998765432 234567889999


Q ss_pred             cccccCCC---ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          829 AAHQTACN---SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       829 APEvl~~~---~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +||.+.+.   ..+|||+||+++|+|++|..||..
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99988743   348999999999999999999866

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.92  E-value=4.1e-26  Score=248.52  Aligned_cols=198  Identities=21%  Similarity=0.312  Sum_probs=168.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCC--C----CeeeEEeEEe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH--P----NVVLFMGAVT  726 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH--P----NIVkl~ga~~  726 (867)
                      ++..++|.+...+|+|.||+|-.+.++  +..||||+++.-   .+..+..+-|+++|.++.+  |    -+|++.++|.
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            344689999999999999999999774  567999998743   3555667889999999943  2    3788889999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-----------
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-----------  795 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-----------  795 (867)
                      -.++.|||+|.+ |-+++++|..++ -..++..+++.|+.|++.+++|||+.+  ++|-||||+|||+-           
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccC
Confidence            999999999988 779999998755 345888999999999999999999999  99999999999982           


Q ss_pred             ---------CCCcEEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          796 ---------KNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       796 ---------~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                               ++-.|||+|||.++......   .+...|-.|.|||++.+-.|   +||||+||+|+|+++|..-|++.-
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                     13469999999998765443   57788999999999999888   699999999999999999888653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=258.60  Aligned_cols=197  Identities=26%  Similarity=0.420  Sum_probs=165.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ..++..++||+|+||+||+|.|  +|.    +||||++.... ..+...+++.|+-+|.+|.|||++++++++.... +.
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            3456678999999999999999  333    58999987554 3344678999999999999999999999998766 88


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||++||+.|.|.++++..  +..+..+..+.|..||++||.|||.+.  +|||||..+||||.+-.+|||+|||+++.+.
T Consensus       774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999999999999874  345888899999999999999999999  9999999999999999999999999999875


Q ss_pred             CCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....  ......-.+-|||-|.++...+   +||||||+++||++| |.-||..+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi  904 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI  904 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence            4332  2233344679999999997766   799999999999877 45666654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-26  Score=261.26  Aligned_cols=198  Identities=30%  Similarity=0.459  Sum_probs=177.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|.++.++|.|+||.||+|++  .+...|+|+++...  .+.++-+..|+-+++.++|||||.+++.+.....+||+|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            47899999999999999999988  57789999998653  344556778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |||.+|+|.++-+-   ...+.+.++.++.++.++||+|||+.|  -+|||||-.|||++..|.||++|||.+..+..+-
T Consensus        92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999999998775   446999999999999999999999999  9999999999999999999999999999888888


Q ss_pred             ccccccCCCcccccccccC------CCChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTA------CNSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~------~~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...+++.|||.|||||+..      .+..+|||++|++..|+-.-.+|.+.++
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh  219 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH  219 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence            8889999999999999965      2444899999999999988778777654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-26  Score=241.68  Aligned_cols=193  Identities=25%  Similarity=0.363  Sum_probs=159.1

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----eEEEEEec
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLSIVTEY  737 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-----~l~LVmEy  737 (867)
                      +.||.|+||+||.+.+  .|+.||+|.+..-.-.....+++.+|+++|.-.+|.|++..++..+-..     .+|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            4599999999999987  6888999988755444455678899999999999999999988776543     36889998


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc-c
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-I  816 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~-~  816 (867)
                      | ..+|..+|-.+.   .++...+.-+..||++||+|||+.+  |.||||||.|+|++.+..+|||||||+|...... .
T Consensus       139 m-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  139 M-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             H-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            8 568888887643   4888888889999999999999999  9999999999999999999999999999654321 2


Q ss_pred             cccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      ......-|..|.|||++++...    .||||.||++.|++..+.-|+--+.
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            2233456889999999997543    6999999999999988877775443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.2e-26  Score=239.39  Aligned_cols=199  Identities=22%  Similarity=0.337  Sum_probs=159.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--------C
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--------R  728 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--------~  728 (867)
                      +.|....+||+|.||+||+|+.  .|+.||+|++....-....-...++|+.+|..|+|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            5667778899999999999987  46678888654322112222345789999999999999998877743        2


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+|+||.+|+. +|.-+|....  ..++..++.+++.+++.||.|+|+..  |+|||+|++|+||+++|.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence            358999999955 7888886532  35888999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCccc----ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          809 RFKANTFIS----SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s----~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      |.+......    .....-|.-|..||.+.+.    +..|||.-||++.+||++.+-|+.-.
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            876433221    1233558999999999963    34799999999999999999888654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.91  E-value=3e-23  Score=202.37  Aligned_cols=180  Identities=36%  Similarity=0.558  Sum_probs=156.1

Q ss_pred             eccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHH
Q 002910          667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY  744 (867)
Q Consensus       667 LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~  744 (867)
                      ||.|.+|.||++...  +..+++|++....... ....+.+|+.+++.++|++|+++++++......+++|||+.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999996  8889999987654322 3567899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCccccccCCcccccccCC
Q 002910          745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAG  823 (867)
Q Consensus       745 ~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~~~t~~s~~s~aG  823 (867)
                      .++....  ..+++..+..++.+++.+|.|||+.+  ++|+||+|.||+++. .+.++|+|||++..............+
T Consensus        80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            9997632  34789999999999999999999999  999999999999999 899999999999866544312344568


Q ss_pred             CcccccccccCCC----ChHHHHHHHHHHHHH
Q 002910          824 TVVFFAAHQTACN----SLALIFSLSGWLQSS  851 (867)
Q Consensus       824 Tp~YmAPEvl~~~----~~SDIwSLG~lLyeM  851 (867)
                      ...|++||.+...    ..+|+|+||+++++|
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            8999999998765    448999999999988

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=6.3e-25  Score=245.16  Aligned_cols=200  Identities=22%  Similarity=0.285  Sum_probs=169.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC------CCeeeEEeEEe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH------PNVVLFMGAVT  726 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH------PNIVkl~ga~~  726 (867)
                      ++.-..|.+....|+|-|++|.+|..  .|..||||+|....+   -.+.=++|++||++|..      -|+++|+..|.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            34447899999999999999999988  577999999987542   22345789999999953      37999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEec
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDF  805 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDF  805 (867)
                      ..+++|||+|-+ ..+|..+|++.+....+....+..|+.|+..||..|...|  |+|.||||.||||+..- .+|||||
T Consensus       505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence            999999999988 6699999998776667888899999999999999999999  99999999999998654 5699999


Q ss_pred             CccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          806 GLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       806 GLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      |.|........  ....-+-.|.|||++.+.++   .|+||.||+|||+|||+..|.+-+
T Consensus       582 GSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  582 GSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            99977655433  22334557999999999988   599999999999999998887643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.90  E-value=9.6e-25  Score=254.76  Aligned_cols=190  Identities=31%  Similarity=0.398  Sum_probs=153.5

Q ss_pred             EEEeccCCceE-EEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          664 KERVGAGSFGT-VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       664 ~e~LG~GsFG~-VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .+.+|.|+-|+ ||+|...|+.||||.+-.     ....-..+|+..|+.-. |||||++|+.=+++..+||..|.| ..
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             HHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            45688999876 799999999999997643     23344578999998875 999999999999999999999999 67


Q ss_pred             CHHHHHhcCCCCCCCCH-HHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---C--CcEEEEecCccccccC--
Q 002910          742 SLYRLIHRPAAGEMMDQ-RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---N--WTVKVCDFGLSRFKAN--  813 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e-~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~--g~VKLsDFGLAr~~~~--  813 (867)
                      +|.+++........... ...+....|++.||+|||+.+  ||||||||.||||+.   +  ..++|+|||+|+.+..  
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999987311111111 334667899999999999999  999999999999976   3  4689999999997643  


Q ss_pred             -CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcC-CCCcccc
Q 002910          814 -TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE-SPQMRSL  861 (867)
Q Consensus       814 -t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG-~~Pf~sl  861 (867)
                       .+....+..||-+|+|||+++....   +|||||||++|+.++| .+||...
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence             2333457799999999999996544   7999999999988877 8999754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=228.78  Aligned_cols=191  Identities=21%  Similarity=0.334  Sum_probs=157.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcC--ceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEe-EEeeCCeEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMG-AVTKRPHLSI  733 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~g--~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~g-a~~~~~~l~L  733 (867)
                      .+.|.|.+.||+|.||++-++++++  +.+++|.+....   -..++|.+|...--.|. |.||+.-|+ +|++.+.+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            3789999999999999999999964  568999887654   23456788877655554 889998775 5888999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc--CCCcEEEEecCccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFK  811 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd--~~g~VKLsDFGLAr~~  811 (867)
                      +|||++.|+|..-+...    .+-|.-..+++.|+++||.|||+.+  +||||||.+||||-  +...|||||||+.+..
T Consensus       100 ~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999999888653    3778888999999999999999999  99999999999993  4458999999999877


Q ss_pred             cCCcccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +.+..   ..--+..|.+||+...        .+.+|||.||+++|..+||.+||+.
T Consensus       174 g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  174 GTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             Cceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            66542   3344667999988653        3347999999999999999999984

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=8e-23  Score=228.20  Aligned_cols=164  Identities=18%  Similarity=0.115  Sum_probs=129.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE---cCceEEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeee-EEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVL-FMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~---~g~~VAVKvi~~~~~---~~~~~k~f~~Ei~ILk~LrHPNIVk-l~ga~~~~  728 (867)
                      ...++|.+.+.||+|+||+||+|.+   +++.+|||++.....   .....+.+.+|+++|++++|+||+. +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            3447899999999999999999987   356689998753311   1234566899999999999999985 4432    


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCC-CCCcEEEcCCCcEEEEecCc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL-KSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDL-KPeNILLd~~g~VKLsDFGL  807 (867)
                      +..||||||++|++|.. +..      ..   ...++.+++.+|.|||++|  |+|||| ||+|||++.++.+||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            46899999999999973 211      11   1357889999999999999  999999 99999999999999999999


Q ss_pred             cccccCCccc--------ccccCCCcccccccccCC
Q 002910          808 SRFKANTFIS--------SKSVAGTVVFFAAHQTAC  835 (867)
Q Consensus       808 Ar~~~~t~~s--------~~s~aGTp~YmAPEvl~~  835 (867)
                      |+........        -....+++.|+|||.+.-
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9865443211        135678889999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=225.13  Aligned_cols=129  Identities=29%  Similarity=0.405  Sum_probs=110.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-----C---CCeeeEEeEEee-
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----H---PNVVLFMGAVTK-  727 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-----H---PNIVkl~ga~~~-  727 (867)
                      .+|.+.++||.|.|++||+|.+  ..+.||+|+.+...   ...+..+.||++|++++     |   .+||+|++.|.. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            7999999999999999999987  46679999987543   34456788999999984     3   369999999975 


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEE
Q 002910          728 ---RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLV  794 (867)
Q Consensus       728 ---~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILL  794 (867)
                         ..++|||+|++ |.+|..+|...+.. .++...+..|++||+.||.|||. .|  |||-||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence               34799999999 88999999876643 48889999999999999999996 66  9999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=6e-24  Score=218.95  Aligned_cols=190  Identities=19%  Similarity=0.342  Sum_probs=158.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC--eE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP--HL  731 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~--~l  731 (867)
                      ..++|++.+++|+|.|++||.|..  +...++||+++.-     ..+.+.+|+.||..|+ ||||+++++.+.++.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            458999999999999999999985  6778999998753     3567899999999998 999999999997654  57


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCcccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF  810 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLAr~  810 (867)
                      .||+||+++.+...+...      +....+..++.+++.||.|||+.|  |.|||+||.|++||.. -.++|+|+|||.+
T Consensus       111 aLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhh
Confidence            899999988887765532      777888999999999999999999  9999999999999864 5689999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .+... .-+....+-.|--||++.+-..    -|+|||||+|..|...+.||..
T Consensus       183 YHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh  235 (338)
T KOG0668|consen  183 YHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  235 (338)
T ss_pred             cCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence            65321 1233455667788999887544    4999999999999888877764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=225.63  Aligned_cols=192  Identities=23%  Similarity=0.289  Sum_probs=162.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------e
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------H  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------~  730 (867)
                      .+|.-+..+|.|.- .|..|.+  .++.||+|............++..+|..+|..+.|+||++++.+|+-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46677778898888 6666655  6888999988765333345677889999999999999999999997543      4


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||| ..+|...++-     .++-++..++..|+++|+.|||+.|  |+||||||+||++..+..+||+|||+++.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcc
Confidence            79999999 6688888862     4788899999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .... ........|-.|.|||++.+..+   +||||+||++.+|.+|+..|.+
T Consensus       168 e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  168 EDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             cCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            6555 34456688899999999997666   7999999999999999988774

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1e-21  Score=199.50  Aligned_cols=198  Identities=27%  Similarity=0.397  Sum_probs=169.6

Q ss_pred             eEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchH-HHHHHHHHHHHHHhcCCC-CeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHP-NVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~LrHP-NIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      |.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+.+++.+......+++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            678899999999999999988 7789999987765543 677899999999999988 7999999998888889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCccccccCCcc-
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKANTFI-  816 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~~~t~~-  816 (867)
                      .++++..++........+.......++.|++.++.|+|+.+  ++|||+||+||+++..+ .++++|||+++....... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            99999977765321125889999999999999999999999  99999999999999988 799999999985544321 


Q ss_pred             -----cccccCCCcccccccccCCC---Ch---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 -----SSKSVAGTVVFFAAHQTACN---SL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 -----s~~s~aGTp~YmAPEvl~~~---~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                           ......||..|+|||.+.+.   ..   .|+|++|+++++++.|..||...
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence                 24677999999999998863   22   79999999999999999996554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=6.1e-20  Score=201.06  Aligned_cols=197  Identities=20%  Similarity=0.219  Sum_probs=160.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCc---eEEEEEEeecccchHHHHHHHHHHHHHHhcCC----CCeeeEEeEE-eeCCeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWHGS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH----PNVVLFMGAV-TKRPHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~g~---~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH----PNIVkl~ga~-~~~~~l  731 (867)
                      .|.+.+.||+|+||.||.+.....   .+|+|+.........  ..+..|+.+|..+..    +++..+++.. .....-
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            899999999999999999987543   588888765432211  156778888888873    5888999888 577789


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-----CcEEEEecC
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-----WTVKVCDFG  806 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-----g~VKLsDFG  806 (867)
                      +|||+.+ |.+|.++..... ...++....+.++.|++.+|++||+.|  ++||||||.|+++...     -.+.|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999988 999999886544 456899999999999999999999999  9999999999999765     469999999


Q ss_pred             ccc--cccCCc------cc--ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          807 LSR--FKANTF------IS--SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       807 LAr--~~~~t~------~s--~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +++  ......      ..  ...+.||..|+++.+..+.+.   .|+||++-++.+++.|..||..+.
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            998  322111      10  124569999999999998666   699999999999999999987665

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.83  E-value=6.9e-21  Score=207.80  Aligned_cols=208  Identities=18%  Similarity=0.267  Sum_probs=169.4

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcCc-------eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG  723 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~-------~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~g  723 (867)
                      ..++.+...++++...+.+|.||.||+|.|...       .|-+|.++. ..+.-++..++.|.-.+..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            445667778899999999999999999988432       355665542 334456677899999999999999999999


Q ss_pred             EEee-CCeEEEEEeccCCCCHHHHHh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          724 AVTK-RPHLSIVTEYLPRGSLYRLIH-----RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       724 a~~~-~~~l~LVmEy~~gGSL~~~L~-----~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      ++.. ....+.++.++.-|+|..+|.     +......+...+...|+.|++.||+|||+++  |||.||..+|++||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh
Confidence            8754 456788999999999999998     5555556788889999999999999999999  9999999999999999


Q ss_pred             CcEEEEecCcccccc--CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          798 WTVKVCDFGLSRFKA--NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       798 g~VKLsDFGLAr~~~--~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      -.|||+|=.|+|.+-  +........-....||+||.+.+..+   +|+||||++||||+| |..||-..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI  502 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI  502 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence            999999999999753  22233334455679999999998777   799999999999976 55666543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.82  E-value=7.7e-21  Score=231.28  Aligned_cols=146  Identities=14%  Similarity=0.132  Sum_probs=111.4

Q ss_pred             HhcCC-CCeeeEEeEE-------eeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 002910          711 KRVRH-PNVVLFMGAV-------TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI  782 (867)
Q Consensus       711 k~LrH-PNIVkl~ga~-------~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~I  782 (867)
                      +.++| +||++++++|       .....++++|||+ +++|+++|...  ...+++..++.++.||+.||+|||++|  |
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--I  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--I  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence            34556 5777888877       2334577889987 67999999753  345899999999999999999999999  9


Q ss_pred             cccCCCCCcEEEcCC-------------------CcEEEEecCccccccCCc----------------ccccccCCCccc
Q 002910          783 LHWDLKSPNLLVDKN-------------------WTVKVCDFGLSRFKANTF----------------ISSKSVAGTVVF  827 (867)
Q Consensus       783 VHRDLKPeNILLd~~-------------------g~VKLsDFGLAr~~~~t~----------------~s~~s~aGTp~Y  827 (867)
                      |||||||+||||+..                   +.+||+|||+++......                ......+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   455666666665321100                001124688999


Q ss_pred             ccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          828 FAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       828 mAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||||++.+..+   +|||||||+||||++|.+|+...
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            99999987555   79999999999999999988654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=7.6e-20  Score=196.83  Aligned_cols=195  Identities=18%  Similarity=0.256  Sum_probs=167.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVm  735 (867)
                      -.|.++++||.|+||+++.|+.  ++..||||.-....    ..-.+.-|.+..+.|. .++|...|.+-+...+-.|||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            5799999999999999999976  89999999754432    1224556777777775 689999999988888999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-----CCcEEEEecCcccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFGLSRF  810 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-----~g~VKLsDFGLAr~  810 (867)
                      |++ |-+|.+++.-  ++..++.+....+|.|++.-++|+|++.  +|+|||||+|+||..     ...|.|+|||+++.
T Consensus       104 dLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            998 8899998876  4567999999999999999999999999  999999999999953     34689999999997


Q ss_pred             ccC-------CcccccccCCCcccccccccCCCChH---HHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KAN-------TFISSKSVAGTVVFFAAHQTACNSLA---LIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~-------t~~s~~s~aGTp~YmAPEvl~~~~~S---DIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..+       .+...++..||..||+-....+.+.+   |.=|||.++.+++-|..||++|.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            644       34556788999999999999998885   99999999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=5e-20  Score=188.07  Aligned_cols=142  Identities=15%  Similarity=0.163  Sum_probs=107.8

Q ss_pred             EEEeccCCceEEEEEEE-cCceEEEEEEeecccchHH------------------------HHHHHHHHHHHHhcCCCCe
Q 002910          664 KERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQ------------------------LKEFLREVAIMKRVRHPNV  718 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~------------------------~k~f~~Ei~ILk~LrHPNI  718 (867)
                      ...||+|+||.||+|.. +|+.||||+++........                        .....+|+.+|.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999987 5889999999865321110                        1122459999999988776


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCccccCCCCCcEEEcCC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL-HNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YL-Hs~gp~IVHRDLKPeNILLd~~  797 (867)
                      ....... .. ..+|||||++++++...+..   ...+++..+..++.|++.+|.|| |+.|  |+||||||+|||++ +
T Consensus        82 ~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPIL-LK-SHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEE-ec-CCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence            4332222 22 23899999998877654322   23478899999999999999999 7999  99999999999998 4


Q ss_pred             CcEEEEecCccccccC
Q 002910          798 WTVKVCDFGLSRFKAN  813 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~  813 (867)
                      +.++|+|||++....+
T Consensus       154 ~~v~LiDFG~a~~~~~  169 (190)
T cd05147         154 GKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CcEEEEEccccccCCC
Confidence            7899999999865433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.7e-21  Score=223.60  Aligned_cols=185  Identities=24%  Similarity=0.258  Sum_probs=160.8

Q ss_pred             eccCCceEEEEEE-----EcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          667 VGAGSFGTVHRAE-----WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       667 LG~GsFG~VykA~-----~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +|+|+||+|++++     ..+.-+|+|++++.............|..++..++ ||++|++..+|+.+..++++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999999764     35667999999877654433336678889999988 99999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|+..+...   ..+.+.....+...++.+++++|+.+  |+|||+|++||+++.+|++|+.|||+++.......    
T Consensus        82 g~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   82 GDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             chhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            9999887753   34677777778889999999999999  99999999999999999999999999988765433    


Q ss_pred             cCCCcccccccccC-CCChHHHHHHHHHHHHHhcCCCCccc
Q 002910          821 VAGTVVFFAAHQTA-CNSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       821 ~aGTp~YmAPEvl~-~~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .|||.+|||||++. +....|+||||+++++|++|..||++
T Consensus       153 ~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence            29999999999999 45558999999999999999999987

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.81  E-value=1.5e-20  Score=207.40  Aligned_cols=191  Identities=21%  Similarity=0.273  Sum_probs=158.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~  732 (867)
                      +.|.+.++||.|+|++||+|..     ....||+|.+....    ....+.+|+++|..+. +.||+.+.+++..++.+.
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            6788899999999999999975     34569999886432    3446889999999996 899999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~  811 (867)
                      +||||++.....++...      ++-..+..+++.++.||.++|.+|  ||||||||.|+|.+. .+.-.|+||||+...
T Consensus       112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence            99999999988888764      667888899999999999999999  999999999999975 466799999998620


Q ss_pred             c-----------------C------------------Cc---------ccccccCCCcccccccccCCCC----hHHHHH
Q 002910          812 A-----------------N------------------TF---------ISSKSVAGTVVFFAAHQTACNS----LALIFS  843 (867)
Q Consensus       812 ~-----------------~------------------t~---------~s~~s~aGTp~YmAPEvl~~~~----~SDIwS  843 (867)
                      .                 .                  .+         ...-..+||++|.|||++...+    ..||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            0                 0                  00         0012448999999999988543    379999


Q ss_pred             HHHHHHHHhcCCCCcccc
Q 002910          844 LSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       844 LG~lLyeM~tG~~Pf~sl  861 (867)
                      -|+++..++++..||...
T Consensus       264 ~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             ccceeehhhccccccccC
Confidence            999999999999998643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=3.1e-19  Score=181.21  Aligned_cols=141  Identities=16%  Similarity=0.156  Sum_probs=110.2

Q ss_pred             EEEeccCCceEEEEEEE-cCceEEEEEEeecccch----------------------HH--HHHHHHHHHHHHhcCCCCe
Q 002910          664 KERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD----------------------DQ--LKEFLREVAIMKRVRHPNV  718 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~----------------------~~--~k~f~~Ei~ILk~LrHPNI  718 (867)
                      ...||+|+||+||+|.. +|+.||||++.......                      ..  ...+.+|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999987 58999999998653210                      00  1224578999999999987


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRL-IHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~-L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~  796 (867)
                      .....+....  .+|||||++|+++... +..    ..++......++.|++.+|.+||. .|  |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-
Confidence            5443333222  4899999998855433 332    246788889999999999999999 99  99999999999998 


Q ss_pred             CCcEEEEecCccccccC
Q 002910          797 NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~  813 (867)
                      ++.++|+|||+++....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.2e-19  Score=184.55  Aligned_cols=183  Identities=16%  Similarity=0.118  Sum_probs=140.6

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEeecccchH--HHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD--QLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~--~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      +...|+.|+||+||.+...+..++.+.+........  ....+.+|+++|++|. |++|++++++    ...+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            456899999999998888888888777665443222  1235789999999996 5789999886    44799999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCC-CCCcEEEcCCCcEEEEecCccccccCCcc--
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL-KSPNLLVDKNWTVKVCDFGLSRFKANTFI--  816 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDL-KPeNILLd~~g~VKLsDFGLAr~~~~t~~--  816 (867)
                      |.+|...+..         . ...++.|++.+|.+||++|  |+|||| ||+|||++.++.++|+|||++........  
T Consensus        82 G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         82 GAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             CccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            9999754321         1 1346789999999999999  999999 79999999999999999999985433221  


Q ss_pred             ---c--------ccccCCCcccccccccC---CCCh--HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 ---S--------SKSVAGTVVFFAAHQTA---CNSL--ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 ---s--------~~s~aGTp~YmAPEvl~---~~~~--SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                         .        ..-...+++|++|+.-.   ...+  .++++.|+.+|.|+|+..+.|+=
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence               0        01123578899997644   2333  69999999999999999998864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=4.3e-19  Score=184.51  Aligned_cols=198  Identities=20%  Similarity=0.239  Sum_probs=165.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH-PNIVkl~ga~~~~~~l~  732 (867)
                      |....|.++++||.|+||.+|.|..  .|.+||||+-....-    .-.+..|..+.+.|++ ..|..+..+.++..+-.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            4568999999999999999999987  789999998654321    2246788999999986 57888888888888999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSR  809 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGLAr  809 (867)
                      +||+.+ |-+|.+++.-  +...++-.+.+-+|.|++.-++|+|.++  .|||||||+|.|..   ....+.++||||++
T Consensus        88 lVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchh
Confidence            999998 8899998864  3345788899999999999999999999  99999999999985   34578999999998


Q ss_pred             cccC-------CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKAN-------TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~-------t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...+       .....+...||..|.+-....+...   -|+=|+|-+|.++--|..||+.+.
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            6432       2334567789999999888777666   499999999999999999999875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=1.3e-18  Score=183.41  Aligned_cols=173  Identities=14%  Similarity=0.094  Sum_probs=131.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchH-HHHH------HHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKE------FLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~-~~k~------f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +--++|++.+.||.|+||.||++..++..+|||++.......+ ....      +.+|+..+.++.||+|....+++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            4458999999999999999999877788899999976544332 2233      57899999999999999998886543


Q ss_pred             --------CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcE
Q 002910          729 --------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV  800 (867)
Q Consensus       729 --------~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~V  800 (867)
                              +..+|||||++|.+|.++..       +++.    ...+|+.+|..||..|  ++|||+||.||+++.+| +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-E
Confidence                    35899999999999987632       3332    3558999999999999  99999999999999998 9


Q ss_pred             EEEecCccccccCCcccccccCCCcccccccccCCCChHHHHHHHHHHHHH
Q 002910          801 KVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSS  851 (867)
Q Consensus       801 KLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~SDIwSLG~lLyeM  851 (867)
                      +|+|||..+.........        ..--|.--+ ..+|+|+||+++..+
T Consensus       174 ~liDfg~~~~~~e~~a~d--------~~vler~y~-~~~di~~lg~~~~~~  215 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKD--------RIDLERHYG-IKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEEECCCcccccchhhHH--------HHHHHhHhc-ccccccceeEeehHH
Confidence            999999876542211100        011111112 358999999987543

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=8.5e-18  Score=174.91  Aligned_cols=135  Identities=16%  Similarity=0.239  Sum_probs=104.2

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhc-----CCCCeeeEEeEEeeCC---eEE-EE
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-----RHPNVVLFMGAVTKRP---HLS-IV  734 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-----rHPNIVkl~ga~~~~~---~l~-LV  734 (867)
                      .+.||+|+||.||.-...+. .+||++.....  ...+.+.+|+.+++.+     .||||+++++++++..   .++ +|
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            45799999999996222333 46888765432  2346789999999999     5799999999998873   444 78


Q ss_pred             Eec--cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCccccCCCCCcEEEcC----CCcEEEEecCc
Q 002910          735 TEY--LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI-NYLHNLNPPILHWDLKSPNLLVDK----NWTVKVCDFGL  807 (867)
Q Consensus       735 mEy--~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL-~YLHs~gp~IVHRDLKPeNILLd~----~g~VKLsDFGL  807 (867)
                      |||  +.+|+|.+++.+.    .+++.  ..++.+++.++ +|||+++  ||||||||+|||++.    ++.++|+||+.
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            999  5579999999752    25555  34577888888 9999999  999999999999974    34899999544


Q ss_pred             cc
Q 002910          808 SR  809 (867)
Q Consensus       808 Ar  809 (867)
                      ++
T Consensus       156 ~~  157 (210)
T PRK10345        156 ES  157 (210)
T ss_pred             Cc
Confidence            43

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.75  E-value=3.4e-19  Score=187.40  Aligned_cols=202  Identities=24%  Similarity=0.493  Sum_probs=170.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .|+..++.++.+|.....|+.|+|+|.|..+++|++............|..|.-.|+-..||||+.++++|..++++.++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            45667788888999999999999999999999999998887777677888999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      ..||+.|+|+.+||... ...++..++.+++.+|++||.|||+..|-|.---|.+..++||++.+.+|. .+-.++.   
T Consensus       266 sq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs---  340 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS---  340 (448)
T ss_pred             eeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee---
Confidence            99999999999999854 445788899999999999999999987655556799999999999888875 1111110   


Q ss_pred             cccccccCCCcccccccccCCCCh------HHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL------ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~------SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                       .+....+-.|.||+||.++..+.      +|+|||.++|||+.|.+.||..+.
T Consensus       341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls  393 (448)
T KOG0195|consen  341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS  393 (448)
T ss_pred             -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence             11123355789999999996553      799999999999999999998764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2e-17  Score=168.38  Aligned_cols=137  Identities=22%  Similarity=0.354  Sum_probs=115.9

Q ss_pred             EEeccCCceEEEEEEEcCceEEEEEEeecccchH------HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~------~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      +.||+|++|.||+|.+.+..+++|+.........      ....+.+|+.++..++|++|+....++......++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            4689999999999999999999998765433211      2245789999999999999887776776777889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +|++|.+++...      .. .+..++.+++.+|.+||..+  ++|||++|.|||++ ++.++|+|||+++..
T Consensus        82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            999999998642      12 77889999999999999999  99999999999999 789999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=8.5e-19  Score=207.24  Aligned_cols=195  Identities=19%  Similarity=0.260  Sum_probs=154.8

Q ss_pred             EEEEEeccCCceEEEEEEE--cCceEEEEEEe----ecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          662 HVKERVGAGSFGTVHRAEW--HGSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~----~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .....+|.|++|.|+.+..  ....++.|...    ......+....+..|.-+-..+.|||++..+..++.....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3466799999998877755  23334444433    11111222233677888888899999988887777666665669


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |||++ +|+.++.+.   ..+....+..++.|++.|++|||..|  |.|||||++|+++..+|.+||+|||.+......+
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 999999763   35788888899999999999999999  9999999999999999999999999987654332


Q ss_pred             ----ccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ----ISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ----~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                          .....++|+..|+|||++.+.+|    .||||.|+++..|.+|+.||....
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~  529 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK  529 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence                33567799999999999998777    799999999999999999987653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.73  E-value=1.1e-17  Score=164.63  Aligned_cols=104  Identities=21%  Similarity=0.207  Sum_probs=90.6

Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      |+|.++++..  +..+++..++.++.||+.||.|||+++        ||+|||++.++.+|+  ||+++.....     .
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence            6899999753  335899999999999999999999876        999999999999999  9999876443     2


Q ss_pred             cCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          821 VAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..||+.|||||++.+..+   +|||||||++|+|++|..||...
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            268999999999987654   89999999999999999999754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=3.6e-17  Score=165.26  Aligned_cols=132  Identities=19%  Similarity=0.304  Sum_probs=109.3

Q ss_pred             eccCCceEEEEEEEcCceEEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       667 LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~------~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      ||+|+||+||+|.+.+..+++|+........      ....++.+|++++..++|+++.....++......++||||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            7999999999999999999999876433211      1235678999999999988765555555566678999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++|.+++....    .      .++.+++.+|.+||+.+  ++|||++|.||+++ ++.++|+|||+++..
T Consensus        82 ~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        82 KPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99998875421    0      68899999999999999  99999999999999 889999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=5.6e-17  Score=189.68  Aligned_cols=140  Identities=19%  Similarity=0.302  Sum_probs=116.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~------~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ..|...+.||+|+||+||++.+.+..+++|+........      ...+++.+|+++++.++|++|+..+.++......+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            344567899999999999999988877777654332211      12356889999999999999998877777777889


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++++|.+++.           ....++.+++.+|.|||+.+  |+||||||+|||+ .++.++|+|||+++...
T Consensus       413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            9999999999998875           24568899999999999999  9999999999999 67799999999998643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=1.2e-16  Score=194.05  Aligned_cols=195  Identities=23%  Similarity=0.293  Sum_probs=156.6

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeEEe
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVT  726 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr---HPNIVkl~ga~~  726 (867)
                      ....++..+.|.|.+.||+|+||+||+|.. +|+.||+|+-+....-+-.+     =..++.||+   -+.|..++.++.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHc
Confidence            345677889999999999999999999987 68889999876654322111     022333443   234666666666


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-------CCc
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-------NWT  799 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-------~g~  799 (867)
                      -.+.-+||+||.+.|+|.+++..   .+.++|.....++.|++.-+++||..+  |||+||||+|+||..       .-.
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             cCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccc
Confidence            67778999999999999999973   556999999999999999999999999  999999999999942       345


Q ss_pred             EEEEecCccccccC--CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCC
Q 002910          800 VKVCDFGLSRFKAN--TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEES  855 (867)
Q Consensus       800 VKLsDFGLAr~~~~--t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~  855 (867)
                      ++|+|||.+-.+.-  .....+..++|-.+-++|...|.+|   +|.|.|..++|.|+.|.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            89999999865431  2234567899999999999999999   69999999999999886

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=2e-16  Score=167.24  Aligned_cols=145  Identities=17%  Similarity=0.124  Sum_probs=110.4

Q ss_pred             CeEEEEEeccCCceEEEEEE-E--cCceEEEEEEeecccch---------------------H-HHHHHHHHHHHHHhcC
Q 002910          660 ELHVKERVGAGSFGTVHRAE-W--HGSDVAVKVLTVQDFLD---------------------D-QLKEFLREVAIMKRVR  714 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~-~--~g~~VAVKvi~~~~~~~---------------------~-~~k~f~~Ei~ILk~Lr  714 (867)
                      .|.+.+.||+|+||.||+|. .  +|+.||||++.......                     . ....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46788899999999999998 3  68899999998643210                     0 1123568999999997


Q ss_pred             CCC--eeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcE
Q 002910          715 HPN--VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL  792 (867)
Q Consensus       715 HPN--IVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNI  792 (867)
                      +.+  +..+++.    ...+|||||++|++|...+..   ...........++.||+.+|.+||.+| .|+||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhE
Confidence            633  3344432    235899999999888665422   123556667889999999999999875 499999999999


Q ss_pred             EEcCCCcEEEEecCccccccC
Q 002910          793 LVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       793 LLd~~g~VKLsDFGLAr~~~~  813 (867)
                      +++ ++.++|+|||++.....
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 88999999999875544

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=3.1e-16  Score=159.62  Aligned_cols=138  Identities=20%  Similarity=0.162  Sum_probs=107.3

Q ss_pred             eEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccch--------------------HHHHHHHHHHHHHHhcCCCC--
Q 002910          661 LHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD--------------------DQLKEFLREVAIMKRVRHPN--  717 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~--------------------~~~k~f~~Ei~ILk~LrHPN--  717 (867)
                      |.+.+.||.|+||.||++.+ +|+.||||++.......                    .......+|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            66778899999999999988 68899999976532110                    01123577899999998874  


Q ss_pred             eeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       718 IVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      ++..++    ....++||||++|++|..+...         .....++.+++.++.++|..+  |+||||||+||+++.+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCC
Confidence            444443    2446899999999998765421         234568889999999999999  9999999999999999


Q ss_pred             CcEEEEecCccccccC
Q 002910          798 WTVKVCDFGLSRFKAN  813 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~  813 (867)
                      +.++|+|||++.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999865433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=9.5e-17  Score=176.15  Aligned_cols=206  Identities=21%  Similarity=0.280  Sum_probs=148.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC--c-----------------------------------eEEEEEEeecccc-
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG--S-----------------------------------DVAVKVLTVQDFL-  696 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g--~-----------------------------------~VAVKvi~~~~~~-  696 (867)
                      .+.+++|.+++.||+|.-..||.|+...  .                                   +.|||.+..-... 
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            4567899999999999999999885410  0                                   2466655432221 


Q ss_pred             --hHHHHHHHHHHH------H--------HHh--------cCCCCeeeEEeEEee-------------------------
Q 002910          697 --DDQLKEFLREVA------I--------MKR--------VRHPNVVLFMGAVTK-------------------------  727 (867)
Q Consensus       697 --~~~~k~f~~Ei~------I--------Lk~--------LrHPNIVkl~ga~~~-------------------------  727 (867)
                        ..-++.+-+|..      .        .+.        -+|||||++.++|.+                         
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence              122333334421      1        111        269999999988843                         


Q ss_pred             --CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE--cCCC--cEE
Q 002910          728 --RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV--DKNW--TVK  801 (867)
Q Consensus       728 --~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL--d~~g--~VK  801 (867)
                        +..+|+||.-. ..+|..++...    ..+.+...-|+.|+++|+.|||++|  |.|||||++||||  |+++  .+.
T Consensus       313 g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LV  385 (598)
T KOG4158|consen  313 GEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLV  385 (598)
T ss_pred             CCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEE
Confidence              22488999877 45888888653    3677778889999999999999999  9999999999998  4444  468


Q ss_pred             EEecCccccccCC-----cccc-cccCCCcccccccccCC---------CChHHHHHHHHHHHHHhcCCCCccccchhhc
Q 002910          802 VCDFGLSRFKANT-----FISS-KSVAGTVVFFAAHQTAC---------NSLALIFSLSGWLQSSFEESPQMRSLMFIVL  866 (867)
Q Consensus       802 LsDFGLAr~~~~t-----~~s~-~s~aGTp~YmAPEvl~~---------~~~SDIwSLG~lLyeM~tG~~Pf~sl~~LV~  866 (867)
                      |+|||.|--..+.     +.+. -...|.-.-||||+...         -.++|.|+.|.+.||+|+..+||.+-+...+
T Consensus       386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L  465 (598)
T KOG4158|consen  386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL  465 (598)
T ss_pred             EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence            8999987433321     1111 13366778899999874         2347999999999999999999999777655


Q ss_pred             C
Q 002910          867 E  867 (867)
Q Consensus       867 E  867 (867)
                      |
T Consensus       466 ~  466 (598)
T KOG4158|consen  466 D  466 (598)
T ss_pred             c
Confidence            4

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.64  E-value=6.3e-17  Score=193.74  Aligned_cols=198  Identities=22%  Similarity=0.269  Sum_probs=157.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCceEEEEEEeeccc--chHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~--~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      ++...+.||.+.|=+|.+|+++...|.||++-+++-  .-...++-+.|++ ...++|||++.+..+-.+...-|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            778889999999999999999777799999987763  2344555566666 6778999999998887777888999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc----cC
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK----AN  813 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~----~~  813 (867)
                      + ..+|++.|..   +.++..-+...|+.|++.||..+|+.|  |+|+|||.+||||+.-+.+.|+||.--+..    .+
T Consensus       103 v-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 V-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             H-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9 5689988875   446888888999999999999999999  999999999999999999999999876542    11


Q ss_pred             C---cccccccCCCcccccccccCC--------------CChHHHHHHHHHHHHHhcCCCCccccchh
Q 002910          814 T---FISSKSVAGTVVFFAAHQTAC--------------NSLALIFSLSGWLQSSFEESPQMRSLMFI  864 (867)
Q Consensus       814 t---~~s~~s~aGTp~YmAPEvl~~--------------~~~SDIwSLG~lLyeM~tG~~Pf~sl~~L  864 (867)
                      .   ..-..+...-.+|+|||.+..              .+..||||+||++.|+|+..-|.+.+..|
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL  244 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL  244 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH
Confidence            1   011123344568999999774              12269999999999999885555555443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=8e-16  Score=144.17  Aligned_cols=135  Identities=19%  Similarity=0.206  Sum_probs=113.1

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH--PNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH--PNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      +.+.||.|.++.||++...+..+++|.......    ...+.+|+.+++.++|  .++++++.++...+..+++|||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            356799999999999999888899998865432    4568899999999987  5899999988888889999999988


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g-p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +.+..+          +......++.+++.+|++||... ..++|+||+|.||++++.+.++++|||+++..
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            877543          44556678889999999999742 23999999999999999899999999998653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.3e-15  Score=150.47  Aligned_cols=138  Identities=19%  Similarity=0.124  Sum_probs=99.1

Q ss_pred             EEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHH----------------------HHHHHHHHHhcCCCC--e
Q 002910          664 KERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKE----------------------FLREVAIMKRVRHPN--V  718 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~----------------------f~~Ei~ILk~LrHPN--I  718 (867)
                      .+.||+|+||+||+|... ++.||||++............                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            457999999999999885 889999998765432211111                      135666666665443  3


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~-~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~  796 (867)
                      .+.++.    ...++||||++++.+.. .+...     .....+..++.+++.++.+||. .+  |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLLEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhcccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence            444443    23589999999854321 12110     0115567889999999999999 98  99999999999999 


Q ss_pred             CCcEEEEecCccccccC
Q 002910          797 NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~  813 (867)
                      ++.++|+|||+++....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            89999999999975544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=3.4e-16  Score=187.60  Aligned_cols=160  Identities=23%  Similarity=0.309  Sum_probs=121.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      -++|..++.|-.|+||-||..+++  .+.+|+|+ .++.+...         +|+.....|++|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR---------nilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR---------NILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhh---------ccccccCCccee----------------
Confidence            378999999999999999999885  77899954 43332111         144455566555                


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc---
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~---  812 (867)
                           |+-...++..+   .++-        +++.+++|||..+  |+|||+||+|+||..-|++|++||||++..-   
T Consensus       136 -----gDc~tllk~~g---~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -----chhhhhcccCC---CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                 45555554322   2222        3378899999999  9999999999999999999999999987521   


Q ss_pred             ------------CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 ------------NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ------------~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                                  ......+.+||||+|+|||++....|   .|||++|+++|+++.|..||..-
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence                        12234567899999999999886544   89999999999999999888764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.58  E-value=1.1e-14  Score=158.08  Aligned_cols=198  Identities=18%  Similarity=0.215  Sum_probs=128.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCC----------CCeeeEEeE-
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRH----------PNVVLFMGA-  724 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrH----------PNIVkl~ga-  724 (867)
                      ..+..++.||.|+|+.||.+++  +++.+|||++...... ...++++.+|.-....+.+          -.++.-++. 
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3567899999999999999999  4688999998765532 3456777776644433222          111111111 


Q ss_pred             --------EeeCC--------eEEEEEeccCCCCHHHHHhc---CCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCccc
Q 002910          725 --------VTKRP--------HLSIVTEYLPRGSLYRLIHR---PAAG-EMMDQRRRLRMALDVAKGINYLHNLNPPILH  784 (867)
Q Consensus       725 --------~~~~~--------~l~LVmEy~~gGSL~~~L~~---~~~~-~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVH  784 (867)
                              +....        +.+++|+-+ .++|..++..   .... ..+....++.+..|+++.+++||.+|  |||
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH  168 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH  168 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence                    11111        246778777 6688877542   1111 11333445566789999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCcccccccccCC-----------CChHHHHHHHHHHHHHhc
Q 002910          785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTAC-----------NSLALIFSLSGWLQSSFE  853 (867)
Q Consensus       785 RDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~-----------~~~SDIwSLG~lLyeM~t  853 (867)
                      +||+|+|+|++.+|.++|+||+...........   ...+..|.+||....           ....|.|+||++||.||+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999999987655443321   233467888887643           122699999999999999


Q ss_pred             CCCCccccc
Q 002910          854 ESPQMRSLM  862 (867)
Q Consensus       854 G~~Pf~sl~  862 (867)
                      +..||....
T Consensus       246 ~~lPf~~~~  254 (288)
T PF14531_consen  246 GRLPFGLSS  254 (288)
T ss_dssp             SS-STCCCG
T ss_pred             ccCCCCCCC
Confidence            999997543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.3e-14  Score=151.74  Aligned_cols=137  Identities=17%  Similarity=0.222  Sum_probs=106.5

Q ss_pred             EEec-cCCceEEEEEEEcCceEEEEEEeecccc-----------hHHHHHHHHHHHHHHhcCCCCe--eeEEeEEeeC-C
Q 002910          665 ERVG-AGSFGTVHRAEWHGSDVAVKVLTVQDFL-----------DDQLKEFLREVAIMKRVRHPNV--VLFMGAVTKR-P  729 (867)
Q Consensus       665 e~LG-~GsFG~VykA~~~g~~VAVKvi~~~~~~-----------~~~~k~f~~Ei~ILk~LrHPNI--Vkl~ga~~~~-~  729 (867)
                      ..|| .|+.|+||.+...+..++||.+......           ......+.+|+.++.+|+|++|  +..+++.... .
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4576 7888899998888899999988653321           1223567899999999998875  6666664332 2


Q ss_pred             e---EEEEEeccCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEec
Q 002910          730 H---LSIVTEYLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF  805 (867)
Q Consensus       730 ~---l~LVmEy~~g-GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDF  805 (867)
                      .   .++||||++| .+|.+++...    .+++.    .+.+|+.+|.+||+.|  |+||||||.|||++.++.++|+||
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEEC
Confidence            2   3599999997 6999888642    24443    3568999999999999  999999999999999999999999


Q ss_pred             Cccccc
Q 002910          806 GLSRFK  811 (867)
Q Consensus       806 GLAr~~  811 (867)
                      |.++..
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            998653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.44  E-value=8e-14  Score=160.13  Aligned_cols=148  Identities=28%  Similarity=0.420  Sum_probs=123.8

Q ss_pred             HHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-cccCCC
Q 002910          710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI-LHWDLK  788 (867)
Q Consensus       710 Lk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~I-VHRDLK  788 (867)
                      |+.+.|.|+.+|+|.+...+..++|.+||..|+|.+.+...  ...+++.-...++++|+.||+|||...  | .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            45788999999999999999999999999999999999863  235788888899999999999999854  4 999999


Q ss_pred             CCcEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCC----------ChHHHHHHHHHHHHHhcCCC
Q 002910          789 SPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACN----------SLALIFSLSGWLQSSFEESP  856 (867)
Q Consensus       789 PeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~----------~~SDIwSLG~lLyeM~tG~~  856 (867)
                      +.|+++|..|.+||+|||+.......  ...........-|.|||++++.          +.+||||+|++++++++-..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998766321  1111222344679999999973          33799999999999999999


Q ss_pred             Ccccc
Q 002910          857 QMRSL  861 (867)
Q Consensus       857 Pf~sl  861 (867)
                      ||...
T Consensus       157 ~~~~~  161 (484)
T KOG1023|consen  157 PFDLR  161 (484)
T ss_pred             ccccc
Confidence            98763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=1.2e-14  Score=172.26  Aligned_cols=200  Identities=22%  Similarity=0.296  Sum_probs=160.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc-Cc--eEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH-GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~-g~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..|.+.+.||+|+|+.|-.+... ..  .+|+|.+....-..........|..+-+.+. |.|++.+++........+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            46677778999999999887662 22  3566655544322344556667888888887 99999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCccccCCCCCcEEEcCCC-cEEEEecCcccccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKA  812 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLH-s~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~~  812 (867)
                      ++|..|++++..+.... ....+...+-.+..|+..++.|+| ..+  +.||||||+|.+++..+ .+|+.|||++....
T Consensus       100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999998883212 113555666778999999999999 888  99999999999999999 99999999997654


Q ss_pred             C---CcccccccCC-CcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 N---TFISSKSVAG-TVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~---t~~s~~s~aG-Tp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .   ........+| ++.|+|||...+    .+..|+||.|+++..|++|..|+...
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~  233 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP  233 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence            4   3344456688 999999999998    45589999999999999999887643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=6.2e-12  Score=144.36  Aligned_cols=141  Identities=24%  Similarity=0.263  Sum_probs=97.0

Q ss_pred             EEeccCCceEEEEEEE-cCceEEEEEEeecccch----------------------------HHH----------HHHHH
Q 002910          665 ERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD----------------------------DQL----------KEFLR  705 (867)
Q Consensus       665 e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~----------------------------~~~----------k~f~~  705 (867)
                      +.||.|++|.||+|+. +|+.||||+.+......                            ...          -.+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            4699999999999998 68999999986542100                            000          02445


Q ss_pred             HHHHHHhcC----CCCeeeEEeEE-eeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 002910          706 EVAIMKRVR----HPNVVLFMGAV-TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK-GINYLHNLN  779 (867)
Q Consensus       706 Ei~ILk~Lr----HPNIVkl~ga~-~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~-GL~YLHs~g  779 (867)
                      |...+.+++    |.+-|.+-..+ ......+|||||++|++|.++......  ..+   ...++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC
Confidence            666555552    32223322222 223346899999999999887653211  122   2345666665 478899999


Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       780 p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                        ++|+|+||.||+++.++.++|+|||++..+.
T Consensus       278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.2e-11  Score=121.26  Aligned_cols=130  Identities=16%  Similarity=0.075  Sum_probs=96.8

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee-eEEeEEeeCCeEEEEEeccCCCC
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LFMGAVTKRPHLSIVTEYLPRGS  742 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIV-kl~ga~~~~~~l~LVmEy~~gGS  742 (867)
                      .+.|+.|.++.||+++..+..|++|+......   ....+.+|+.+++.+.+.+++ +++....  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            45789999999999999999999998754421   122456889999988755544 4554433  33579999999988


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---CccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP---PILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       743 L~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp---~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +....        ..   ....+.+++.+|..||..+.   .++|+|++|.||+++ ++.++|+|||.+..
T Consensus        78 l~~~~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            75420        11   12356789999999998761   249999999999999 66899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.23  E-value=2.6e-12  Score=146.34  Aligned_cols=120  Identities=22%  Similarity=0.308  Sum_probs=104.9

Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .++||.|++|...+|.++|.++......+....+.++.|++.|++|   ++  .+|||+||.||+...+..+||.||||.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence            3589999999999999999877777778888999999999999999   78  999999999999999989999999998


Q ss_pred             ccccCC------cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc
Q 002910          809 RFKANT------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE  853 (867)
Q Consensus       809 r~~~~t------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t  853 (867)
                      ......      ......-.||.-||+||.+.+..+   +|||+||++|+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            655432      233445689999999999998776   799999999999987

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=8.7e-12  Score=146.01  Aligned_cols=144  Identities=20%  Similarity=0.247  Sum_probs=91.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE-c-CceEEEEEEeecccc--------------------------------hHHHHH--
Q 002910          659 DELHVKERVGAGSFGTVHRAEW-H-GSDVAVKVLTVQDFL--------------------------------DDQLKE--  702 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~-~-g~~VAVKvi~~~~~~--------------------------------~~~~k~--  702 (867)
                      .+|.. +.||.|++|+||+|++ + |+.||||++++....                                .+..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45555 6899999999999998 3 899999999754210                                011112  


Q ss_pred             ----HHHHHHHHHhcC----CCCeeeEEeEEee-CCeEEEEEeccCCCCHHHHHhcCCCCC---CCCHHHHHHHHHHHHH
Q 002910          703 ----FLREVAIMKRVR----HPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGE---MMDQRRRLRMALDVAK  770 (867)
Q Consensus       703 ----f~~Ei~ILk~Lr----HPNIVkl~ga~~~-~~~l~LVmEy~~gGSL~~~L~~~~~~~---~l~e~~~l~ia~qIa~  770 (867)
                          +.+|+..+.+++    +.+.+.+-.++.+ ....+|||||+.|+.+.++-.-...+.   .+.+..+..++     
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~-----  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF-----  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence                334444444442    3333333333321 345679999999999987432111110   12222222223     


Q ss_pred             HHHHHHhcCCCccccCCCCCcEEEcCCC----cEEEEecCcccccc
Q 002910          771 GINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLSRFKA  812 (867)
Q Consensus       771 GL~YLHs~gp~IVHRDLKPeNILLd~~g----~VKLsDFGLAr~~~  812 (867)
                        ..++..|  ++|+|+||.||+++.+|    .++++|||++..+.
T Consensus       274 --~Qif~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 --TQVFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             --HHHHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence              3345678  99999999999999888    99999999987653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.12  E-value=3.4e-10  Score=132.37  Aligned_cols=162  Identities=17%  Similarity=0.225  Sum_probs=123.9

Q ss_pred             cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHH
Q 002910          681 HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRR  760 (867)
Q Consensus       681 ~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~  760 (867)
                      .+.+|.|.+.+...-  .......+-++-|+.+|||||++++..+...+.+|||+|-+  .-|..++.+      +....
T Consensus        36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE  105 (690)
T ss_pred             cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence            466777777765542  33344567788899999999999999999999999999987  346666665      23455


Q ss_pred             HHHHHHHHHHHHHHHH-hcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCcccccccccCCCCh-
Q 002910          761 RLRMALDVAKGINYLH-NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL-  838 (867)
Q Consensus       761 ~l~ia~qIa~GL~YLH-s~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~-  838 (867)
                      ....+.||+.||-||| +.+  ++|++|.-.-|+|+..|..||++|-++..........+...---.|..|+.+.-..+ 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s  183 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWS  183 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccc
Confidence            5667889999999998 466  999999999999999999999999988654433211122222235677877665555 


Q ss_pred             HHHHHHHHHHHHHhcC
Q 002910          839 ALIFSLSGWLQSSFEE  854 (867)
Q Consensus       839 SDIwSLG~lLyeM~tG  854 (867)
                      .|.|.|||+++++|.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            5999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.09  E-value=6.5e-10  Score=115.10  Aligned_cols=138  Identities=16%  Similarity=0.121  Sum_probs=98.1

Q ss_pred             EEeccCCceEEEEEEEc--------CceEEEEEEeecccc--------------------hHHHHHH----HHHHHHHHh
Q 002910          665 ERVGAGSFGTVHRAEWH--------GSDVAVKVLTVQDFL--------------------DDQLKEF----LREVAIMKR  712 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~--------g~~VAVKvi~~~~~~--------------------~~~~k~f----~~Ei~ILk~  712 (867)
                      ..||.|.-+.||.|...        +..+|||+.+.....                    ....+.+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            36899999999999754        368999998753210                    0011122    389999999


Q ss_pred             cCC--CCeeeEEeEEeeCCeEEEEEeccCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCccccCCC
Q 002910          713 VRH--PNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINYL-HNLNPPILHWDLK  788 (867)
Q Consensus       713 LrH--PNIVkl~ga~~~~~~l~LVmEy~~gGSL~~-~L~~~~~~~~l~e~~~l~ia~qIa~GL~YL-Hs~gp~IVHRDLK  788 (867)
                      +..  -++...+++    ..-+|||||+.++.+.. .++.    ..+++.....+..+++.+|..| |+.|  |||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence            863  345566654    45789999997654422 2322    1244555667788999999998 8999  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCccccccC
Q 002910          789 SPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       789 PeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      +.|||++ ++.+.|+|||-+-...+
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999996 46899999998755443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=8.9e-10  Score=111.88  Aligned_cols=141  Identities=17%  Similarity=0.213  Sum_probs=106.9

Q ss_pred             EEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEeEEeeC---CeEEEEEecc
Q 002910          665 ERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGAVTKR---PHLSIVTEYL  738 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP--NIVkl~ga~~~~---~~l~LVmEy~  738 (867)
                      +.|+.|.++.||++...+ ..+++|+....... .....+.+|+.+++.+++.  ++.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998865 78999987654321 1244678999999999763  456677766543   3678999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL----------------------------------------  778 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~----------------------------------------  778 (867)
                      +|.++...+..    ..+++.....++.+++..|.+||+.                                        
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99888765431    2366777777888888888888842                                        


Q ss_pred             --------------CCCccccCCCCCcEEEcC--CCcEEEEecCcccc
Q 002910          779 --------------NPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRF  810 (867)
Q Consensus       779 --------------gp~IVHRDLKPeNILLd~--~g~VKLsDFGLAr~  810 (867)
                                    ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          134799999999999998  67789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=9.5e-11  Score=135.44  Aligned_cols=195  Identities=26%  Similarity=0.241  Sum_probs=152.2

Q ss_pred             CCeEEEEEecc--CCceEEEEEEE----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeE
Q 002910          659 DELHVKERVGA--GSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~--GsFG~VykA~~----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l  731 (867)
                      ..+.+.+.+|.  |.+|.||.+..    .+..+|+|.-+...-.......-++|....+++. |+|+++.+.++...+.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45566778999  99999998876    3566888874433222222233356666666665 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecC
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----GINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFG  806 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~----GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFG  806 (867)
                      ++-+|++ +.+|..+.+..  ...++....+....+...    ||.++|..+  |+|-|+||+||++..+ ..++++|||
T Consensus       194 fiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcc
Confidence            9999998 57888888763  334778888888888888    999999998  9999999999999999 778999999


Q ss_pred             ccccccCCcccc-----cccCCCcccccccccCC--CChHHHHHHHHHHHHHhcCCCCc
Q 002910          807 LSRFKANTFISS-----KSVAGTVVFFAAHQTAC--NSLALIFSLSGWLQSSFEESPQM  858 (867)
Q Consensus       807 LAr~~~~t~~s~-----~s~aGTp~YmAPEvl~~--~~~SDIwSLG~lLyeM~tG~~Pf  858 (867)
                      +...+.......     ...-|...|++||+..+  ....|||+||.+..+..++..++
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence            998776543222     22367789999999986  44589999999998887765544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=4.5e-09  Score=107.54  Aligned_cols=132  Identities=21%  Similarity=0.300  Sum_probs=101.7

Q ss_pred             EeccCCceEEEEEEEcCceEEEEEEeecccchH------HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~------~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      .+++|+-+.+|.+.|.|..+.+|.=.....-..      ...+..+|..++.+++-..|..-+-+..++....|+|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            578999999999999888877776444333222      23457899999999875555443444556777889999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      |-.|.+++...          ...++..|-.-+.-||..|  |||+||.++||++...+ +.++||||+..
T Consensus        83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            98888888753          1345667777788899999  99999999999997664 99999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=1.8e-10  Score=139.22  Aligned_cols=203  Identities=20%  Similarity=0.193  Sum_probs=157.7

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      .....+.+.+.+-+-.|+++.++.+.-.  |...++|+........ ...+....+-.++-..+||.++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            4467889999999999999999988653  3345666555443322 335556666777777788999988777777888


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++++|+|+.+++|...|+...   ..++.-+.-++..+...++|||...  ++|||++|.|+|+...|+.+++|||+...
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccc
Confidence            999999999999999998754   2555555667778999999999987  99999999999999999999999984322


Q ss_pred             cc-------C-------------------C-----cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCC
Q 002910          811 KA-------N-------------------T-----FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESP  856 (867)
Q Consensus       811 ~~-------~-------------------t-----~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~  856 (867)
                      ..       .                   .     ........||+.|++||.+.+...   +|+|++|+++++.++|.+
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            10       0                   0     011234578999999999887544   799999999999999999


Q ss_pred             Ccccc
Q 002910          857 QMRSL  861 (867)
Q Consensus       857 Pf~sl  861 (867)
                      ||...
T Consensus      1034 p~na~ 1038 (1205)
T KOG0606|consen 1034 PFNAE 1038 (1205)
T ss_pred             CCCCc
Confidence            99764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.91  E-value=1.4e-08  Score=103.82  Aligned_cols=146  Identities=20%  Similarity=0.245  Sum_probs=108.0

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEeecccch-----H-HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD-----D-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~-----~-~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .+..|-||+-+.|+++.+.|+.+.||.-.......     + ..++..+|+++|.+++--.|.--.-+|.+...-.|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            46678999999999999999998888654433321     1 23567899999999875555443444556667789999


Q ss_pred             ccCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC---cEEEEecCccccc
Q 002910          737 YLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSRFK  811 (867)
Q Consensus       737 y~~g-GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g---~VKLsDFGLAr~~  811 (867)
                      |++| .++.+++....... ........++..|-+.+.-||.++  |||+||..+||+|..++   .+.++||||+...
T Consensus        91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9977 47777776533222 223333678888999999999999  99999999999996544   4689999998543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=7.9e-10  Score=120.29  Aligned_cols=148  Identities=20%  Similarity=0.303  Sum_probs=111.8

Q ss_pred             HHhcCCCCeeeEEeEEeeC-----CeEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcc
Q 002910          710 MKRVRHPNVVLFMGAVTKR-----PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPIL  783 (867)
Q Consensus       710 Lk~LrHPNIVkl~ga~~~~-----~~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IV  783 (867)
                      |-.+-|.|||+++.+|.+.     ....+++|||..|+|..+|++-. ....+......+|+.||+.||.|||+..|+|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            4455699999999988654     45889999999999999998622 33457777888999999999999999999999


Q ss_pred             ccCCCCCcEEEcCCCcEEEEecCc--cccccCCc--ccccccCCCcccccccccC---CCChHHHHHHHHHHHHHhcCCC
Q 002910          784 HWDLKSPNLLVDKNWTVKVCDFGL--SRFKANTF--ISSKSVAGTVVFFAAHQTA---CNSLALIFSLSGWLQSSFEESP  856 (867)
Q Consensus       784 HRDLKPeNILLd~~g~VKLsDFGL--Ar~~~~t~--~s~~s~aGTp~YmAPEvl~---~~~~SDIwSLG~lLyeM~tG~~  856 (867)
                      |+++...-|++..+|.|||.--.-  .....+..  .....-.+-++|.|||.=.   .+..+|||++|+...+|.-+..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            999999999999999999852111  11111111  1112234568999998754   3445899999999999987764


Q ss_pred             C
Q 002910          857 Q  857 (867)
Q Consensus       857 P  857 (867)
                      .
T Consensus       281 q  281 (458)
T KOG1266|consen  281 Q  281 (458)
T ss_pred             c
Confidence            4

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.79  E-value=2.7e-09  Score=123.63  Aligned_cols=199  Identities=22%  Similarity=0.181  Sum_probs=149.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE---cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP  729 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~---~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~  729 (867)
                      ......+|.++..||.|.|+.|+....   .+..|++|.+.........-..-+.|+-+...+ .|.+++..+..|....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            445667899999999999999998764   356688888766544433323335666666665 4889999988888888


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCcc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLA  808 (867)
                      ..||-.|||+++++...+.   ....+++..++++..|++.++.++|+..  ++|+|+||+||++..+ +..++.|||..
T Consensus       340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccc
Confidence            8899999999998876653   2345888999999999999999999988  9999999999999875 78899999987


Q ss_pred             ccccCCcccccccCCCccccc-ccccC----CCChHHHHHHHHHHHHHhcCCCCccc
Q 002910          809 RFKANTFISSKSVAGTVVFFA-AHQTA----CNSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmA-PEvl~----~~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..+.-.   .....+.-.+++ .|++.    .....|+||||..+.+..++.+--+.
T Consensus       415 t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~  468 (524)
T KOG0601|consen  415 TRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES  468 (524)
T ss_pred             ccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence            542211   122233344442 33333    34558999999999999988765554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=1.4e-07  Score=102.08  Aligned_cols=134  Identities=20%  Similarity=0.124  Sum_probs=96.3

Q ss_pred             eEEEEEEEcCceEEEEEEeecccchHHHH----------HHHHHHHHHHhcCCCCe--eeEEeEEee-----CCeEEEEE
Q 002910          673 GTVHRAEWHGSDVAVKVLTVQDFLDDQLK----------EFLREVAIMKRVRHPNV--VLFMGAVTK-----RPHLSIVT  735 (867)
Q Consensus       673 G~VykA~~~g~~VAVKvi~~~~~~~~~~k----------~f~~Ei~ILk~LrHPNI--Vkl~ga~~~-----~~~l~LVm  735 (867)
                      ..|.+..+.|+.|.||........ ...+          .+.+|...+.+|..-+|  +..+++...     ...-+|||
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            346678888889999976433211 1111          36788888887753333  233444432     23578999


Q ss_pred             eccCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-------CCcEEEEecCc
Q 002910          736 EYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-------NWTVKVCDFGL  807 (867)
Q Consensus       736 Ey~~gG-SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-------~g~VKLsDFGL  807 (867)
                      |++++. +|.+++.... ....+......++.+++..+.-||..|  |+|+||++.|||++.       ++.+.|+||+.
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            999876 8988875321 123556677789999999999999999  999999999999975       57899999998


Q ss_pred             ccc
Q 002910          808 SRF  810 (867)
Q Consensus       808 Ar~  810 (867)
                      ++.
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.55  E-value=3.8e-07  Score=94.03  Aligned_cols=127  Identities=26%  Similarity=0.213  Sum_probs=81.1

Q ss_pred             EEEEEEE-cCceEEEEEEeeccc----------------------ch--HHHHHHHHHHHHHHhcCCC--CeeeEEeEEe
Q 002910          674 TVHRAEW-HGSDVAVKVLTVQDF----------------------LD--DQLKEFLREVAIMKRVRHP--NVVLFMGAVT  726 (867)
Q Consensus       674 ~VykA~~-~g~~VAVKvi~~~~~----------------------~~--~~~k~f~~Ei~ILk~LrHP--NIVkl~ga~~  726 (867)
                      .||.|.. .|..+|||+.+....                      ..  -......+|.+.|.++...  ++.+.+++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899987 678899999875311                      00  1123467899999999866  455666442 


Q ss_pred             eCCeEEEEEeccC--CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          727 KRPHLSIVTEYLP--RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY-LHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       727 ~~~~l~LVmEy~~--gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~Y-LHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                         .-.|||||+.  |..+..+....     ++......++.+++..+.. +|..|  |||+||.+.|||++.+ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEE
Confidence               3479999998  65665544321     1123345566777775555 57999  9999999999999887 89999


Q ss_pred             ecCcccccc
Q 002910          804 DFGLSRFKA  812 (867)
Q Consensus       804 DFGLAr~~~  812 (867)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999875543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.45  E-value=1.1e-06  Score=91.00  Aligned_cols=107  Identities=26%  Similarity=0.330  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHHhcCCCC--eeeEEeEEeeC----CeEEEEEeccCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 002910          701 KEFLREVAIMKRVRHPN--VVLFMGAVTKR----PHLSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN  773 (867)
Q Consensus       701 k~f~~Ei~ILk~LrHPN--IVkl~ga~~~~----~~l~LVmEy~~gG-SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~  773 (867)
                      ....+|...+.+|..-.  +...+++....    ...+||||++++. +|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            35677888777775333  33455554442    2358999999884 79998875322   556667788999999999


Q ss_pred             HHHhcCCCccccCCCCCcEEEcCCC---cEEEEecCcccccc
Q 002910          774 YLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSRFKA  812 (867)
Q Consensus       774 YLHs~gp~IVHRDLKPeNILLd~~g---~VKLsDFGLAr~~~  812 (867)
                      -||..|  |+|+|+++.|||++.++   .+.|+||+.++...
T Consensus       133 ~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  133 KLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999999  99999999999999887   89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.30  E-value=5.5e-07  Score=108.90  Aligned_cols=79  Identities=10%  Similarity=0.024  Sum_probs=61.7

Q ss_pred             cccCCCCC-cEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCC
Q 002910          783 LHWDLKSP-NLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESP  856 (867)
Q Consensus       783 VHRDLKPe-NILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~  856 (867)
                      .+++..|. |++++..+.+++.|||.++.....  ........||+.|||||++.+..+   +|||||||+||+|++|.+
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~  578 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIP  578 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            44566666 677788888899999998765322  222345689999999999997655   799999999999999999


Q ss_pred             Ccccc
Q 002910          857 QMRSL  861 (867)
Q Consensus       857 Pf~sl  861 (867)
                      ||...
T Consensus       579 pf~~~  583 (669)
T cd05610         579 PFNDE  583 (669)
T ss_pred             CCCCC
Confidence            99653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.28  E-value=8.3e-06  Score=86.13  Aligned_cols=138  Identities=14%  Similarity=0.172  Sum_probs=84.8

Q ss_pred             EEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeEEeeCCeEEEEEeccCCCC
Q 002910          665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRPHLSIVTEYLPRGS  742 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga~~~~~~l~LVmEy~~gGS  742 (867)
                      ..||+|..+.||+.  .+..+++|......    ......+|.++++.+..-.  +.+.+++....+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984  35567788875432    1234678999998886433  4567777777778899999998863


Q ss_pred             -HHHH---------------------HhcCC-CCCCCCHHHHHHHHH----------HHHH-HHHHHH--hcCCCccccC
Q 002910          743 -LYRL---------------------IHRPA-AGEMMDQRRRLRMAL----------DVAK-GINYLH--NLNPPILHWD  786 (867)
Q Consensus       743 -L~~~---------------------L~~~~-~~~~l~e~~~l~ia~----------qIa~-GL~YLH--s~gp~IVHRD  786 (867)
                       +...                     ||... ....+.... ..+..          .+.. ...+|.  ...+.++|+|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence             2111                     22110 011111100 00100          0111 122222  2223578999


Q ss_pred             CCCCcEEEcCCCcEEEEecCcccc
Q 002910          787 LKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       787 LKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +.|.||++++++ +.|+||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.28  E-value=6.9e-06  Score=94.65  Aligned_cols=166  Identities=16%  Similarity=0.133  Sum_probs=122.1

Q ss_pred             eEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC----CeEEEEEeccCC-CCHHH
Q 002910          673 GTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR----PHLSIVTEYLPR-GSLYR  745 (867)
Q Consensus       673 G~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~----~~l~LVmEy~~g-GSL~~  745 (867)
                      .+-|++..  +|..|.+|.+......  .......-+++++++.|+|||.|..+|.+.    ..+++|++|.++ ++|++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            56788866  6888999988322211  111223347889999999999999998743    458999999885 47776


Q ss_pred             HHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          746 LIHRPA------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       746 ~L~~~~------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      +--...            .+...+|+..|.|+.|+..||.++|+.|  +.-+-|.+.+||++.+..++|...|.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            543321            2334678999999999999999999999  88899999999999888888887666543322


Q ss_pred             CcccccccCCCcccccccccCCCChHHHHHHHHHHHHHhcCCC
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESP  856 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~SDIwSLG~lLyeM~tG~~  856 (867)
                      ..              -|.+...+.-|.=.||.++..+.||..
T Consensus       446 d~--------------~~~le~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DP--------------TEPLESQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC--------------CcchhHHhhhhHHHHHHHHHHHhhccc
Confidence            11              134445556799999999999999843

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.27  E-value=3.5e-06  Score=91.02  Aligned_cols=134  Identities=22%  Similarity=0.221  Sum_probs=95.0

Q ss_pred             EEEEEeccCCceEEEEEEE-cCceEEEEEEeecccc--------------------hHHHHHHHHHHHHHHhcCCC--Ce
Q 002910          662 HVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL--------------------DDQLKEFLREVAIMKRVRHP--NV  718 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~--------------------~~~~k~f~~Ei~ILk~LrHP--NI  718 (867)
                      .++..||-|.-+.||.|.. .|.++|||.-+....+                    .-......+|.++|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            5678899999999999988 5999999975432211                    01123357899999998644  45


Q ss_pred             eeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC
Q 002910          719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW  798 (867)
Q Consensus       719 Vkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g  798 (867)
                      .+-++    .+...+||||+.|-.|...-        ++....-.++..|++-+.-+-..|  |||+|+.+-|||++.+|
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCC
Confidence            55443    35678999999997776432        112222334444555555555778  99999999999999999


Q ss_pred             cEEEEecCccc
Q 002910          799 TVKVCDFGLSR  809 (867)
Q Consensus       799 ~VKLsDFGLAr  809 (867)
                      .+.|+||-=+-
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999997553

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.25  E-value=6.1e-06  Score=93.10  Aligned_cols=193  Identities=13%  Similarity=0.066  Sum_probs=125.6

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHH-hcCCCCeeeEEeEE------ee-CCeEEEE
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK-RVRHPNVVLFMGAV------TK-RPHLSIV  734 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk-~LrHPNIVkl~ga~------~~-~~~l~LV  734 (867)
                      .++.||+|+-+-+|-.-.-+..|| |+........+.  +   -+..|. .-.||-+-.-+.+-      -. ...+-++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a--q---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA--Q---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhhchhh-eeecCCCchHHH--H---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            356799999999996543333344 776654322211  1   122222 23455332211111      11 2236788


Q ss_pred             EeccCCCCHHHHHhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          735 TEYLPRGSLYRLIHR----PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       735 mEy~~gGSL~~~L~~----~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      |..+++..=-..+.+    .......+|.-.++.++.++.+.+-||.+|  .+-+|+.++|+|+.+++.|.|.|=..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence            888877533223322    222344789999999999999999999999  99999999999999999999986332211


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh--------HHHHHHHHHHHHHhcC-CCCccccchh
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL--------ALIFSLSGWLQSSFEE-SPQMRSLMFI  864 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~--------SDIwSLG~lLyeM~tG-~~Pf~sl~~L  864 (867)
                      . ..........|.++|..||..+-..+        .|-|.||+++++++.| ++||.+...+
T Consensus       167 ~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~  228 (637)
T COG4248         167 N-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI  228 (637)
T ss_pred             c-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence            1 22222345678999999999773322        6999999999988666 9999887654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.24  E-value=1.1e-05  Score=82.05  Aligned_cols=143  Identities=20%  Similarity=0.261  Sum_probs=85.1

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeEEe---eCCeEEEEEecc
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVT---KRPHLSIVTEYL  738 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga~~---~~~~l~LVmEy~  738 (867)
                      ++.|+.|..+.||+....+..+++|+....    .....+.+|..+++.+....  +.+++....   .....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            467999999999999998789999986543    34456778888888875332  456665432   334579999999


Q ss_pred             CCCCHHH----------------HH---hcCC-CCCCCCHHHH--HH-------H------------HHHHHH-HHHHHH
Q 002910          739 PRGSLYR----------------LI---HRPA-AGEMMDQRRR--LR-------M------------ALDVAK-GINYLH  776 (867)
Q Consensus       739 ~gGSL~~----------------~L---~~~~-~~~~l~e~~~--l~-------i------------a~qIa~-GL~YLH  776 (867)
                      +|..+..                .+   |... ..........  ..       .            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   1110 1111111100  00       0            111222 333444


Q ss_pred             h-----cCCCccccCCCCCcEEEc-CCCcEEEEecCcccc
Q 002910          777 N-----LNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRF  810 (867)
Q Consensus       777 s-----~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr~  810 (867)
                      .     ....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2     223499999999999999 667778999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=2.5e-05  Score=82.61  Aligned_cols=141  Identities=19%  Similarity=0.217  Sum_probs=97.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccch-HHHHHH------HHHHHHHHhcC---CCCeeeEEeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD-DQLKEF------LREVAIMKRVR---HPNVVLFMGAV  725 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~-~~~k~f------~~Ei~ILk~Lr---HPNIVkl~ga~  725 (867)
                      +.-.+|.+.+.+-......|.+-..+|..+.+|..+...... .....|      .+++..+.+++   -..+..++.+.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            344788999999998899999998999999999877644221 112222      23333333333   23333333333


Q ss_pred             eeC-----CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcE
Q 002910          726 TKR-----PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV  800 (867)
Q Consensus       726 ~~~-----~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~V  800 (867)
                      ...     ...+|||||++|-.|.++..       +++    .++..|+.+|.-||+.|  +.|+|..|.|+++++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-E
Confidence            322     33568999999988866532       333    24456778899999999  99999999999998664 9


Q ss_pred             EEEecCcccc
Q 002910          801 KVCDFGLSRF  810 (867)
Q Consensus       801 KLsDFGLAr~  810 (867)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.15  E-value=2.8e-05  Score=81.79  Aligned_cols=139  Identities=21%  Similarity=0.137  Sum_probs=101.9

Q ss_pred             ccCCceEEEEEEEcCceEEEEEEeecccc----hHHHHHHHHHHHHHHhcCCCC--eeeEEeEEe---eC--CeEEEEEe
Q 002910          668 GAGSFGTVHRAEWHGSDVAVKVLTVQDFL----DDQLKEFLREVAIMKRVRHPN--VVLFMGAVT---KR--PHLSIVTE  736 (867)
Q Consensus       668 G~GsFG~VykA~~~g~~VAVKvi~~~~~~----~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga~~---~~--~~l~LVmE  736 (867)
                      |.|+.+.|++-...|..+-+|........    .-....|.+|...+.+|..-+  +.+.. ++.   ..  -.-+||+|
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence            66899999999888888888876421110    123457899999998885322  33443 222   11  13689999


Q ss_pred             ccCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc--EEEEecCcccc
Q 002910          737 YLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRF  810 (867)
Q Consensus       737 y~~g-GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~--VKLsDFGLAr~  810 (867)
                      -+.+ -+|.+++.... ....+...+..++.+|+..+.-||..|  +.|+|+.+.|||++.++.  |+++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8753 58888876532 224577777889999999999999999  999999999999987777  99999987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=1.3e-05  Score=94.28  Aligned_cols=141  Identities=23%  Similarity=0.265  Sum_probs=90.3

Q ss_pred             EEeccCCceEEEEEEEc-CceEEEEEEeeccc---------------------------c-hHHHH----------HHHH
Q 002910          665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDF---------------------------L-DDQLK----------EFLR  705 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~---------------------------~-~~~~k----------~f~~  705 (867)
                      +.|+.++-|+||+|++. |+.||||+.+..-.                           . ...++          .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56899999999999995 99999999875321                           0 00011          1344


Q ss_pred             HHHHHHhcC-----CCCeeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 002910          706 EVAIMKRVR-----HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG-INYLHNLN  779 (867)
Q Consensus       706 Ei~ILk~Lr-----HPNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~G-L~YLHs~g  779 (867)
                      |..-+.+++     .++|.--.=+++-...-.|+|||+.|-.+.++......  .++.+.   ++..++.+ +..+-..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhcC
Confidence            555555542     23322111122223456799999999988887432221  244332   33333332 33344568


Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       780 p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                        +.|.|..|.||+++.+|.+.+.|||+...+.
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              9999999999999999999999999987643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=4.9e-05  Score=79.91  Aligned_cols=140  Identities=21%  Similarity=0.176  Sum_probs=85.1

Q ss_pred             EeccCCc-eEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEeccCCCCH
Q 002910          666 RVGAGSF-GTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       666 ~LG~GsF-G~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      .|-.|.. ..||+....+..+.||+.....     ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3444555 8899998777778888775432     234567888888774 33355777777766778999999999877


Q ss_pred             HHHH-------------------hcCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----
Q 002910          744 YRLI-------------------HRPAA-GEMMDQR--RRLRMAL--------------------DVAKGINYLHN----  777 (867)
Q Consensus       744 ~~~L-------------------~~~~~-~~~l~e~--~~l~ia~--------------------qIa~GL~YLHs----  777 (867)
                      ....                   |.... ...+...  .......                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6431                   11110 0011100  0000000                    01111222211    


Q ss_pred             -cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          778 -LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       778 -~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                       ..+.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence             224589999999999999988889999998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.96  E-value=1.2e-06  Score=102.55  Aligned_cols=180  Identities=17%  Similarity=0.109  Sum_probs=127.8

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCCeEEEEEeccCCC-
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLSIVTEYLPRG-  741 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN-IVkl~ga~~~~~~l~LVmEy~~gG-  741 (867)
                      .+.+++|+++++++.+-..+    |.+....+...  ....-++++|.+++||| .+..++-++.+...+++|+|+.++ 
T Consensus       247 fh~fvK~altknpKkRptae----klL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAE----KLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHhcCCCccCCChh----hheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            34468899999999875433    33322221111  33455789999999999 777777888888999999999887 


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV  821 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~  821 (867)
                      +-...+..  ....+.+.....+.+.-+++++|||+..  -+|||    |||... +.+|..||+....+.... ..++.
T Consensus       321 s~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~  390 (829)
T KOG0576|consen  321 SSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTA  390 (829)
T ss_pred             cccccCCh--hhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccccC
Confidence            22211111  1112334444556667788999999865  58999    777755 689999999987766554 45688


Q ss_pred             CCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          822 AGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       822 aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      .+|++|+|||+...+.+   .|.|+++.-..+|--|.+|-.
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            99999999998887766   699999987777877777654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.81  E-value=7.6e-05  Score=87.90  Aligned_cols=140  Identities=23%  Similarity=0.265  Sum_probs=87.4

Q ss_pred             EEeccCCceEEEEEEE-cCceEEEEEEeecccc-----------------------------hHHHH------HHHHHHH
Q 002910          665 ERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL-----------------------------DDQLK------EFLREVA  708 (867)
Q Consensus       665 e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~-----------------------------~~~~k------~f~~Ei~  708 (867)
                      +.||..+.|.||+|+. .|+.||||+.+..--.                             ++..+      .|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            4689999999999998 5888999997653210                             00001      1344544


Q ss_pred             HHHh----cCCCC------eeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHh
Q 002910          709 IMKR----VRHPN------VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI-NYLHN  777 (867)
Q Consensus       709 ILk~----LrHPN------IVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL-~YLHs  777 (867)
                      -..+    +.|-+      |.++|--++  ..-.|+||||+|..+.++-.-..  ..++...+..   .+.++. +-|-.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~---~l~~~~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDK--RGISPHDILN---KLVEAYLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHH--cCCCHHHHHH---HHHHHHHHHHHh
Confidence            3333    34555      334443332  34579999999986665433211  1255444333   333332 22334


Q ss_pred             cCCCccccCCCCCcEEEcC----CCcEEEEecCccccccC
Q 002910          778 LNPPILHWDLKSPNLLVDK----NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       778 ~gp~IVHRDLKPeNILLd~----~g~VKLsDFGLAr~~~~  813 (867)
                      .|  .+|+|=.|.|||+++    ++.+.+.|||+......
T Consensus       320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            68  999999999999984    67899999999876543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.78  E-value=0.00011  Score=75.54  Aligned_cols=135  Identities=24%  Similarity=0.273  Sum_probs=94.3

Q ss_pred             eEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee-eEEeEEeeCCeEEEEEeccC
Q 002910          661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIV-kl~ga~~~~~~l~LVmEy~~  739 (867)
                      .+..+.|++|.+|.||++.|.|..+|+|+-+.+    .....+..|+++|..+.-.++. ++|.+    +..++.|||+.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhc
Confidence            345677999999999999999999999987654    3456688999999998866554 34433    23356699999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCC-CCcEEEcCCCcEEEEecCccccccCCc
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK-SPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLK-PeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |-.|...-..      .+.++..    .+++.---|-..|  |-|..|. |...+|-.++.+.|+||.-|+....+.
T Consensus        96 G~~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~  160 (201)
T COG2112          96 GRPLGKLEIG------GDRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPR  160 (201)
T ss_pred             Ccchhhhhhc------ccHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhccCCc
Confidence            9888765432      1233333    3444433455678  9998887 554555455599999999998655443

>PLN02876 acyl-CoA dehydrogenase

Probab=97.73  E-value=0.00027  Score=87.85  Aligned_cols=146  Identities=18%  Similarity=0.236  Sum_probs=90.1

Q ss_pred             EEEeccCCceEEEEEEEcC----ceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCe--eeEEeEEeeC---CeEEE
Q 002910          664 KERVGAGSFGTVHRAEWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNV--VLFMGAVTKR---PHLSI  733 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g----~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNI--Vkl~ga~~~~---~~l~L  733 (867)
                      .+.|+.|.+..+|+..+.+    ..+++|+....... .....+.+|..+|+.+. |++|  .+++.++.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            5678999999999987754    35777765433221 12245779999999996 6665  6778877654   46789


Q ss_pred             EEeccCCCCHHH--------------------H---HhcCCC--------CCC--CCHHHHHHHHH--------------
Q 002910          734 VTEYLPRGSLYR--------------------L---IHRPAA--------GEM--MDQRRRLRMAL--------------  766 (867)
Q Consensus       734 VmEy~~gGSL~~--------------------~---L~~~~~--------~~~--l~e~~~l~ia~--------------  766 (867)
                      ||||++|..+.+                    .   ||....        +..  ...++...+..              
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998764321                    1   222110        000  00112211111              


Q ss_pred             -HHHHHHHHHHhcC---------CCccccCCCCCcEEEcCC-C-cEEEEecCcccc
Q 002910          767 -DVAKGINYLHNLN---------PPILHWDLKSPNLLVDKN-W-TVKVCDFGLSRF  810 (867)
Q Consensus       767 -qIa~GL~YLHs~g---------p~IVHRDLKPeNILLd~~-g-~VKLsDFGLAr~  810 (867)
                       .+...+.+|..+-         +.+||+|+++.|||++.+ + .+-|.||.++..
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence             1233456665422         249999999999999853 3 357999999764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.66  E-value=0.00087  Score=70.27  Aligned_cols=127  Identities=26%  Similarity=0.390  Sum_probs=91.9

Q ss_pred             CCeEEEEEeccCCc-eEEEEEEEcCceEEEEEEeeccc----------ch---------HHHHHHHHHHHHHHhcC---C
Q 002910          659 DELHVKERVGAGSF-GTVHRAEWHGSDVAVKVLTVQDF----------LD---------DQLKEFLREVAIMKRVR---H  715 (867)
Q Consensus       659 ~dy~i~e~LG~GsF-G~VykA~~~g~~VAVKvi~~~~~----------~~---------~~~k~f~~Ei~ILk~Lr---H  715 (867)
                      .+++.++.||.|.- |.||+++..|..+|+|+++.-..          ..         ....-|..|-+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78999999999999 99999999999999999432111          00         11234678888777765   4


Q ss_pred             CCe--eeEEeEEeeC------------------CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 002910          716 PNV--VLFMGAVTKR------------------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL  775 (867)
Q Consensus       716 PNI--Vkl~ga~~~~------------------~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YL  775 (867)
                      .++  |+++|+..-.                  ....||.||++...            .+..    .-+.+|.+-|..|
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence            566  8999987321                  12468888876543            1222    2345677788999


Q ss_pred             HhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       776 Hs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      |..|  |+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC--eeeccCcccccc-----CCEEEecccC
Confidence            9999  999999999976     3589999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.59  E-value=0.00014  Score=78.10  Aligned_cols=138  Identities=19%  Similarity=0.140  Sum_probs=90.3

Q ss_pred             EEeccCCceEEEEEEE-cCceEEEEEEeecccchHHH--------------------H--HHHHHHHHHHhcCCCC--ee
Q 002910          665 ERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQL--------------------K--EFLREVAIMKRVRHPN--VV  719 (867)
Q Consensus       665 e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~--------------------k--~f~~Ei~ILk~LrHPN--IV  719 (867)
                      -.|.+|.-+.||+|.. .+..+|||+++.....-..+                    .  -..+|..-|+++....  +.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            3788899999999976 58889999997653221111                    0  1245666666654322  22


Q ss_pred             eEEeEEeeCCeEEEEEeccCCCCH-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCC
Q 002910          720 LFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       720 kl~ga~~~~~~l~LVmEy~~gGSL-~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~  797 (867)
                      +-+.+    .+..|||||+....+ .-.|..    ..+.......+..++++.|.-|-. .+  +||+||..-|||+. +
T Consensus       134 ~Pi~~----~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAF----RNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-D  202 (268)
T ss_pred             Cceee----cCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-C
Confidence            22322    234689999954311 111111    112333567778889899888776 78  99999999999998 7


Q ss_pred             CcEEEEecCccccccC
Q 002910          798 WTVKVCDFGLSRFKAN  813 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~  813 (867)
                      +.+.|+|||=+-...+
T Consensus       203 ~~p~iID~~QaV~~~h  218 (268)
T COG1718         203 GEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CeEEEEECccccccCC
Confidence            8999999997755443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.49  E-value=0.00054  Score=72.06  Aligned_cols=72  Identities=19%  Similarity=0.220  Sum_probs=44.2

Q ss_pred             EEeccCCce-EEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC---CeeeEEeEEeeC---CeEEEEEec
Q 002910          665 ERVGAGSFG-TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP---NVVLFMGAVTKR---PHLSIVTEY  737 (867)
Q Consensus       665 e~LG~GsFG-~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP---NIVkl~ga~~~~---~~l~LVmEy  737 (867)
                      +.|+.|+.. .||+.   +..+.+|+.....    ....+.+|..+|..+...   -+..+++.....   +..+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457777766 58875   3457777644321    234678899998877532   233444433322   235889999


Q ss_pred             cCCCCH
Q 002910          738 LPRGSL  743 (867)
Q Consensus       738 ~~gGSL  743 (867)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.49  E-value=2e-05  Score=93.59  Aligned_cols=95  Identities=17%  Similarity=0.256  Sum_probs=71.2

Q ss_pred             HHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC-C------c--ccccccCCCcccccccccCC-
Q 002910          766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-T------F--ISSKSVAGTVVFFAAHQTAC-  835 (867)
Q Consensus       766 ~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~-t------~--~s~~s~aGTp~YmAPEvl~~-  835 (867)
                      .+++.||.|+|.. ..+||+.|.|++|.++.++.+||+.|+++-.... +      +  ...........|.|||++.+ 
T Consensus       106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3566999999974 3599999999999999999999999998754322 0      0  00112244579999999885 


Q ss_pred             --CChHHHHHHHHHHHHHh-cCCCCcccc
Q 002910          836 --NSLALIFSLSGWLQSSF-EESPQMRSL  861 (867)
Q Consensus       836 --~~~SDIwSLG~lLyeM~-tG~~Pf~sl  861 (867)
                        +..+|+||||+++|.++ +|+.-+..-
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhcc
Confidence              45589999999999999 665554443

>PRK10593 hypothetical protein; Provisional

Probab=97.43  E-value=0.0016  Score=71.61  Aligned_cols=78  Identities=9%  Similarity=-0.050  Sum_probs=55.9

Q ss_pred             EEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC---CCeeeEEeEEee---CCeEEEEE
Q 002910          662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---PNVVLFMGAVTK---RPHLSIVT  735 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH---PNIVkl~ga~~~---~~~l~LVm  735 (867)
                      .-.+.||.|..+.||+....+..+.+|..+.. .   ....+.+|...|+.|.-   -.+.++++++..   .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~-~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGNPMPLMARSF-S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCCEEEEEeccc-c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34667999999999998775556777774321 0   12357788998888853   256778877654   36689999


Q ss_pred             eccCCCCH
Q 002910          736 EYLPRGSL  743 (867)
Q Consensus       736 Ey~~gGSL  743 (867)
                      |+++|+++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.43  E-value=0.00041  Score=71.60  Aligned_cols=103  Identities=17%  Similarity=0.177  Sum_probs=78.7

Q ss_pred             HHHHHHHHhcCC-CCeeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CC
Q 002910          704 LREVAIMKRVRH-PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-PP  781 (867)
Q Consensus       704 ~~Ei~ILk~LrH-PNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g-p~  781 (867)
                      ..|.-+|+.+.+ +++++++|+|-   + ++|+||+..++++..-..-......+|..+.++|.+++..+++|+..- ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888886 68999999983   2 568899987766532000001123689999999999999999998621 12


Q ss_pred             ccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       782 IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +...|++++|+-++.+|.+|++|...+-.
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            77799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.37  E-value=0.0015  Score=68.11  Aligned_cols=73  Identities=16%  Similarity=0.202  Sum_probs=47.5

Q ss_pred             EEEeccCCceEEEEEEEc---CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC-CeeeEEeEEeeCCeEEEEEeccC
Q 002910          664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP-NVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~---g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP-NIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      ++.|..|-...+|+....   +..|.+|+......   ......+|+.+++.+... ..+++++.+. .   .+||||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence            456788888999999875   46788897654321   112234688888888533 3445554432 2   47999998


Q ss_pred             CCCH
Q 002910          740 RGSL  743 (867)
Q Consensus       740 gGSL  743 (867)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>smart00460 TGc Transglutaminase/protease-like homologues

Probab=97.33  E-value=0.00035  Score=59.17  Aligned_cols=53  Identities=26%  Similarity=0.331  Sum_probs=43.4

Q ss_pred             cccccchhhHHHHHhhhhhcCCCceeecccccc---------CCCCcceEEEEecCCCCCCceEEEe
Q 002910          404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYC---------EADHRSSCLVKIEDDRRSSREYVVD  461 (867)
Q Consensus       404 l~~Gl~rHRALLFKvLAD~IglpcrLvrG~~y~---------~~~~~a~n~V~l~~~~~~~~eyiVD  461 (867)
                      -+.|.|.+.|.||+.|+-.+|||||+|.|..--         .....+||+|.++ ++    =|.+|
T Consensus         4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~----W~~~D   65 (68)
T smart00460        4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GG----WVPVD   65 (68)
T ss_pred             ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CC----eEEEe
Confidence            367999999999999999999999999995432         2567899999995 44    46666

Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.31  E-value=0.00076  Score=71.73  Aligned_cols=136  Identities=17%  Similarity=0.163  Sum_probs=78.2

Q ss_pred             eccCCceEEEEEEEcCceEEEEEEeecccchHHH-HHHHHHHHHHHhcCCCCe-eeEEeEEeeCCeEEEEEeccCCCCHH
Q 002910          667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYLPRGSLY  744 (867)
Q Consensus       667 LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~-k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~~l~LVmEy~~gGSL~  744 (867)
                      +..|-...+|+....+..+.+|+.....   ... -...+|..+++.+....+ .+++....    -++||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            4567788999988778788888754321   111 124678888888864333 33443332    36899999986653


Q ss_pred             H--------------H---HhcCCC-CCCCCHH-HHHHHHHHH---------HHHHHHHHhc------CCCccccCCCCC
Q 002910          745 R--------------L---IHRPAA-GEMMDQR-RRLRMALDV---------AKGINYLHNL------NPPILHWDLKSP  790 (867)
Q Consensus       745 ~--------------~---L~~~~~-~~~l~e~-~~l~ia~qI---------a~GL~YLHs~------gp~IVHRDLKPe  790 (867)
                      .              .   ||.... ...++.. ....+..++         ...+..+-..      .+.++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              1   222111 1111211 111221111         1112222211      235899999999


Q ss_pred             cEEEcCCCcEEEEecCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~  810 (867)
                      |||++.++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998865

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.26  E-value=0.0032  Score=65.77  Aligned_cols=133  Identities=17%  Similarity=0.239  Sum_probs=91.5

Q ss_pred             EEeccCCceEEEEEEEcCceEEEEEEeecc--------------cchHHHHHHHHHHHHHHhcC------CCCeeeEEeE
Q 002910          665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQD--------------FLDDQLKEFLREVAIMKRVR------HPNVVLFMGA  724 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~~VAVKvi~~~~--------------~~~~~~k~f~~Ei~ILk~Lr------HPNIVkl~ga  724 (867)
                      ..||+|+.=.||.--. .....||+.....              ......++..+|+.-...+.      +.+|.+++|+
T Consensus         7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~   85 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF   85 (199)
T ss_pred             cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence            4589999988886433 3446788887665              11122455677777666665      7889999999


Q ss_pred             EeeCCeEEEEEeccCC------CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-
Q 002910          725 VTKRPHLSIVTEYLPR------GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-  797 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~g------GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-  797 (867)
                      .++.--+-+|+|.+..      -+|.+++...    .+++ ....   .+-.-..||-.++  |+.+||+|.||++... 
T Consensus        86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~---~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQ---ALDEFKRYLLDHH--IVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHH---HHHHHHHHHHHcC--CeecCCCcccEEEEecC
Confidence            9999889999998642      3788888542    2555 3332   3334466888888  9999999999999533 


Q ss_pred             --C-cEEEEe-cCcc
Q 002910          798 --W-TVKVCD-FGLS  808 (867)
Q Consensus       798 --g-~VKLsD-FGLA  808 (867)
                        . .+.|+| ||-.
T Consensus       156 ~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  156 SGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCceEEEEEeCCCCc
Confidence              2 467776 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.12  E-value=0.00014  Score=92.11  Aligned_cols=188  Identities=14%  Similarity=0.075  Sum_probs=129.3

Q ss_pred             eEEEEEEEcCce---EEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeEEe--eCCeEEEEEeccCCCCHH
Q 002910          673 GTVHRAEWHGSD---VAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHLSIVTEYLPRGSLY  744 (867)
Q Consensus       673 G~VykA~~~g~~---VAVKvi~~~~~~---~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~--~~~~l~LVmEy~~gGSL~  744 (867)
                      +.-++++|-+..   +-+|+.+..++.   +...+-...|+..++...|+++...+.-..  +....++.++|+.+|.++
T Consensus      1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred             ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence            344566663222   455555443322   222333456666777789999887665443  334578999999999999


Q ss_pred             HHHhcCCCCC-CCCHHHHHHHHHHHHHHHHHHHh---cCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          745 RLIHRPAAGE-MMDQRRRLRMALDVAKGINYLHN---LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       745 ~~L~~~~~~~-~l~e~~~l~ia~qIa~GL~YLHs---~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      ..|-+..... .+++.-+.....+.+....-+|.   .|...+|++||+-|.+|..+..+|+.++||.+...........
T Consensus      1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred             HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence            9987633222 23333333333333667777664   3345899999999999999999999999999966655555567


Q ss_pred             cCCCcccccccccCC---CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          821 VAGTVVFFAAHQTAC---NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       821 ~aGTp~YmAPEvl~~---~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..+++.|++|++...   ...+|||.+|+-+|..-.|.++|.-
T Consensus      1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred             hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence            788999999988664   3348999999999999888877754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.85  E-value=0.014  Score=63.17  Aligned_cols=142  Identities=18%  Similarity=0.124  Sum_probs=84.5

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEe------EEeeCCeEEEEE
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMG------AVTKRPHLSIVT  735 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~g------a~~~~~~l~LVm  735 (867)
                      .+.|..|....+|+....+..+++|+....  .   ...+..|+.++..+.+.+  +.+.+.      +....+..++||
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            556777888899998877778999987641  1   234566777777775332  344433      123345678999


Q ss_pred             eccCCCCHHH--------------HHhcCCCC--------CCCCHHHHH----------HHHHHHHHHHHHHHh-----c
Q 002910          736 EYLPRGSLYR--------------LIHRPAAG--------EMMDQRRRL----------RMALDVAKGINYLHN-----L  778 (867)
Q Consensus       736 Ey~~gGSL~~--------------~L~~~~~~--------~~l~e~~~l----------~ia~qIa~GL~YLHs-----~  778 (867)
                      +|++|..+..              .+|.....        ....+....          .....+...+.++..     .
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998866421              11110000        001111100          011112334444443     1


Q ss_pred             CCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       779 gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ...+||+|+.|.|||++.++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            12399999999999999987789999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.83  E-value=0.007  Score=65.83  Aligned_cols=140  Identities=18%  Similarity=0.244  Sum_probs=81.9

Q ss_pred             EEEeccCCceEEEEEEEc--------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCeEEEE
Q 002910          664 KERVGAGSFGTVHRAEWH--------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIV  734 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~--------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~~l~LV  734 (867)
                      ++.|..|-...||+....        +..+.+|+.....   .......+|..++..+....+ .++++++. .   .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            345666777789988764        3678889865432   122345678888888753333 35555553 2   358


Q ss_pred             EeccCCCCHHHH-----------------HhcCCCCC------CCC--HHHHHH--------------------------
Q 002910          735 TEYLPRGSLYRL-----------------IHRPAAGE------MMD--QRRRLR--------------------------  763 (867)
Q Consensus       735 mEy~~gGSL~~~-----------------L~~~~~~~------~l~--e~~~l~--------------------------  763 (867)
                      |||++|..+...                 +|......      ..+  ++....                          
T Consensus        76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (302)
T cd05156          76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL  155 (302)
T ss_pred             hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence            999988765321                 12211110      000  111111                          


Q ss_pred             HHHHHHHHHHHHHh-------cCCCccccCCCCCcEEEcCC----CcEEEEecCcccc
Q 002910          764 MALDVAKGINYLHN-------LNPPILHWDLKSPNLLVDKN----WTVKVCDFGLSRF  810 (867)
Q Consensus       764 ia~qIa~GL~YLHs-------~gp~IVHRDLKPeNILLd~~----g~VKLsDFGLAr~  810 (867)
                      +...+..-+.+|-.       ....++|+|+.+.|||++++    +.++|+||..|..
T Consensus       156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            11122223344432       23358999999999999985    8899999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.82  E-value=0.022  Score=62.42  Aligned_cols=142  Identities=12%  Similarity=0.122  Sum_probs=76.3

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-----CCCeeeEE---eEEeeCCeEEEEE
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----HPNVVLFM---GAVTKRPHLSIVT  735 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-----HPNIVkl~---ga~~~~~~l~LVm  735 (867)
                      .+.|+.|....+|+....+..+.+|++.  .....   .+..|+.++..|.     .|.++.-.   .+....+..+++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEec--cCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            3457778888999988766678999875  12222   2333455555543     23333210   0123356679999


Q ss_pred             eccCCCCHH-----------HH---HhcCCCC--------CCCCH-HHHHH------------HHHH-HHHHHHHHHh--
Q 002910          736 EYLPRGSLY-----------RL---IHRPAAG--------EMMDQ-RRRLR------------MALD-VAKGINYLHN--  777 (867)
Q Consensus       736 Ey~~gGSL~-----------~~---L~~~~~~--------~~l~e-~~~l~------------ia~q-Ia~GL~YLHs--  777 (867)
                      ||++|..+.           ..   +|.....        ..+.+ .....            .+.+ +...++.+..  
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            999887431           11   1111100        00111 11110            1111 1112233321  


Q ss_pred             ---cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          778 ---LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       778 ---~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                         ....+||+|+.+.|||++.+..+-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               112399999999999998776668999999854

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.81  E-value=0.016  Score=63.54  Aligned_cols=146  Identities=17%  Similarity=0.119  Sum_probs=83.4

Q ss_pred             eEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeE------EeeCCeEE
Q 002910          661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGA------VTKRPHLS  732 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga------~~~~~~l~  732 (867)
                      ...++.++.|.-..+|+....+..+.+|+..... .   ...+..|.+++..|....  +.+++..      ....+..+
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            3445667778778999987766678888765421 1   123445677777664222  3343331      12245678


Q ss_pred             EEEeccCCCCHH-----------H---HHhcCCCCC---------CCCHHHHH------------HHHHHHHHHHHHHHh
Q 002910          733 IVTEYLPRGSLY-----------R---LIHRPAAGE---------MMDQRRRL------------RMALDVAKGINYLHN  777 (867)
Q Consensus       733 LVmEy~~gGSL~-----------~---~L~~~~~~~---------~l~e~~~l------------~ia~qIa~GL~YLHs  777 (867)
                      ++|||++|..+.           .   .+|....+-         ...|....            .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885432           1   122111100         00111000            011123345555542


Q ss_pred             -----cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          778 -----LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       778 -----~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                           ....+||+|+.+.||+++.++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                 123499999999999999988779999999853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.73  E-value=0.018  Score=66.21  Aligned_cols=77  Identities=18%  Similarity=0.042  Sum_probs=52.4

Q ss_pred             EEEeccCCceEEEEEEEcC--ceEEEEEEeecccc-----hHHHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCeEEE
Q 002910          664 KERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFL-----DDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g--~~VAVKvi~~~~~~-----~~~~k~f~~Ei~ILk~Lr---HPNIVkl~ga~~~~~~l~L  733 (867)
                      .+.||.|.+..||++...+  +.+.||.-......     .-...++..|.+.|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4578999999999998854  37999975321110     113456677888888763   2456777765  4455789


Q ss_pred             EEeccCCCC
Q 002910          734 VTEYLPRGS  742 (867)
Q Consensus       734 VmEy~~gGS  742 (867)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning]

Probab=96.71  E-value=0.0014  Score=75.53  Aligned_cols=54  Identities=31%  Similarity=0.535  Sum_probs=45.7

Q ss_pred             cccchhhHHHHHhhhhhcCCCceeeccccccC-------CCCcceEEEEecCCCCCCceEEEeccC
Q 002910          406 MGLCRHRAILFKKLADYIGLPCRIARGCRYCE-------ADHRSSCLVKIEDDRRSSREYVVDLVG  464 (867)
Q Consensus       406 ~Gl~rHRALLFKvLAD~IglpcrLvrG~~y~~-------~~~~a~n~V~l~~~~~~~~eyiVDLm~  464 (867)
                      -+.|-.-|.|||.||-..||||-+|+|.--.+       ..+.|||.|+|++ .    =|+||.--
T Consensus       209 eavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~-~----yy~VDtTw  269 (521)
T COG5279         209 EAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDN-E----YYLVDTTW  269 (521)
T ss_pred             ccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECC-e----EEEEeeec
Confidence            47899999999999999999999999962222       4589999999977 3    59999765

>PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i

Probab=96.54  E-value=0.0017  Score=59.94  Aligned_cols=48  Identities=25%  Similarity=0.368  Sum_probs=37.0

Q ss_pred             ccccchhhHHHHHhhhhhcCCCceeecccccc----------CCCCcceEEEEecCCC
Q 002910          405 SMGLCRHRAILFKKLADYIGLPCRIARGCRYC----------EADHRSSCLVKIEDDR  452 (867)
Q Consensus       405 ~~Gl~rHRALLFKvLAD~IglpcrLvrG~~y~----------~~~~~a~n~V~l~~~~  452 (867)
                      +.|.|...|.||..|+-.+|||||+|.|...-          +....+||+|.+.+++
T Consensus        50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~  107 (113)
T PF01841_consen   50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGG  107 (113)
T ss_dssp             EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTE
T ss_pred             CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCc
Confidence            45999999999999999999999999984431          2335799999995443

e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.15  E-value=0.035  Score=62.15  Aligned_cols=148  Identities=17%  Similarity=0.230  Sum_probs=81.3

Q ss_pred             EEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeEEeeCC--eEEEEEec
Q 002910          662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRP--HLSIVTEY  737 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga~~~~~--~l~LVmEy  737 (867)
                      .+.+.+..|---.+|.....++.+.+. ...............+|..+|+.+.--.  +...++.|....  ..|.||+|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             ceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            344445444444455555557777777 3321222244556677888888764311  234455555444  67999999


Q ss_pred             cCCCCHHHHH------------------h---c------CCCCC--CCCHHHHHHHHHH--------------HHHHHHH
Q 002910          738 LPRGSLYRLI------------------H---R------PAAGE--MMDQRRRLRMALD--------------VAKGINY  774 (867)
Q Consensus       738 ~~gGSL~~~L------------------~---~------~~~~~--~l~e~~~l~ia~q--------------Ia~GL~Y  774 (867)
                      +.|..+...+                  .   +      ...+.  ....++...+..+              ...-..|
T Consensus       107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            9883222111                  1   1      00000  0011111111111              1222445


Q ss_pred             HHhcC------CCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          775 LHNLN------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       775 LHs~g------p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      |+.+.      ++++|+|+.+.||+|+..+-+-|.||+++..
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            55433      3699999999999999998899999999865

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.08  E-value=0.066  Score=58.12  Aligned_cols=29  Identities=28%  Similarity=0.329  Sum_probs=25.3

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       781 ~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++|+|+.+.|||++. +.+.|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            4899999999999987 6789999997754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.04  E-value=0.049  Score=60.08  Aligned_cols=76  Identities=20%  Similarity=0.169  Sum_probs=47.9

Q ss_pred             eEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCeEEEEEec
Q 002910          661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr---HPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .+-.+.|+-|....+|+....+..+.||+-....     ...|..|..-|+.|.   --.+.+.+++....+.-+|||||
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            3456778999999999999888889999876321     234667777777773   33567888888777777999999


Q ss_pred             cCCC
Q 002910          738 LPRG  741 (867)
Q Consensus       738 ~~gG  741 (867)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.02  E-value=0.044  Score=61.62  Aligned_cols=145  Identities=16%  Similarity=0.249  Sum_probs=82.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee-eEEeEEeeCCeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LFMGAVTKRPHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIV-kl~ga~~~~~~l  731 (867)
                      +.+.+ +.|-.|-.-.+|++.+.      +..|.+|+.....   ...-.-.+|..+++.+...++. ++++.+.. +  
T Consensus        37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g--  109 (344)
T PLN02236         37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G--  109 (344)
T ss_pred             CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECC-c--
Confidence            34444 45555888999998763      2468888775432   1111225688888887644333 55565532 2  


Q ss_pred             EEEEeccCCCCHHHH-----------------HhcCCC---CCCCCHHHHHHHHHHH-----------------HHHHHH
Q 002910          732 SIVTEYLPRGSLYRL-----------------IHRPAA---GEMMDQRRRLRMALDV-----------------AKGINY  774 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~-----------------L~~~~~---~~~l~e~~~l~ia~qI-----------------a~GL~Y  774 (867)
                       .|+||+++.+|...                 +|....   .....+.+...+..++                 ..-+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             58999987665311                 222110   1111223333332211                 111222


Q ss_pred             HH----h--cCCCccccCCCCCcEEEcC-CCcEEEEecCccccc
Q 002910          775 LH----N--LNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFK  811 (867)
Q Consensus       775 LH----s--~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~~  811 (867)
                      |.    .  ....++|+|+++.|||+++ ++.+.|+||.++...
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            22    1  1225899999999999986 478999999998653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=95.99  E-value=0.028  Score=70.99  Aligned_cols=185  Identities=16%  Similarity=0.137  Sum_probs=127.3

Q ss_pred             eccCCceEEEEEEEcCc------eEEEEEEeec-ccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe----EEEEE
Q 002910          667 VGAGSFGTVHRAEWHGS------DVAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH----LSIVT  735 (867)
Q Consensus       667 LG~GsFG~VykA~~~g~------~VAVKvi~~~-~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~----l~LVm  735 (867)
                      |..-.+|+|+..+|.-+      .+-++.-... ............|...+....|+|++.++.+-.....    +.+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            55567788888877311      1211111101 1112345555677788889999999999887654432    33556


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC---cEEEcCCCcEEEE--ecCcccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP---NLLVDKNWTVKVC--DFGLSRF  810 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe---NILLd~~g~VKLs--DFGLAr~  810 (867)
                      |||..-++...++..   ..++....+.+..++.+||.|+|+..  ..|.-|...   +..++..+.+.++  ||+.++.
T Consensus       266 ~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~  340 (1351)
T KOG1035|consen  266 EICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP  340 (1351)
T ss_pred             hhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhccccc
Confidence            788888888888763   34778888889999999999999987  666666555   5556677788887  9998887


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh-----HHHHHHHHHHHHHhcCCCC
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL-----ALIFSLSGWLQSSFEESPQ  857 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~-----SDIwSLG~lLyeM~tG~~P  857 (867)
                      ..+.... ....-+..|.++|....+..     .|+|.+|..+..+..|..+
T Consensus       341 l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i  391 (1351)
T KOG1035|consen  341 LPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI  391 (1351)
T ss_pred             CCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence            6654332 23345677889988886544     5999999999888776543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.75  E-value=0.048  Score=62.00  Aligned_cols=139  Identities=17%  Similarity=0.204  Sum_probs=91.2

Q ss_pred             EEEEeccCCceEEEEEEE-cCceEEEEEEeecccc----------------------hHHHHHH--HHHHHHHHhcCCCC
Q 002910          663 VKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL----------------------DDQLKEF--LREVAIMKRVRHPN  717 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~----------------------~~~~k~f--~~Ei~ILk~LrHPN  717 (867)
                      |--+|..|.-+-||.|.. +|..+|||+++..-+.                      ...+-..  ..|++-|++|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            445788999999999977 6888999998754221                      0111122  35777788887655


Q ss_pred             eeeEEeEEeeCCeEEEEEeccCCCCH-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEc
Q 002910          718 VVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       718 IVkl~ga~~~~~~l~LVmEy~~gGSL-~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd  795 (867)
                      |.---- ..- ....|||+|+.+... .-.|+.    ..+....+..+-.+++.-|.-|-+ .+  +||.||.--|+|+ 
T Consensus       228 IP~PeP-IlL-k~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly-  298 (520)
T KOG2270|consen  228 IPCPEP-ILL-KNHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY-  298 (520)
T ss_pred             CCCCCc-eee-ecceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE-
Confidence            431100 000 124689999953221 112221    236666777788888888887764 55  9999999999999 


Q ss_pred             CCCcEEEEecCcccc
Q 002910          796 KNWTVKVCDFGLSRF  810 (867)
Q Consensus       796 ~~g~VKLsDFGLAr~  810 (867)
                      .+|.+.|+|-+=+-.
T Consensus       299 hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVE  313 (520)
T ss_pred             ECCEEEEEEcccccc
Confidence            566899999986643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.65  E-value=0.012  Score=65.89  Aligned_cols=133  Identities=20%  Similarity=0.169  Sum_probs=91.1

Q ss_pred             eEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchH------------------HH--HHHHHHHHHHHhcC-CCC-
Q 002910          661 LHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDD------------------QL--KEFLREVAIMKRVR-HPN-  717 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~------------------~~--k~f~~Ei~ILk~Lr-HPN-  717 (867)
                      +.++++||-|.-+-||.+-. .|++.++|+-+....+-.                  .+  -...+|...|+.|. |.+ 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45788999999999999987 589999886443221100                  01  12457888888875 333 


Q ss_pred             eeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       718 IVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      +.+-+    +....++|||++.|-.|.+.-+-      .+...+.   ..++.-+.-|-.+|  +||+|..-=||+|+.+
T Consensus       174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly---~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  174 VPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLY---DDLMGLIVRLANHG--LIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCcc----cccceeeHHHhhcccceeeeeec------CChHHHH---HHHHHHHHHHHHcC--ceecccchheeEEecC
Confidence            22333    34567899999988877654332      2333332   33444455677889  9999999999999999


Q ss_pred             CcEEEEecCcc
Q 002910          798 WTVKVCDFGLS  808 (867)
Q Consensus       798 g~VKLsDFGLA  808 (867)
                      +.++++||-=+
T Consensus       239 ~~i~vIDFPQm  249 (465)
T KOG2268|consen  239 DKIVVIDFPQM  249 (465)
T ss_pred             CCEEEeechHh
Confidence            99999999643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.65  E-value=0.073  Score=59.50  Aligned_cols=148  Identities=17%  Similarity=0.253  Sum_probs=82.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCc-----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~-----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~  728 (867)
                      .+..+++.+....| |-...+|+....+.     .|.+|+.....   +..-.-.+|..+++.+..-++ .++++++. .
T Consensus        11 ~~~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~   85 (330)
T PLN02421         11 DLDDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFG-N   85 (330)
T ss_pred             cCCcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeC-C
Confidence            33445566555444 88888999876432     68888765432   112223568888888865444 35565553 3


Q ss_pred             CeEEEEEeccCCCCHHH-----------------HHhcCC-CC--CCCCHHHHHHHHHHH--------------------
Q 002910          729 PHLSIVTEYLPRGSLYR-----------------LIHRPA-AG--EMMDQRRRLRMALDV--------------------  768 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~-----------------~L~~~~-~~--~~l~e~~~l~ia~qI--------------------  768 (867)
                      +   +|.+|+++..|..                 .+|... ..  ...-+.....+..++                    
T Consensus        86 G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~  162 (330)
T PLN02421         86 G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFE  162 (330)
T ss_pred             c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHH
Confidence            2   5899997765421                 122211 00  011122222222221                    


Q ss_pred             --HHHHHHHH----hcC--CCccccCCCCCcEEEcC-CCcEEEEecCcccc
Q 002910          769 --AKGINYLH----NLN--PPILHWDLKSPNLLVDK-NWTVKVCDFGLSRF  810 (867)
Q Consensus       769 --a~GL~YLH----s~g--p~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~  810 (867)
                        ..-+..+.    ..+  ...+|.||.+.|||+++ ++.++++||..|..
T Consensus       163 ~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        163 ELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              11111111    111  24799999999999974 57899999999865

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.60  E-value=0.091  Score=60.77  Aligned_cols=75  Identities=13%  Similarity=-0.010  Sum_probs=50.9

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeeccc--ch---HHHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCeEEEEE
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--LD---DQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~--~~---~~~k~f~~Ei~ILk~Lr---HPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .+.||-|.-..||+....+..+.||.-.....  ..   -...+-..|.+.|+.+.   ..++.+++.++.  ..-+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            56789999999999887766788887552211  00   12344455677776653   246778887776  4467889


Q ss_pred             eccCC
Q 002910          736 EYLPR  740 (867)
Q Consensus       736 Ey~~g  740 (867)
                      ||+++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99976

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.40  E-value=0.11  Score=56.79  Aligned_cols=31  Identities=19%  Similarity=0.392  Sum_probs=25.9

Q ss_pred             CCccccCCCCCcEEEcCCCc-EEEEecCcccc
Q 002910          780 PPILHWDLKSPNLLVDKNWT-VKVCDFGLSRF  810 (867)
Q Consensus       780 p~IVHRDLKPeNILLd~~g~-VKLsDFGLAr~  810 (867)
                      +.++|+|+.+.|||+++++. +-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 57999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.05  E-value=0.67  Score=51.01  Aligned_cols=30  Identities=20%  Similarity=0.283  Sum_probs=27.4

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       781 ~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .+||+|+.+.|+|++.++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.97  E-value=0.34  Score=52.36  Aligned_cols=75  Identities=27%  Similarity=0.297  Sum_probs=51.2

Q ss_pred             EEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC---CCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---PNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       665 e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH---PNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      +.+.-|.--..|+.......+-||+-..     ..+..|..|+.=|+.|.-   -.+.+++.+-....+.|+||||++.|
T Consensus        22 ~~v~gG~inea~~v~dg~~~~FvK~n~~-----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          22 EEVSGGDINEAWRLRDGTDPFFVKCNQR-----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cccCCccccceeEeecCCcceEEEecch-----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            3444455555677666677788887432     334556677766665543   45667888888899999999999886


Q ss_pred             CHH
Q 002910          742 SLY  744 (867)
Q Consensus       742 SL~  744 (867)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            554

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=93.42  E-value=0.29  Score=53.02  Aligned_cols=30  Identities=30%  Similarity=0.452  Sum_probs=25.5

Q ss_pred             CccccCCCCCcEEEcCC--C---cEEEEecCcccc
Q 002910          781 PILHWDLKSPNLLVDKN--W---TVKVCDFGLSRF  810 (867)
Q Consensus       781 ~IVHRDLKPeNILLd~~--g---~VKLsDFGLAr~  810 (867)
                      .|+|+|+++.|||+..+  |   .+++.||-+++.
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence            59999999999999654  3   689999998865

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.39  E-value=0.092  Score=54.31  Aligned_cols=30  Identities=33%  Similarity=0.545  Sum_probs=21.6

Q ss_pred             CccccCCCCCcEEE-cCCCcEEEEecCcccc
Q 002910          781 PILHWDLKSPNLLV-DKNWTVKVCDFGLSRF  810 (867)
Q Consensus       781 ~IVHRDLKPeNILL-d~~g~VKLsDFGLAr~  810 (867)
                      .++|.||.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=92.68  E-value=0.42  Score=54.63  Aligned_cols=74  Identities=19%  Similarity=0.044  Sum_probs=46.6

Q ss_pred             EeccCCceEEEEEEEcC--ceEEEEEEeeccc-----chHHHHHHHHHHHHHHhcC--CC-CeeeEEeEEeeCCeEEEEE
Q 002910          666 RVGAGSFGTVHRAEWHG--SDVAVKVLTVQDF-----LDDQLKEFLREVAIMKRVR--HP-NVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~g--~~VAVKvi~~~~~-----~~~~~k~f~~Ei~ILk~Lr--HP-NIVkl~ga~~~~~~l~LVm  735 (867)
                      .||-|-...||++...+  +.|+||.-.....     ..-...+...|...|+...  -| .+.++|.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47899999999998753  4688886432111     0112345567788887653  34 45555533  455567999


Q ss_pred             eccCCC
Q 002910          736 EYLPRG  741 (867)
Q Consensus       736 Ey~~gG  741 (867)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.48  E-value=0.35  Score=55.21  Aligned_cols=74  Identities=22%  Similarity=0.242  Sum_probs=55.3

Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ..++|++|++- |+.|.. +      ....+.+...++.+.+.-+.-|.. .-+.-||||.-.||||+ +|+|.|+||-+
T Consensus       298 ~~y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeee
Confidence            34578888875 666642 2      124567777787777666666654 34689999999999999 99999999999


Q ss_pred             cccc
Q 002910          808 SRFK  811 (867)
Q Consensus       808 Ar~~  811 (867)
                      ||.-
T Consensus       368 sRl~  371 (488)
T COG5072         368 SRLS  371 (488)
T ss_pred             eecc
Confidence            9853

>PTZ00384 choline kinase; Provisional

Probab=92.42  E-value=0.84  Score=52.48  Aligned_cols=84  Identities=12%  Similarity=0.120  Sum_probs=47.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC---ceEEEEE-Eeec-ccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHG---SDVAVKV-LTVQ-DFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g---~~VAVKv-i~~~-~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~  729 (867)
                      +..+++.+. .|..|-...+|++...+   ..+.+|. +... .......-.-.+|+.+++.+...++ .++++.+.   
T Consensus        48 ~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---  123 (383)
T PTZ00384         48 VNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---  123 (383)
T ss_pred             CCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC---
Confidence            333455554 45458889999997632   2232331 1110 0111111223568899999875544 45666653   


Q ss_pred             eEEEEEeccCCCCHH
Q 002910          730 HLSIVTEYLPRGSLY  744 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~  744 (867)
                       -++|.||++|..|.
T Consensus       124 -~g~l~efIeGr~l~  137 (383)
T PTZ00384        124 -DFTIQEWVEGNTMG  137 (383)
T ss_pred             -CEEEEEEeccccCC
Confidence             26999999887654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.83  E-value=0.55  Score=50.60  Aligned_cols=103  Identities=14%  Similarity=0.100  Sum_probs=66.0

Q ss_pred             eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHH
Q 002910          684 DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR  763 (867)
Q Consensus       684 ~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~  763 (867)
                      ...+|++......- ...-+.++.+++.++.  .|+++..=  ..-.+-++.|+|-.-..            .   . ..
T Consensus        87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~---~-~N  145 (308)
T PF07387_consen   87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N---F-SN  145 (308)
T ss_pred             hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c---h-hH
Confidence            44566665443321 1233567788888874  47777621  33346789998832111            0   0 11


Q ss_pred             HHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       764 ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ++.-=+..|.-.|+.+...+|+|..|+||+-|+.|.+||.|-+.
T Consensus       146 ~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  146 FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            11111466788896555699999999999999999999999875

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	867
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-72
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-71
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-28
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-28
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-28
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-27
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-27
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-27
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-27
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-27
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-27
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-27
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-27
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-26
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-26
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-26
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-24
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-18
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-14
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-04

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  270 bits (690), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 130/192 (67%), Positives = 159/192 (82%)
Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD 697
           P    L  + ++  D ++I W +L++KE++GAGSFGTVHRAEWHGSDVAVK+L  QDF  
Sbjct: 16  PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA 75
Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD 757
           +++ EFLREVAIMKR+RHPN+VLFMGAVT+ P+LSIVTEYL RGSLYRL+H+  A E +D
Sbjct: 76  ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
           +RRRL MA DVAKG+NYLHN NPPI+H +LKSPNLLVDK +TVKVCDFGLSR KA+TF+S
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 818 SKSVAGTVVFFA 829
           SKS AGT  + A
Sbjct: 196 SKSAAGTPEWMA 207

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  266 bits (679), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 128/192 (66%), Positives = 156/192 (81%)
Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD 697
           P    L  + ++  D ++I W +L++KE++GAGSFGTVHRAEWHGSDVAVK+L  QDF  
Sbjct: 16  PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA 75
Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD 757
           +++ EFLREVAIMKR+RHPN+VLFMGAVT+ P+LSIVTEYL RGSLYRL+H+  A E +D
Sbjct: 76  ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
           +RRRL MA DVAKG+NYLHN NPPI+H DLKSPNLLVDK +TVKVCDFGLSR KA+ F+ 
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX 195
Query: 818 SKSVAGTVVFFA 829
           SK  AGT  + A
Sbjct: 196 SKXAAGTPEWMA 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  124 bits (312), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 71/180 (39%), Positives = 115/180 (63%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 6   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 63
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H  A+    + ++ + +A   A+G
Sbjct: 64  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARG 120
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 121 MDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  124 bits (310), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 71/180 (39%), Positives = 115/180 (63%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 18  DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H  A+    + ++ + +A   A+G
Sbjct: 76  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARG 132
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 133 MDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  122 bits (307), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 104/160 (65%), Gaps = 6/160 (3%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           + EI   E+ +  R+G+GSFGTV++ +WHG DVAVK+L V D   +Q + F  EVA++++
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRK 88
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
            RH N++LFMG +TK  +L+IVT++    SLY+ +H       M Q   + +A   A+G+
Sbjct: 89  TRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQ--LIDIARQTAQGM 145
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
           +YLH  N  I+H D+KS N+ + +  TVK+ DFGL+  K+
Sbjct: 146 DYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  122 bits (305), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 115/182 (63%), Gaps = 9/182 (4%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           A DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +
Sbjct: 16  ADDW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           +++ RH N++LFMG  T  P L+IVT++    SLY  +H  A+    + ++ + +A   A
Sbjct: 74  LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVF 827
           +G++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++
Sbjct: 131 RGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 828 FA 829
            A
Sbjct: 189 MA 190

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  120 bits (300), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 30  DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 87
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 88  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 144
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 145 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 29  DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 86
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 87  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 143
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 144 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 7   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 65  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 121
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 122 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  119 bits (298), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 7   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 64
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 65  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 121
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 122 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 4   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 61
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 62  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 118
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 119 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 2   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 60  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  119 bits (297), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 72/181 (39%), Positives = 114/181 (62%), Gaps = 11/181 (6%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 30  DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 87
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVAK 770
           + RH N++LFMG  TK P L+IVT++    SLY  +H      EM+   + + +A   A+
Sbjct: 88  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQ 143
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFF 828
           G++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ 
Sbjct: 144 GMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 829 A 829
           A
Sbjct: 202 A 202

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 22  DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 79
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 80  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 136
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 137 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 112/180 (62%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 2   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  TK P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 60  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  117 bits (293), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/180 (38%), Positives = 111/180 (61%), Gaps = 9/180 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 2   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  T  P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 60  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++++ A
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/168 (38%), Positives = 98/168 (58%), Gaps = 7/168 (4%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ 699
           PR  +       +W +I +++L + E +G G FG V+   WHG +VA++++ ++   +DQ
Sbjct: 15  PRKASQTSIFLQEW-DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ 72
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
           LK F REV   ++ RH NVVLFMGA    PHL+I+T      +LY ++    A  ++D  
Sbjct: 73  LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVN 130
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
           +  ++A ++ KG+ YLH     ILH DLKS N+  D N  V + DFGL
Sbjct: 131 KTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGL 175

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 111/214 (51%), Gaps = 12/214 (5%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVA 708
           +MD  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAA 80
Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
           +MK ++HPN+V  +G  T  P   IVTEY+P G+L   + R    E +     L MA  +
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQI 139
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVF 827
           +  + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + +
Sbjct: 140 SSAMEYLEKKN--FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKW 197
Query: 828 FAAHQTACNSLAL-----IFSLSGWLQSSFEESP 856
            A    A N+ ++      F +  W  +++  SP
Sbjct: 198 TAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/164 (38%), Positives = 95/164 (57%), Gaps = 18/164 (10%)
Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-----LDDQLKEFLREVAIMK 711
           +E+  ++++G G FG VH+       S VA+K L + D      + ++ +EF REV IM 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAK 770
            + HPN+V   G +   P +  V E++P G LY RL+ +      +    +LR+ LD+A 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133
Query: 771 GINYLHNLNPPILHWDLKSPNLL---VDKNWTV--KVCDFGLSR 809
           GI Y+ N NPPI+H DL+SPN+    +D+N  V  KV DFGLS+
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 12/219 (5%)
Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEF 703
           ++PS   D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EF
Sbjct: 3   MDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEF 60
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
           L+E A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L 
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLY 119
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVA 822
           MA  ++  + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +     
Sbjct: 120 MATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 823 GTVVFFAAHQTACNSLAL-----IFSLSGWLQSSFEESP 856
             + + A    A N  ++      F +  W  +++  SP
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 12/215 (5%)
Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREV 707
           +++D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEA 58
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +     L MA  
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQ 117
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVV 826
           ++  + YL   N   +H DL + N LV +N  VKV DFGLSR    +TF +       + 
Sbjct: 118 ISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK 175
Query: 827 FFAAHQTACNSLAL-----IFSLSGWLQSSFEESP 856
           + A    A N  ++      F +  W  +++  SP
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 102/192 (53%), Gaps = 10/192 (5%)
Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREV 707
           +++D  E+   ++ +K ++G G FG V+   W    + V V T+++  D  +++EFL+E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEA 58
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +     L MA  
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQ 117
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
           ++  + YL   N   +H DL + N LV +N  VKV DFGLSR       ++ + A     
Sbjct: 118 ISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK---- 171
Query: 828 FAAHQTACNSLA 839
           F    TA  SLA
Sbjct: 172 FPIKWTAPESLA 183

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/164 (37%), Positives = 94/164 (57%), Gaps = 18/164 (10%)
Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-----LDDQLKEFLREVAIMK 711
           +E+  ++++G G FG VH+       S VA+K L + D      + ++ +EF REV IM 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAK 770
            + HPN+V   G +   P +  V E++P G LY RL+ +      +    +LR+ LD+A 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133
Query: 771 GINYLHNLNPPILHWDLKSPNLL---VDKNWTV--KVCDFGLSR 809
           GI Y+ N NPPI+H DL+SPN+    +D+N  V  KV DFG S+
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/164 (37%), Positives = 94/164 (57%), Gaps = 18/164 (10%)
Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-----LDDQLKEFLREVAIMK 711
           +E+  ++++G G FG VH+       S VA+K L + D      + ++ +EF REV IM 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAK 770
            + HPN+V   G +   P +  V E++P G LY RL+ +      +    +LR+ LD+A 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133
Query: 771 GINYLHNLNPPILHWDLKSPNLL---VDKNWTV--KVCDFGLSR 809
           GI Y+ N NPPI+H DL+SPN+    +D+N  V  KV DF LS+
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 85/155 (54%), Gaps = 8/155 (5%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           I + E+ V+E VG G+FG V +A+W   DVA+K    Q   + + K F+ E+  + RV H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIK----QIESESERKAFIVELRQLSRVNH 61
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           PN+V   GA      + +V EY   GSLY ++H             +   L  ++G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 776 HNLNP-PILHWDLKSPNLLVDKNWTV-KVCDFGLS 808
           H++ P  ++H DLK PNLL+    TV K+CDFG +
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 128 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 185
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 12/221 (5%)
Query: 643 LNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLK 701
           L  + S   D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++
Sbjct: 10  LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVE 67
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
           EFL+E A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    
Sbjct: 68  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVL 126
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKS 820
           L MA  ++  + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +   
Sbjct: 127 LYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 184
Query: 821 VAGTVVFFAAHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               + + A    A N  ++      F +  W  +++  SP
Sbjct: 185 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 64
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 123
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 124 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA 181
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 85/155 (54%), Gaps = 8/155 (5%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           I + E+ V+E VG G+FG V +A+W   DVA+K    Q   + + K F+ E+  + RV H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIK----QIESESERKAFIVELRQLSRVNH 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           PN+V   GA      + +V EY   GSLY ++H             +   L  ++G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 776 HNLNP-PILHWDLKSPNLLVDKNWTV-KVCDFGLS 808
           H++ P  ++H DLK PNLL+    TV K+CDFG +
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 124
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 125 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA 182
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 124
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 125 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 182
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 128 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 185
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 124
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 125 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 182
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +     L MA  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 128 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 185
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +     L MA  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 123 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRV 713
           E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+MK +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI 66
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           +HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++  + 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAME 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFAAHQ 832
           YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A   
Sbjct: 126 YLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 833 TACNSLAL-----IFSLSGWLQSSFEESP 856
            A N  ++      F +  W  +++  SP
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +     L MA  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 123 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRV 713
           E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+MK +
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEI 66
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           +HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++  + 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAME 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFAAHQ 832
           YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A   
Sbjct: 126 YLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 833 TACNSLAL-----IFSLSGWLQSSFEESP 856
            A N  ++      F +  W  +++  SP
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFL 696
           GP P Y         D  E+   ++ +K ++G G +G V+   W    + V V T+++  
Sbjct: 1   GPSPNY---------DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-- 49
Query: 697 DD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM 755
           D  +++EFL+E A+MK ++HPN+V  +G  T+ P   I+ E++  G+L   + R    + 
Sbjct: 50  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQE 108
Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815
           ++    L MA  ++  + YL   N   +H DL + N LV +N  VKV DFGLSR      
Sbjct: 109 VNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166
Query: 816 ISSKSVAGTVVFFAAHQTACNSLA 839
            ++ + A     F    TA  SLA
Sbjct: 167 XTAHAGAK----FPIKWTAPESLA 186

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 12/223 (5%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ 699
           P    + P+   D  E+   ++ +K ++G G +G V+   W    + V V T+++    +
Sbjct: 242 PTVYGVSPNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTME 298
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
           ++EFL+E A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++  
Sbjct: 299 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAV 357
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISS 818
             L MA  ++  + YL   N   +H +L + N LV +N  VKV DFGLSR    +T+ + 
Sbjct: 358 VLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 415
Query: 819 KSVAGTVVFFAAHQTACNSLAL-----IFSLSGWLQSSFEESP 856
                 + + A    A N  ++      F +  W  +++  SP
Sbjct: 416 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 100/189 (52%), Gaps = 10/189 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + ++    L MA  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA 830
            + YL   N   +H DL + N LV +N  VKV DFGLSR       ++ + A     F  
Sbjct: 128 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK----FPI 181
Query: 831 HQTACNSLA 839
             TA  SLA
Sbjct: 182 KWTAPESLA 190

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 111/223 (49%), Gaps = 12/223 (5%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ 699
           P    + P+   D  E+   ++ +K ++G G +G V+   W    + V V T+++    +
Sbjct: 203 PTIYGVSPNY--DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TME 259
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
           ++EFL+E A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +   
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAV 318
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISS 818
             L MA  ++  + YL   N   +H +L + N LV +N  VKV DFGLSR    +T+ + 
Sbjct: 319 VLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376
Query: 819 KSVAGTVVFFAAHQTACNSLAL-----IFSLSGWLQSSFEESP 856
                 + + A    A N  ++      F +  W  +++  SP
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 68
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+ E++  G+L   + R    + ++    L MA  ++ 
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 128 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 185
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+ E++  G+L   + R    + +     L MA  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 123 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIM 710
           D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A+M
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVM 63
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++HPN+V  +G  T+ P   I+ E++  G+L   + R    + +     L MA  ++ 
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
            + YL   N   +H DL + N LV +N  VKV DFGLSR    +T+ +       + + A
Sbjct: 123 AMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 830 AHQTACNSLAL-----IFSLSGWLQSSFEESP 856
               A N  ++      F +  W  +++  SP
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVA 708
           ++D  E+   ++ +K ++G G +G V+   W    + V V T+++  D  +++EFL+E A
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAA 59
Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
           +MK ++HPN+V  +G  T+ P   I+ E++  G+L   + R    + +     L MA  +
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 118
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           +  + YL   N   +H DL + N LV +N  VKV DFGLSR       ++ + A     F
Sbjct: 119 SSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK----F 172
Query: 829 AAHQTACNSLA 839
               TA  SLA
Sbjct: 173 PIKWTAPESLA 183

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 101/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 312
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA 
Sbjct: 313 AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAA 370
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 371 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 428
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 429 KWTAPEAA 436

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 101/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L   +   +    FL+E
Sbjct: 174 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQE 230
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA 
Sbjct: 231 AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 288
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL R   +   +++  A   +
Sbjct: 289 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPI 346
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 347 KWTAPEAA 354

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 101/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 101/187 (54%), Gaps = 8/187 (4%)
Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREV 707
           LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E 
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEA 230
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQ 288
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
           +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   + 
Sbjct: 289 IASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 828 FAAHQTA 834
           + A + A
Sbjct: 347 WTAPEAA 353

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 101/187 (54%), Gaps = 8/187 (4%)
Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREV 707
           LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E 
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEA 230
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQ 288
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
           +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   + 
Sbjct: 289 IASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 828 FAAHQTA 834
           + A + A
Sbjct: 347 WTAPEAA 353

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/187 (32%), Positives = 100/187 (53%), Gaps = 17/187 (9%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVL--TVQDFLDDQLKEFLREVAIMK 711
           LEI + EL ++E +G G FG V+RA W G +VAVK       + +   ++   +E  +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            ++HPN++   G   K P+L +V E+   G L R++    +G+ +     +  A+ +A+G
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARG 117
Query: 772 INYLHN-LNPPILHWDLKSPNLLVDK--------NWTVKVCDFGLSRFKANTFISSKSVA 822
           +NYLH+    PI+H DLKS N+L+ +        N  +K+ DFGL+R    T  +  S A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175
Query: 823 GTVVFFA 829
           G   + A
Sbjct: 176 GAYAWMA 182

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 101/187 (54%), Gaps = 8/187 (4%)
Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREV 707
           LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E 
Sbjct: 1   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEA 57
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  
Sbjct: 58  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQ 115
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
           +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   + 
Sbjct: 116 IASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 173
Query: 828 FAAHQTA 834
           + A + A
Sbjct: 174 WTAPEAA 180

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 90/158 (56%), Gaps = 8/158 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           +E+  +E+ + + +G+G FG V   +W G  DVAVK++      +D   EF +E   M +
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           + HP +V F G  +K   + IVTEY+  G L  L +  + G+ ++  + L M  DV +G+
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            +L +     +H DL + N LVD++  VKV DFG++R+
Sbjct: 118 AFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 101/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL + N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 101/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 4   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 60
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + M+ 
Sbjct: 61  AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSA 118
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 119 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 176
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 177 KWTAPEAA 184

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +G L   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 173 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 229
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IV EY+ +GSL   + +   G+ +   + + MA 
Sbjct: 230 AQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAA 287
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 288 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 346 KWTAPEAA 353

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IV EY+ +GSL   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 101/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 4   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 60
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + M+ 
Sbjct: 61  AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSA 118
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 119 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPI 176
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 177 KWTAPEAA 184

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 99/184 (53%), Gaps = 8/184 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E  +M
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 57
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  +A 
Sbjct: 58  KKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIAS 115
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA 830
           G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   + + A
Sbjct: 116 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA 173
Query: 831 HQTA 834
            + A
Sbjct: 174 PEAA 177

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IV EY+ +GSL   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IV EY+ +GSL   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 99/184 (53%), Gaps = 8/184 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E  +M
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVM 58
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K++RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  +A 
Sbjct: 59  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIAS 116
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA 830
           G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   + + A
Sbjct: 117 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 174
Query: 831 HQTA 834
            + A
Sbjct: 175 PEAA 178

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 92/169 (54%), Gaps = 8/169 (4%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQ-DFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           ++G G FG V++   + + VAVK L    D   ++LK+ F +E+ +M + +H N+V  +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             +    L +V  Y+P GSL   +        +    R ++A   A GIN+LH  +   +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--I 155
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFK---ANTFISSKSVAGTVVFFA 829
           H D+KS N+L+D+ +T K+ DFGL+R     A T + S+ + GT  + A
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR-IVGTTAYMA 203

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 87/149 (58%), Gaps = 3/149 (2%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           I + +L+   ++     G + +  W G+D+ VKVL V+D+   + ++F  E   ++   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 716 PNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           PNV+  +GA      PH +++T ++P GSLY ++H      ++DQ + ++ ALD+A+G+ 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMA 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKV 802
           +LH L P I    L S ++++D++ T ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARI 154

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 98/181 (54%), Gaps = 8/181 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E  +MK++
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKL 59
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           RH  +V     V++ P + IVTEY+ +GSL   + +   G+ +   + + MA  +A G+ 
Sbjct: 60  RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQT 833
           Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   + + A + 
Sbjct: 118 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 175
Query: 834 A 834
           A
Sbjct: 176 A 176

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 8/188 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLRE 706
            LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L       +    FL+E
Sbjct: 7   GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQE 63
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK++RH  +V     V++ P + IV EY+ +G L   + +   G+ +   + + MA 
Sbjct: 64  AQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAA 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R   +   +++  A   +
Sbjct: 122 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 827 FFAAHQTA 834
            + A + A
Sbjct: 180 KWTAPEAA 187

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 94/184 (51%), Gaps = 8/184 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L + +R+G G FG V    W+G + VA+K L       +    FL E  IM
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES---FLEEAQIM 58
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K+++H  +V     V++ P + IVTEY+ +GSL   + +   G  +     + MA  VA 
Sbjct: 59  KKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAA 116
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA 830
           G+ Y+  +N   +H DL+S N+LV      K+ DFGL+R   +   +++  A   + + A
Sbjct: 117 GMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTA 174
Query: 831 HQTA 834
            + A
Sbjct: 175 PEAA 178

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 91/169 (53%), Gaps = 8/169 (4%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQ-DFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           ++G G FG V++   + + VAVK L    D   ++LK+ F +E+ +M + +H N+V  +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             +    L +V  Y+P GSL   +        +    R ++A   A GIN+LH  +   +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--I 155
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFK---ANTFISSKSVAGTVVFFA 829
           H D+KS N+L+D+ +T K+ DFGL+R     A T +  + + GT  + A
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR-IVGTTAYMA 203

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 89/168 (52%), Gaps = 6/168 (3%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQ-DFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           ++G G FG V++   + + VAVK L    D   ++LK+ F +E+ +M + +H N+V  +G
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             +    L +V  Y+P GSL   +        +    R ++A   A GIN+LH  +   +
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--I 149
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFA 829
           H D+KS N+L+D+ +T K+ DFGL+R   K    +    + GT  + A
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 11  WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 67
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 68  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 125
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 126 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 166

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 9   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 65
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 123
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 124 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 164

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 13  WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 69
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 70  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 127
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 128 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 168

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 12  WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 68
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 69  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 126
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 127 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 167

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           I + +L+   ++     G + +  W G+D+ VKVL V+D+   + ++F  E   ++   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 716 PNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           PNV+  +GA      PH +++T + P GSLY ++H      ++DQ + ++ ALD A+G  
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHE-GTNFVVDQSQAVKFALDXARGXA 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKV 802
           +LH L P I    L S ++ +D++ T ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVXIDEDXTARI 154

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 117
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 118 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 82/149 (55%), Gaps = 4/149 (2%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           E +G G FG   +     +   + +  +  F ++  + FL+EV +M+ + HPNV+ F+G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           + K   L+ +TEY+  G+L  +I   +        +R+  A D+A G+ YLH++N  I+H
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIH 131
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
            DL S N LV +N  V V DFGL+R   +
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVD 160

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 8   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 64
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 65  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 122
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 123 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 163

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 9   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 65
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 123
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 124 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 164

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 4   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 60
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 61  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 118
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 119 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 159

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 5   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 61
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 62  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 119
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 120 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 160

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 117
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 118 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E  W+     L + ER+GAG FG V    ++G + VAVK L       D    FL E 
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQ 117
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 118 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 88/160 (55%), Gaps = 9/160 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           +W E+  + L + ER+GAG FG V    ++G + VAVK L       D    FL E  +M
Sbjct: 2   EW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 57
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  +A+
Sbjct: 58  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 115
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 116 GMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 153

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 87/160 (54%), Gaps = 8/160 (5%)
Query: 655 EISWDELHVKERVGAGSFGTV---HRAEWHGSDVAVKVLTVQD-FLDDQLKEFLREVAIM 710
           EI    + +++ +GAG FG V   H       ++ V + T++  + + Q ++FL E +IM
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 88
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
            +  HPNV+   G VTK   + I+TE++  GSL   + +      + Q   + M   +A 
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ--LVGMLRGIAA 146
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           G+ YL ++N   +H DL + N+LV+ N   KV DFGLSRF
Sbjct: 147 GMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRF 184

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    + ++E +GAG FG V R          S VA+K L    + + Q +EFL E +I
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQRREFLSEASI 70
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VT    + I+TE++  G+L   +        + Q   + M   +A
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--LVGMLRGIA 128
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            G+ YL  ++   +H DL + N+LV+ N   KV DFGLSRF
Sbjct: 129 SGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRF 167

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 8/156 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M ++RH N+V
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 77
Query: 720 LFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
             +G + + +  L IVTEY+ +GSL   + R     ++     L+ +LDV + + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
           N   +H DL + N+LV ++   KV DFGL++  ++T
Sbjct: 137 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 8/156 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M ++RH N+V
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 249
Query: 720 LFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
             +G + + +  L IVTEY+ +GSL   + R     ++     L+ +LDV + + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
           N   +H DL + N+LV ++   KV DFGL++  ++T
Sbjct: 309 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 88/160 (55%), Gaps = 9/160 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           +W E+  + L + ER+GAG FG V    ++G + VAVK L       D    FL E  +M
Sbjct: 3   EW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLM 58
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K+++H  +V     VT+ P + I+TEY+  GSL   +  P+ G  +   + L MA  +A+
Sbjct: 59  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 116
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           G+ ++   N   +H +L++ N+LV    + K+ DFGL+R 
Sbjct: 117 GMAFIEERN--YIHRNLRAANILVSDTLSCKIADFGLARL 154

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 6/168 (3%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQ-DFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           + G G FG V++   + + VAVK L    D   ++LK+ F +E+ +  + +H N+V  +G
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             +    L +V  Y P GSL   +        +    R ++A   A GIN+LH  +   +
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH--I 146
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFA 829
           H D+KS N+L+D+ +T K+ DFGL+R   K    +    + GT  + A
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    + ++E +GAG FG V R          S VA+K L    + + Q +EFL E +I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQRREFLSEASI 68
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VT    + I+TE++  G+L   +        + Q   + M   +A
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--LVGMLRGIA 126
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            G+ YL  ++   +H DL + N+LV+ N   KV DFGLSRF
Sbjct: 127 SGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRF 165

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 653 WLEISWD----ELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREV 707
           W E +W+     L + ER+GAG  G V    ++G + VAVK L       D    FL E 
Sbjct: 3   WWEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            +MK+++H  +V     VT+ P + I+TEY+  GSL   +  P +G  +   + L MA  
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQ 117
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +A+G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 118 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 8/156 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M ++RH N+V
Sbjct: 13  ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 68
Query: 720 LFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
             +G + + +  L IVTEY+ +GSL   + R     ++     L+ +LDV + + YL   
Sbjct: 69  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
           N   +H DL + N+LV ++   KV DFGL++  ++T
Sbjct: 128 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 161

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 8/156 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M ++RH N+V
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 62
Query: 720 LFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
             +G + + +  L IVTEY+ +GSL   + R     ++     L+ +LDV + + YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
           N   +H DL + N+LV ++   KV DFGL++  ++T
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 70
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 128
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 129 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 166

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 87
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 145
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 146 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 183

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 97
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 155
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 156 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 193

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI   +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  +
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 76
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVA 769
            H  +V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVC 130
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + + YL   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 131 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH   W   D VA+K +      ++   +F+ E  +M ++ HP +
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKL 65
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G   ++  + +VTE++  G L   + R   G +      L M LDV +G+ YL   
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRG-LFAAETLLGMCLDVCEGMAYLEE- 122
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              ++H DL + N LV +N  +KV DFG++RF
Sbjct: 123 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI   +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  +
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 76
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVA 769
            H  +V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVC 130
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + + YL   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 131 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLD 697
           G  ++ I+PS           EL   + +G+G FG VH   W   D VA+K +      +
Sbjct: 18  GSLHMVIDPS-----------ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE 66
Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD 757
           D   +F+ E  +M ++ HP +V   G   ++  + +V E++  G L   + R   G +  
Sbjct: 67  D---DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRG-LFA 121
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
               L M LDV +G+ YL      ++H DL + N LV +N  +KV DFG++RF
Sbjct: 122 AETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 172

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGL+R
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLAR 195

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI   +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  +
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 67
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVA 769
            H  +V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV 
Sbjct: 68  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVC 121
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + + YL   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 122 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 160

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/149 (34%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +GAG FG V++     S       VA+K L    + + Q  +FL E  IM +  H N++ 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
             G ++K   + I+TEY+  G+L + + R   GE     + + M   +A G+ YL N+N 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL-REKDGE-FSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             +H DL + N+LV+ N   KV DFGLSR
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSR 195

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI   +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  +
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 61
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVA 769
            H  +V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVC 115
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + + YL   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 116 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 154

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI   +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  +
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 60
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVA 769
            H  +V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV 
Sbjct: 61  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVC 114
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + + YL   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 115 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 153

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 21/172 (12%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + W+++  ++ +G G+FG V +A         D A+K +      DD  ++F  E+ ++ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 80
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMD 757
           ++  HPN++  +GA   R +L +  EY P G+L   + +       PA          + 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            ++ L  A DVA+G++YL       +H DL + N+LV +N+  K+ DFGLSR
Sbjct: 141 SQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI   +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  +
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 61
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVA 769
            H  +V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVC 115
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + + YL   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 116 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 154

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGL R
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGR 195

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 86/160 (53%), Gaps = 8/160 (5%)
Query: 655 EISWDELHVKERVGAGSFGTV---HRAEWHGSDVAVKVLTVQD-FLDDQLKEFLREVAIM 710
           EI    + +++ +GAG FG V   H       ++ V + T++  + + Q ++FL E +IM
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 62
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
            +  HPNV+   G VTK   + I+TE++  GSL   + +      + Q   + M   +A 
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ--LVGMLRGIAA 120
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           G+ YL ++N   +H  L + N+LV+ N   KV DFGLSRF
Sbjct: 121 GMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRF 158

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 21/172 (12%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + W+++  ++ +G G+FG V +A         D A+K +      DD  ++F  E+ ++ 
Sbjct: 12  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 70
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMD 757
           ++  HPN++  +GA   R +L +  EY P G+L   + +       PA          + 
Sbjct: 71  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            ++ L  A DVA+G++YL       +H DL + N+LV +N+  K+ DFGLSR
Sbjct: 131 SQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           +L   + +G G FG V   +W G  DVA+K++      +D   EF+ E  +M  + H  +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKL 61
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVAKGINY 774
           V   G  TK+  + I+TEY+  G L   +    HR         ++ L M  DV + + Y
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR------FQTQQLLEMCKDVCEAMEY 115
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           L   +   LH DL + N LV+    VKV DFGLSR+
Sbjct: 116 LE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGT 824
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++   +   F   K    +
Sbjct: 122 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 825 VVFFAAHQTACNS 837
            +F+ A ++   S
Sbjct: 180 PIFWYAPESLTES 192

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 66
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   +   A  E +D  + L+   
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKLLQYTS 124
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 125 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 165

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 85/160 (53%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGS---DVAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    + ++  +GAG FG V   R +  G     VA+K L V  + + Q ++FL E +I
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV-GYTEKQRRDFLGEASI 76
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTEY+  GSL   + +      + Q   + M   ++
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ--LVGMLRGIS 134
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 135 AGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 172

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 109/219 (49%), Gaps = 11/219 (5%)
Query: 639 GPRYLNIEPSLAM--DWLEISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQD 694
           GP     +P  A+  D    +     +++++G G F  V+RA     G  VA+K + + D
Sbjct: 10  GPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69
Query: 695 FLDDQLK-EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAA 752
            +D + + + ++E+ ++K++ HPNV+ +  +  +   L+IV E    G L R+I H    
Sbjct: 70  LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
             ++ +R   +  + +   + ++H+    ++H D+K  N+ +     VK+ D GL RF +
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 813 NTFISSKSVAGTVVFFA---AHQTACNSLALIFSLSGWL 848
           +   ++ S+ GT  + +    H+   N  + I+SL   L
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH   W   D VA+K +      ++   +F+ E  +M ++ HP +
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKL 64
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G   ++  + +V E++  G L   + R   G +      L M LDV +G+ YL   
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRG-LFAAETLLGMCLDVCEGMAYLEEA 122
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +  ++H DL + N LV +N  +KV DFG++RF
Sbjct: 123 S--VIHRDLAARNCLVGENQVIKVSDFGMTRF 152

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH   W   D VA+K +      ++   +F+ E  +M ++ HP +
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKL 64
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G   ++  + +V E++  G L   + R   G +      L M LDV +G+ YL   
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRG-LFAAETLLGMCLDVCEGMAYLEE- 121
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              ++H DL + N LV +N  +KV DFG++RF
Sbjct: 122 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 152

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH   W   D VA+K +      ++   +F+ E  +M ++ HP +
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKL 62
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G   ++  + +V E++  G L   + R   G +      L M LDV +G+ YL   
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRG-LFAAETLLGMCLDVCEGMAYLEE- 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              ++H DL + N LV +N  +KV DFG++RF
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTE +  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           EL   + +G+G FG VH   W   D VA+K +      ++   +F+ E  +M ++ HP +
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKL 67
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V   G   ++  + +V E++  G L   + R   G +      L M LDV +G+ YL   
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRG-LFAAETLLGMCLDVCEGMAYLEE- 124
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              ++H DL + N LV +N  +KV DFG++RF
Sbjct: 125 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 70
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTE +  GSL   + +  A   + Q   + M   +A
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 128
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 129 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 166

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVL 720
           ++E +G G FG V R +W G +VAVK+     F   + + + RE  I + V  RH N++ 
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILG 100
Query: 721 FMGAVTKR----PHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYL 775
           F+ A  K       L +V++Y   GSL+  ++R     E M     +++AL  A G+ +L
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHL 155
Query: 776 H------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H         P I H DLKS N+LV KN T  + D GL+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + + + +R+GAG FG V    ++ S  VAVK L         ++ FL E  +M
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLM 62
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++H  +V     VT+   + I+TEY+ +GSL   +     G+++   + +  +  +A+
Sbjct: 63  KTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAE 121
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ Y+   N   +H DL++ N+LV ++   K+ DFGL+R
Sbjct: 122 GMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLAR 158

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 152
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 153 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK 193

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVL 720
           ++E +G G FG V R +W G +VAVK+     F   + + + RE  I + V  RH N++ 
Sbjct: 33  LQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILG 87
Query: 721 FMGAVTK----RPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYL 775
           F+ A  K       L +V++Y   GSL+  ++R     E M     +++AL  A G+ +L
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHL 142
Query: 776 H------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H         P I H DLKS N+LV KN T  + D GL+
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 70
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 128
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 129 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 169

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVL 720
           ++E +G G FG V R +W G +VAVK+     F   + + + RE  I + V  RH N++ 
Sbjct: 13  LQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILG 67
Query: 721 FMGAVTK----RPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYL 775
           F+ A  K       L +V++Y   GSL+  ++R     E M     +++AL  A G+ +L
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHL 122
Query: 776 H------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H         P I H DLKS N+LV KN T  + D GL+
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 88/172 (51%), Gaps = 21/172 (12%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + W+++  ++ +G G+FG V +A         D A+K +      DD  ++F  E+ ++ 
Sbjct: 19  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 77
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMD 757
           ++  HPN++  +GA   R +L +  EY P G+L   + +       PA          + 
Sbjct: 78  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            ++ L  A DVA+G++YL       +H +L + N+LV +N+  K+ DFGLSR
Sbjct: 138 SQQLLHFAADVARGMDYLSQ--KQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVL 720
           ++E +G G FG V R +W G +VAVK+     F   + + + RE  I + V  RH N++ 
Sbjct: 8   LQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILG 62
Query: 721 FMGAVTK----RPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYL 775
           F+ A  K       L +V++Y   GSL+  ++R     E M     +++AL  A G+ +L
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHL 117
Query: 776 H------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H         P I H DLKS N+LV KN T  + D GL+
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           E+    + + + VGAG FG V              VA+K L V  + + Q ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASI 99
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + IVTE +  GSL   + +  A   + Q   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL ++    +H DL + N+L++ N   KV DFGLSR
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSR 195

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVL 720
           ++E +G G FG V R +W G +VAVK+     F   + + + RE  I + V  RH N++ 
Sbjct: 10  LQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILG 64
Query: 721 FMGAVTK----RPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYL 775
           F+ A  K       L +V++Y   GSL+  ++R     E M     +++AL  A G+ +L
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHL 119
Query: 776 H------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H         P I H DLKS N+LV KN T  + D GL+
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVL 720
           ++E +G G FG V R +W G +VAVK+     F   + + + RE  I + V  RH N++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILG 61
Query: 721 FMGAVTK----RPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYL 775
           F+ A  K       L +V++Y   GSL+  ++R     E M     +++AL  A G+ +L
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHL 116
Query: 776 H------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H         P I H DLKS N+LV KN T  + D GL+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 66
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 124
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 125 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 165

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 68
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 126
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 127 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 167

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 122 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 162

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 61
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 119
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 120 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 160

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 69
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 127
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 128 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 168

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 121
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 122 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 162

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 81
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 139
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 140 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 180

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 62
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 120
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 121 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 161

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    + +++ +G G FG V   R +  G     VA+K L    + D Q ++FL E +I
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKA-GYTDKQRRDFLSEASI 83
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + I+TEY+  GSL   + +      + Q   + M   + 
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIG 141
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL +++   +H DL + N+LV+ N   KV DFG+SR
Sbjct: 142 SGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSR 179

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 67
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 125
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 126 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK 166

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 81
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 139
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 140 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 180

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 89/163 (54%), Gaps = 10/163 (6%)
Query: 650 AMD--WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLRE 706
           AMD  W EI  + + + +++GAG FG V    ++ S  VAVK L         ++ FL E
Sbjct: 2   AMDPAW-EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEE 57
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +MK ++H  +V     VTK   + I+TE++ +GSL   +     G+++   + +  + 
Sbjct: 58  ANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSA 116
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +A+G+ Y+   N   +H DL++ N+LV ++   K+ DFGL+R
Sbjct: 117 QIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLAR 157

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    + +++ +G G FG V   R +  G     VA+K L    + D Q ++FL E +I
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKA-GYTDKQRRDFLSEASI 68
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VTK   + I+TEY+  GSL   + +      + Q   + M   + 
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIG 126
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL +++   +H DL + N+LV+ N   KV DFG+SR
Sbjct: 127 SGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSR 164

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGS-DVAVKVLTVQ-DFLDDQLKEFLREVAIM 710
           EI    + +++ +G G FG V   R +  G  ++ V + T++  + D Q ++FL E +IM
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
            +  HPN++   G VTK   + I+TEY+  GSL   + +      + Q   + M   +  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIGS 121
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ YL +++   +H DL + N+LV+ N   KV DFG+SR
Sbjct: 122 GMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSR 158

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGS---DVAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    +H+++ +G+G  G V   R    G     VA+K L    + + Q ++FL E +I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA-GYTERQRRDFLSEASI 103
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VT+     IVTEY+  GSL   + R   G+     + + M   V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIM-QLVGMLRGVG 161
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL +L    +H DL + N+LVD N   KV DFGLSR
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGS---DVAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    +H+++ +G+G  G V   R    G     VA+K L    + + Q ++FL E +I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA-GYTERQRRDFLSEASI 103
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPN++   G VT+     IVTEY+  GSL   + R   G+     + + M   V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIM-QLVGMLRGVG 161
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            G+ YL +L    +H DL + N+LVD N   KV DFGLSR
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 8/153 (5%)
Query: 661 LHVKERVGAGSFGTV--HRAEWHGS-DVAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHP 716
           + ++  +GAG FG V   R +  G  DVAV + T++  + + Q ++FL E +IM +  HP
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NVV   G VT+   + IV E++  G+L   + +      + Q   + M   +A G+ YL 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQ--LVGMLRGIAAGMRYLA 162
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++    +H DL + N+LV+ N   KV DFGLSR
Sbjct: 163 DMG--YVHRDLAARNILVNSNLVCKVSDFGLSR 193

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPN 717
           ++ + E VG G +G V R  W G +VAVK+ + +D      K + RE  +   V  RH N
Sbjct: 38  QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHEN 92
Query: 718 VVLFMGAVTKRPH----LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           ++ F+ +     H    L ++T Y   GSLY  +        +D    LR+ L +A G+ 
Sbjct: 93  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLA 148
Query: 774 YLH------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +LH         P I H DLKS N+LV KN    + D GL+
Sbjct: 149 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 189

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAVK++         L++  REV IMK + HPN+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCH--QKFIVH 136
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVF 827
            DLK+ NLL+D +  +K+ DFG S       K +TF  S   A   +F
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K  +++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 64
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ EYLP GSL   + +    E +D  + L+   
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTS 122
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGT 824
            + KG+ YL       +H +L + N+LV+    VK+ DFGL++   +   +   K    +
Sbjct: 123 QICKGMEYLG--TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 825 VVFFAAHQTACNS 837
            +F+ A ++   S
Sbjct: 181 PIFWYAPESLTES 193

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAVK++         L++  REV IMK + HPN+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCH--QKFIVH 136
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVF 827
            DLK+ NLL+D +  +K+ DFG S       K +TF  S   A   +F
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 16/163 (9%)
Query: 657 SWDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVA 708
            ++E H+K   ++G G+FG+V    +       G  VAVK L  Q   ++ L++F RE+ 
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 66
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           I+K ++H N+V + G      R +L ++ E+LP GSL   + +    E +D  + L+   
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHK--ERIDHIKLLQYTS 124
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + KG+ YL       +H DL + N+LV+    VK+ DFGL++
Sbjct: 125 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTK 165

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPN 717
           ++ + E VG G +G V R  W G +VAVK+ + +D      K + RE  +   V  RH N
Sbjct: 9   QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHEN 63
Query: 718 VVLFMGAVTKRPH----LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           ++ F+ +     H    L ++T Y   GSLY  +        +D    LR+ L +A G+ 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLA 119
Query: 774 YLH------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +LH         P I H DLKS N+LV KN    + D GL+
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPN 717
           ++ + +++G G +G V   +W G  VAVKV     F   +   + RE  I + V  RH N
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWRGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHEN 92
Query: 718 VVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           ++ F+ A  K       L ++T+Y   GSLY  +        +D +  L++A     G+ 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLC 148
Query: 774 YLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANT 814
           +LH         P I H DLKS N+LV KN T  + D GL+ +F ++T
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPN 717
           ++ + E VG G +G V R  W G +VAVK+ + +D      K + RE  +   V  RH N
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHEN 63
Query: 718 VVLFMGAVTKRPH----LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           ++ F+ +     H    L ++T Y   GSLY  +        +D    LR+ L +A G+ 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLA 119
Query: 774 YLH------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +LH         P I H DLKS N+LV KN    + D GL+
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 12/172 (6%)
Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +++ +G G+F  V  A     G +VAVK++         L++  REV IMK + HPN+V 
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
               +     L +V EY   G ++  +   A G M ++  R +    +   + Y H    
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCH--QK 133
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVF 827
            I+H DLK+ NLL+D +  +K+ DFG S       K +TF  S   A   +F
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELF 185

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAVK++         L++  REV IMK + HPN+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCH--QKFIVH 136
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS 808
            DLK+ NLL+D +  +K+ DFG S
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAV+++         L++  REV IMK + HPN+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCH--QKFIVH 136
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVF 827
            DLK+ NLL+D +  +K+ DFG S       K +TF  S   A   +F
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 5/161 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPN 717
           ++L + E++G G+FG V        +  V V + ++ L   LK +FL+E  I+K+  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V  +G  T++  + IV E +  G     +     G  +  +  L+M  D A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
            +   +H DL + N LV +   +K+ DFG+SR +A+   ++
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAA 270

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 5/161 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPN 717
           ++L + E++G G+FG V        +  V V + ++ L   LK +FL+E  I+K+  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V  +G  T++  + IV E +  G     +     G  +  +  L+M  D A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
            +   +H DL + N LV +   +K+ DFG+SR +A+   ++
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 87/162 (53%), Gaps = 8/162 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L +++++GAG FG V  A ++  + VAVK +         ++ FL E  +M
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVM 231
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++H  +V     VTK P + I+TE++ +GSL   + +   G      + +  +  +A+
Sbjct: 232 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAE 289
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
           G+ ++   N   +H DL++ N+LV  +   K+ DFGL+R  A
Sbjct: 290 GMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVGA 329

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 21/161 (13%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPN 717
           ++ + E VG G +G V R  WHG  VAVK+ + +D      + + RE  I   V  RH N
Sbjct: 9   QVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRD-----EQSWFRETEIYNTVLLRHDN 63
Query: 718 VVLFMGA-VTKR---PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           ++ F+ + +T R     L ++T Y   GSLY  + R    + ++    LR+A+  A G+ 
Sbjct: 64  ILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQR----QTLEPHLALRLAVSAACGLA 119
Query: 774 YLH------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +LH         P I H D KS N+LV  N    + D GL+
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAVK++         L++  REV IMK + HPN+V     
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFR-QIVSAVQYCH--QKFIVH 129
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVF 827
            DLK+ NLL+D +  +K+ DFG S       K +TF  S   A   +F
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 177

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAV+++         L++  REV IMK + HPN+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCH--QKFIVH 136
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS 808
            DLK+ NLL+D +  +K+ DFG S
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS 160

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VA+K++         L++  REV IMK + HPN+V     
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L ++ EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-QIVSAVQYCH--QKRIVH 134
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVF 827
            DLK+ NLL+D +  +K+ DFG S       K +TF  S   A   +F
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELF 182

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L +++++GAG FG V  A ++  + VAVK +         ++ FL E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVM 237
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++H  +V     VTK P + I+TE++ +GSL   + +   G      + +  +  +A+
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAE 295
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ ++   N   +H DL++ N+LV  +   K+ DFGL+R
Sbjct: 296 GMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR 332

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 96/187 (51%), Gaps = 13/187 (6%)
Query: 663 VKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           V E++G GS+G+V++A  +  G  VA+K + V    +  L+E ++E++IM++   P+VV 
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
           + G+  K   L IV EY   GS+  +I      + + +     +     KG+ YLH +  
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA---AHQTACNS 837
             +H D+K+ N+L++     K+ DFG++    +       V GT  + A     +   N 
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 838 LALIFSL 844
           +A I+SL
Sbjct: 205 VADIWSL 211

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 17/162 (10%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE +        + V V T++D  D+  K+F RE  ++  ++H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEM--------MDQRRRLRMALD 767
           +V F G   +   L +V EY+  G L + +  H P A  M        + Q + L +A  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +A G+ YL + +   +H DL + N LV +N  VK+ DFG+SR
Sbjct: 137 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQD--FLDDQLKEFLREVAIMKRVRHPNVVLFM-- 722
           +G GSF TV++     + V V    +QD      + + F  E   +K ++HPN+V F   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 723 --GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
               V  +  + +VTE    G+L   + R    ++   R   R  L   KG+ +LH   P
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL---KGLQFLHTRTP 150
Query: 781 PILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           PI+H DLK  N+ +     +VK+ D GL+  K  +F  +K+V GT  F A
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFXA 198

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 89/167 (53%), Gaps = 5/167 (2%)
Query: 665 ERVGAGSFG--TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +++G GSFG   + ++   G    +K + +      + +E  REVA++  ++HPN+V + 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +  +   L IV +Y   G L++ I+    G +  + + L   + +   + ++H+    I
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVHDRK--I 146
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LH D+KS N+ + K+ TV++ DFG++R   +T   +++  GT  + +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VA+K++         L++  REV IMK + HPN+V     
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L ++ EY   G ++  +   A G M ++  R +    +   + Y H     I+H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-QIVSAVQYCH--QKRIVH 137
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS 808
            DLK+ NLL+D +  +K+ DFG S
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFS 161

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 4/160 (2%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           L+++ D    K  +G G FG V++     G+ VAVK L  +     +L +F  EV ++  
Sbjct: 33  LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL-QFQTEVEMISM 91
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKG 771
             H N++   G         +V  Y+  GS+   L  RP +   +D  +R R+AL  A+G
Sbjct: 92  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 151
Query: 772 INYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + YLH+  +P I+H D+K+ N+L+D+ +   V DFGL++ 
Sbjct: 152 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L +++++GAG FG V  A ++  + VAVK +         ++ FL E  +M
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVM 64
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++H  +V     VTK P + I+TE++ +GSL   + +   G      + +  +  +A+
Sbjct: 65  KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAE 122
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ ++   N   +H DL++ N+LV  +   K+ DFGL+R
Sbjct: 123 GMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR 159

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 658 WDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           ++E H+K   ++G G+FG+V    +       G+ VAVK L  Q    DQ ++F RE+ I
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 61
Query: 710 MKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           +K +    +V + G      RP L +V EYLP G L   + R  A   +D  R L  +  
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQ 119
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + KG+ YL +     +H DL + N+LV+    VK+ DFGL++ 
Sbjct: 120 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 160

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 135
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 136 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 135
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 136 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-----EFLREVAIMKRVR 714
           EL   + +G+G+FGTV++  W      VK+      L++        EF+ E  IM  + 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP++V  +G V   P + +VT+ +P G L   +H     + +  +  L   + +AKG+ Y
Sbjct: 99  HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMY 155
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           L      ++H DL + N+LV     VK+ DFGL+R 
Sbjct: 156 LEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL 189

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-----EFLREVAIMKRVR 714
           EL   + +G+G+FGTV++  W      VK+      L++        EF+ E  IM  + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP++V  +G V   P + +VT+ +P G L   +H     + +  +  L   + +AKG+ Y
Sbjct: 76  HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMY 132
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           L      ++H DL + N+LV     VK+ DFGL+R 
Sbjct: 133 LEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL 166

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 73  DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 129
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 130 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 129
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 130 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 16/157 (10%)
Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G G FG+V  A+    D     VAVK+L         ++EFLRE A MK   HP+V   
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 722 MG------AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGE---MMDQRRRLRMALDVAKGI 772
           +G      A  + P   ++  ++  G L+  +     GE    +  +  +R  +D+A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            YL + N   +H DL + N ++ ++ TV V DFGLSR
Sbjct: 151 EYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 4/160 (2%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           L+++ D    K  +G G FG V++     G  VAVK L  +     +L +F  EV ++  
Sbjct: 25  LQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL-QFQTEVEMISM 83
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKG 771
             H N++   G         +V  Y+  GS+   L  RP +   +D  +R R+AL  A+G
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 772 INYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + YLH+  +P I+H D+K+ N+L+D+ +   V DFGL++ 
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 126 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 126 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 660 ELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLD--DQLKEFLREVAIMKRV 713
           +L + E++G GSFG V R EW    G  V+V V  ++ D L   + + +F+REV  M  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H N++   G V   P + +VTE  P GSL   + +     ++      R A+ VA+G+ 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMG 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL +     +H DL + NLL+     VK+ DFGL R
Sbjct: 126 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 7/144 (4%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+F  V  A     G +VAVK++         L++  REV I K + HPN+V     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +     L +V EY   G ++  +      +  + R + R    +   + Y H     I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ---IVSAVQYCH--QKFIVH 136
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS 808
            DLK+ NLL+D +  +K+ DFG S
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS 160

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 92/175 (52%), Gaps = 11/175 (6%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEF 703
           E S A+ W  I+ D+  ++E +G+G+   V  A        VA+K + ++      + E 
Sbjct: 3   EDSSALPW-SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDEL 60
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGE----MMDQ 758
           L+E+  M +  HPN+V +  +   +  L +V + L  GS+  +I H  A GE    ++D+
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
                +  +V +G+ YLH      +H D+K+ N+L+ ++ +V++ DFG+S F A 
Sbjct: 121 STIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 8/150 (5%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   + E  G  VAVK+L  Q     D + +  RE+  +K  RHP+++    
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
            ++    + +V EY+  G L+  I        +D++   R+   +  G++Y H     ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM--VV 138
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           H DLK  N+L+D +   K+ DFGLS   ++
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSD 168

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  ++ L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEEDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDYYKKTTNG 219

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERV-GAGSFGTVH--RAEWHGSDVAVKVLTVQ 693
           GPG  +L+  P + +      + + +  +RV G GSFG V   + +  G + AVKV++ +
Sbjct: 27  GPGD-HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 85
Query: 694 DFLDDQLKE-FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPA 751
                  KE  LREV ++K++ HPN++        + +  +V E    G L+  +I R  
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
             E +D  R +R  L    GI Y+H     I+H DLK  NLL++   K+  +++ DFGLS
Sbjct: 146 FSE-VDAARIIRQVL---SGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 199
Query: 809 -RFKANTFISSKSVAGTVVFFA 829
             F+A+  +  K   GT  + A
Sbjct: 200 THFEASKKMKDK--IGTAYYIA 219

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERV-GAGSFGTVH--RAEWHGSDVAVKVLTVQ 693
           GPG  +L+  P + +      + + +  +RV G GSFG V   + +  G + AVKV++ +
Sbjct: 28  GPGD-HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 86
Query: 694 DFLDDQLKE-FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPA 751
                  KE  LREV ++K++ HPN++        + +  +V E    G L+  +I R  
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
             E +D  R +R  L    GI Y+H     I+H DLK  NLL++   K+  +++ DFGLS
Sbjct: 147 FSE-VDAARIIRQVL---SGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 200
Query: 809 -RFKANTFISSKSVAGTVVFFA 829
             F+A+  +  K   GT  + A
Sbjct: 201 THFEASKKMKDK--IGTAYYIA 220

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDYYKKTTNG 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 658 WDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           ++E H+K   ++G G+FG+V    +       G+ VAVK L  Q    DQ ++F RE+ I
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 64
Query: 710 MKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           +K +    +V + G      R  L +V EYLP G L   + R  A   +D  R L  +  
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQ 122
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + KG+ YL +     +H DL + N+LV+    VK+ DFGL++ 
Sbjct: 123 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 163

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 658 WDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           ++E H+K   ++G G+FG+V    +       G+ VAVK L  Q    DQ ++F RE+ I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 77
Query: 710 MKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           +K +    +V + G      R  L +V EYLP G L   + R  A   +D  R L  +  
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQ 135
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + KG+ YL +     +H DL + N+LV+    VK+ DFGL++ 
Sbjct: 136 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 658 WDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           ++E H+K   ++G G+FG+V    +       G+ VAVK L  Q    DQ ++F RE+ I
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 65
Query: 710 MKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           +K +    +V + G      R  L +V EYLP G L   + R  A   +D  R L  +  
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQ 123
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + KG+ YL +     +H DL + N+LV+    VK+ DFGL++ 
Sbjct: 124 ICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 164

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDXXKKTTNG 219

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDXXKKTTNG 219

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G G FG+V        D     VAVK + + +    +++EFL E A MK   HPNV+  
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 722 MGAVTKR-----PHLSIVTEYLPRGSL--YRLIHRPAAG-EMMDQRRRLRMALDVAKGIN 773
           +G   +      P   ++  ++  G L  Y L  R   G + +  +  L+  +D+A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL N N   LH DL + N ++  + TV V DFGLS+
Sbjct: 162 YLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 637 GPGPR--YLNIEPSLAMDWLEISWDELHVKERV-GAGSFGTVH--RAEWHGSDVAVKVLT 691
           GPG    +L+  P + +      + + +  +RV G GSFG V   + +  G + AVKV++
Sbjct: 1   GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 692 VQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR 749
            +       KE  LREV ++K++ HPN++        + +  +V E    G L+  +I R
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFG 806
               E +D  R +R  L    GI Y+H     I+H DLK  NLL++   K+  +++ DFG
Sbjct: 121 KRFSE-VDAARIIRQVL---SGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 807 LS-RFKANTFISSKSVAGTVVFFA 829
           LS  F+A+  +  K   GT  + A
Sbjct: 175 LSTHFEASKKMKDK--IGTAYYIA 196

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDYYKKTTNG 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 15/168 (8%)
Query: 667 VGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+FG   + R +     VAVK +     +D+ ++   RE+   + +RHPN+V F   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +    HL+I+ EY   G LY  I    AG   +   R      +  G++Y H++   I H
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQ-QLLSGVSYCHSMQ--ICH 139
Query: 785 WDLKSPNLLVDKNWT--VKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
            DLK  N L+D +    +K+CDFG S  K++   S  KS  GT  + A
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKSTVGTPAYIA 185

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 123
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREV 707
           A+ W  I+ D+  ++E +G+G+   V  A        VA+K + ++      + E L+E+
Sbjct: 2   ALPW-SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEI 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGE----MMDQRRRL 762
             M +  HPN+V +  +   +  L +V + L  GS+  +I H  A GE    ++D+    
Sbjct: 60  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 119
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
            +  +V +G+ YLH      +H D+K+ N+L+ ++ +V++ DFG+S F A 
Sbjct: 120 TILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLAT 168

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 13  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 71
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 190 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 82
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 250

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 82
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 250

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 74
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 193 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 242

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 76
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 77  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIADFGLARDI 194
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 195 NNIDYYKKTTNG 206

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 81
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 82  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 141
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 199
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 200 NNIDYYKKTTNG 211

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 78
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 79  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 138
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 196
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 197 NNIDYYKKTTNG 208

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 75
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 194 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 243

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 45/232 (19%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 82
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL---------------YRLIHR 749
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L               Y   H 
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           P   E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R
Sbjct: 143 PE--EQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 810 -------FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                  +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 250

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 67
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 810 -----FK--ANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                +K   N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 810 ----FKANTF---ISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
               +  NT    +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 208 NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLF 721
           + +G G+FG V   E    G  VAVK+L  Q     D + +  RE+  +K  RHP+++  
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              ++      +V EY+  G L+  I +    E M+ RR  +  L     ++Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCH--RHM 131
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           ++H DLK  N+L+D +   K+ DFGLS   ++
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLF 721
           + +G G+FG V   E    G  VAVK+L  Q     D + +  RE+  +K  RHP+++  
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              ++      +V EY+  G L+  I +    E M+ RR  +  L     ++Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCH--RHM 131
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           ++H DLK  N+L+D +   K+ DFGLS   ++
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 135
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 254 NNIDYYKKTTNG 265

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 41/230 (17%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 82
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-- 809
             E +  +  +  A  VA+G+ YL +     +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 810 -------FKANTFISSKSVAGTVVF--FAAHQTACNSLAL----IFSLSG 846
                     N  +  K +A   +F     HQ+   S  +    IF+L G
Sbjct: 201 HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 250

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 83/145 (57%), Gaps = 6/145 (4%)
Query: 667 VGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
           +G G FG V++     G+ VA+K  T +      ++EF  E+  +   RHP++V  +G  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHNLNPPILH 784
            +R  + ++ +Y+  G+L R ++      M M   +RL + +  A+G++YLH     I+H
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIH 162
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR 809
            D+KS N+L+D+N+  K+ DFG+S+
Sbjct: 163 RDVKSINILLDENFVPKITDFGISK 187

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 83/145 (57%), Gaps = 6/145 (4%)
Query: 667 VGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
           +G G FG V++     G+ VA+K  T +      ++EF  E+  +   RHP++V  +G  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHNLNPPILH 784
            +R  + ++ +Y+  G+L R ++      M M   +RL + +  A+G++YLH     I+H
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIH 162
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR 809
            D+KS N+L+D+N+  K+ DFG+S+
Sbjct: 163 RDVKSINILLDENFVPKITDFGISK 187

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 15/176 (8%)
Query: 659 DELHVKERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + + +G+G+FG   + R +     VAVK +   + +D+ +K   RE+   + +RHP
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRHP 74
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V F   +    HL+IV EY   G L+  I    AG   +   R      +  G++Y H
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ-QLISGVSYCH 131
Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
            +   + H DLK  N L+D +    +K+CDFG S  K++   S  KS  GT  + A
Sbjct: 132 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKSTVGTPAYIA 183

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +++ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDYYKKTTNG 219

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAI 709
           EIS   +   E +G   FG V++    G        AV + T++D  +  L+E  R  A+
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 81
Query: 710 MK-RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM--MDQRRRLRMA 765
           ++ R++HPNVV  +G VTK   LS++  Y   G L+  L+ R    ++   D  R ++ A
Sbjct: 82  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 141
Query: 766 LD----------VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           L+          +A G+ YL + +  ++H DL + N+LV     VK+ D GL R
Sbjct: 142 LEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAI 709
           EIS   +   E +G   FG V++    G        AV + T++D  +  L+E  R  A+
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 710 MK-RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM--MDQRRRLRMA 765
           ++ R++HPNVV  +G VTK   LS++  Y   G L+  L+ R    ++   D  R ++ A
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 766 LD----------VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           L+          +A G+ YL + +  ++H DL + N+LV     VK+ D GL R
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 650 AMDWLEISW--DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLK 701
           AM+  +  W  ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
              REV I   +RHPN++   G       + ++ EY PRG +Y+ + + +     D++R 
Sbjct: 62  ---REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRT 115
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
                ++A  ++Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 116 ATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKF--SLDLAS 492
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           +E+    L V+  +  G F  V+ A+  GS  + A+K L   +  +++ +  ++EV  MK
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMK 80
Query: 712 RVR-HPNVVLFMGAV--------TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
           ++  HPN+V F  A         T +    ++TE L +G L   + +  +   +     L
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
           ++     + + ++H   PPI+H DLK  NLL+    T+K+CDFG
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 11/179 (6%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723
           E VG G++G V++   H     +  + V D   D+ +E  +E+ ++K+   H N+  + G
Sbjct: 30  ELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 724 AVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           A  K+        L +V E+   GS+  LI +   G  + +     +  ++ +G+++LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN 836
               ++H D+K  N+L+ +N  VK+ DFG+S     T     +  GT  + A    AC+
Sbjct: 148 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 103/193 (53%), Gaps = 13/193 (6%)
Query: 659 DELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K E++G GSFG V +   + +   VA+K++ +++  D+      +E+ ++ +   
Sbjct: 26  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDS 84
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P V  + G+  K   L I+ EYL  GS   L+  P     +D+ +   +  ++ KG++YL
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKGLDYL 140
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---Q 832
           H+     +H D+K+ N+L+ ++  VK+ DFG++    +T I   +  GT  + A     Q
Sbjct: 141 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 833 TACNSLALIFSLS 845
           +A +S A I+SL 
Sbjct: 199 SAYDSKADIWSLG 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 650 AMDWLEISW--DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLK 701
           AM+  +  W  ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
              REV I   +RHPN++   G       + ++ EY PRG +Y+ + + +     D++R 
Sbjct: 62  ---REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRT 115
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
                ++A  ++Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 116 ATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTV 692
           P Y +       D  E++ +++ +   +G GSFG V+     G       + VA+K +  
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RP 750
              + +++ EFL E ++MK     +VV  +G V++     ++ E + RG L   +   RP
Sbjct: 66  AASMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 124
Query: 751 AAGEM-----MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805
           A             + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DF
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 806 GLSR 809
           G++R
Sbjct: 183 GMTR 186

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 50  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 107
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 108 HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 160
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 161 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 88
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 89  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 141
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 142 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 103/193 (53%), Gaps = 13/193 (6%)
Query: 659 DELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K E++G GSFG V +   + +   VA+K++ +++  D+      +E+ ++ +   
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDS 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P V  + G+  K   L I+ EYL  GS   L+  P     +D+ +   +  ++ KG++YL
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKGLDYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---Q 832
           H+     +H D+K+ N+L+ ++  VK+ DFG++    +T I   +  GT  + A     Q
Sbjct: 121 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 833 TACNSLALIFSLS 845
           +A +S A I+SL 
Sbjct: 179 SAYDSKADIWSLG 191

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 15/170 (8%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G GSFG V + +      + AVKV+      +      LREV ++K++ HPN++     
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 725 VTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +       IV E    G L+  +I R    E        R+   V  GI Y+H  N  I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSGITYMHKHN--IV 143
Query: 784 HWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTVVFFA 829
           H DLK  N+L+   +K+  +K+ DFGLS  F+ NT    K   GT  + A
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIA 191

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 89
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 90  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 142
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 143 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKF--SLDLAS 112
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 160

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 10/175 (5%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
            +G G+FG V++A+   + V      +    +++L++++ E+ I+    HPN+V  + A 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 726 TKRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
               +L I+ E+   G++  +   + RP     +  +   +  LD    +NYLH  +  I
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH--DNKI 156
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS 837
           +H DLK+ N+L   +  +K+ DFG+S     T     S  GT  + A     C +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 51  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 108
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 109 HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 161
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 162 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE H        + V V  +++  +   ++F RE  ++  ++H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRP-----AAGE-----MMDQRRRLRMA 765
           +V F G  T+   L +V EY+  G L R +  H P     A GE      +   + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             VA G+ YL  L+   +H DL + N LV +   VK+ DFG+SR
Sbjct: 165 SQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   +RHPN++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLR---REVEIQSHLRHPNILR 76
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
             G       + ++ EY P G++YR + + +     D++R      ++A  ++Y H+   
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYCHSKR- 132
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            ++H D+K  NLL+  N  +K+ DFG S
Sbjct: 133 -VIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 24  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 81
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 82  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 134
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 135 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 88
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 89  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 141
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 142 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 27  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 84
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 85  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 137
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 138 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 69  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 115
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 116 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 163

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 87
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 88  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 140
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 141 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   +RHPN++ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLR---REVEIQSHLRHPNILR 76
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
             G       + ++ EY P G++YR + + +     D++R      ++A  ++Y H+   
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYCHSKR- 132
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            ++H D+K  NLL+  N  +K+ DFG S
Sbjct: 133 -VIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 89
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 90  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 142
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 143 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 92/182 (50%), Gaps = 7/182 (3%)
Query: 652 DWLEISWDELHVKERV--GAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           D LE  ++     +RV  G G++G V+      + V + +  + +      +    E+A+
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDV 768
            K ++H N+V ++G+ ++   + I  E +P GSL  L+ R   G + D  + +      +
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQI 131
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
            +G+ YLH+    I+H D+K  N+L++  +  +K+ DFG S+  A     +++  GT+ +
Sbjct: 132 LEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQY 189
Query: 828 FA 829
            A
Sbjct: 190 MA 191

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 94  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 140
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 141 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 188

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 650 AMDWLEISWDELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLRE 706
            M  L+   +EL  K E++G GSFG V +   + +   VA+K++ +++  D+      +E
Sbjct: 12  GMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQE 70
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           + ++ +   P V  + G+  K   L I+ EYL  GS   L+  P     +D+ +   +  
Sbjct: 71  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILR 126
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
           ++ KG++YLH+     +H D+K+ N+L+ ++  VK+ DFG++    +T I      GT  
Sbjct: 127 EILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF 184
Query: 827 FFAAH---QTACNSLALIFSL 844
           + A     Q+A +S A I+SL
Sbjct: 185 WMAPEVIKQSAYDSKADIWSL 205

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 68  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 114
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 115 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 162

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 86
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 87  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 139
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ YL   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 140 AKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 14/165 (8%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEF 703
           AM   + + ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+  
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR-- 59
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
            REV I   +RHPN++   G       + ++ EY P G++YR + + +     D++R   
Sbjct: 60  -REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTAT 115
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
              ++A  ++Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 116 YITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++  Y  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDYYKKTTNG 219

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 71  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 117
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 662 HVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           H    +G G FG V+  E+     +    A+K L+    +  Q++ FLRE  +M+ + HP
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-QVEAFLREGLLMRGLNHP 82
Query: 717 NVVLFMGAVTK---RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           NV+  +G +      PH  ++  Y+  G L + I  P     +  +  +   L VA+G+ 
Sbjct: 83  NVLALIGIMLPPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGME 138
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           YL       +H DL + N ++D+++TVKV DFGL+R
Sbjct: 139 YLAEQK--FVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 90
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 147
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 148 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           ++ H  E++G G++G V++A+  +G   A+K + ++   +      +RE++I+K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V     +  +  L +V E+L +  L +L+     G  ++        L +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD 118
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +LH DLK  NLL+++   +K+ DFGL+R
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 90
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 147
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 148 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           ++ H  E++G G++G V++A+  +G   A+K + ++   +      +RE++I+K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V     +  +  L +V E+L +  L +L+     G  ++        L +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD 118
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +LH DLK  NLL+++   +K+ DFGL+R
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 81
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 138
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 139 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           ++ H  E++G G++G V++A+  +G   A+K + ++   +      +RE++I+K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V     +  +  L +V E+L +  L +L+     G  ++        L +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD 118
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +LH DLK  NLL+++   +K+ DFGL+R
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 87/172 (50%), Gaps = 25/172 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 63  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 109
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+  ++
Sbjct: 110 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 667 VGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V    +       G  VAVK L  +    + + +  +E+ I++ + H N+V 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVK 87
Query: 721 FMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           + G  T+     + ++ E+LP GSL   +  P     ++ +++L+ A+ + KG++YL + 
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +H DL + N+LV+    VK+ DFGL++
Sbjct: 146 Q--YVHRDLAARNVLVESEHQVKIGDFGLTK 174

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 21/197 (10%)
Query: 659 DELHVK-ERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVAIMK 711
           +EL  K E++G GSFG V +    G D      VA+K++ +++  D+      +E+ ++ 
Sbjct: 6   EELFTKLEKIGKGSFGEVFK----GIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLS 60
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           +   P V  + G+  K   L I+ EYL  GS   L+  P     +D+ +   +  ++ KG
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH 831
           ++YLH+     +H D+K+ N+L+ ++  VK+ DFG++    +T I      GT  + A  
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 832 ---QTACNSLALIFSLS 845
              Q+A +S A I+SL 
Sbjct: 175 VIKQSAYDSKADIWSLG 191

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
           E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++   
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+ 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGLT 180
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
           YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 181 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 230

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 650 AMDWLEISW--DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLK 701
           AM+  +  W  ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+
Sbjct: 2   AMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
              REV I   +RHPN++   G       + ++ EY P G++YR + + +     D++R 
Sbjct: 62  ---REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRT 115
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
                ++A  ++Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 116 ATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 36/203 (17%)
Query: 656 ISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQ-------------- 699
           +  ++  +K+ +G GS+G V  A  E   +  A+KVL+ +  +                 
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 700 ----------LKEFLREVAIMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSLYRLI 747
                     +++  +E+AI+K++ HPNVV  +  +      HL +V E + +G +  + 
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV- 128
Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
             P    + + + R     D+ KGI YLH     I+H D+K  NLLV ++  +K+ DFG+
Sbjct: 129 --PTLKPLSEDQARFYFQ-DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 808 S-RFKANTFISSKSVAGTVVFFA 829
           S  FK +  + S +V GT  F A
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMA 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 667 VGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V    +       G  VAVK L  +    + + +  +E+ I++ + H N+V 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVK 75
Query: 721 FMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           + G  T+     + ++ E+LP GSL   +  P     ++ +++L+ A+ + KG++YL + 
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +H DL + N+LV+    VK+ DFGL++
Sbjct: 134 Q--YVHRDLAARNVLVESEHQVKIGDFGLTK 162

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 112
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 160

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 9/172 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKR 712
           +E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
              P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGL 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
            YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 118 TYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKY--SLDLAS 112
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 160

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 89
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
           E+ +MK + +H N++  +GA T+   L ++  Y  +G+L  Y    RP            
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
             E M  +  +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+R  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 812 ANTFISSKSVAG 823
            N     K+  G
Sbjct: 208 NNIDYYKKTTNG 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 659 DELHVKERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + + +GAG+FG   + R +     VAVK +   + +D+ +K   RE+   + +RHP
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK---REIINHRSLRHP 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V F   +    HL+IV EY   G L+  I    AG   +   R      +  G++Y H
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ-QLISGVSYAH 132
Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
            +   + H DLK  N L+D +    +K+ DFG S  KA+   S  KS  GT  + A
Sbjct: 133 AMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYS--KASVLHSQPKSAVGTPAYIA 184

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTV 692
           P Y +       D  E++ +++ +   +G GSFG V+     G       + VA+K +  
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA 752
              + +++ EFL E ++MK     +VV  +G V++     ++ E + RG L   + R   
Sbjct: 66  AASMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLR 123
Query: 753 GEMMDQ--------RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
            EM +          + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ D
Sbjct: 124 PEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGD 181
Query: 805 FGLSR 809
           FG++R
Sbjct: 182 FGMTR 186

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 9/172 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKR 712
           +E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
              P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGL 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
            YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 118 TYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 88/171 (51%), Gaps = 16/171 (9%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V   + +  G + AVKV++ +       KE  LREV ++K++ HPN++    
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 724 AVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
               + +  +V E    G L+  +I R    E +D  R +R  L    GI Y+H     I
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-VDAARIIRQVLS---GITYMH--KNKI 153
Query: 783 LHWDLKSPNLLVD---KNWTVKVCDFGLS-RFKANTFISSKSVAGTVVFFA 829
           +H DLK  NLL++   K+  +++ DFGLS  F+A+  +  K   GT  + A
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIA 202

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 91  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 148
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 149 HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 201
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 202 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE H        + V V  +++  +   ++F RE  ++  ++H +
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRP-----AAGE-----MMDQRRRLRMA 765
           +V F G  T+   L +V EY+  G L R +  H P     A GE      +   + L +A
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             VA G+ YL  L+   +H DL + N LV +   VK+ DFG+SR
Sbjct: 136 SQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 622 KEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWH 681
           K + S+L   G       P Y +       D  E++ +++ +   +G GSFG V+     
Sbjct: 11  KRNNSRL-GNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAK 69
Query: 682 G-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734
           G       + VA+K +     + +++ EFL E ++MK     +VV  +G V++     ++
Sbjct: 70  GVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 128
Query: 735 TEYLPRGSLYRLIHRPAAGEMMDQ--------RRRLRMALDVAKGINYLHNLNPPILHWD 786
            E + RG L   + R    EM +          + ++MA ++A G+ YL N N   +H D
Sbjct: 129 MELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL-NAN-KFVHRD 185
Query: 787 LKSPNLLVDKNWTVKVCDFGLSR 809
           L + N +V +++TVK+ DFG++R
Sbjct: 186 LAARNCMVAEDFTVKIGDFGMTR 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 65
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 122
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 123 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 9/172 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKR 712
           +E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
              P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGL 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
            YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 118 TYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 9/172 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKR 712
           +E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
              P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGL 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
            YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 118 TYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 9/172 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKR 712
           +E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
              P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGL 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
            YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 118 TYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE H        + V V  +++  +   ++F RE  ++  ++H +
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRP-----AAGE-----MMDQRRRLRMA 765
           +V F G  T+   L +V EY+  G L R +  H P     A GE      +   + L +A
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             VA G+ YL  L+   +H DL + N LV +   VK+ DFG+SR
Sbjct: 142 SQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 69
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 126
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 67
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 124
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 659 DELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K ER+G GSFG V +   + +   VA+K++ +++  D+      +E+ ++ +   
Sbjct: 22  EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDS 80
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
             V  + G+  K   L I+ EYL  GS   L+    AG   D+ +   M  ++ KG++YL
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR---AGPF-DEFQIATMLKEILKGLDYL 136
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA---AHQ 832
           H+     +H D+K+ N+L+ +   VK+ DFG++    +T I   +  GT  + A     Q
Sbjct: 137 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 833 TACNSLALIFSL 844
           +A +S A I+SL
Sbjct: 195 SAYDSKADIWSL 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 66
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 123
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 124 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 90
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 91  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 143
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 144 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 90
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 91  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 143
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 144 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 65
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 122
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 123 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 65
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 122
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 123 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 637 GPGPR--YLNIEPSLAMDWLEISWDELHVKERV-GAGSFGTVH--RAEWHGSDVAVKVLT 691
           GPG    +L+  P   +      + + +  +RV G GSFG V   + +  G + AVKV++
Sbjct: 1   GPGSXXDHLHATPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 692 VQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR 749
            +       KE  LREV ++K++ HPN+         + +  +V E    G L+  +I R
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFG 806
               E +D  R +R  L    GI Y H     I+H DLK  NLL++   K+  +++ DFG
Sbjct: 121 KRFSE-VDAARIIRQVL---SGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 807 LS-RFKANTFISSKSVAGTVVFFA 829
           LS  F+A+     K   GT  + A
Sbjct: 175 LSTHFEASK--KXKDKIGTAYYIA 196

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
           E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++   
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+ 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGLT 145
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
           YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 146 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 195

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H  +  ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCH--SKKVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 69
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 126
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 89/174 (51%), Gaps = 8/174 (4%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+FG V++A  +  G+  A KV+  +   +++L++++ E+ I+    HP +V  +GA
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
                 L I+ E+ P G++  ++     G  + + +   +   + + +N+LH+    I+H
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKR--IIH 140
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL 838
            DLK+ N+L+     +++ DFG+S     T     S  GT  + A     C ++
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 659 DELHVKERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + + +G+G+FG   + R +     VAVK +   + +D+ +K   RE+   + +RHP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRHP 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V F   +    HL+IV EY   G L+  I    AG   +   R      +  G++Y H
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ-QLISGVSYCH 132
Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
            +   + H DLK  N L+D +    +K+C FG S  K++   S  KS  GT  + A
Sbjct: 133 AMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYS--KSSVLHSQPKSTVGTPAYIA 184

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 89
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 90  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 142
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 143 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G GSFG V + +      + AVKV+      +      LREV ++K++ HPN++     
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +       IV E    G L+  I +       D  R ++    V  GI Y+H  N  I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---QVFSGITYMHKHN--IVH 144
Query: 785 WDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTVVFFA 829
            DLK  N+L+   +K+  +K+ DFGLS  F+ NT    K   GT  + A
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIA 191

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 87
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 88  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 140
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 141 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 37  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 94
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 95  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 147
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 148 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G GSFG V + +      + AVKV+      +      LREV ++K++ HPN++     
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
           +       IV E    G L+  I +       D  R ++    V  GI Y+H  N  I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---QVFSGITYMHKHN--IVH 144
Query: 785 WDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTVVFFA 829
            DLK  N+L+   +K+  +K+ DFGLS  F+ NT    K   GT  + A
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIA 191

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKF--SLDLAS 492
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV     VK+ DFGLSR+
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRY 540

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 89/174 (51%), Gaps = 8/174 (4%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G+FG V++A  +  G+  A KV+  +   +++L++++ E+ I+    HP +V  +GA
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
                 L I+ E+ P G++  ++     G  + + +   +   + + +N+LH+    I+H
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKR--IIH 132
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL 838
            DLK+ N+L+     +++ DFG+S     T     S  GT  + A     C ++
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVR 714
           +H  E +G G FG V+      +D      AVK L  + D    ++ +FL E  IMK   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFS 89
Query: 715 HPNVVLFMGAVTKRPHLS--IVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDV 768
           HPNV+  +G +  R   S  +V  Y+  G L   I    H P   +++         L V
Sbjct: 90  HPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG------FGLQV 142
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           AKG+ +L   +   +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 143 AKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +DE   +  +G G++G V+      + V + +  + +      +    E+A+ K ++H N
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 66
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLH 776
           +V ++G+ ++   + I  E +P GSL  L+ R   G + D  + +      + +G+ YLH
Sbjct: 67  IVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 777 NLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +    I+H D+K  N+L++  +  +K+ DFG S+  A     +++  GT+ + A
Sbjct: 126 DNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 177

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVLFM 722
           VG GS+G V   R +  G  VA+K     D  DD++  K  +RE+ ++K++RH N+V  +
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
               K+    +V E++    L  L   P     +D +   +    +  GI + H+ N  I
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHN--I 145
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H D+K  N+LV ++  VK+CDFG +R
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFAR 172

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 68
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 125
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 126 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 159

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 83/175 (47%), Gaps = 10/175 (5%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
            +G G+FG V++A+   + V      +    +++L++++ E+ I+    HPN+V  + A 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 726 TKRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
               +L I+ E+   G++  +   + RP     +  +   +  LD    +NYLH  +  I
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH--DNKI 156
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS 837
           +H DLK+ N+L   +  +K+ DFG+S           S  GT  + A     C +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 67
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 124
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 67
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 124
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 27/158 (17%)
Query: 663 VKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVV 719
           ++E +G GSFG V  A  + +   VA+K ++ Q     D      RE++ +K +RHP+++
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD---QRRRL------RMALDVAK 770
                +T    + +V EY             A GE+ D   +++R+      R    +  
Sbjct: 73  KLYDVITTPTDIVMVIEY-------------AGGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            I Y H     I+H DLK  NLL+D N  VK+ DFGLS
Sbjct: 120 AIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 67
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 124
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 66
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEM-----MD 757
            E ++MK     +VV  +G V++     ++ E + RG L   +   RPA           
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 127 LSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 40/207 (19%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTV---QDFLDDQLKE 702
           EPSL +D        L + E +G G +G V++       VAVKV +    Q+F+++  K 
Sbjct: 7   EPSLDLD-------NLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINE--KN 57
Query: 703 FLREVAIMKRVRHPNVVLFMGA---VTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMD 757
             R V +M+   H N+  F+     VT   R    +V EY P GSL + +    +    D
Sbjct: 58  IYR-VPLME---HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----D 109
Query: 758 QRRRLRMALDVAKGINYLH-------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-R 809
                R+A  V +G+ YLH       +  P I H DL S N+LV  + T  + DFGLS R
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 810 FKANTFI-------SSKSVAGTVVFFA 829
              N  +       ++ S  GT+ + A
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMA 196

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 63
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 120
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 121 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 25/168 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREVAIM 710
           EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++  HP++V  +G +T+ P + I+ E    G L   +          Q R+   +LD+A 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----------QVRKF--SLDLAS 112
Query: 771 GINYLHNLNPPI--------LHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            I Y + L+  +        +H D+ + N+LV     VK+ DFGLSR+
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRY 160

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLR-EVAIMK 711
           + + D+  +   +G G FG V+  R + +   +A+KVL       + ++  LR E+ I  
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            +RHPN++        R  + ++ E+ PRG LY+ + +       D++R      ++A  
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADA 127
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           ++Y H     ++H D+K  NLL+     +K+ DFG S
Sbjct: 128 LHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
           E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ ++   
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V KG+ 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGLT 137
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
           YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 138 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 187

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 646 EPSLAMDWLEISW---DELHVKERVGAGSFGTVHRA--EWHGSDVAVK-VLTV-QDFLDD 698
           +P+ +M      W   D   ++  +G GS+G V  A  +     VA+K +L V +D +D 
Sbjct: 37  KPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID- 95
Query: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAG 753
             K  LRE+AI+ R+ H +VV  +  V      K   L +V E +      +L   P   
Sbjct: 96  -CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPV-- 151
Query: 754 EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             + +     +  ++  G+ Y+H+    ILH DLK  N LV+++ +VKVCDFGL+R
Sbjct: 152 -YLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 129
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 130 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH  +  +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH--SNQV 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 84
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH  +  +
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH--SNQV 138
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGF 163

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 70
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 129
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 130 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH  +  +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH--SNQV 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 66
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 123
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ +FG S
Sbjct: 124 SYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 659 DELHVK-ERVGAGSFGTVHRA-EWHGSDV-AVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +EL  K +R+G GSFG V++  + H  +V A+K++ +++  D+      +E+ ++ +   
Sbjct: 18  EELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDS 76
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +  + G+  K   L I+ EYL  GS   L+ +P   E       LR   ++ KG++YL
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILR---EILKGLDYL 132
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH---Q 832
           H+     +H D+K+ N+L+ +   VK+ DFG++    +T I      GT  + A     Q
Sbjct: 133 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 833 TACNSLALIFSL 844
           +A +  A I+SL
Sbjct: 191 SAYDFKADIWSL 202

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH  +  +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH--SNQV 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H D+KS N+L+  + +VK+ DFG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 63
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 122
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 123 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLR-EVAIMK 711
           + + D+  +   +G G FG V+  R + +   +A+KVL       + ++  LR E+ I  
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            +RHPN++        R  + ++ E+ PRG LY+ + +       D++R      ++A  
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADA 126
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           ++Y H     ++H D+K  NLL+     +K+ DFG S
Sbjct: 127 LHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 659 DELHVKERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + + +G+G+FG   + R +     VAVK +   + +   +K   RE+   + +RHP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVK---REIINHRSLRHP 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V F   +    HL+IV EY   G L+  I    AG   +   R      +  G++Y H
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ-QLISGVSYCH 132
Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
            +   + H DLK  N L+D +    +K+CDFG S  K++   S  KS  GT  + A
Sbjct: 133 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKSTVGTPAYIA 184

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 69
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 128
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 129 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 61
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 120
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 121 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 67
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 126
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 127 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 69
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 128
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N +V +++TVK+ DFG++R
Sbjct: 129 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGS-------DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + L   + +GAG+FG V  A   G         VAVK+L      D++ +  + E+ IM 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-EALMSELKIMS 96
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM-------MDQRRRLR 763
            + +H N+V  +GA T    + ++TEY   G L   + R A  ++       ++ R  L 
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  VA+G+ +L + N   +H D+ + N+L+      K+ DFGL+R
Sbjct: 157 FSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-------DVAVK 688
           G  Y  I+P+       W E   + L   + +GAG+FG V  A   G         VAVK
Sbjct: 24  GNSYTFIDPTQLPYNEKW-EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L      D++ +  + E+ IM  + +H N+V  +GA T    + ++TEY   G L   +
Sbjct: 83  MLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
Query: 748 HRPAAGEM-------MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV 800
            R A  ++       ++ R  L  +  VA+G+ +L + N   +H D+ + N+L+      
Sbjct: 142 RRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA 199
Query: 801 KVCDFGLSR 809
           K+ DFGL+R
Sbjct: 200 KIGDFGLAR 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLDDQLKEFLREVAIMK 711
           I+ +++ +   +G G FG V+   +    G  + V V T + D   D  ++F+ E  IMK
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            + HP++V  +G + + P   I+ E  P G L   + R      +     +  +L + K 
Sbjct: 81  NLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKA 137
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-------FKAN-TFISSKSVAG 823
           + YL ++N   +H D+   N+LV     VK+ DFGLSR       +KA+ T +  K ++ 
Sbjct: 138 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 195
Query: 824 TVVFFAAHQTACNSLALIFSLSGWLQSSFEESP 856
             + F    TA  S   +F++  W   SF + P
Sbjct: 196 ESINFRRFTTA--SDVWMFAVCMWEILSFGKQP 226

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 659 DELHVKERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + + +G+G+FG   + R +     VAVK +   + +D+ +K   RE+   + +RHP
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRHP 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V F   +    HL+IV EY   G L+  I    AG   +   R      +  G++Y H
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQ-QLISGVSYCH 132
Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFKANTFISS-KSVAGTVVFFA 829
            +   + H DLK  N L+D +    +K+C FG S  K++   S  K   GT  + A
Sbjct: 133 AMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYS--KSSVLHSQPKDTVGTPAYIA 184

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 667 VGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +G G FG V+   +    G  + V V T + D   D  ++F+ E  IMK + HP++V  +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G + + P   I+ E  P G L   + R      +     +  +L + K + YL ++N   
Sbjct: 76  GIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESIN--C 130
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR-------FKAN-TFISSKSVAGTVVFFAAHQTA 834
           +H D+   N+LV     VK+ DFGLSR       +KA+ T +  K ++   + F    TA
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 190
Query: 835 CNSLALIFSLSGWLQSSFEESP 856
             S   +F++  W   SF + P
Sbjct: 191 --SDVWMFAVCMWEILSFGKQP 210

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 89/175 (50%), Gaps = 9/175 (5%)
Query: 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAI 709
           M   E+  D+      +GAG+ G V +     S + +    +   +   ++ + +RE+ +
Sbjct: 1   MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 60
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           +     P +V F GA      +SI  E++  GSL +++ +  AG + +Q    ++++ V 
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVI 117
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF----KANTFISSKS 820
           KG+ YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN F+ ++S
Sbjct: 118 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS 171

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 83/146 (56%), Gaps = 6/146 (4%)
Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           E+VG G++G V++A +  G  VA+K + +    +      +RE++++K + HPN+V  + 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
            +     L++V E++ +  L +++     G + D + ++ +   + +G+ + H     IL
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL-YQLLRGVAHCHQHR--IL 141
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H DLK  NLL++ +  +K+ DFGL+R
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFLDDQLKEFL---REVAIMKRVR 714
           + H  + +G GSFG V  A     +V  AVKVL  +  L  + ++ +   R V ++K V+
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVK 97
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP +V    +      L  V +Y+  G L+  + R      ++ R R   A ++A  + Y
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAA-EIASALGY 154
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LH+LN  I++ DLK  N+L+D    + + DFGL +       ++ +  GT  + A
Sbjct: 155 LHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+  R +     +A+KVL         ++ QL+   REV I   
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 61
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 118
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ DFG S
Sbjct: 119 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS 152

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQ-DFLDDQLKEFLREVAIMK 711
           I+ +++ +   +G G FG V+   +    G  + V V T + D   D  ++F+ E  IMK
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            + HP++V  +G + + P   I+ E  P G L   + R      +     +  +L + K 
Sbjct: 69  NLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKA 125
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-------FKAN-TFISSKSVAG 823
           + YL ++N   +H D+   N+LV     VK+ DFGLSR       +KA+ T +  K ++ 
Sbjct: 126 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183
Query: 824 TVVFFAAHQTACNSLALIFSLSGWLQSSFEESP 856
             + F    TA  S   +F++  W   SF + P
Sbjct: 184 ESINFRRFTTA--SDVWMFAVCMWEILSFGKQP 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 83/146 (56%), Gaps = 6/146 (4%)
Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           E+VG G++G V++A +  G  VA+K + +    +      +RE++++K + HPN+V  + 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
            +     L++V E++ +  L +++     G + D + ++ +   + +G+ + H     IL
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL-YQLLRGVAHCHQHR--IL 141
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H DLK  NLL++ +  +K+ DFGL+R
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDF----LDDQLKEFLREVAIMKR 712
           ++  +   +G G FG V+ A    S   +A+KVL         ++ QL+   REV I   
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSH 67
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++   G       + ++ EY P G++YR + + +     D++R      ++A  +
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 124
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +Y H+    ++H D+K  NLL+     +K+ +FG S
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +K  +G G+FG V  AE +        + V V  ++D      K+F RE  ++  ++H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRR-----------LRM 764
           +V F G       L +V EY+  G L + +  H P A  ++D + R           L +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           A  +A G+ YL + +   +H DL + N LV  N  VK+ DFG+SR
Sbjct: 139 ASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 82/175 (46%), Gaps = 10/175 (5%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
            +G G+FG V++A+   + V      +    +++L++++ E+ I+    HPN+V  + A 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 726 TKRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
               +L I+ E+   G++  +   + RP     +  +   +  LD    +NYLH  +  I
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH--DNKI 156
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS 837
           +H DLK+ N+L   +  +K+ DFG+S              GT  + A     C +
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCET 211

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFL-----DDQLKEFLREVAIMKRVRHPN 717
           + +++G G   TV+ AE    ++ V +  +  F+     ++ LK F REV    ++ H N
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAI--FIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 718 VVLFMGAVTKRPHLSIVTEYL--PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           +V  +    +     +V EY+  P  S Y   H P + +       +     +  GI + 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTA-----INFTNQILDGIKHA 127
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS-SKSVAGTVVFFAAHQT- 833
           H++   I+H D+K  N+L+D N T+K+ DFG+++  + T ++ +  V GTV +F+  Q  
Sbjct: 128 HDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 834 --ACNSLALIFSLSGWL 848
             A +    I+S+   L
Sbjct: 186 GEATDECTDIYSIGIVL 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF----- 721
           +G G+FG V +A  +  D     +      +++L   L EV ++  + H  VV +     
Sbjct: 14  LGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 722 --------MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
                   M AV K+  L I  EY   G+LY LIH     +  D+  RL     + + ++
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQILEALS 130
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           Y+H+    I+H DLK  N+ +D++  VK+ DFGL++
Sbjct: 131 YIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 19/173 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E++ +++ +   +G GSFG V+     G       + VA+K +     + +++ EFL
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFL 63
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ------ 758
            E ++MK     +VV  +G V++     ++ E + RG L   + R    EM +       
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPP 122
Query: 759 --RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              + ++MA ++A G+ YL N N   +H DL + N  V +++TVK+ DFG++R
Sbjct: 123 SLSKMIQMAGEIADGMAYL-NAN-KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 150
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 151 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 79/145 (54%), Gaps = 10/145 (6%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     +L   + E+ +M+  ++PN+V ++
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 84
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH  +  +
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH--SNQV 138
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGL 807
           +H ++KS N+L+  + +VK+ DFG 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGF 163

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREV 707
           E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 70
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ-----RR 760
           ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +     + 
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 131 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 68
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 68
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 150
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 151 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 178
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 179 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 65
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 68
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 79/150 (52%), Gaps = 12/150 (8%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E +G G FG VH+ E    G  +A K++  +   D +  E   E+++M ++ H N++   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE--EVKNEISVMNQLDHANLIQLY 152
Query: 723 GAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
            A   +  + +V EY+  G L+ R+I        +D    ++    + +GI ++H +   
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ---ICEGIRHMHQMY-- 207
Query: 782 ILHWDLKSPNLL-VDKNW-TVKVCDFGLSR 809
           ILH DLK  N+L V+++   +K+ DFGL+R
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 68
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H DL + N +V  ++TVK+ DFG++R
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 8/174 (4%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G GS+G     R +  G  +  K L      + + +  + EV +++ ++HPN+V +   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 725 VTKRPH--LSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHNLNP- 780
           +  R +  L IV EY   G L  +I +     + +D+   LR+   +   +   H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 781 --PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
              +LH DLK  N+ +D    VK+ DFGL+R   +    +K+  GT  + +  Q
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPN 717
            + + +G GSFG V  A +H   G  VA+K++  +      ++  + RE++ ++ +RHP+
Sbjct: 17  QIVKTLGEGSFGKVKLA-YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++     +  +  + +V EY        ++ R    +M +Q  R R    +   + Y H 
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR---DKMSEQEAR-RFFQQIISAVEYCHR 131
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
               I+H DLK  NLL+D++  VK+ DFGLS
Sbjct: 132 --HKIVHRDLKPENLLLDEHLNVKIADFGLS 160

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 8/174 (4%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G GS+G     R +  G  +  K L      + + +  + EV +++ ++HPN+V +   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 725 VTKRPH--LSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHNLNP- 780
           +  R +  L IV EY   G L  +I +     + +D+   LR+   +   +   H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 781 --PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
              +LH DLK  N+ +D    VK+ DFGL+R   +    +K+  GT  + +  Q
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 187

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++GTV +A+   +   VA+K + + D  +      LRE+ ++K ++H N+V   
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             +     L++V E+  +    +       G++ D          + KG+ + H+ N  +
Sbjct: 68  DVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN--V 122
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           LH DLK  NLL+++N  +K+ DFGL+R
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPN 717
            + + +G GSFG V  A +H   G  VA+K++  +      ++  + RE++ ++ +RHP+
Sbjct: 16  QIVKTLGEGSFGKVKLA-YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++     +  +  + +V EY        ++ R    + M ++   R    +   + Y H 
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHR 130
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
               I+H DLK  NLL+D++  VK+ DFGLS
Sbjct: 131 --HKIVHRDLKPENLLLDEHLNVKIADFGLS 159

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 26/193 (13%)
Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-------DVAVK 688
           G  Y  I+P+       W E   + L   + +GAG+FG V  A   G         VAVK
Sbjct: 24  GNSYTFIDPTQLPYNEKW-EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L      D++ +  + E+ IM  + +H N+V  +GA T    + ++TEY   G L   +
Sbjct: 83  MLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
Query: 748 HR--------PA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796
            R        PA   A   +  R  L  +  VA+G+ +L + N   +H D+ + N+L+  
Sbjct: 142 RRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN 199
Query: 797 NWTVKVCDFGLSR 809
               K+ DFGL+R
Sbjct: 200 GHVAKIGDFGLAR 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVV---- 719
           + +G G++G V  A  H     V +  +  F      +  LRE+ I+ R RH NV+    
Sbjct: 49  QYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +   +  +      + + L    LY+L+      + +           + +G+ Y+H+ N
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLL----KSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             +LH DLK  NLL++    +K+CDFGL+R 
Sbjct: 165 --VLHRDLKPSNLLINTTCDLKICDFGLARI 193

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 108 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 162
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 163 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 191

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVLFMG 723
           ++G GS+G V +     +   V +    +  DD +  K  LRE+ ++K+++HPN+V  + 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 724 AVTKRPHLSIVTEYLPRGSLYRL--IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              ++  L +V EY     L+ L    R     ++       +     + +N+ H  N  
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS-----ITWQTLQAVNFCHKHN-- 122
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            +H D+K  N+L+ K+  +K+CDFG +R 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARL 151

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+P G ++  + R   G   +   R   A  +     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 143
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 144 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVR 714
           EL   + +G+G+FGTV++  W      VK+      L +       KE L E  +M  V 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
            P V   +G +     + +VT+ +P G L   + R   G +  Q   L   + +AKG++Y
Sbjct: 78  SPYVSRLLG-ICLTSTVQLVTQLMPYGCLLDHV-RENRGRLGSQDL-LNWCMQIAKGMSY 134
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           L ++   ++H DL + N+LV     VK+ DFGL+R 
Sbjct: 135 LEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARL 168

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           DE  + E +G G++G V   R    G  VA+K +     +    K  LRE+ I+K  +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 717 NVVLFMGAVTKR-PHLSIVTEY----LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           N++     +    P+    + Y    L    L+++IH      +   R  L   L   +G
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLL---RG 171
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + Y+H+    ++H DLK  NLLV++N  +K+ DFG++R
Sbjct: 172 LKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPN 717
            + + +G GSFG V  A +H   G  VA+K++  +      ++  + RE++ ++ +RHP+
Sbjct: 7   QIVKTLGEGSFGKVKLA-YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++     +  +  + +V EY        ++ R    +M +Q  R R    +   + Y H 
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR---DKMSEQEAR-RFFQQIISAVEYCHR 121
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
               I+H DLK  NLL+D++  VK+ DFGLS
Sbjct: 122 --HKIVHRDLKPENLLLDEHLNVKIADFGLS 150

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 75/171 (43%), Gaps = 31/171 (18%)
Query: 667 VGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           +G G+FG V +A   G       + VAVK+L  +   D Q  +F RE A+M    +PN+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIV 113
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-----HRPAAGEMMDQRRRLR----------- 763
             +G       + ++ EY+  G L   +     H   +    D   R R           
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 764 -----MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                +A  VA G+ YL       +H DL + N LV +N  VK+ DFGLSR
Sbjct: 174 AEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPN 717
            + + +G GSFG V  A +H   G  VA+K++  +      ++  + RE++ ++ +RHP+
Sbjct: 11  QIVKTLGEGSFGKVKLA-YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++     +  +  + +V EY        ++ R    + M ++   R    +   + Y H 
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHR 125
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
               I+H DLK  NLL+D++  VK+ DFGLS
Sbjct: 126 --HKIVHRDLKPENLLLDEHLNVKIADFGLS 154

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 5/152 (3%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPN 717
           +  +K  +G G++G V  A    +   V +  ++ F D  L     LRE+ I+K  +H N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHEN 70
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++            +    Y+ +  +   +HR  + +M+             + +  LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            N  ++H DLK  NLL++ N  +KVCDFGL+R
Sbjct: 131 SN--VIHRDLKPSNLLINSNCDLKVCDFGLAR 160

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 86  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 140
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 85  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 139
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 93  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 147
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 148 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 176

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 24/181 (13%)
Query: 666 RVGAGSFGTVHRA-EWHG-SDVAVKVLTVQDF-----------LDDQLKEFLREVAIMKR 712
           ++G+G++G V    E +G S+ A+KV+    F           ++   +E   E++++K 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + HPN++        + +  +VTE+   G L+ ++I+R       D+     +   +  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSG 158
Query: 772 INYLHNLNPPILHWDLKSPNLLV-DKN--WTVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           I YLH  N  I+H D+K  N+L+ +KN    +K+ DFGLS F +  +   +   GT  + 
Sbjct: 159 ICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYI 215
Query: 829 A 829
           A
Sbjct: 216 A 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 137
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 89  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 143
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 144 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 172

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 86  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 140
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 5/153 (3%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPN 717
           +  +K  +G G++G V  A    +   V +  ++ F D  L     LRE+ I+K  +H N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHEN 70
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++            +    Y+ +  +   +HR  + +M+             + +  LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            N  ++H DLK  NLL++ N  +KVCDFGL+R 
Sbjct: 131 SN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 86  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 140
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 5/152 (3%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPN 717
           +  +K  +G G++G V  A    +   V +  ++ F D  L     LRE+ I+K  +H N
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHEN 70
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++            +    Y+ +  +   +HR  + +M+             + +  LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            N  ++H DLK  NLL++ N  +KVCDFGL+R
Sbjct: 131 SN--VIHRDLKPSNLLINSNCDLKVCDFGLAR 160

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGXLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 137
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   +++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFGL+ R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 663 VKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKRVRHP 716
           + E +G+G F  V   R +  G + A K +  +     +     +E  REV+I+++V HP
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N++        R  + ++ E +  G L+  +   A  E + +         +  G+NYLH
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 777 NLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
                I H+DLK  N +L+DKN     +K+ DFGL+  +    +  K++ GT  F A
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVA 186

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           ++ +G G+F  V  AE   +   VA+K +  ++ L+ +      E+A++ +++HPN+V  
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 722 MGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                   HL ++ + +  G L+ R++ +        +R   R+   V   + YLH+L  
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG- 136
Query: 781 PILHWDLKSPNLL---VDKNWTVKVCDFGLSRFK 811
            I+H DLK  NLL   +D++  + + DFGLS+ +
Sbjct: 137 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 90  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 144
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+      +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I + V  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 137
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 77  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 131
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 132 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 160

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 657 SWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV 713
           S  +  +   +G GSFG VH  R+  +G   A+KVL  +  +   Q++    E  ++  V
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HP ++   G       + ++ +Y+  G L+ L+ +    +          A +V   + 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALE 120
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           YLH+ +  I++ DLK  N+L+DKN  +K+ DFG +++
Sbjct: 121 YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY 155

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-------DVAVK 688
           G  Y  I+P+       W E   + L   + +GAG+FG V  A   G         VAVK
Sbjct: 24  GNSYTFIDPTQLPYNEKW-EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L      D++ +  + E+ IM  + +H N+V  +GA T    + ++TEY   G L   +
Sbjct: 83  MLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
Query: 748 HR--------PA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796
            R        PA   A      R  L  +  VA+G+ +L + N   +H D+ + N+L+  
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN 199
Query: 797 NWTVKVCDFGLSR 809
               K+ DFGL+R
Sbjct: 200 GHVAKIGDFGLAR 212

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           DE  + E +G G++G V   R    G  VA+K +     +    K  LRE+ I+K  +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 717 NVVLFMGAVTKR-PHLSIVTEY----LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           N++     +    P+    + Y    L    L+++IH      +   R  L   L   +G
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLL---RG 170
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + Y+H+    ++H DLK  NLLV++N  +K+ DFG++R
Sbjct: 171 LKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 653 WLEISWDELHV-KERVGAGSFGTVHRAEWHGSDVAVKVLTV-QDFLDDQLKEFLREVAIM 710
           + + + D+L + K ++G+G+FG VH  E   S +   + T+ +D     +++   E+ ++
Sbjct: 15  YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVA 769
           K + HPN++          ++ IV E    G L  R++   A G+ + +     +   + 
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSR-FKANTFISSKSVAGTV 825
             + Y H+ +  ++H DLK  N+L      +  +K+ DFGL+  FK++    S + AGT 
Sbjct: 135 NALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTA 190
Query: 826 VFFA 829
           ++ A
Sbjct: 191 LYMA 194

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 11/158 (6%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726
           +G GS+G V  A   G+ +      +  +  + +  F +E+ IMK + HPN++       
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 727 KRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
               + +V E    G L+ R++H+     +  +    R+  DV   + Y H LN  + H 
Sbjct: 94  DNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLN--VAHR 147
Query: 786 DLKSPNLLV---DKNWTVKVCDFGL-SRFKANTFISSK 819
           DLK  N L      +  +K+ DFGL +RFK    + +K
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 185

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 11/158 (6%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726
           +G GS+G V  A   G+ +      +  +  + +  F +E+ IMK + HPN++       
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 727 KRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
               + +V E    G L+ R++H+     +  +    R+  DV   + Y H LN  + H 
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLN--VAHR 130
Query: 786 DLKSPNLLV---DKNWTVKVCDFGL-SRFKANTFISSK 819
           DLK  N L      +  +K+ DFGL +RFK    + +K
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 8/174 (4%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G GS+G     R +  G  +  K L      + + +  + EV +++ ++HPN+V +   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 725 VTKRPH--LSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHNLNP- 780
           +  R +  L IV EY   G L  +I +     + +D+   LR+   +   +   H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 781 --PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
              +LH DLK  N+ +D    VK+ DFGL+R   +    +K   GT  + +  Q
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQ 187

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 80/190 (42%), Gaps = 15/190 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRH 715
           D   + E +G G    VH A       DVAVKVL      D      F RE      + H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 716 PNVVLFM----GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           P +V             P   IV EY+   +L  ++H       M  +R + +  D  + 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTVVFF 828
           +N+ H     I+H D+K  N+L+     VKV DFG++R  A   N+   + +V GT  + 
Sbjct: 129 LNFSHQNG--IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 829 AAHQTACNSL 838
           +  Q   +S+
Sbjct: 187 SPEQARGDSV 196

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           ++ +G G+F  V  AE   +   VA+K +  ++ L+ +      E+A++ +++HPN+V  
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 722 MGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                   HL ++ + +  G L+ R++ +        +R   R+   V   + YLH+L  
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG- 136
Query: 781 PILHWDLKSPNLL---VDKNWTVKVCDFGLSRFK 811
            I+H DLK  NLL   +D++  + + DFGLS+ +
Sbjct: 137 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+ W  +  + RVG GSFG VHR +    G   AVK + ++ F        + E+     
Sbjct: 56  EVHW--MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAG 106
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +  P +V   GAV + P ++I  E L  GSL +LI +      + + R L       +G+
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGL 163
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT-VKVCDFG 806
            YLH     ILH D+K+ N+L+  + +   +CDFG
Sbjct: 164 EYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFG 196

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W        + V ++ +++    +  KE L E  +M  V +P+V   
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 117 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 171
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 172 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 16/192 (8%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKR 712
           D   + E +G+G F  V   R +  G + A K +  +     +     +E  REV I++ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++        +  + ++ E +  G L+  +   A  E + +    +    +  G+
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 142
Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           +YLH  +  I H+DLK  N +L+DKN     +K+ DFG++  K       K++ GT  F 
Sbjct: 143 HYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFV 199
Query: 829 AAHQTACNSLAL 840
           A        L L
Sbjct: 200 APEIVNYEPLGL 211

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+ W  +  + RVG GSFG VHR +    G   AVK + ++ F        + E+     
Sbjct: 72  EVHW--MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAG 122
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +  P +V   GAV + P ++I  E L  GSL +LI +      + + R L       +G+
Sbjct: 123 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGL 179
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT-VKVCDFG 806
            YLH     ILH D+K+ N+L+  + +   +CDFG
Sbjct: 180 EYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFG 212

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           ++ +G G+F  V  AE   +   VA+K +  ++ L+ +      E+A++ +++HPN+V  
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 722 MGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                   HL ++ + +  G L+ R++ +        +R   R+   V   + YLH+L  
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG- 136
Query: 781 PILHWDLKSPNLL---VDKNWTVKVCDFGLSRFK 811
            I+H DLK  NLL   +D++  + + DFGLS+ +
Sbjct: 137 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
           E+  D+      +GAG+ G V + +   S + +    +   +   ++ + +RE+ ++   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             P +V F GA      +SI  E++  GSL +++      + + +    ++++ V +G+ 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLA 128
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR----FKANTFISSKS 820
           YL   +  I+H D+K  N+LV+    +K+CDFG+S       AN+F+ ++S
Sbjct: 129 YLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 69
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H +L + N +V  ++TVK+ DFG++R
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 17/172 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFL 704
           D  E+S +++ +   +G GSFG V+             + VAVK +     L +++ EFL
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFL 68
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ---- 758
            E ++MK     +VV  +G V+K     +V E +  G L   +   RP A     +    
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 759 -RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  ++MA ++A G+ YL+      +H +L + N +V  ++TVK+ DFG++R
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRH 715
           D+  +   +G G FG V+ A    S   VA+KVL       + ++  LR E+ I   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           PN++        R  + ++ EY PRG LY+ + +       D++R   +  ++A  + Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELADALMYC 139
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           H     ++H D+K  NLL+     +K+ DFG S    +  +  K++ GT+ + 
Sbjct: 140 HGKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPS--LRRKTMCGTLDYL 188

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 7/188 (3%)
Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLK 701
           +E SLA     ++ +E    + +G G+FG V   + +  G   A+K+L  +  +  D++ 
Sbjct: 137 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 196
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
             L E  +++  RHP +     +      L  V EY   G L+  + R       + R R
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRAR 254
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
              A ++   ++YLH+    +++ DLK  NL++DK+  +K+ DFGL +       + K+ 
Sbjct: 255 FYGA-EIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312
Query: 822 AGTVVFFA 829
            GT  + A
Sbjct: 313 CGTPEYLA 320

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +++G+G++G V   R +    + A+K++           + L EVA++K + HPN++   
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 723 GAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                + +  +V E    G L+  +IHR    E +D    ++  L    G+ YLH  N  
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-VDAAVIIKQVL---SGVTYLHKHN-- 156
Query: 782 ILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           I+H DLK  NLL+   +K+  +K+ DFGLS    N     K   GT  + A
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIA 206

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 17/191 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAE---WHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVR 714
           D   + E +G G    VH A     H  DVAVKVL      D      F RE      + 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 715 HPNVVLFMGA----VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           HP +V             P   IV EY+   +L  ++H       M  +R + +  D  +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTVVF 827
            +N+ H     I+H D+K  N+++     VKV DFG++R  A   N+   + +V GT  +
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 828 FAAHQTACNSL 838
            +  Q   +S+
Sbjct: 186 LSPEQARGDSV 196

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++GTV +A+   +   VA+K + + D  +      LRE+ ++K ++H N+V   
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             +     L++V E+  +    +       G++ D          + KG+ + H+ N  +
Sbjct: 68  DVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN--V 122
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           LH DLK  NLL+++N  +K+ +FGL+R
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 7/188 (3%)
Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLK 701
           +E SLA     ++ +E    + +G G+FG V   + +  G   A+K+L  +  +  D++ 
Sbjct: 134 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
             L E  +++  RHP +     +      L  V EY   G L+  + R       + R R
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRAR 251
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
              A ++   ++YLH+    +++ DLK  NL++DK+  +K+ DFGL +       + K+ 
Sbjct: 252 FYGA-EIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 822 AGTVVFFA 829
            GT  + A
Sbjct: 310 CGTPEYLA 317

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 15/190 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRH 715
           D   + E +G G    VH A       DVAVKVL      D      F RE      + H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 716 PNVVLFM----GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           P +V             P   IV EY+   +L  ++H       M  +R + +  D  + 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTVVFF 828
           +N+ H     I+H D+K  N+++     VKV DFG++R  A   N+   + +V GT  + 
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 829 AAHQTACNSL 838
           +  Q   +S+
Sbjct: 187 SPEQARGDSV 196

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 16/192 (8%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKR 712
           D   + E +G+G F  V   R +  G + A K +  +     +     +E  REV I++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++        +  + ++ E +  G L+  +   A  E + +    +    +  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 128
Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           +YLH  +  I H+DLK  N +L+DKN     +K+ DFG++  K       K++ GT  F 
Sbjct: 129 HYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFV 185
Query: 829 AAHQTACNSLAL 840
           A        L L
Sbjct: 186 APEIVNYEPLGL 197

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +     +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 17/191 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAE---WHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVR 714
           D   + E +G G    VH A     H  DVAVKVL      D      F RE      + 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 715 HPNVVLFM----GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           HP +V             P   IV EY+   +L  ++H       M  +R + +  D  +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTVVF 827
            +N+ H     I+H D+K  N+++     VKV DFG++R  A   N+   + +V GT  +
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 828 FAAHQTACNSL 838
            +  Q   +S+
Sbjct: 186 LSPEQARGDSV 196

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 665 ERVGAGSFGTVHR--AEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLF 721
           + +G G F  V +  ++  G + A K L  +    D   E L E+A+++  +  P V+  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                    + ++ EY   G ++ L   P   EM+ +   +R+   + +G+ YLH  N  
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQNN-- 151
Query: 782 ILHWDLKSPNLLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           I+H DLK  N+L+   +    +K+ DFG+SR K       + + GT  + A
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLA 201

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+ W    +  R+G GSFG VHR E    G   AVK + ++ F  +       E+     
Sbjct: 91  EVHWATHQL--RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAG 141
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +  P +V   GAV + P ++I  E L  GSL +L+        + + R L       +G+
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC---LPEDRALYYLGQALEGL 198
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT-VKVCDFG 806
            YLH+    ILH D+K+ N+L+  + +   +CDFG
Sbjct: 199 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFG 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   +++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   ++V DFGL+ R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + +++A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF----- 721
           +G G+FG V +A  +  D     +      +++L   L EV ++  + H  VV +     
Sbjct: 14  LGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 722 --------MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
                   M AV K+  L I  EY    +LY LIH     +  D+  RL     + + ++
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEALS 130
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           Y+H+    I+H DLK  N+ +D++  VK+ DFGL++
Sbjct: 131 YIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 15/190 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRH 715
           D   + E +G G    VH A       DVAVKVL      D      F RE      + H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 716 PNVVLFM----GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           P +V             P   IV EY+   +L  ++H       M  +R + +  D  + 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTVVFF 828
           +N+ H     I+H D+K  N+++     VKV DFG++R  A   N+   + +V GT  + 
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 829 AAHQTACNSL 838
           +  Q   +S+
Sbjct: 187 SPEQARGDSV 196

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 16/192 (8%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKR 712
           D   + E +G+G F  V   R +  G + A K +  +     +     +E  REV I++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +RHPN++        +  + ++ E +  G L+  +   A  E + +    +    +  G+
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 121
Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
           +YLH  +  I H+DLK  N +L+DKN     +K+ DFG++  K       K++ GT  F 
Sbjct: 122 HYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFV 178
Query: 829 AAHQTACNSLAL 840
           A        L L
Sbjct: 179 APEIVNYEPLGL 190

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           ++ +G G+F  V  AE   +   VA+K +  +  L+ +      E+A++ +++HPN+V  
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 722 MGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                   HL ++ + +  G L+ R++ +        +R   R+   V   + YLH+L  
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG- 136
Query: 781 PILHWDLKSPNLL---VDKNWTVKVCDFGLSRFK 811
            I+H DLK  NLL   +D++  + + DFGLS+ +
Sbjct: 137 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +     +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+ W    +  R+G GSFG VHR E    G   AVK + ++ F  +       E+     
Sbjct: 72  EVHWATHQL--RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAG 122
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +  P +V   GAV + P ++I  E L  GSL +L+        + + R L       +G+
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC---LPEDRALYYLGQALEGL 179
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT-VKVCDFG 806
            YLH+    ILH D+K+ N+L+  + +   +CDFG
Sbjct: 180 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFG 212

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-------DVAVKVLTVQDFLDDQLKEFLREV 707
           E   + L   + +GAG+FG V  A   G         VAVK+L      D++ +  + E+
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-EALMSEL 100
Query: 708 AIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-----------PAAG-- 753
            IM  + +H N+V  +GA T    + ++TEY   G L   + R           P+    
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPE 160
Query: 754 EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           E +  R  L  +  VA+G+ +L + N   +H D+ + N+L+      K+ DFGL+R
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+ W  +  + R+G GSFG VHR +    G   AVK + ++ F        + E+     
Sbjct: 70  EVHW--MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAG 120
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +  P +V   GAV + P ++I  E L  GSL +LI +      + + R L       +G+
Sbjct: 121 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGL 177
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT-VKVCDFG 806
            YLH     ILH D+K+ N+L+  + +   +CDFG
Sbjct: 178 EYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFG 210

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +A+G+NYL +  
Sbjct: 80  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAEGMNYLEDRR 134
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 135 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 163

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 23/166 (13%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           L VK R   G FG V +A+     VAVK+  +QD    Q  +   EV  +  ++H N++ 
Sbjct: 29  LEVKAR---GRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQ 82
Query: 721 FMGAVTKRPH----LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           F+GA  +       L ++T +  +GSL   +       ++       +A  +A+G+ YLH
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLH 138
Query: 777 --------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKAN 813
                      P I H D+KS N+L+  N T  + DFGL+ +F+A 
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +     +     +L +V EY P G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   +KV DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A E H G  VAVK +   D    Q +E L  EV IM+   H NVV   
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++YLHN    +
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQG--V 162
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  +K+ DFG     +      K + GT  + A
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 87  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 141
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 142 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 84  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 138
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 139 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 85  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 139
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFAEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 83  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 137
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 30  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 70
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 71  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 125
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 126 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 180

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 22  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 62
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 63  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 117
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 118 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 172

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK 711
           +++ ++    + +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
             RHP +     A      L  V EY   G L+  + R       ++R R   A ++   
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSA 120
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YLH+ +  +++ D+K  NL++DK+  +K+ DFGL +   +   + K+  GT  + A
Sbjct: 121 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 176

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 152
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 153 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFXEPHARF-YAAQIVLTFEYL 178
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 179 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 86  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 140
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHP 716
           D   +K  +G GS+G V+ A    ++  V +  V    +D +  K  LRE+ I+ R++  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 717 NVVLFMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            ++     +      K   L IV E +    L +L   P     + +     +  ++  G
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPI---FLTEEHIKTILYNLLLG 141
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            N++H     I+H DLK  N L++++ +VKVCDFGL+R
Sbjct: 142 ENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 660 ELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           E ++K +++G G++ TV++ +   +D  VA+K + ++   +      +REV+++K ++H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 60
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V     +     L++V EYL +     L      G +++          + +G+ Y H
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
                +LH DLK  NLL+++   +K+ DFGL+R K+   I +K+    VV
Sbjct: 118 R--QKVLHRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYDNEVV 162

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 84  LG-ICLTSTVQLIMQLMPFGXLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 138
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 139 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK 711
           +++ ++    + +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
             RHP +     A      L  V EY   G L+  + R       ++R R   A ++   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSA 117
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YLH+ +  +++ D+K  NL++DK+  +K+ DFGL +   +   + K+  GT  + A
Sbjct: 118 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK 711
           +++ ++    + +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
             RHP +     A      L  V EY   G L+  + R       ++R R   A ++   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSA 117
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YLH+ +  +++ D+K  NL++DK+  +K+ DFGL +   +   + K+  GT  + A
Sbjct: 118 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 31/179 (17%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + L   + +GAG+FG V  A   G         VAVK+L      D++ +  + E+ IM 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-EALMSELKIMS 89
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA------------------ 752
            + +H N+V  +GA T    + ++TEY   G L   + R A                   
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 753 --GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             G  ++ R  L  +  VA+G+ +L + N   +H D+ + N+L+      K+ DFGL+R
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 22  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 62
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 63  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 117
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 118 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 172

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 24  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 64
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 65  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 119
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 120 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 174

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 17/191 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAE---WHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVR 714
           D   + E +G G    VH A     H  DVAVKVL      D      F RE      + 
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 715 HPNVVLFM----GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           HP +V             P   IV EY+   +L  ++H       M  +R + +  D  +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTVVF 827
            +N+ H     I+H D+K  N+++     VKV DFG++R  A   N+   + +V GT  +
Sbjct: 145 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 828 FAAHQTACNSL 838
            +  Q   +S+
Sbjct: 203 LSPEQARGDSV 213

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 26  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQ 66
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 67  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 121
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 122 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 27  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 67
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 68  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 122
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 123 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 177

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 28  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 68
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 69  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 123
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 124 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 178

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 19  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 59
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 60  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 114
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 115 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 169

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 26  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 67  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 121
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 122 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+++
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 20  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 60
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 61  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 115
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 116 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 170

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 26  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 67  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 121
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 122 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 27  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 67
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 68  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 122
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 123 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 177

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 158
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 159 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 20  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 60
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 61  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 115
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 116 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 170

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 42  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 82
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       +  +L    LY+L+     
Sbjct: 83  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYLVTHLMGADLYKLL----K 137
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 138 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR 192

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 26  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 67  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 121
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 122 CQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           + +G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 137
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 42  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 82
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 83  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 137
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 138 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 192

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 85  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 139
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFG ++ 
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 22  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 62
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 63  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 117
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 118 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR 172

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 137
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFG ++ 
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGRAKL 166

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           + +G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 90  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 144
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 178
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 179 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGY 236
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 26  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 67  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 121
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 122 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR 176

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 26  GPRYTNLS-------------------YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ 66
Query: 699 QLKE-FLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 67  TYXQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 121
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 122 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR 176

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E +G+G F  V   R +  G   A K +    T         ++  REV+I+K ++HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +        +  + ++ E +  G L+  +   A  E + +         +  G+ YLH+L
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 779 NPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
              I H+DLK  N +L+D+N     +K+ DFGL+  K +     K++ GT  F A     
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTPAFVAPEIVN 190
Query: 835 CNSLAL 840
              L L
Sbjct: 191 YEPLGL 196

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 118
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 119 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 175
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGL 195

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E +G+G F  V   R +  G   A K +    T         ++  REV+I+K ++HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +        +  + ++ E +  G L+  +   A  E + +         +  G+ YLH+L
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 779 NPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
              I H+DLK  N +L+D+N     +K+ DFGL+  K +     K++ GT  F A     
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTPEFVAPEIVN 190
Query: 835 CNSLAL 840
              L L
Sbjct: 191 YEPLGL 196

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 22  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 62
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 63  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 117
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 118 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR 172

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 7   PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 64
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++TE+   G+L             Y
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 182
Query: 805 FGLSR 809
           FGL+R
Sbjct: 183 FGLAR 187

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++  RHP +     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           A      L  V EY   G L+  + R       ++R R   A ++   + YLH+ +  ++
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSALEYLHSRD--VV 132
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + D+K  NL++DK+  +K+ DFGL +   +   + K   GT  + A
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 178

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 30/197 (15%)
Query: 639 GPRYLNIEPS-LAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG---SD----VAVK 688
           G  Y+ I+P+ L  D  W E   + L   + +GAG+FG V  A  +G   SD    VAVK
Sbjct: 1   GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L     L ++ +  + E+ ++  +  H N+V  +GA T      ++TEY   G L   +
Sbjct: 60  MLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 748 HRPAAGEMMDQRRRLRM---------------ALDVAKGINYLHNLNPPILHWDLKSPNL 792
            R     +  +     M               +  VAKG+ +L + N   +H DL + N+
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176
Query: 793 LVDKNWTVKVCDFGLSR 809
           L+      K+CDFGL+R
Sbjct: 177 LLTHGRITKICDFGLAR 193

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++T+ +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 90  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 144
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFG ++ 
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGRAKL 173

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 118
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 119 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 175
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGL 195

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 76  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 126 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 86/178 (48%), Gaps = 8/178 (4%)
Query: 655 EISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK 711
           +++ ++    + +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
             RHP +     A      L  V EY   G L+  + R       ++R R   A ++   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSA 117
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YLH+ +  +++ D+K  NL++DK+  +K+ DFGL +   +   + K   GT  + A
Sbjct: 118 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 7   PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 64
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++TE+   G+L             Y
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 182
Query: 805 FGLSR 809
           FGL+R
Sbjct: 183 FGLAR 187

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 71  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 121 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 70  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 120 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 86/178 (48%), Gaps = 8/178 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK 711
           +++ ++    + +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
             RHP +     A      L  V EY   G L+  + R       ++R R   A ++   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSA 117
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YLH+ +  +++ D+K  NL++DK+  +K+ DFGL +   +   + K   GT  + A
Sbjct: 118 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 73  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 123 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 71  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 121 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 72  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 76  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 126 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 7   PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 64
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++TE+   G+L             Y
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 182
Query: 805 FGLSR 809
           FGL+R
Sbjct: 183 FGLAR 187

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 144
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NLL+D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 145 HSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 70  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 120 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E +G+G F  V   R +  G   A K +    T         ++  REV+I+K ++HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +        +  + ++ E +  G L+  +   A  E + +         +  G+ YLH+L
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 779 NPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
              I H+DLK  N +L+D+N     +K+ DFGL+  K +     K++ GT  F A     
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTPEFVAPEIVN 190
Query: 835 CNSLAL 840
              L L
Sbjct: 191 YEPLGL 196

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L               + MD      + L + K        G+ +
Sbjct: 71  DVIHTENKLYLVFEFLSMD----------LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 121 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 68  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 72  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 71  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 121 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 68  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 70  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 120 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 73  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 123 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 68  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E +G+G F  V   R +  G   A K +    T         ++  REV+I+K ++HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +        +  + ++ E +  G L+  +   A  E + +         +  G+ YLH+L
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 779 NPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
              I H+DLK  N +L+D+N     +K+ DFGL+  K +     K++ GT  F A     
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTPEFVAPEIVN 190
Query: 835 CNSLAL 840
              L L
Sbjct: 191 YEPLGL 196

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   R +  G   A+K+L  +  +  D++   + E  +++  RHP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           A      L  V EY   G L+  + R       ++R R   A ++   + YLH+ +  ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSALEYLHSRD--VV 127
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + D+K  NL++DK+  +K+ DFGL +   +   + K   GT  + A
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLA 173

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 70  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 120 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 68  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L               + MD      + L + K        G+ +
Sbjct: 72  DVIHTENKLYLVFEFLSMD----------LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGS--DVAVKVLTVQ---DFLDDQLKEF----LREVAIMKRVR 714
           KE +G G    V R     +  + AVK++ V     F  ++++E     L+EV I+++V 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 715 -HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HPN++             +V + + +G L+  +         + R+ +R  L+V   I 
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---IC 138
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQT 833
            LH LN  I+H DLK  N+L+D +  +K+ DFG S  + +     +SV GT  + A    
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRSVCGTPSYLAPEII 195
Query: 834 ACN 836
            C+
Sbjct: 196 ECS 198

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 30/201 (14%)
Query: 639 GPRYLNIEPS-LAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG---SD----VAVK 688
           G  Y+ I+P+ L  D  W E   + L   + +GAG+FG V  A  +G   SD    VAVK
Sbjct: 24  GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 82
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L     L ++ +  + E+ ++  +  H N+V  +GA T      ++TEY   G L   +
Sbjct: 83  MLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
Query: 748 HR-----------PA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
            R           PA        +D    L  +  VAKG+ +L + N   +H DL + N+
Sbjct: 142 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 199
Query: 793 LVDKNWTVKVCDFGLSRFKAN 813
           L+      K+CDFGL+R   N
Sbjct: 200 LLTHGRITKICDFGLARHIKN 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L               + MD      + L + K        G+ +
Sbjct: 72  DVIHTENKLYLVFEFLSMD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 122 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 30/197 (15%)
Query: 639 GPRYLNIEPS-LAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG---SD----VAVK 688
           G  Y+ I+P+ L  D  W E   + L   + +GAG+FG V  A  +G   SD    VAVK
Sbjct: 24  GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 82
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L     L ++ +  + E+ ++  +  H N+V  +GA T      ++TEY   G L   +
Sbjct: 83  MLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
Query: 748 HR-----------PA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
            R           PA        +D    L  +  VAKG+ +L + N   +H DL + N+
Sbjct: 142 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 199
Query: 793 LVDKNWTVKVCDFGLSR 809
           L+      K+CDFGL+R
Sbjct: 200 LLTHGRITKICDFGLAR 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 75/147 (51%), Gaps = 6/147 (4%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             +     L +V E+L +     +      G  +   +     L   +G+ + H+    +
Sbjct: 72  DVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHR--V 127
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           LH DLK  NLL++    +K+ DFGL+R
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 7/177 (3%)
Query: 656 ISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR 712
           ++ +E    + +G G+FG V   + +  G   A+K+L  +  +  D++   L E  +++ 
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
            RHP +     +      L  V EY   G L+  + R       + R R   A ++   +
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIVSAL 121
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +YLH+    +++ DLK  NL++DK+  +K+ DFGL +       + K   GT  + A
Sbjct: 122 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 177

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L               + MD      + L + K        G+ +
Sbjct: 70  DVIHTENKLYLVFEFLSMD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 120 CHSHR--VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   + +  G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARF-YAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFI---SSKSVAGTVVFFAAH 831
           H+L+  +++ DLK  NL++D+   ++V DFG + R K  T+    + + +A  ++    +
Sbjct: 158 HSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 832 QTACNSLA---LIFSLSGWLQSSFEESP 856
             A +  A   LI+ ++      F + P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 55  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 107
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 108 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 167 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 224
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 225 RAPELIFGA 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 57  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 109
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 110 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 169 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 226
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 227 RAPELIFGA 235

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 7/177 (3%)
Query: 656 ISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR 712
           ++ +E    + +G G+FG V   + +  G   A+K+L  +  +  D++   L E  +++ 
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
            RHP +     +      L  V EY   G L+  + R       + R R   A ++   +
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIVSAL 123
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +YLH+    +++ DLK  NL++DK+  +K+ DFGL +       + K   GT  + A
Sbjct: 124 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 179

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 30/197 (15%)
Query: 639 GPRYLNIEPS-LAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG---SD----VAVK 688
           G  Y+ I+P+ L  D  W E   + L   + +GAG+FG V  A  +G   SD    VAVK
Sbjct: 19  GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 77
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L     L ++ +  + E+ ++  +  H N+V  +GA T      ++TEY   G L   +
Sbjct: 78  MLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 136
Query: 748 HR-----------PA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
            R           PA        +D    L  +  VAKG+ +L + N   +H DL + N+
Sbjct: 137 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 194
Query: 793 LVDKNWTVKVCDFGLSR 809
           L+      K+CDFGL+R
Sbjct: 195 LLTHGRITKICDFGLAR 211

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 47  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 99
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 100 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 159 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 216
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 217 RAPELIFGA 225

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 7/177 (3%)
Query: 656 ISWDELHVKERVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR 712
           ++ +E    + +G G+FG V   + +  G   A+K+L  +  +  D++   L E  +++ 
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
            RHP +     +      L  V EY   G L+  + R       + R R   A ++   +
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIVSAL 122
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +YLH+    +++ DLK  NL++DK+  +K+ DFGL +       + K   GT  + A
Sbjct: 123 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 178

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV+I+K ++HPNV+        +  + ++ E +  G L+  +   A  E + +      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEF 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKS 820
              +  G+ YLH+L   I H+DLK  N +L+D+N     +K+ DFGL+  K +     K+
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 821 VAGTVVFFAAHQTACNSLAL 840
           + GT  F A        L L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGL 196

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 675 VHRAEWHGSDVAVKVLTVQDFLDDQLKEFL----REVAIMKRVR-HPNVVLFMGAVTKRP 729
           VHRA  H   V +  +T +    +QL+E      RE  I+++V  HP+++  + +     
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
            + +V + + +G L+  +    A    + R  +R  L+    +++LH  N  I+H DLK 
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE---AVSFLHANN--IVHRDLKP 228
Query: 790 PNLLVDKNWTVKVCDFGLS 808
            N+L+D N  +++ DFG S
Sbjct: 229 ENILLDDNMQIRLSDFGFS 247

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 663 VKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKRVRHP 716
           + E +G+G F  V   R +  G + A K +  +     +     +E  REV+I+++V H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NV+        R  + ++ E +  G L+  +   A  E + +         +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 777 NLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
                I H+DLK  N +L+DKN     +K+ DFGL+  +    +  K++ GT  F A   
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 833 TACNSLAL 840
                L L
Sbjct: 190 VNYEPLGL 197

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 53  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 105
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 223 RAPELIFGA 231

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
              KE +G G+F  V  AE    G   AVK +  +  L  +      E+A++++++H N+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIP-KKALKGKESSIENEIAVLRKIKHENI 82
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V          HL +V + +  G L+  I         D    +R  LD    + YLH +
Sbjct: 83  VALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD---AVYYLHRM 139
Query: 779 NPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
              I+H DLK  NLL    D+   + + DFGLS+ +    + S +  GT  + A
Sbjct: 140 G--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS-TACGTPGYVA 190

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 81/148 (54%), Gaps = 10/148 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTV---QDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G G F TV++A    ++  VA+K + +    +  D   +  LRE+ +++ + HPN++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
           + A   + ++S+V +++       +I +  +  +     +  M + + +G+ YLH     
Sbjct: 78  LDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTL-QGLEYLHQHW-- 132
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ILH DLK  NLL+D+N  +K+ DFGL++
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           E +G+G F  V   R +  G   A K +    T         ++  REV+I+K ++HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +        +  + ++ E +  G L+  +   A  E + +         +  G+ YLH+L
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 779 NPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
              I H+DLK  N +L+D+N     +K+ DFGL+  K +     K++ GT  F A     
Sbjct: 134 Q--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTPEFVAPEIVN 190
Query: 835 CNSLAL 840
              L L
Sbjct: 191 YEPLGL 196

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 663 VKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKRVRHP 716
           + E +G+G F  V   R +  G + A K +  +     +     +E  REV+I+++V H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NV+        R  + ++ E +  G L+  +   A  E + +         +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 777 NLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
                I H+DLK  N +L+DKN     +K+ DFGL+  +    +  K++ GT  F A   
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 833 TACNSLAL 840
                L L
Sbjct: 190 VNYEPLGL 197

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 98  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 150
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 151 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 209
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 210 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 267
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 268 RAPELIFGA 276

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 31/177 (17%)
Query: 661 LHVKERVGAGSFGTVHRA-EWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           L + + +G G FG V +A  +H       + VAVK+L  ++    +L++ L E  ++K+V
Sbjct: 25  LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQV 83
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------------YRLIHRPAAGEMMDQ-- 758
            HP+V+   GA ++   L ++ EY   GSL             Y           +D   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 759 RRRLRM------ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            R L M      A  +++G+ YL  ++  ++H DL + N+LV +   +K+ DFGLSR
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 663 VKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKRVRHP 716
           + E +G+G F  V   R +  G + A K +  +     +     +E  REV+I+++V H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NV+        R  + ++ E +  G L+  +   A  E + +         +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 777 NLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
                I H+DLK  N +L+DKN     +K+ DFGL+  +    +  K++ GT  F A   
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 833 TACNSLAL 840
                L L
Sbjct: 190 VNYEPLGL 197

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 663 VKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKRVRHP 716
           + E +G+G F  V   R +  G + A K +  +     +     +E  REV+I+++V H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NV+        R  + ++ E +  G L+  +   A  E + +         +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 777 NLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
                I H+DLK  N +L+DKN     +K+ DFGL+  +    +  K++ GT  F A   
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 833 TACNSLAL 840
                L L
Sbjct: 190 VNYEPLGL 197

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHP 716
           D   +K  +G GS+G V+ A    ++  V +  V    +D +  K  LRE+ I+ R++  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 717 NVVLFMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            ++     +      K   L IV E +    L +L   P     + ++    +  ++  G
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPI---FLTEQHVKTILYNLLLG 143
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             ++H     I+H DLK  N L++++ +VK+CDFGL+R
Sbjct: 144 EKFIHE--SGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 32  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 84
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 85  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 143
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 144 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 201
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 202 RAPELIFGA 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-----LKEFLREVAIMKRVR 714
           EL   + +G+G FGTVH+  W     ++K+      ++D+      +     +  +  + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGI 772
           H ++V  +G +     L +VT+YLP GSL   +  HR A G  +     L   + +AKG+
Sbjct: 92  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL----LLNWGVQIAKGM 146
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            YL      ++H +L + N+L+     V+V DFG++
Sbjct: 147 YYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVA 180

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 23/189 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 24  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 76
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 77  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 135
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSKSV 821
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+  
Sbjct: 136 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 193
Query: 822 AGTVVFFAA 830
               + F A
Sbjct: 194 RAPELIFGA 202

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 663 VKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL----KEFLREVAIMKRVRHP 716
           + E +G+G F  V   R +  G + A K +  +     +     +E  REV+I+++V H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NV+        R  + ++ E +  G L+  +   A  E + +         +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 777 NLNPPILHWDLKSPN-LLVDKNW---TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
                I H+DLK  N +L+DKN     +K+ DFGL+  +    +  K++ GT  F A   
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEI 189
Query: 833 TACNSLAL 840
                L L
Sbjct: 190 VNYEPLGL 197

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 31/177 (17%)
Query: 661 LHVKERVGAGSFGTVHRA-EWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           L + + +G G FG V +A  +H       + VAVK+L  ++    +L++ L E  ++K+V
Sbjct: 25  LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQV 83
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------------YRLIHRPAAGEMMDQ-- 758
            HP+V+   GA ++   L ++ EY   GSL             Y           +D   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 759 RRRLRM------ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            R L M      A  +++G+ YL  +   ++H DL + N+LV +   +K+ DFGLSR
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 31/177 (17%)
Query: 661 LHVKERVGAGSFGTVHRA-EWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           L + + +G G FG V +A  +H       + VAVK+L  ++    +L++ L E  ++K+V
Sbjct: 25  LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQV 83
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------------YRLIHRPAAGEMMDQ-- 758
            HP+V+   GA ++   L ++ EY   GSL             Y           +D   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 759 RRRLRM------ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            R L M      A  +++G+ YL  +   ++H DL + N+LV +   +K+ DFGLSR
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     G +VAVK L+         K   RE+ ++K V H N++  +  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++IH       +D  R   +   +  GI +LH+ 
Sbjct: 90  FTPQKTLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHSA 143
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R  +  F+ +  V 
Sbjct: 144 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV 185

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 45/189 (23%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL 696
           G RY++++P                   +G G  G V  A  +  D  VA+K + + D  
Sbjct: 10  GSRYMDLKP-------------------LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-- 48
Query: 697 DDQLKEFLREVAIMKRVRHPNVV-LF-------------MGAVTKRPHLSIVTEYLPRGS 742
              +K  LRE+ I++R+ H N+V +F             +G++T+   + IV EY+    
Sbjct: 49  PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD- 107
Query: 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVK 801
              L +    G ++++  RL M   + +G+ Y+H+ N  +LH DLK  NL ++ ++  +K
Sbjct: 108 ---LANVLEQGPLLEEHARLFMY-QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161
Query: 802 VCDFGLSRF 810
           + DFGL+R 
Sbjct: 162 IGDFGLARI 170

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA-- 724
           +G G+FG V +A  +  D     +      +++L   L EV ++  + H  VV +  A  
Sbjct: 14  LGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 725 -----------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
                      V K+  L I  EY    +LY LIH     +  D+  RL     + + ++
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR--QILEALS 130
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           Y+H+    I+H +LK  N+ +D++  VK+ DFGL++
Sbjct: 131 YIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 53  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 105
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 27/191 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+S+ +  V   +G GSFG V++A+    G  VA+K    +   D + K   RE+ IM++
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRK 69
Query: 713 VRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
           + H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +         
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISSK 819
             + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S+
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 820 SVAGTVVFFAA 830
                 + F A
Sbjct: 187 YYRAPELIFGA 197

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGS--DVAVKVLTVQ---DFLDDQLKEF----LREVAIMKRVR 714
           KE +G G    V R     +  + AVK++ V     F  ++++E     L+EV I+++V 
Sbjct: 9   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 715 -HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HPN++             +V + + +G L+  +         + R+ +R  L+V   I 
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---IC 125
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQT 833
            LH LN  I+H DLK  N+L+D +  +K+ DFG S  + +     + V GT  + A    
Sbjct: 126 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAPEII 182
Query: 834 ACN 836
            C+
Sbjct: 183 ECS 185

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLF 721
           +G G++GTV++A     G  VA+K + V +  +      +REVA+++R+    HPNVV  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 722 MGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           M         +   +++V E++ +     L   P  G   +  + L       +G+++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF--LRGLDFLH 129
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
                I+H DLK  N+LV    TVK+ DFGL+R 
Sbjct: 130 ANC--IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 53  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 110
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L             Y
Sbjct: 111 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 170
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 171 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 228
Query: 805 FGLSR 809
           FGL+R
Sbjct: 229 FGLAR 233

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLF 721
           +G G++GTV++A     G  VA+K + V +  +      +REVA+++R+    HPNVV  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 722 MGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           M         +   +++V E++ +     L   P  G   +  + L       +G+++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF--LRGLDFLH 129
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
                I+H DLK  N+LV    TVK+ DFGL+R 
Sbjct: 130 ANC--IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 16  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 73
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L             Y
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 191
Query: 805 FGLSR 809
           FGL+R
Sbjct: 192 FGLAR 196

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 16  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 73
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L             Y
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 191
Query: 805 FGLSR 809
           FGL+R
Sbjct: 192 FGLAR 196

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLF 721
           +G G++GTV++A     G  VA+K + V +  +      +REVA+++R+    HPNVV  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 722 MGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           M         +   +++V E++ +     L   P  G   +  + L       +G+++LH
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF--LRGLDFLH 129
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
                I+H DLK  N+LV    TVK+ DFGL+R 
Sbjct: 130 ANC--IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 16  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 73
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L             Y
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 191
Query: 805 FGLSR 809
           FGL+R
Sbjct: 192 FGLAR 196

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 658 WDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +D   + E +G+G+FG VHR   +  G     K +     LD    +   E++IM ++ H
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK--NEISIMNQLHH 107
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P ++    A   +  + ++ E+L  G L+  I   A    M +   +       +G+ ++
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 776 HNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLS 808
           H  +  I+H D+K  N++ +  K  +VK+ DFGL+
Sbjct: 166 HEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           + +G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 90  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 144
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-----LKEFLREVAIMKRVR 714
           EL   + +G+G FGTVH+  W     ++K+      ++D+      +     +  +  + 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGI 772
           H ++V  +G +     L +VT+YLP GSL   +  HR A G  +     L   + +AKG+
Sbjct: 74  HAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL----LLNWGVQIAKGM 128
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            YL      ++H +L + N+L+     V+V DFG++
Sbjct: 129 YYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVA 162

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 85  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 139
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFG ++ 
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 29/192 (15%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVK-VLTVQDFLDDQLKEFLREVAIMK 711
           E+S+ +  V   +G GSFG V++A+    G  VA+K VL  + F +       RE+ IM+
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMR 68
Query: 712 RVRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRM 764
           ++ H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +        
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY 127
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISS 818
              + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 819 KSVAGTVVFFAA 830
           +      + F A
Sbjct: 186 RYYRAPELIFGA 197

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     G +VAVK L+         K   RE+ ++K V H N++  +  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++IH       +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R     F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV 187

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 29/192 (15%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVK-VLTVQDFLDDQLKEFLREVAIMK 711
           E+S+ +  V   +G GSFG V++A+    G  VA+K VL  + F +       RE+ IM+
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMR 68
Query: 712 RVRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRM 764
           ++ H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +        
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY 127
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFG----LSRFKAN-TFISS 818
              + + + Y+H+    I H D+K  NLL+D +  V K+CDFG    L R + N ++I S
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 819 KSVAGTVVFFAA 830
           +      + F A
Sbjct: 186 RYYRAPELIFGA 197

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 85  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 139
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFG ++ 
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 664 KERVGAGSFGTVHRAEWHGS--DVAVKVLTVQ---DFLDDQLKEF----LREVAIMKRVR 714
           KE +G G    V R     +  + AVK++ V     F  ++++E     L+EV I+++V 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 715 -HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HPN++             +V + + +G L+  +         + R+ +R  L+V   I 
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---IC 138
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQT 833
            LH LN  I+H DLK  N+L+D +  +K+ DFG S  + +     + V GT  + A    
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAPEII 195
Query: 834 ACN 836
            C+
Sbjct: 196 ECS 198

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 7   PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 64
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L             Y
Sbjct: 65  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 124
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           ++       + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 182
Query: 805 FGLSR 809
           FGL+R
Sbjct: 183 FGLAR 187

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E++ +             + MD      + L + K        G+ +
Sbjct: 72  DVIHTENKLYLVFEHVDQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 122 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 22/181 (12%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L++ + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 16  PYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSE 73
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSLYRLI---------H 748
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L   +         +
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +    + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+
Sbjct: 134 KDLYKDFLTLEHLICYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 809 R 809
           R
Sbjct: 192 R 192

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 24  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 64
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+   RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 65  TYCQRTLREIKILLAFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 119
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 120 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 174

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPNVVLF 721
           +G+G+FGTV++  W      VK+      L +       KE L E  +M  V +P+V   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           +G +     + ++ + +P G L   +  H+   G     +  L   + +AKG+NYL +  
Sbjct: 87  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLEDRR 141
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             ++H DL + N+LV     VK+ DFG ++ 
Sbjct: 142 --LVHRDLAARNVLVKTPQHVKITDFGRAKL 170

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 31  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 83
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 143 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 31/180 (17%)
Query: 644 NIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF 703
            ++    MD+ EI        E +G+G FG V +A+ H  D    V+    + +++ +  
Sbjct: 4   TVDKRFGMDFKEI--------ELIGSGGFGQVFKAK-HRIDGKTYVIKRVKYNNEKAE-- 52
Query: 704 LREVAIMKRVRHPNVVLFMG----------------AVTKRPHLSIVTEYLPRGSLYRLI 747
            REV  + ++ H N+V + G                + +K   L I  E+  +G+L + I
Sbjct: 53  -REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111
Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
            +   GE +D+   L +   + KG++Y+H  +  +++ DLK  N+ +     VK+ DFGL
Sbjct: 112 EK-RRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGL 168

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 31  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 83
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 143 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 27  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 79
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 80  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 138
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 139 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 38  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 90
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 91  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 149
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 150 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 24  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 64
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+   RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 65  TYCQRTLREIKILLAFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 119
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 120 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLAR 174

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           E++G G++ TV++     + V V +  V+ D  +      +RE+++MK ++H N+V    
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL------DVAKGINYLHN 777
            +     L++V E++    L + +     G   +  R L + L       + +G+ + H 
Sbjct: 71  VIHTENKLTLVFEFM-DNDLKKYMDSRTVG---NTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR---FKANTFIS 817
               ILH DLK  NLL++K   +K+ DFGL+R      NTF S
Sbjct: 127 --NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 24/166 (14%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVK-VLTVQDFLDDQLKEFLREVAIMK 711
           E+S+ +  V   +G GSFG V++A+    G  VA+K VL  + F +       RE+ IM+
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMR 68
Query: 712 RVRHPNVV----LFMGAVTKR--PHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRM 764
           ++ H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +        
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLY 127
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
              + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   VKE +G G+F  V R   +  G + A K++  +       ++  RE  I ++++HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++ +     +V + +  G L+  I    A E   +         + + I Y H
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCH 145
Query: 777 NLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLS 808
           +    I+H +LK  NLL+    K   VK+ DFGL+
Sbjct: 146 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+  + +    +      +RE++++K + HPN+V  +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 69  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 119 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+  + +    +      +RE++++K + HPN+V  +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+L +             + MD      + L + K        G+ +
Sbjct: 68  DVIHTENKLYLVFEFLHQD----------LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 667 VGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVL 720
           +G G++G V +A   +  G  VA+K + VQ   +      +REVA+++ +    HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 721 FMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
                T     +   L++V E++ +     L   P  G   +  +   M   + +G+++L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLRGLDFL 136
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H+    ++H DLK  N+LV  +  +K+ DFGL+R 
Sbjct: 137 HSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 22/155 (14%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G++G V++A  +  G  VA+K + +    +      +RE++++K + HPN+V  +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
             +     L +V E+         +H+      MD      + L + K        G+ +
Sbjct: 68  DVIHTENKLYLVFEH---------VHQDLK-TFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 CHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+S+ +  V   +G GSFG V++A+    G  VA+K    +   D + K   RE+ IM++
Sbjct: 20  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRK 70
Query: 713 VRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
           + H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +         
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
             + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 130 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+S+ +  V   +G GSFG V++A+    G  VA+K    +   D + K   RE+ IM++
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRK 69
Query: 713 VRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
           + H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +         
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
             + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 12/167 (7%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEF 703
           PSL +  L+I   ELH  + +G GSFG V  AE+  ++   A+K L     L DD ++  
Sbjct: 9   PSLQIK-LKIEDFELH--KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 65
Query: 704 LREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
           + E  ++     HP +         + +L  V EYL  G L   ++   +    D  R  
Sbjct: 66  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRAT 122
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             A ++  G+ +LH+    I++ DLK  N+L+DK+  +K+ DFG+ +
Sbjct: 123 FYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+S+ +  V   +G GSFG V++A+    G  VA+K    +   D + K   RE+ IM++
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRK 69
Query: 713 VRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
           + H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +         
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
             + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           E+S+ +  V   +G GSFG V++A+   S   V +  V    D + K   RE+ IM+++ 
Sbjct: 23  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN--RELQIMRKLD 75
Query: 715 HPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALD 767
           H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +           
Sbjct: 76  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 134
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
           + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 135 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+S+ +  V   +G GSFG V++A+    G  VA+K    +   D + K   RE+ IM++
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKN--RELQIMRK 69
Query: 713 VRHPNVV----LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
           + H N+V     F  +  K+   +L++V +Y+P  ++YR+  H   A + +         
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSR 809
             + + + Y+H+    I H D+K  NLL+D +  V K+CDFG ++
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 24/183 (13%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 18  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSE 75
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSLYRLI---------H 748
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L   +         +
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 135
Query: 749 RPA--AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
           +P     + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFG
Sbjct: 136 KPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFG 193
Query: 807 LSR 809
           L+R
Sbjct: 194 LAR 196

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHG---SD----VAVKVLTVQDFLDDQLKEFLREVAIMK 711
           + L   + +GAG+FG V  A  +G   SD    VAVK+L     L ++ +  + E+ ++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLS 97
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM------ 764
            +  H N+V  +GA T      ++TEY   G L   + R     +  +     M      
Sbjct: 98  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 157
Query: 765 ---------ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                    +  VAKG+ +L + N   +H DL + N+L+      K+CDFGL+R
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLAR 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 667 VGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVL 720
           +G G++G V +A   +  G  VA+K + VQ   +      +REVA+++ +    HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 721 FMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
                T     +   L++V E++ +     L   P  G   +  +   M   + +G+++L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLRGLDFL 136
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H+    ++H DLK  N+LV  +  +K+ DFGL+R 
Sbjct: 137 HSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 7/153 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRH 715
           ++  V   +G GSF  V+RAE    G +VA+K++  +      + + ++ EV I  +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P+++          ++ +V E    G + R +         ++ R       +  G+ YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH--QIITGMLYL 128
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H+    ILH DL   NLL+ +N  +K+ DFGL+
Sbjct: 129 HS--HGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 18  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 75
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSL-------------Y 744
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L             Y
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 135
Query: 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
           +        + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 136 KEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 193
Query: 805 FGLSR 809
           FGL+R
Sbjct: 194 FGLAR 198

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 644 NIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF 703
            ++    MD+ EI        E +G+G FG V +A+ H  D    V+    + +++ +  
Sbjct: 5   TVDKRFGMDFKEI--------ELIGSGGFGQVFKAK-HRIDGKTYVIRRVKYNNEKAE-- 53
Query: 704 LREVAIMKRVRHPNVVLFMG-----------------------------AVTKRPHLSIV 734
            REV  + ++ H N+V + G                             + +K   L I 
Sbjct: 54  -REVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQ 112
Query: 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV 794
            E+  +G+L + I +   GE +D+   L +   + KG++Y+H+    ++H DLK  N+ +
Sbjct: 113 MEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFL 169
Query: 795 DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
                VK+ DFGL     N    ++S  GT+ + +  Q +
Sbjct: 170 VDTKQVKIGDFGLVTSLKNDGKRTRS-KGTLRYMSPEQIS 208

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           L +K R   G FG V +A+     VAVK+  +QD    Q  +  RE+     ++H N++ 
Sbjct: 20  LEIKAR---GRFGCVWKAQLMNDFVAVKIFPLQD---KQSWQSEREIFSTPGMKHENLLQ 73
Query: 721 FMGAVTKRPHLSI----VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           F+ A  +  +L +    +T +  +GSL   +     G ++       +A  +++G++YLH
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLH 129
Query: 777 ---------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFK 811
                       P I H D KS N+L+  + T  + DFGL+ RF+
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFE 174

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   VKE +G G+F  V R   +  G + A K++  +       ++  RE  I ++++HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++ +     +V + +  G L+  I    A E   +         + + I Y H
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCH 121
Query: 777 NLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           +    I+H +LK  NLL+    K   VK+ DFGL+  + N   +    AGT
Sbjct: 122 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGT 169

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 667 VGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVL 720
           +G G++G V +A   +  G  VA+K + VQ   +      +REVA+++ +    HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 721 FMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
                T     +   L++V E++ +     L   P  G   +  +   M   + +G+++L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLRGLDFL 136
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H+    ++H DLK  N+LV  +  +K+ DFGL+R 
Sbjct: 137 HSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   VKE +G G+F  V R   +  G + A K++  +       ++  RE  I ++++HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++ +     +V + +  G L+  I    A E   +         + + I Y H
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCH 122
Query: 777 NLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           +    I+H +LK  NLL+    K   VK+ DFGL+  + N   +    AGT
Sbjct: 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGT 170

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 94/191 (49%), Gaps = 24/191 (12%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V+ A    +   VA+K ++      +++ ++ ++EV  ++++RHPN + + G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGINYLH 776
              +     +V EY   GS         A ++++  ++    +++A       +G+ YLH
Sbjct: 122 CYLREHTAWLVMEYC-LGS---------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK--ANTFISSKSVAGTVVFFAAHQTA 834
           + N  ++H D+K+ N+L+ +   VK+ DFG +     AN F+ +       V  A  +  
Sbjct: 172 SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 229
Query: 835 CNSLALIFSLS 845
            +    ++SL 
Sbjct: 230 YDGKVDVWSLG 240

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 667 VGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLF 721
           +G G FG V    +     G+   V V  +++    QL+  + RE+ I++ + H ++V +
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 722 MGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            G    +   S+  V EY+P GSL   + R   G      + L  A  + +G+ YLH  +
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG----LAQLLLFAQQICEGMAYLHAQH 132
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              +H  L + N+L+D +  VK+ DFGL++
Sbjct: 133 --YIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   VKE +G G+F  V R   +  G + A K++  +       ++  RE  I ++++HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++ +     +V + +  G L+  I    A E   +         + + I Y H
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCH 122
Query: 777 NLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           +    I+H +LK  NLL+    K   VK+ DFGL+  + N   +    AGT
Sbjct: 123 SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGT 170

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 667 VGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLF 721
           +G G FG V    +     G+   V V  +++    QL+  + RE+ I++ + H ++V +
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 722 MGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            G    +   S+  V EY+P GSL   + R   G      + L  A  + +G+ YLH  +
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG----LAQLLLFAQQICEGMAYLHAQH 131
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              +H  L + N+L+D +  VK+ DFGL++
Sbjct: 132 --YIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 94/190 (49%), Gaps = 24/190 (12%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V+ A    +   VA+K ++      +++ ++ ++EV  ++++RHPN + + G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGINYLH 776
              +     +V EY   GS         A ++++  ++    +++A       +G+ YLH
Sbjct: 83  CYLREHTAWLVMEYC-LGS---------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK--ANTFISSKSVAGTVVFFAAHQTA 834
           + N  ++H D+K+ N+L+ +   VK+ DFG +     AN F+ +       V  A  +  
Sbjct: 133 SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 835 CNSLALIFSL 844
            +    ++SL
Sbjct: 191 YDGKVDVWSL 200

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 14/170 (8%)
Query: 667 VGAGSFGTVHRAEW-----HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V           G   A+KVL      + D+++  + E  I+  V HP VV 
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILADVNHPFVVK 94
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLN 779
              A      L ++ ++L  G L+  + +    E+M     ++  L ++A G+++LH+L 
Sbjct: 95  LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALGLDHLHSLG 150
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             I++ DLK  N+L+D+   +K+ DFGLS+   +    + S  GTV + A
Sbjct: 151 --IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 29/178 (16%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKE-FLREVAIMKR 712
           + L   + +G+G+FG V  A  +G       + V V  +++  D   +E  + E+ +M +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 713 V-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG------EMMDQRRR---- 761
           +  H N+V  +GA T    + ++ EY   G L   +            E  +Q+R     
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 762 ----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                     L  A  VAKG+ +L       +H DL + N+LV     VK+CDFGL+R
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLXQVIQME-----LDHERMSYLLYQMLXGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV 187

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 13/176 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRH 715
           D   + E +G G+FG VHR      G++ A K +      D   KE +R E+  M  +RH
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 107
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    A      + ++ E++  G L+  +        M +   +     V KG+ ++
Sbjct: 108 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 776 HNLNPPILHWDLKSPNLL--VDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           H  N   +H DLK  N++    ++  +K+ DFGL+    +   S K   GT  F A
Sbjct: 166 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAA 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREV-AIMKRVRHPNVVLFMGA 724
           +G G++G+V++     S   + V  ++  +D+ + K+ L ++  +M+    P +V F GA
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 725 VTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           + +     I  E +       Y+ ++     +++ +    ++ L   K +N+L   N  I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKE-NLKI 147
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +H D+K  N+L+D++  +K+CDFG+S
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 13/176 (7%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRH 715
           D   + E +G G+FG VHR      G++ A K +      D   KE +R E+  M  +RH
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 213
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    A      + ++ E++  G L+  +        M +   +     V KG+ ++
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 776 HNLNPPILHWDLKSPNLL--VDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           H  N   +H DLK  N++    ++  +K+ DFGL+    +   S K   GT  F A
Sbjct: 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAA 324

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 97  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 150
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 151 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 192

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 667 VGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V    +       G  VAVK L   D        + +E+ I++ + H +++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 721 FMGAV--TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           + G         L +V EY+P GSL   + R + G      + L  A  + +G+ YLH  
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGMAYLHAQ 153
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +   +H DL + N+L+D +  VK+ DFGL++
Sbjct: 154 H--YIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 27/185 (14%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L++ + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 17  PYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 74
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMD 757
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L   + R    E + 
Sbjct: 75  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVP 133
Query: 758 QR-------------RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804
            +               +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CD
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD 191
Query: 805 FGLSR 809
           FGL+R
Sbjct: 192 FGLAR 196

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 130 FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 183
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 184 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V   +   GSD     A+KVL      + D+++  + E  I+  V HP +V 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 90
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLN 779
              A      L ++ ++L  G L+  + +    E+M     ++  L ++A  +++LH+L 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             I++ DLK  N+L+D+   +K+ DFGLS+   +    + S  GTV + A
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 7/147 (4%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLFMG 723
           VG+G++G V  A     G+ VA+K L  + F  +   K   RE+ ++K +RH NV+  + 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 724 AVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
             T    L   T+ YL    +   + +    E + + R   +   + KG+ Y+H     I
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--I 149
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H DLK  NL V+++  +K+ DFGL+R
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEF 703
           PSL    +++  ++  + + +G GSFG V  AE+  ++   A+K L     L DD ++  
Sbjct: 8   PSLQ---IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 704 LREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
           + E  ++     HP +         + +L  V EYL  G L   ++   +    D  R  
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRAT 121
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             A ++  G+ +LH+    I++ DLK  N+L+DK+  +K+ DFG+ +
Sbjct: 122 FYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 93  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 146
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 147 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 86  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 139
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 140 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 181

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 32/177 (18%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
           GPRY N+                     +G G++G V  A  + + V V +  +  F   
Sbjct: 22  GPRYTNLS-------------------YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ 62
Query: 699 QL-KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAA 752
              +  LRE+ I+ R RH N++  +  + + P +       + + L    LY+L+     
Sbjct: 63  TYCQRTLREIKILLRFRHENII-GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----K 117
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + +           + +G+ Y+H+ N  +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 118 TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLAR 172

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLSQVIQME-----LDHERMSYLLYQMLVGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV 187

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+    V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV 187

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLSQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV 187

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 87/170 (51%), Gaps = 31/170 (18%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
           EI++    V   +G GSFG V +A+   SD VA+K    +   D + K   RE+ IM+ V
Sbjct: 39  EIAYTNCKV---IGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKN--RELQIMRIV 89
Query: 714 RHPNVV----LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL- 766
           +HPNVV     F     K+    L++V EY+P  ++YR     A+      ++ + M L 
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR-----ASRHYAKLKQTMPMLLI 143
Query: 767 -----DVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRF 810
                 + + + Y+H++   I H D+K  NLL+D  +  +K+ DFG ++ 
Sbjct: 144 KLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLSQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 15/177 (8%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 7   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 62
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 119
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS---RFKANTFISSKSVAGTVVFFA 829
           H +   I H D+K  NLL+D+   +K+ DFGL+   R+     + +K + GT+ + A
Sbjct: 120 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVA 173

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+    V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV 187

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 667 VGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V    +       G  VAVK L   D        + +E+ I++ + H +++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 721 FMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           + G    +    L +V EY+P GSL   + R + G      + L  A  + +G+ YLH+ 
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGMAYLHSQ 136
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +   +H +L + N+L+D +  VK+ DFGL++
Sbjct: 137 H--YIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V   +   GSD     A+KVL      + D+++  + E  I+  V HP +V 
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 91
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLN 779
              A      L ++ ++L  G L+  + +    E+M     ++  L ++A  +++LH+L 
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG 147
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             I++ DLK  N+L+D+   +K+ DFGLS+   +    + S  GTV + A
Sbjct: 148 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLSQVIQME-----LDHERMSYLLYQMLVGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V   +   GSD     A+KVL      + D+++  + E  I+  V HP +V 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 90
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLN 779
              A      L ++ ++L  G L+  + +    E+M     ++  L ++A  +++LH+L 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             I++ DLK  N+L+D+   +K+ DFGLS+   +    + S  GTV + A
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPN 717
           D   VKE +G GS+    R     +++   V      +D   ++   E+ I+ R  +HPN
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAV----KIIDKSKRDPTEEIEILLRYGQHPN 77
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++          ++ +VTE +  G L   I R    +   +R    +   + K + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHA 134
Query: 778 LNPPILHWDLKSPNLL-VDKNW---TVKVCDFGLSR 809
               ++H DLK  N+L VD++    ++++CDFG ++
Sbjct: 135 QG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLSQVIQME-----LDHERMSYLLYQMLVGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV 187

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLXQVIQME-----LDHERMSYLLYQMLXGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 130 FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 183
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 184 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKSLEEFQDVYIVME-LMDANLSQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV 187

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 85  FTPQKTLEEFQDVYLVME-LMDANLXQVIQME-----LDHERMSYLLYQMLXGIKHLHSA 138
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 139 G--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV 180

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLK---EFLREVAIMKRVR---HPNV 718
           +G G++GTV++A     G  VA+K + V +            +REVA+++R+    HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 719 VLFMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           V  M         +   +++V E++ +     L   P  G   +  + L       +G++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF--LRGLD 134
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +LH     I+H DLK  N+LV    TVK+ DFGL+R 
Sbjct: 135 FLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLXQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E +G+G+F  V   +    G   A+K +       D   E   E+A++K+++H N+V   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVTLE 72
Query: 723 GAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                  H  +V + +  G L+ R++ R    E  D    ++  L   K   YLH     
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTE-KDASLVIQQVLSAVK---YLH--ENG 126
Query: 782 ILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISS 818
           I+H DLK  NLL    ++N  + + DFGLS+ + N  +S+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       IV E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 94  FTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 147
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816
              I+H DLK  N++V  + T+K+ DFGL+R    +F+
Sbjct: 148 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 183

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEIXINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD--DQLKEFLREVAIMKRV 713
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D  + +K   +E+ I K +
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKML 61
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVV 118
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           YLH +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
           VKE +G GS+    R     +++  AVKV+      D   ++   E+ I+ R  +HPN++
Sbjct: 31  VKETIGVGSYSECKRCVHKATNMEYAVKVI------DKSKRDPSEEIEILLRYGQHPNII 84
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
                     H+ +VTE +  G L   I R    +   +R    +   + K + YLH+  
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQ---KFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 780 PPILHWDLKSPNLL-VDKNWT---VKVCDFGLSR 809
             ++H DLK  N+L VD++     +++CDFG ++
Sbjct: 142 --VVHRDLKPSNILYVDESGNPECLRICDFGFAK 173

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           DE  + E +G G+F  V R      G + A K++  +       ++  RE  I + ++HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++++     +V + +  G L+  I    A E   +         + + +N+ H
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESVNHCH 120
Query: 777 NLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLS 808
            LN  I+H DLK  NLL+    K   VK+ DFGL+
Sbjct: 121 -LN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 4/145 (2%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           VG+G++G+V  A  +  G  VA+K L+     +   K   RE+ ++K ++H NV+  +  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
            T    L    ++       +   +   G    + +   +   + KG+ Y+H+    ++H
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG--VVH 167
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR 809
            DLK  NL V+++  +K+ DFGL+R
Sbjct: 168 RDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD--DQLKEFLREVAIMKRV 713
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D  + +K   +E+ I K +
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEIXINKML 62
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVV 119
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           YLH +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A     G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 214
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++ LH     +
Sbjct: 215 NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 268
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 315

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 659 DELHVKERVGAGSFGT----VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV- 713
           D   VKE +G GS+      +H+A     + AVK++      D   ++   E+ I+ R  
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKAT--NXEFAVKII------DKSKRDPTEEIEILLRYG 73
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           +HPN++          ++ +VTE    G L   I R    +   +R    +   + K + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ---KFFSEREASAVLFTITKTVE 130
Query: 774 YLHNLNPPILHWDLKSPNLL-VDKNW---TVKVCDFGLSR 809
           YLH     ++H DLK  N+L VD++    ++++CDFG ++
Sbjct: 131 YLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD--DQLKEFLREVAIMKRV 713
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D  + +K   +E+ I K +
Sbjct: 8   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEIXINKML 61
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            H NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVV 118
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           YLH +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 667 VGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G G FG V    +       G  VAVK L   D        + +E+ I++ + H +++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 721 FMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           + G    +    L +V EY+P GSL   + R + G      + L  A  + +G+ YLH  
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGMAYLHAQ 136
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +   +H +L + N+L+D +  VK+ DFGL++
Sbjct: 137 H--YIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 93  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 146
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 147 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 4/145 (2%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           VG+G++G+V  A  +  G  VA+K L+     +   K   RE+ ++K ++H NV+  +  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
            T    L    ++       +   +   G    + +   +   + KG+ Y+H+    ++H
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG--VVH 149
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR 809
            DLK  NL V+++  +K+ DFGL+R
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 93  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 146
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 147 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 92  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 145
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 146 G--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV 187

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 91  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 144
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 145 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 186

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 86  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 139
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 140 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 181

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 86  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 139
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 140 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 181

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V  A     D  VA+K L+         K   RE+ +MK V H N++  +  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
            T +  L       +V E L   +L ++I        +D  R   +   +  GI +LH+ 
Sbjct: 85  FTPQKTLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
              I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 139 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 180

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V   R +  G  VAVK++   D    Q +E L  EV IM+  +H NVV   
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L ++ E+L  G+L  ++ +      +++ +   +   V + + YLH     +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG--V 162
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMA 209

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 11/180 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDD---QLKEFLREVAIMKRV 713
           D   + E +G G+F  V R      G   AVK++ V  F        ++  RE +I   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +HP++V  +   +    L +V E++    L + ++ R  AG +  +         + + +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 773 NYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            Y H+ N  I+H D+K  N+L+   + +  VK+ DFG++     + + +    GT  F A
Sbjct: 144 RYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMA 201

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
           VKE +G GS+    R     +++  AVKV+      D   ++   E+ I+ R  +HPN++
Sbjct: 31  VKETIGVGSYSECKRCVHKATNMEYAVKVI------DKSKRDPSEEIEILLRYGQHPNII 84
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
                     H+ +VTE +  G L   I R    +   +R    +   + K + YLH+  
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQ---KFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 780 PPILHWDLKSPNLL-VDKNWT---VKVCDFGLSR 809
             ++H DLK  N+L VD++     +++CDFG ++
Sbjct: 142 --VVHRDLKPSNILYVDESGNPECLRICDFGFAK 173

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           DE  + E +G G+F  V R      G + A K++  +       ++  RE  I + ++HP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++++     +V + +  G L+  I    A E   +         + + +N+ H
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESVNHCH 120
Query: 777 NLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLS 808
            LN  I+H DLK  NLL+    K   VK+ DFGL+
Sbjct: 121 -LN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLF 721
           +++G+G++G V   + +  G++ A+K++              L EVA++K++ HPN++  
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 722 MGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                 + +  +V E    G L+  +I R    E +D    ++  L    G  YLH  N 
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE-VDAAVIMKQVL---SGTTYLHKHN- 124
Query: 781 PILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
            I+H DLK  NLL++   ++  +K+ DFGLS
Sbjct: 125 -IVHRDLKPENLLLESKSRDALIKIVDFGLS 154

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L++ + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 16  PYDASKW-EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSE 73
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSLYRLI---------H 748
            +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+L   +         +
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +    + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+ DFGL+
Sbjct: 134 KDLYKDFLTLEHLIXYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 809 R 809
           R
Sbjct: 192 R 192

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 155
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN+F+ +       +     ++AC
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEKSAC 213
Query: 836 NS 837
            S
Sbjct: 214 KS 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A     G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 137
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++ LH     +
Sbjct: 138 NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 191
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 13/176 (7%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-LKEFLREVAI-MK 711
            E+  D+L     +G G++G V +     S   + V  ++  ++ Q  K  L ++ I M+
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 105
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRLRMALDVA 769
            V  P  V F GA+ +   + I  E +       Y+ +     G+ + +    ++A+ + 
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVID--KGQTIPEDILGKIAVSIV 163
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
           K + +LH+    ++H D+K  N+L++    VK+CDFG+S +  +      SVA T+
Sbjct: 164 KALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------SVAKTI 212

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVV-L 720
           +G G+   V R      G   A+KV     FL   D Q++EF     ++K++ H N+V L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF----EVLKKLNHKNIVKL 72
Query: 721 F-MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           F +   T   H  ++ E+ P GSLY ++  P+    + +   L +  DV  G+N+L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--E 130
Query: 780 PPILHWDLKSPNLL----VDKNWTVKVCDFGLSR 809
             I+H ++K  N++     D     K+ DFG +R
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A     G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++ LH     +
Sbjct: 93  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 146
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 193

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A     G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++ LH     +
Sbjct: 95  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 148
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 195

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVV-L 720
           +G G+   V R      G   A+KV     FL   D Q++EF     ++K++ H N+V L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF----EVLKKLNHKNIVKL 72
Query: 721 F-MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
           F +   T   H  ++ E+ P GSLY ++  P+    + +   L +  DV  G+N+L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--E 130
Query: 780 PPILHWDLKSPNLL----VDKNWTVKVCDFGLSR 809
             I+H ++K  N++     D     K+ DFG +R
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 77
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 78  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 132
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 133 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 190
Query: 836 NS 837
            S
Sbjct: 191 KS 192

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLF 721
           +++G+G++G V   + +  G++ A+K++              L EVA++K++ HPN++  
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 722 MGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                 + +  +V E    G L+  +I R    E +D    ++  L    G  YLH  N 
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE-VDAAVIMKQVLS---GTTYLHKHN- 141
Query: 781 PILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
            I+H DLK  NLL++   ++  +K+ DFGLS
Sbjct: 142 -IVHRDLKPENLLLESKSRDALIKIVDFGLS 171

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 76
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 77  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 131
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 132 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 189
Query: 836 NS 837
            S
Sbjct: 190 KS 191

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 151
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN+F+ +       +     ++AC
Sbjct: 152 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEKSAC 209
Query: 836 NS 837
            S
Sbjct: 210 KS 211

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E+AI K + +P+VV F G       + +V E   R SL  L  R  A    + R  +R  
Sbjct: 76  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 135
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +   +G+ YLHN    ++H DLK  NL ++ +  VK+ DFGL+
Sbjct: 136 I---QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E+AI K + +P+VV F G       + +V E   R SL  L  R  A    + R  +R  
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +   +G+ YLHN    ++H DLK  NL ++ +  VK+ DFGL+
Sbjct: 152 I---QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 104
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 105 CFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 159
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 160 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 217
Query: 836 NS 837
            S
Sbjct: 218 KS 219

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E+AI K + +P+VV F G       + +V E   R SL  L  R  A    + R  +R  
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +   +G+ YLHN    ++H DLK  NL ++ +  VK+ DFGL+
Sbjct: 152 I---QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E+AI K + +P+VV F G       + +V E   R SL  L  R  A    + R  +R  
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +   +G+ YLHN    ++H DLK  NL ++ +  VK+ DFGL+
Sbjct: 152 I---QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G++G V  A    ++  VAVK++ ++  +D   +   +E+ I   + H
Sbjct: 9   WD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINAMLNH 64
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
           H +   I H D+K  NLL+D+   +K+ DFGL+  F+ N 
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 154
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 212
Query: 836 NS 837
            S
Sbjct: 213 KS 214

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 74
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 75  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 129
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 130 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 187
Query: 836 NS 837
            S
Sbjct: 188 KS 189

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 152
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL--TEKSAC 210
Query: 836 NS 837
            S
Sbjct: 211 KS 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 130
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 188
Query: 836 NS 837
            S
Sbjct: 189 KS 190

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           WD   + + +G G+ G V  A    ++  VAVK++ ++  +D   +   +E+ I K + H
Sbjct: 8   WD---LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNH 63
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            NVV F G   +     +  EY   G L+  I  P  G  M +    R    +  G+ YL
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIG--MPEPDAQRFFHQLMAGVVYL 120
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           H +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 155
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 213
Query: 836 NS 837
            S
Sbjct: 214 KS 215

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A     G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++ LH     +
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 184

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 152
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 210
Query: 836 NS 837
            S
Sbjct: 211 KS 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 154
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 212
Query: 836 NS 837
            S
Sbjct: 213 KS 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 152
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 210
Query: 836 NS 837
            S
Sbjct: 211 KS 212

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
           ++G GS G V  A     G  VAVK +   D    Q +E L  EV IM+  +H NVV   
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V E+L  G+L  ++        M++ +   + L V + ++ LH     +
Sbjct: 88  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 141
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +H D+KS ++L+  +  VK+ DFG     +      K + GT  + A
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 188

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 100 TFQDDEKLYFGLSYAKNGCLLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 154
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISS 818
           H DLK  N+L++++  +++ DFG ++         +AN+F+ +
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 154
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 212
Query: 836 NS 837
            S
Sbjct: 213 KS 214

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +G G+FG+V    +R      DVA+KVL  Q       +E +RE  IM ++ +P +V  +
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G V +   L +V E    G L++ +      E +       +   V+ G+ YL   N   
Sbjct: 77  G-VCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN--F 131
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H DL + N+L+      K+ DFGLS+
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSK 158

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 154
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 212
Query: 836 NS 837
            S
Sbjct: 213 KS 214

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 102
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 103 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 157
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 158 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 215
Query: 836 NS 837
            S
Sbjct: 216 KS 217

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 15/154 (9%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           ++G G+FG V +A     G  VA+K + +++  +      LRE+ I++ ++H NVV  + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 724 AVTKR--PH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
               +  P+      + +V ++        L +      + + +R ++M L+   G+ Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---GLYYI 141
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H     ILH D+K+ N+L+ ++  +K+ DFGL+R
Sbjct: 142 HR--NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 80/161 (49%), Gaps = 7/161 (4%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-LKEFLREVAI-MK 711
           +E+  D+L     +G G++G V +     S   + V  ++  ++ Q  K  L ++ I M+
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRLRMALDVA 769
            V  P  V F GA+ +   + I  E +       Y+ +     G+ + +    ++A+ + 
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVID--KGQTIPEDILGKIAVSIV 119
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           K + +LH+    ++H D+K  N+L++    VK+CDFG+S +
Sbjct: 120 KALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 82  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 136
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 137 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 194
Query: 836 NS 837
            S
Sbjct: 195 KS 196

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 21/157 (13%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM- 722
           ++G G+FG V +A     G  VA+K + +++  +      LRE+ I++ ++H NVV  + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 723 -----GAVTKRPHLSI-----VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
                 +   R   SI       E+   G L  ++ +    E+   +R ++M L+   G+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI---KRVMQMLLN---GL 138
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            Y+H     ILH D+K+ N+L+ ++  +K+ DFGL+R
Sbjct: 139 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 151
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 152 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 209
Query: 836 NS 837
            S
Sbjct: 210 KS 211

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 15/154 (9%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           ++G G+FG V +A     G  VA+K + +++  +      LRE+ I++ ++H NVV  + 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 724 AVTKR--PH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
               +  P+      + +V ++        L +      + + +R ++M L+   G+ Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---GLYYI 140
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H     ILH D+K+ N+L+ ++  +K+ DFGL+R
Sbjct: 141 HR--NKILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E +G G+F  V R      G + A K++  +       ++  RE  I + ++HPN+V   
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            ++++  H  ++ + +  G L+  I    A E   +         + + + + H +   +
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQMG--V 142
Query: 783 LHWDLKSPNLLVD---KNWTVKVCDFGLS 808
           +H DLK  NLL+    K   VK+ DFGL+
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA 171

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 15/154 (9%)
Query: 666 RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
           ++G G+FG V +A     G  VA+K + +++  +      LRE+ I++ ++H NVV  + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 724 AVTKR--PH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
               +  P+      + +V ++        L +      + + +R ++M L+   G+ Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---GLYYI 141
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H     ILH D+K+ N+L+ ++  +K+ DFGL+R
Sbjct: 142 HR--NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +G G+FG+V    +R      DVA+KVL  Q       +E +RE  IM ++ +P +V  +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G V +   L +V E    G L++ +      E +       +   V+ G+ YL   N   
Sbjct: 403 G-VCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN--F 457
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H +L + N+L+      K+ DFGLS+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSK 484

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 5/124 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E  I++ V+HP +V  + A      L ++ EYL  G L+  + R   G  M+      +A
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLA 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
            +++  + +LH     I++ DLK  N++++    VK+ DFGL +   +    + +  GT+
Sbjct: 129 -EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 826 VFFA 829
            + A
Sbjct: 186 EYMA 189

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRHPN 717
           D   V+  +G G+   V+R +  G+     +  ++  +D   K+ +R E+ ++ R+ HPN
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPN 109
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           ++           +S+V E +  G L+ R++ +    E    R        + + + YLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE----RDAADAVKQILEAVAYLH 165
Query: 777 NLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKANTFISSKSVAGT 824
                I+H DLK  NLL      +  +K+ DFGLS+   +  +  K+V GT
Sbjct: 166 ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGT 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 667 VGAGSFGTVHRAEWHGS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +  + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 154
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISS 818
           H DLK  N+L++++  +++ DFG ++         +AN F+ +
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D+  + E +G G+F  V R   +    + A K++  +       ++  RE  I + ++HP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++++     +V + +  G L+  I    A E   +         + + +N++H
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIHQILESVNHIH 147
Query: 777 NLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
             +  I+H DLK  NLL+    K   VK+ DFGL+
Sbjct: 148 QHD--IVHRDLKPENLLLASKCKGAAVKLADFGLA 180

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-LKEFLREVA 708
           A +  E+  D+L     +G G++G V +     S     V  ++  ++ Q  K  L ++ 
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD 84
Query: 709 IMKR-VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMAL 766
           I  R V  P  V F GA+ +   + I  E L   SL +   +    G+ + +    ++A+
Sbjct: 85  ISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAV 143
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            + K + +LH+    ++H D+K  N+L++    VK CDFG+S +
Sbjct: 144 SIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKXCDFGISGY 186

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 94
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 152
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           I+H DLK  NL V+++  +K+ DFGL+R  A+
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 18/182 (9%)
Query: 667 VGAGSFGT--VHRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF T  + R      + A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 152
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTVVFFAAHQTAC 835
           H DLK  N+L++++  +++ DFG ++         +AN F+ +       +     ++AC
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAC 210
Query: 836 NS 837
            S
Sbjct: 211 KS 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 9/178 (5%)
Query: 656 ISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR 712
           +  D       +G GSFG V   R +  G   AVKVL     L DD ++  + E  I+  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 713 VR-HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            R HP +            L  V E++  G L   I +       D+ R    A ++   
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISA 136
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + +LH+    I++ DLK  N+L+D     K+ DFG+ +      +++ +  GT  + A
Sbjct: 137 LMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 94
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 152
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           I+H DLK  NL V+++  +K+ DFGL+R  A+
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 94
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 152
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
           I+H DLK  NL V+++  +K+ DFGL+R  A+
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   V+   G G+FGTV   + +  G  VA+K +       ++  + ++++A++    HP
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL---HHP 79
Query: 717 NVVLF------MGAVTKRP-HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DV 768
           N+V        +G   +R  +L++V EY+P  +L+R        ++      +++ L  +
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFG----LSRFKANT-FISSKSV- 821
            + I  LH  +  + H D+K  N+LV++ + T+K+CDFG    LS  + N  +I S+   
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 822 AGTVVFFAAHQTACN---SLALIFS 843
           A  ++F   H T      S+  IF+
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFA 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 61/124 (49%), Gaps = 5/124 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E  I++ V+HP +V  + A      L ++ EYL  G L+  + R   G  M+      +A
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLA 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
            +++  + +LH     I++ DLK  N++++    VK+ DFGL +   +    +    GT+
Sbjct: 129 -EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTI 185
Query: 826 VFFA 829
            + A
Sbjct: 186 EYMA 189

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ ++ H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 98  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 158 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ ++ H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 84  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 144 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 123
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 184 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 158 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNV 718
           +G+G+FG V  A  +    +V VK +  +  L+D      +L +   E+AI+ RV H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 719 VLFMGAVTKRPHLSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +  +     +    +V E    G  L+  I R      +D+     +   +   + YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRL 148
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            +  I+H D+K  N+++ +++T+K+ DFG + +
Sbjct: 149 KD--IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 40  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 99
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 100 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 159
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 160 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 41  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 100
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 101 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 160
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 161 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 97
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 155
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 143 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFL-REVAIM 710
           L++  ++  V + +G G+FG V       S    A+K+L+  + +      F   E  IM
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
                P VV    A     +L +V EY+P G L  L+      E   +     + L    
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL---- 185
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
            ++ +H++   ++H D+K  N+L+DK+  +K+ DFG
Sbjct: 186 ALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 106
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 164
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 83
Query: 723 GAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
              T    L       +  +L    L  ++      ++ D   +  +   + +G+ Y+H+
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCAKLTDDHVQF-LIYQILRGLKYIHS 139
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +  I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 140 AD--IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM 97
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 158 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 15  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 74
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 75  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 134
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 135 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 107
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 165
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 107
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 165
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 144 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 30  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 89
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 90  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 149
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 150 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 110
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 168
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 143 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSII--HAKRTYRELRLLKHMKHENVIGLL 99
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 157
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 93
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 151
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 50  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 109
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 110 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 169
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 170 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  +     G  +AVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 116
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 174
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 175 IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 89
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 147
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 99
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 157
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 98
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 156
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 99
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 157
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 89
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 147
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 83
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 83
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 92
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 150
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 94
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 152
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 92
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 150
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 86
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 144
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 145 IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 106
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 164
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 98
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 156
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 89
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 147
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 93
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 151
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 107
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 165
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 110
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 168
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL R
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 93
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 151
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 152 IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 92
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 150
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 84
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 142
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 85
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 143
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 144 IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 89
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 147
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 93
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 151
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 84
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 142
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           +G+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 92
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 150
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 13/174 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V  +E  G+D   AVK+L     +QD  DD     + +  +    + P +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD--DDVECTMVEKRVLALPGKPPFLTQ 406
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                     L  V EY+  G L  + H    G    +   +  A ++A G+ +L +   
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRF-KEPHAVFYAAEIAIGLFFLQSKG- 462
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
            I++ DLK  N+++D    +K+ DFG+ +      +++K   GT  + A    A
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 515

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           DE  + E +G G+F  V R      G + A K++  +       ++  RE  I + ++H 
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++++     +V + +  G L+  I    A E   +         + + + + H
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCH 120
Query: 777 NLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
            +   ++H DLK  NLL+    K   VK+ DFGL+
Sbjct: 121 QMG--VVHRDLKPENLLLASKCKGAAVKLADFGLA 153

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           +E  + E +G G+F  V R      G + A  ++  +       ++  RE  I + ++HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V    ++++  H  ++ + +  G L+  I    A E   +         + + + + H
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCH 127
Query: 777 NLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLS 808
            +   ++H +LK  NLL+    K   VK+ DFGL+
Sbjct: 128 QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLA 160

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 83
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL-REVAI 709
           L +  ++  V + +G G+FG V     H S     A+K+L+  + +      F   E  I
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVR-HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M     P VV    A     +L +V EY+P G L  L+      E   +  R   A +V 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVV 178
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
             ++ +H++    +H D+K  N+L+DK+  +K+ DFG
Sbjct: 179 LALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 13/174 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +G GSFG V  +E  G+D   AVK+L     +QD  DD     + +  +    + P +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD--DDVECTMVEKRVLALPGKPPFLTQ 85
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                     L  V EY+  G L  + H    G    +   +  A ++A G+ +L +   
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRF-KEPHAVFYAAEIAIGLFFLQSKG- 141
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
            I++ DLK  N+++D    +K+ DFG+ +      +++K   GT  + A    A
Sbjct: 142 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 194

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL-REVAI 709
           L +  ++  V + +G G+FG V     H S     A+K+L+  + +      F   E  I
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVR-HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M     P VV    A     +L +V EY+P G L  L+      E   +  R   A +V 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVV 183
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
             ++ +H++    +H D+K  N+L+DK+  +K+ DFG
Sbjct: 184 LALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL-REVAI 709
           L +  ++  V + +G G+FG V     H S     A+K+L+  + +      F   E  I
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVR-HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M     P VV    A     +L +V EY+P G L  L+      E   +  R   A +V 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTA-EVV 183
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
             ++ +H++    +H D+K  N+L+DK+  +K+ DFG
Sbjct: 184 LALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 15/171 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLK-EFLR 705
           D  E+    + +   +G G+FG V+  +  G     S + V V T+ +   +Q + +FL 
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH----RPAAGEMMDQRRR 761
           E  I+ +  H N+V  +G   +     I+ E +  G L   +     RP+    +     
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR 809
           L +A D+A G  YL   +   +H D+ + N L+         K+ DFG+++
Sbjct: 144 LHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 660 ELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRV-R 714
           E H  E++G+G FG+V +      G   A+K     +   +D+Q    LREV     + +
Sbjct: 10  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHAVLGQ 67
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------YRLIHRPAAGEMMDQRRRLRMALD 767
           H +VV +  A  +  H+ I  EY   GSL       YR++      E+ D      + L 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD------LLLQ 121
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKN 797
           V +G+ Y+H+++  ++H D+K  N+ + + 
Sbjct: 122 VGRGLRYIHSMS--LVHMDIKPSNIFISRT 149

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ D+GL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 660 ELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRV-R 714
           E H  E++G+G FG+V +      G   A+K     +   +D+Q    LREV     + +
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHAVLGQ 69
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------YRLIHRPAAGEMMDQRRRLRMALD 767
           H +VV +  A  +  H+ I  EY   GSL       YR++      E+ D      + L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD------LLLQ 123
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKN 797
           V +G+ Y+H+++  ++H D+K  N+ + + 
Sbjct: 124 VGRGLRYIHSMS--LVHMDIKPSNIFISRT 151

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 660 ELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRV-R 714
           E H  E++G+G FG+V +      G   A+K     +   +D+Q    LREV     + +
Sbjct: 10  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHAVLGQ 67
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------YRLIHRPAAGEMMDQRRRLRMALD 767
           H +VV +  A  +  H+ I  EY   GSL       YR++      E+ D      + L 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD------LLLQ 121
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKN 797
           V +G+ Y+H+++  ++H D+K  N+ + + 
Sbjct: 122 VGRGLRYIHSMS--LVHMDIKPSNIFISRT 149

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 83/172 (48%), Gaps = 9/172 (5%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V  A+  G++   A+K+L     + DD ++  + E  ++  +  P  +  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 724 AVTKR-PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           +  +    L  V EY+  G L  + H    G+   + + +  A +++ G+ +LH     I
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPQAVFYAAEISIGLFFLHKRG--I 141
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA 834
           ++ DLK  N+++D    +K+ DFG+ +      ++++   GT  + A    A
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIA 193

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 660 ELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRV-R 714
           E H  E++G+G FG+V +      G   A+K     +   +D+Q    LREV     + +
Sbjct: 8   EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHAVLGQ 65
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL-------YRLIHRPAAGEMMDQRRRLRMALD 767
           H +VV +  A  +  H+ I  EY   GSL       YR++      E+ D      + L 
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD------LLLQ 119
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKN 797
           V +G+ Y+H+++  ++H D+K  N+ + + 
Sbjct: 120 VGRGLRYIHSMS--LVHMDIKPSNIFISRT 147

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/157 (22%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK 711
           ++++D   +   +G GSFG V   + + +    A+K +  Q  ++ ++++   +E+ IM+
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            + HP +V    +      + +V + L  G L    H        ++  +L +  ++   
Sbjct: 71  GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFIC-ELVMA 127
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           ++YL N    I+H D+K  N+L+D++  V + DF ++
Sbjct: 128 LDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIA 162

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 5/124 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E++I + + H +VV F G       + +V E   R SL  L  R  A    + R  LR  
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 124
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
             +  G  YLH     ++H DLK  NL ++++  VK+ DFGL+          K++ GT 
Sbjct: 125 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 826 VFFA 829
            + A
Sbjct: 182 NYIA 185

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 5/124 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E++I + + H +VV F G       + +V E   R SL  L  R  A    + R  LR  
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 128
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
             +  G  YLH     ++H DLK  NL ++++  VK+ DFGL+          K++ GT 
Sbjct: 129 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 826 VFFA 829
            + A
Sbjct: 186 NYIA 189

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 5/124 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E++I + + H +VV F G       + +V E   R SL  L  R  A    + R  LR  
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 124
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
             +  G  YLH     ++H DLK  NL ++++  VK+ DFGL+          K++ GT 
Sbjct: 125 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 826 VFFA 829
            + A
Sbjct: 182 NYIA 185

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           +++  + E +G G FG VHR     S        V+    DQ+    +E++I+   RH N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRN 62
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++    +      L ++ E++    ++  I+  A    +++R  +     V + + +LH+
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS 120
Query: 778 LNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSR 809
            N  I H+D++  N++    ++ T+K+ +FG +R
Sbjct: 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E++I + + H +VV F G       + +V E   R SL  L  R  A    + R  LR  
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 122
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
             +  G  YLH     ++H DLK  NL ++++  VK+ DFGL+
Sbjct: 123 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVL--TVQDFLDDQLKEFLREVAIMKRVR-HPNVV 719
           +++G G++G V ++     G  VAVK +    Q+  D Q     RE+ I+  +  H N+V
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFREIMILTELSGHENIV 72
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
             +  +       +   YL    +   +H      +++   +  +   + K I YLH+  
Sbjct: 73  NLLNVLRADNDRDV---YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS-- 127
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
             +LH D+K  N+L++    VKV DFGLSR    +F++ + V   +
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSR----SFVNIRRVTNNI 169

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 660 ELHVKER-VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPN 717
           +L +K++ +G GSF    +     S+ A  V  +   ++   +   +E+  +K    HPN
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPN 67
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V        + H  +V E L  G L+  I +       +    +R    +   ++++H+
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR---KLVSAVSHMHD 124
Query: 778 LNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFK 811
           +   ++H DLK  NLL    + N  +K+ DFG +R K
Sbjct: 125 VG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E++I + + H +VV F G       + +V E   R SL  L  R  A    + R  LR  
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 146
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
             +  G  YLH     ++H DLK  NL ++++  VK+ DFGL+
Sbjct: 147 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E++I + + H +VV F G       + +V E   R SL  L  R  A    + R  LR  
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 148
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
             +  G  YLH     ++H DLK  NL ++++  VK+ DFGL+
Sbjct: 149 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
           +F  E+ I+  +++   +   G +T    + I+ EY+   S+ +         ++D+   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF---DEYFFVLDKNYT 145
Query: 762 LRMALDVAKGI--------NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
             + + V K I        +Y+HN    I H D+K  N+L+DKN  VK+ DFG S +  +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 814 TFISSKSVAGTVVF----FAAHQTACNSLAL-IFSLSGWLQSSF 852
             I  K   GT  F    F +++++ N   + I+SL   L   F
Sbjct: 205 KKI--KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 11/180 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDD---QLKEFLREVAIMKRV 713
           D   + E +G G F  V R      G   AVK++ V  F        ++  RE +I   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +HP++V  +   +    L +V E++    L + ++ R  AG +  +         + + +
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 773 NYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            Y H+ N  I+H D+K   +L+   + +  VK+  FG++     + + +    GT  F A
Sbjct: 146 RYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 203

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ DF L+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+  FGL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 11/180 (6%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDD---QLKEFLREVAIMKRV 713
           D   + E +G G F  V R      G   AVK++ V  F        ++  RE +I   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           +HP++V  +   +    L +V E++    L + ++ R  AG +  +         + + +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 773 NYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            Y H+ N  I+H D+K   +L+   + +  VK+  FG++     + + +    GT  F A
Sbjct: 144 RYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A        VAVK L+   Q  +    +   RE+ ++K ++H NV+  +
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLI--HARRTYRELRLLKHLKHENVIGLL 93
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    +   +E YL    +   ++     + +       +   + +G+ Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  N+ V+++  +++ DFGL+R
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 663 VKERVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           +KER+G G FG V R  W     G  VA+K    Q+      + +  E+ IMK++ HPNV
Sbjct: 19  MKERLGTGGFGYVLR--WIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNV 75
Query: 719 V--------LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           V        L   A    P L++  EY   G L + +++      + +     +  D++ 
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAM--EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 771 GINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
            + YLH     I+H DLK  N+++    +    K+ D G ++      + ++ V GT+ +
Sbjct: 134 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQY 190
Query: 828 FA 829
            A
Sbjct: 191 LA 192

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 663 VKERVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           +KER+G G FG V R  W     G  VA+K    Q+      + +  E+ IMK++ HPNV
Sbjct: 18  MKERLGTGGFGYVLR--WIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 719 V--------LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           V        L   A    P L++  EY   G L + +++      + +     +  D++ 
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAM--EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 771 GINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
            + YLH     I+H DLK  N+++    +    K+ D G ++      + ++ V GT+ +
Sbjct: 133 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQY 189
Query: 828 FA 829
            A
Sbjct: 190 LA 191

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 32/168 (19%)
Query: 663 VKERVGAGSFGTV-HRAEWHGSDVAVKVL--TVQD-----FLDDQL--KEFLREVAIMKR 712
           V+  + +GS+G V    +  G  VA+K +  TV D      L D    K  LRE+ ++  
Sbjct: 26  VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 713 VRHPNVV----LFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR---- 763
             HPN++    +F+       H L +VTE L R  L ++IH        DQR  +     
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIH--------DQRIVISPQHI 136
Query: 764 --MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                 +  G++ LH     ++H DL   N+L+  N  + +CDF L+R
Sbjct: 137 QYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 32/168 (19%)
Query: 663 VKERVGAGSFGTV-HRAEWHGSDVAVKVL--TVQD-----FLDDQL--KEFLREVAIMKR 712
           V+  + +GS+G V    +  G  VA+K +  TV D      L D    K  LRE+ ++  
Sbjct: 26  VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 713 VRHPNVV----LFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR---- 763
             HPN++    +F+       H L +VTE L R  L ++IH        DQR  +     
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIH--------DQRIVISPQHI 136
Query: 764 --MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                 +  G++ LH     ++H DL   N+L+  N  + +CDF L+R
Sbjct: 137 QYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A        VAVK L+   Q  +    +   RE+ ++K ++H NV+  +
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLI--HARRTYRELRLLKHLKHENVIGLL 85
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    +   +E YL    +   ++     + +       +   + +G+ Y+H+    
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  N+ V+++  +++ DFGL+R
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A        VAVK L+   Q  +    +   RE+ ++K ++H NV+  +
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLI--HARRTYRELRLLKHLKHENVIGLL 93
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    +   +E YL    +   ++     + +       +   + +G+ Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  N+ V+++  +++ DFGL+R
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ D GL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 50/216 (23%)
Query: 662 HVKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFLDDQLKEFLR---EVAIMKRVRHP 716
           H+K  +G GS+G V  A  + +    A+K++          K+  R   EV +MK++ HP
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYR----LIHRPAAGEMMD--------------- 757
           N+           ++ +V E    G L       I        MD               
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 758 ----------------QRRRL--RMALDVAKGINYLHNLNPPILHWDLKSPNLL--VDKN 797
                           QR +L   +   +   ++YLHN    I H D+K  N L   +K+
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKS 206
Query: 798 WTVKVCDFGLSR--FKANT--FISSKSVAGTVVFFA 829
           + +K+ DFGLS+  +K N   +    + AGT  F A
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ D GL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           VG+G++G+V  A     G  VAVK L+   Q  +    K   RE+ ++K ++H NV+  +
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 87
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
              T    L    + YL    +   ++     + +       +   + +G+ Y+H+ +  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 145
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           I+H DLK  NL V+++  +K+ D GL+R
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQD 694
           GPG   ++  PS        S D      ++G G++G V++A        VA+K + ++ 
Sbjct: 18  GPGSMSVSAAPSAT------SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 695 FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGE 754
             +      +REV+++K ++H N++     +     L ++ EY     L + + +     
Sbjct: 72  EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVS 130
Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-----DKNWTVKVCDFGLSR 809
           M   +  L   ++   G+N+ H+     LH DLK  NLL+      +   +K+ DFGL+R
Sbjct: 131 MRVIKSFLYQLIN---GVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 15/154 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMGAV 725
           +G G FG V  A+    D    +  ++    +  +E  +REV  + ++ HP +V +  A 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 726 TKRPHLSIVTEYLPRGSLY---RLIHRPAAGEMM------DQRRR---LRMALDVAKGIN 773
            ++     +    P+  LY   +L  +    + M      ++R R   L + L +A+ + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
           +LH+    ++H DLK  N+    +  VKV DFGL
Sbjct: 133 FLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGL 164

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVL 720
           + +G+G+FGTV +  +            +   +  D  LK E L E  +M+++ +P +V 
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
            +G + +     +V E    G L + + +      +  +  + +   V+ G+ YL   N 
Sbjct: 435 MIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN- 489
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             +H DL + N+L+      K+ DFGLS+
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSK 517

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVL 720
           + +G+G+FGTV +  +            +   +  D  LK E L E  +M+++ +P +V 
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
            +G + +     +V E    G L + + +      +  +  + +   V+ G+ YL   N 
Sbjct: 436 MIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN- 490
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             +H DL + N+L+      K+ DFGLS+
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSK 518

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 76/235 (32%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 18  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 75
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTK--RPHLSIV----------------TEYLP- 739
            +  + E+ I+  +  H NVV  +GA TK   P + IV                 E++P 
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 135
Query: 740 --RGSLYRLIHRPAAGEMMDQRRRLR---------------------------------- 763
             +G+ +R          +D +RRL                                   
Sbjct: 136 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 195
Query: 764 ---------MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                     +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+R
Sbjct: 196 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 248

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 76/235 (32%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 11  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 68
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTK--RPHLSIV----------------TEYLP- 739
            +  + E+ I+  +  H NVV  +GA TK   P + IV                 E++P 
Sbjct: 69  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 740 --RGSLYRLIHRPAAGEMMDQRRRLR---------------------------------- 763
             +G+ +R          +D +RRL                                   
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 764 ---------MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                     +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+R
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 76/235 (32%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 16  PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 73
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTK--RPHLSIV----------------TEYLP- 739
            +  + E+ I+  +  H NVV  +GA TK   P + IV                 E++P 
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 740 --RGSLYRLIHRPAAGEMMDQRRRLR---------------------------------- 763
             +G+ +R          +D +RRL                                   
Sbjct: 134 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 193
Query: 764 ---------MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                     +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+R
Sbjct: 194 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 246

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 76/235 (32%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQ 699
           P  A  W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     +
Sbjct: 9   PYDASKW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSE 66
Query: 700 LKEFLREVAIMKRV-RHPNVVLFMGAVTK--RPHLSIV----------------TEYLP- 739
            +  + E+ I+  +  H NVV  +GA TK   P + IV                 E++P 
Sbjct: 67  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 126
Query: 740 --RGSLYRLIHRPAAGEMMDQRRRLR---------------------------------- 763
             +G+ +R          +D +RRL                                   
Sbjct: 127 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 186
Query: 764 ---------MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                     +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+R
Sbjct: 187 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 239

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLR-EVAIMKRV-RHPNVVLFM 722
           +G GS+  V       +D   A+KV+  +   DD+  ++++ E  + ++   HP +V   
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V EY+  G L  + H     ++ ++  R   A +++  +NYLH     I
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--I 142
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++ DLK  N+L+D    +K+ D+G+ +
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/144 (22%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G+G+ G V +  +   G  +AVK +      ++  +  +    ++K    P +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
                 + I  E +  G+    + +   G +  +R   +M + + K + YL   +  ++H
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQGPI-PERILGKMTVAIVKALYYLKEKHG-VIH 148
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS 808
            D+K  N+L+D+   +K+CDFG+S
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGIS 172

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 667 VGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLFM 722
           +G+G+FGTV +  +            +   +  D  LK E L E  +M+++ +P +V  +
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G + +     +V E    G L + + +      +  +  + +   V+ G+ YL   N   
Sbjct: 95  G-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN--F 148
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H DL + N+L+      K+ DFGLS+
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSK 175

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 667 VGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLFM 722
           +G+G+FGTV +  +            +   +  D  LK E L E  +M+++ +P +V  +
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G + +     +V E    G L + + +      +  +  + +   V+ G+ YL   N   
Sbjct: 95  G-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN--F 148
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +H DL + N+L+      K+ DFGLS+
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSK 175

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVL 720
           + +G+G+FGTV +  +            +   +  D  LK E L E  +M+++ +P +V 
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
            +G + +     +V E    G L + + +      +  +  + +   V+ G+ YL   N 
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN- 145
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             +H DL + N+L+      K+ DFGLS+
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSK 173

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	867
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-98
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-83
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-83
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-82
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-82
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-80
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-77
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-77
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-75
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-67
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-65
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-64
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-63
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-63
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-62
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-38
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-34
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-33
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-33
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-04
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  307 bits (789), Expect = 4e-98
 Identities = 129/188 (68%), Positives = 157/188 (83%)

Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD 697
           P    L  + ++  D ++I W +L++KE++GAGSFGTVHRAEWHGSDVAVK+L  QDF  
Sbjct: 16  PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA 75

Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD 757
           +++ EFLREVAIMKR+RHPN+VLFMGAVT+ P+LSIVTEYL RGSLYRL+H+  A E +D
Sbjct: 76  ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135

Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
           +RRRL MA DVAKG+NYLHN NPPI+H +LKSPNLLVDK +TVKVCDFGLSR KA+TF+S
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195

Query: 818 SKSVAGTV 825
           SKS AGT 
Sbjct: 196 SKSAAGTP 203

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  266 bits (681), Expect = 8e-83
 Identities = 46/172 (26%), Positives = 89/172 (51%), Gaps = 8/172 (4%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
            I + +L+   ++     G + +  W G+D+ VKVL V+D+   + ++F  E   ++   
Sbjct: 6   GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65

Query: 715 HPNVVLFMGAVTKRP--HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           HPNV+  +GA    P  H +++T ++P GSLY ++H      ++DQ + ++ ALD+A+G+
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGM 124

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
            +LH L P I    L S ++++D++ T ++    +          S      
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYA 171

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  267 bits (685), Expect = 9e-83
 Identities = 63/181 (34%), Positives = 98/181 (54%), Gaps = 7/181 (3%)

Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ 699
           PR  +       +W +I +++L + E +G G FG V+   WHG +VA++++ ++   +DQ
Sbjct: 15  PRKASQTSIFLQEW-DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ 72

Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
           LK F REV   ++ RH NVVLFMGA    PHL+I+T      +LY ++       ++D  
Sbjct: 73  LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVN 130

Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
           +  ++A ++ KG+ YLH     ILH DLKS N+  D N  V + DFGL           +
Sbjct: 131 KTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187

Query: 820 S 820
            
Sbjct: 188 E 188

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  264 bits (676), Expect = 7e-82
 Identities = 68/176 (38%), Positives = 110/176 (62%), Gaps = 9/176 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 18  DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 75

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  T  P L+IVT++    SLY  +H        + ++ + +A   A+G
Sbjct: 76  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARG 132

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTV 825
           ++YLH  +  I+H DLKS N+ + ++ TVK+ DFGL+  K+    S +   ++G++
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  257 bits (660), Expect = 7e-80
 Identities = 61/183 (33%), Positives = 96/183 (52%), Gaps = 17/183 (9%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD--DQLKEFLREVAIMK 711
           LEI + EL ++E +G G FG V+RA W G +VAVK        D    ++   +E  +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            ++HPN++   G   K P+L +V E+   G L R++     G+ +     +  A+ +A+G
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARG 117

Query: 772 INYLHNLNP-PILHWDLKSPNLLVDK--------NWTVKVCDFGLSRFKANTFISSKSVA 822
           +NYLH+    PI+H DLKS N+L+ +        N  +K+ DFGL+R    T  +  S A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175

Query: 823 GTV 825
           G  
Sbjct: 176 GAY 178

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  253 bits (647), Expect = 2e-77
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 4/170 (2%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
                +L   E +G G FG   +     +   + +  +  F ++  + FL+EV +M+ + 
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HPNV+ F+G + K   L+ +TEY+  G+L  +I            +R+  A D+A G+ Y
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAY 123

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           LH++N  I+H DL S N LV +N  V V DFGL+R   +     + +   
Sbjct: 124 LHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  250 bits (641), Expect = 7e-77
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 19/185 (10%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-----QLKEFL 704
               ++ +E+  ++++G G FG VH+       S VA+K L + D   +     + +EF 
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
           REV IM  + HPN+V   G +   P   +V E++P G LY  +        +    +LR+
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRL 127

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFGLSRFKANTFISSK 819
            LD+A GI Y+ N NPPI+H DL+SPN+ +           KV DFGLS+   ++     
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VS 184

Query: 820 SVAGT 824
            + G 
Sbjct: 185 GLLGN 189

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  246 bits (630), Expect = 4e-75
 Identities = 58/172 (33%), Positives = 90/172 (52%), Gaps = 11/172 (6%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
            I + E+ V+E VG G+FG V +A+W   DVA+K +  +     + K F+ E+  + RV 
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----ERKAFIVELRQLSRVN 59

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HPN+V   GA      + +V EY   GSLY ++H             +   L  ++G+ Y
Sbjct: 60  HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 775 LHNLNP-PILHWDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKSVAGT 824
           LH++ P  ++H DLK PNLL+    TV K+CDFG +        ++K   G+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GS 166

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  226 bits (579), Expect = 2e-67
 Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 25/186 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKR 712
                ++ + +++G G +G V   +W G  VAVKV    +        + RE  I     
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE-----ASWFRETEIYQTVL 87

Query: 713 VRHPNVVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
           +RH N++ F+ A  K       L ++T+Y   GSLY  +        +D +  L++A   
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSS 143

Query: 769 AKGINYLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT----FISS 818
             G+ +LH         P I H DLKS N+LV KN T  + D GL+    +      I  
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 819 KSVAGT 824
            +  GT
Sbjct: 204 NTRVGT 209

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  221 bits (564), Expect = 1e-65
 Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 25/181 (13%)

Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKRVRHPN 717
           ++ + E VG G +G V R  W G +VAVK+ + +D      K + RE  +     +RH N
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHEN 63

Query: 718 VVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           ++ F+ +          L ++T Y   GSLY  +        +D    LR+ L +A G+ 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLA 119

Query: 774 YLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF----ISSKSVAG 823
           +LH         P I H DLKS N+LV KN    + D GL+   + +     + +    G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 824 T 824
           T
Sbjct: 180 T 180

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  214 bits (546), Expect = 6e-63
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 21/203 (10%)

Query: 636 VGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF 695
           +G    + +    L  + L      L + E    G FG V +A+     VAVK+  +QD 
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD- 59

Query: 696 LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH----LSIVTEYLPRGSLYRLIHRPA 751
              Q  +   EV  +  ++H N++ F+GA  +       L ++T +  +GSL   +    
Sbjct: 60  --KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117

Query: 752 AGEMMDQRRRLRMALDVAKGINYLHN--------LNPPILHWDLKSPNLLVDKNWTVKVC 803
               +       +A  +A+G+ YLH           P I H D+KS N+L+  N T  + 
Sbjct: 118 ----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 804 DFGLSRFK--ANTFISSKSVAGT 824
           DFGL+       +   +    GT
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  214 bits (546), Expect = 8e-63
 Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 32/197 (16%)

Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI 709
           A +   +  D L + E +G G +G V++       VAVKV +  +      + F+ E  I
Sbjct: 5   ASEP-SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNI 58

Query: 710 MK--RVRHPNVVLFMGAVTK-----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
            +   + H N+  F+    +     R    +V EY P GSL + +         D     
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 763 RMALDVAKGINYLHN-------LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815
           R+A  V +G+ YLH          P I H DL S N+LV  + T  + DFGLS       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 816 --------ISSKSVAGT 824
                    ++ S  GT
Sbjct: 175 LVRPGEEDNAAISEVGT 191

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  213 bits (543), Expect = 2e-62
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 25/186 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKR 712
                 + ++E +G G FG V R +W G +VAVK+ + ++      + + RE  I     
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVM 92

Query: 713 VRHPNVVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
           +RH N++ F+ A  K       L +V++Y   GSL+  ++R      +     +++AL  
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 148

Query: 769 AKGINYLH------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT----FISS 818
           A G+ +LH         P I H DLKS N+LV KN T  + D GL+    +      I+ 
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 819 KSVAGT 824
               GT
Sbjct: 209 NHRVGT 214

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (373), Expect = 1e-39
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 12/173 (6%)

Query: 664 KERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
              +G GSF TV++        +VA   L  +     + + F  E  ++K ++HPN+V F
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 722 MGA----VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
             +    V  +  + +VTE +  G+L   + R      M  +        + KG+ +LH 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT 147

Query: 778 LNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             PPI+H DLK  N+ +     +VK+ D GL+  K  +F  +K+V GT  F A
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMA 198

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  146 bits (371), Expect = 2e-39
 Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 9/159 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
            W  ++  EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M 
Sbjct: 15  GW-ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMT 69

Query: 712 RVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           ++RH N+V  +G + + +  L IVTEY+ +GSL   + R     ++     L+ +LDV +
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCE 128

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            + YL   N   +H DL + N+LV ++   KV DFGL++
Sbjct: 129 AMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (369), Expect = 7e-39
 Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 16/186 (8%)

Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT 691
           G  PR      +   D   I  + L + + +G G FG+V        D     VAVK + 
Sbjct: 13  GLVPRGSEELQNKLEDV-VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK 71

Query: 692 VQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHLSIVTEYLPRGSL--Y 744
           + +    +++EFL E A MK   HPNV+  +G   +      P   ++  ++  G L  Y
Sbjct: 72  LDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY 131

Query: 745 RLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803
            L  R   G   +  +  L+  +D+A G+ YL N N   LH DL + N ++  + TV V 
Sbjct: 132 LLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVA 189

Query: 804 DFGLSR 809
           DFGLS+
Sbjct: 190 DFGLSK 195

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  144 bits (365), Expect = 4e-38
 Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 17/184 (9%)

Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTV 692
           P Y +       D  E++ +++ +   +G GSFG V+     G         VA+K +  
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN- 64

Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP 750
           +     +  EFL E ++MK     +VV  +G V++     ++ E + RG L  Y    RP
Sbjct: 65  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 124

Query: 751 AAGEM-----MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805
           A             + ++MA ++A G+ YL+      +H DL + N +V +++TVK+ DF
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDF 182

Query: 806 GLSR 809
           G++R
Sbjct: 183 GMTR 186

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 5e-38
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 23/198 (11%)

Query: 631 QGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------ 684
           +GK     G    N +         I   ++ +K  +G G+FG V  AE H         
Sbjct: 13  EGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKM 72

Query: 685 -VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743
            VAVK   +++  +   ++F RE  ++  ++H ++V F G  T+   L +V EY+  G L
Sbjct: 73  LVAVK--ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130

Query: 744 --YRLIHRPAAGEMMDQRRR----------LRMALDVAKGINYLHNLNPPILHWDLKSPN 791
             +   H P A  +                L +A  VA G+ YL  L+   +H DL + N
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRN 188

Query: 792 LLVDKNWTVKVCDFGLSR 809
            LV +   VK+ DFG+SR
Sbjct: 189 CLVGQGLVVKIGDFGMSR 206

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (368), Expect = 5e-38
 Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 8/174 (4%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVLTVQDFLDDQLKEFLREVAI 709
            W  ++ ++L + E++G G+FG V           VAVK    +    D   +FL+E  I
Sbjct: 108 KW-VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           +K+  HPN+V  +G  T++  + IV E +  G     +     G  +  +  L+M  D A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAA 223

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823
            G+ YL +     +H DL + N LV +   +K+ DFG+SR +A+   ++     
Sbjct: 224 AGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  142 bits (361), Expect = 6e-38
 Identities = 53/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
            I   ++ +K  +G G+FG V  AE +          VAVK   ++D      K+F RE 
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREA 68

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR---- 761
            ++  ++H ++V F G       L +V EY+  G L  +   H P A  ++D + R    
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128

Query: 762 -------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                  L +A  +A G+ YL + +   +H DL + N LV  N  VK+ DFG+SR
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 181

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  143 bits (362), Expect = 9e-38
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 16/181 (8%)

Query: 643 LNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLD 697
           ++ E    ++ + I   +  +   +G G FG+V  A+    D     VAVK+L       
Sbjct: 7   ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66

Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PHLSIVTEYLPRGSL--YRLIHR 749
             ++EFLRE A MK   HP+V   +G   +       P   ++  ++  G L  + L  R
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126

Query: 750 PAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
                  +  +  +R  +D+A G+ YL + N   +H DL + N ++ ++ TV V DFGLS
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLS 184

Query: 809 R 809
           R
Sbjct: 185 R 185

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  140 bits (356), Expect = 2e-37
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 11/168 (6%)

Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKE 702
           S+      I+ +++ +   +G G FG V+   +         VAVK    +D   D  ++
Sbjct: 1   SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEK 59

Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
           F+ E  IMK + HP++V  +G + + P   I+ E  P G L   + R      +     +
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLV 116

Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             +L + K + YL ++N   +H D+   N+LV     VK+ DFGLSR+
Sbjct: 117 LYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (358), Expect = 3e-37
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 13/170 (7%)

Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQL 700
           P+ A+    +   E    + +G+G+FGTV++  W          VA+K L  +       
Sbjct: 4   PNQAL-LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKAN 61

Query: 701 KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRR 760
           KE L E  +M  V +P+V   +G       + ++T+ +P G L   +      + +  + 
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQY 118

Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            L   + +AKG+NYL +    ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 119 LLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  141 bits (357), Expect = 5e-37
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 22/183 (12%)

Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD----VAVKVLTVQDFLDDQL 700
             P   +    + W+++  ++ +G G+FG V +A           A+K +  +    D  
Sbjct: 12  NNPDPTIYP-VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDH 69

Query: 701 KEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMD 757
           ++F  E+ ++ ++  HPN++  +GA   R +L +  EY P G+L  +    R    +   
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129

Query: 758 QRRR-----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
                          L  A DVA+G++YL       +H DL + N+LV +N+  K+ DFG
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 187

Query: 807 LSR 809
           LSR
Sbjct: 188 LSR 190

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  140 bits (356), Expect = 5e-37
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)

Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVL 690
               +          D  +     L   +++G G+FG+V    +          VAVK L
Sbjct: 19  NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 78

Query: 691 TVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIH 748
             Q   ++ L++F RE+ I+K ++H N+V + G      R +L ++ EYLP GSL   + 
Sbjct: 79  --QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136

Query: 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           +    E +D  + L+    + KG+ YL       +H DL + N+LV+    VK+ DFGL+
Sbjct: 137 KH--KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192

Query: 809 R 809
           +
Sbjct: 193 K 193

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  139 bits (353), Expect = 6e-37
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 9/176 (5%)

Query: 637 GPGPRYLN-IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQD 694
           GP           L     EI   +L   + +G G FG V   +W G  DVA+K++  + 
Sbjct: 1   GPLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EG 59

Query: 695 FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGE 754
            + +   EF+ E  +M  + H  +V   G  TK+  + I+TEY+  G L   +       
Sbjct: 60  SMSED--EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RH 115

Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
               ++ L M  DV + + YL +     LH DL + N LV+    VKV DFGLSR+
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  144 bits (364), Expect = 7e-37
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 8/166 (4%)

Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFL 704
            +         ++  EL + + +G G FG V   ++ G+ VAVK +      D   + FL
Sbjct: 179 AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFL 234

Query: 705 REVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
            E ++M ++RH N+V  +G + + +  L IVTEY+ +GSL   + R     ++     L+
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLK 293

Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +LDV + + YL   N   +H DL + N+LV ++   KV DFGL++
Sbjct: 294 FSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  139 bits (353), Expect = 7e-37
 Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 23/175 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
           EIS   +   E +G   FG V++    G         VA+K L          +EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 63

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR---- 761
            +  R++HPNVV  +G VTK   LS++  Y   G L  + ++  P +        R    
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 762 -------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                  + +   +A G+ YL + +  ++H DL + N+LV     VK+ D GL R
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 176

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (357), Expect = 1e-36
 Identities = 64/246 (26%), Positives = 95/246 (38%), Gaps = 17/246 (6%)

Query: 574 AAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGK 633
           +   P+  +        A  AA       S     I        S   K     L  QG 
Sbjct: 2   SPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGA 61

Query: 634 FPVGPGPRYLNIEPSLAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VA 686
             V      LN E   A+    +  S   +H  E +G G FG V+      +D      A
Sbjct: 62  NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 121

Query: 687 VKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSL-- 743
           VK L  +     ++ +FL E  IMK   HPNV+  +G   +      +V  Y+  G L  
Sbjct: 122 VKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180

Query: 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803
           +              +  +   L VAKG+ +L +     +H DL + N ++D+ +TVKV 
Sbjct: 181 FIRNETHN----PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVA 234

Query: 804 DFGLSR 809
           DFGL+R
Sbjct: 235 DFGLAR 240

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (351), Expect = 1e-36
 Identities = 55/171 (32%), Positives = 80/171 (46%), Gaps = 12/171 (7%)

Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFL-DDQ 699
            P  ++    I   +L + E++G GSFG V R EW         VAVK L        + 
Sbjct: 6   GPLQSLTC-LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64

Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
           + +F+REV  M  + H N++   G V   P + +VTE  P GSL   + +          
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH--QGHFLLG 121

Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              R A+ VA+G+ YL +     +H DL + NLL+     VK+ DFGL R 
Sbjct: 122 TLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (349), Expect = 1e-36
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 9/159 (5%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           W  I   EL   + +G+G FG VH   W     VA+K +  +  + ++  +F+ E  +M 
Sbjct: 3   W-VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEE--DFIEEAEVMM 58

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           ++ HP +V   G   ++  + +VTE++  G L   +       +      L M LDV +G
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEG 116

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + YL      ++H DL + N LV +N  +KV DFG++RF
Sbjct: 117 MAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF 153

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 2e-36
 Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 9/159 (5%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
             E+  +E+ + + +G+G FG V   +W G  DVAVK++  +  + +   EF +E   M 
Sbjct: 3   M-ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSED--EFFQEAQTMM 58

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           ++ HP +V F G  +K   + IVTEY+  G L   +     G+ ++  + L M  DV +G
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEG 116

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           + +L +     +H DL + N LVD++  VKV DFG++R+
Sbjct: 117 MAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (350), Expect = 2e-36
 Identities = 45/174 (25%), Positives = 86/174 (49%), Gaps = 17/174 (9%)

Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQ 699
           +P+  +D        L     +G G FG V    +          VAVK L   +   + 
Sbjct: 8   KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH 66

Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEM 755
           + +  +E+ I++ + H N+V + G  T+     + ++ E+LP GSL  Y   ++      
Sbjct: 67  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---- 122

Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           ++ +++L+ A+ + KG++YL +     +H DL + N+LV+    VK+ DFGL++
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  137 bits (348), Expect = 2e-36
 Identities = 56/161 (34%), Positives = 88/161 (54%), Gaps = 9/161 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVLTVQDFLDDQLKEFLREVAI 709
            W E+   ++ +K ++G G +G V+   W      VAVK L  +D ++ +  EFL+E A+
Sbjct: 7   KW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE--EFLKEAAV 62

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R    + +     L MA  ++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 121

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             + YL   N   +H DL + N LV +N  VKV DFGLSR 
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (349), Expect = 3e-36
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 18/166 (10%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
           +     L   +++G G+FG+V    +          VAVK L  Q   ++ L++F RE+ 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63

Query: 709 IMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
           I+K ++H N+V + G      R +L ++ EYLP GSL  Y   H+      +D  + L+ 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQY 119

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              + KG+ YL       +H DL + N+LV+    VK+ DFGL++ 
Sbjct: 120 TSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 163

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  139 bits (352), Expect = 3e-36
 Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 35/203 (17%)

Query: 638 PGPRYLNIEPSL---AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAV 687
           P P Y  +   L    +   E   + +     +G G+FG V +A   G         VAV
Sbjct: 24  PNPMYQRMPLLLNPKLLSL-EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAV 82

Query: 688 KVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YR 745
           K+L  ++   D   +F RE A+M    +PN+V  +G       + ++ EY+  G L  + 
Sbjct: 83  KMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141

Query: 746 LIHRPAAGEMMDQRRR-------------------LRMALDVAKGINYLHNLNPPILHWD 786
               P     +                        L +A  VA G+ YL       +H D
Sbjct: 142 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD 199

Query: 787 LKSPNLLVDKNWTVKVCDFGLSR 809
           L + N LV +N  VK+ DFGLSR
Sbjct: 200 LATRNCLVGENMVVKIADFGLSR 222

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  138 bits (349), Expect = 5e-36
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)

Query: 639 GPRYLNIEPS--LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKV 689
           GP  L+++    L     E     L + + +G G FG V +A             VAVK+
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60

Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLI 747
           L  ++    +L++ L E  ++K+V HP+V+   GA ++   L ++ EY   GSL  +   
Sbjct: 61  LK-ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119

Query: 748 HRPAAGEMMDQRRR-------------------LRMALDVAKGINYLHNLNPPILHWDLK 788
            R      +                        +  A  +++G+ YL  +   ++H DL 
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLA 177

Query: 789 SPNLLVDKNWTVKVCDFGLSR 809
           + N+LV +   +K+ DFGLSR
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (345), Expect = 6e-36
 Identities = 54/160 (33%), Positives = 87/160 (54%), Gaps = 9/160 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIM 710
           +W E+  + L + ER+GAG FG V    ++G   VAVK L  Q  +      FL E  +M
Sbjct: 7   EW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPD--AFLAEANLM 62

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K+++H  +V     VT+ P   I+TEY+  GSL   + +  +G  +   + L MA  +A+
Sbjct: 63  KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAE 120

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           G+ ++   N   +H DL++ N+LV    + K+ DFGL+R 
Sbjct: 121 GMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  137 bits (347), Expect = 9e-36
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 18/186 (9%)

Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVL 690
           P   +     S++    E+    + +   +G G+FG V+  +  G         VAVK L
Sbjct: 10  PNYCFAGKTSSISDLK-EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68

Query: 691 TVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIH 748
             +   +    +FL E  I+ +  H N+V  +G   +     I+ E +  G L  +    
Sbjct: 69  P-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127

Query: 749 RPAAGEM--MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVC 803
           RP   +   +     L +A D+A G  YL   +   +H D+ + N L+         K+ 
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG 185

Query: 804 DFGLSR 809
           DFG++R
Sbjct: 186 DFGMAR 191

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (343), Expect = 1e-35
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 16/166 (9%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLRE 706
           D+ EI  + + +   +G G FG VH+  +   +     VA+K        D   ++FL+E
Sbjct: 9   DY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQE 66

Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
              M++  HP++V  +G +T+ P   I+ E    G L  +  + + +    +D    +  
Sbjct: 67  ALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS----LDLASLILY 121

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           A  ++  + YL +     +H D+ + N+LV  N  VK+ DFGLSR+
Sbjct: 122 AYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (345), Expect = 2e-35
 Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 19/174 (10%)

Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQ 699
                 D        L     +G G FG V    +  ++      VAVK L   D     
Sbjct: 18  LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH 76

Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEM 755
              + +E+ I++ + H +++ + G         L +V EY+P GSL  Y   H     ++
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL 136

Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +        A  + +G+ YLH  +   +H DL + N+L+D +  VK+ DFGL++
Sbjct: 137 LL------FAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (343), Expect = 2e-35
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 15/165 (9%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREV 707
            +  S   +H  E +G G FG V+      +D      AVK L  +     ++ +FL E 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77

Query: 708 AIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
            IMK   HPNV+  +G   +      +V  Y+  G L  +              +  +  
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 133

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            L VAKG+ YL +     +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 134 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  136 bits (344), Expect = 2e-35
 Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 18/165 (10%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
                 L    ++G G+FG+V    +          VAVK L  Q    DQ ++F RE+ 
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQ 76

Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
           I+K +    +V + G      R  L +V EYLP G L  +   HR      +D  R L  
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLY 132

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +  + KG+ YL +     +H DL + N+LV+    VK+ DFGL++
Sbjct: 133 SSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  135 bits (342), Expect = 3e-35
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 28/197 (14%)

Query: 637 GPGPRYLN-IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVK 688
           G    Y++  +      W E   + L   + +GAG+FG V  A  +G         VAVK
Sbjct: 1   GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YR 745
           +L        + +  + E+ ++  +  H N+V  +GA T      ++TEY   G L  + 
Sbjct: 60  MLK-PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 746 LIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
              R +                 +D    L  +  VAKG+ +L + N   +H DL + N+
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176

Query: 793 LVDKNWTVKVCDFGLSR 809
           L+      K+CDFGL+R
Sbjct: 177 LLTHGRITKICDFGLAR 193

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  136 bits (345), Expect = 3e-35
 Identities = 44/224 (19%), Positives = 85/224 (37%), Gaps = 18/224 (8%)

Query: 600 IVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWD 659
            + +  ++  +    +     + +              P   +     S++    E+   
Sbjct: 13  DIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK-EVPRK 71

Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREVAIMKR 712
            + +   +G G+FG V+  +  G         VAVK L  +   +    +FL E  I+ +
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISK 130

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGE--MMDQRRRLRMALDV 768
             H N+V  +G   +     I+ E +  G L  +    RP   +   +     L +A D+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSR 809
           A G  YL   +   +H D+ + N L+         K+ DFG++R
Sbjct: 191 ACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  134 bits (340), Expect = 4e-35
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 11/163 (6%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREV 707
            +       H    +G G FG V+  E+          A+K L+ +     Q++ FLRE 
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREG 73

Query: 708 AIMKRVRHPNVVLFMGAVTKR-PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
            +M+ + HPNV+  +G +        ++  Y+  G L + I  P        +  +   L
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGL 131

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            VA+G+ YL       +H DL + N ++D+++TVKV DFGL+R
Sbjct: 132 QVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLAR 172

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (342), Expect = 4e-35
 Identities = 55/183 (30%), Positives = 82/183 (44%), Gaps = 11/183 (6%)

Query: 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAV 687
           +F   P           +    EI    +H+++ +G+G  G V              VA+
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTR-EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82

Query: 688 KVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           K L    + + Q ++FL E +IM +  HPN++   G VT+     IVTEY+  GSL   +
Sbjct: 83  KALK-AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141

Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
                       + + M   V  G+ YL +L    +H DL + N+LVD N   KV DFGL
Sbjct: 142 RTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGL 197

Query: 808 SRF 810
           SR 
Sbjct: 198 SRV 200

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (342), Expect = 4e-35
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 16/164 (9%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
                EL   + +G+G FGTVH+  W          V +KV+          +     + 
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHML 67

Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMAL 766
            +  + H ++V  +G       L +VT+YLP GSL  +   HR A    +  +  L   +
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGV 122

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            +AKG+ YL      ++H +L + N+L+     V+V DFG++  
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADL 164

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 5e-35
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 13/171 (7%)

Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQ 699
            P+ A+    +   E    + +G+G+FGTV++  W          VA+K L  +      
Sbjct: 3   APNQAL-LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKA 60

Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
            KE L E  +M  V +P+V   +G       + ++T+ +P G L   +      + +  +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQ 117

Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             L   + +AKG+NYL +    ++H DL + N+LV     VK+ DFGL++ 
Sbjct: 118 YLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  136 bits (345), Expect = 5e-35
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)

Query: 622 KEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWH 681
             D      +  +  G        E      W E+  D L + + +G G+FG V  AE  
Sbjct: 33  HHDYDIPTTENLYFQGMLAGVSEYELPEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAI 91

Query: 682 G---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731
           G         + VAVK+L   D  +  L + + E+ +MK + +H N++  +GA T+   L
Sbjct: 92  GLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150

Query: 732 SIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR-----------LRMALDVAKGINYLHNL 778
            ++ EY  +G+L  Y    RP   E                  +  A  VA+G+ YL + 
Sbjct: 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +H DL + N+LV ++  +K+ DFGL+R
Sbjct: 211 K--CIHRDLAARNVLVTEDNVMKIADFGLAR 239

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  134 bits (339), Expect = 5e-35
 Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 12/164 (7%)

Query: 652 DWLEISWDELHVKERV-GAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLRE 706
           +   +    L ++++  G+G+FGTV +  +        VAVK+L  +        E L E
Sbjct: 10  EV-YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68

Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             +M+++ +P +V  +G       + +V E    G L + + +      +  +  + +  
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVH 124

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            V+ G+ YL   N   +H DL + N+L+      K+ DFGLS+ 
Sbjct: 125 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 166

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  138 bits (350), Expect = 8e-35
 Identities = 57/180 (31%), Positives = 92/180 (51%), Gaps = 8/180 (4%)

Query: 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVL 690
            +P     +      S   D  E+   ++ +K ++G G +G V+   W      VAVK L
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253

Query: 691 TVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP 750
             +D ++ +  EFL+E A+MK ++HPN+V  +G  T+ P   I+TE++  G+L   + R 
Sbjct: 254 K-EDTMEVE--EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RE 309

Query: 751 AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              + +     L MA  ++  + YL   N   +H +L + N LV +N  VKV DFGLSR 
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  133 bits (338), Expect = 1e-34
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 29/200 (14%)

Query: 632 GKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------- 684
            + P+      L  + S    W E   D L + + +G G+FG V  A+  G D       
Sbjct: 4   DELPLDEHCERLPYDAS---KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT 59

Query: 685 VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR-PHLSIVTEYLPRGS 742
           VAVK+L  +     + +  + E+ I+  +  H NVV  +GA TK    L ++ E+   G+
Sbjct: 60  VAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118

Query: 743 L-------------YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
           L             Y++       + +     +  +  VAKG+ +L +     +H DL +
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176

Query: 790 PNLLVDKNWTVKVCDFGLSR 809
            N+L+ +   VK+CDFGL+R
Sbjct: 177 RNILLSEKNVVKICDFGLAR 196

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  134 bits (340), Expect = 1e-34
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKE 702
            W E   D+L + + +G G+FG V  AE  G D         VAVK+L   D  +  L +
Sbjct: 29  KW-EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSD 86

Query: 703 FLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQR 759
            + E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP   E     
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 760 RR-----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            R           +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204

Query: 809 R 809
           R
Sbjct: 205 R 205

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (335), Expect = 1e-34
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 12/164 (7%)

Query: 652 DWLEISWDELH-VKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLRE 706
               +  D L      +G G+FG+V +  +       DVA+KVL  Q       +E +RE
Sbjct: 3   KL-FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMRE 60

Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
             IM ++ +P +V  +G       + +V E    G L++ +      E +       +  
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLH 117

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            V+ G+ YL   N   +H DL + N+L+      K+ DFGLS+ 
Sbjct: 118 QVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 159

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  133 bits (338), Expect = 2e-34
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)

Query: 622 KEDESKLEKQGKFPVGPGPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRA 678
              ES+L +  +        Y  ++       + W E   + L   + +G+G+FG V  A
Sbjct: 7   FRYESQL-QMVQVTGSSDNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMNA 64

Query: 679 EWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH 730
             +G         VAVK+L  +     + +  + E+ +M ++  H N+V  +GA T    
Sbjct: 65  TAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123

Query: 731 LSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR------------------LRMALDVAK 770
           + ++ EY   G L  Y    R    E   +                     L  A  VAK
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           G+ +L   +   +H DL + N+LV     VK+CDFGL+R
Sbjct: 184 GMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLAR 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (337), Expect = 2e-34
 Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 19/188 (10%)

Query: 637 GPGPRYLNIEPSLAMD----WLEISW----DELHVKERVGAGSFGTVHRAEWHGS----- 683
            P    L  + ++  D     L+ +       +  ++ +GAG FG V++     S     
Sbjct: 14  IPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE 73

Query: 684 -DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS 742
             VA+K L    + + Q  +FL E  IM +  H N++   G ++K   + I+TEY+  G+
Sbjct: 74  VPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 132

Query: 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV 802
           L + +            + + M   +A G+ YL N+N   +H DL + N+LV+ N   KV
Sbjct: 133 LDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKV 188

Query: 803 CDFGLSRF 810
            DFGLSR 
Sbjct: 189 SDFGLSRV 196

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  134 bits (339), Expect = 3e-34
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 27/181 (14%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKE 702
            W E   D+L + + +G G FG V  AE  G D         VAVK+L   D  +  L +
Sbjct: 75  KW-EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSD 132

Query: 703 FLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQR 759
            + E+ +MK + +H N++  +GA T+   L ++ EY  +G+L  Y    RP   E     
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 760 RR-----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            R           +     +A+G+ YL +     +H DL + N+LV +N  +K+ DFGL+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 250

Query: 809 R 809
           R
Sbjct: 251 R 251

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (335), Expect = 4e-34
 Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 26/193 (13%)

Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVK 688
           G  Y  I+P+       W E   + L   + +GAG+FG V  A   G         VAVK
Sbjct: 24  GNSYTFIDPTQLPYNEKW-EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YR 745
           +L       D+ +  + E+ IM  + +H N+V  +GA T    + ++TEY   G L  + 
Sbjct: 83  MLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141

Query: 746 LIHRP---------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796
                          A      R  L  +  VA+G+ +L + N   +H D+ + N+L+  
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN 199

Query: 797 NWTVKVCDFGLSR 809
               K+ DFGL+R
Sbjct: 200 GHVAKIGDFGLAR 212

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (342), Expect = 5e-34
 Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 8/174 (4%)

Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFL 696
             P        LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L     +
Sbjct: 163 VCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM 221

Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMM 756
             +   FL+E  +MK++RH  +V     V++ P   IVTEY+ +GSL   + +   G+ +
Sbjct: 222 SPE--AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFL-KGETGKYL 277

Query: 757 DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              + + MA  +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R 
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 329

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (336), Expect = 6e-34
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 623 EDESKLEKQGKFPVGPGPRYLNIEPSLAMD----WLEISW----DELHVKERVGAGSFGT 674
            DE +L         PG R   ++P    D      E +       + + + VGAG FG 
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTF-VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGE 60

Query: 675 VHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729
           V              VA+K L V  + + Q ++FL E +IM +  HPN++   G VTK  
Sbjct: 61  VCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119

Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
            + IVTEY+  GSL   + +          + + M   +A G+ YL ++    +H DL +
Sbjct: 120 PVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAA 175

Query: 790 PNLLVDKNWTVKVCDFGLSRF 810
            N+L++ N   KV DFGL R 
Sbjct: 176 RNILINSNLVCKVSDFGLGRV 196

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  131 bits (331), Expect = 1e-33
 Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 15/193 (7%)

Query: 646 EPSLAMDWLEI-SWDELHV-------KERVGAGSFGTVHRAE-WHGSDVAVKVLTVQDFL 696
           +P + +  L+  S  EL V       K  +G G FG V++     G+ VAVK L  +   
Sbjct: 9   DPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68

Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM- 755
             +  +F  EV ++    H N++   G         +V  Y+  GS+   +      +  
Sbjct: 69  GGE-LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127

Query: 756 MDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KA 812
           +D  +R R+AL  A+G+ YLH+  +P I+H D+K+ N+L+D+ +   V DFGL++     
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 813 NTFISSKSVAGTV 825
           +T +++  V GT+
Sbjct: 188 DTHVTTA-VRGTI 199

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  130 bits (329), Expect = 2e-33
 Identities = 51/164 (31%), Positives = 88/164 (53%), Gaps = 8/164 (4%)

Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNVVLFMG 723
           ++G G FG V++   + + VAVK L     +  +   ++F +E+ +M + +H N+V  +G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             +    L +V  Y+P GSL   +        +    R ++A   A GIN+LH      +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHI 155

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGT 824
           H D+KS N+L+D+ +T K+ DFGL+R     A T ++S+ + GT
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGT 198

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  134 bits (339), Expect = 3e-33
 Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 8/174 (4%)

Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFL 696
             P        LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L     +
Sbjct: 246 VCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM 304

Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMM 756
             +   FL+E  +MK++RH  +V     V++ P   IVTEY+ +GSL   + +   G+ +
Sbjct: 305 SPE--AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFL-KGETGKYL 360

Query: 757 DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              + + MA  +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R 
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 412

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (336), Expect = 3e-33
 Identities = 48/160 (30%), Positives = 85/160 (53%), Gaps = 8/160 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIM 710
           D  EI  + L +++++GAG FG V  A ++    VAVK +     +  +   FL E  +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVE--AFLAEANVM 237

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K ++H  +V     VTK P + I+TE++ +GSL   + +   G      + +  +  +A+
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAE 295

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           G+ ++   N   +H DL++ N+LV  +   K+ DFGL+R 
Sbjct: 296 GMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARV 333

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  129 bits (327), Expect = 4e-33
 Identities = 51/164 (31%), Positives = 90/164 (54%), Gaps = 12/164 (7%)

Query: 667 VGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G FG V++     G+ VA+K  T +     Q ++EF  E+  +   RHP++V  +G 
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGF 103

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             +R  + ++ +Y+  G+L R ++        M   +RL + +  A+G++YLH     I+
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAII 161

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGT 824
           H D+KS N+L+D+N+  K+ DFG+S+       T +S+  V GT
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGT 204

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (325), Expect = 5e-33
 Identities = 43/167 (25%), Positives = 88/167 (52%), Gaps = 6/167 (3%)

Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNV 718
            +++++G G F  V+RA     G  VA+K + + D +D + +    +E+ ++K++ HPNV
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           + +  +  +   L+IV E    G L R+I H      ++ +R   +  + +   + ++H+
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
               ++H D+K  N+ +     VK+ D GL RF ++   ++ S+ GT
Sbjct: 155 RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  129 bits (325), Expect = 1e-32
 Identities = 43/165 (26%), Positives = 85/165 (51%), Gaps = 5/165 (3%)

Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
              +++G GSFG     +    G    +K + +      + +E  REVA++  ++HPN+V
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            +  +  +   L IV +Y   G L++ I+    G +  + + L   + +   + ++H+  
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
             ILH D+KS N+ + K+ TV++ DFG++R   +T   +++  GT
Sbjct: 146 --ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGT 188

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (322), Expect = 1e-32
 Identities = 35/189 (18%), Positives = 67/189 (35%), Gaps = 13/189 (6%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           + I        +++G G F  V   E     G   A+K +   +      +E  RE  + 
Sbjct: 24  VIIDNKHYLFIQKLGEGGFSYVDLVE-GLHDGHFYALKRILCHE--QQDREEAQREADMH 80

Query: 711 KRVRHPNVVLFMGAVTKRP----HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
           +   HPN++  +    +         ++  +  RG+L+  I      G  + + + L + 
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
           L + +G+  +H       H DLK  N+L+       + D G           S+      
Sbjct: 141 LGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198

Query: 826 VFFAAHQTA 834
            + A   T 
Sbjct: 199 DWAAQRCTI 207

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (317), Expect = 4e-32
 Identities = 32/173 (18%), Positives = 72/173 (41%), Gaps = 23/173 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           +I  ++L   E +G G+F  + +                V +KVL       +  + F  
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFE 61

Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
             ++M ++ H ++VL  G         +V E++  GSL   + +      ++   +L +A
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVA 119

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDK--------NWTVKVCDFGLSRF 810
             +A  +++L      ++H ++ + N+L+ +           +K+ D G+S  
Sbjct: 120 KQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  126 bits (319), Expect = 5e-32
 Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 12/180 (6%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           +E+    L V+  +  G F  V+ A+    G + A+K L   +  +++ +  ++EV  MK
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMK 80

Query: 712 RVR-HPNVVLFMGAVTKRPHLS-------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
           ++  HPN+V F  A +     S       ++   L +G L   + +  +   +     L+
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823
           +     + + ++H   PPI+H DLK  NLL+    T+K+CDFG +   ++    S S   
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  131 bits (331), Expect = 7e-32
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 21/213 (9%)

Query: 610 KQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEP------SLAMDWLEISWDELHV 663
           +   A         +E +  +     V     Y  I          +    EI  + + +
Sbjct: 335 EGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL 394

Query: 664 KERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
              +G G FG VH+  +   +     VA+K        D   ++FL+E   M++  HP++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHI 453

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           V  +G +T+ P   I+ E    G L  +  + + +    +D    +  A  ++  + YL 
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE 508

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +     +H D+ + N+LV  N  VK+ DFGLSR
Sbjct: 509 SKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (312), Expect = 2e-31
 Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 8/171 (4%)

Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
            V   +G GS+G   +      G  +  K L      + + +  + EV +++ ++HPN+V
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68

Query: 720 LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
            +   +  R    L IV EY   G L  +I       + +D+   LR+   +   +   H
Sbjct: 69  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

Query: 777 NLNPP---ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
             +     +LH DLK  N+ +D    VK+ DFGL+R   +    +K+  GT
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (325), Expect = 3e-31
 Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 10/163 (6%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREV 707
                  + L     +G G+FG+V +  +       DVA+KVL  Q       +E +RE 
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREA 387

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
            IM ++ +P +V  +G       + +V E    G L++ +      E +       +   
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQ 444

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           V+ G+ YL   N   +H +L + N+L+      K+ DFGLS+ 
Sbjct: 445 VSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (296), Expect = 3e-29
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 18/174 (10%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
            + + +G G+   V R   H   G   A+KV          +   +RE  ++K++ H N+
Sbjct: 12  LLSDILGQGATANVFRGR-HKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 719 V-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           V LF      T R H  ++ E+ P GSLY ++  P+    + +   L +  DV  G+N+L
Sbjct: 70  VKLFAIEEETTTR-HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 776 HNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
                 I+H ++K  N++     D     K+ DFG +R  + +      S+ GT
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGT 178

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (292), Expect = 1e-28
 Identities = 50/234 (21%), Positives = 83/234 (35%), Gaps = 23/234 (9%)

Query: 618 SQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTV-- 675
            QL     S   +  +    PG      E      +  +         R+G GS+G V  
Sbjct: 24  HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL--------SRLGHGSYGEVFK 75

Query: 676 --HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732
              + +  G   AVK               L EV   ++V +HP  V    A  +   L 
Sbjct: 76  VRSKED--GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133

Query: 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
           + TE     SL +       G  + + +      D    + +LH+    ++H D+K  N+
Sbjct: 134 LQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANI 188

Query: 793 LVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA--AHQTACNSLALIFSL 844
            +      K+ DFGL   +  T  + +   G   + A    Q +  + A +FSL
Sbjct: 189 FLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSL 241

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  114 bits (288), Expect = 3e-28
 Identities = 42/163 (25%), Positives = 85/163 (52%), Gaps = 9/163 (5%)

Query: 667 VGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           +G G++G V+   +      +A+K +  +D      +    E+A+ K ++H N+V ++G+
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDVAKGINYLHNLNPPIL 783
            ++   + I  E +P GSL  L+ R   G + D  + +      + +G+ YLH+    I+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IV 144

Query: 784 HWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
           H D+K  N+L++  +  +K+ DFG S+  A     +++  GT+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (291), Expect = 6e-28
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 18/174 (10%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
            + + +G G+   V R   H   G   A+KV          +   +RE  ++K++ H N+
Sbjct: 12  LLSDILGQGATANVFRGR-HKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 719 V-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           V LF      T R H  ++ E+ P GSLY ++  P+    + +   L +  DV  G+N+L
Sbjct: 70  VKLFAIEEETTTR-HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 776 HNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
                 I+H ++K  N++     D     K+ DFG +R  + +      S+ GT
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGT 178

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (284), Expect = 1e-27
 Identities = 40/192 (20%), Positives = 82/192 (42%), Gaps = 20/192 (10%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
            +    + +G G FG V  A+ +  D    A+K + + +  +   ++ +REV  + ++ H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAK-NKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEH 62

Query: 716 PNVVLFMGA------------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
           P +V +  A             + + +L I  +   + +L   ++     E  ++   L 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823
           + L +A+ + +LH+    ++H DLK  N+    +  VKV DFGL           ++V  
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE-EEQTVLT 179

Query: 824 TVVFFAAHQTAC 835
            +  +A H    
Sbjct: 180 PMPAYARHTGQV 191

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  113 bits (284), Expect = 1e-27
 Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 25/190 (13%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
               +G G+FG V +A  +       A+K +      +++L   L EV ++  + H  VV
Sbjct: 10  EIAVLGQGAFGQVVKAR-NALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 720 LFMGA-------------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
            +  A             V K+  L I  EY   G+LY LIH         +    R+  
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFR 123

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
            + + ++Y+H+    I+H DLK  N+ +D++  VK+ DFGL++    +    K  +  + 
Sbjct: 124 QILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 827 FFAAH-QTAC 835
             + +  +A 
Sbjct: 182 GSSDNLTSAI 191

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  112 bits (282), Expect = 1e-27
 Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 30/182 (16%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
              E +G+G FG V +A+ H   G    +K +   +      ++  REV  + ++ H N+
Sbjct: 14  KEIELIGSGGFGQVFKAK-HRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNI 66

Query: 719 VLFMGA----------------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
           V + G                  +K   L I  E+  +G+L + I +   GE +D+   L
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLAL 125

Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
            +   + KG++Y+H+    +++ DLK  N+ +     VK+ DFGL     N    ++S  
Sbjct: 126 ELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182

Query: 823 GT 824
           GT
Sbjct: 183 GT 184

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (286), Expect = 1e-27
 Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 655 EISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+  D+      +GAG+ G V +   +  G  +A K++ + +       + +RE+ ++  
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHE 87

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
              P +V F GA      +SI  E++  GSL +++ +      + ++   ++++ V KG+
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 144

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG----LSRFKANTFI 816
            YL      I+H D+K  N+LV+    +K+CDFG    L    AN+F+
Sbjct: 145 TYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (282), Expect = 4e-27
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 20/170 (11%)

Query: 664 KERVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           + RVG GSFG VHR  +   G   AVK + ++ F  +       E+     +  P +V  
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPL 115

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
            GAV + P ++I  E L  GSL +LI +      + + R L       +G+ YLH     
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR-- 170

Query: 782 ILHWDLKSPNLLVDKN-WTVKVCDFGLSR-----FKANTFISSKSVAGTV 825
           ILH D+K+ N+L+  +     +CDFG +          + ++   + GT 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (277), Expect = 8e-27
 Identities = 45/211 (21%), Positives = 77/211 (36%), Gaps = 35/211 (16%)

Query: 662 HVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPN 717
           H  E++G+G FG+V +      D    A+K            +  LREV     + +H +
Sbjct: 14  HELEKIGSGEFGSVFKCV-KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           VV +  A  +  H+ I  EY   GSL   I           +     + L V +G+ Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 777 NLNPPILHWDLKSPNLLVDKN-------------------WTVKVCDFGLSRFKANTFIS 817
           +++  ++H D+K  N+ + +                       K+ D G     ++    
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--- 187

Query: 818 SKSVAGTVVFFA----AHQTACNSLALIFSL 844
            +   G   F A             A IF+L
Sbjct: 188 -QVEEGDSRFLANEVLQENYTHLPKADIFAL 217

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  109 bits (275), Expect = 2e-26
 Identities = 44/160 (27%), Positives = 88/160 (55%), Gaps = 15/160 (9%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G GSFG V +         VA+K++ +++  +D++++  +E+ ++ +   P V  + 
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYY 86

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G+  K   L I+ EYL  GS   L+        +D+ +   +  ++ KG++YLH+     
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--K 140

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           +H D+K+ N+L+ ++  VK+ DFG++      + K NTF+
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (271), Expect = 6e-26
 Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 23/177 (12%)

Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D+  ++E +G+G+   V  A        VA+K + + +     + E L+E+  M +  HP
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-EKCQTSMDELLKEIQAMSQCHHP 73

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR------MALDVAK 770
           N+V +  +   +  L +V + L  GS+  +I +    +   +   L       +  +V +
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-----------KANTFI 816
           G+ YLH      +H D+K+ N+L+ ++ +V++ DFG+S F              TF+
Sbjct: 133 GLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  106 bits (268), Expect = 1e-25
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 18/180 (10%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAI-M 710
           +E+  D+L     +G G++G V +      G  +AVK +        + K  L ++ I M
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISM 60

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RM 764
           + V  P  V F GA+ +   + I  E +   SL +   +     ++D+ + +      ++
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ-----VIDKGQTIPEDILGKI 114

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           A+ + K + +LH+    ++H D+K  N+L++    VK+CDFG+S +  +  ++    AG 
Sbjct: 115 AVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGC 172

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (273), Expect = 1e-25
 Identities = 33/219 (15%), Positives = 83/219 (37%), Gaps = 24/219 (10%)

Query: 617 PSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVH 676
            S + +   +K E+Q       G    +   S A + + +      + +++G+G    V 
Sbjct: 14  GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF 73

Query: 677 RAE-WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRPHLSI 733
           +         A+K + +++  +  L  +  E+A + +++  +  ++          ++ +
Sbjct: 74  QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133

Query: 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL------DVAKGINYLHNLNPPILHWDL 787
           V E      L   +          +++ +          ++ + ++ +H     I+H DL
Sbjct: 134 VMEC-GNIDLNSWLK---------KKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDL 181

Query: 788 KSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGT 824
           K  N L+     +K+ DFG++       T +   S  G 
Sbjct: 182 KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (268), Expect = 1e-25
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 26/166 (15%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
             +G G+FG V++A+    G+  A KV+  +   +++L++++ E+ I+    HP +V  +
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLL 82

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR------MALDVAKGINYLH 776
           GA      L I+ E+ P G++  +        M++  R L       +   + + +N+LH
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAI--------MLELDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           +    I+H DLK+ N+L+     +++ DFG+S        K ++FI
Sbjct: 135 SKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (266), Expect = 2e-25
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 16/148 (10%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           G G FG V+ A         +A+KVL      +  ++ QL+   REV I   +RHPN++ 
Sbjct: 18  GKGKFGNVYLAR-EKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 73

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
             G       + ++ EY P G++YR + +    +  +QR       ++A  ++Y H+   
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTA-TYITELANALSYCHSKR- 129

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            ++H D+K  NLL+     +K+ DFG S
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWS 156

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (268), Expect = 3e-25
 Identities = 29/168 (17%), Positives = 70/168 (41%), Gaps = 12/168 (7%)

Query: 662 HVKERVGAGSFGTVHRAE-WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--V 718
            + +++G+G    V +         A+K + +++  +  L  +  E+A + +++  +  +
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +          ++ +V E      L   + +    + +D   R     ++ + ++ +H  
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGT 824
              I+H DLK  N L+     +K+ DFG++       T +   S  GT
Sbjct: 128 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 3e-25
 Identities = 29/168 (17%), Positives = 70/168 (41%), Gaps = 12/168 (7%)

Query: 662 HVKERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--V 718
            + +++G+G    V +         A+K + +++  +  L  +  E+A + +++  +  +
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           +          ++ +V E      L   + +    + +D   R     ++ + ++ +H  
Sbjct: 91  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGT 824
              I+H DLK  N L+     +K+ DFG++       T +   S  GT
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (266), Expect = 4e-25
 Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 16/160 (10%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G GS+G+V++A     G  VA+K +     ++  L+E ++E++IM++   P+VV + 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
           G+  K   L IV EY   GS+  +I      + + +     +     KG+ YLH +    
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMR--K 146

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           +H D+K+ N+L++     K+ DFG++        K NT I
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 4e-25
 Identities = 41/160 (25%), Positives = 84/160 (52%), Gaps = 16/160 (10%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
           E++G G+ GTV+ A     G +VA++ + +Q     + +  + E+ +M+  ++PN+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 83

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH+    +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--V 137

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           +H D+KS N+L+  + +VK+ DFG        + K +T +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (262), Expect = 7e-25
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 15/148 (10%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           G GSF  V+RAE     G +VA+K++      +  +  +++    EV I  +++HP+++ 
Sbjct: 20  GKGSFAGVYRAE-SIHTGLEVAIKMIDKKAMYKAGMVQRVQ---NEVKIHCQLKHPSILE 75

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                    ++ +V E    G + R +         +   R  M   +  G+ YLH+   
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMH-QIITGMLYLHSHG- 132

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            ILH DL   NLL+ +N  +K+ DFGL+
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (262), Expect = 9e-25
 Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 10/145 (6%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           G G F                A K++     L    +E    E++I + + H +VV F G
Sbjct: 24  GKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  + +V E   R SL  L  R     + +   R      +  G  YLH     ++
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEAR-YYLRQIVLGCQYLHRNR--VI 137

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS 808
           H DLK  NL ++++  VK+ DFGL+
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLA 162

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  109 bits (273), Expect = 9e-25
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 16/161 (9%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
            +KER+G G FG V R   H   G  VA+K    Q+      + +  E+ IMK++ HPNV
Sbjct: 17  EMKERLGTGGFGYVLRWI-HQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 719 V-LF-----MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           V        +  +       +  EY   G L + +++      + +     +  D++  +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSRF 810
            YLH     I+H DLK  N+++         K+ D G ++ 
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (260), Expect = 1e-24
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 16/148 (10%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           G G FG V+ A         +A+KVL      ++ ++ QL+   RE+ I   +RHPN++ 
Sbjct: 23  GKGKFGNVYLAR-EKQNKFIMALKVLFKSQLEKEGVEHQLR---REIEIQSHLRHPNILR 78

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
                  R  + ++ E+ PRG LY+ + +   G   +QR       ++A  ++Y H    
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSA-TFMEELADALHYCHERK- 134

Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            ++H D+K  NLL+     +K+ DFG S
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWS 161

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  105 bits (263), Expect = 1e-24
 Identities = 35/169 (20%), Positives = 66/169 (39%), Gaps = 27/169 (15%)

Query: 668 GAGSFGTVHRAEWHGSDVAVKVL---------------TVQDFLDDQLKEFLREVAIMKR 712
             G F  +   E      A+K                   +  +  +  +F  E+ I+  
Sbjct: 40  NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK-- 770
           +++   +   G +T    + I+ EY+   S+ +         ++D+     + + V K  
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY---FFVLDKNYTCFIPIQVIKCI 156

Query: 771 ------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813
                   +Y+HN    I H D+K  N+L+DKN  VK+ DFG S +  +
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (261), Expect = 2e-24
 Identities = 45/202 (22%), Positives = 93/202 (46%), Gaps = 21/202 (10%)

Query: 628 LEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRA--EWHGSDV 685
           +E  GK  + P   +            + + ++L     +G G++G+V++   +  G  +
Sbjct: 3   IESSGKLKISPEQHW------------DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIM 50

Query: 686 AVKVLTVQDFLDDQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY 744
           AVK +      + + K+ L ++ + M+    P +V F GA+ +     I  E +   S  
Sbjct: 51  AVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFD 108

Query: 745 RLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV 802
           +          +++ +    ++ L   K +N+L   N  I+H D+K  N+L+D++  +K+
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKL 167

Query: 803 CDFGLSRFKANTFISSKSVAGT 824
           CDFG+S    ++ I+    AG 
Sbjct: 168 CDFGISGQLVDS-IAKTRDAGC 188

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  102 bits (257), Expect = 3e-24
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 25/174 (14%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +   +G GSFG V + +      + AVKV+      +      LREV ++K++ HPN++ 
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
               +       IV E    G L+  +I R       A  ++ Q         V  GI Y
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ---------VFSGITY 136

Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
           +H  N  I+H DLK  N+L+   +K+  +K+ DFGLS  F+ NT +  K   GT
Sbjct: 137 MHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGT 186

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (259), Expect = 3e-24
 Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 16/160 (10%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
            ++G GS G V  A     G  VAVK++ ++     + +    EV IM+  +H NVV   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L ++ E+L  G+L  ++ +      +++ +   +   V + + YLH     +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG--V 162

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           +H D+KS ++L+  +  VK+ DFG          K  + +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 3e-24
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           VKE +G G+F  V R   H   G + A K++  +       ++  RE  I ++++HPN+V
Sbjct: 10  VKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGIN 773
               ++ +     +V + +  G L+  ++ R       A   + Q         + + I 
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---------ILESIA 119

Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
           Y H+    I+H +LK  NLL+    K   VK+ DFGL+     +        AGT
Sbjct: 120 YCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 170

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  102 bits (257), Expect = 3e-24
 Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 29/166 (17%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKV-------LTVQDFLDDQLKEFLREVAIMK 711
             KE +G G    V R   H     + AVK+           + + +  +  L+EV I++
Sbjct: 20  EPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRM 764
           +V  HPN++             +V + + +G L+  L  +         ++M        
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA------ 132

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
              + + I  LH LN  I+H DLK  N+L+D +  +K+ DFG S  
Sbjct: 133 ---LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (255), Expect = 4e-24
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 30/154 (19%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFM 722
           G G++G V  A  +      VAVK++ ++  +D  + +K   +E+ I K + H NVV F 
Sbjct: 16  GEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKFY 71

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
           G   +     +  EY   G L+  I              + M    A+        G+ Y
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-----------EPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           LH +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 121 LHGIG--ITHRDIKPENLLLDERDNLKISDFGLA 152

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  102 bits (257), Expect = 6e-24
 Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 11/145 (7%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LFMG 723
           G G+F  V  A  H   G +VA+K++         L++  REV IMK + HPN+V LF  
Sbjct: 24  GKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
             T++  L ++ EY   G ++  +   A G M ++  R      +   + Y H     I+
Sbjct: 83  IETEK-TLYLIMEYASGGEVFDYLV--AHGRMKEKEAR-SKFRQIVSAVQYCHQKR--IV 136

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS 808
           H DLK+ NLL+D +  +K+ DFG S
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFS 161

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (257), Expect = 7e-24
 Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 10/145 (6%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
           G G F                A K++     L    +E    E++I + + H +VV F G
Sbjct: 50  GKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  + +V E   R SL  L  R     + +   R      +  G  YLH     ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEAR-YYLRQIVLGCQYLHRNR--VI 163

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS 808
           H DLK  NL ++++  VK+ DFGL+
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLA 188

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 8e-24
 Identities = 30/163 (18%), Positives = 66/163 (40%), Gaps = 5/163 (3%)

Query: 668 GAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
           G     TV+ A     G  V V+ + ++   ++ +     E+ + K   HPN+V +    
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
                L +VT ++  GS   LI      + M++     +   V K ++Y+H++    +H 
Sbjct: 96  IADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHR 152

Query: 786 DLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFF 828
            +K+ ++L+  +  V +     +    +     + V     + 
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (258), Expect = 8e-24
 Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 28/164 (17%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL------TVQDFLDDQLKEFLREVAIMKRV 713
            K+ +G G    V R   H   G + AVK++         + L++  +   RE  I+++V
Sbjct: 98  PKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 714 R-HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMAL 766
             HP+++  + +      + +V + + +G L+  L  +          +M          
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS-------- 208

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            + + +++LH  N  I+H DLK  N+L+D N  +++ DFG S  
Sbjct: 209 -LLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCH 249

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (256), Expect = 1e-23
 Identities = 41/157 (26%), Positives = 81/157 (51%), Gaps = 10/157 (6%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLF 721
             +G GSFG V+ A    +   VA+K ++      +++ ++ ++EV  ++++RHPN + +
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
            G   +     +V EY   GS   L+      + + +     +     +G+ YLH+ N  
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLS--RFKANTFI 816
           ++H D+K+ N+L+ +   VK+ DFG +     AN+F+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 1e-23
 Identities = 36/173 (20%), Positives = 74/173 (42%), Gaps = 17/173 (9%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAI-M 710
            +   ++L     +G+G+ G V +      G  +AVK +       ++ K  L ++ + +
Sbjct: 20  YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVL 78

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS--LYRLIHRPAAGEMMDQRRRLRMALDV 768
           K    P +V   G       + I  E +   +  L + +  P     + +R   +M + +
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-----IPERILGKMTVAI 133

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-----RFKANTFI 816
            K + YL   +  ++H D+K  N+L+D+   +K+CDFG+S         +   
Sbjct: 134 VKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  103 bits (258), Expect = 2e-23
 Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 20/176 (11%)

Query: 664 KERVGAGSFGTVHRAE-WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
           K+ +G G+ GT+     +   DVAVK +     L +      REV +++    HPNV+ +
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPNVIRY 83

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
                 R    I  E     +L   + +     +  +   L        G+ +LH+LN  
Sbjct: 84  FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITL--LQQTTSGLAHLHSLN-- 138

Query: 782 ILHWDLKSPNLLV-----DKNWTVKVCDFGLSRF---KANTFISSKSVAGTVVFFA 829
           I+H DLK  N+L+            + DFGL +      ++F     V GT  + A
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (259), Expect = 2e-23
 Identities = 38/173 (21%), Positives = 75/173 (43%), Gaps = 22/173 (12%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           + E +G G+F  V R      G + A  ++  +       ++  RE  I + ++HPN+V 
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
              ++++  H  ++ + +  G L+  ++ R       A   + Q         + + + +
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ---------ILEAVLH 125

Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
            H +   ++H +LK  NLL+    K   VK+ DFGL+        +    AGT
Sbjct: 126 CHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (252), Expect = 2e-23
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 26/173 (15%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
             E +G+G+F  V   +    G   A+K +       D       E+A++K+++H N+V 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLKKIKHENIVT 70

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
                    H  +V + +  G L+ R++ R       A  ++ Q         V   + Y
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---------VLSAVKY 121

Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           LH     I+H DLK  NLL    ++N  + + DFGLS+ + N  +   +  GT
Sbjct: 122 LHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGT 170

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  101 bits (254), Expect = 2e-23
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 30/156 (19%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
           G+G+FG              VAVK +     +D+ ++   RE+   + +RHPN+V F   
Sbjct: 29  GSGNFGVARLMR-DKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84

Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINYLH 776
           +    HL+I+ EY   G LY  I               R + D A+        G++Y H
Sbjct: 85  ILTPTHLAIIMEYASGGELYERI-----------CNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRF 810
           ++   I H DLK  N L+D +    +K+CDFG S+ 
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (251), Expect = 2e-23
 Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 30/157 (19%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVV-LF 721
           G GS+G V             AVK+L  +        E    +E+ +++R+RH NV+ L 
Sbjct: 14  GEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 722 --MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------G 771
             +    K+  + +V EY   G            EM+D     R  +  A         G
Sbjct: 73  DVLYNEEKQ-KMYMVMEYCVCGM----------QEMLDSVPEKRFPVCQAHGYFCQLIDG 121

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           + YLH+    I+H D+K  NLL+    T+K+   G++
Sbjct: 122 LEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVA 156

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (252), Expect = 3e-23
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 30/154 (19%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFM 722
           G G++G V  A  +      VAVK++ ++  +D  + +K   +E+ I K + H NVV F 
Sbjct: 16  GEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKFY 71

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
           G   +     +  EY   G L+  I              + M    A+        G+ Y
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-----------EPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
           LH +   I H D+K  NLL+D+   +K+ DFGL+
Sbjct: 121 LHGIG--ITHRDIKPENLLLDERDNLKISDFGLA 152

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (250), Expect = 4e-23
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 25/169 (14%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
           E VG G++G V++      G   A+KV+   D   D+ +E  +E+ ++K+   H N+  +
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 722 MGAVTKRP------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR--LRMALDVAKGIN 773
            GA  K+        L +V E+   GS+  LI       + ++      R  L   +G++
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGLS 143

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFI 816
           +LH     ++H D+K  N+L+ +N  VK+ DFG+S        + NTFI
Sbjct: 144 HLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  100 bits (252), Expect = 5e-23
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 22/159 (13%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           VKE +G G+F  V R      G + A K++  +       ++  RE  I ++++HPN+V 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
              ++ +     +V + +  G L+  ++ R       A   + Q         + + I Y
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---------ILESIAY 143

Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF 810
            H+    I+H +LK  NLL+    K   VK+ DFGL+  
Sbjct: 144 CHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 40/179 (22%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL------------------------TVQDF 695
           +K+ +G GS+G V  A  +    +  A+KVL                             
Sbjct: 17  LKDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75

Query: 696 LDDQLKEFLREVAIMKRVRHPNVV-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA 752
               +++  +E+AI+K++ HPNVV L   +    +  HL +V E + +G +  +      
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPL 134

Query: 753 GEMMDQ-RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
            E  DQ R   +   D+ KGI YLH     I+H D+K  NLLV ++  +K+ DFG+S  
Sbjct: 135 SE--DQARFYFQ---DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 12/170 (7%)

Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
             K ++G+G+FG VH  E    G +  +K +  +D     +++   E+ ++K + HPN++
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
                     ++ IV E    G L  R++   A G+ + +     +   +   + Y H+ 
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 779 NPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
           +  ++H DLK  N+L      +  +K+ DFGL+  FK++      + AGT
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGT 189

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (251), Expect = 2e-22
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 35/224 (15%)

Query: 619 QLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRA 678
                    L  QG     PG    + +  L+        +     +++G+G++G V   
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLS--------EMYQRVKKLGSGAYGEVLLC 56

Query: 679 EWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735
                   + A+K++           + L EVA++K + HPN++        + +  +V 
Sbjct: 57  R-DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115

Query: 736 EYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
           E    G L+  +IHR       A  ++ Q         V  G+ YLH  N  I+H DLK 
Sbjct: 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQ---------VLSGVTYLHKHN--IVHRDLKP 164

Query: 790 PNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTVVFFA 829
            NLL+   +K+  +K+ DFGLS  F+    +  K   GT  + A
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIA 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 27/175 (15%)

Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
            ++  +G GS+G V  A         A K +  + F++D    F +E+ IMK + HPN++
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDV-DRFKQEIEIMKSLDHPNII 69

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGIN 773
                      + +V E    G L+ R++H+       A  +M           V   + 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD---------VLSAVA 120

Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
           Y H LN  + H DLK  N L      +  +K+ DFGL+  FK    +  ++  GT
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGT 171

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (251), Expect = 3e-22
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 27/184 (14%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +  ++   +G GSFG V + +       + AVKV+      +      LREV ++K++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
           PN++     +       IV E    G L+  +I R       A  ++ Q         V 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ---------VF 131

Query: 770 KGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTV 825
            GI Y+H  N  I+H DLK  N+L+   +K+  +K+ DFGLS  F+ NT +  K   GT 
Sbjct: 132 SGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187

Query: 826 VFFA 829
            + A
Sbjct: 188 YYIA 191

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 29/165 (17%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
           + E +G+G F  V +       G + A K +              +E  REV I++ +RH
Sbjct: 9   MGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
           PN++        +  + ++ E +  G L+  L  +       A + + Q         + 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ---------IL 118

Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF 810
            G++YLH+    I H+DLK  N+++      N  +K+ DFG++  
Sbjct: 119 DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 28/154 (18%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVV-LFM 722
           G G+FG V   E H   G  VAVK+L  Q      +   + RE+  +K  RHP+++ L+ 
Sbjct: 20  GVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
              T      +V EY+  G L+  I            +  R+    A+         ++Y
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYI-----------CKHGRVEEMEARRLFQQILSAVDY 126

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            H     ++H DLK  N+L+D +   K+ DFGLS
Sbjct: 127 CHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS 158

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.2 bits (245), Expect = 4e-22
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 14/157 (8%)

Query: 660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
            +   E +G G FG VH+ E     G  +A K++  +  + D+ +E   E+++M ++ H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRG-MKDK-EEVKNEISVMNQLDHA 146

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           N++    A   +  + +V EY+  G L+ R+I        + +   +     + +GI ++
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHM 203

Query: 776 HNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRF 810
           H +   ILH DLK  N+L        +K+ DFGL+R 
Sbjct: 204 HQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.6 bits (246), Expect = 5e-22
 Identities = 34/167 (20%), Positives = 65/167 (38%), Gaps = 31/167 (18%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVL------TVQDFLDDQLKEFLREVAIMKR 712
            + + +G+G+ G V  A         VA++++             D       E+ I+K+
Sbjct: 138 IMSKTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMAL 766
           + HP ++             IV E +  G L+ +++               Q        
Sbjct: 197 LNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-------- 247

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF 810
            +   + YLH     I+H DLK  N+L+   +++  +K+ DFG S+ 
Sbjct: 248 -MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 35/166 (21%), Positives = 65/166 (39%), Gaps = 31/166 (18%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL------TVQDFLDDQLKEFLREVAIMKRV 713
           + + +G+G+ G V  A         VA+K++             D       E+ I+K++
Sbjct: 14  MSKTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALD 767
            HP ++             IV E +  G L+ +++               Q         
Sbjct: 73  NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------- 122

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF 810
           +   + YLH     I+H DLK  N+L+   +++  +K+ DFG S+ 
Sbjct: 123 MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 29/165 (17%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
           + E +G+G F  V +       G + A K +    +         +E  REV+I+++V H
Sbjct: 16  IGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
            NV+        R  + ++ E +  G L+  L  +       A   + Q         + 
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ---------IL 125

Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF 810
            G+NYLH     I H+DLK  N+++         +K+ DFGL+  
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 50/157 (31%), Positives = 71/157 (45%), Gaps = 31/157 (19%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVV-LFM 722
           G GSFG V  A  H      VA+K ++ Q      +   + RE++ +K +RHP+++ L+ 
Sbjct: 18  GEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ-RRRLRMALDVAK--------GIN 773
              T    + +V EY             A GE+ D    + RM  D  +         I 
Sbjct: 77  VITTPT-DIVMVIEY-------------AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           Y H     I+H DLK  NLL+D N  VK+ DFGLS  
Sbjct: 123 YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNI 157

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 96.2 bits (240), Expect = 2e-21
 Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 17/174 (9%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKV-----LTVQDFLDDQLKEFLREVAIMKRVR 714
           + E +G G F  V R   +   G   AVK+      T    L  +  +  RE +I   ++
Sbjct: 28  LCEVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTE--DLKREASICHMLK 84

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           HP++V  +   +    L +V E++    L   ++ R  AG +  +         + + + 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           Y H+ N  I+H D+K   +L+   + +  VK+  FG++     + + +    GT
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 28/185 (15%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVR 714
           D    +  +G GSFG V   +     G + AVKV++ +        +  LREV ++K++ 
Sbjct: 26  DRYKGQRVLGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDV 768
           HPN++        + +  +V E    G L+  +I R       A  ++ Q         V
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ---------V 135

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
             GI Y+H     I+H DLK  NLL+    K+  +++ DFGLS  F+A+  +  K   GT
Sbjct: 136 LSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGT 191

Query: 825 VVFFA 829
             + A
Sbjct: 192 AYYIA 196

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.1 bits (242), Expect = 2e-21
 Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 37/164 (22%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVK-VLTVQDFLDDQLKEF-LREVAIMKRVRHPNVV- 719
           + +G GSFG V++A+    G  VA+K VL  QD      K F  RE+ IM+++ H N+V 
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVL--QD------KRFKNRELQIMRKLDHCNIVR 111

Query: 720 ---LFMGAVTKR--PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK---- 770
               F  +  K+   +L++V +Y+P  ++YR+    +       R +  + +   K    
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS-------RAKQTLPVIYVKLYMY 163

Query: 771 ----GINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSR 809
                + Y+H+    I H D+K  NLL+D +   +K+CDFG ++
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 96.6 bits (241), Expect = 2e-21
 Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 20/155 (12%)

Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV---- 719
           + +G GSFG V +A      +VA+K    +   D + K   RE+ IM+ V+HPNVV    
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFK--NRELQIMRIVKHPNVVDLKA 99

Query: 720 LFMGAVTKR--PHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRR-RLRMALDVAKGINYL 775
            F     K+    L++V EY+P  ++YR   H     + M     +L M   + + + Y+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM-YQLLRSLAYI 157

Query: 776 HNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSR 809
           H++   I H D+K  NLL+D     +K+ DFG ++
Sbjct: 158 HSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 29/165 (17%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
             E +G+G F  V +       G   A K +    T         ++  REV+I+K ++H
Sbjct: 15  TGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
           PNV+        +  + ++ E +  G L+  L  +       A E + Q         + 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ---------IL 124

Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF 810
            G+ YLH+L   I H+DLK  N+++         +K+ DFGL+  
Sbjct: 125 NGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 16/154 (10%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
           + +G G F TV++A        VA+K + +      + K+      LRE+ +++ + HPN
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGH--RSEAKDGINRTALREIKLLQELSHPN 73

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLH 776
           ++  + A   + ++S+V +++    L  +I   +        +  + M L   +G+ YLH
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLH 129

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
                ILH DLK  NLL+D+N  +K+ DFGL++ 
Sbjct: 130 QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 95.4 bits (237), Expect = 3e-21
 Identities = 43/236 (18%), Positives = 80/236 (33%), Gaps = 40/236 (16%)

Query: 604 ESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYL-------NIEPSLAMDWLEI 656
            S   +  PN  + +  D +   KL      PV   P           I+P       ++
Sbjct: 6   SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTE---FQL 62

Query: 657 SWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEF---LRE 706
               ++V   +G G+F  V+ A     +         +KV            EF    + 
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-----PANPWEFYIGTQL 117

Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRM 764
           +  +K       + F  A   +    +V E    G+L   I  ++    ++M Q   +  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLV-----------DKNWTVKVCDFGLSR 809
           A+ +   I  +H+    I+H D+K  N ++           D +  + + D G S 
Sbjct: 178 AMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.6 bits (238), Expect = 3e-21
 Identities = 38/155 (24%), Positives = 70/155 (45%), Gaps = 14/155 (9%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
            + E +G+G+FG VHR       G     K +     LD        E++IM ++ HP +
Sbjct: 54  DILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKL 110

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +    A   +  + ++ E+L  G L+ R+         M +   +       +G+ ++H 
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE 167

Query: 778 LNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRF 810
            +  I+H D+K  N++    K  +VK+ DFGL+  
Sbjct: 168 HS--IVHLDIKPENIMCETKKASSVKIIDFGLATK 200

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 29/165 (17%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
           + E +G+G F  V +       G + A K +    +         +E  REV+I+++V H
Sbjct: 16  IGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
           PN++        R  + ++ E +  G L+  L  +       A   + Q         + 
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ---------IL 125

Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF 810
            G+NYLH     I H+DLK  N+++         +K+ DFGL+  
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 31/179 (17%)

Query: 660 ELHVKERV-GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR- 714
           +L +K++  G GSF    +   H       AVK+++             +E+  +K    
Sbjct: 11  DLDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIIS-----KRMEANTQKEITALKLCEG 64

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDV 768
           HPN+V        + H  +V E L  G L+ R+  +       A  +M +         +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK---------L 115

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
              ++++H++   ++H DLK  NLL    + N  +K+ DFG +R K       K+   T
Sbjct: 116 VSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 93.3 bits (233), Expect = 5e-21
 Identities = 45/152 (29%), Positives = 81/152 (53%), Gaps = 18/152 (11%)

Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPNV 718
           E++G G++G V++A   +G   A+K + +     ++  E      +RE++I+K ++H N+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNI 62

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHN 777
           V     +  +  L +V E+L +  L +L+     G E +  +  L   L    GI Y H+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               +LH DLK  NLL+++   +K+ DFGL+R
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLAR 148

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.8 bits (234), Expect = 6e-21
 Identities = 33/161 (20%), Positives = 68/161 (42%), Gaps = 27/161 (16%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
            + E +G G FG VHR             K + V+      +K   +E++I+   RH N+
Sbjct: 8   MIAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNI 63

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR------PAAGEMMDQRRRLRMALDVAKG 771
           +    +      L ++ E++    ++ R+               + Q         V + 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ---------VCEA 114

Query: 772 INYLHNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRF 810
           + +LH+ N  I H+D++  N++    ++ T+K+ +FG +R 
Sbjct: 115 LQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.9 bits (239), Expect = 8e-21
 Identities = 46/195 (23%), Positives = 87/195 (44%), Gaps = 38/195 (19%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVL-----------TVQDFLDDQLKEFL 704
           +      ++G+G++G V   +      S+ A+KV+                ++   +E  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCK-EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQ 758
            E++++K + HPN++        + +  +VTE+   G L+ ++I+R       A  +M Q
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANT 814
                    +  GI YLH  N  I+H D+K  N+L+   +    +K+ DFGLS  F  + 
Sbjct: 155 ---------ILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 815 FISSKSVAGTVVFFA 829
            +  +   GT  + A
Sbjct: 204 KL--RDRLGTAYYIA 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.5 bits (233), Expect = 9e-21
 Identities = 39/177 (22%), Positives = 70/177 (39%), Gaps = 30/177 (16%)

Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVV 719
            + +G G F  V +       G + A K L  +    D   E L E+A+++  +  P V+
Sbjct: 34  SKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMALDVAKG 771
                      + ++ EY   G ++   +              ++ Q         + +G
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ---------ILEG 143

Query: 772 INYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
           + YLH  N  I+H DLK  N+L+        +K+ DFG+SR       +  + + GT
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGT 196

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 44/154 (28%), Positives = 81/154 (52%), Gaps = 18/154 (11%)

Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPNV 718
           E+VG G++G V++A +  G  VA+K + +     D   E      +RE++++K + HPN+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRL-----DAEDEGIPSTAIREISLLKELHHPNI 81

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHN 777
           V  +  +     L++V E++ +  L +++     G +    +  L   L   +G+ + H 
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
               ILH DLK  NLL++ +  +K+ DFGL+R  
Sbjct: 138 HR--ILHRDLKPQNLLINSDGALKLADFGLARAF 169

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 27/160 (16%)

Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVV 719
           ++ +G G+   V     +     + AVK++  Q           REV ++ + + H NV+
Sbjct: 18  EDVLGEGAHARVQTCI-NLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQGHRNVL 74

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGIN 773
             +    +     +V E +  GS+   +  R       A  ++           VA  ++
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD---------VASALD 125

Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF 810
           +LHN    I H DLK  N+L    ++   VK+CDF L   
Sbjct: 126 FLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 29/178 (16%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   V+  +G G+   V+R +  G+    A+KVL               E+ ++ R+ HP
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHP 108

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAK 770
           N++           +S+V E +  G L+ R++ +       A + + Q         + +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ---------ILE 159

Query: 771 GINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF-KANTFISSKSVAGT 824
            + YLH     I+H DLK  NLL      +  +K+ DFGLS+  +    +  K+V GT
Sbjct: 160 AVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGT 213

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 20/154 (12%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
           E++G G++G V++A     G  VA+K + +     D   E      +RE++++K + HPN
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRL-----DTETEGVPSTAIREISLLKELNHPN 63

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR--LRMALDVAKGINYL 775
           +V  +  +     L +V E+L +  L + +   A   +     +  L   L   +G+ + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL---QGLAFC 119

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           H+    +LH DLK  NLL++    +K+ DFGL+R
Sbjct: 120 HSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 19/153 (12%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF-----LREVAIMKRVRHPN 717
            ++G GS+G V +      G  VA+K      FL+ +         LRE+ ++K+++HPN
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           +V  +    ++  L +V EY    ++   +            +      L   + +N+ H
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCH 119

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             N   +H D+K  N+L+ K+  +K+CDFG +R
Sbjct: 120 KHN--CIHRDVKPENILITKHSVIKLCDFGFAR 150

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.8 bits (229), Expect = 2e-20
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 19/155 (12%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
           E++G G++GTV +A+       VA+K + +     D   E      LRE+ ++K ++H N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKELKHKN 62

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR-LRMALDVAKGINYLH 776
           +V     +     L++V E+  +  L +           +  +  L   L   KG+ + H
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCH 118

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
           + N  +LH DLK  NLL+++N  +K+ +FGL+R  
Sbjct: 119 SRN--VLHRDLKPQNLLINRNGELKLANFGLARAF 151

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 32/161 (19%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT------VQDFLDDQLKEFLREVAIMKRVRHPNV 718
           G+G+FG V  A        +V VK +            D +L +   E+AI+ RV H N+
Sbjct: 33  GSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ-RRRLRMALDVAK------- 770
           +  +     +    +V E    G            ++     R  R+   +A        
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-----------LDLFAFIDRHPRLDEPLASYIFRQLV 140

Query: 771 -GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             + YL   +  I+H D+K  N+++ +++T+K+ DFG + +
Sbjct: 141 SAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.1 bits (234), Expect = 2e-20
 Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 31/184 (16%)

Query: 664 KERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
           ++ +G GS GTV     + G  VAVK +     L D     L E+ ++     HPNV+ +
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDHPNVIRY 74

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----GINYLHN 777
             + T    L I  E     +L  L+      +   + ++    + + +    G+ +LH+
Sbjct: 75  YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 778 LNPPILHWDLKSPNLLVD-------------KNWTVKVCDFGLSRF----KANTFISSKS 820
           L   I+H DLK  N+LV              +N  + + DFGL +     +++   +  +
Sbjct: 134 LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 821 VAGT 824
            +GT
Sbjct: 192 PSGT 195

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 94.5 bits (235), Expect = 2e-20
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 28/154 (18%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVV-LFM 722
           G G+FG V   + H   G  VAVK+L  Q      +   + RE+  +K  RHP+++ L+ 
Sbjct: 25  GVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
              T    + +V EY+  G L+  I            +  R+    ++        G++Y
Sbjct: 84  VISTPS-DIFMVMEYVSGGELFDYI-----------CKNGRLDEKESRRLFQQILSGVDY 131

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
            H     ++H DLK  N+L+D +   K+ DFGLS
Sbjct: 132 CHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS 163

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 19/153 (12%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF-----LREVAIMKRVRHPN 717
             VG GS+G V +      G  VA+K      FL+    +      +RE+ ++K++RH N
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           +V  +    K+    +V E++   ++   +   P   +    ++ L   +    GI + H
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCH 141

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           + N  I+H D+K  N+LV ++  VK+CDFG +R
Sbjct: 142 SHN--IIHRDIKPENILVSQSGVVKLCDFGFAR 172

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.1 bits (234), Expect = 4e-20
 Identities = 53/250 (21%), Positives = 96/250 (38%), Gaps = 34/250 (13%)

Query: 578 PIQEYS-RLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPV 636
             ++Y  R++ EN   ++   E    +   +I              E    +  +G    
Sbjct: 74  AGKQYEFRIIAENKHGQSKPCEP---TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSS 130

Query: 637 GPGPRYLNIEPSLAMDWLEISWDELH----VKERVGAGSFGTVHRAEWH---GSDVAVKV 689
                  +I        +EI  D +     + E +G G+FG VHR       G++ A K 
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT-ERATGNNFAAKF 189

Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIH 748
           +      D +     +E+  M  +RHP +V    A      + ++ E++  G L+ ++  
Sbjct: 190 VMTPHESDKE--TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 247

Query: 749 R------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV--DKNWTV 800
                    A E M Q         V KG+ ++H  N   +H DLK  N++    ++  +
Sbjct: 248 EHNKMSEDEAVEYMRQ---------VCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL 296

Query: 801 KVCDFGLSRF 810
           K+ DFGL+  
Sbjct: 297 KLIDFGLTAH 306

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 39/166 (23%), Positives = 72/166 (43%), Gaps = 32/166 (19%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKR-VR 714
           D   VKE +G GS+    R   H     + AVK++      D   ++   E+ I+ R  +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCI-HKATNMEFAVKII------DKSKRDPTEEIEILLRYGQ 74

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDV 768
           HPN++          ++ +VTE +  G L  +++ +       A  ++           +
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT---------I 125

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF 810
            K + YLH     ++H DLK  N+L         ++++CDFG ++ 
Sbjct: 126 TKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 11/168 (6%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNV 718
           + +++G G   TV+ AE       VA+K +      + +  LK F REV    ++ H N+
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V  +    +     +V EY+   +L   I        +     +     +  GI + H++
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM 130

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTV 825
              I+H D+K  N+L+D N T+K+ DFG+++     +   +  V GTV
Sbjct: 131 R--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.4 bits (225), Expect = 9e-20
 Identities = 42/155 (27%), Positives = 80/155 (51%), Gaps = 20/155 (12%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
           +++G G++ TV++ +     + VA+K + ++       +E      +REV+++K ++H N
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH------EEGAPCTAIREVSLLKDLKHAN 61

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLH 776
           +V     +     L++V EYL +  L + +        M + +  L   L   +G+ Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCH 117

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
                +LH DLK  NLL+++   +K+ DFGL+R K
Sbjct: 118 RQK--VLHRDLKPQNLLINERGELKLADFGLARAK 150

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.8 bits (226), Expect = 1e-19
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 35/168 (20%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMK---RVRHPN 717
           V+   G G+FGTV   +    G  VA+K +      D + +   RE+ IM+    + HPN
Sbjct: 27  VERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFR--NRELQIMQDLAVLHHPN 80

Query: 718 VV----LFMGAVTKRPH---LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           +V     F     +      L++V EY+P  +L+R             RR++     + K
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-------RRQVAPPPILIK 132

Query: 771 --------GINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSR 809
                    I  LH  +  + H D+K  N+LV++ + T+K+CDFG ++
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 51/220 (23%), Positives = 82/220 (37%), Gaps = 44/220 (20%)

Query: 610 KQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGA 669
             P    P+      +       +FP       L I+ +  +D  +++   L      G 
Sbjct: 19  PPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVL------GL 72

Query: 670 GSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA- 724
           G  G V +   +       A+K+L           +  REV +  R  + P++V  +   
Sbjct: 73  GINGKVLQIF-NKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVY 124

Query: 725 ---VTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMALDVAKGIN 773
                 R  L IV E L  G L+ R+  R         A E+M           + + I 
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS---------IGEAIQ 175

Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF 810
           YLH++N  I H D+K  NLL      N  +K+ DFG ++ 
Sbjct: 176 YLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 40/180 (22%)

Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
           K+ +G G  G V     H   G   A+K+L           +  +EV    +    P++V
Sbjct: 34  KQVLGLGVNGKVLECF-HRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIV 85

Query: 720 LFMGA----VTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMALD 767
             +         +  L I+ E +  G L+ R+  R         A E+M           
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD--------- 136

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           +   I +LH+ N  I H D+K  NLL    +K+  +K+ DFG ++      +  ++   T
Sbjct: 137 IGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYT 192

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 34/177 (19%), Positives = 67/177 (37%), Gaps = 19/177 (10%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPN 717
            ++  VG G  G V+ AE       VA+K+++ +    D        RE     R++ P+
Sbjct: 37  RLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 718 VVLFMGAV----TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           VV     +         L +    +    L  ++ R      +   R + +   +   ++
Sbjct: 96  VV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALD 148

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI-SSKSVAGTVVFFA 829
             H       H D+K  N+LV  +    + DFG++    +  +    +  GT+ + A
Sbjct: 149 AAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 44/220 (20%), Positives = 79/220 (35%), Gaps = 52/220 (23%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLT---VQDFLDDQLKEFLREVAIMKR 712
            + H+K  +G GS+G V  A       +  A+K++    ++      ++    EV +MK+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMAL----- 766
           + HPN+           ++ +V E    G L  +L               ++  +     
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 767 -------------------------------DVAKGINYLHNLNPPILHWDLKSPNLLV- 794
                                           +   ++YLHN    I H D+K  N L  
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS 202

Query: 795 -DKNWTVKVCDFGLSRF----KANTFISSKSVAGTVVFFA 829
            +K++ +K+ DFGLS+         +    + AGT  F A
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.4 bits (220), Expect = 6e-19
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 27/162 (16%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKE-F----LREVAIMKRVRHPN 717
            ++G G+FG V +A     G  VA+K + +     +  KE F    LRE+ I++ ++H N
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGFPITALREIKILQLLKHEN 77

Query: 718 VVLFMGAVTKRPH--------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL-RMALDV 768
           VV  +     +          + +V ++     L  L+        + + +R+ +M L  
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL-- 134

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
             G+ Y+H     ILH D+K+ N+L+ ++  +K+ DFGL+R 
Sbjct: 135 -NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA 173

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 8e-19
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 23/159 (14%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
            ++G G++G V++A        VA+K + +     +  +E      +REV+++K ++H N
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLKELQHRN 94

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           ++     +     L ++ EY     L + + +     M   +  L   +    G+N+ H+
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFCHS 150

Query: 778 LNPPILHWDLKSPNLLVDKNWT-----VKVCDFGLSRFK 811
                LH DLK  NLL+  +       +K+ DFGL+R  
Sbjct: 151 RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 52/178 (29%), Positives = 77/178 (43%), Gaps = 25/178 (14%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNV 718
           + E +G G    VH A       DVAVKVL   D   D      F RE      + HP +
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 719 VLFMGAV--------TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           V    AV           P   IV EY+   +L  ++H       M  +R + +  D  +
Sbjct: 75  V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS---SKSVAGTV 825
            +N+ H     I+H D+K  N+++     VKV DFG++R  A++  S   + +V GT 
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 25/160 (15%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
           E++G G++ TV++      G  VA+K + +        +E      +RE+++MK ++H N
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREISLMKELKHEN 64

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM------MDQRRRLRMALDVAKG 771
           +V     +     L++V E++    L + +     G           +      L   +G
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QG 120

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
           + + H     ILH DLK  NLL++K   +K+ DFGL+R  
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 38/164 (23%)

Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNV 718
             + +G G  G V +   +       A+K+L           +  REV +  R  + P++
Sbjct: 22  TSQVLGLGINGKVLQIF-NKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73

Query: 719 VLFMGA----VTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMAL 766
           V  +         R  L IV E L  G L+ R+  R         A E+M          
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS-------- 125

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGL 807
            + + I YLH++N  I H D+K  NLL      N  +K+ DFG 
Sbjct: 126 -IGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 86.6 bits (214), Expect = 4e-18
 Identities = 23/182 (12%), Positives = 56/182 (30%), Gaps = 35/182 (19%)

Query: 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR----- 712
           L     +G         A     G    V V    +    + +K+   EV  ++      
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 713 -----------------VRHPNVVLFMGAVTKRPHLSIVTEYL----PRGSLYRLI---- 747
                            V+ P     +        + +++ +      + +L        
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
              +  + +    RL++ L V + +  LH+    ++H  L+  ++++D+   V +  F  
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 808 SR 809
             
Sbjct: 258 LV 259

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 86.3 bits (213), Expect = 4e-18
 Identities = 20/181 (11%), Positives = 41/181 (22%), Gaps = 34/181 (18%)

Query: 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPN 717
           L + E +  G    V          D A+KV T+       +L+          R+   +
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 718 VV---------------------LFMGAVTKRPHLSIVTEYL----PRGSLYRLIHR--- 749
                                   F      +   ++    L        L  L      
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 750 -PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
                          +   + +    L +    ++H      NL +  +  + + D    
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 809 R 809
            
Sbjct: 242 W 242

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 87.6 bits (217), Expect = 6e-18
 Identities = 39/176 (22%), Positives = 70/176 (39%), Gaps = 23/176 (13%)

Query: 663 VKERVGAGSFGTVHRAE---WHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNV 718
           VK  +  G  G ++ A     +G  V +K L      D + +   + E   +  V HP++
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSI 141

Query: 719 VL-----FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
           V              P   IV EY+   SL R   +      +     +   L++   ++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALS 196

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           YLH++   +++ DLK  N+++ +   +K+ D G          S   + GT  F A
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQA 245

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 23/147 (15%), Positives = 43/147 (29%), Gaps = 10/147 (6%)

Query: 663 VKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVV 719
           +    G        +A        VA+  +  Q  L D + +  L     + R+  P V 
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
             +  V  R    +V E++  GSL  +               +R    +A   +  H   
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG 149

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFG 806
             +         + V  +  V +    
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPA 174

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 32/164 (19%), Positives = 57/164 (34%), Gaps = 35/164 (21%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVR----HP 716
           G G FGTV            VA+KV+     +             EVA++ +V     HP
Sbjct: 40  GKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ-RRRLRMALDVAK----- 770
            V+  +     +    +V E                 ++ D    +  +    ++     
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA-----------QDLFDYITEKGPLGEGPSRCFFGQ 147

Query: 771 ---GINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRF 810
               I + H+    ++H D+K  N+L+D +    K+ DFG    
Sbjct: 148 VVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.5 bits (206), Expect = 4e-17
 Identities = 27/203 (13%), Positives = 60/203 (29%), Gaps = 39/203 (19%)

Query: 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVR-- 714
            L     +G         A     G    V V    +    + +K+   EV  ++ +R  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 715 -----------------------HPNVVLFMGAVTKRPHLSIVTEY-LPRGSLYR----L 746
                                     ++           LS    Y   + +L      L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 747 IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
           +   +  + +    RL++ L V + +  LH+    ++H  L+  ++++D+   V +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 807 LSRFKANTFISSKSVAGTVVFFA 829
               +          + +  F  
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEP 270

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 20/168 (11%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
           + +G+G+ G V  A       +VA+K L+      +Q   K   RE+ +MK V H N++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIG 88

Query: 721 FMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
            +   T +  L       IV E +   +L ++I       +  +R    +   +  GI +
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIKH 142

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
           LH+    I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 143 LHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 35/168 (20%)

Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF----LREVAIMKRVR---H 715
             +G G++GTV++A     G  VA+K + V               +REVA+++R+    H
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 716 PNVV-----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           PNVV            +   +++V E++ +  L            +D+     +  +  K
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTY---------LDKAPPPGLPAETIK 123

Query: 771 --------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
                   G+++LH     I+H DLK  N+LV    TVK+ DFGL+R 
Sbjct: 124 DLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI 169

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.9 bits (205), Expect = 6e-17
 Identities = 43/194 (22%), Positives = 78/194 (40%), Gaps = 65/194 (33%)

Query: 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV--- 719
           + +G GSFG V        G   A+K    +   D + K   RE+ IMK + H N++   
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRYK--NRELDIMKVLDHVNIIKLV 66

Query: 720 -LFMGAVTKRPH----------------------------------LSIVTEYLPRGSLY 744
             F     + P                                   L+++ EY+P  +L+
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125

Query: 745 RLIHRPAAGEMMDQRRRLRMALD--------VAKGINYLHNLNPPILHWDLKSPNLLVD- 795
           +++           R    + ++        + + + ++H+L   I H D+K  NLLV+ 
Sbjct: 126 KVLKSFI-------RSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNS 176

Query: 796 KNWTVKVCDFGLSR 809
           K+ T+K+CDFG ++
Sbjct: 177 KDNTLKLCDFGSAK 190

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 8e-17
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 20/171 (11%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
              + +G+G+ G V  A       +VA+K L+      +Q   K   RE+ +MK V H N
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKN 122

Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           ++  +   T +  L       +V E +   +L ++I       +  +R    +   +  G
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCG 176

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
           I +LH+    I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V 
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 38/182 (20%), Positives = 68/182 (37%), Gaps = 32/182 (17%)

Query: 662 HVKERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEF---------LREVAIMK 711
            V+  + +GS+G V    +  G  VA+K +         +            LRE+ ++ 
Sbjct: 25  TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 712 RVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAAGEMMDQRRR----- 761
              HPN++            +     +VTE +    L ++IH      +  Q  +     
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI-VISPQHIQYFMYH 142

Query: 762 -LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820
            L        G++ LH     ++H DL   N+L+  N  + +CDF L+R        +  
Sbjct: 143 ILL-------GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193

Query: 821 VA 822
           V 
Sbjct: 194 VT 195

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 41/169 (24%)

Query: 665 ERVGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVR-- 714
             +G G++G V +A   +  G  VA+K + V        +E      +REVA+++ +   
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETF 71

Query: 715 -HPNVV----LFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
            HPNVV    +   + T R   L++V E++ +  L            +D+     +  + 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTY---------LDKVPEPGVPTET 121

Query: 769 AK--------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            K        G+++LH+    ++H DLK  N+LV  +  +K+ DFGL+R
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 34/162 (20%), Positives = 63/162 (38%), Gaps = 33/162 (20%)

Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT---VQDFLDDQLKEFL-REVAIMKRVRH--PNV 718
           G+G FG+V+           VA+K +    + D+ +      +  EV ++K+V      V
Sbjct: 52  GSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD---QRRRL------RMALDVA 769
           +  +    +     ++ E  P              ++ D   +R  L           V 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPV----------QDLFDFITERGALQEELARSFFWQVL 159

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF 810
           + + + HN    +LH D+K  N+L+D N   +K+ DFG    
Sbjct: 160 EAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 199

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 23/164 (14%)

Query: 663 VKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
              +VG G++G V++A+        D A+K +              RE+A+++ ++HPNV
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNV 80

Query: 719 VLFMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA------LDVAK 770
           +             +  + +Y     L+ +I    A +   +  +L           +  
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 771 GINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF 810
           GI+YLH     +LH DLK  N+LV     +   VK+ D G +R 
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 16/160 (10%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSF TV  A    +    A+K+L  +  + ++++    RE  +M R+ HP  V    
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  L     Y   G L + I +   G   +   R   A ++   + YLH     I+
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 152

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR--------FKANTF 815
           H DLK  N+L++++  +++ DFG ++         +AN+F
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 31/163 (19%)

Query: 663 VKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNV 718
           +K  +G GS+G V+ A  +    +VA+K   V    +D +  K  LRE+ I+ R++   +
Sbjct: 30  IKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYI 87

Query: 719 VLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
           +     +     L       IV E      L +L   P    + ++  +      L    
Sbjct: 88  IRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI--FLTEEHIKTILYNLLL--- 140

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               G N++H     I+H DLK  N L++++ +VKVCDFGL+R
Sbjct: 141 ----GENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.6 bits (196), Expect = 5e-16
 Identities = 36/167 (21%), Positives = 62/167 (37%), Gaps = 20/167 (11%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFL 704
            W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     + +  +
Sbjct: 16  KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73

Query: 705 REVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
            E+ I+  +  H NVV  +GA TK    L ++ E+   G+L   +           +R  
Sbjct: 74  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS---------KRNE 124

Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
            +                  +  DLK     +  + +     F   +
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 18/48 (37%), Positives = 30/48 (62%), Gaps = 2/48 (4%)

Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
           +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+R
Sbjct: 196 ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 31/181 (17%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTV-QDFLDDQLKEFLREVAIMKRVRHPNV 718
            +K  +G G++G V  A  +  G  VA+K +      L       LRE+ I+K  +H N+
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF--ALRTLREIKILKHFKHENI 71

Query: 719 VLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
           +     + +           I+ E +    L+R+I       + D   +      LR   
Sbjct: 72  ITIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFIYQTLR--- 123

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
                +  LH  N  ++H DLK  NLL++ N  +KVCDFGL+R    +   +    G   
Sbjct: 124 ----AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 827 F 827
            
Sbjct: 178 G 178

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.9 bits (197), Expect = 8e-16
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 31/164 (18%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
            ++  +G GS+G V  A  +     VA+K   +    +D +  K  LRE+AI+ R+ H +
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDH 113

Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMA 765
           VV  +  +     +       +V E        +L   P    + +   +      L   
Sbjct: 114 VVKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP--VYLTELHIKTLLYNLLV-- 167

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                G+ Y+H+    ILH DLK  N LV+++ +VKVCDFGL+R
Sbjct: 168 -----GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 30/184 (16%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
              + +G G  G V  A        VA+K + + D     +K  LRE+ I++R+ H N+V
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS--VKHALREIKIIRRLDHDNIV 71

Query: 720 ----LFMGAVTKRPHLS----------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM- 764
               +   + ++               IV EY+    L  ++     G ++++  RL M 
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMY 127

Query: 765 -ALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVA 822
             L   +G+ Y+H+ N  +LH DLK  NL ++ ++  +K+ DFGL+R     +     ++
Sbjct: 128 QLL---RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 823 GTVV 826
             +V
Sbjct: 183 EGLV 186

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 24/119 (20%), Positives = 49/119 (41%), Gaps = 2/119 (1%)

Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           ++  M      N V  +   + + +L I  +   + +L   ++R  + E  +    L + 
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           + +A+ + +LH+    ++H DLK  N+    +  VKV DFGL             +   
Sbjct: 171 IQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 14/63 (22%), Positives = 31/63 (49%), Gaps = 3/63 (4%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
            +    + +G G FG V  A+      + A+K + + +  +   ++ +REV  + ++ HP
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 64

Query: 717 NVV 719
            +V
Sbjct: 65  GIV 67

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 37/170 (21%), Positives = 70/170 (41%), Gaps = 24/170 (14%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   +   +D   A+K+L   + L   +   F  E  ++       +     
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINYL 775
           A     +L +V +Y   G L  L+           +   R+  ++A+         I+ +
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGT 824
           H L+   +H D+K  N+L+D N  +++ DFG   +   +  + S    GT
Sbjct: 192 HQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 36/170 (21%), Positives = 70/170 (41%), Gaps = 24/170 (14%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+F  V   +   +    A+K++   D L   ++  F  E  ++       +     
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINYL 775
           A     +L +V EY   G L  L+           +   R+  ++A+         I+ +
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGT 824
           H L    +H D+K  N+L+D+   +++ DFG   + +A+  + S    GT
Sbjct: 179 HRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 10/175 (5%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIM 710
           L +  ++  V + +G G+FG V       +    A+K+L+  + +       F  E  IM
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 123

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
                P VV    A     +L +V EY+P G L  L+      ++ ++  R   A +V  
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTA-EVVL 179

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGT 824
            ++ +H++    +H D+K  N+L+DK+  +K+ DFG   +      +   +  GT
Sbjct: 180 ALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 32/164 (19%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
                VG+G++G+V  A  +  G  VA+K L+       ++  K   RE+ ++K ++H N
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHEN 84

Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMA 765
           V+  +   T    L       +V  ++    L +++         +++ +      L+  
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEKIQYLVYQMLK-- 137

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                G+ Y+H+    ++H DLK  NL V+++  +K+ DFGL+R
Sbjct: 138 -----GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 31/161 (19%)

Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
           + VG+G++G V  A     G+ VA+K L        +L  K   RE+ ++K +RH NV+ 
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMRHENVIG 88

Query: 721 FMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMALDV 768
            +   T    L       +V  ++    L +L+      ++ + R +      L+     
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQMLK----- 139

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
             G+ Y+H     I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 140 --GLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 11/167 (6%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK 711
               D+    + +G GSFG V   +   S    A+K+L  Q  +   Q++  L E  I++
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
            V  P +V    +     +L +V EY+  G ++  + R   G   +   R   A  +   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAA-QIVLT 153

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTF 815
             YLH+L+  +++ DLK  NLL+D+   ++V DFG ++    +  T 
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 25/155 (16%)

Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVV- 719
            ++G G +  V  A  +      V VK+L        + K+  RE+ I++ +R  PN++ 
Sbjct: 42  RKLGRGKYSEVFEA-INITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIIT 95

Query: 720 ---LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
              +    V++ P L  V E++      +L          D R  +   L   K ++Y H
Sbjct: 96  LADIVKDPVSRTPAL--VFEHVNNTDFKQLYQTL---TDYDIRFYMYEIL---KALDYCH 147

Query: 777 NLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRF 810
           ++   I+H D+K  N+++D ++  +++ D+GL+ F
Sbjct: 148 SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 31/163 (19%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTV-QDFLDDQLKEFLREVAIMKRVRHPNV 718
                +G G++G V  A    +   VA+K ++  +       +  LRE+ I+ R RH N+
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY--CQRTLREIKILLRFRHENI 87

Query: 719 VLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
           +     + + P +       IV + +    LY+L+       + +          LR   
Sbjct: 88  IGIN-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILR--- 139

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               G+ Y+H+ N  +LH DLK  NLL++    +K+CDFGL+R
Sbjct: 140 ----GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 31/164 (18%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
                VG+G++G+V  A     G  VAVK L+        +  K   RE+ ++K ++H N
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHEN 89

Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMA 765
           V+  +   T    L       +VT  +    L  ++      ++ D   +      LR  
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILR-- 143

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                G+ Y+H+ +  I+H DLK  NL V+++  +K+ DFGL+R
Sbjct: 144 -----GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 32/163 (19%)

Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVR-HP 716
            + +++G G++G V ++     G  VAVK   + D   +    +   RE+ I+  +  H 
Sbjct: 12  ELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHE 69

Query: 717 NVVLFMGAVTKRP----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
           N+V  +  +  R      + +V +Y+    L+ +I    A  +    ++      ++   
Sbjct: 70  NIVNLLNVL--RADNDRDVYLVFDYME-TDLHAVIR---ANILEPVHKQYVVYQLIK--- 120

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
                I YLH+    +LH D+K  N+L++    VKV DFGLSR
Sbjct: 121 ----VIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSR 157

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V       +    A+K+L  +  +  D++   + E  +++  RHP +     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           A      L  V EY   G L+  + R       ++R R   A ++   + YLH+ +  ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGA-EIVSALEYLHSRD--VV 127

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           + D+K  NL++DK+  +K+ DFGL +          TF
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 11/155 (7%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG VH      +    A+KVL  +  +   Q++    E  ++  V HP ++   G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
                  + ++ +Y+  G L+ L+ +  +    +   +   A +V   + YLH+ +  I+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAA-EVCLALEYLHSKD--II 128

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTF 815
           + DLK  N+L+DKN  +K+ DFG +++      T 
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 163

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 37/162 (22%), Positives = 78/162 (48%), Gaps = 11/162 (6%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G GSFG V   + + +    A+K +  Q  +  ++++   +E+ IM+ + HP +V    
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +      + +V + L  G L   + +       ++  +L +  ++   ++YL N    I+
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFIC-ELVMALDYLQNQR--II 137

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGT 824
           H D+K  N+L+D++  V + DF ++      T     ++AGT
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGT 177

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 7/166 (4%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G+FG V   +   +    A+K+L  +  +  D++   L E  +++  RHP +     
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           +      L  V EY   G L+  + R       + R R   A ++   ++YLH+    ++
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGA-EIVSALDYLHSEKN-VV 271

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + DLK  NL++DK+  +K+ DFGL +       + K+  GT  + A
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 22/171 (12%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---- 715
            V + +G GSFG V +A  H     VA+K++  +     Q      E+ I++ +R     
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA---AEEIRILEHLRKQDKD 156

Query: 716 --PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGI 772
              NV+  +   T R H+ +  E L   +LY LI      G  +   R  + A  + + +
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR--KFAHSILQCL 213

Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNWT-VKVCDFGLSRFKAN---TFISS 818
           + LH     I+H DLK  N LL  +  + +KV DFG S ++     T+I S
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 7e-12
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 16/160 (10%)

Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           +G GSFG V   +   GSD     A+KVL               E  I+  V HP +V  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
             A      L ++ ++L  G L+  + +       ++  +  +A ++A  +++LH+L   
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELALALDHLHSLG-- 146

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           I++ DLK  N+L+D+   +K+ DFGLS+       KA +F
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.5 bits (163), Expect = 8e-12
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
           +G GSFG V  AE+  ++   A+K L     L DD ++  + E  ++     HP +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                + +L  V EYL  G L   I      +    R     A ++  G+ +LH+    I
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAA-EIILGLQFLHSKG--I 139

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           ++ DLK  N+L+DK+  +K+ DFG+ +       K NTF
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 178

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 67.5 bits (165), Expect = 9e-12
 Identities = 39/171 (22%), Positives = 64/171 (37%), Gaps = 17/171 (9%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G FG V   +   +    A K L  +           L E  I+++V    VV    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
           A   +  L +V   +  G L   I+        + R     A ++  G+  LH     I+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER--IV 308

Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTVVFFA 829
           + DLK  N+L+D +  +++ D GL+                   GTV + A
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTVGYMA 353

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.7 bits (165), Expect = 1e-11
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
           +G GSFG V  +E  G+D   AVK+L     + DD ++  + E  ++    + P +    
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V EY+  G L   I +   G   +       A ++A G+ +L +    I
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA-EIAIGLFFLQSKG--I 463

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTF 815
           ++ DLK  N+++D    +K+ DFG+ +          TF
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 502

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 22/172 (12%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRHP-- 716
            +   +G GSFG V +A        VA+K++   + FL+    E    V +++ +     
Sbjct: 57  EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDT 112

Query: 717 ----NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKG 771
                +V        R HL +V E L   +LY L+ +    G  ++  R+   A  +   
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 169

Query: 772 INYLHNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRFKAN---TFISS 818
           + +L      I+H DLK  N+L+   K   +K+ DFG S         +I S
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 6/167 (3%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
           +G G FG V   +   +    A K L  +        +  + E  I+ +V    +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDVAKGINYLHNLNPPI 782
           A   +  L +V   +  G +   I+         Q  R       +  G+ +LH  N  I
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--I 310

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           ++ DLK  N+L+D +  V++ D GL+         +K  AGT  F A
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.4 bits (155), Expect = 9e-11
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
           +G GS+  V       +D   A+KV+  +    D+ +     E  + ++   HP +V   
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V EY+  G L   + R    ++ ++  R   A +++  +NYLH     I
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSA-EISLALNYLHERG--I 131

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTF 815
           ++ DLK  N+L+D    +K+ D+G+ +         +TF
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 170

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 46/245 (18%), Positives = 91/245 (37%), Gaps = 20/245 (8%)

Query: 591 AIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLA 650
           AIE      +       + +     +   L  +   K  +  KF      + + +   L 
Sbjct: 128 AIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLT 187

Query: 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREV 707
           M+   +      +   +G G FG V+      +    A+K L  +           L E 
Sbjct: 188 MNDFSV----HRI---IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 708 AIMKRV---RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
            ++  V     P +V    A      LS + + +  G L+  + +   G   +   R   
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYA 298

Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
           A ++  G+ ++HN    +++ DLK  N+L+D++  V++ D GL+     +     +  GT
Sbjct: 299 A-EIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGT 353

Query: 825 VVFFA 829
             + A
Sbjct: 354 HGYMA 358

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.9 bits (154), Expect = 1e-10
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 22/164 (13%)

Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPN 717
           +G G +G V +     G++     A+KVL     V++           E  I++ V+HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPF 82

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V  + A      L ++ EYL  G L+  + R   G  M+      +A +++  + +LH 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLA-EISMALGHLHQ 139

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTF 815
               I++ DLK  N++++    VK+ DFGL +         +TF
Sbjct: 140 KG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
           +G GSFG V  +E  G+D   AVK+L     + DD ++  + E  ++    + P +    
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V EY+  G L   I +   G   +       A ++A G+ +L +    I
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA-EIAIGLFFLQSKG--I 142

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           ++ DLK  N+++D    +K+ DFG+ +          TF
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 181

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
           +G GSFG V  A    +    AVKVL     L DD ++  + E  I+     HP +    
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V E++  G L   I +  +    + R R   A ++   + +LH+    I
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAA-EIISALMFLHDKG--I 145

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           ++ DLK  N+L+D     K+ DFG+ +          TF
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
           +G GS+  V       +D   A++V+  +    D+ +     E  + ++   HP +V   
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
                   L  V EY+  G L   + R    ++ ++  R   A +++  +NYLH     I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSA-EISLALNYLHERG--I 174

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           ++ DLK  N+L+D    +K+ D+G+ +         +TF
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 213

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 33/180 (18%), Positives = 73/180 (40%), Gaps = 31/180 (17%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR----- 714
            +  ++G G F TV  A+     + VA+K++       +       E+ +++RV      
Sbjct: 22  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNT 78

Query: 715 ------HPNVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLR 763
                   +++     F        H+ +V E L   +L  LI +    G  +   +  +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK--Q 135

Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVD------KNWTVKVCDFGLSRFKANTFIS 817
           ++  +  G++Y+H     I+H D+K  N+L++          +K+ D G + +    + +
Sbjct: 136 ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 15/159 (9%)

Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIM-KRVRHPNVVLFM 722
           +G GSFG V  A     +V  AVKVL  +  L   + K  + E  ++ K V+HP +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
            +      L  V +Y+  G L+  + R      ++ R R   A ++A  + YLH+LN  I
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAA-EIASALGYLHSLN--I 160

Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTF 815
           ++ DLK  N+L+D    + + DFGL +         +TF
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 2e-09
 Identities = 28/195 (14%), Positives = 59/195 (30%), Gaps = 42/195 (21%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK------EFLREVAI 709
           +  ++L   E++G G FG V +     + VA+K++ ++              E L E+ I
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 710 MKRV---------RHPNVVLFMGA--VTKRPHLSIVTEY----------------LPRGS 742
            K +         R    +       V       ++  +                     
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 743 LYRLIHRPAAGEMMDQRRR--------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV 794
           L+ ++     G  ++Q R           +   +   +      +    H DL   N+L+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLL 195

Query: 795 DKNWTVKVCDFGLSR 809
            K    K+      +
Sbjct: 196 KKTSLKKLHYTLNGK 210

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 43/179 (24%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRH--- 715
            V  ++G G+FG V   +        AVKV+  ++ +          E  I+K++++   
Sbjct: 38  LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDI 93

Query: 716 --PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGI 772
              N+V + G      H+ ++ E L   SLY +I      G  ++  +     +++ K +
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK--LYCIEILKAL 150

Query: 773 NYLHNLNPPILHWDLKSPN-LLVD------------------------KNWTVKVCDFG 806
           NYL  ++  + H DLK  N LL D                        K+  +K+ DFG
Sbjct: 151 NYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 3e-08
 Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 42/190 (22%)

Query: 662 HVKERVGAGSFGTVHRA---EWHGSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRHP- 716
            + + +G G+FG V      +  G  VAVK++  V  + +        E+ +++ +    
Sbjct: 17  EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTD 72

Query: 717 -----NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAK 770
                  V  +       H+ IV E L   S Y  I         +D  R  +MA  + K
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR--KMAYQICK 129

Query: 771 GINYLHNLNPPILHWDLKSPN-LLVD------------------KNWTVKVCDFGLSRFK 811
            +N+LH+    + H DLK  N L V                    N  +KV DFG + + 
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187

Query: 812 AN---TFISS 818
                T +S+
Sbjct: 188 DEHHSTLVST 197

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 42/190 (22%)

Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRHP- 716
            +   +G G+FG V     H    S VA+K++  V  + +        E+ ++K+++   
Sbjct: 22  EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKD 77

Query: 717 -----NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAK 770
                  VL         H+ I  E L   + +  +         +   R   MA  +  
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVR--HMAYQLCH 134

Query: 771 GINYLHNLNPPILHWDLKSPN-LLVD------------------KNWTVKVCDFGLSRFK 811
            + +LH     + H DLK  N L V+                  KN +++V DFG + F 
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 812 AN---TFISS 818
                T +++
Sbjct: 193 HEHHTTIVAT 202

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDFL--DDQLKEFLREVAIMKRVRH-PNV 718
           +G G++G V       G D     A+KVL     +      +    E  +++ +R  P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
           V    A      L ++ +Y+  G L+  + +       +   ++ +  ++   + +LH L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVG-EIVLALEHLHKL 178

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-------FKANTF 815
              I++ D+K  N+L+D N  V + DFGLS+        +A  F
Sbjct: 179 G--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.4 bits (135), Expect = 4e-08
 Identities = 61/351 (17%), Positives = 105/351 (29%), Gaps = 101/351 (28%)

Query: 534 LKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIE 593
            K I L K   D ++    A   +  +   L    +              + VEE   + 
Sbjct: 42  PKSI-LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEM----------VQKFVEE--VLR 88

Query: 594 AAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQG-KFPVGPGPRYLNIEPSLAM- 651
             Y  + ++S      +QP  ++ +++  E   +L      F      R   ++P L + 
Sbjct: 89  INY--KFLMSPIKTEQRQP--SMMTRMYIEQRDRLYNDNQVFAKYNVSR---LQPYLKLR 141

Query: 652 DWLEISWDELHVKERV---GAGSFG-TVHRAEWHGSDVAVKVL---TVQDFLDDQ---LK 701
             L     EL   + V   G    G T          VA+ V     VQ  +D +   L 
Sbjct: 142 QALL----ELRPAKNVLIDGVLGSGKTW---------VALDVCLSYKVQCKMDFKIFWLN 188

Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR--PAAGEMMDQR 759
                   +K    P  VL M                    L +L+++  P      D  
Sbjct: 189 --------LKNCNSPETVLEM--------------------LQKLLYQIDPNWTSRSDHS 220

Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-----DKNWTVKVCDFG-----LSR 809
             +++ +   +    L  L   +     ++  LLV     +        +        +R
Sbjct: 221 SNIKLRIHSIQ--AELRRL---LKSKPYEN-CLLVLLNVQNA-KAWNAFNLSCKILLTTR 273

Query: 810 FKANTFISSKSVAGTVVFFAAHQ----TACNSLALIFSLSGWLQSSFEESP 856
           FK  T     S A T      H     T     +L   L  +L    ++ P
Sbjct: 274 FKQVT--DFLSAATTTHISLDHHSMTLTPDEVKSL---LLKYLDCRPQDLP 319

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 8e-05
 Identities = 85/643 (13%), Positives = 173/643 (26%), Gaps = 184/643 (28%)

Query: 64  TTTTTKNLKNSAAPLSVSD-LFTSGDEKFKVKKQQFAAFC--------DWLTE--KKEDR 112
           +     ++  S   +S +  LF +   K   +++    F          +L    K E R
Sbjct: 47  SKEEIDHIIMSKDAVSGTLRLFWTLLSK---QEEMVQKFVEEVLRINYKFLMSPIKTEQR 103

Query: 113 SASRHVKSFQSRLSSGADEDREPLLPPPEP-EPVPVPVPDTVTNIDNDRNFDRQVSLPRL 171
             S   + +  +        R+ L    +      V        +        + +L  L
Sbjct: 104 QPSMMTRMYIEQ--------RDRLYNDNQVFAKYNVSRLQPYLKL--------RQALLEL 147

Query: 172 SSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMLQ 231
                            +DG   S                     K   A     SY +Q
Sbjct: 148 RPAK----------NVLIDGVLGS--------------------GKTWVALDVCLSYKVQ 177

Query: 232 LTLARR---LTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNIL 288
             +  +   L L+ C     +L     L         Y++  +   S +D  S+    I 
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKL--------LYQIDPNWT-SRSDHSSNIKLRIH 228

Query: 289 GMNPYLWVMCNDLEEGKRLP-SLMSLKDIDSTE-------------TSMEVVLIDRHGDS 334
            +   L      L + K     L+ L ++ + +             T+    + D    +
Sbjct: 229 SIQAEL----RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284

Query: 335 RLKEL----------EDKAQELY--CASENTLVLVEE--LGKLVAICMGGTFPIEQGDLH 380
               +           D+ + L           L  E        + +      +     
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344

Query: 381 KRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLA---DYIGLP----CRI-ARG 432
             WK  +    K    I   +  L     R    +F +L+       +P      I    
Sbjct: 345 DNWKHVNCD--KLTTIIESSLNVLEPAEYRK---MFDRLSVFPPSAHIPTILLSLIWFDV 399

Query: 433 CRYCEAD-----HRSSCLVKIEDDRRSSREYVVDL-------VGEPGNIHGP---NFSIN 477
            +          H+ S + K     + S   +  +       +     +H     +++I 
Sbjct: 400 IKSDVMVVVNKLHKYSLVEK---QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456

Query: 478 GGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRK------- 530
             F           D  +   PY+D   Y  +     N   PE      + R        
Sbjct: 457 KTF-----------DSDDLIPPYLDQYFYSHIGHHLKNIEHPER---MTLFRMVFLDFRF 502

Query: 531 -GQKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGN--PKNSDAAAGAPIQEYSRLVE 587
             QK++      ++  +++N        +L  LK        N          +Y RLV 
Sbjct: 503 LEQKIRHDSTAWNASGSILN--------TLQQLKFYKPYICDNDP--------KYERLVN 546

Query: 588 ENVAIEAAYKEEIVVSESSVIIK----QPNATL----PSQLDK 622
             +      +E ++ S+ + +++      +  +      Q+ +
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 45/196 (22%)

Query: 618 SQLDKEDESKLEKQGKFPVGPG----PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFG 673
              ++ED +   K G   V  G     RY                   HV  ++G G F 
Sbjct: 11  DDDEQEDPNDYCKGGYHLVKIGDLFNGRY-------------------HVIRKLGWGHFS 51

Query: 674 TVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----HPN---VVLFMG 723
           TV  +        VA+KV+   +   +       E+ ++K VR      PN   VV  + 
Sbjct: 52  TVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNREMVVQLLD 108

Query: 724 AVT-KRP---HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNL 778
                     H+ +V E L    L + I +    G  +   ++  +   V +G++YLH  
Sbjct: 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTK 165

Query: 779 NPPILHWDLKSPNLLV 794
              I+H D+K  N+L+
Sbjct: 166 CR-IIHTDIKPENILL 180

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 34/166 (20%), Positives = 66/166 (39%), Gaps = 24/166 (14%)

Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           + +++G+G FG ++ A         A  V+ V+   +  L     E+   +RV   + + 
Sbjct: 41  LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIK 97

Query: 721 FMGAVTKRPHLSIVTEY-----LPRGSLYRLIHRPAAG----EMMDQRRR------LRMA 765
                 +  +L I   Y       +G  YR +     G    ++  Q         L++ 
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV--CDFGLSR 809
           + +   + Y+H      +H D+K+ NLL+      +V   D+GLS 
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 33/173 (19%), Positives = 61/173 (35%), Gaps = 35/173 (20%)

Query: 663 VKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
           V   +G G FG ++ A+ +    V      V             E+   +R   P  +  
Sbjct: 39  VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 722 MGAVTKRPHLSIVTEY-----LPRGSLYRLIHRPAAGEMMD------------QRRR--- 761
                K  +L +   +        G  YR +       +MD              +R   
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM-------IMDRFGSDLQKIYEANAKRFSR 151

Query: 762 ---LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV--CDFGLSR 809
              L+++L +   + Y+H      +H D+K+ NLL++     +V   D+GL+ 
Sbjct: 152 KTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	867
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.98
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.98
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.09
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.35
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.29
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.06
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.57
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.19
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.05
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.02
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.87
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.76
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.36
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.25
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.23
3isr_A	293	Transglutaminase-like enzymes, putative cysteine;	96.06
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.71
3kd4_A	506	Putative protease; structural genomics, joint cent	94.98
2f4m_A	295	Peptide N-glycanase; glycoproteins, ubiquitin-depe	94.13
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.02
1x3z_A	335	Peptide: N-glycanase; hydrolase-hydrolase inhibito	92.54
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	88.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.17

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-46  Score=415.25  Aligned_cols=202  Identities=23%  Similarity=0.395  Sum_probs=178.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++.+........+.+.+|+.+|++|+|||||+++++|++.+.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            47999999999999999999998  4888999999988777777889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |||+||+|.++|.... ...+++..++.|+.||+.||+|||++|  ||||||||+||||+.+|++||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999997533 345799999999999999999999999  9999999999999999999999999999876544


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....+.+||+.|||||++.+..+   +|||||||+||+|++|.+||....
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  229 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS  229 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            34456799999999999998665   899999999999999999997643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-46  Score=404.49  Aligned_cols=199  Identities=22%  Similarity=0.360  Sum_probs=179.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++++.||+|+||+||+|++  +++.||||++.+..... ...+.+.+|+++|++++|||||+++++|++.+.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999998  57889999998765433 3467789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC-
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~-  813 (867)
                      ||||+||+|.++|.+.   ..+++..+..++.||+.||+|||+++  ||||||||+||||+.+|++||+|||+|+.... 
T Consensus       111 mEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999999863   35999999999999999999999999  99999999999999999999999999997643 


Q ss_pred             -CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 -TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 -t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       ......+.+||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             2334567899999999999987655   89999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=401.05  Aligned_cols=205  Identities=34%  Similarity=0.557  Sum_probs=177.3

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ..|+|..++|++.++||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||++++++.. +.+
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            4679999999999999999999999999865 59999998776667778899999999999999999999998864 568


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +||||||++|+|.++|+..  ...+++..++.|+.||+.||+|||+++  ||||||||+||||+.++++||+|||+|+..
T Consensus       107 ~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            9999999999999999763  235899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCC--cccccccCCCcccccccccCCC------ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANT--FISSKSVAGTVVFFAAHQTACN------SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t--~~s~~s~aGTp~YmAPEvl~~~------~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...  .......+||+.|||||++.+.      ..+|||||||+||||++|..||....
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~  241 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN  241 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence            432  2234567999999999998632      24899999999999999999997653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.3e-45  Score=390.89  Aligned_cols=196  Identities=26%  Similarity=0.406  Sum_probs=174.1

Q ss_pred             eEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCeEEEE
Q 002910          661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLSIV  734 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----~~~l~LV  734 (867)
                      |++.+.||+|+||+||+|.+.  +..||||++..........+.+.+|+.+|++|+|||||+++++|.+    ...+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            478889999999999999984  6789999998877777778889999999999999999999999875    3568999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEEEecCccccccC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+||+|.+++++.   ..+++..+..|+.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+....
T Consensus       108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999999863   358999999999999999999999888899999999999998 479999999999987554


Q ss_pred             CcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..  ..+.+|||.|||||++.+.  ..+|||||||+||+|++|.+||...
T Consensus       185 ~~--~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~  232 (290)
T 3fpq_A          185 SF--AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             TS--BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             Cc--cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            43  3577999999999998752  3489999999999999999999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-45  Score=404.67  Aligned_cols=196  Identities=26%  Similarity=0.339  Sum_probs=177.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|+++++||+|+||+||+|++  +|+.||||++......  ..+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999998  5788999999765432  23467899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||+||+|.+++.+.    .+++..+..|+.||+.||+|||++|  ||||||||+||||+.+|++||+|||+|+.......
T Consensus       152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999999752    4899999999999999999999999  99999999999999999999999999998766555


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...+.+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            5678899999999999987665   799999999999999999997643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.5e-46  Score=402.08  Aligned_cols=201  Identities=23%  Similarity=0.288  Sum_probs=171.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ..++|++++.||+|+||+||+|+.     .++.||||++.+..........+.+|+.+|++++|||||+++++|++.+.+
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            347899999999999999999987     356799999987655444445688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |||||||+||+|.++|.+.   ..+++..+..++.||+.||+|||++|  ||||||||+|||++.+|++||+|||+|+..
T Consensus       102 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999999863   35999999999999999999999999  999999999999999999999999999976


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ........+.+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  230 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD  230 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence            655555567899999999999987655   899999999999999999997643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-44  Score=391.18  Aligned_cols=204  Identities=27%  Similarity=0.393  Sum_probs=177.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      .|..++|.+.+.||+|+||+||+|++.       +..||||+++..  .....++|.+|+++|++++|||||+++++|.+
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            466789999999999999999999873       567999998754  34566789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPA----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~----------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      .+.+|||||||++|+|.++|+...          ....+++..++.++.||+.||+|||+++  ||||||||+||||+.+
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence            999999999999999999997632          2346899999999999999999999999  9999999999999999


Q ss_pred             CcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          798 WTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +++||+|||+|+......  ......+||+.|||||++.+..+   +|||||||+||||+| |..||....
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~  235 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  235 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999998764432  22334579999999999987655   899999999999998 899998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=407.66  Aligned_cols=196  Identities=26%  Similarity=0.339  Sum_probs=178.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|++++.||+|+||+||+|++  +|+.||||++......  ..+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            6799999999999999999998  4788999999865432  23468899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||+||+|.+++...    .+++..+..|+.||+.||+|||++|  ||||||||+||||+.+|++||+|||+|+.......
T Consensus       229 y~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          229 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999999752    4899999999999999999999999  99999999999999999999999999998766555


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...+.+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            5678899999999999997665   799999999999999999997643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=391.20  Aligned_cols=205  Identities=27%  Similarity=0.382  Sum_probs=172.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ..|..++|.+.+.||+|+||+||+|++.       ++.||||+++..  .....++|.+|+++|++++|||||+++++|.
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3566789999999999999999999874       567999998754  3456678999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAA------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV  794 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL  794 (867)
                      +.+.+|||||||++|+|.++|+....            ...+++..++.|+.||+.||+|||+++  ||||||||+||||
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl  191 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV  191 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence            99999999999999999999986431            235899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          795 DKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       795 d~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +.++++||+|||+++......  ......+||+.|||||++.+..+   +|||||||+||||+| |+.||....
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            999999999999998764332  22345689999999999998665   799999999999998 899997654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.3e-44  Score=383.99  Aligned_cols=197  Identities=24%  Similarity=0.395  Sum_probs=160.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +++|++++.||+|+||+||+|++  +|+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            47899999999999999999987  58889999998766544 3356789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||| +|+|.+++.+.   ..+++..+..++.||+.||+|||++|  ||||||||+||||+.++++||+|||+|+.....
T Consensus        92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            9999 78999999763   35999999999999999999999999  999999999999999999999999999876543


Q ss_pred             cccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      . ...+.+||+.|||||++.+..    .+|||||||++|+|++|.+||...
T Consensus       166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence            3 235679999999999998754    489999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.8e-44  Score=389.77  Aligned_cols=206  Identities=25%  Similarity=0.359  Sum_probs=178.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      .++..+++++.+.||+|+||+||+|++.       ++.||||+++... .....++|.+|+.+|++++|||||+++|+|.
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            3567789999999999999999999973       4679999987542 3344578999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEE
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLL  793 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNIL  793 (867)
                      +.+.++||||||++|+|.++|+....             ...+++..++.|+.||+.||+|||+++  ||||||||+|||
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL  177 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL  177 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence            99999999999999999999975321             235899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          794 VDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       794 Ld~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      |+.++++||+|||+++.....  .......+||+.|||||++.+..+   +|||||||+||||+| |..||....
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999876432  223456789999999999987655   799999999999998 899998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-44  Score=393.49  Aligned_cols=193  Identities=27%  Similarity=0.388  Sum_probs=170.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..+.|++.++||+|+||+||+|++  +|+.||||+++.....       .+|+.+|++++|||||+++++|.+.+.+|||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457899999999999999999998  4788999999865432       4699999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCccccccC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKAN  813 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~~~  813 (867)
                      ||||+||+|.++|++..   .+++..+..|+.||+.||+|||+++  ||||||||+||||+.+| ++||+|||+|+....
T Consensus       129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            99999999999998643   5999999999999999999999999  99999999999999988 699999999987643


Q ss_pred             Cc-----ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TF-----ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~-----~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..     ......+||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  259 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY  259 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            21     22345789999999999998665   79999999999999999999764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.7e-43  Score=375.85  Aligned_cols=196  Identities=23%  Similarity=0.356  Sum_probs=159.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-------
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-------  729 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-------  729 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|...+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            5799999999999999999998  48889999998654 2344577899999999999999999999997544       


Q ss_pred             -----eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          730 -----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       730 -----~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                           .+|||||||++|+|.+++.........++..++.++.||+.||+|||++|  ||||||||+||||+.+|++||+|
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence                 37999999999999999987544344567778899999999999999999  99999999999999999999999


Q ss_pred             cCccccccCCc------------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          805 FGLSRFKANTF------------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       805 FGLAr~~~~t~------------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ||+|+......            ....+.+||+.|||||++.+..+   +|||||||++|+|++   ||..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            99998764321            12235689999999999997655   799999999999996   5543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.8e-43  Score=386.38  Aligned_cols=209  Identities=24%  Similarity=0.400  Sum_probs=180.0

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEE
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFM  722 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH-PNIVkl~  722 (867)
                      ...|+|..++|++++.||+|+||+||+|++.+       +.||||++.... .....+.+.+|+.+|.+++| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            35689999999999999999999999999854       359999987543 34456789999999999976 8999999


Q ss_pred             eEEeeC-CeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCC
Q 002910          723 GAVTKR-PHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK  788 (867)
Q Consensus       723 ga~~~~-~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLK  788 (867)
                      ++|... ..++||||||++|+|.++|+....             ...+++..++.|+.||+.||+|||+++  |||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK  212 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  212 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccC
Confidence            999764 569999999999999999975321             345899999999999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          789 SPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       789 PeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      |+||||+.++++||+|||+|+.....  .....+.+||+.|||||++.+..+   +|||||||+||||+| |..||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999976432  233456789999999999987655   799999999999998 899998653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-42  Score=371.71  Aligned_cols=194  Identities=28%  Similarity=0.422  Sum_probs=159.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----eEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----HLSIV  734 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~----~l~LV  734 (867)
                      .+|.+.+.||+|+||+||+|+++|+.||||++....   .....+..|+.++.+++|||||++++++...+    .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            578999999999999999999999999999986543   21122334566667899999999999998654    58999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~------gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ||||++|+|.++|+..    .+++..+++++.|++.||+|||++      .++||||||||+||||+.++++||+|||++
T Consensus        80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999863    489999999999999999999986      223999999999999999999999999999


Q ss_pred             ccccCCc----ccccccCCCcccccccccCCC---------ChHHHHHHHHHHHHHhcCCCCcc
Q 002910          809 RFKANTF----ISSKSVAGTVVFFAAHQTACN---------SLALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       809 r~~~~t~----~s~~s~aGTp~YmAPEvl~~~---------~~SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      +......    ......+||+.|||||++.+.         ..+|||||||+||||+||.+||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            8764432    123356899999999999764         23799999999999999977653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=381.70  Aligned_cols=197  Identities=22%  Similarity=0.354  Sum_probs=172.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee------CCe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK------RPH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~------~~~  730 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++.+........+.+.+|+.+|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            6899999999999999999998  58889999998776666667889999999999999999999998764      367


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|||||||. |+|.+++...   ..+++..+..++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeee
Confidence            999999995 6799999763   35999999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCC----cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANT----FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t----~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....    .....+.+||+.|||||++.+.    ..+|||||||++|+|++|.+||..-
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            6432    2234577999999999998764    3379999999999999999999754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.1e-41  Score=398.86  Aligned_cols=200  Identities=21%  Similarity=0.251  Sum_probs=173.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-HHHHHH---HHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFL---REVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~~k~f~---~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .++.++|++++.||+|+||+||+|++  +|+.||||++.+..+... ....+.   .++.+++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            45779999999999999999999998  578899999987654321 122233   445666778999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+|||||||+||+|..+|.+.   ..+++..+..|+.||+.||+|||++|  ||||||||+||||+.+|+|||+|||+|
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEeccccee
Confidence            9999999999999999999864   35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCC-CC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTAC-NS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~-~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +......  ..+.+|||.|||||++.. ..   .+|||||||+||+|++|.+||...
T Consensus       340 ~~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          340 CDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             EECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             eecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8765543  357899999999999964 33   389999999999999999999753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.5e-40  Score=364.64  Aligned_cols=190  Identities=20%  Similarity=0.270  Sum_probs=164.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~  732 (867)
                      +.|++++.||+|+||+||+|+.+     ++.||||++....    ...++.+|+++|+.+ .|||||+++++|.+.+++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            67999999999999999999863     4579999886543    234578999999998 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLAr~~  811 (867)
                      ||||||++|+|.+++..      +++..+..++.||+.||+|||++|  ||||||||+||||+.+ +.+||+|||+|+..
T Consensus        97 lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           97 IAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999853      889999999999999999999999  9999999999999876 89999999999865


Q ss_pred             cCCc----------------------------ccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcc
Q 002910          812 ANTF----------------------------ISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       812 ~~t~----------------------------~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      ....                            ....+.+||+.|||||++.+..    .+||||+||++|+|++|++||+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            4321                            1123568999999999997643    3799999999999999999996


Q ss_pred             c
Q 002910          860 S  860 (867)
Q Consensus       860 s  860 (867)
                      .
T Consensus       249 ~  249 (361)
T 4f9c_A          249 K  249 (361)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-39  Score=379.91  Aligned_cols=198  Identities=23%  Similarity=0.379  Sum_probs=176.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++....  ....+.+.+|+.+|+.|+|||||+++++|.+...+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            47899999999999999999998  57889999997654  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC--CcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN--WTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~--g~VKLsDFGLAr~~~~  813 (867)
                      |||+||+|.++|...  ...+++..+..|+.||+.||.|||+++  |+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       234 E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          234 EFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             ECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             eecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999999753  235899999999999999999999999  9999999999999854  8999999999998754


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .. ...+.+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       310 ~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~  360 (573)
T 3uto_A          310 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  360 (573)
T ss_dssp             TS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            32 2356799999999999998766   799999999999999999997643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.2e-39  Score=343.07  Aligned_cols=212  Identities=62%  Similarity=0.958  Sum_probs=177.7

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ...+++.+++|++.+.||+|+||+||+|+++++.||||++..........+.+.+|+.+|++++||||+++++++...+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            45567888999999999999999999999999999999998877777778889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+++|+|.+++........+++..++.++.||+.||+|||+++++|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            99999999999999999864333348999999999999999999999888899999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...........+||+.|+|||++.+..+   +|||||||++|+|++|..||....
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~  243 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN  243 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            6665555567789999999999987644   899999999999999999997653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.5e-38  Score=342.32  Aligned_cols=201  Identities=21%  Similarity=0.348  Sum_probs=179.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +..++|++++.||+|+||+||+|+.  +++.||||++.+.... ......+.+|+.+|+.++||||+++++++.....+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            4568999999999999999999998  4788999999865432 234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++|+|..++.+.   ..+++..++.++.||+.||+|||++|  |+||||||+||||+.+|++||+|||+++...
T Consensus        82 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999999763   34899999999999999999999999  9999999999999999999999999998755


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence            44444567899999999999987654   89999999999999999999754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.9e-38  Score=344.16  Aligned_cols=202  Identities=23%  Similarity=0.318  Sum_probs=171.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~  730 (867)
                      .+..++|++++.||+|+||+||+|++  +++.||||++.+..... ...+.+.+|+.+|+.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            35668999999999999999999998  47789999998754332 3456788999999998 69999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +||||||+++|+|..++.+.   ..+++..++.++.||+.||+|||+++  |+||||||+||||+.+|++||+|||+++.
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999999864   34899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCC---CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTAC---NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~---~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .........+.+||+.|+|||++.+   ...+|||||||++|+|++|.+||...
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            5544445567899999999999885   34589999999999999999999764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-37  Score=335.22  Aligned_cols=199  Identities=24%  Similarity=0.383  Sum_probs=180.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..++|++.+.||+|+||+||+|++  +|+.||||++..........+.+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            458999999999999999999998  688899999988776667778899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999999763   34899999999999999999999999  999999999999999999999999999876543


Q ss_pred             cccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      . .....+||+.|+|||++.+..    .+|||||||++|+|++|..||...
T Consensus       168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  217 (328)
T 3fe3_A          168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ  217 (328)
T ss_dssp             C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            2 235678999999999998654    489999999999999999999754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-37  Score=337.22  Aligned_cols=200  Identities=19%  Similarity=0.284  Sum_probs=178.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l  731 (867)
                      +..++|++++.||+|+||+||+|++.  ++.||||++.+.... ....+.+.+|+.+++++ +|||||+++++|.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            45689999999999999999999984  778999999877654 34567788999999988 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+||||+++|+|..++.+.   ..+++..++.++.||+.||+|||+++  |+||||||+||||+.+|++||+|||+++..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999999763   34899999999999999999999999  999999999999999999999999999865


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ..........+||+.|+|||++.+..+   +|||||||++|+|++|.+||..
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            444444567799999999999987654   8999999999999999999965

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-37  Score=346.94  Aligned_cols=201  Identities=18%  Similarity=0.282  Sum_probs=177.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~  730 (867)
                      .+..++|++++.||+|+||+||+|++.  ++.||||++++..... ...+.+.+|+.+|.++ +|||||+++++|++...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            345689999999999999999999984  6679999998765543 3456688999999887 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +||||||+++|+|..++.+.   ..+++..++.++.||+.||+|||+++  |+||||||+||||+.+|++||+|||+++.
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999999863   34899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .........+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||..
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            5444444567899999999999997655   7999999999999999999963

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-37  Score=338.08  Aligned_cols=202  Identities=24%  Similarity=0.350  Sum_probs=176.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~  730 (867)
                      .+..++|++.+.||+|+||+||+|++  +++.||||++.+.... ......+.+|..++..+ +||||+++++++++...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999998  4778999999875432 23456678999999887 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+++|+|.+++...   ..+++..+..++.||+.||+|||++|  |+||||||+||||+.+|++||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999863   34899999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...........+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence            5443344567899999999999987554   79999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-37  Score=331.81  Aligned_cols=198  Identities=23%  Similarity=0.404  Sum_probs=176.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +..++|++++.||+|+||+||+|+.  +|+.||||++.+..... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            3568999999999999999999998  57889999998654322 34567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||.|||++|  |+||||||+|||++.+|++||+|||+++...
T Consensus        83 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             EEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999999863   35899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..   ..+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          158 DV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Cc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            43   246799999999999987654   79999999999999999999754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-37  Score=338.03  Aligned_cols=201  Identities=21%  Similarity=0.311  Sum_probs=177.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l  731 (867)
                      +..++|++++.||+|+||+||+|++.  ++.||||++.+.... ....+.+.+|..+|..+ +||||+++++++++...+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            45689999999999999999999985  567999999875432 23456788999999987 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ||||||++||+|.+++....   .+++..++.++.||+.||+|||++|  |+||||||+||||+.+|++||+|||+++..
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999998633   4899999999999999999999999  999999999999999999999999999875


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..........+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence            444444567899999999999987654   79999999999999999999754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-37  Score=347.47  Aligned_cols=203  Identities=21%  Similarity=0.303  Sum_probs=177.2

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      .+.+..++|.+++.||+|+||+||+|++  +++.||+|++.+..... ...+.+.+|+.+|+.++|||||+++++|.+..
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            3456678999999999999999999998  46789999997643221 22345789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|||||||+||+|.++++..    .+++..+..++.||+.||+|||+++  ||||||||+||||+.+|++||+|||+++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            999999999999999999752    3899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCCC-------hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACNS-------LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~~-------~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... ....+.+||+.|+|||++.+..       .+|||||||++|+|++|.+||...
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            765432 2345779999999999998643       489999999999999999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.7e-37  Score=338.69  Aligned_cols=202  Identities=26%  Similarity=0.366  Sum_probs=169.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHH-HHhcCCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~I-Lk~LrHPNIVkl~ga~~~~~~  730 (867)
                      .+..++|++++.||+|+||+||+|++  ++..||||++.+..... .....+.+|..+ ++.++|||||+++++|++...
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            34668999999999999999999998  46679999998776543 445667788877 577899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +||||||++||+|..++.+..   .+++..++.++.||+.||+|||++|  |+||||||+||||+.+|++||+|||+++.
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999999998633   4889999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .........+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  242 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  242 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            5444444567899999999999987654   89999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-36  Score=328.52  Aligned_cols=202  Identities=21%  Similarity=0.329  Sum_probs=166.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      .+..++|++.+.||+|+||+||+|+.     .++.||||++.+.....  .....+.+|+.+|+.++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            35568999999999999999999987     57789999998764432  345667899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      .+.+|+||||+++|+|.+++...   ..+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCc
Confidence            99999999999999999999763   34889999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++............+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  224 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE  224 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence            9865444333456789999999999986544   89999999999999999999754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=346.00  Aligned_cols=206  Identities=18%  Similarity=0.259  Sum_probs=178.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ....+..++|++++.||+|+||+||+|+.  +++.||||++.+..... ...+.+.+|+.+|..++||||++++++|++.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34456779999999999999999999998  57889999998654322 2345578999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+||||||+++|+|.+++.+..  ..+++..++.++.||+.||+|||+++  ||||||||+||||+.+|++||+|||++
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999997632  35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc-ccccccCCCcccccccccCC----------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTF-ISSKSVAGTVVFFAAHQTAC----------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~-~s~~s~aGTp~YmAPEvl~~----------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +...... ......+||+.|+|||++..          ...+|||||||++|+|++|.+||...
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            8765432 23345799999999999872          34589999999999999999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=338.64  Aligned_cols=201  Identities=19%  Similarity=0.331  Sum_probs=177.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ..+..++|++++.||+|+||+||+|++  +++.||||++.+..... ...+.+.+|+.+|+.++|||||+++++|.+...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            356779999999999999999999998  46779999998654332 345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+.+|+|..++...   ..+++..++.++.||+.||.|||++|  |+||||||+||||+.+|++||+|||+++.
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeee
Confidence            99999999999999999863   35899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .... ....+.+||+.|+|||++.+      ...+|||||||++|+|++|..||..
T Consensus       165 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          165 LPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             CCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence            6443 23457799999999999974      2248999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-36  Score=322.50  Aligned_cols=196  Identities=24%  Similarity=0.373  Sum_probs=175.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||+||+|.+  +++.||||++.......  .+.+.+|+.+++.++||||+++++++.....+++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            36899999999999999999986  57889999997654332  356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|.+++...    .+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999999999763    3899999999999999999999999  9999999999999999999999999998776555


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            55567799999999999987654   89999999999999999999654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.6e-37  Score=346.25  Aligned_cols=206  Identities=17%  Similarity=0.250  Sum_probs=177.5

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      .+.+..++|++++.||+|+||+||+|++.  ++.||||++.+..... .....+.+|+.++..++||||++++++|.+..
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34566789999999999999999999984  6779999997643222 22334789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|||||||++|+|.+++.+.  ...+++..++.++.||+.||+|||+++  ||||||||+||||+.+|++||+|||+++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            999999999999999999863  235899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccC-----C---CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTA-----C---NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~-----~---~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...... ......+||+.|+|||++.     .   ...+|||||||++|+|++|.+||....
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            654432 2334579999999999987     2   345899999999999999999997543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.9e-36  Score=318.06  Aligned_cols=200  Identities=30%  Similarity=0.452  Sum_probs=174.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      .+..++|++++.||+|+||+||+|.+  ++..||+|++...  .....+.+.+|+.+|++++||||+++++++......+
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            45668999999999999999999998  4778999988543  3456678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            999999999999999863  235899999999999999999999999  9999999999999999999999999998764


Q ss_pred             CCccc--------------ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          813 NTFIS--------------SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       813 ~t~~s--------------~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .....              ....+||+.|+|||++.+..+   +||||||+++|+|++|..|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            33221              125689999999999987554   8999999999999999988865

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.7e-36  Score=316.34  Aligned_cols=197  Identities=22%  Similarity=0.321  Sum_probs=172.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++++.||+|+||+||+|++  +++.||||++............+.+|+.++++++||||+++++++.....+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            6899999999999999999998  47789999998776656666788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+.+ +|...+...  ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9976 555555432  235899999999999999999999999  99999999999999999999999999987765544


Q ss_pred             cccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ......||+.|+|||++.+..    .+|||||||++|+|++|..||+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            456678999999999987643    48999999999999988877643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-36  Score=332.83  Aligned_cols=197  Identities=23%  Similarity=0.363  Sum_probs=176.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..++|++++.||+|+||+||+|++  +++.||||++.+..... ...+.+.+|+.+|+.++||||+++++++.+...+||
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            458999999999999999999998  47889999998754332 345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++|+|.+++.+..   .+++..++.++.||+.||.|||++|  |+||||||+||||+.+|++||+|||+++....
T Consensus       119 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999998633   4899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .   ..+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  241 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence            3   246789999999999987554   89999999999999999999754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.2e-36  Score=320.38  Aligned_cols=201  Identities=23%  Similarity=0.341  Sum_probs=170.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      .++|++++.||+|+||+||+|++  +++.||||++.... .....+.+.+|+.+|++++|||||+++++|....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            36899999999999999999998  57889999998654 2334577899999999999999999999986543      


Q ss_pred             ---------------------------------------------------eEEEEEeccCCCCHHHHHhcCCCCCCCCH
Q 002910          730 ---------------------------------------------------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQ  758 (867)
Q Consensus       730 ---------------------------------------------------~l~LVmEy~~gGSL~~~L~~~~~~~~l~e  758 (867)
                                                                         .+++|||||++|+|.+++..........+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               38999999999999999987655555677


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc------------ccccccCCCcc
Q 002910          759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF------------ISSKSVAGTVV  826 (867)
Q Consensus       759 ~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~------------~s~~s~aGTp~  826 (867)
                      ..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++......            ......+||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            788999999999999999999  9999999999999999999999999998765432            22345689999


Q ss_pred             cccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          827 FFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       827 YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |+|||++.+..   .+|||||||++|+|++|..|+...
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~  279 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER  279 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH
Confidence            99999988754   489999999999999999887654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.9e-36  Score=329.06  Aligned_cols=198  Identities=23%  Similarity=0.367  Sum_probs=177.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||.||+|.+  ++..||||++..........+.+.+|+.+|++++|||||++++++......|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            36899999999999999999998  4788999999887777777788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC---CcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~---g~VKLsDFGLAr~~~  812 (867)
                      ||+.+|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+   +.+||+|||+++...
T Consensus       108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999763   35899999999999999999999999  9999999999999765   459999999998765


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ... .....+||+.|+|||++.+..+   +|||||||++|+|++|.+||+..
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          183 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             TCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            432 2346789999999999987554   89999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=319.07  Aligned_cols=200  Identities=25%  Similarity=0.389  Sum_probs=169.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch------------------------HHHHHHHHHHHH
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD------------------------DQLKEFLREVAI  709 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~------------------------~~~k~f~~Ei~I  709 (867)
                      +..++|++.+.||+|+||+||+|+.  +++.||||++.......                        ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3458999999999999999999987  57789999997654321                        124568899999


Q ss_pred             HHhcCCCCeeeEEeEEee--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCC
Q 002910          710 MKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL  787 (867)
Q Consensus       710 Lk~LrHPNIVkl~ga~~~--~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDL  787 (867)
                      |++++||||+++++++..  ...+++||||+++++|.+++..    ..+++..++.++.||+.||.|||+++  |+||||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl  163 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDI  163 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCC
Confidence            999999999999999986  5689999999999999876542    35899999999999999999999999  999999


Q ss_pred             CCCcEEEcCCCcEEEEecCccccccCCcccccccCCCcccccccccCCCC------hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          788 KSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS------LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       788 KPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~------~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+|||++.++.+||+|||+++.............||+.|+|||++.+..      .+|||||||++|+|++|..||...
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999999987765444445678999999999998643      379999999999999999999754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=328.11  Aligned_cols=203  Identities=17%  Similarity=0.160  Sum_probs=175.1

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEE-------EcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAE-------WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLF  721 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~-------~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr---HPNIVkl  721 (867)
                      ..+++..++|.+.+.||+|+||+||+|.       ..++.||||++....     ..++.+|+.++++++   |+||+.+
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            4566778999999999999999999994       257789999987543     345778888888887   9999999


Q ss_pred             EeEEeeCCeEEEEEeccCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---
Q 002910          722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPA--AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---  796 (867)
Q Consensus       722 ~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~--~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---  796 (867)
                      ++++...+..+||||||++|+|.+++....  ....+++..++.++.||+.||+|||+++  ||||||||+||||+.   
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence            999999999999999999999999997421  2345999999999999999999999999  999999999999998   


Q ss_pred             --------CCcEEEEecCcccccc--CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          797 --------NWTVKVCDFGLSRFKA--NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       797 --------~g~VKLsDFGLAr~~~--~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                              ++.+||+|||+++...  .........+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                    8999999999997653  22233456789999999999998655   79999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-36  Score=339.49  Aligned_cols=199  Identities=20%  Similarity=0.311  Sum_probs=178.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|.+  +++.+|+|++..........+.+.+|+.+|++++|||||++++++...+..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            36899999999999999999987  5788999999988777777788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGLAr~~~  812 (867)
                      ||+.+|+|.+.+...   ..+++..+..++.||+.||.|||++|  |+||||||+|||++   .++.+||+|||+++...
T Consensus        90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999863   35899999999999999999999999  99999999999998   56889999999998776


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .........+||+.|+|||++.+..+   +|||||||++|+|++|.+||+..
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~  216 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE  216 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence            55444456799999999999987554   89999999999999999999754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.8e-36  Score=310.55  Aligned_cols=202  Identities=25%  Similarity=0.461  Sum_probs=180.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CeE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHL  731 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~l  731 (867)
                      ..+..++|++.+.||+|+||+||+|+++++.||||++..........+.+.+|+.++++++||||+++++++...  ..+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            456779999999999999999999999999999999998776777778899999999999999999999999877  789


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++++|+||||||+|||++.++.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            99999999999999998643 23589999999999999999999998888999999999999999999999999987543


Q ss_pred             cCCcccccccCCCcccccccccCCCC------hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNS------LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~------~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..     ....||+.|+|||++.+..      .+|||||||++|+|++|..||...
T Consensus       164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  214 (271)
T 3kmu_A          164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL  214 (271)
T ss_dssp             SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred             cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            22     3457899999999998643      389999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.7e-36  Score=317.79  Aligned_cols=200  Identities=25%  Similarity=0.388  Sum_probs=171.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||.||+|++  .+..||+|++...... ....+.+.+|+.++++++||||+++++++...+.+++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            47899999999999999999987  5778999999765443 35567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999763   35899999999999999999999999  999999999999999999999999999876543


Q ss_pred             c-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 F-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      . ......+||+.|+|||++.+..+   +||||||+++|+|++|..||....
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2 22345689999999999887554   899999999999999999997643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-36  Score=329.02  Aligned_cols=201  Identities=22%  Similarity=0.307  Sum_probs=174.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch---HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~---~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +.|++.+.||+|+||+||+|.+  +++.||||++.......   ...+.+.+|+.+|+.++||||+++++++...+.+||
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            6899999999999999999988  47889999997643221   134678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc---EEEEecCccc
Q 002910          734 VTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSR  809 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~---VKLsDFGLAr  809 (867)
                      |||||++|+|.+++.... ....+++..++.++.||+.||.|||+++  |+||||||+|||++.++.   +||+|||+++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            999999999988776432 2345899999999999999999999999  999999999999986654   9999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ............+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            87665444456789999999999987554   89999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.6e-36  Score=320.08  Aligned_cols=202  Identities=22%  Similarity=0.353  Sum_probs=171.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +.-.++|++++.||+|+||+||+|++ +++.||||++............+.+|+.+|++++||||+++++++.....+++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            33458999999999999999999998 67889999997665444456778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++ +|.+++....  ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus        97 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9999975 7888776532  35899999999999999999999999  99999999999999999999999999987765


Q ss_pred             CcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........+||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            44444566899999999998753    3489999999999999999999654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-36  Score=341.25  Aligned_cols=203  Identities=23%  Similarity=0.348  Sum_probs=168.2

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ..+..++|++++.||+|+||+||+|+.  +++.||||++...... ......+.+|+.+|+.++||||++++++|...+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            345668999999999999999999998  5778999999865432 3445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ++|||||+++|+|..++...   ..+++..+..++.||+.||+|||+ +|  ||||||||+||||+.++.+||+|||+++
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCce
Confidence            99999999999999999763   358999999999999999999998 89  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ............+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            75544444567899999999999986554   89999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-36  Score=317.21  Aligned_cols=198  Identities=24%  Similarity=0.378  Sum_probs=168.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      ++|++++.||+|+||+||+|++ .++.||||++............+.+|+.++++++||||+++++++...+.+++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            6899999999999999999998 478899999976654444446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +.+ +|.+++...  ...+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            975 899888763  235889999999999999999999999  999999999999999999999999999876544333


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4456889999999998753    3489999999999999999999754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.8e-36  Score=329.03  Aligned_cols=198  Identities=24%  Similarity=0.392  Sum_probs=175.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~----~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+.|++++.||+|+||+||+|++  +|..||||++.+......    ..+.+.+|+.+|++++||||++++++|.....+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            36799999999999999999998  478899999987654321    246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC----cEEEEecCc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGL  807 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g----~VKLsDFGL  807 (867)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999763   35899999999999999999999999  99999999999998877    799999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++...... .....+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            98765432 2356789999999999987554   89999999999999999999754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-36  Score=323.23  Aligned_cols=200  Identities=25%  Similarity=0.324  Sum_probs=173.3

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--  729 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~--  729 (867)
                      .++.+..++|++.+.||+|+||+||+|++.++.||||++....   .......+|+.+|++++|||||++++++....  
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            4456778999999999999999999999999999999997543   33445567999999999999999999998754  


Q ss_pred             --eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCccccCCCCCcEEEcCC
Q 002910          730 --HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL----------NPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       730 --~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~----------gp~IVHRDLKPeNILLd~~  797 (867)
                        .+++||||+++|+|.++++..    .+++..++.++.||+.||.|||+.          +  |+||||||+|||++.+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred             CceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence              479999999999999999763    389999999999999999999998          8  9999999999999999


Q ss_pred             CcEEEEecCccccccCCc--ccccccCCCcccccccccCCC-----C---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          798 WTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACN-----S---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~-----~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +.+||+|||+++......  ......+||+.|+|||++.+.     .   .+|||||||++|+|++|..||..
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            999999999998764432  223446899999999999863     2   26999999999999999999865

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.8e-36  Score=328.01  Aligned_cols=205  Identities=26%  Similarity=0.401  Sum_probs=176.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG  723 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~g  723 (867)
                      +++..++|++++.||+|+||+||+|++.         +..||||++... ......+.+.+|+.+|+++ +||||+++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            4567789999999999999999999873         235999998754 3445677899999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                      +|...+.+|+||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++  |+||||||+
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~  232 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR  232 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence            99999999999999999999999986431             234789999999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       791 NILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ||||+.++.+||+|||+++......  .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999998664432  22334567899999999987554   899999999999999 99998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.4e-36  Score=346.78  Aligned_cols=205  Identities=22%  Similarity=0.260  Sum_probs=181.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|.+.+.||+|+||+||+|++  +|+.||||++.+..... .....+.+|+.+|++++||||++++++|.....+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            45678999999999999999999998  47889999998654432 3356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~-~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ||||||++||+|..++..... ...+++..++.++.||+.||.|||++|  |+||||||+||||+.+|++||+|||+++.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence            999999999999999976432 335899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...........+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            6554444456799999999999987655   79999999999999999999764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-35  Score=324.70  Aligned_cols=203  Identities=17%  Similarity=0.211  Sum_probs=178.6

Q ss_pred             cCCCCeEEEEEeccC--CceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          656 ISWDELHVKERVGAG--SFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       656 i~~~dy~i~e~LG~G--sFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ...++|++++.||+|  +||+||+|++.  ++.||||++..........+.+.+|+.+|++++|||||+++++|...+.+
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            356899999999999  99999999984  78899999998776677778899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++  |+||||||+||||+.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999997643 235899999999999999999999999  999999999999999999999999998654


Q ss_pred             cCCc-------ccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTF-------ISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~-------~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....       ......+||+.|+|||++.+.     ..+|||||||++|+|++|..||...
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            2211       112345899999999999872     3489999999999999999999764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-35  Score=318.95  Aligned_cols=196  Identities=18%  Similarity=0.325  Sum_probs=173.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||+||+|.+  ++..||+|++....   .....+.+|+.+|+.++||||+++++++.....+++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            47899999999999999999998  46789999987543   34556889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC--CCcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~--~g~VKLsDFGLAr~~~~  813 (867)
                      ||+++|+|.+++...  ...+++..++.++.||+.||.|||++|  |+||||||+|||++.  ++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           81 EFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999999753  235899999999999999999999999  999999999999987  78999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. ......||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  206 (321)
T 1tki_A          157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence            32 2345689999999999987643   89999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=313.12  Aligned_cols=199  Identities=21%  Similarity=0.322  Sum_probs=169.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|++.  ++.||||++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            368999999999999999999984  788999999776655566678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|..++...   ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus        82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999988753   34899999999999999999999999  9999999999999999999999999998776544


Q ss_pred             ccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......+||+.|+|||++.+    ...+||||||+++|+|++|.+||...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            44456689999999999865    34589999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=315.77  Aligned_cols=201  Identities=23%  Similarity=0.342  Sum_probs=173.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--eE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HL  731 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~--~l  731 (867)
                      +.-++|++.+.||+|+||+||+|++.  ++.||||++...... ...+.+.+|+.+|++++||||+++++++....  .+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            34578999999999999999999984  788999999764432 23566789999999999999999999998665  78


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE----cCCCcEEEEecCc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL  807 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL----d~~g~VKLsDFGL  807 (867)
                      ++||||+++++|.+++........+++..++.++.||+.||.|||+++  |+||||||+||||    +.++.+||+|||+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            999999999999999987554445899999999999999999999999  9999999999999    8888999999999


Q ss_pred             cccccCCcccccccCCCcccccccccC--------C---CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTA--------C---NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~--------~---~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++....... .....||+.|+|||++.        +   ...+|||||||++|+|++|..||..
T Consensus       163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             CEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            987654332 34568999999999975        2   2348999999999999999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-35  Score=324.56  Aligned_cols=198  Identities=27%  Similarity=0.388  Sum_probs=174.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      .+++|.+.+.||+|+||+||+|.+  +++.||||++....... .....+.+|+.+|+.++||||+++++++.....+++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            458999999999999999999998  67889999997654322 223568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+ +|+|.+++...   ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus        87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            99999 78898888763   34899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ... ....+||+.|+|||++.+..+    +|||||||++|+|++|..||...
T Consensus       161 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          161 GNF-LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             SBT-TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             Ccc-cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            332 356789999999999987553    79999999999999999999754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-35  Score=309.92  Aligned_cols=193  Identities=29%  Similarity=0.473  Sum_probs=165.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHh--cCCCCeeeEEeEEee----CCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--VRHPNVVLFMGAVTK----RPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~--LrHPNIVkl~ga~~~----~~~  730 (867)
                      ..++|++.+.||+|+||+||+|+++++.||||++....     ...+.+|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            45799999999999999999999999999999986542     3456677777777  789999999998654    345


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCccccCCCCCcEEEcCCCcEEE
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH--------NLNPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLH--------s~gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                      +++||||+++|+|.++++.    ..+++..++.++.||+.||+|||        +++  |+||||||+|||++.++.+||
T Consensus        81 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred             eEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence            8999999999999999964    34899999999999999999999        888  999999999999999999999


Q ss_pred             EecCccccccCCcc----cccccCCCcccccccccCCC---------ChHHHHHHHHHHHHHhcC----------CCCcc
Q 002910          803 CDFGLSRFKANTFI----SSKSVAGTVVFFAAHQTACN---------SLALIFSLSGWLQSSFEE----------SPQMR  859 (867)
Q Consensus       803 sDFGLAr~~~~t~~----s~~s~aGTp~YmAPEvl~~~---------~~SDIwSLG~lLyeM~tG----------~~Pf~  859 (867)
                      +|||+++.......    .....+||+.|+|||++.+.         ..+|||||||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999986544322    12345899999999999876         348999999999999999          88885


Q ss_pred             c
Q 002910          860 S  860 (867)
Q Consensus       860 s  860 (867)
                      .
T Consensus       235 ~  235 (301)
T 3q4u_A          235 D  235 (301)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-35  Score=320.65  Aligned_cols=209  Identities=24%  Similarity=0.388  Sum_probs=176.6

Q ss_pred             cccccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeE
Q 002910          650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF  721 (867)
Q Consensus       650 ~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl  721 (867)
                      ....|++..++|++++.||+|+||.||+|++.       ++.||||++.... .....+.+.+|+.+|.++ +|||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34567888999999999999999999999853       3579999997543 344567899999999999 78999999


Q ss_pred             EeEEeeCCe-EEEEEeccCCCCHHHHHhcCCC------------------------------------------------
Q 002910          722 MGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAA------------------------------------------------  752 (867)
Q Consensus       722 ~ga~~~~~~-l~LVmEy~~gGSL~~~L~~~~~------------------------------------------------  752 (867)
                      ++++...+. +++||||+++|+|.++++....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999986432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC--c
Q 002910          753 ---------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--F  815 (867)
Q Consensus       753 ---------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~  815 (867)
                                     ...+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++.....  .
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                           122889999999999999999999999  999999999999999999999999999865332  2


Q ss_pred             ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .......||+.|+|||++.+..   .+|||||||++|+|++ |..||...
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  299 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  299 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence            2334567899999999987654   4899999999999998 99999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-35  Score=316.94  Aligned_cols=197  Identities=23%  Similarity=0.380  Sum_probs=173.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch----HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~----~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +.|.+.+.||+|+||+||+|.+  ++..||||++.......    ...+.+.+|+.+|++++||||+++++++.....++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            6799999999999999999998  47889999998764332    13567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC----cEEEEecCcc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLS  808 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g----~VKLsDFGLA  808 (867)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++    .+||+|||++
T Consensus        91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999753   35899999999999999999999999  99999999999999887    8999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +...... .....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       166 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  220 (326)
T 2y0a_A          166 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  220 (326)
T ss_dssp             EECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             eECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            8764332 2346689999999999986554   89999999999999999999653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-35  Score=319.84  Aligned_cols=198  Identities=24%  Similarity=0.341  Sum_probs=171.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||+||+|++  +++.||||++...... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            47999999999999999999988  4778999999755422 23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t-  814 (867)
                      ||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999988753   35899999999999999999999999  999999999999999999999999999865322 


Q ss_pred             -cccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 -FISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 -~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       .......+||+.|+|||++.+..+    +|||||||++|+|++|..||...
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  211 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence             222346789999999999986553    79999999999999999999754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-35  Score=306.07  Aligned_cols=202  Identities=25%  Similarity=0.447  Sum_probs=176.0

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .|.+..++|++.+.||+|+||+||+|.+ ++..||+|++.......   +.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            3567789999999999999999999998 67779999998665433   4688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccc
Confidence            9999999999999999763  235899999999999999999999999  999999999999999999999999999865


Q ss_pred             cCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          812 ANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       812 ~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .... .......+|+.|+|||++.+..+   +||||||+++|+|++ |.+||...
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            4432 22345567889999999875444   899999999999999 89998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-35  Score=317.25  Aligned_cols=207  Identities=26%  Similarity=0.374  Sum_probs=176.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA  724 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga  724 (867)
                      ..+++..++|++.+.||+|+||.||+|++.+       +.||||++.... .....+.+.+|+.+|++++||||++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456778999999999999999999999864       679999987543 34556789999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcc
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPIL  783 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~---------------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IV  783 (867)
                      +.....+++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+++  |+
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv  196 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV  196 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            9999999999999999999999976321                     145899999999999999999999999  99


Q ss_pred             ccCCCCCcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCC
Q 002910          784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQ  857 (867)
Q Consensus       784 HRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~P  857 (867)
                      ||||||+|||++.++.+||+|||+++......  .......+|+.|+|||++.+..   .+||||||+++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999999999999999999998654322  2234557899999999987544   4899999999999999 9999


Q ss_pred             cccc
Q 002910          858 MRSL  861 (867)
Q Consensus       858 f~sl  861 (867)
                      |...
T Consensus       277 ~~~~  280 (343)
T 1luf_A          277 YYGM  280 (343)
T ss_dssp             TTTS
T ss_pred             CCCC
Confidence            8764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.9e-35  Score=303.93  Aligned_cols=199  Identities=23%  Similarity=0.356  Sum_probs=177.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||.||+|.+  ++..||+|++..........+.+.+|+.++++++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            47899999999999999999988  4778999999887777777788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc---EEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~---VKLsDFGLAr~~~  812 (867)
                      ||+++++|.+.+...   ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999888763   35899999999999999999999999  999999999999976655   9999999997765


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .... .....||+.|+|||++.+..+   +||||||+++|+|++|..||+...
T Consensus       160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  211 (284)
T 3kk8_A          160 DSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  211 (284)
T ss_dssp             SSCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCcc-ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence            4332 345689999999999987654   899999999999999999997543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-35  Score=324.00  Aligned_cols=198  Identities=23%  Similarity=0.319  Sum_probs=161.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC--eEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP--HLS  732 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~--~l~  732 (867)
                      .++|++++.||+|+||+||+|.+  +++.||||++..........+.+.+|+.+|+.+. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            47899999999999999999987  5788999999766555666778899999999998 999999999997554  799


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +|||||. |+|..++..    ..+++..+..++.||+.||+|||++|  |+||||||+||||+.++.+||+|||+++...
T Consensus        88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            9999996 689999875    24889999999999999999999999  9999999999999999999999999998653


Q ss_pred             CC---------------------cccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          813 NT---------------------FISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       813 ~t---------------------~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..                     .......+||+.|+|||++.+    ...+|||||||++|+|++|.+||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21                     111234689999999999876    334899999999999999999997643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-35  Score=316.48  Aligned_cols=200  Identities=23%  Similarity=0.330  Sum_probs=158.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|.+  +++.||||++..... ....+.+.+|+.+|++++||||+++++++...+.++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            47899999999999999999987  478899999976542 223356789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~---~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||+. |+|.+++....   ....+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9997 69998886532   1234889999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .........+||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            444344566899999999998753    3489999999999999999999654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.2e-35  Score=305.61  Aligned_cols=202  Identities=31%  Similarity=0.492  Sum_probs=164.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ++..++|++.+.||+|+||.||+|.+.++.||||++.......  ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            5677999999999999999999999999999999987654322  33567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ccccCCCCCcEEEcC--------CCcEEEE
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP-ILHWDLKSPNLLVDK--------NWTVKVC  803 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~-IVHRDLKPeNILLd~--------~g~VKLs  803 (867)
                      +||||+++++|.+++..    ..+++..++.++.||+.||.|||+++.. |+||||||+|||++.        ++.+||+
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            99999999999999864    3589999999999999999999998733 889999999999986        7889999


Q ss_pred             ecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          804 DFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       804 DFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      |||+++.......  ....||+.|+|||.+.+..+   +||||||+++|+|++|..||....
T Consensus       159 Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  218 (271)
T 3dtc_A          159 DFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID  218 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             cCCcccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999986654332  35689999999999876544   899999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-35  Score=351.61  Aligned_cols=202  Identities=21%  Similarity=0.309  Sum_probs=177.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~  730 (867)
                      .+..++|++++.||+|+||+||+|++  +++.||||++.+.... ....+.+..|..+|..+ +||||++++++|++...
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            45678999999999999999999998  4667999999865432 23456788999999987 69999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +||||||+++|+|..+++...   .+++..++.|+.||+.||+|||+++  ||||||||+||||+.+|++||+|||+++.
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeec
Confidence            999999999999999998643   4899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .........+.+||+.|+|||++.+..+   +|||||||+||+|++|.+||...
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            5544445567899999999999987665   79999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=316.58  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=172.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ++..++|++.+.||+|+||+||+|++.     +..||||++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            566789999999999999999999983     3349999987542 3455678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .++|||||+++|+|.++++..  ...+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             ccEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999999999753  235899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ......   .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||+...
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  259 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT  259 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence            764322   12233456889999999986544   799999999999998 999997653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.1e-35  Score=314.44  Aligned_cols=194  Identities=25%  Similarity=0.353  Sum_probs=172.8

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .|...+.||+|+||+||+|++  +|+.||||++.....  ...+.+.+|+.+|++++||||+++++++.....+++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            477788999999999999998  488899999976542  2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +++++|.+++..    ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus       124 ~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          124 LQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            999999999874    24899999999999999999999999  999999999999999999999999999877654444


Q ss_pred             ccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....+||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            467789999999999987554   89999999999999999999754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-35  Score=344.30  Aligned_cols=203  Identities=21%  Similarity=0.258  Sum_probs=179.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|++.+.||+|+||+||+|++  +|+.||||++.+..... .....+.+|+.+|+.++|||||++++++.+...+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            36678999999999999999999998  57889999998754332 3345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ||||||++||+|..++.... ...+++..++.++.||+.||+|||++|  ||||||||+||||+.+|++||+|||+++..
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999999998643 234899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .... .....+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       337 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          337 PEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             CTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             ccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            5432 2245689999999999987554   79999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.4e-35  Score=305.82  Aligned_cols=204  Identities=26%  Similarity=0.431  Sum_probs=174.4

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ...+++..++|++++.||+|+||+||+|.+. +..||||++.......   +++.+|+.++++++||||+++++++....
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            4567788899999999999999999999985 4479999998665433   45889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++++|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~  168 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSR  168 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred             CeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccc
Confidence            9999999999999999997632  34899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...... .......+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            664432 22334567889999999885444   799999999999998 99998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-35  Score=316.63  Aligned_cols=201  Identities=26%  Similarity=0.368  Sum_probs=166.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe---
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH---  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~---  730 (867)
                      ..++|++.+.||+|+||+||+|++  +++.||||++...... ......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            347899999999999999999997  5778999999876443 3456788999999999999999999999876543   


Q ss_pred             -EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          731 -LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       731 -l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                       .|+||||+++++|.++++..   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             49999999999999999763   35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ......   .......||+.|+|||++.+..+   +||||||+++|+|++|..||....
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            654322   22345679999999999987554   899999999999999999997643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4e-35  Score=314.65  Aligned_cols=195  Identities=18%  Similarity=0.233  Sum_probs=171.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||+||+|+.  +++.||||++.....    ...+.+|+.+++++ +||||+++++++......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            37899999999999999999996  678899999875532    23578899999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc-----EEEEecCccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-----VKVCDFGLSR  809 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~-----VKLsDFGLAr  809 (867)
                      |||+ +++|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++.     +||+|||+++
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           84 LELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            9999 99999999863  345899999999999999999999999  999999999999999887     9999999998


Q ss_pred             cccCCcc-------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFI-------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~-------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......       .....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~  220 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL  220 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence            7544321       1346789999999999997654   79999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.9e-35  Score=330.78  Aligned_cols=200  Identities=27%  Similarity=0.456  Sum_probs=174.2

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-e
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-H  730 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~-~  730 (867)
                      ..|++..++|++.+.||+|+||+||+|.++++.||||+++...    ..+.+.+|+.+|++++|||||++++++.... .
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            4567888999999999999999999999999999999997653    3457899999999999999999999987665 7


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++|||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++.
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            999999999999999998643 234789999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      .....   ....+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       339 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  390 (450)
T 1k9a_A          339 ASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  390 (450)
T ss_dssp             CC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred             ccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            54332   23467899999999986554   899999999999998 99999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-35  Score=331.28  Aligned_cols=189  Identities=26%  Similarity=0.357  Sum_probs=152.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----CeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~l  731 (867)
                      ++|++++.||+|+||+||+|++  +++.||||++..........+++.+|+.+|++++|||||++++++...     ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            7899999999999999999987  578899999977655556678899999999999999999999998433     579


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |+||||+ +|+|.+++...   ..+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+++..
T Consensus       133 ~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhc
Confidence            9999998 67999999763   35899999999999999999999999  999999999999999999999999999875


Q ss_pred             cCCc---------------------------ccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhc
Q 002910          812 ANTF---------------------------ISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFE  853 (867)
Q Consensus       812 ~~t~---------------------------~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~t  853 (867)
                      ....                           ......+||+.|+|||++..    ...+|||||||++|+|++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            4221                           12245588999999998643    334899999999999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-35  Score=326.15  Aligned_cols=207  Identities=26%  Similarity=0.400  Sum_probs=178.1

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+.|.+..++|.+.+.||+|+||+||+|++  +++.||||++... ......+.+.+|+.+|++++|||||++++++...
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            345678889999999999999999999999  4788999998744 3345566789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      +.++|||||+++|+|.++++...  ..+++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||++
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s  260 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMS  260 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence            99999999999999999997632  34889999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccc--cccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          809 RFKANTFISS--KSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~~s~--~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +.........  ....+++.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~  320 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS  320 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            8754432211  12245778999999886554   899999999999998 999997653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-35  Score=320.52  Aligned_cols=197  Identities=26%  Similarity=0.378  Sum_probs=163.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ...++|++++.||+|+||+||+|+.  +++.||||++.......   +.+.+|+.+++.++||||+++++++.....+++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            3458999999999999999999998  57789999998654333   357799999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc--EEEEecCccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFK  811 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~--VKLsDFGLAr~~  811 (867)
                      ||||+++|+|.+++....   .+++..++.++.||+.||.|||++|  |+||||||+||||+.++.  +||+|||+++..
T Consensus        94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999997633   4899999999999999999999999  999999999999987765  999999999754


Q ss_pred             cCCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .... .....+||+.|+|||++.+..+    +|||||||++|+|++|..||...
T Consensus       169 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (361)
T 3uc3_A          169 VLHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP  221 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred             cccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence            3322 2345689999999999876554    79999999999999999999764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-35  Score=308.64  Aligned_cols=207  Identities=24%  Similarity=0.377  Sum_probs=177.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA  724 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga  724 (867)
                      ..+++..++|.+.+.||+|+||.||+|.+.       +..||||++.... .....+.+.+|+.+|++++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            456777899999999999999999999862       3679999987543 44566789999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcc
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPIL  783 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~---------------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IV  783 (867)
                      +...+.+++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+++  |+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv  172 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV  172 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence            9999999999999999999999986432                     123889999999999999999999999  99


Q ss_pred             ccCCCCCcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCC
Q 002910          784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQ  857 (867)
Q Consensus       784 HRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~P  857 (867)
                      ||||||+|||++.++.+||+|||+++......  .......+|+.|+|||++.+..   .+|||||||++|+|++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998664322  2234557789999999988654   4899999999999999 9999


Q ss_pred             cccc
Q 002910          858 MRSL  861 (867)
Q Consensus       858 f~sl  861 (867)
                      |...
T Consensus       253 ~~~~  256 (314)
T 2ivs_A          253 YPGI  256 (314)
T ss_dssp             STTC
T ss_pred             CCCC
Confidence            8754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.1e-35  Score=307.72  Aligned_cols=204  Identities=33%  Similarity=0.574  Sum_probs=167.1

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      +..++..++|++.+.||+|+||+||+|++.+ .||||++..........+.+.+|+.+|++++||||+++++++ ..+..
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            4457788999999999999999999998765 599999987776677788899999999999999999999954 56678


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999999999753  345899999999999999999999999  999999999999999999999999999765


Q ss_pred             cCC--cccccccCCCcccccccccC---CCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANT--FISSKSVAGTVVFFAAHQTA---CNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t--~~s~~s~aGTp~YmAPEvl~---~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  ........||+.|+|||++.   +..   .+||||||+++|+|++|..||...
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  228 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI  228 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence            421  22234568999999999987   333   489999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-35  Score=315.50  Aligned_cols=207  Identities=25%  Similarity=0.348  Sum_probs=173.9

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEE-------cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA  724 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~-------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga  724 (867)
                      .+++..++|.+.+.||+|+||+||+|.+       .+..||||++.... .....+.+.+|+.+|+++ +||||++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4678889999999999999999999997       23469999997542 234456789999999999 89999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCccc
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAG--------------------EMMDQRRRLRMALDVAKGINYLHNLNPPILH  784 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~~--------------------~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVH  784 (867)
                      +...+.+++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||++|  |+|
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH  195 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH  195 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence            99999999999999999999999864321                    23789999999999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCc
Q 002910          785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQM  858 (867)
Q Consensus       785 RDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf  858 (867)
                      |||||+||||+.++.+||+|||+++......  .......||+.|+|||++.+..+   +|||||||++|+|++ |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999999998654322  12334567889999999875444   899999999999998 99999


Q ss_pred             cccc
Q 002910          859 RSLM  862 (867)
Q Consensus       859 ~sl~  862 (867)
                      ....
T Consensus       276 ~~~~  279 (344)
T 1rjb_A          276 PGIP  279 (344)
T ss_dssp             TTCC
T ss_pred             ccCC
Confidence            7653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.6e-35  Score=302.63  Aligned_cols=201  Identities=28%  Similarity=0.498  Sum_probs=174.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +++..++|++.+.||+|+||.||+|++.+ ..||||++.......   +++.+|+.++++++||||+++++++......+
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            45677899999999999999999999854 479999998765433   45889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        80 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             EEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecc
Confidence            9999999999999997632  34899999999999999999999999  9999999999999999999999999998664


Q ss_pred             CCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ... .......+|+.|+|||++.+..   .+||||||+++|+|++ |..||...
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY  209 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence            432 2233456778899999987644   4899999999999998 99998654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-35  Score=319.49  Aligned_cols=206  Identities=26%  Similarity=0.415  Sum_probs=178.3

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC---------ceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g---------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      .+++..++|.+++.||+|+||+||+|++.+         ..||||++... ......+.+.+|+.+++++ +|||||+++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            457788999999999999999999998732         45999998755 3445667899999999999 899999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      +++...+.+++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++  |+||||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp  219 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA  219 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCc
Confidence            999999999999999999999999986431             235899999999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +||||+.++.+||+|||+++......  .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999998764422  22345577899999999887554   899999999999999 99998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-35  Score=304.60  Aligned_cols=201  Identities=22%  Similarity=0.370  Sum_probs=157.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..++|++.+.||+|+||.||+|++  +++.||||++....... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            347899999999999999999997  68889999997654322 234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus        89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999999863  235899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........+||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  215 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD  215 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence            4433456789999999999987554   79999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.7e-35  Score=301.03  Aligned_cols=197  Identities=25%  Similarity=0.345  Sum_probs=172.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||+||+|.+  +++.||||++............+.+|+.++..+ +||||+++++++...+.+++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            37899999999999999999998  488899999987765566677889999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC----------------
Q 002910          735 TEYLPRGSLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN----------------  797 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~-~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~----------------  797 (867)
                      |||+++++|.+++..... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.+                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999976321 245899999999999999999999999  9999999999999844                


Q ss_pred             ---CcEEEEecCccccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          798 ---WTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       798 ---g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                         +.+||+|||+++.....    ....||+.|+|||++.+.    ..+|||||||++|+|++|.+++..
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence               47999999999876543    345699999999999865    248999999999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.1e-35  Score=312.42  Aligned_cols=201  Identities=25%  Similarity=0.341  Sum_probs=172.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..++|++++.||+|+||.||+|++.  ++.||||++..........+.+.+|+.++++++||||+++++++.....+++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            4589999999999999999999984  78899999987765556667788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+.+++|..++...   ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999887653   34899999999999999999999999  999999999999999999999999999876554


Q ss_pred             cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ........||+.|+|||++.+.    ..+|||||||++|+|++|.+||....
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4444567899999999998764    34899999999999999999997543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-34  Score=313.23  Aligned_cols=197  Identities=24%  Similarity=0.350  Sum_probs=173.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-----CCCeeeEEeEEee
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----HPNVVLFMGAVTK  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-----HPNIVkl~ga~~~  727 (867)
                      .+..++|++++.||+|+||+||+|++  +++.||||++...   ......+..|+.+++.++     |||||++++++..
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            34558999999999999999999998  6778999998743   344566788999999997     9999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-----------
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----------  796 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-----------  796 (867)
                      ...+++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+||||+.           
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence            99999999999 999999998643 234899999999999999999999999  999999999999975           


Q ss_pred             --------------CCcEEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          797 --------------NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       797 --------------~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                                    ++.+||+|||+++......   ...+||+.|+|||++.+..+   +|||||||++|+|++|..||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                          8899999999998654432   46689999999999987654   899999999999999999997


Q ss_pred             cc
Q 002910          860 SL  861 (867)
Q Consensus       860 sl  861 (867)
                      ..
T Consensus       261 ~~  262 (360)
T 3llt_A          261 TH  262 (360)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-35  Score=316.54  Aligned_cols=200  Identities=21%  Similarity=0.307  Sum_probs=162.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ...++|++++.||+|+||+||+|++  +++.||||++..........+.+.+|+.+|++++||||+++++++.....++|
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999987  57789999998765555556678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE-----cCCCcEEEEecCcc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-----DKNWTVKVCDFGLS  808 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL-----d~~g~VKLsDFGLA  808 (867)
                      ||||+. |+|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+||||     +..+.+||+|||++
T Consensus       111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999997 59999998643   4899999999999999999999999  9999999999999     45566999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +............+||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            8765544444566889999999998763    3489999999999999999999754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4e-35  Score=311.65  Aligned_cols=210  Identities=23%  Similarity=0.318  Sum_probs=178.7

Q ss_pred             ccccccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeE
Q 002910          649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF  721 (867)
Q Consensus       649 l~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl  721 (867)
                      ...+.+++..++|++.+.||+|+||.||+|.+.       +..||||++.... .......+.+|+.+|+.++||||+++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            345677888899999999999999999999864       4679999987543 33455678999999999999999999


Q ss_pred             EeEEeeCCeEEEEEeccCCCCHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE
Q 002910          722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPA-------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV  794 (867)
Q Consensus       722 ~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~-------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL  794 (867)
                      ++++......++||||+++|+|.+++....       ....+++..++.++.||+.||.|||++|  |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli  171 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV  171 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEE
Confidence            999999999999999999999999997522       1134689999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          795 DKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       795 d~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +.++.+||+|||+++......  .......+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            999999999999998654332  22234567899999999876443   899999999999999 88998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8e-35  Score=314.86  Aligned_cols=201  Identities=16%  Similarity=0.251  Sum_probs=171.4

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH--PNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH--PNIVkl~ga~~~~~~  730 (867)
                      +.+..+.|++.+.||+|+||+||+|.. +++.||||++..........+.+.+|+.+|++++|  |||+++++++.....
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            345668899999999999999999987 56779999998877666777889999999999987  999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++||||| .+++|.+++...   ..+++..+..++.||+.||.|||+++  |+||||||+||||+ ++.+||+|||+++.
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEEeC-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            9999994 588999999863   35899999999999999999999999  99999999999997 67899999999987


Q ss_pred             ccCCc--ccccccCCCcccccccccCC--------------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTF--ISSKSVAGTVVFFAAHQTAC--------------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~--~s~~s~aGTp~YmAPEvl~~--------------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....  ......+||+.|+|||++.+              ...+|||||||++|+|++|..||...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            64332  12346689999999999853              23489999999999999999999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2e-34  Score=302.91  Aligned_cols=200  Identities=22%  Similarity=0.279  Sum_probs=178.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..++|.+.+.||+|+||+||+|.+.  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            4578999999999999999999984  678999999876543 3456778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999988763   35899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .........||+.|+|||++.+..   .+||||||+++|+|++|..||...
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            444445678999999999998654   489999999999999999999764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.4e-35  Score=312.88  Aligned_cols=209  Identities=24%  Similarity=0.347  Sum_probs=161.0

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCc-----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~-----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ..+.+..++|++++.||+|+||+||+|++...     .||||++..........+.+.+|+.++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            44566778999999999999999999987432     6999999876656667788999999999999999999999998


Q ss_pred             eCCeE------EEEEeccCCCCHHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          727 KRPHL------SIVTEYLPRGSLYRLIHRPAA---GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       727 ~~~~l------~LVmEy~~gGSL~~~L~~~~~---~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      .....      ++||||+.+|+|.+++.....   ...+++..++.++.||+.||.|||+++  |+||||||+|||++.+
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED  173 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence            76654      999999999999999965321   124899999999999999999999999  9999999999999999


Q ss_pred             CcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          798 WTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +.+||+|||+++......  .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            999999999998654322  12234467889999999886543   899999999999999 899997643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-34  Score=305.24  Aligned_cols=207  Identities=26%  Similarity=0.366  Sum_probs=177.6

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE-------cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG  723 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~-------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~g  723 (867)
                      ..+++..++|.+.+.||+|+||.||+|++       .+..||||++.... .....+.+.+|+.+++++ +||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            45678889999999999999999999986       24579999997553 234567899999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCC
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK  788 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~---------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLK  788 (867)
                      ++...+..++||||+++|+|.+++.....               ...+++..++.++.||+.||.|||+++  |+|||||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk  172 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA  172 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence            99999999999999999999999986432               124899999999999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCccccccCCcc--cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          789 SPNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       789 PeNILLd~~g~VKLsDFGLAr~~~~t~~--s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |+|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999999987654321  2234567889999999876444   899999999999998 99998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.8e-34  Score=301.27  Aligned_cols=200  Identities=25%  Similarity=0.385  Sum_probs=175.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----~~~  730 (867)
                      ....|++.+.||+|+||.||+|.+  ++..||+|++..........+.+.+|+.+|++++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            345689999999999999999998  46679999998877777778889999999999999999999999875    356


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEEEecCccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSR  809 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr  809 (867)
                      +++||||+++|+|.+++...   ..+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||+++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            89999999999999999763   348999999999999999999999877799999999999997 78999999999997


Q ss_pred             cccCCcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......  .....||+.|+|||++.+.  ..+|||||||++|+|++|..||...
T Consensus       181 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          181 LKRASF--AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             GCCTTS--BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccc--cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            654443  2456899999999998753  3489999999999999999999763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6e-35  Score=307.05  Aligned_cols=201  Identities=27%  Similarity=0.488  Sum_probs=168.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-  727 (867)
                      ++..++|++++.||+|+||+||+|++      +++.||||++....  ....+.+.+|+.+|++++||||+++++++.. 
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            44568999999999999999999985      46789999987543  4556789999999999999999999999864 


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          728 -RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       728 -~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                       ...+++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCc
Confidence             356899999999999999998643  24899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++......   .......+|+.|+|||++.+..+   +||||||+++|+|++|..|+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            998764321   22234567888999999886544   89999999999999998887653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.8e-35  Score=304.27  Aligned_cols=201  Identities=23%  Similarity=0.396  Sum_probs=171.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~-~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|++.+.||+|+||+||+|.+.  +..||||++........ ....+.+|+.++++++||||+++++++......
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            346689999999999999999999884  56799999976543322 245688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++...
T Consensus        85 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccC
Confidence            9999999999999999763   34899999999999999999999999  999999999999999999999999998655


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....  .....||+.|+|||++.+..+   +||||||+++|+|++|..||....
T Consensus       160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  211 (279)
T 3fdn_A          160 PSSR--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  211 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             Cccc--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence            4432  245689999999999987554   899999999999999999997543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-35  Score=333.34  Aligned_cols=200  Identities=24%  Similarity=0.410  Sum_probs=177.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +..++|.+++.||+|+||+||+|++  +|+.||||++....... +....+.+|+.+|+.++||||+++++++.....++
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4568999999999999999999998  58889999998654332 33567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        93 lv~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999999763   35899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCcccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ... ...+.+||+.|+|||++.+..    .+|||||||++|+|++|..||...
T Consensus       168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          168 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             TTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence            432 235678999999999998754    389999999999999999999754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-34  Score=310.65  Aligned_cols=200  Identities=22%  Similarity=0.280  Sum_probs=178.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..++|.+.+.||+|+||.||++.+.  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4578999999999999999999984  678999999876543 3556778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+.+++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus       119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999998763   35899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ........+||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence            4444556789999999999886544   89999999999999999999754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.2e-35  Score=318.24  Aligned_cols=192  Identities=24%  Similarity=0.373  Sum_probs=167.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||+||+|.+  +++.||||++.....      ...+|+++|.++ +||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            36899999999999999999998  477899999976542      234688888887 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC----CcEEEEecCcccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN----WTVKVCDFGLSRF  810 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~----g~VKLsDFGLAr~  810 (867)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||+...    +.+||+|||+++.
T Consensus        95 ~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999763   35899999999999999999999999  9999999999998433    3599999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .........+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            6554444457799999999999986544   7999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2e-34  Score=320.45  Aligned_cols=198  Identities=21%  Similarity=0.335  Sum_probs=173.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||+||+|.+  +++.||+|++....  ......+.+|+.+|+.++||||+++++++.....+++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            37899999999999999999998  47789999987653  233457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC--CCcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~--~g~VKLsDFGLAr~~~~  813 (867)
                      ||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.  .+.+||+|||+++....
T Consensus       128 E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          128 EFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             ECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999999753  235899999999999999999999999  999999999999974  57899999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ... ....+||+.|+|||++.+..+   +|||||||++|+|++|..||....
T Consensus       204 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  254 (387)
T 1kob_A          204 DEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  254 (387)
T ss_dssp             TSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             Ccc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence            322 245589999999999987654   899999999999999999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-34  Score=302.90  Aligned_cols=201  Identities=22%  Similarity=0.396  Sum_probs=175.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ..+..++|++.+.||+|+||.||+|++.  +..||||++....... .....+.+|+.++++++||||+++++++.....
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            3456789999999999999999999984  6679999997654322 224568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+++|+|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            999999999999999998643   4899999999999999999999999  99999999999999999999999999976


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....  .....||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          164 APSLR--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             CSSSC--BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Ccccc--cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence            54432  346689999999999987554   89999999999999999999754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.8e-35  Score=304.12  Aligned_cols=205  Identities=28%  Similarity=0.479  Sum_probs=179.2

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ...+++..++|++.+.||+|+||+||+|.+.  +..||+|++....   ...+.+.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3567788899999999999999999999985  7789999987543   3456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccc
Confidence            99999999999999999998643 345899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          809 RFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +...... .......+|+.|+|||++.+..+   +||||||+++|+|++ |.+||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8765432 23344567889999999876544   899999999999999 99998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.7e-35  Score=330.69  Aligned_cols=195  Identities=24%  Similarity=0.318  Sum_probs=165.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------C
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~  729 (867)
                      .++|++++.||+|+||+||+|.+  +++.||||++..........+++.+|+.+|+.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999987  577899999987655566678899999999999999999999999655      4


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+||||||+.++ |.+.+..     .+++..+..++.||+.||+|||++|  |+||||||+||||+.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            579999999764 6666643     3889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... .....+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       213 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          213 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             ----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            765432 2356789999999999987655   79999999999999999999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-34  Score=323.96  Aligned_cols=195  Identities=25%  Similarity=0.295  Sum_probs=164.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----Ce
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PH  730 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~  730 (867)
                      .++|++++.||+|+||+||+|++  +++.||||++..........+++.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            37899999999999999999988  467799999986655556678899999999999999999999999766     57


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+||||+. |+|.+++...   ..+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            999999985 6999999763   35899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcc----------------------cccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCc
Q 002910          811 KANTFI----------------------SSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQM  858 (867)
Q Consensus       811 ~~~t~~----------------------s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf  858 (867)
                      ......                      .....+||+.|+|||++..    ...+|||||||++|+|++|..||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            643221                      1356789999999998743    33489999999999999854433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.8e-34  Score=303.37  Aligned_cols=201  Identities=24%  Similarity=0.430  Sum_probs=170.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+..+.|++.+.||+|+||.||+|++      +++.||||++.... .....+.+.+|+.+|++++||||+++++++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34557899999999999999999985      46789999987543 223356789999999999999999999999876


Q ss_pred             --CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          729 --PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       729 --~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                        ..+++||||+++|+|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccc
Confidence              6789999999999999999653  235899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          807 LSRFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       807 LAr~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +++......   .......||+.|+|||++.+..+   +||||||+++|+|++|..|+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  231 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS  231 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence            998765432   22345678899999999886654   7999999999999999988654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.6e-34  Score=300.60  Aligned_cols=199  Identities=32%  Similarity=0.556  Sum_probs=170.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH-H----HHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-Q----LKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~-~----~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +..++|++.+.||+|+||+||+|++  +++.||||++........ .    .+.+.+|+.++++++||||+++++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            4568999999999999999999998  578899999876543321 1    26789999999999999999999999766


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc-----EEEE
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-----VKVC  803 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~-----VKLs  803 (867)
                      .  ++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++++|+||||||+|||++.++.     +||+
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             C--eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            5  7999999999999988763  33589999999999999999999998877999999999999988776     9999


Q ss_pred             ecCccccccCCcccccccCCCcccccccccCC--C---ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          804 DFGLSRFKANTFISSKSVAGTVVFFAAHQTAC--N---SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       804 DFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~--~---~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |||+++.....   .....||+.|+|||++..  .   ..+|||||||++|+|++|..||...
T Consensus       172 Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          172 DFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             CCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999865443   345689999999999853  2   3489999999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=314.70  Aligned_cols=195  Identities=24%  Similarity=0.314  Sum_probs=156.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..+.|++.+.||+|+||+||+|++.  ++.||||++....    ..+.+.+|+.+|++++||||+++++++.....+++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3478999999999999999999984  6679999987542    235678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecCccccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFK  811 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFGLAr~~  811 (867)
                      |||+++|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.   ++.+||+|||+++..
T Consensus       127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999999763   35899999999999999999999999  999999999999975   899999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..... ....+||+.|+|||++.+..   .+|||||||++|+|++|..||...
T Consensus       202 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  253 (349)
T 2w4o_A          202 EHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE  253 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred             Ccccc-cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            54322 34568999999999998754   489999999999999999999653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.1e-35  Score=317.80  Aligned_cols=201  Identities=23%  Similarity=0.360  Sum_probs=175.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~------~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      .++|++.+.||+|+||+||+|++  +++.||||++.......      .....+.+|+.+|++++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            36899999999999999999987  57789999998765322      13445778999999999999999999999999


Q ss_pred             eEEEEEeccCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          730 HLSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gG-SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .+++||||+.+| +|..++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccc
Confidence            999999999777 999999863   35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccchh
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMFI  864 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~L  864 (867)
                      +....... ....+||+.|+|||++.+..+    +|||||||++|+|++|..||......
T Consensus       178 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  236 (335)
T 3dls_A          178 AYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET  236 (335)
T ss_dssp             EECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG
T ss_pred             eECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH
Confidence            87654322 345689999999999987543    79999999999999999999876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-34  Score=331.80  Aligned_cols=206  Identities=28%  Similarity=0.476  Sum_probs=179.6

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ...|++..++|++.+.||+|+||+||+|.+.  +..||||++.....   ..+.+.+|+.+|++++|||||++++++...
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4567888899999999999999999999995  67899999876543   246789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..++|||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||++
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccc
Confidence            99999999999999999998643 345899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          809 RFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +...... .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence            8764432 22334566789999999886544   899999999999999 999987643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-35  Score=309.72  Aligned_cols=196  Identities=30%  Similarity=0.531  Sum_probs=164.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .+..++|++.+.||+|+||+||+|++.++.||||++...    ...+.+.+|+.+|++++||||+++++++.+  ..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            356789999999999999999999999999999998643    345678999999999999999999998873  48999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCCccccCCCCCcEEEcCCCc-EEEEecCcccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN---LNPPILHWDLKSPNLLVDKNWT-VKVCDFGLSRF  810 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs---~gp~IVHRDLKPeNILLd~~g~-VKLsDFGLAr~  810 (867)
                      |||+++|+|.+++........+++..++.++.||+.||.|||+   ++  |+||||||+|||++.++. +||+|||+++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999875443457899999999999999999999   77  999999999999998886 79999999976


Q ss_pred             ccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....   ....||+.|+|||++.+..   .+||||||+++|+|++|..||...
T Consensus       156 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          156 IQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             ccccc---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            54432   3457999999999998754   489999999999999999999754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.5e-35  Score=313.25  Aligned_cols=193  Identities=22%  Similarity=0.351  Sum_probs=149.4

Q ss_pred             CCeEEE---EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVK---ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~---e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~  732 (867)
                      ++|.+.   +.||+|+||+||+|.+  +++.||||++...     ....+.+|+.+++.+. ||||+++++++.+....|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            345553   6799999999999998  4778999998754     2346778999999997 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC---cEEEEecCccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSR  809 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g---~VKLsDFGLAr  809 (867)
                      |||||+++|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++   .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999863   35899999999999999999999999  99999999999997765   89999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ............+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence            76555444567789999999999987655   79999999999999999999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-35  Score=319.12  Aligned_cols=201  Identities=19%  Similarity=0.304  Sum_probs=173.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccc--hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFL--DDQLKEFLREVAIMKRV-RHPNVVLFMGAVT  726 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~--~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~  726 (867)
                      .+..++|++.+.||+|+||+||+|++     +++.||||++......  ....+.+.+|+.+|+++ .||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            45668999999999999999999987     5788999998764432  12334567899999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ....++|||||+++|+|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999999998633   4899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCC-cccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          807 LSRFKANT-FISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       807 LAr~~~~t-~~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +++..... .......+||+.|+|||++.+.     ..+|||||||++|+|++|..||..
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            99865432 2223456899999999999853     348999999999999999999964

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-35  Score=312.77  Aligned_cols=202  Identities=22%  Similarity=0.311  Sum_probs=167.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~---~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      .++|++.+.||+|+||+||+|.+  ++..||+|++.....   .....+.+.+|+.+|++++||||+++++++...+.++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            37899999999999999999988  466799999976533   2345678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 002910          733 IVTEYLPRGSLYRLIHRPA-------------------------------------AGEMMDQRRRLRMALDVAKGINYL  775 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~-------------------------------------~~~~l~e~~~l~ia~qIa~GL~YL  775 (867)
                      +||||+++|+|.+++....                                     ....+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999999999999985210                                     011246778889999999999999


Q ss_pred             HhcCCCccccCCCCCcEEEcCCC--cEEEEecCccccccCC----cccccccCCCcccccccccCC--C---ChHHHHHH
Q 002910          776 HNLNPPILHWDLKSPNLLVDKNW--TVKVCDFGLSRFKANT----FISSKSVAGTVVFFAAHQTAC--N---SLALIFSL  844 (867)
Q Consensus       776 Hs~gp~IVHRDLKPeNILLd~~g--~VKLsDFGLAr~~~~t----~~s~~s~aGTp~YmAPEvl~~--~---~~SDIwSL  844 (867)
                      |+++  |+||||||+||||+.++  .+||+|||+++.....    ........||+.|+|||++.+  .   ..+|||||
T Consensus       185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            9999  99999999999998766  8999999999865331    112346689999999999864  2   35899999


Q ss_pred             HHHHHHHhcCCCCcccc
Q 002910          845 SGWLQSSFEESPQMRSL  861 (867)
Q Consensus       845 G~lLyeM~tG~~Pf~sl  861 (867)
                      ||++|+|++|..||...
T Consensus       263 G~il~el~~g~~pf~~~  279 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGV  279 (345)
T ss_dssp             HHHHHHHHHSSCSSCCS
T ss_pred             HHHHHHHHHCCCCCCCC
Confidence            99999999999999754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-34  Score=307.42  Aligned_cols=197  Identities=21%  Similarity=0.176  Sum_probs=166.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||+||+|++  +++.||||++...............|+..+.++ +||||++++++|...+.+++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            37899999999999999999998  478899999876655555555666777666655 899999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+ +++|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            9999 779988887643  35899999999999999999999999  999999999999999999999999999876543


Q ss_pred             cccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      . ......||+.|+|||++.+.  ..+|||||||++|+|++|..|++.
T Consensus       211 ~-~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          211 G-AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             C-CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2 23456799999999998862  338999999999999999766654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.6e-34  Score=303.19  Aligned_cols=203  Identities=23%  Similarity=0.425  Sum_probs=164.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ...++|++.+.||+|+||.||+|..  ++..||||++...... ......+.+|+.++++++||||+++++++...+.++
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            3457999999999999999999997  5888999999865433 456678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +||||+.+++|.+++.... ....+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999987421 2345899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ...........||+.|+|||++.+..+   +||||||+++|+|++|..||..
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            554443456689999999999987554   7999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-35  Score=319.79  Aligned_cols=205  Identities=21%  Similarity=0.273  Sum_probs=173.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      .++..++|++++.||+|+||+||+|++.       +..||||++... ........+.+|+.++++++|||||++++++.
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4567799999999999999999999963       446999998643 23455567899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC---c
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---T  799 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~----~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g---~  799 (867)
                      .....++||||+++|+|.+++....    ....+++..++.++.||+.||.|||++|  |+||||||+||||+.++   .
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999998632    1235889999999999999999999999  99999999999999554   5


Q ss_pred             EEEEecCccccccC--CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          800 VKVCDFGLSRFKAN--TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       800 VKLsDFGLAr~~~~--t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +||+|||+++....  .........||+.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~  290 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  290 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999986432  2222345678999999999876544   899999999999998 99998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.9e-35  Score=328.78  Aligned_cols=205  Identities=24%  Similarity=0.439  Sum_probs=176.2

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ...+++..++|++.+.||+|+||+||+|.++ +..||||+++....   ..+.+.+|+.+|++++|||||++++++. ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3567888999999999999999999999995 66799999986543   2467899999999999999999999986 56


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .++|||||+++|+|.++++... ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            7999999999999999998532 224788899999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ...... .......+|+.|+|||++....+   +|||||||++|+|++ |..||....
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~  390 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  390 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence            765432 22234467889999999875444   899999999999999 999997643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=306.00  Aligned_cols=200  Identities=25%  Similarity=0.355  Sum_probs=166.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch---HHHHHHHHHHHHHHhc---CCCCeeeEEeEEeeC
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRV---RHPNVVLFMGAVTKR  728 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~---~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~~~  728 (867)
                      ..++|++.+.||+|+||+||+|++  +++.||||++.......   .....+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357999999999999999999996  57889999997644221   1123456777777666   499999999999876


Q ss_pred             C-----eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          729 P-----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       729 ~-----~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                      .     .+++||||+. |+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence            5     5899999996 69999998643 234899999999999999999999999  9999999999999999999999


Q ss_pred             ecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          804 DFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       804 DFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |||+++...... .....+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999998765432 2356689999999999876544   89999999999999999999654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-34  Score=298.10  Aligned_cols=201  Identities=26%  Similarity=0.459  Sum_probs=175.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |.+..++|++.+.||+|+||.||+|.+ ++..||+|++.......   +.+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            567779999999999999999999998 56679999998665433   46889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccc
Confidence            999999999999999763  235889999999999999999999999  9999999999999999999999999998764


Q ss_pred             CCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ... .......+|+.|+|||++.+..   .+||||||+++|+|++ |..||...
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  209 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence            322 2233456788999999987544   4899999999999999 89998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-34  Score=307.52  Aligned_cols=198  Identities=23%  Similarity=0.371  Sum_probs=174.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~----~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .++|++.+.||+|+||.||+|++  ++..||||++........    ..+.+.+|+.++++++||||+++++++.....+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            36899999999999999999998  478899999987643321    356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC----cEEEEecCc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGL  807 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g----~VKLsDFGL  807 (867)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999763   35899999999999999999999999  99999999999999888    799999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++...... ......||+.|+|||++.+..   .+|||||||++|+|++|..||...
T Consensus       166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  221 (321)
T 2a2a_A          166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (321)
T ss_dssp             CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence            98765432 234568999999999998655   489999999999999999999653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.4e-35  Score=302.53  Aligned_cols=205  Identities=24%  Similarity=0.396  Sum_probs=174.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe--eCCeEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHLSI  733 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~--~~~~l~L  733 (867)
                      .++|++.+.||+|+||.||+|++  +++.||+|++..........+.+.+|+.++++++||||+++++++.  ....+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            47999999999999999999998  5788999999887766677788999999999999999999999885  4678999


Q ss_pred             EEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          734 VTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLN---PPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~g---p~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+++   .+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997532 2334899999999999999999999876   349999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .............||+.|+|||++.+..+   +||||||+++|+|++|..||....
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence            76543332345689999999999887544   899999999999999999997643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-34  Score=320.37  Aligned_cols=193  Identities=25%  Similarity=0.313  Sum_probs=158.4

Q ss_pred             CCCeEEE-EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHH-hcCCCCeeeEEeEEee----CC
Q 002910          658 WDELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMK-RVRHPNVVLFMGAVTK----RP  729 (867)
Q Consensus       658 ~~dy~i~-e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk-~LrHPNIVkl~ga~~~----~~  729 (867)
                      .++|.+. +.||.|+||+||+|.+  +++.||||++...       ..+.+|+.++. ..+||||++++++|..    ..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            4677776 7899999999999998  4778999998643       24667888874 4589999999999875    56


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFG  806 (867)
                      .+|||||||++|+|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+||||+.   ++.+||+|||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence            7999999999999999998643 235899999999999999999999999  999999999999997   7899999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++...... .....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            998765432 2346789999999999987554   79999999999999999999754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.3e-35  Score=304.06  Aligned_cols=195  Identities=18%  Similarity=0.292  Sum_probs=167.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--C-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--G-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV  725 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~  725 (867)
                      ++..++|++.+.||+|+||+||+|++.  +       ..||+|++....  ....+.+.+|+.+|++++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            456789999999999999999999874  3       459999986543  23456789999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc------
Q 002910          726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT------  799 (867)
Q Consensus       726 ~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~------  799 (867)
                      ...+..++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.      
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccccccc
Confidence            99999999999999999999998643  24899999999999999999999999  999999999999998887      


Q ss_pred             --EEEEecCccccccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcc
Q 002910          800 --VKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       800 --VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                        +||+|||+++.....    ....||+.|+|||++.+    ...+|||||||++|+|++|..|++
T Consensus       158 ~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             CEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence              999999998765433    34568899999999886    234899999999999999654443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=320.83  Aligned_cols=201  Identities=23%  Similarity=0.346  Sum_probs=173.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--eE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HL  731 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~--~l  731 (867)
                      +.-++|++.+.||+|+||+||+|++.  ++.||||++...... ...+.+.+|+.+|++++||||+++++++....  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            34578999999999999999999984  788999999764432 23466789999999999999999999998765  78


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE----cCCCcEEEEecCc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL  807 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL----d~~g~VKLsDFGL  807 (867)
                      ++||||+++|+|.+++........+++..++.++.||+.||+|||+++  |+||||||+|||+    +.++.+||+|||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999999999999987554445899999999999999999999999  9999999999999    8888899999999


Q ss_pred             cccccCCcccccccCCCcccccccccCC--------C---ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTAC--------N---SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~--------~---~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ++...... .....+||+.|+|||++.+        .   ..+|||||||++|+|++|..||..
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            98765432 2345689999999999864        2   237999999999999999999974

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-35  Score=315.43  Aligned_cols=207  Identities=25%  Similarity=0.384  Sum_probs=176.8

Q ss_pred             cccccccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          650 AMDWLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       650 ~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ....+.+..++|.+.+.||+|+||+||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            4556677889999999999999999999987 5788999998754322 1223588999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhc---CCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNL---NPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~---gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                      ...++||||+.+|+|.+++.... ....+++..++.++.||+.||.|||++   +  |+||||||+|||++.++.+||+|
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECC
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEecc
Confidence            99999999999999999998643 233589999999999999999999998   8  99999999999999999999999


Q ss_pred             cCccccccCCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcc
Q 002910          805 FGLSRFKANTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       805 FGLAr~~~~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      ||+++...... .......||+.|+|||++.+..   .+|||||||++|+|++|..||.
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            99998764332 2234557999999999987644   4899999999999999999995

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.5e-34  Score=302.55  Aligned_cols=203  Identities=22%  Similarity=0.360  Sum_probs=161.7

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      .+++..++|++.+.||+|+||+||+|.+.     +..||+|++.... .....+.+.+|+.++++++||||+++++++. 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            45677899999999999999999999873     2358888876432 3445677899999999999999999999984 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      .+..++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccc
Confidence            56789999999999999999763  235899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          808 SRFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ++...... .......+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            98765432 22334567889999999875443   899999999999996 99998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-34  Score=312.95  Aligned_cols=198  Identities=23%  Similarity=0.381  Sum_probs=173.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +..++|++.+.||+|+||+||+|.+.  +..||+|++.... .....+.+.+|+.+|++++||||+++++++...+.+++
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            45589999999999999999999985  7789999987653 34556788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||||+++++|.+++....   .+++..+..++.||+.||.|||+. +  |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999998643   489999999999999999999985 8  9999999999999999999999999997654


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  .....||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          184 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HHC------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ccc--ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            332  245689999999999987654   79999999999999999999753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=310.06  Aligned_cols=196  Identities=28%  Similarity=0.408  Sum_probs=161.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHH--HHhcCCCCeeeEEeEEee----
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKRVRHPNVVLFMGAVTK----  727 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~I--Lk~LrHPNIVkl~ga~~~----  727 (867)
                      ..+..++|++++.||+|+||+||+|+++++.||||++....     ...+..|.++  +..++||||+++++.+..    
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            35677999999999999999999999999999999997543     2234444444  445899999999986542    


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCccccCCCCCcEEEcCC
Q 002910          728 -RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL---------NPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       728 -~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~---------gp~IVHRDLKPeNILLd~~  797 (867)
                       ...++|||||+++|+|.+++...    ..++..++.++.||+.||.|||+.         +  |+||||||+||||+.+
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND  156 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC
Confidence             33679999999999999999753    258889999999999999999998         8  9999999999999999


Q ss_pred             CcEEEEecCccccccCC--------cccccccCCCcccccccccCCC-------C---hHHHHHHHHHHHHHhcCCCCcc
Q 002910          798 WTVKVCDFGLSRFKANT--------FISSKSVAGTVVFFAAHQTACN-------S---LALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~t--------~~s~~s~aGTp~YmAPEvl~~~-------~---~SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      +.+||+|||+++.....        .......+||+.|+|||++.+.       .   .+|||||||++|+|++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999999875432        1222355799999999999872       2   3799999999999999977764


Q ss_pred             c
Q 002910          860 S  860 (867)
Q Consensus       860 s  860 (867)
                      .
T Consensus       237 ~  237 (336)
T 3g2f_A          237 P  237 (336)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.6e-35  Score=313.36  Aligned_cols=204  Identities=26%  Similarity=0.415  Sum_probs=175.0

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .++...++|.+.+.||+|+||+||+|++. +..||||++....  ....+.+.+|+.+++.++||||+++++++...+.+
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34446689999999999999999999984 7889999876543  23456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~-~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999999875332 235899999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCC--cccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCccc
Q 002910          811 KANT--FISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       811 ~~~t--~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....  ........||+.|+|||++.+..   .+|||||||++|+|++|..||..
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence            5432  12224457899999999987544   48999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7e-35  Score=321.10  Aligned_cols=203  Identities=27%  Similarity=0.433  Sum_probs=162.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ++..++|.+.+.||+|+||+||+|++.     +..||||++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            456689999999999999999999874     5569999987543 3455678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .++|||||+++|+|.++++..  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             ceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            999999999999999999863  335899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcc---cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTFI---SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~---s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      .......   ......+|+.|+|||++.+..+   +||||||+++|+|++ |..||+...
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~  255 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS  255 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            7644321   1223345788999999886544   899999999999997 999997643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.2e-34  Score=317.60  Aligned_cols=199  Identities=16%  Similarity=0.238  Sum_probs=171.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC--CCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR--HPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr--HPNIVkl~ga~~~~~~l~  732 (867)
                      +...+|.+++.||+|+||+||+|.. .++.||||++..........+.+.+|+.+|++++  |||||++++++.....+|
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            4456799999999999999999987 4778999999887666677788999999999997  599999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      |||| +.+++|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+||||+ ++.+||+|||+++...
T Consensus       133 lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             EEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            9999 56889999998643   5888999999999999999999999  99999999999995 5799999999998764


Q ss_pred             CCc--ccccccCCCcccccccccCC--------------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTF--ISSKSVAGTVVFFAAHQTAC--------------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~--~s~~s~aGTp~YmAPEvl~~--------------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  ......+||+.|+|||++.+              ...+|||||||++|+|++|..||...
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence            322  22346689999999999864              23489999999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-35  Score=313.84  Aligned_cols=197  Identities=21%  Similarity=0.349  Sum_probs=161.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++++.||+|+||+||+|++  +++.||||++..... ......+.+|+.+|++++||||+++++++.....+++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            6899999999999999999998  477899999875431 1122245679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+. |+|.+++...  ...+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           81 YLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            996 5888888763  345899999999999999999999999  99999999999999999999999999987654444


Q ss_pred             cccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......||+.|+|||++.+    ...+|||||||++|+|++|.+||...
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4456688999999999876    33489999999999999999999764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-34  Score=303.71  Aligned_cols=197  Identities=27%  Similarity=0.433  Sum_probs=172.1

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEeeccc--chHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEeccCC
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~--~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      .++.||+|+||+||+|.++++.||||++.....  .....+.+.+|+.++++++||||+++++++......++||||+++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            457899999999999999999999999875432  234567789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc--ccc
Q 002910          741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISS  818 (867)
Q Consensus       741 GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s~  818 (867)
                      |+|.+++........+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......  ...
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            999999986544556899999999999999999999999  9999999999999999999999999998654322  223


Q ss_pred             cccCCCcccccccccCC--CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          819 KSVAGTVVFFAAHQTAC--NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       819 ~s~aGTp~YmAPEvl~~--~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....||+.|+|||++.+  ...+||||||+++|+|++|.+||...
T Consensus       193 ~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             SSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             cccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            45689999999999876  34589999999999999999999754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-34  Score=327.06  Aligned_cols=198  Identities=26%  Similarity=0.412  Sum_probs=172.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||+||+|++  +++.||||++............+.+|+.+|++++|||||++++++.....+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            37899999999999999999998  4788999999765444444577899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGLAr~~~  812 (867)
                      |||.+|+|.+.+...   ..+++..+..++.||+.||.|||++|  |+||||||+|||++   .++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999988763   34899999999999999999999999  99999999999995   56689999999998664


Q ss_pred             CCcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ... .....+||+.|+|||++.+.  ..+|||||||++|+|++|.+||...
T Consensus       176 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          176 QNT-KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             CC-----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC-ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            432 23466899999999999864  3389999999999999999999754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.2e-34  Score=308.16  Aligned_cols=206  Identities=26%  Similarity=0.396  Sum_probs=176.2

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      .+++..++|++.+.||+|+||+||+|++.         +..||||++.... .....+.+.+|+.+|+++ +||||++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            45677899999999999999999999873         4569999987543 345677899999999999 899999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      +++...+.+++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++  |+||||||
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp  185 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA  185 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCcc
Confidence            999999999999999999999999986432             124889999999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||++.++.+||+|||+++......  .......+|+.|+|||++.+..   .+||||||+++|+|++ |..||...
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            99999999999999999998765432  2233456789999999987644   3899999999999999 99998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-34  Score=305.24  Aligned_cols=187  Identities=29%  Similarity=0.454  Sum_probs=159.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhc--CCCCeeeEEeEEeeC----Ce
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVLFMGAVTKR----PH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L--rHPNIVkl~ga~~~~----~~  730 (867)
                      ..++|++.+.||+|+||.||+|+++++.||||++....     ...+.+|.+++..+  +||||+++++++...    ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            34789999999999999999999999999999986442     23445566666554  899999999999887    78


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCccccCCCCCcEEEcCCCcEEE
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL--------NPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~--------gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                      +++||||+++|+|.++++..    .+++..++.++.||+.||.|||++        +  |+||||||+|||++.++.+||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence            99999999999999999753    489999999999999999999998        7  999999999999999999999


Q ss_pred             EecCccccccCCcc----cccccCCCcccccccccCCCC---------hHHHHHHHHHHHHHhcC
Q 002910          803 CDFGLSRFKANTFI----SSKSVAGTVVFFAAHQTACNS---------LALIFSLSGWLQSSFEE  854 (867)
Q Consensus       803 sDFGLAr~~~~t~~----s~~s~aGTp~YmAPEvl~~~~---------~SDIwSLG~lLyeM~tG  854 (867)
                      +|||+++.......    .....+||+.|+|||++.+..         .+|||||||++|+|++|
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            99999976543322    123568999999999987532         27999999999999999

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-34  Score=307.97  Aligned_cols=207  Identities=27%  Similarity=0.393  Sum_probs=176.2

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG  723 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~g  723 (867)
                      +.+++..++|.+.+.||+|+||.||+|.+.+       ..||+|++.... .....+.+.+|+.+|+++ +||||+++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4577888999999999999999999999842       369999987543 334567899999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcE
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPA-----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL  792 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~-----------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNI  792 (867)
                      ++...+.+++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+++  |+||||||+||
T Consensus       118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI  195 (333)
T 2i1m_A          118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV  195 (333)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence            9999999999999999999999997532           1234789999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          793 LVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       793 LLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |++.++.+||+|||+++......  .......+|+.|+|||++.+..   .+|||||||++|+|++ |.+||...
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999999999998654322  2233456788999999987544   3899999999999998 89998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.9e-34  Score=300.11  Aligned_cols=197  Identities=26%  Similarity=0.420  Sum_probs=176.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .+.|++.+.||+|+||.||+|..  .++.||||++...... ...+.+.+|+.++++++||||+++++++.....+++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            36799999999999999999987  4778999999765432 34577899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++..    ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus       100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999999864    34899999999999999999999999  9999999999999999999999999998776655


Q ss_pred             ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .......||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence            44567789999999999987554   89999999999999999999764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-34  Score=311.04  Aligned_cols=199  Identities=21%  Similarity=0.315  Sum_probs=169.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--------  727 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--------  727 (867)
                      .++|++++.||+|+||+||+|++  +++.||||++............+.+|+.+|+.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            47999999999999999999998  57889999987665444445567899999999999999999999987        


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      .+.+++||||+.+ +|...+....  ..+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4568999999975 7777776532  34899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccC----CcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKAN----TFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~----t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++....    .........||+.|+|||++.+    ...+|||||||++|+|++|.+||...
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            986542    2222345688999999999875    33489999999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.7e-34  Score=296.44  Aligned_cols=201  Identities=23%  Similarity=0.398  Sum_probs=167.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .+..++|++.+.||+|+||.||+|.+  +++.||||++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            34568999999999999999999998  48889999997654322 2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999997632   4899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..... .....||+.|+|||++.+..    .+||||||+++|+|++|..||...
T Consensus       162 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          162 SDGEF-LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             CC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcc-eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            54322 24568999999999998754    389999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.4e-34  Score=303.31  Aligned_cols=207  Identities=23%  Similarity=0.343  Sum_probs=158.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEe--
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVT--  726 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~--  726 (867)
                      ..+++...+|++.+.||+|+||.||+|++  +++.||||++....  ....+.+.+|+.+++++. ||||+++++++.  
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            45566778999999999999999999998  67889999986553  345567899999999996 999999999984  


Q ss_pred             ------eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcE
Q 002910          727 ------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV  800 (867)
Q Consensus       727 ------~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~V  800 (867)
                            ....+++||||+. |+|.+++........+++..++.++.||+.||.|||+++++|+||||||+||||+.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3445899999995 789888876434456999999999999999999999988779999999999999999999


Q ss_pred             EEEecCccccccCCcc------------cccccCCCcccccccccC---CCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          801 KVCDFGLSRFKANTFI------------SSKSVAGTVVFFAAHQTA---CNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       801 KLsDFGLAr~~~~t~~------------s~~s~aGTp~YmAPEvl~---~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+|||+++.......            .....+||+.|+|||++.   +..   .+|||||||++|+|++|..||...
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            9999999987543211            112457999999999983   332   489999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.9e-34  Score=295.87  Aligned_cols=195  Identities=22%  Similarity=0.307  Sum_probs=171.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++.+.||+|+||+||+|.+.  +..+|+|++......  ..+.+.+|+.++++++||||+++++++......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            67999999999999999999984  557999998765432  34578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCccccccC
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~~~~  813 (867)
                      |+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999988763   34899999999999999999999999  9999999999999   8889999999999987654


Q ss_pred             CcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. ......||+.|+|||++.+.  ..+||||||+++|+|++|..||...
T Consensus       162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          162 GK-MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             TS-CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cc-chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence            32 23566899999999998763  3489999999999999999999754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6e-34  Score=313.96  Aligned_cols=194  Identities=24%  Similarity=0.378  Sum_probs=164.2

Q ss_pred             eEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEecc
Q 002910          661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL  738 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy~  738 (867)
                      +...+.||+|+||+||+|.+  ++..||+|++.....  ...+.+.+|+.+|++++|||||++++++...+.++|||||+
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            34477899999999999988  578899999986542  44567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE--cCCCcEEEEecCccccccCCcc
Q 002910          739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       739 ~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL--d~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus       169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999999887532  34889999999999999999999999  9999999999999  5678999999999987654322


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       ....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence             345679999999999987554   89999999999999999999754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.7e-34  Score=297.51  Aligned_cols=197  Identities=18%  Similarity=0.232  Sum_probs=171.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~  732 (867)
                      +..++|++.+.||+|+||+||+|++  +++.||||++.....    .+.+.+|+.+++.+ +|+||+++++++......+
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            3457899999999999999999996  688899999875432    23577899999999 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc-----EEEEecCc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-----VKVCDFGL  807 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~-----VKLsDFGL  807 (867)
                      +||||+ +++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.     +||+|||+
T Consensus        83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            999999 99999999863  235899999999999999999999999  999999999999987776     99999999


Q ss_pred             cccccCCcc-------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFI-------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~-------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.......       ......||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  221 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  221 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence            987654321       2356689999999999987554   89999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-34  Score=314.46  Aligned_cols=200  Identities=16%  Similarity=0.195  Sum_probs=165.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchH-H---H-----HHHHHHHHHHHhcCCCCee
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDD-Q---L-----KEFLREVAIMKRVRHPNVV  719 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~-~---~-----k~f~~Ei~ILk~LrHPNIV  719 (867)
                      +..++|++.+.||+|+||+||+|.+.       ++.||||++........ .   +     ..+..|+.++..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            55679999999999999999999883       36799999876542111 1   1     1234566677888999999


Q ss_pred             eEEeEEeeC----CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc
Q 002910          720 LFMGAVTKR----PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       720 kl~ga~~~~----~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd  795 (867)
                      ++++++...    ..++|||||+ +++|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+||||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence            999998765    4589999999 99999999863  245899999999999999999999999  99999999999999


Q ss_pred             --CCCcEEEEecCccccccCCc-------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          796 --KNWTVKVCDFGLSRFKANTF-------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       796 --~~g~VKLsDFGLAr~~~~t~-------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                        .++.+||+|||+++......       ......+||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              88999999999998654321       11234569999999999987654   7999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-34  Score=310.41  Aligned_cols=195  Identities=24%  Similarity=0.365  Sum_probs=170.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.|.+.+.||+|+||+||+|+.  +++.||||++...... ....+.+.+|+.+|++++||||+++++++......+|||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            5699999999999999999997  5788999999865433 345678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+. |+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++..... 
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9997 6787777542  235899999999999999999999999  999999999999999999999999999876432 


Q ss_pred             ccccccCCCcccccccccC---C---CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTA---C---NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~---~---~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                         ...+||+.|+|||++.   .   ...+|||||||++|+|++|.+||....
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  257 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  257 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence               4568999999999984   2   334899999999999999999987643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.1e-34  Score=295.06  Aligned_cols=198  Identities=24%  Similarity=0.344  Sum_probs=173.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||.||+|.+  +++.||||++...... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            36899999999999999999998  4788999999765432 34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999998865   335899999999999999999999999  9999999999999999999999999998653221


Q ss_pred             --ccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCcccc
Q 002910          816 --ISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       816 --~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                        ......+||+.|+|||++.+..+    +||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence              22345689999999999987543    79999999999999999999754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-34  Score=303.72  Aligned_cols=204  Identities=26%  Similarity=0.404  Sum_probs=168.1

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEee-
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK-  727 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~-  727 (867)
                      ..+....++|++.+.||.|+||.||+|++  +++.||||++.....   ....+.+|+.+++++ +||||+++++++.. 
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33445668999999999999999999998  688899999976542   235678999999999 79999999999977 


Q ss_pred             -----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEE
Q 002910          728 -----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV  802 (867)
Q Consensus       728 -----~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKL  802 (867)
                           ...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEE
Confidence                 467999999999999999998643 235889999999999999999999999  999999999999999999999


Q ss_pred             EecCccccccCCcccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          803 CDFGLSRFKANTFISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       803 sDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +|||+++.............||+.|+|||++.+        ...+|||||||++|+|++|..||...
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876554434456689999999999872        23489999999999999999999754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-34  Score=324.75  Aligned_cols=204  Identities=27%  Similarity=0.487  Sum_probs=170.3

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ...|++..++|++.+.||+|+||+||+|.+++ ..||||++......   .+.+.+|+.+|++++||||+++++++.. +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            45678889999999999999999999999965 56999998765433   3568999999999999999999999876 6


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .++|||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             ceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccce
Confidence            7899999999999999997532 235889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...... .......+|+.|+|||++.+..   .+||||||+++|+|++ |..||...
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence            764332 2223456788999999987544   3899999999999999 99999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.3e-34  Score=311.87  Aligned_cols=196  Identities=24%  Similarity=0.313  Sum_probs=162.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      .++|++++.||+|+||+||+|..  .++.||||++..........+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47999999999999999999987  5778999999876555566778899999999999999999999997665      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+.+ +|.+++..     .+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            78999999964 78888753     3889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...... .....+||+.|+|||++.+..+   +|||||||++|+|++|..||....
T Consensus       176 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          176 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            765432 2345689999999999987554   899999999999999999997643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-34  Score=301.08  Aligned_cols=199  Identities=22%  Similarity=0.353  Sum_probs=167.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|.+.+.||+|+||+||+|+.  .+..+|+|++..... ....+.+.+|+.+|++++||||+++++++.....+++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            7899999999999999999998  477899999986542 2235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCcccccc
Q 002910          737 YLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       737 y~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~~~  812 (867)
                      |+++|+|.+++... .....+++..++.++.||+.||+|||+++  |+||||||+|||+   +.++.+||+|||+++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999988642 12345899999999999999999999999  9999999999999   556889999999998755


Q ss_pred             CCcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .... ....+||+.|+|||++...  ..+||||||+++|+|++|..||...
T Consensus       179 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          179 SDEH-STNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             ---------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cccc-CcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence            4322 3466899999999998753  2389999999999999999999754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=299.49  Aligned_cols=205  Identities=23%  Similarity=0.365  Sum_probs=172.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      +.+.+++|.....||+|+||.||+|.+  ++..||||++....  ....+.+.+|+.+++.++||||+++++++...+.+
T Consensus        17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            344556666667899999999999998  56789999987653  34456789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCcccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRF  810 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLAr~  810 (867)
                      ++||||+++++|.+++........+++..+..++.||+.||.|||+++  |+||||||+|||++. ++.+||+|||+++.
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccc
Confidence            999999999999999987543445778999999999999999999999  999999999999987 89999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ............||+.|+|||++.+.     ..+||||||+++|+|++|..||....
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            65543334566899999999998753     34899999999999999999997643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-34  Score=326.62  Aligned_cols=197  Identities=24%  Similarity=0.361  Sum_probs=167.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|++++.||+|+||+||+|++  ++..||||++............+.+|+.+|+.++|||||+++++|.....+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            5799999999999999999998  47789999998765544445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecCccccccC
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFGLAr~~~~  813 (867)
                      ||++|+|.+++...   ..+++..+..++.||+.||.|||++|  |+||||||+|||++.   ++.+||+|||+++....
T Consensus       117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            99999999988763   34899999999999999999999999  999999999999976   45699999999987654


Q ss_pred             CcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. .....+||+.|+|||++...  ..+|||||||++|+|++|.+||...
T Consensus       192 ~~-~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~  240 (494)
T 3lij_A          192 QK-KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ  240 (494)
T ss_dssp             TB-CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cc-cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            33 23567899999999998753  3489999999999999999999754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.3e-34  Score=296.55  Aligned_cols=197  Identities=22%  Similarity=0.404  Sum_probs=170.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~----~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ++|++.+.||+|+||.||+|++.  ++.||+|++........    ..+.+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999984  78899999987654321    3567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC----cEEEEecCcc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLS  808 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g----~VKLsDFGLA  808 (867)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999763   34899999999999999999999999  99999999999998877    8999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +...... ......||+.|+|||++.+..   .+||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          160 HKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             EECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence            8764432 224567999999999998654   489999999999999999999754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-34  Score=303.32  Aligned_cols=208  Identities=24%  Similarity=0.393  Sum_probs=175.5

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      ...+++..++|++.+.||+|+||+||+|++.       ++.||||++.... .....+.+.+|+.+++++ +||||++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3456777899999999999999999999862       4679999987543 344567889999999999 699999999


Q ss_pred             eEEeeCC-eEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCC
Q 002910          723 GAVTKRP-HLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK  788 (867)
Q Consensus       723 ga~~~~~-~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLK  788 (867)
                      +++...+ .+++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++  |+|||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dik  175 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  175 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCc
Confidence            9987754 59999999999999999986432             123789999999999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          789 SPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       789 PeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      |+|||++.++.+||+|||+++.....  ........||+.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999865432  222345578899999999876543   899999999999998 99999654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-34  Score=315.74  Aligned_cols=194  Identities=24%  Similarity=0.337  Sum_probs=165.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++..........+++.+|+.+|+.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            37899999999999999999998  5788999998765545566778999999999999999999999997653      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|+||||+ +++|.+++..    ..+++..+..++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 8899999975    24899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....   ....++|+.|+|||++.+    ...+|||||||++|+|++|.+||...
T Consensus       177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          177 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            76543   245689999999999875    33489999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.8e-34  Score=298.67  Aligned_cols=203  Identities=23%  Similarity=0.331  Sum_probs=160.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      +++..++|++.+.||+|+||+||+|++  +++.||||++..........+.+..+..+++.++||||+++++++...+..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            356779999999999999999999998  678899999976654444444555666668889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          732 SIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ++||||++ |+|.+++... .....+++..++.++.||+.||.|||++ +  |+||||||+|||++.++.+||+|||+++
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            99999997 5887776541 1234689999999999999999999998 9  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccC----C---CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTA----C---NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~----~---~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....... .....||+.|+|||++.    +   ...+|||||||++|+|++|..||..
T Consensus       159 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          159 YLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            7654332 24458999999999973    2   2348999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.5e-34  Score=297.56  Aligned_cols=203  Identities=27%  Similarity=0.458  Sum_probs=173.4

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +.|++..++|++.+.||+|+||.||+|.+. +..||||++......   .+.+.+|+.+|++++||||+++++++. .+.
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            356788899999999999999999999985 457999998765432   356889999999999999999999886 456


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            899999999999999997532 124889999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCc-ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          811 KANTF-ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       811 ~~~t~-~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ..... .......+|+.|+|||++.+..   .+||||||+++|+|++ |..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence            65432 2233456788999999987544   3799999999999999 89998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-34  Score=310.74  Aligned_cols=200  Identities=23%  Similarity=0.303  Sum_probs=165.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch---HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~---~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ..++|++++.||+|+||.||+|++  +++.||||++.......   ...+.+.+|+.+++.++||||+++++++.....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            347899999999999999999998  47889999987643322   1234678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+.+ +|..++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            999999976 888888753  235788899999999999999999999  999999999999999999999999999877


Q ss_pred             cCCcccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..........+||+.|+|||++.+..    .+|||||||++|+|++|.+||...
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            65544445678999999999987532    379999999999999999998754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6e-34  Score=301.91  Aligned_cols=209  Identities=23%  Similarity=0.352  Sum_probs=167.1

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV  725 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~  725 (867)
                      +..+.+..++|.+.+.||+|+||+||+|.+.     +..||||++..........+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3455677799999999999999999999873     23699999987766667778899999999999999999999999


Q ss_pred             eeCC-----eEEEEEeccCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          726 TKRP-----HLSIVTEYLPRGSLYRLIHRP---AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       726 ~~~~-----~l~LVmEy~~gGSL~~~L~~~---~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      ....     ..++||||+++|+|.+++...   .....+++..++.++.||+.||.|||+++  |+||||||+|||++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence            7654     459999999999999998532   12345899999999999999999999999  9999999999999999


Q ss_pred             CcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          798 WTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       798 g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +.+||+|||+++......  .......+++.|+|||.+.+..+   +||||||+++|+|++ |.+||...
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            999999999998654322  22234567889999999987554   799999999999999 88888654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.9e-34  Score=299.46  Aligned_cols=204  Identities=22%  Similarity=0.356  Sum_probs=170.0

Q ss_pred             cccccCCCCeEEEE-EeccCCceEEEEEEE----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          652 DWLEISWDELHVKE-RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       652 ~~~ei~~~dy~i~e-~LG~GsFG~VykA~~----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ....+..++|.+.+ .||+|+||+||+|.+    .+..||||++..........+.+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34456678999998 999999999999966    256799999987655555677899999999999999999999999 


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ..+..++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCC
Confidence            567799999999999999999863   34899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcc---cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          807 LSRFKANTFI---SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~---s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +++.......   ......+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  224 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  224 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            9987643221   1223456789999999876544   899999999999999 99999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7e-34  Score=302.78  Aligned_cols=200  Identities=20%  Similarity=0.257  Sum_probs=166.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      .+++|++.+.||+|+||.||+|.+  +++.||||++....... ...+.+.+|+.++++++||||+++++++...+.+++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            358999999999999999999997  47789999987654443 445778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus       112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999999863   35899999999999999999999999  99999999999999999999999999986654


Q ss_pred             Cc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. .......||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence            32 22345689999999999987654   79999999999999999999754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4e-34  Score=307.39  Aligned_cols=200  Identities=24%  Similarity=0.400  Sum_probs=162.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCce----EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~----VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      +..++|++.+.||+|+||+||+|++  +++.    ||+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            3458899999999999999999997  3444    4666654322 2234567899999999999999999999998754


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                       .++||||+.+|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCccee
Confidence             789999999999999998633  35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          810 FKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ......  .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  223 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence            764332  22234467889999999886544   899999999999999 99999754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.4e-34  Score=300.42  Aligned_cols=198  Identities=28%  Similarity=0.438  Sum_probs=170.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      ..++|++.+.||.|+||.||+|.+.  ++.||||++....    ..+.+.+|+.++++++||||+++++++...+.+++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            4578999999999999999999984  7889999997643    235688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+.+++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             eecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999998742  235899999999999999999999999  999999999999999999999999999877655


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ........||+.|+|||++.+..+   +||||||+++|+|++|..||....
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            444566789999999999987544   899999999999999999997643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.2e-34  Score=323.75  Aligned_cols=198  Identities=23%  Similarity=0.407  Sum_probs=169.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-----------HHHHHHHHHHHHHHhcCCCCeeeEEeE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-----------DQLKEFLREVAIMKRVRHPNVVLFMGA  724 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-----------~~~k~f~~Ei~ILk~LrHPNIVkl~ga  724 (867)
                      .++|.+++.||+|+||+||+|++  ++..||||++.......           ...+.+.+|+.+|++++|||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            47899999999999999999998  46789999998754332           224678899999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC---cEE
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVK  801 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g---~VK  801 (867)
                      +.....++||||||++|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++   .+|
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999998763   34899999999999999999999999  99999999999998776   699


Q ss_pred             EEecCccccccCCcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          802 VCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       802 LsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |+|||+++...... .....+||+.|+|||++.+.  ..+|||||||++|+|++|.+||...
T Consensus       190 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             ECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEECCCCEEcCCCC-ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999998765432 23566899999999998853  3489999999999999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-33  Score=301.93  Aligned_cols=196  Identities=24%  Similarity=0.387  Sum_probs=169.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ce
Q 002910          659 DELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~--~~  730 (867)
                      ..|++++.||+|+||+||++.+      +++.||||++... ......+.+.+|+.+|++++||||+++++++...  ..
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            4569999999999999999876      4677999999765 3345567899999999999999999999999874  67


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+++|+|.+++...    .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccc
Confidence            89999999999999999763    3899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....   .......+|+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            65432   22345578899999999987554   79999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.2e-34  Score=303.02  Aligned_cols=196  Identities=23%  Similarity=0.323  Sum_probs=163.9

Q ss_pred             CCeEEE-EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEE
Q 002910          659 DELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       659 ~dy~i~-e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LV  734 (867)
                      +.|++. +.||+|+||+||+|++  +++.||||++.....  .....+.+|+.+|.++ +||||+++++++...+.+++|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            678884 7899999999999987  578899999976532  2345788999999985 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc---EEEEecCccccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSRFK  811 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~---VKLsDFGLAr~~  811 (867)
                      |||+++|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.   +||+|||+++..
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999999863   34899999999999999999999999  999999999999988776   999999998765


Q ss_pred             cCCc-------ccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTF-------ISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~-------~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....       ......+||+.|+|||++.+        ...+|||||||++|+|++|..||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            3211       11234579999999999874        34489999999999999999999754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-33  Score=295.87  Aligned_cols=203  Identities=23%  Similarity=0.368  Sum_probs=172.7

Q ss_pred             cccCCCCeEEEE-EeccCCceEEEEEEE----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          654 LEISWDELHVKE-RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       654 ~ei~~~dy~i~e-~LG~GsFG~VykA~~----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +.+..++|.+.+ .||+|+||.||+|.+    .+..||||++.... .....+.+.+|+.++++++||||+++++++ ..
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            445668888887 999999999999986    46679999997653 345677899999999999999999999999 55


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      +..++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccce
Confidence            6799999999999999999753  345899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc---ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCccccc
Q 002910          809 RFKANTF---ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       809 r~~~~t~---~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      +......   .......+|+.|+|||++.+..   .+||||||+++|+|++ |..||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  218 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  218 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            8764321   1223446789999999987544   3899999999999998 999997643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.8e-34  Score=299.56  Aligned_cols=194  Identities=23%  Similarity=0.338  Sum_probs=169.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|.+.+.||+|+||+||+|++  +++.||||++.....  .....+.+|+.++++++||||+++++++.....+++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            6899999999999999999998  488899999986532  233568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCccccccC
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~~~~  813 (867)
                      |+++++|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++....
T Consensus        87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999987632   4899999999999999999999999  9999999999999   7889999999999976544


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..  ....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          162 GI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             BT--THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             Cc--cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            32  234579999999999987654   89999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.1e-34  Score=324.59  Aligned_cols=200  Identities=26%  Similarity=0.385  Sum_probs=175.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..++|++.+.||+|+||+||+|++  +++.||||++...... ......+.+|+.+|++++|||||++++++...+.+++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            347899999999999999999998  5788999999876543 2345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCcccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF  810 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~  810 (867)
                      ||||+.+|+|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999998763   35899999999999999999999999  9999999999999   5678999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCC--CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTAC--NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~--~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..... .....+||+.|+|||++.+  ...+|||||||++|+|++|.+||....
T Consensus       179 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  231 (484)
T 3nyv_A          179 FEASK-KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN  231 (484)
T ss_dssp             BCCCC-SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccc-ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence            65432 2345689999999999876  334899999999999999999997643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.1e-34  Score=303.17  Aligned_cols=193  Identities=29%  Similarity=0.462  Sum_probs=169.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHh--cCCCCeeeEEeEEeeCC----eE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--VRHPNVVLFMGAVTKRP----HL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~--LrHPNIVkl~ga~~~~~----~l  731 (867)
                      .++|++.+.||+|+||+||+|+++++.||||++....     ...+.+|++++..  ++||||+++++++....    .+
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            4789999999999999999999999999999986432     3567789999988  78999999999998776    79


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH--------NLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLH--------s~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                      ++||||+++|+|.+++.+.    .+++..++.++.||+.||.|||        +++  |+||||||+||||+.++.+||+
T Consensus       116 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999753    4899999999999999999999        888  9999999999999999999999


Q ss_pred             ecCccccccCCcc----cccccCCCcccccccccCCC---------ChHHHHHHHHHHHHHhcC----------CCCccc
Q 002910          804 DFGLSRFKANTFI----SSKSVAGTVVFFAAHQTACN---------SLALIFSLSGWLQSSFEE----------SPQMRS  860 (867)
Q Consensus       804 DFGLAr~~~~t~~----s~~s~aGTp~YmAPEvl~~~---------~~SDIwSLG~lLyeM~tG----------~~Pf~s  860 (867)
                      |||+++.......    ......||+.|+|||++.+.         ..+|||||||++|+|++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            9999987654321    23456899999999999875         358999999999999999          778765


Q ss_pred             c
Q 002910          861 L  861 (867)
Q Consensus       861 l  861 (867)
                      .
T Consensus       270 ~  270 (342)
T 1b6c_B          270 L  270 (342)
T ss_dssp             T
T ss_pred             c
Confidence            4

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-33  Score=305.21  Aligned_cols=202  Identities=27%  Similarity=0.403  Sum_probs=167.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCc------eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~------~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ++..++|.+.+.||+|+||+||+|.+...      .||||++.... .......+.+|+.++++++||||+++++++...
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            56778999999999999999999987422      49999987543 345566799999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..++|||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcc
Confidence            9999999999999999999763  235899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          809 RFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +......   .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||...
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  254 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL  254 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence            8764322   11223456889999999886554   899999999999998 99999754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.2e-34  Score=296.40  Aligned_cols=201  Identities=22%  Similarity=0.358  Sum_probs=168.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-----ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g-----~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +.+..++|.+.+.||+|+||+||+|.+.+     ..||+|++.... .....+.+.+|+.++++++||||+++++++.. 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence            45677899999999999999999998742     249999987543 34456789999999999999999999999865 


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      +..++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             CCCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCC
Confidence            4578999999999999999763  235899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccc
Q 002910          809 RFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       809 r~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +...... .......+|+.|+|||++.+..+   +||||||+++|+|++ |..||..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence            8764432 22344567889999999875443   899999999999998 9999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-34  Score=308.72  Aligned_cols=201  Identities=22%  Similarity=0.382  Sum_probs=164.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc--Cce----EEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWH--GSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~--g~~----VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      +..++|++.+.||+|+||+||+|++.  +..    ||+|++.... .....+.+.+|+.++++++||||+++++++. ..
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            45589999999999999999999983  444    6666664332 1222345778999999999999999999886 56


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ..++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccc
Confidence            6999999999999999997642  35888999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ......  .......||+.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            764332  22345578889999999885544   899999999999999 999997643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-33  Score=299.65  Aligned_cols=189  Identities=20%  Similarity=0.323  Sum_probs=166.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEee--CCeEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTK--RPHLS  732 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~--~~~l~  732 (867)
                      .++|++++.||+|+||+||+|++  +++.||||++....     .+.+.+|+.+|++++ ||||+++++++..  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            47899999999999999999987  57889999987433     356889999999998 9999999999987  66799


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~  811 (867)
                      +||||+.+++|..++..      +++..++.++.||+.||.|||++|  |+||||||+|||++.++ .+||+|||+++..
T Consensus       110 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999998864      789999999999999999999999  99999999999999776 8999999999866


Q ss_pred             cCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      .... ......||+.|+|||++.+    ...+|||||||++|+|++|..||..
T Consensus       182 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          182 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            4432 2345689999999999876    2348999999999999999999943

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-34  Score=300.23  Aligned_cols=199  Identities=27%  Similarity=0.449  Sum_probs=164.9

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-CeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-PHL  731 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-~~l  731 (867)
                      .+.+..++|++.+.||+|+||+||+|+++++.||||++....    ..+.+.+|+.++++++||||+++++++... +.+
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            356778999999999999999999999999999999987543    346788999999999999999999987544 579


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            99999999999999997532 123788999999999999999999999  999999999999999999999999999865


Q ss_pred             cCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....   ....+++.|+|||++.+..   .+||||||+++|+|++ |..||...
T Consensus       168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          168 SSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             cccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            4432   3447789999999987544   4899999999999998 99998754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-34  Score=307.83  Aligned_cols=202  Identities=22%  Similarity=0.305  Sum_probs=177.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchH---------------HHHHHHHHHHHHHhcCCCCee
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD---------------QLKEFLREVAIMKRVRHPNVV  719 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~---------------~~k~f~~Ei~ILk~LrHPNIV  719 (867)
                      .+..++|++.+.||+|+||.||+|+++++.||||++........               ..+.+.+|+.++++++||||+
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            34568999999999999999999999999999999976532211               126789999999999999999


Q ss_pred             eEEeEEeeCCeEEEEEeccCCCCHHHH------HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcE
Q 002910          720 LFMGAVTKRPHLSIVTEYLPRGSLYRL------IHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNL  792 (867)
Q Consensus       720 kl~ga~~~~~~l~LVmEy~~gGSL~~~------L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNI  792 (867)
                      ++++++...+.+++||||+++|+|.++      +... ....+++..++.++.||+.||.|||+ +|  |+||||||+||
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni  183 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI  183 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence            999999999999999999999999988      5432 14568999999999999999999999 99  99999999999


Q ss_pred             EEcCCCcEEEEecCccccccCCcccccccCCCcccccccccCCC-C----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          793 LVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN-S----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       793 LLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~-~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |++.++.+||+|||+++.....  ......||+.|+|||++.+. .    .+|||||||++|+|++|..||...
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999876544  23566899999999999876 3    589999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-33  Score=316.24  Aligned_cols=197  Identities=22%  Similarity=0.344  Sum_probs=160.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~------~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      .++|.+.+.||+|+||+||+|.+  +++.||||++.......      .....+.+|+.+|++++|||||++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            47899999999999999999988  46789999998764321      22335789999999999999999999985 45


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC---CcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~---g~VKLsDFG  806 (867)
                      ..++||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+   +.+||+|||
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             ceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence            689999999999999988753   35899999999999999999999999  9999999999999654   459999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCC---CC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTAC---NS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~---~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++...... .....+||+.|+|||++.+   ..   .+|||||||++|+|++|.+||...
T Consensus       288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            998765432 2346789999999999864   22   379999999999999999999753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.1e-34  Score=329.16  Aligned_cols=204  Identities=27%  Similarity=0.494  Sum_probs=176.0

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ...|++..++|++.+.||+|+||+||+|.+.+ ..||||++......   .+.+.+|+.+|++++|||||++++++.. +
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            45678899999999999999999999999965 56999999865433   3568999999999999999999999876 6


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .++|||||+.+|+|.++|+... ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             cceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            7999999999999999997532 234889999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          810 FKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...... .......+++.|+|||++.+..+   +|||||||+||+|++ |..||...
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            765422 22234567889999999876544   899999999999999 89999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-33  Score=293.84  Aligned_cols=200  Identities=23%  Similarity=0.362  Sum_probs=173.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeeccc---c----hHHHHHHHHHHHHHHhcC-CCCeeeEEeEEe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF---L----DDQLKEFLREVAIMKRVR-HPNVVLFMGAVT  726 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~---~----~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~  726 (867)
                      ..++|++.+.||.|+||.||+|.+  +++.||||++.....   .    ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            358999999999999999999998  467899999976531   1    133566889999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      .....++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999863   35899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcccccccCCCcccccccccC---------CCChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTA---------CNSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~---------~~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +++...... ......||+.|+|||++.         ....+||||||+++|+|++|..||....
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            998765432 234568999999999985         1345899999999999999999996543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=298.96  Aligned_cols=203  Identities=19%  Similarity=0.277  Sum_probs=170.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee----
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----  727 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----  727 (867)
                      +.+..++|++.+.||+|+||.||+|+.  +++.||||++....  ....+.+.+|+.+++.++||||+++++++..    
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            456678999999999999999999997  67889999987643  3456778999999999999999999999863    


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ....++||||+.+|+|.+++.... ....+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecC
Confidence            347899999999999999987521 2345899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcc---------cccccCCCcccccccccCCC------ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          807 LSRFKANTFI---------SSKSVAGTVVFFAAHQTACN------SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       807 LAr~~~~t~~---------s~~s~aGTp~YmAPEvl~~~------~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +++.......         ......||+.|+|||++.+.      ..+||||||+++|+|++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            9876532111         11234679999999998753      358999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-34  Score=302.05  Aligned_cols=205  Identities=24%  Similarity=0.390  Sum_probs=155.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      +.+..++|++.+.||+|+||.||+|.+  ++..||||++..... ....+++.+|+.++++++||||+++++++...+..
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            456779999999999999999999987  678899998865432 23456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          732 SIVTEYLPRGSLYRLIHRP-----AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~-----~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ++||||+++++|.+++...     .....+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEecc
Confidence            9999999999999998741     12345899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCC-----cccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANT-----FISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t-----~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++.....     ........||+.|+|||++.+    ...+||||||+++|+|++|..||...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  230 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY  230 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence            98765432     112245689999999999753    45589999999999999999999763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-34  Score=300.26  Aligned_cols=199  Identities=25%  Similarity=0.394  Sum_probs=166.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .+.|++.+.||+|+||.||+|++.  +..||+|++....  ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            478999999999999999999984  7789999987543  233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|..++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        96 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999999887532  34899999999999999999999999  9999999999999999999999999986543333


Q ss_pred             ccccccCCCcccccccccC-----C---CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          816 ISSKSVAGTVVFFAAHQTA-----C---NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       816 ~s~~s~aGTp~YmAPEvl~-----~---~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .......||+.|+|||++.     +   ...+||||||+++|+|++|..||....
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  226 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  226 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            3334568999999999983     2   334899999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-33  Score=302.06  Aligned_cols=200  Identities=28%  Similarity=0.446  Sum_probs=172.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe--e
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--K  727 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~--~  727 (867)
                      +..++|++.+.||+|+||.||+|++      .+..||||++....  ....+.+.+|+.++++++||||+++++++.  .
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            3458999999999999999999985      46679999987653  445677899999999999999999999886  4


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ...+++||||+++++|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccc
Confidence            567999999999999999997632  24899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++......   .......||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            98764322   22345578899999999887554   89999999999999999998654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-33  Score=293.65  Aligned_cols=193  Identities=24%  Similarity=0.390  Sum_probs=168.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee---------
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK---------  727 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~---------  727 (867)
                      .+|++.+.||+|+||.||+|++.  ++.||||++....      ..+.+|+.++++++||||+++++++..         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            68999999999999999999984  8889999997653      246789999999999999999998864         


Q ss_pred             -------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcE
Q 002910          728 -------RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV  800 (867)
Q Consensus       728 -------~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~V  800 (867)
                             ...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCE
Confidence                   445899999999999999997532 245899999999999999999999999  9999999999999999999


Q ss_pred             EEEecCccccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          801 KVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       801 KLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ||+|||+++....... .....||+.|+|||++.+..   .+||||||+++|+|++|..|+...
T Consensus       162 kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  224 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET  224 (284)
T ss_dssp             EECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred             EECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH
Confidence            9999999987654332 34567999999999988654   489999999999999999988654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.8e-34  Score=306.17  Aligned_cols=202  Identities=21%  Similarity=0.356  Sum_probs=170.9

Q ss_pred             cCCCCeEEE-EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeE
Q 002910          656 ISWDELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       656 i~~~dy~i~-e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l  731 (867)
                      .-.+.|.+. +.||+|+||+||+|.+  +++.||||++............+.+|+.+++.+. ||||+++++++.....+
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            334677777 8999999999999998  4788999999876554444667899999999995 69999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecCcc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLS  808 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFGLA  808 (867)
                      ++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+|||++.   ++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            99999999999999886532 345899999999999999999999999  999999999999987   789999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +...... .....+||+.|+|||++.+..+   +||||||+++|+|++|..||...
T Consensus       182 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          182 RKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             EEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            8765432 2345689999999999987554   89999999999999999999654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-33  Score=302.27  Aligned_cols=203  Identities=25%  Similarity=0.481  Sum_probs=168.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCce--EEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~--VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~  729 (867)
                      .+.+++|++.+.||+|+||.||+|++  ++..  +|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            45679999999999999999999987  3444  4888886432 234456789999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~-------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~  796 (867)
                      .+++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+++  |+||||||+|||++.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  177 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence            9999999999999999997642             2245899999999999999999999999  999999999999999


Q ss_pred             CCcEEEEecCccccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          797 NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ++.+||+|||+++..... .......+|+.|+|||++.+..   .+|||||||++|+|++ |..||...
T Consensus       178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999754332 1223456789999999987644   4899999999999998 99999654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.5e-34  Score=313.08  Aligned_cols=197  Identities=12%  Similarity=0.037  Sum_probs=153.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhc--CCCCeeeEE-------eE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV--RHPNVVLFM-------GA  724 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~L--rHPNIVkl~-------ga  724 (867)
                      ...+|++.+.||+|+||+||+|++  +++.||||++...... ....+.+.+|+.+++.|  +||||++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            345799999999999999999997  5778999999987653 35566778886655555  699988755       44


Q ss_pred             EeeC-----------------CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 002910          725 VTKR-----------------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMALDVAKGINYLHNLNPP  781 (867)
Q Consensus       725 ~~~~-----------------~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~------l~ia~qIa~GL~YLHs~gp~  781 (867)
                      +...                 ..+||||||++ |+|.+++.....  .+.+..+      +.++.||+.||+|||+++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            4433                 33899999998 899999986422  2344455      677899999999999999  


Q ss_pred             ccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCcccccccccCC-----CChHHHHHHHHHHHHHhcCCC
Q 002910          782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTAC-----NSLALIFSLSGWLQSSFEESP  856 (867)
Q Consensus       782 IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~-----~~~SDIwSLG~lLyeM~tG~~  856 (867)
                      ||||||||+||||+.++.+||+|||+++......   ....+|+.|+|||++.+     ...+|||||||++|+|++|..
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999998765432   24567799999999986     234899999999999999999


Q ss_pred             Ccccc
Q 002910          857 QMRSL  861 (867)
Q Consensus       857 Pf~sl  861 (867)
                      ||...
T Consensus       292 Pf~~~  296 (371)
T 3q60_A          292 PFGLV  296 (371)
T ss_dssp             STTBC
T ss_pred             CCCCc
Confidence            99876

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-33  Score=307.09  Aligned_cols=198  Identities=21%  Similarity=0.396  Sum_probs=173.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeeccc--ch----HHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF--LD----DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR  728 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~--~~----~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~  728 (867)
                      .++|.+.+.||.|+||.||+|.+  +|+.||||++.....  ..    ...+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            36799999999999999999998  488999999976532  11    2345678999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ...++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.|  |+||||||+|||++.+|.+||+|||++
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS  247 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence            9999999999999999999753   34899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCC---------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTAC---------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~---------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +...... .....+||+.|+|||++.+         ...+|||||||++|+|++|..||+..
T Consensus       248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          248 CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            8765432 2346789999999999862         23489999999999999999999764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.6e-34  Score=307.45  Aligned_cols=199  Identities=19%  Similarity=0.194  Sum_probs=163.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccchH---------HHHHHHHHHHHHHhcCCCCeeeE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDD---------QLKEFLREVAIMKRVRHPNVVLF  721 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~~---------~~k~f~~Ei~ILk~LrHPNIVkl  721 (867)
                      +..++|++.+.||+|+||+||+|.+     .+..+|||++........         ....+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            4558999999999999999999998     356799999886542211         11236688899999999999999


Q ss_pred             EeEEee----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC
Q 002910          722 MGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN  797 (867)
Q Consensus       722 ~ga~~~----~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~  797 (867)
                      ++++..    ...+++||||+ +++|.+++....   .+++..++.++.||+.||+|||+++  |+||||||+||||+.+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence            999987    77899999999 999999998643   5899999999999999999999999  9999999999999988


Q ss_pred             C--cEEEEecCccccccCCc-------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          798 W--TVKVCDFGLSRFKANTF-------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       798 g--~VKLsDFGLAr~~~~t~-------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +  .+||+|||+++......       .......||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            7  99999999998653321       11245689999999999987654   8999999999999999999954

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.4e-33  Score=306.79  Aligned_cols=195  Identities=23%  Similarity=0.245  Sum_probs=165.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC--------CCCeeeEEeEEe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR--------HPNVVLFMGAVT  726 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr--------HPNIVkl~ga~~  726 (867)
                      ..++|++.+.||+|+||+||+|++  +++.||||++...   ....+.+.+|+.+|+.++        |+||++++++|.
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            347899999999999999999987  4778999998744   344567889999999986        788999999997


Q ss_pred             ----eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCC---
Q 002910          727 ----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNW---  798 (867)
Q Consensus       727 ----~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g---  798 (867)
                          ....++|||||+ +++|.+.+.... ...+++..++.++.||+.||.|||++ |  |+||||||+||||+.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence                556799999999 556666665432 23589999999999999999999998 9  99999999999998775   


Q ss_pred             ----------------------------------------------cEEEEecCccccccCCcccccccCCCcccccccc
Q 002910          799 ----------------------------------------------TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ  832 (867)
Q Consensus       799 ----------------------------------------------~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEv  832 (867)
                                                                    .+||+|||+++.....   ....+||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence                                                          7999999999876543   245689999999999


Q ss_pred             cCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          833 TACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       833 l~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +.+..+   +|||||||++|+|++|..||...
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            987544   89999999999999999999753

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-33  Score=292.95  Aligned_cols=195  Identities=26%  Similarity=0.425  Sum_probs=164.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--Cc---eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE-EE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL-SI  733 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~---~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l-~L  733 (867)
                      .|.+.+.||+|+||+||+|.+.  +.   .||+|++.... .....+.+.+|+.++++++||||+++++++...... ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            5667899999999999999872  22   58999886432 345567899999999999999999999999876665 99


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||+.+|+|.+++...  ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus       101 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999999863  345899999999999999999999999  99999999999999999999999999986543


Q ss_pred             C----cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          814 T----FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       814 t----~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      .    ........+|+.|+|||.+.+..+   +||||||+++|+|++|..|++
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence            2    122345678899999999987554   799999999999999655543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-34  Score=318.12  Aligned_cols=200  Identities=13%  Similarity=0.074  Sum_probs=162.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHH---HHHhcCCCCeeeEE-------
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVA---IMKRVRHPNVVLFM-------  722 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~---ILk~LrHPNIVkl~-------  722 (867)
                      ...++|++.+.||+|+||+||+|++  +++.||||++...... ....+.+.+|+.   +|++++|||||+++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3457999999999999999999996  4889999999865433 345678899995   55556899999998       


Q ss_pred             eEEeeCC-----------------eEEEEEeccCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002910          723 GAVTKRP-----------------HLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPP  781 (867)
Q Consensus       723 ga~~~~~-----------------~l~LVmEy~~gGSL~~~L~~~~~----~~~l~e~~~l~ia~qIa~GL~YLHs~gp~  781 (867)
                      +++...+                 ..||||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||+++  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            6666553                 389999999 6899999986321    112335888889999999999999999  


Q ss_pred             ccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCcccccccccCCC-----------C---hHHHHHHHHH
Q 002910          782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN-----------S---LALIFSLSGW  847 (867)
Q Consensus       782 IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~-----------~---~SDIwSLG~l  847 (867)
                      |+||||||+||||+.++.+||+|||+++.....   ....+| +.|+|||++.+.           .   .+|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999999864432   345678 999999998765           3   3899999999


Q ss_pred             HHHHhcCCCCccccc
Q 002910          848 LQSSFEESPQMRSLM  862 (867)
Q Consensus       848 LyeM~tG~~Pf~sl~  862 (867)
                      +|+|++|..||....
T Consensus       303 l~elltg~~Pf~~~~  317 (377)
T 3byv_A          303 IYWIWCADLPITKDA  317 (377)
T ss_dssp             HHHHHHSSCCC----
T ss_pred             HHHHHHCCCCCcccc
Confidence            999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.1e-34  Score=312.75  Aligned_cols=194  Identities=24%  Similarity=0.344  Sum_probs=153.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Ce
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~~  730 (867)
                      ++|++++.||+|+||.||+|.+  +|+.||||++..........+.+.+|+.+|+.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            7899999999999999999987  577899999876554556677889999999999999999999998754      56


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+ +++|.+++..    ..+++..+..++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++.
T Consensus       109 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC------
T ss_pred             EEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            89999999 7899988864    34899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....   .....||+.|+|||++.+    ...+|||||||++|+|++|.+||....
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          182 TADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5443   245689999999999876    234899999999999999999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-33  Score=296.57  Aligned_cols=195  Identities=22%  Similarity=0.294  Sum_probs=169.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE---cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC------CeeeEEeEEee
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP------NVVLFMGAVTK  727 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~---~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP------NIVkl~ga~~~  727 (867)
                      ..++|++.+.||+|+||+||+|.+   .++.||||++...   ....+.+.+|+.+++.++|+      +|+++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            447999999999999999999987   4678999998753   24456788999999988765      49999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-----------
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----------  796 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-----------  796 (867)
                      .+.+++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.           
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999 899999997643 235889999999999999999999999  999999999999987           


Q ss_pred             --------CCcEEEEecCccccccCCcccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          797 --------NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       797 --------~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                              ++.+||+|||+++.....   ....+||+.|+|||++.+..   .+|||||||++|+|++|..||...
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                    678999999999875443   24568999999999998754   489999999999999999999754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-33  Score=294.86  Aligned_cols=198  Identities=27%  Similarity=0.375  Sum_probs=163.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcC---c--eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEE-eeCCeE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWHG---S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV-TKRPHL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~g---~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~-~~~~~l  731 (867)
                      ..+|++.+.||+|+||+||+|.+..   +  .+|+|.+.... .....+.+.+|+.++++++||||+++++++ ...+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            3579999999999999999998732   2  37888876432 345567899999999999999999999985 456688


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999999999763  345789999999999999999999999  999999999999999999999999999865


Q ss_pred             cCCc----ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCccc
Q 002910          812 ANTF----ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       812 ~~t~----~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      ....    .......+|+.|+|||.+.+..   .+||||||+++|+|++ +.+||..
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            4322    2233457788999999987644   4799999999999999 5566654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=307.47  Aligned_cols=206  Identities=31%  Similarity=0.513  Sum_probs=173.9

Q ss_pred             cccccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       650 ~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ....+++..++|++.+.||+|+||.||+|++.+ .+|+|++..........+.+.+|+.++++++||||+++++++...+
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            456778899999999999999999999999876 5999998766544444556788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++ ++.+||+|||+++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            999999999999999999763  235889999999999999999999999  99999999999998 6799999999987


Q ss_pred             cccC-----CcccccccCCCcccccccccCC------------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKAN-----TFISSKSVAGTVVFFAAHQTAC------------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~-----t~~s~~s~aGTp~YmAPEvl~~------------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....     .........||+.|+|||++.+            ...+||||||+++|+|++|..||...
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            5432     1122234578999999999875            33489999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-33  Score=301.24  Aligned_cols=196  Identities=23%  Similarity=0.365  Sum_probs=163.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc------hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL------DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~------~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      ++|++.+.||+|+||.||+|.+  +++.||||++......      ......+.+|+.+|++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            6899999999999999999988  4678999999765432      123345789999999999999999999987655 


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc---EEEEecCc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGL  807 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~---VKLsDFGL  807 (867)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.   +||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            89999999999999998753   35899999999999999999999999  999999999999987654   99999999


Q ss_pred             cccccCCcccccccCCCcccccccccC---C---CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTA---C---NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~---~---~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++....... ....+||+.|+|||++.   .   ...+|||||||++|+|++|..||...
T Consensus       164 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          164 SKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             CEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             ceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            987654322 23567999999999973   2   33589999999999999999999654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-33  Score=308.26  Aligned_cols=197  Identities=23%  Similarity=0.317  Sum_probs=162.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-----
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-----  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-----  727 (867)
                      +...++|++++.||+|+||+||+|++  +++.||||++.....      ...+|+.+|+.++|||||+++++|..     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            34568999999999999999999988  578899999875432      22379999999999999999999844     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHH
Q 002910          728 ---------------------------------RPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGIN  773 (867)
Q Consensus       728 ---------------------------------~~~l~LVmEy~~gGSL~~~L~~~-~~~~~l~e~~~l~ia~qIa~GL~  773 (867)
                                                       ...+++||||++ |+|.+.+... .....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             334899999997 5777776531 12346899999999999999999


Q ss_pred             HHHhcCCCccccCCCCCcEEEc-CCCcEEEEecCccccccCCcccccccCCCcccccccccCCCC----hHHHHHHHHHH
Q 002910          774 YLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWL  848 (867)
Q Consensus       774 YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lL  848 (867)
                      |||++|  |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+..    .+|||||||++
T Consensus       156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            999999  99999999999998 689999999999987644332 34568899999999987633    48999999999


Q ss_pred             HHHhcCCCCcccc
Q 002910          849 QSSFEESPQMRSL  861 (867)
Q Consensus       849 yeM~tG~~Pf~sl  861 (867)
                      |+|++|.+||...
T Consensus       233 ~ell~g~~pf~~~  245 (383)
T 3eb0_A          233 GELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHSSCSSCCS
T ss_pred             HHHHhCCCCCCCC
Confidence            9999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-33  Score=298.25  Aligned_cols=200  Identities=26%  Similarity=0.389  Sum_probs=168.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE---cCceEEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeEEe-----
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVT-----  726 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~---~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~-----  726 (867)
                      .++|++.+.||+|+||+||+|++   .++.||||++............+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            37899999999999999999987   367799999986554332233456777777766   8999999999987     


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      ....+++||||+. |+|.+++.... ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCc
Confidence            5567999999997 69999997643 234899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +++...... ......||+.|+|||++.+..+   +|||||||++|+|++|.+||....
T Consensus       166 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (326)
T 1blx_A          166 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  223 (326)
T ss_dssp             SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            998765332 2346689999999999986544   899999999999999999997643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=303.37  Aligned_cols=201  Identities=24%  Similarity=0.394  Sum_probs=161.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceE----EEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDV----AVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~V----AVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      +..++|++.+.||+|+||+||+|.+  +++.+    |+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            3558999999999999999999998  45555    555554322 2234567899999999999999999999998754


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                       .++||||+.+|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             -ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence             889999999999999998632  35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ......  .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  224 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            764322  22234467889999999886544   799999999999999 999997643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.1e-33  Score=306.34  Aligned_cols=193  Identities=23%  Similarity=0.344  Sum_probs=166.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE-----
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL-----  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l-----  731 (867)
                      ++|.+.+.||+|+||+||+|.+  +++.||||++..........+.+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            7999999999999999999988  478899999987665566678899999999999999999999999877655     


Q ss_pred             -EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          732 -SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       732 -~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                       ++||||+. ++|.+++..     .+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence             99999996 688888743     3899999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....   ....+||+.|+|||++.+    ...+|||||||++|+|++|..||....
T Consensus       194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5443   245688999999999876    334899999999999999999997643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.3e-33  Score=290.98  Aligned_cols=194  Identities=23%  Similarity=0.240  Sum_probs=163.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEE-eeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV-TKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~-~~~~~l~LVm  735 (867)
                      ++|++.+.||+|+||+||+|++  .++.||||++.....    ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            7899999999999999999996  577899998765432    23578899999999988777666555 6777889999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~~~  812 (867)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 99999999753  235899999999999999999999999  9999999999999   889999999999998764


Q ss_pred             CCcc-------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFI-------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~-------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....       ......||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence            4321       2346689999999999987654   79999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=296.47  Aligned_cols=200  Identities=19%  Similarity=0.260  Sum_probs=167.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc--hHHHHHHHHHHHHHHhcCCCCeeeEEeEE--eeCCeE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL--DDQLKEFLREVAIMKRVRHPNVVLFMGAV--TKRPHL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~--~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~--~~~~~l  731 (867)
                      .++|++++.||+|+||.||+|.+  ++..||||++......  ......+.+|+.++++++||||+++++++  .....+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            47899999999999999999998  5678999999765432  23457789999999999999999999998  445689


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+.++ |.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999877 766666533 345899999999999999999999999  999999999999999999999999999875


Q ss_pred             cCC--cccccccCCCcccccccccCCC-----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANT--FISSKSVAGTVVFFAAHQTACN-----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t--~~s~~s~aGTp~YmAPEvl~~~-----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  ........||+.|+|||++.+.     ..+||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD  216 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            431  2223456799999999998863     2489999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.9e-33  Score=304.02  Aligned_cols=195  Identities=24%  Similarity=0.375  Sum_probs=168.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----CeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~l  731 (867)
                      ++|++++.||+|+||+||+|.+  ++..||||++.... .....+.+.+|+.+|++++||||+++++++...     ..+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            6899999999999999999987  47779999987533 334557789999999999999999999999765     468


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ++||||+. |+|.+++...    .+++..++.++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999996 5999998752    4899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCcc---cccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFI---SSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~---s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....   .....+||+.|+|||++.+    ...+|||||||++|+|++|.+||...
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            43221   1245689999999998653    33489999999999999999999754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.9e-33  Score=289.54  Aligned_cols=195  Identities=23%  Similarity=0.232  Sum_probs=166.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEE-eeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV-TKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~-~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||+||+|++  +++.||||++......    ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            37899999999999999999996  6888999998765432    3578899999999988866655554 667788999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCccccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~~  811 (867)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999 99999999753  235899999999999999999999999  9999999999999   58899999999999876


Q ss_pred             cCCcc-------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFI-------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~-------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....       ......||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            54322       2346689999999999987554   79999999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-33  Score=300.66  Aligned_cols=204  Identities=22%  Similarity=0.267  Sum_probs=169.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~-------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      ++..++|++.+.||+|+||.||+|++       .+..||||++.... .......+.+|+.++++++||||+++++++..
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            56778999999999999999999984       35579999986432 34556678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcE
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTV  800 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~----~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~V  800 (867)
                      ....++||||+++|+|.+++.....    ...+++..++.++.||+.||.|||+++  |+||||||+|||++.   ++.+
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence            9999999999999999999986431    134889999999999999999999999  999999999999984   4569


Q ss_pred             EEEecCccccccCCc--ccccccCCCcccccccccCCCC---hHHHHHHHHHHHHHhc-CCCCcccc
Q 002910          801 KVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNS---LALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       801 KLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~---~SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ||+|||+++......  .......||+.|+|||++.+..   .+|||||||++|+|++ |..||...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            999999997653322  2223457899999999987544   4899999999999998 99998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-33  Score=304.83  Aligned_cols=202  Identities=23%  Similarity=0.292  Sum_probs=154.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe-
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH-  730 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~-  730 (867)
                      .....++|++.+.||+|+||+||+|++.  +..||||++......   .....+|+..+..++||||++++++|...+. 
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3455689999999999999999999984  788999998654322   2345677888899999999999999976443 


Q ss_pred             ------EEEEEeccCCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCccccCCCCCcEEEcC-CCcE
Q 002910          731 ------LSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLH--NLNPPILHWDLKSPNLLVDK-NWTV  800 (867)
Q Consensus       731 ------l~LVmEy~~gGSL~~~L~~-~~~~~~l~e~~~l~ia~qIa~GL~YLH--s~gp~IVHRDLKPeNILLd~-~g~V  800 (867)
                            +++||||+.++ |...+.. ......+++..+..++.||+.||.|||  +++  |+||||||+||||+. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcE
Confidence                  89999999764 4433332 223446889999999999999999999  888  999999999999997 8999


Q ss_pred             EEEecCccccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          801 KVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       801 KLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ||+|||+++....... .....||+.|+|||++.+.    ..+|||||||++|+|++|.+||....
T Consensus       172 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  236 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN  236 (360)
T ss_dssp             EECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence            9999999987654332 3456889999999998653    34899999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.6e-33  Score=289.98  Aligned_cols=189  Identities=25%  Similarity=0.397  Sum_probs=158.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee---------
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK---------  727 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~---------  727 (867)
                      ++|++.+.||+|+||.||+|++  +++.||||++...   ....+.+.+|+.++++++||||+++++++..         
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            6899999999999999999997  5788999999653   3556788999999999999999999998865         


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          728 ----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       728 ----~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                          ...+++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEe
Confidence                35689999999999999999853  235788899999999999999999999  9999999999999999999999


Q ss_pred             ecCccccccCC--------------cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcC
Q 002910          804 DFGLSRFKANT--------------FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEE  854 (867)
Q Consensus       804 DFGLAr~~~~t--------------~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG  854 (867)
                      |||+++.....              ........||+.|+|||++.+.    ..+|||||||++|+|+++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p  227 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP  227 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence            99999865422              1123456799999999998753    348999999999999984

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.7e-33  Score=311.58  Aligned_cols=195  Identities=23%  Similarity=0.295  Sum_probs=168.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc------CCCCeeeEEeEEeeC
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV------RHPNVVLFMGAVTKR  728 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L------rHPNIVkl~ga~~~~  728 (867)
                      ...+|++++.||+|+||+||+|.+  .++.||||++....   .....+.+|+.+++.+      .|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            346899999999999999999988  46789999997542   3445677888888887      577999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc--EEEEecC
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--VKVCDFG  806 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~--VKLsDFG  806 (867)
                      ..++|||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++  ||||||||+||||+.++.  +||+|||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999995 69999887643 234899999999999999999999999  999999999999999987  9999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++.....   ..+.+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99765443   245689999999999886544   89999999999999999999754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.9e-33  Score=298.64  Aligned_cols=196  Identities=25%  Similarity=0.382  Sum_probs=166.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----Ce
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PH  730 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~-----~~  730 (867)
                      .++|++.+.||+|+||+||+|.+.  ++.||||++.... .......+.+|+.++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            479999999999999999999984  7889999986432 234556788999999999999999999988654     67


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++||||+. |+|.+++..    ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            999999996 689998875    24899999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcc----------cccccCCCcccccccccCC-C---ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFI----------SSKSVAGTVVFFAAHQTAC-N---SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~----------s~~s~aGTp~YmAPEvl~~-~---~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......          .....+||+.|+|||++.+ .   ..+|||||||++|+|++|.+||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            543211          1234588999999998754 2   3489999999999999999999764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.6e-33  Score=294.43  Aligned_cols=206  Identities=16%  Similarity=0.240  Sum_probs=172.3

Q ss_pred             ccccccccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC--CCCeeeEEeEE
Q 002910          649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR--HPNVVLFMGAV  725 (867)
Q Consensus       649 l~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr--HPNIVkl~ga~  725 (867)
                      +......+..++|++.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            34556677788999999999999999999988 4778999999877666677788999999999997  59999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEec
Q 002910          726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF  805 (867)
Q Consensus       726 ~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDF  805 (867)
                      .....+++||| +.+++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++. +.+||+||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Df  170 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDF  170 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCC
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeec
Confidence            99999999999 5688999999863   35899999999999999999999999  999999999999964 89999999


Q ss_pred             CccccccCCc--ccccccCCCcccccccccCC--------------CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          806 GLSRFKANTF--ISSKSVAGTVVFFAAHQTAC--------------NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       806 GLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~--------------~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |+++......  ......+||+.|+|||++.+              ...+||||||+++|+|++|..||...
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            9998754322  12245689999999999875              22489999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.1e-33  Score=291.97  Aligned_cols=196  Identities=21%  Similarity=0.327  Sum_probs=160.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe---------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT---------  726 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~---------  726 (867)
                      .++|++++.||+|+||.||+|.+.  ++.||||++....  ....+.+.+|+.++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            378999999999999999999984  7789999987543  455678899999999999999999999873         


Q ss_pred             -----eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcE
Q 002910          727 -----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTV  800 (867)
Q Consensus       727 -----~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~V  800 (867)
                           ....+++||||+. |+|.+++..    ..+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence                 4467899999997 699999864    34889999999999999999999999  99999999999997 56799


Q ss_pred             EEEecCccccccCCc---ccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          801 KVCDFGLSRFKANTF---ISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       801 KLsDFGLAr~~~~t~---~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ||+|||+++......   .......+|+.|+|||++.+    ...+|||||||++|+|++|..||....
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            999999998754321   12234577999999998764    233899999999999999999997654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.1e-33  Score=309.79  Aligned_cols=196  Identities=23%  Similarity=0.280  Sum_probs=161.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH------  730 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~------  730 (867)
                      ..+|++.+.||+|+||+||+|++ .+..+|+|++......      ..+|+.+|+.++|||||+++++|...+.      
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            36799999999999999999998 4556899988654321      2369999999999999999999965443      


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEEEecCccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSR  809 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr  809 (867)
                      +++||||++++.+..+.+.......+++..++.++.||+.||+|||++|  |+||||||+||||+ .++.+||+|||+++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8899999987654443332222346899999999999999999999999  99999999999999 79999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....... .....||+.|+|||++.+.    ..+|||||||++|+|++|.+||....
T Consensus       191 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          191 ILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             ECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            7644322 3456889999999998753    34899999999999999999997643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-33  Score=328.37  Aligned_cols=204  Identities=22%  Similarity=0.361  Sum_probs=167.9

Q ss_pred             ccccCCCCeEEEE-EeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          653 WLEISWDELHVKE-RVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       653 ~~ei~~~dy~i~e-~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      .+.+..+++.+.+ .||+|+||+||+|.+.    +..||||+++... .....+.+.+|+.+|++++|||||++++++..
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3455667777777 8999999999999873    4459999987653 23346789999999999999999999999976


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                       +.++||||||++|+|.+++...  ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence             5699999999999999999753  345899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          808 SRFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       808 Ar~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ++......   .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  544 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  544 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            98764321   11223356789999999875444   899999999999998 999997653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=304.32  Aligned_cols=194  Identities=16%  Similarity=0.147  Sum_probs=166.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc----------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeee------
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH----------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL------  720 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~----------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVk------  720 (867)
                      ..++|++.+.||+|+||.||+|++.          ++.||||++...       +.+.+|+.++++++||||++      
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            3589999999999999999999884          578999998754       35788999999999999987      


Q ss_pred             ---------EEeEEee-CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCC
Q 002910          721 ---------FMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP  790 (867)
Q Consensus       721 ---------l~ga~~~-~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPe  790 (867)
                               +++++.. ...++|||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~  188 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE  188 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence                     5667665 67899999999 999999998642 245899999999999999999999999  999999999


Q ss_pred             cEEEcCCC--cEEEEecCccccccCCcc-------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCc
Q 002910          791 NLLVDKNW--TVKVCDFGLSRFKANTFI-------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQM  858 (867)
Q Consensus       791 NILLd~~g--~VKLsDFGLAr~~~~t~~-------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf  858 (867)
                      |||++.++  .+||+|||+++.......       ......||+.|+|||++.+..+   +|||||||++|+|++|..||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  999999999986543211       1234589999999999987554   89999999999999999999


Q ss_pred             ccc
Q 002910          859 RSL  861 (867)
Q Consensus       859 ~sl  861 (867)
                      ...
T Consensus       269 ~~~  271 (352)
T 2jii_A          269 TNC  271 (352)
T ss_dssp             GGG
T ss_pred             ccC
Confidence            875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-33  Score=312.22  Aligned_cols=193  Identities=24%  Similarity=0.307  Sum_probs=159.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Ce
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~~  730 (867)
                      .+|++.+.||+|+||+||+|++  +++.||||++.....      ...+|+.+|+.++|||||+++++|...      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            5799999999999999999998  478899999875431      234799999999999999999988542      24


Q ss_pred             EEEEEeccCCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-CcEEEEecCcc
Q 002910          731 LSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLS  808 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~-~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-g~VKLsDFGLA  808 (867)
                      +++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+++  |+||||||+||||+.+ +.+||+|||++
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            7899999976 56665542 112346899999999999999999999999  9999999999999955 67899999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +....... ....+||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       205 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          205 KQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             EECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            87644322 2456889999999998753    3489999999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-33  Score=292.69  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=161.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc---Cc--eEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH---GS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~---g~--~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+..++|++.+.||+|+||+||+|++.   ++  .||||++...... ....+.+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            455689999999999999999999873   22  4899998766443 35677899999999999999999999999876


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      . .++||||+++++|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             C-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccc
Confidence            5 899999999999999997632  34889999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          809 RFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +......   .......+|+.|+|||++.+..+   +||||||+++|+|++ |..||...
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  228 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL  228 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence            8764332   12234577889999999886554   899999999999999 99999754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.3e-33  Score=300.98  Aligned_cols=202  Identities=21%  Similarity=0.303  Sum_probs=162.4

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccc---------hHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL---------DDQLKEFLREVAIMKRVRHPNVVLFMG  723 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~---------~~~~k~f~~Ei~ILk~LrHPNIVkl~g  723 (867)
                      +....++|++.+.||+|+||.||+|.. .+..||||++......         ....+.+.+|+.+|++++||||+++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            344568999999999999999999987 5788999998654321         234578999999999999999999999


Q ss_pred             EEee-----CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC
Q 002910          724 AVTK-----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW  798 (867)
Q Consensus       724 a~~~-----~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g  798 (867)
                      ++..     ...+++||||+. |+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN  171 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCC
Confidence            9854     346899999997 6888888753  335899999999999999999999999  99999999999999999


Q ss_pred             cEEEEecCccccccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          799 TVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       799 ~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .+||+|||+++...... .....+||+.|+|||++.+    ...+|||||||++|+|++|..||...
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          172 DITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999998654432 2345689999999999875    33489999999999999999999764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.1e-33  Score=328.74  Aligned_cols=204  Identities=22%  Similarity=0.350  Sum_probs=168.2

Q ss_pred             ccccCCCCeEEE-EEeccCCceEEEEEEE----cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          653 WLEISWDELHVK-ERVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       653 ~~ei~~~dy~i~-e~LG~GsFG~VykA~~----~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      .+.+....+.+. +.||+|+||+||+|.+    .++.||||+++.........+++.+|+.+|++++|||||++++++..
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            344555666664 4899999999999976    24579999998765545556789999999999999999999999864


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                       +.++||||||++|+|.+++...   ..+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+
T Consensus       442 -~~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          442 -ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             -CCEEEEEEccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCC
Confidence             5689999999999999999763   35899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          808 SRFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       808 Ar~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ++......   .......+|+.|+|||++.+..+   +|||||||++|+|++ |..||....
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  577 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  577 (635)
T ss_dssp             HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            98764321   22234467889999999976544   899999999999998 999997653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-34  Score=311.73  Aligned_cols=194  Identities=19%  Similarity=0.236  Sum_probs=163.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccc------hHHHHHHHHHHHHHHhcC---------CCCeee
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFL------DDQLKEFLREVAIMKRVR---------HPNVVL  720 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~------~~~~k~f~~Ei~ILk~Lr---------HPNIVk  720 (867)
                      +..++|++++.||+|+||+||+|+++++.||||++......      ....+.+.+|+.+|+.++         |||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            44578999999999999999999999999999999876431      233467889999999886         777777


Q ss_pred             EEeEE-----------------ee-------------CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 002910          721 FMGAV-----------------TK-------------RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK  770 (867)
Q Consensus       721 l~ga~-----------------~~-------------~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~  770 (867)
                      +++++                 ..             ...+||||||+++|++.+.+.+    ..+++..++.++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence            76654                 22             6789999999999976666643    34899999999999999


Q ss_pred             HHHHHH-hcCCCccccCCCCCcEEEcCCC--------------------cEEEEecCccccccCCcccccccCCCccccc
Q 002910          771 GINYLH-NLNPPILHWDLKSPNLLVDKNW--------------------TVKVCDFGLSRFKANTFISSKSVAGTVVFFA  829 (867)
Q Consensus       771 GL~YLH-s~gp~IVHRDLKPeNILLd~~g--------------------~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmA  829 (867)
                      ||+||| +++  ||||||||+||||+.++                    .+||+|||+++.....     ..+||+.|||
T Consensus       173 aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            999999 899  99999999999999887                    9999999999876543     4589999999


Q ss_pred             ccccCCCC--hHHHHHHHHH-HHHHhcCCCCccc
Q 002910          830 AHQTACNS--LALIFSLSGW-LQSSFEESPQMRS  860 (867)
Q Consensus       830 PEvl~~~~--~SDIwSLG~l-LyeM~tG~~Pf~s  860 (867)
                      ||++.+..  .+|||||+++ .++++.|..||..
T Consensus       246 PE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             SGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hhhhcCCCccceehhhhhCCCCcccccccCCCcc
Confidence            99998654  4899998777 7889999999965

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.3e-33  Score=300.90  Aligned_cols=193  Identities=22%  Similarity=0.340  Sum_probs=165.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe------
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH------  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~------  730 (867)
                      ++|.+.+.||+|+||.||+|.+  +|+.||||++..........+.+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            7899999999999999999988  47889999998765555667789999999999999999999999987654      


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +++||||+. ++|.+++..     .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence            499999996 688777643     3899999999999999999999999  99999999999999999999999999986


Q ss_pred             ccCCcccccccCCCcccccccccCC----CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTAC----NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~----~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ....   .....||+.|+|||++.+    ...+|||||||++|+|++|..||....
T Consensus       176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5433   245688999999999876    334899999999999999999997643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-33  Score=296.02  Aligned_cols=200  Identities=27%  Similarity=0.483  Sum_probs=171.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE------cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~------~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+..++|++++.||+|+||.||+|++      +++.||||++....  ....+.+.+|+.++++++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            34568899999999999999999985      46789999987542  45567899999999999999999999998765


Q ss_pred             C--eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          729 P--HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       729 ~--~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      +  .+++||||+++++|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCc
Confidence            4  7899999999999999998642  35899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcc---cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          807 LSRFKANTFI---SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       807 LAr~~~~t~~---s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +++.......   ......+|+.|+|||++.+..+   +||||||+++|+|++|..|+..
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            9987654321   1234567888999999886544   8999999999999999988864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-33  Score=309.08  Aligned_cols=198  Identities=27%  Similarity=0.388  Sum_probs=156.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc---C--ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH---G--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT-KRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~---g--~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~-~~~~l~  732 (867)
                      ..|.+.+.||+|+||+||+|++.   +  ..||||.+... ......+.+.+|+.+|++++||||+++++++. ..+..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            46788999999999999999873   2  24788887643 23456778999999999999999999999865 456789


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++...
T Consensus       168 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999999763  335789999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCc----ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTF----ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~----~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...    .......+|+.|+|||++.+..+   +|||||||++|+|++ |.+||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~  300 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  300 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence            321    11234567889999999876544   899999999999999 67777653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-32  Score=293.41  Aligned_cols=196  Identities=20%  Similarity=0.302  Sum_probs=167.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc--C-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC------eeeEEeEEee
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH--G-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN------VVLFMGAVTK  727 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~--g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN------IVkl~ga~~~  727 (867)
                      ..++|++.+.||+|+||+||+|.+.  + ..||||++...   ....+.+.+|+.++++++|++      |+.+++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3489999999999999999999883  3 57999998743   244567888999999997765      9999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE-------------
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-------------  794 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL-------------  794 (867)
                      .+.++|||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+||||             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccc
Confidence            99999999999 667777776532 235899999999999999999999999  9999999999999             


Q ss_pred             ------cCCCcEEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          795 ------DKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       795 ------d~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                            +.++.+||+|||+++.....   ....+||+.|+|||++.+..+   +|||||||++|+|++|..||....
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                  67889999999999865443   245689999999999986554   899999999999999999997643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.5e-33  Score=290.48  Aligned_cols=198  Identities=26%  Similarity=0.402  Sum_probs=172.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++.+.||+|+||.||+|+.  +++.||||++............+.+|+.++++++||||+++++++.....+++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            47899999999999999999998  5788999999876554455678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC---CcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~---g~VKLsDFGLAr~~~  812 (867)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+|||++.+   +.+||+|||+++...
T Consensus       101 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999999887532   4899999999999999999999999  9999999999999754   479999999998654


Q ss_pred             CCcccccccCCCcccccccccCCC--ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACN--SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~--~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ... ......||+.|+|||++.+.  ..+||||||+++|+|++|..||...
T Consensus       176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          176 QNT-KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             CCS-SCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC-ccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence            432 22345689999999998864  3489999999999999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-32  Score=293.95  Aligned_cols=205  Identities=21%  Similarity=0.341  Sum_probs=153.8

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHH-HHHhcCCCCeeeEEeEEeeC
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVA-IMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~-ILk~LrHPNIVkl~ga~~~~  728 (867)
                      ..+.+..++|++++.||+|+||.||+|.+.  ++.||||++..... ......+.+|+. +++.++||||+++++++...
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            345677899999999999999999999984  78899999986543 333455666666 67778999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEec
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRP--AAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDF  805 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~--~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDF  805 (867)
                      +..++||||+.+ +|.+++...  .....+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence            999999999975 777776531  1134589999999999999999999998 9  999999999999999999999999


Q ss_pred             CccccccCCcccccccCCCcccccccccC----C---CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          806 GLSRFKANTFISSKSVAGTVVFFAAHQTA----C---NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       806 GLAr~~~~t~~s~~s~aGTp~YmAPEvl~----~---~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |+++....... .....||+.|+|||++.    +   ...+|||||||++|+|++|..||...
T Consensus       171 g~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          171 GISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             CCceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            99987654322 23447999999999984    2   33589999999999999999999754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-33  Score=310.51  Aligned_cols=195  Identities=22%  Similarity=0.349  Sum_probs=149.3

Q ss_pred             CCeEE-EEEeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeE
Q 002910          659 DELHV-KERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHL  731 (867)
Q Consensus       659 ~dy~i-~e~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l  731 (867)
                      +.|.+ +++||+|+||+||+|++.    +..||||++......    ..+.+|+.+|++++|||||+++++|..  ...+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34554 457999999999999974    667999998755432    357789999999999999999999954  6789


Q ss_pred             EEEEeccCCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE----cCCCcEE
Q 002910          732 SIVTEYLPRGSLYRLIHRPA------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVK  801 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL----d~~g~VK  801 (867)
                      +|||||+. |+|.+++....      ....+++..++.++.||+.||.|||+++  |+||||||+||||    +.++.+|
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999996 57877775311      1224899999999999999999999999  9999999999999    7789999


Q ss_pred             EEecCccccccCCc---ccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCccc
Q 002910          802 VCDFGLSRFKANTF---ISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       802 LsDFGLAr~~~~t~---~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      |+|||+++......   ......+||+.|+|||++.+..    .+|||||||++|+|++|.+||..
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999998765321   2234678999999999998633    37999999999999999999964

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-32  Score=289.59  Aligned_cols=203  Identities=20%  Similarity=0.316  Sum_probs=157.1

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ..+.+..++|++++.||+|+||.||+|.+  +++.||||++..........+.+..+..+++.++||||+++++++....
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            34566789999999999999999999998  4788999999876544444445556666788899999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      .+++||||+ ++.+..+....  ...+++..++.++.||+.||.|||+. +  |+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            999999999 66666665432  23589999999999999999999985 9  999999999999999999999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +....... .....||+.|+|||++..        ...+|||||||++|+|++|..||..
T Consensus       173 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          173 GRLVDDKA-KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             hhccCCcc-ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            76644322 235579999999999853        2348999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-33  Score=298.01  Aligned_cols=201  Identities=20%  Similarity=0.269  Sum_probs=172.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch----HHHHHHHHHHHHHHhcC--CCCeeeEEeEEe
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVR--HPNVVLFMGAVT  726 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~----~~~k~f~~Ei~ILk~Lr--HPNIVkl~ga~~  726 (867)
                      +...++|++.+.||+|+||.||+|++  +++.||||++.......    .....+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34558899999999999999999987  57789999998764332    12345678999999996  599999999999


Q ss_pred             eCCeEEEEEeccCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEEEe
Q 002910          727 KRPHLSIVTEYLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCD  804 (867)
Q Consensus       727 ~~~~l~LVmEy~~g-GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsD  804 (867)
                      ..+..++||||+.+ ++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+||||+ .++.+||+|
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEee
Confidence            99999999999976 8999999763   35899999999999999999999999  99999999999999 789999999


Q ss_pred             cCccccccCCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccc
Q 002910          805 FGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       805 FGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ||+++......  .....||+.|+|||++.+..+    +|||||||++|+|++|..||....
T Consensus       194 fg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  253 (320)
T 3a99_A          194 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE  253 (320)
T ss_dssp             CTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             Ccccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence            99998765543  245689999999999875443    699999999999999999997644

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-33  Score=296.43  Aligned_cols=202  Identities=23%  Similarity=0.278  Sum_probs=164.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch----HHHHHHHHHHHHHHhc----CCCCeeeEEeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRV----RHPNVVLFMGA  724 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~----~~~k~f~~Ei~ILk~L----rHPNIVkl~ga  724 (867)
                      +...++|++.+.||+|+||.||+|++  +++.||||++.......    .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34558899999999999999999987  57789999997654432    1233466899999998    89999999999


Q ss_pred             EeeCCeEEEEEec-cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEE
Q 002910          725 VTKRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKV  802 (867)
Q Consensus       725 ~~~~~~l~LVmEy-~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKL  802 (867)
                      +...+..++|||| +.+++|.+++...   ..+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence            9999999999999 7899999999863   34899999999999999999999999  99999999999999 8899999


Q ss_pred             EecCccccccCCcccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCccccch
Q 002910          803 CDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       803 sDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      +|||+++......  .....||+.|+|||++.+..    .+||||||+++|+|++|..||.....
T Consensus       182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  244 (312)
T 2iwi_A          182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE  244 (312)
T ss_dssp             CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred             EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH
Confidence            9999998765543  24567999999999987543    38999999999999999999976443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-32  Score=298.42  Aligned_cols=196  Identities=18%  Similarity=0.246  Sum_probs=166.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-----------CCCeeeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----------HPNVVLFM  722 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-----------HPNIVkl~  722 (867)
                      +..++|++.+.||+|+||+||+|++  +++.||||++....   .....+.+|+.++++++           ||||++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            3457999999999999999999997  57889999987542   34456788999999886           89999999


Q ss_pred             eEEeeCC----eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCccccCCCCCcEEEc--
Q 002910          723 GAVTKRP----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVD--  795 (867)
Q Consensus       723 ga~~~~~----~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-gp~IVHRDLKPeNILLd--  795 (867)
                      +++...+    .+++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ |  |+||||||+||||+  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence            9997654    789999999 999999997643 23489999999999999999999998 9  99999999999994  


Q ss_pred             ----CCCcEEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          796 ----KNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       796 ----~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                          ..+.+||+|||+++......   ....||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CCCcCcceEEEcccccccccCCCC---CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence                44589999999998765432   45689999999999987554   89999999999999999999754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.98  E-value=4.9e-32  Score=297.65  Aligned_cols=196  Identities=23%  Similarity=0.281  Sum_probs=167.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CC-----CeeeEEeEEee
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HP-----NVVLFMGAVTK  727 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HP-----NIVkl~ga~~~  727 (867)
                      ...++|++.+.||+|+||+||+|++  +++.||||++...   ......+.+|+.+++.++ |+     +|+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3458999999999999999999988  4678999999753   244566788999988885 55     49999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCccccCCCCCcEEEc--CCCcEEEE
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN--LNPPILHWDLKSPNLLVD--KNWTVKVC  803 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs--~gp~IVHRDLKPeNILLd--~~g~VKLs  803 (867)
                      .+.++|||||+. |+|.+++.... ...+++..+..++.||+.||.|||.  .+  ||||||||+||||+  .++.+||+
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999995 59999998643 2348999999999999999999995  56  99999999999994  57889999


Q ss_pred             ecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          804 DFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       804 DFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      |||+++.....   ....+||+.|+|||++.+..+   +|||||||++|+|++|.+||...
T Consensus       204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999876543   245689999999999987554   89999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.98  E-value=7.2e-32  Score=291.73  Aligned_cols=193  Identities=21%  Similarity=0.286  Sum_probs=142.5

Q ss_pred             CCCeEEEE-EeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCe
Q 002910          658 WDELHVKE-RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPH  730 (867)
Q Consensus       658 ~~dy~i~e-~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----~~~  730 (867)
                      .++|.+.+ .||+|+||+||+|.+.  ++.||||++....   ...   ......++.+.||||+++++++..    ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            47899855 6999999999999984  7889999987532   111   122334667899999999999976    455


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecCc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGL  807 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFGL  807 (867)
                      ++|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.   ++.+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            899999999999999998643 245899999999999999999999999  999999999999976   45699999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++......  ....+||+.|+|||++.+..+   +|||||||++|+|++|..||...
T Consensus       178 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            98665432  246688999999999987665   69999999999999999999654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=8e-32  Score=318.85  Aligned_cols=204  Identities=22%  Similarity=0.357  Sum_probs=169.5

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc-----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ..+++..++|++.+.||+|+||+||+|.+.     +..||||++.... .....+.+.+|+.+|++++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            456677899999999999999999999883     2348888876432 3445678999999999999999999999985


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                       .+.+++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecC
Confidence             46689999999999999999853  235899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          807 LSRFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +++...... .......+|+.|+|||++.+..+   +|||||||++|+|++ |.+||...
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  596 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  596 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            998764432 22234567889999999875544   899999999999996 99999764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=8.3e-32  Score=308.32  Aligned_cols=196  Identities=20%  Similarity=0.246  Sum_probs=168.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH-PNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++++.||+|+||.||+|++  .+..||||++......    ..+.+|+.+++.++| ++|+.+..++......+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            47899999999999999999997  4888999988765432    247789999999987 5666677777788889999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEE---cCCCcEEEEecCccccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILL---d~~g~VKLsDFGLAr~~  811 (867)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||+++  ||||||||+||||   +.++.+||+|||+++..
T Consensus        82 me~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999 99999999753  235899999999999999999999999  9999999999999   68899999999999876


Q ss_pred             cCCcc-------cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANTFI-------SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t~~-------s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .....       .....+||+.|+|||++.+..+   +|||||||+||+|++|..||..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            54321       2236789999999999997665   799999999999999999998753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.3e-31  Score=300.65  Aligned_cols=194  Identities=24%  Similarity=0.305  Sum_probs=151.4

Q ss_pred             CCeEEEEEeccCCceEEEEE-EEcCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA-~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|.+.+.||+|+||+||.+ ..+|+.||||++....     .+.+.+|+.+|+++ +|||||++++++.....++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            44566788999999999654 4578999999987542     34567899999876 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCC----CCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCC-------------Cc
Q 002910          737 YLPRGSLYRLIHRPAAGEM----MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-------------WT  799 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~----l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~-------------g~  799 (867)
                      ||. |+|.+++........    ..+..++.++.||+.||+|||+++  |+||||||+||||+..             +.
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence            995 699999986432110    123345679999999999999999  9999999999999754             48


Q ss_pred             EEEEecCccccccCCcc----cccccCCCcccccccccCC----------CChHHHHHHHHHHHHHhc-CCCCccc
Q 002910          800 VKVCDFGLSRFKANTFI----SSKSVAGTVVFFAAHQTAC----------NSLALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       800 VKLsDFGLAr~~~~t~~----s~~s~aGTp~YmAPEvl~~----------~~~SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +||+|||+++.......    .....+||+.|+|||++.+          ...+|||||||++|+|++ |.+||..
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            99999999987654321    1235689999999999865          234899999999999998 8999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=8.6e-32  Score=318.64  Aligned_cols=191  Identities=21%  Similarity=0.254  Sum_probs=164.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE---cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe---
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH---  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~---~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~---  730 (867)
                      ..++|++.+.||+|+||+||+|.+   +++.||||++.... .......+.+|+.+|++++|||||++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            348999999999999999999988   36789999886532 23456678999999999999999999999987665   


Q ss_pred             --EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          731 --LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       731 --l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                        .||||||++|++|.+++..     .+++..++.++.||+.||.|||++|  ||||||||+||||+.+ .+||+|||++
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence              7999999999999987754     4899999999999999999999999  9999999999999885 8999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCC--hHHHHHHHHHHHHHhcCCCCccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNS--LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~--~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      +.....    ....||+.|+|||++.+..  .+|||||||++|+|++|.+||..
T Consensus       229 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          229 SRINSF----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             EETTCC----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hhcccC----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcc
Confidence            876543    4568999999999987544  48999999999999999988865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=301.46  Aligned_cols=197  Identities=25%  Similarity=0.315  Sum_probs=158.1

Q ss_pred             cccCCCCeEEEEEeccCCceE-EEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeE
Q 002910          654 LEISWDELHVKERVGAGSFGT-VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~-VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l  731 (867)
                      +.+...+|.+.+.||+|+||+ ||++..+++.||||++......     .+.+|+.+|+.+ +|||||++++++.....+
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            445557899999999999998 5566668999999998754322     245799999999 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-----CCcEEEEecC
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFG  806 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-----~g~VKLsDFG  806 (867)
                      |||||||. |+|.+++.....  ...+..++.++.||+.||.|||+++  |+||||||+||||+.     ...+||+|||
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            99999995 699999986432  2444456789999999999999999  999999999999943     3468899999


Q ss_pred             ccccccCC---cccccccCCCcccccccccCC---C---ChHHHHHHHHHHHHHhc-CCCCccc
Q 002910          807 LSRFKANT---FISSKSVAGTVVFFAAHQTAC---N---SLALIFSLSGWLQSSFE-ESPQMRS  860 (867)
Q Consensus       807 LAr~~~~t---~~s~~s~aGTp~YmAPEvl~~---~---~~SDIwSLG~lLyeM~t-G~~Pf~s  860 (867)
                      +++.....   .......+||+.|+|||++.+   .   ..+|||||||++|+|++ |.+||..
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            99876432   123345689999999999974   2   24899999999999999 8888854

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=1.1e-30  Score=277.44  Aligned_cols=174  Identities=17%  Similarity=0.104  Sum_probs=152.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++.+.||+|+||.||+|++.  ++.||||++...... ....+.+.+|+.++.+++||||+++++++...+..|||
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            378999999999999999999984  788999999876544 45567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||++|++|.+++...     .....+..++.||+.||+|||++|  |+||||||+||||+.+|.+||+++|        
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999999641     355578889999999999999999  9999999999999999999998544        


Q ss_pred             cccccccCCCcccccccccCCCChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                                  |++|    ....+|||||||++|+|++|..||....
T Consensus       175 ------------~~~~----~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 ------------TMPD----ANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             ------------CCTT----CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             ------------ccCC----CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                        3333    3556999999999999999999997643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=3.2e-31  Score=314.26  Aligned_cols=200  Identities=22%  Similarity=0.302  Sum_probs=170.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee------C
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK------R  728 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~------~  728 (867)
                      ..++|++.+.||.|+||.||+|.+  +|..||||++... ......+.+.+|+.+|++++||||+++++++..      .
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            347899999999999999999987  5788999998754 345566789999999999999999999998765      6


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCc---EEEEec
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDF  805 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~---VKLsDF  805 (867)
                      +..++||||+++|+|.+++........+++..++.++.||+.||+|||++|  |+||||||+|||++.++.   +||+||
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccc
Confidence            678999999999999999987554456889999999999999999999999  999999999999997664   999999


Q ss_pred             CccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          806 GLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       806 GLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      |+++....... .....||+.|+|||++.+..+   +|||||||++|+|++|..||..
T Consensus       169 G~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          169 GYAKELDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCCBTTSCCC-CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccccc-cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            99987654332 345689999999999987554   7999999999999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=9.8e-30  Score=269.16  Aligned_cols=175  Identities=26%  Similarity=0.355  Sum_probs=149.6

Q ss_pred             CCCeEEE-EEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHH-HhcCCCCeeeEEeEEee----CC
Q 002910          658 WDELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIM-KRVRHPNVVLFMGAVTK----RP  729 (867)
Q Consensus       658 ~~dy~i~-e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~IL-k~LrHPNIVkl~ga~~~----~~  729 (867)
                      .++|.+. +.||+|+||.||+|.+  +++.||||++...       ..+.+|+.++ +.++||||+++++++..    ..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            4677777 7899999999999988  5778999998643       2466788887 56689999999999987    67


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFG  806 (867)
                      .+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+|||++.   ++.+||+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             eEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            7999999999999999998743 335899999999999999999999999  999999999999998   7899999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +++......                   ....+|||||||++|+|++|..||...
T Consensus       166 ~a~~~~~~~-------------------~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          166 FAKETTGEK-------------------YDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             TCEECTTCG-------------------GGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             ccccccccc-------------------CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            986543211                   123589999999999999999999654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=2.2e-30  Score=288.99  Aligned_cols=201  Identities=14%  Similarity=0.080  Sum_probs=155.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCC-CCee----------
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRH-PNVV----------  719 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrH-PNIV----------  719 (867)
                      +......|.+.+.||+|+||+||+|++.  |+.||||++...... ....+.+.+|+.+++.++| .|+.          
T Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~  152 (413)
T 3dzo_A           73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  152 (413)
T ss_dssp             SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred             CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence            3445567999999999999999999984  889999998744322 2346778999999999987 2211          


Q ss_pred             -----------eEEeEEee-----CCeEEEEEeccCCCCHHHHHhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 002910          720 -----------LFMGAVTK-----RPHLSIVTEYLPRGSLYRLIHR----PAAGEMMDQRRRLRMALDVAKGINYLHNLN  779 (867)
Q Consensus       720 -----------kl~ga~~~-----~~~l~LVmEy~~gGSL~~~L~~----~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g  779 (867)
                                 .+..++..     ...++++|+++ +++|.+++..    ......+++..++.++.||+.||+|||+++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  231 (413)
T 3dzo_A          153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  231 (413)
T ss_dssp             CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                       11111111     22467788866 7899998852    112335788899999999999999999999


Q ss_pred             CCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccCCCccccccccc----------CCC---ChHHHHHHHH
Q 002910          780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQT----------ACN---SLALIFSLSG  846 (867)
Q Consensus       780 p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl----------~~~---~~SDIwSLG~  846 (867)
                        ||||||||+||||+.++.+||+|||+++.....   ....+| +.|+|||++          .+.   ..+|||||||
T Consensus       232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             --cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence              999999999999999999999999999876544   345678 999999999          332   2589999999


Q ss_pred             HHHHHhcCCCCcccc
Q 002910          847 WLQSSFEESPQMRSL  861 (867)
Q Consensus       847 lLyeM~tG~~Pf~sl  861 (867)
                      ++|+|++|..||...
T Consensus       306 il~elltg~~Pf~~~  320 (413)
T 3dzo_A          306 AIYWIWCADLPNTDD  320 (413)
T ss_dssp             HHHHHHHSSCCCCTT
T ss_pred             HHHHHHHCCCCCCCc
Confidence            999999999999764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.7e-30  Score=302.94  Aligned_cols=186  Identities=15%  Similarity=0.108  Sum_probs=136.1

Q ss_pred             EEeccCCceEEEEEEE--cCceEEEEEEeecccc--------hHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCeEEE
Q 002910          665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL--------DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       665 e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~--------~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~~l~L  733 (867)
                      ..++.|++|.+..++.  .|..+|||++.+....        ....++|.+|+++|+++ .|+||+++++++++.+.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3567788888777654  6999999999875321        23456799999999999 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      ||||++|++|.++|.+.   ..+++.   .|+.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|+....
T Consensus       320 VMEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EEecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999999863   346664   47899999999999999  99999999999999999999999999998766


Q ss_pred             CcccccccCCCcccccccccCCCCh--HHHHHHHHHHHHHhcCCCCc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL--ALIFSLSGWLQSSFEESPQM  858 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~--SDIwSLG~lLyeM~tG~~Pf  858 (867)
                      ......+.+||+.|||||++.+...  +|+||+|++++.|+++..++
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred             CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence            5555567899999999999987533  79999999988776664443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=8e-27  Score=270.43  Aligned_cols=183  Identities=17%  Similarity=0.175  Sum_probs=145.2

Q ss_pred             EEEEEeccCCceEEEEEEEcCceEEEEEEeecccchH------HHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       662 ~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~------~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ...+.||+|+||+||+|.+.+..+++|+.........      ..+++.+|+++|++++||||+++..++......||||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            3467899999999999998999999998766443321      2456899999999999999996555555777789999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++++|.+++..           ++.++.||+.||.|||+++  |+||||||+|||++.  .+||+|||+++......
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            99999999999864           4579999999999999999  999999999999998  99999999999875532


Q ss_pred             c-------cccccCCCcccccccccCC--CCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          816 I-------SSKSVAGTVVFFAAHQTAC--NSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       816 ~-------s~~s~aGTp~YmAPEvl~~--~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      .       ...+.+||+.|||||++..  ..+   .|+|+..+-..+....+.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1       1246799999999999986  333   589999998888877776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=3.7e-22  Score=212.77  Aligned_cols=146  Identities=14%  Similarity=0.067  Sum_probs=116.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccch----------------HHHHHHHHHHHHHHhcCCCCeeeE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD----------------DQLKEFLREVAIMKRVRHPNVVLF  721 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~----------------~~~k~f~~Ei~ILk~LrHPNIVkl  721 (867)
                      ..|.+++.||+|+||.||+|.+ +|+.||||++.......                .....+.+|+.+|++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            3456779999999999999998 57889999997543211                23567899999999999  4 566


Q ss_pred             EeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEE
Q 002910          722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVK  801 (867)
Q Consensus       722 ~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VK  801 (867)
                      ++++.. +..++||||++||+|.+ +..         .....++.||+.||.|||++|  |+||||||+||||+ ++.+|
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEE
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEE
Confidence            665543 55699999999999988 432         123468999999999999999  99999999999999 99999


Q ss_pred             EEecCccccccCCcccccccCCCcccccccccC
Q 002910          802 VCDFGLSRFKANTFISSKSVAGTVVFFAAHQTA  834 (867)
Q Consensus       802 LsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~  834 (867)
                      |+|||+++.             +..++|||.+.
T Consensus       233 l~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          233 IIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             ECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             EEECCCCeE-------------CCCCCHHHHHH
Confidence            999999853             34578898874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2e-19  Score=188.45  Aligned_cols=138  Identities=17%  Similarity=0.151  Sum_probs=107.7

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCce--EEEEEEeecccch----------------------HHHHHHHHHHHHHHhc
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSD--VAVKVLTVQDFLD----------------------DQLKEFLREVAIMKRV  713 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~--VAVKvi~~~~~~~----------------------~~~k~f~~Ei~ILk~L  713 (867)
                      -|.+.+.||+|+||.||+|.+  +|+.  ||||+++......                      .....+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367899999999999999998  7888  9999976542110                      1123578999999999


Q ss_pred             CCCCe--eeEEeEEeeCCeEEEEEeccCC-C----CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcccc
Q 002910          714 RHPNV--VLFMGAVTKRPHLSIVTEYLPR-G----SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHW  785 (867)
Q Consensus       714 rHPNI--Vkl~ga~~~~~~l~LVmEy~~g-G----SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLH-s~gp~IVHR  785 (867)
                      .|++|  +.+++.    ...+|||||+.+ |    +|.+++..      .++..+..++.||+.||.||| ++|  ||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence            88764  344432    356899999942 3    77776532      234456789999999999999 999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCccccc
Q 002910          786 DLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       786 DLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=1.5e-16  Score=178.15  Aligned_cols=136  Identities=16%  Similarity=0.166  Sum_probs=99.1

Q ss_pred             CeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccc---------------h-HH--HH--HHHHHHHHHHhcCCCCe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL---------------D-DQ--LK--EFLREVAIMKRVRHPNV  718 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~---------------~-~~--~k--~f~~Ei~ILk~LrHPNI  718 (867)
                      -|.++.+||.|+||.||+|.. .|+.||||+++.....               . ..  +.  ...+|...|.++.++++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            489999999999999999987 6889999998643110               0 00  11  12457777777765544


Q ss_pred             e--eEEeEEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC
Q 002910          719 V--LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       719 V--kl~ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~  796 (867)
                      .  ..++.  .  ..+|||||+.|+.|.++..       .+  ....++.||+.+|.|||++|  ||||||||.||||++
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~-------~~--~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS-------VP--DPASLYADLIALILRLAKHG--LIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCCC-------CS--CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEE
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhcc-------cH--HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeC
Confidence            2  22221  1  2379999999988865432       11  23457889999999999999  999999999999988


Q ss_pred             CC----------cEEEEecCcccc
Q 002910          797 NW----------TVKVCDFGLSRF  810 (867)
Q Consensus       797 ~g----------~VKLsDFGLAr~  810 (867)
                      +|          .+.|+||+=+-.
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            76          489999996543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.29  E-value=7.3e-12  Score=129.53  Aligned_cols=143  Identities=13%  Similarity=0.036  Sum_probs=113.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEe
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++.|.+...++.|+.+.||++...+..+++|+.......  ....+.+|+.+|+.+. +..+.++++++...+..|+|||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            357888889999999999999888889999998753211  1235788999999985 6678899999998899999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-------------------------------------  779 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g-------------------------------------  779 (867)
                      |++|.+|.+.+..        ......++.+++.+|..||+..                                     
T Consensus        91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999876321        1122367788999999999810                                     


Q ss_pred             --------------------CCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          780 --------------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       780 --------------------p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                                          +.++|+|++|.|||++.++.+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                2389999999999998766678999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.09  E-value=2.2e-10  Score=116.66  Aligned_cols=138  Identities=17%  Similarity=0.123  Sum_probs=100.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga~~~~~~l~LV  734 (867)
                      ..++.+....+.|..+.||++... |..+++|+.....     ...+.+|+.+|+.+.+.+  +.+++++....+..++|
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            345665444446667999999764 5679999976431     235678999999886544  55688888888889999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-----------------------------------  779 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g-----------------------------------  779 (867)
                      |||++|.+|.  ...      .+.   ..++.+++..|..||+..                                   
T Consensus        94 ~e~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           94 LGEVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EECCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999998884  211      121   245677777888888642                                   


Q ss_pred             ---------------------CCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          780 ---------------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       780 ---------------------p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                                           +.++|+|++|.|||++.++.++|+|||.+...
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                 12999999999999988766789999997643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=6e-10  Score=121.04  Aligned_cols=142  Identities=16%  Similarity=0.192  Sum_probs=106.8

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEe--ecccchHHHHHHHHHHHHHHhcCC--CCeeeEEeEEeeC---CeEEEEE
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRH--PNVVLFMGAVTKR---PHLSIVT  735 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~--~~~~~~~~~k~f~~Ei~ILk~LrH--PNIVkl~ga~~~~---~~l~LVm  735 (867)
                      ..+.|+.|.++.||+....+..+++|+..  ..... .....+.+|..+|+.|..  ..+++++.++...   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            36778999999999998888888888765  32211 123467889999999974  4578888888766   4589999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-------------------------------------  778 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-------------------------------------  778 (867)
                      ||++|..+.+..     ...++...+..++.+++..|..||+.                                     
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999987774311     12367788888999999999999973                                     


Q ss_pred             -------------------CCCccccCCCCCcEEEcCCCc--EEEEecCcccc
Q 002910          779 -------------------NPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRF  810 (867)
Q Consensus       779 -------------------gp~IVHRDLKPeNILLd~~g~--VKLsDFGLAr~  810 (867)
                                         .+.+||+|+++.|||++.++.  +.|+||+++..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               135999999999999987653  69999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=2.8e-09  Score=113.24  Aligned_cols=188  Identities=15%  Similarity=0.078  Sum_probs=125.1

Q ss_pred             EeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCC--eeeEEeEEeeCC---eEEEEEeccC
Q 002910          666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPN--VVLFMGAVTKRP---HLSIVTEYLP  739 (867)
Q Consensus       666 ~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPN--IVkl~ga~~~~~---~l~LVmEy~~  739 (867)
                      .++.|....||+..   ..+++|+....    .....+.+|..+|+.+. +..  +.+++.......   ..|+|||+++
T Consensus        27 ~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             EEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             ecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            48999999999864   57888985432    34567889999999884 332  345555443333   3489999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN----------------------------------------  779 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g----------------------------------------  779 (867)
                      |..|......     .++...+..++.+++..|..||+..                                        
T Consensus       100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9888653321     2667777788888888888888611                                        


Q ss_pred             ----------------CCccccCCCCCcEEEcC--CCcEEEEecCccccccCCccccccc-----CC---------Cccc
Q 002910          780 ----------------PPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKANTFISSKSV-----AG---------TVVF  827 (867)
Q Consensus       780 ----------------p~IVHRDLKPeNILLd~--~g~VKLsDFGLAr~~~~t~~s~~s~-----aG---------Tp~Y  827 (867)
                                      +.++|+|++|.|||++.  .+.+.|+||+.+..-..........     .+         ..+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                            24799999999999998  5668999999986532211000000     00         0011


Q ss_pred             cc-ccccCCC-ChHHHHHHHHHHHHHhcCCCCccccchhh
Q 002910          828 FA-AHQTACN-SLALIFSLSGWLQSSFEESPQMRSLMFIV  865 (867)
Q Consensus       828 mA-PEvl~~~-~~SDIwSLG~lLyeM~tG~~Pf~sl~~LV  865 (867)
                      .. |+..... -+.+.|+++.++|.+.+|..+|...+...
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g~~~  294 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGLNE  294 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            11 2222221 12699999999999999999987766543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.35  E-value=6.5e-06  Score=88.10  Aligned_cols=135  Identities=16%  Similarity=0.173  Sum_probs=93.7

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC---CeeeEEeEEe-eCCeEEEEEeccC
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP---NVVLFMGAVT-KRPHLSIVTEYLP  739 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP---NIVkl~ga~~-~~~~l~LVmEy~~  739 (867)
                      .+.++.|....||+.   +..+++|+-..    ......+.+|..+|+.+.+.   .+.+.+.+.. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            345788999999988   67888998421    23456788999999999753   2456666653 4556789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 002910          740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-----------------------------------------  778 (867)
Q Consensus       740 gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~-----------------------------------------  778 (867)
                      |..|....-.     .++......++.++...|..||+.                                         
T Consensus        97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9888663211     134444445555555555555532                                         


Q ss_pred             -----------------CCCccccCCCCCcEEEcC---CCc-EEEEecCcccc
Q 002910          779 -----------------NPPILHWDLKSPNLLVDK---NWT-VKVCDFGLSRF  810 (867)
Q Consensus       779 -----------------gp~IVHRDLKPeNILLd~---~g~-VKLsDFGLAr~  810 (867)
                                       .+.++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             123699999999999987   355 58999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.34  E-value=4.6e-06  Score=86.17  Aligned_cols=133  Identities=14%  Similarity=0.158  Sum_probs=94.2

Q ss_pred             EeccCCce-EEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSFG-TVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsFG-~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH-PNIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .+..|..| .||+...  .+..+.+|+....     ....+.+|..+|+.+.. --+.+++.++...+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445544 6898765  3567889986532     34467789999988852 22567888888899999999999998


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN------------------------------------------  779 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g------------------------------------------  779 (867)
                      ++.+.....       ......++.+++..|.-||...                                          
T Consensus       106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            887665421       1112235556666666666421                                          


Q ss_pred             --------------CCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          780 --------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       780 --------------p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                                    +.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          1379999999999999887778999998864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.06  E-value=1.9e-05  Score=83.64  Aligned_cols=141  Identities=15%  Similarity=0.161  Sum_probs=81.0

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-----CCCeeeEE-e--EEeeCCeEEEEE
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----HPNVVLFM-G--AVTKRPHLSIVT  735 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-----HPNIVkl~-g--a~~~~~~l~LVm  735 (867)
                      .+.|+.|..+.||+....+..+++|+....   ..   .+..|..+++.|.     .|.++... +  +....+..++||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEECC----CEEEEEEETTEEEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCCCEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            456776788999999887667999988752   12   2334455555442     34444311 1  123467789999


Q ss_pred             eccCCCCHH--------------HHHhcCCCCC-----------CCCHHHH-----------------------------
Q 002910          736 EYLPRGSLY--------------RLIHRPAAGE-----------MMDQRRR-----------------------------  761 (867)
Q Consensus       736 Ey~~gGSL~--------------~~L~~~~~~~-----------~l~e~~~-----------------------------  761 (867)
                      ||++|..+.              ..+|......           ...+...                             
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986432              1122211000           0112110                             


Q ss_pred             --HHHHHHHHHHHHHHHh-----------cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          762 --LRMALDVAKGINYLHN-----------LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       762 --l~ia~qIa~GL~YLHs-----------~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                        ..+...+..++.+|+.           ..+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              0111223445666653           234599999999999998888999999998854

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=8.6e-06  Score=87.95  Aligned_cols=82  Identities=10%  Similarity=-0.038  Sum_probs=54.7

Q ss_pred             EEEEEe-ccCCceEEEEEEEc--------CceEEEEEEeeccc-chHHHHHHHHHHHHHHhcC-C--CCeeeEEeEEeeC
Q 002910          662 HVKERV-GAGSFGTVHRAEWH--------GSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVR-H--PNVVLFMGAVTKR  728 (867)
Q Consensus       662 ~i~e~L-G~GsFG~VykA~~~--------g~~VAVKvi~~~~~-~~~~~k~f~~Ei~ILk~Lr-H--PNIVkl~ga~~~~  728 (867)
                      ...+.| +.|....+|+....        +..+++|+...... .......+.+|+.+|+.|. +  -.+.+++.++...
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            445778 88999999998765        66788887654320 0000134667888888774 2  2466777776654


Q ss_pred             ---CeEEEEEeccCCCCH
Q 002910          729 ---PHLSIVTEYLPRGSL  743 (867)
Q Consensus       729 ---~~l~LVmEy~~gGSL  743 (867)
                         +..++||||++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999988654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.78  E-value=7.3e-05  Score=82.19  Aligned_cols=76  Identities=16%  Similarity=0.131  Sum_probs=49.1

Q ss_pred             EEEeccCCceEEEEEEE--cCceEEEEEEeeccc-chH----HHHHHHHHHHHHHhcCC--CC-eeeEEeEEeeCCeEEE
Q 002910          664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDD----QLKEFLREVAIMKRVRH--PN-VVLFMGAVTKRPHLSI  733 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~-~~~----~~k~f~~Ei~ILk~LrH--PN-IVkl~ga~~~~~~l~L  733 (867)
                      .+.||.|.++.||++..  .+..++||....... ...    ...++..|.++|+.+..  |. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            56799999999999964  467899998653221 000    12356778888887742  33 4455543  3455689


Q ss_pred             EEeccCCC
Q 002910          734 VTEYLPRG  741 (867)
Q Consensus       734 VmEy~~gG  741 (867)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.57  E-value=0.00035  Score=75.71  Aligned_cols=138  Identities=20%  Similarity=0.189  Sum_probs=92.1

Q ss_pred             EEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCeEEEEEeccC
Q 002910          663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIVTEYLP  739 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr---HPNIVkl~ga~~~~~~l~LVmEy~~  739 (867)
                      -.+.|+.|....+|+....+..+++|+....     ....+..|...|+.|.   ...+.+.+.+....+..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3567899999999999887888999987643     2445788988888874   2467788888888888999999999


Q ss_pred             CCCHH--------H---HHhcCCC-CC------------------CCCHHHHH---HHH----------------HHHHH
Q 002910          740 RGSLY--------R---LIHRPAA-GE------------------MMDQRRRL---RMA----------------LDVAK  770 (867)
Q Consensus       740 gGSL~--------~---~L~~~~~-~~------------------~l~e~~~l---~ia----------------~qIa~  770 (867)
                      |..+.        .   .||.... ..                  .-+|...+   ++.                ..++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87541        1   2333211 00                  01333221   010                11111


Q ss_pred             HH-HHHH--hcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          771 GI-NYLH--NLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       771 GL-~YLH--s~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      -+ ..|.  ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 2332  2235699999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.19  E-value=0.0012  Score=73.56  Aligned_cols=75  Identities=19%  Similarity=0.216  Sum_probs=44.8

Q ss_pred             CCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccccC-CCcccccccccCCC---C---hHHHHHHHHHHHHH
Q 002910          779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA-GTVVFFAAHQTACN---S---LALIFSLSGWLQSS  851 (867)
Q Consensus       779 gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s~a-GTp~YmAPEvl~~~---~---~SDIwSLG~lLyeM  851 (867)
                      .+.++|+|+++.|||++.++ ++|+||+.+..-.....-..... -...|++|+.....   .   ...+..+...+|.+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            34599999999999998876 99999999875432111000000 01345666554321   1   13445666666666


Q ss_pred             hcC
Q 002910          852 FEE  854 (867)
Q Consensus       852 ~tG  854 (867)
                      |++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.05  E-value=0.0019  Score=67.84  Aligned_cols=78  Identities=17%  Similarity=0.091  Sum_probs=53.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC---CeeeEEeEEeeCCeEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP---NVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP---NIVkl~ga~~~~~~l~LV  734 (867)
                      ....-.+.+|.|..+.||+.+. +|+.|.+|+........  ...+..|...|+.|.-.   -+.+++++.    .-++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            4456678899999999999998 68889999765332111  12467899999887421   244555442    24789


Q ss_pred             EeccCCCC
Q 002910          735 TEYLPRGS  742 (867)
Q Consensus       735 mEy~~gGS  742 (867)
                      |||+.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.02  E-value=0.0047  Score=65.35  Aligned_cols=147  Identities=12%  Similarity=0.103  Sum_probs=82.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeE------EeeCCeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGA------VTKRPHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga------~~~~~~l  731 (867)
                      ...-.+.|+.|....+|+....+..+++|+.....    ....+..|+.+++.|....  +.+++..      ....+..
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            33456778889889999998866688899886521    1123456777776664211  2233211      1234667


Q ss_pred             EEEEeccCCCCHH--------------HHHhcCCCC---C---CC---CHHHHHH------------HHHHHHHHHHHHH
Q 002910          732 SIVTEYLPRGSLY--------------RLIHRPAAG---E---MM---DQRRRLR------------MALDVAKGINYLH  776 (867)
Q Consensus       732 ~LVmEy~~gGSL~--------------~~L~~~~~~---~---~l---~e~~~l~------------ia~qIa~GL~YLH  776 (867)
                      +++|+|++|..+.              ..+|.....   .   ..   .|...+.            +...+...+++|.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            9999999886431              112221000   0   01   1111000            0112344556665


Q ss_pred             hc-----CCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          777 NL-----NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       777 s~-----gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ..     ...+||+|+.+.|||++.++.+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            32     12489999999999998876668999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.87  E-value=0.0014  Score=70.13  Aligned_cols=32  Identities=28%  Similarity=0.303  Sum_probs=27.5

Q ss_pred             CCccccCCCCCcEEEcCC----CcEEEEecCccccc
Q 002910          780 PPILHWDLKSPNLLVDKN----WTVKVCDFGLSRFK  811 (867)
Q Consensus       780 p~IVHRDLKPeNILLd~~----g~VKLsDFGLAr~~  811 (867)
                      +.++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            359999999999999874    68999999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.76  E-value=0.0029  Score=66.81  Aligned_cols=137  Identities=17%  Similarity=0.126  Sum_probs=74.6

Q ss_pred             EEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCeEEEEEecc-CCC
Q 002910          664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYL-PRG  741 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~~l~LVmEy~-~gG  741 (867)
                      .+.|+.|....+|+.    ..+.+|+.....   .......+|..+++.+...++ .+++++.  ...-++|+||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            567888999999998    678889876431   111122457777776642222 4555543  33357899999 654


Q ss_pred             CHHH------------------HHhcCCCC--CCCC-HHHHHHHHH--------------HHHHHHH----HHH--hcCC
Q 002910          742 SLYR------------------LIHRPAAG--EMMD-QRRRLRMAL--------------DVAKGIN----YLH--NLNP  780 (867)
Q Consensus       742 SL~~------------------~L~~~~~~--~~l~-e~~~l~ia~--------------qIa~GL~----YLH--s~gp  780 (867)
                      .|..                  -+|.....  .... ......+..              .+...+.    .|.  ...+
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            4421                  11221110  0011 111111111              1111111    111  1123


Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       781 ~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .++|+|+.+.||| ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5666789999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.64  E-value=0.0035  Score=70.50  Aligned_cols=71  Identities=14%  Similarity=0.236  Sum_probs=48.1

Q ss_pred             EEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCeEEE
Q 002910          664 KERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSI  733 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~~l~L  733 (867)
                      .+.|+.|....||++...         +..+.+|+..... .   ...+.+|..+++.|...++ .++++.+..    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            567888999999999874         3678899874321 1   1344578888888753333 567766542    38


Q ss_pred             EEeccCCCC
Q 002910          734 VTEYLPRGS  742 (867)
Q Consensus       734 VmEy~~gGS  742 (867)
                      ||||++|..
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            999998643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.36  E-value=0.0054  Score=69.89  Aligned_cols=73  Identities=11%  Similarity=0.068  Sum_probs=47.4

Q ss_pred             EEEeccCCceEEEEEEEcC--ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCeEEEEEeccCC
Q 002910          664 KERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYLPR  740 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g--~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~~l~LVmEy~~g  740 (867)
                      .+.|+.|-...+|+....+  ..+.+|+......   ..-...+|..+++.|...++ .++++.+.  +  .+||||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            5678889999999998865  7788998743210   00112478889998875444 56777663  2  359999987


Q ss_pred             CCH
Q 002910          741 GSL  743 (867)
Q Consensus       741 GSL  743 (867)
                      ..|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.34  E-value=0.038  Score=58.43  Aligned_cols=140  Identities=12%  Similarity=0.074  Sum_probs=77.9

Q ss_pred             EeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeE-----EeeCCeEEEEEec
Q 002910          666 RVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGA-----VTKRPHLSIVTEY  737 (867)
Q Consensus       666 ~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN--IVkl~ga-----~~~~~~l~LVmEy  737 (867)
                      .|+ |....||+... +|+.+++|+........   ..+..|..+++.+....  +++++..     ....+..++||||
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            466 78889998876 45679999986432222   24556777777664211  3333332     2235567899999


Q ss_pred             cCCCCHH-----------HH---HhcCC---C---CCCCCHHHH----HHH---------------HHHHHHHHHHHHh-
Q 002910          738 LPRGSLY-----------RL---IHRPA---A---GEMMDQRRR----LRM---------------ALDVAKGINYLHN-  777 (867)
Q Consensus       738 ~~gGSL~-----------~~---L~~~~---~---~~~l~e~~~----l~i---------------a~qIa~GL~YLHs-  777 (867)
                      ++|..+.           ..   +|...   .   ....+....    ..+               ...+-..++.+.. 
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431           11   22100   0   011121110    000               1111122333332 


Q ss_pred             ----cCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          778 ----LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       778 ----~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                          ....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                223489999999999998 4 8999999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.25  E-value=0.0031  Score=68.60  Aligned_cols=72  Identities=11%  Similarity=0.165  Sum_probs=43.0

Q ss_pred             EEEeccCCceEEEEEEEcC----------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCCeEE
Q 002910          664 KERVGAGSFGTVHRAEWHG----------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLS  732 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~g----------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPN-IVkl~ga~~~~~~l~  732 (867)
                      .+.|+.|....+|+....+          ..+.+|+.....   ........|..+++.+...+ +.++++.+  .  -+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            4577888889999998754          578888764321   11112356788887775333 34666544  2  26


Q ss_pred             EEEeccCCCC
Q 002910          733 IVTEYLPRGS  742 (867)
Q Consensus       733 LVmEy~~gGS  742 (867)
                      +||||++|..
T Consensus       111 ~v~e~i~G~~  120 (369)
T 3c5i_A          111 RIEEWLYGDP  120 (369)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEecCCc
Confidence            8999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.23  E-value=0.012  Score=65.57  Aligned_cols=148  Identities=15%  Similarity=0.176  Sum_probs=84.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA  724 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga  724 (867)
                      .+..+.+.+ +.|.-|-...+|++...         +..+.+|+.-..   ......+.+|..+++.|. +.-..++++.
T Consensus        47 ~~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~  122 (379)
T 3feg_A           47 RVQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGV  122 (379)
T ss_dssp             GCCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred             CCCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            333344443 46777888899998863         356888875221   112345568999988875 3333566766


Q ss_pred             EeeCCeEEEEEeccCCCCHH--------------HH---HhcCC--CCCCC--CHHHHHHHHHHHHH-------------
Q 002910          725 VTKRPHLSIVTEYLPRGSLY--------------RL---IHRPA--AGEMM--DQRRRLRMALDVAK-------------  770 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~--------------~~---L~~~~--~~~~l--~e~~~l~ia~qIa~-------------  770 (867)
                      +..    .+||||++|..|.              +.   ||...  .....  -++++.++..++..             
T Consensus       123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~  198 (379)
T 3feg_A          123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE  198 (379)
T ss_dssp             ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred             cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence            543    3999999875542              11   22211  11112  23455555544321             


Q ss_pred             ------HHHHHH----hc--CCCccccCCCCCcEEEcCC----CcEEEEecCcccc
Q 002910          771 ------GINYLH----NL--NPPILHWDLKSPNLLVDKN----WTVKVCDFGLSRF  810 (867)
Q Consensus       771 ------GL~YLH----s~--gp~IVHRDLKPeNILLd~~----g~VKLsDFGLAr~  810 (867)
                            .+..|.    ..  ...++|+|+.+.|||++.+    +.+.|+||.++..
T Consensus       199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                  233333    21  1248999999999999876    7899999999864

>3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii}

Probab=96.06  E-value=0.012  Score=63.50  Aligned_cols=102  Identities=17%  Similarity=0.150  Sum_probs=70.2

Q ss_pred             HHHHHHHHHhhcCCChHHHHHHHHHHHHhhhCCCccCCCchhhHHHHHHHHHHHhhcCCeeEEeeccccccchhhHHHHH
Q 002910          338 ELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFK  417 (867)
Q Consensus       338 ~l~~~a~~~~~~~~~~~~~v~~LA~lV~~~MGG~~~~~~~~l~~~w~~~~~~lk~~l~s~V~piG~l~~Gl~rHRALLFK  417 (867)
                      ++.+.|.++..+..+..+.+++|...|.+.+.=.......  ....   ..-|            .-+.|.|++-|.||-
T Consensus       127 ~i~~~A~~~~~~~~~~~~~~~ai~~~v~~~~~Y~~~~~~~--~~~a---~~~l------------~~~~G~C~d~A~l~v  189 (293)
T 3isr_A          127 KLQKLAYKEFGKIENVYSKVLAITDWIYNNVEYISGSTNS--QTSA---FDTI------------TERAGVCRDFAHLGI  189 (293)
T ss_dssp             GSHHHHHHHHTTCCSHHHHHHHHHHHHHHHSEECTTSCCT--TCCH---HHHH------------HHCEECHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCCHHHHHHHHHHHHHhhcEEeccCCCC--CCCH---HHhh------------cCCcEehHHHHHHHH
Confidence            3566777777777778899999999999875311000000  0000   1111            236899999999999


Q ss_pred             hhhhhcCCCceeecccccc--CCCCcceEEEEecCCCCCCceEEEe
Q 002910          418 KLADYIGLPCRIARGCRYC--EADHRSSCLVKIEDDRRSSREYVVD  461 (867)
Q Consensus       418 vLAD~IglpcrLvrG~~y~--~~~~~a~n~V~l~~~~~~~~eyiVD  461 (867)
                      .|+-.+|||||+|-|--+.  ..+..|||+|.++. .    =+.+|
T Consensus       190 al~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-g----Wv~~D  230 (293)
T 3isr_A          190 ALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-N----WIIFD  230 (293)
T ss_dssp             HHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-E----EEEEC
T ss_pred             HHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-c----EEEEE
Confidence            9999999999999993321  23578999999964 4    45666

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.96  E-value=0.015  Score=62.89  Aligned_cols=31  Identities=19%  Similarity=0.332  Sum_probs=27.6

Q ss_pred             CccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       781 ~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      .++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            4999999999999998888999999987653

>3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503}

Probab=94.98  E-value=0.054  Score=62.41  Aligned_cols=96  Identities=18%  Similarity=0.115  Sum_probs=70.2

Q ss_pred             HHHHHHHHHhhcCCChHHHHHHHHHHHHhhhC---------CCccCCCchhhHHHHHHHHHHHhhcCCeeEEeecccccc
Q 002910          338 ELEDKAQELYCASENTLVLVEELGKLVAICMG---------GTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGL  408 (867)
Q Consensus       338 ~l~~~a~~~~~~~~~~~~~v~~LA~lV~~~MG---------G~~~~~~~~l~~~w~~~~~~lk~~l~s~V~piG~l~~Gl  408 (867)
                      .+.+.|.++..+..+..+.+++|-.+|.+.+.         |..+   ..    ..   .-|+.            +.|-
T Consensus       229 ~i~~~a~~l~~~~~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~---~~----a~---~vl~~------------~~G~  286 (506)
T 3kd4_A          229 ESKTFAQFLTDKSGNEQEKVNIIRDHILNNLSTCPIPMAMTGYTV---RD----ID---TVLRS------------AYGT  286 (506)
T ss_dssp             HHHHHHHHHHSSCSSHHHHHHHHHHHHHHHCEECCCCGGGGTTCC---CC----HH---HHHHH------------TEEC
T ss_pred             HHHHHHHHHHhcCCCHHHHHHHHHHHHHhccEecceecccCCCCC---CC----HH---HHHHh------------CCcc
Confidence            34556777788888999999999999998874         2111   00    00   11111            2699


Q ss_pred             chhhHHHHHhhhhhcCCCceeeccccccCC----------CCcceEEEEecCCCCCCceEEEec
Q 002910          409 CRHRAILFKKLADYIGLPCRIARGCRYCEA----------DHRSSCLVKIEDDRRSSREYVVDL  462 (867)
Q Consensus       409 ~rHRALLFKvLAD~IglpcrLvrG~~y~~~----------~~~a~n~V~l~~~~~~~~eyiVDL  462 (867)
                      |+--|+||..|+-..|||||+|-+.  ++.          -+.+|+.|.+ +++    .|++|-
T Consensus       287 C~d~a~Ll~AllRa~GIpA~~v~~~--t~~~~~~~~~lp~~nh~i~~v~~-~g~----~y~lDa  343 (506)
T 3kd4_A          287 PLEIAQLLNVMLNAAGIPSEVLAVY--PGHLDTDACGLAAIQTLAVKATV-DGK----DQYLSA  343 (506)
T ss_dssp             HHHHHHHHHHHHHHTTCCEEEEEEE--ETTSCGGGCCSTTCCEEEEEEEE-TTE----EEEESS
T ss_pred             hHHHHHHHHHHHHHCCCCcEEEEEE--cCCCCCccCCCCCCCEEEEEEEE-CCE----EEEEec
Confidence            9999999999999999999999873  221          1779999998 444    899997

>2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A*

Probab=94.13  E-value=0.036  Score=59.77  Aligned_cols=42  Identities=19%  Similarity=0.205  Sum_probs=39.0

Q ss_pred             cccccchhhHHHHHhhhhhcCCCceeeccccccCCCCcceEEEEecC
Q 002910          404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIED  450 (867)
Q Consensus       404 l~~Gl~rHRALLFKvLAD~IglpcrLvrG~~y~~~~~~a~n~V~l~~  450 (867)
                      -+.|.|++-|.||-.|+=.+|||||+|-|  |   +..||++|-++.
T Consensus       138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g  179 (295)
T 2f4m_A          138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPS  179 (295)
T ss_dssp             HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETT
T ss_pred             cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECC
Confidence            47899999999999999999999999999  3   789999999965

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.02  E-value=0.25  Score=55.67  Aligned_cols=139  Identities=12%  Similarity=0.151  Sum_probs=82.1

Q ss_pred             EEEeccCCceEEEEEEEc---------CceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEE
Q 002910          664 KERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~~---------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~L  733 (867)
                      .+.|..|-...+|+....         +..+.+++.....   +..-...+|..+++.+. +.-..++++.+.    -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence            456777888999999875         5778888864321   11112346788887775 322345665432    278


Q ss_pred             EEeccCCCCHH--------------H---HHhcCC----------CCCCCCHHHHHHHHHHH------------------
Q 002910          734 VTEYLPRGSLY--------------R---LIHRPA----------AGEMMDQRRRLRMALDV------------------  768 (867)
Q Consensus       734 VmEy~~gGSL~--------------~---~L~~~~----------~~~~l~e~~~l~ia~qI------------------  768 (867)
                      ||||++|..|.              +   -||...          ...+.-++.+.++..++                  
T Consensus       148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  227 (424)
T 3mes_A          148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK  227 (424)
T ss_dssp             EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred             EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence            99999986531              1   111110          11111234333333221                  


Q ss_pred             -HHHHHHHHh----------------------cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          769 -AKGINYLHN----------------------LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       769 -a~GL~YLHs----------------------~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                       ...+.+|.+                      ....++|+|+.+.||+ +.++.+.|+||.++..
T Consensus       228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence             223333331                      1124899999999999 7888999999999864

>1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A*

Probab=92.54  E-value=0.092  Score=57.39  Aligned_cols=43  Identities=19%  Similarity=0.197  Sum_probs=39.1

Q ss_pred             cccccchhhHHHHHhhhhhcCCCceeeccccccCCCCcceEEEEecCC
Q 002910          404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDD  451 (867)
Q Consensus       404 l~~Gl~rHRALLFKvLAD~IglpcrLvrG~~y~~~~~~a~n~V~l~~~  451 (867)
                      .+.|.|.|-|.||=.|+=.+|||||+|.|     .++.+|++|-+...
T Consensus       179 tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~  221 (335)
T 1x3z_A          179 TRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFL  221 (335)
T ss_dssp             HCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTT
T ss_pred             hCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCC
Confidence            45799999999999999999999999988     68899999999653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.47  E-value=0.9  Score=50.17  Aligned_cols=29  Identities=24%  Similarity=0.422  Sum_probs=25.2

Q ss_pred             ccccCCCCCcEEE------cCCCcEEEEecCcccc
Q 002910          782 ILHWDLKSPNLLV------DKNWTVKVCDFGLSRF  810 (867)
Q Consensus       782 IVHRDLKPeNILL------d~~g~VKLsDFGLAr~  810 (867)
                      ++|+|+.+.|||+      +.+..++|+||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999999865

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=88.11  E-value=1.4  Score=45.84  Aligned_cols=95  Identities=13%  Similarity=0.100  Sum_probs=61.3

Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcccccc
Q 002910          742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS  820 (867)
Q Consensus       742 SL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLH-s~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s~~s  820 (867)
                      +|.++|...  +.++++.++|-++.|.+.+|.-+- ...  -..+=+-|..|+|..+|.|.+.+ +.+            
T Consensus        34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s------------   96 (229)
T 2yle_A           34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AAD------------   96 (229)
T ss_dssp             EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-ccc------------
Confidence            788999864  457999999999999999877652 112  11222347899999999988863 211            


Q ss_pred             cCCCcccccccccC--CCChHHHHHHHHHHHHHhc
Q 002910          821 VAGTVVFFAAHQTA--CNSLALIFSLSGWLQSSFE  853 (867)
Q Consensus       821 ~aGTp~YmAPEvl~--~~~~SDIwSLG~lLyeM~t  853 (867)
                      ......+.+||...  .....-|||||++||..+.
T Consensus        97 ~~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           97 DAGEPPPVAGKLGYSQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSSSSSCHHHHHHHHHHHHHHHHT
T ss_pred             cccccCCCChhhccccchHHHHHHHHHHHHHHHhh
Confidence            01233466888764  2345799999999998764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.17  E-value=0.17  Score=57.54  Aligned_cols=55  Identities=11%  Similarity=0.112  Sum_probs=13.7

Q ss_pred             ceEEEEEEEcC--ceEEE------EEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          672 FGTVHRAEWHG--SDVAV------KVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       672 FG~VykA~~~g--~~VAV------Kvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      ||.||++.+.+  .+||+      |..+......+....+.+|..+++.++|||+++.+++..
T Consensus       152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            99999999964  47888      766555555566678899999999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	867
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-34
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-26
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-13

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-48
 Identities = 67/180 (37%), Positives = 110/180 (61%), Gaps = 9/180 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
           DW EI   ++ V +R+G+GSFGTV++ +WHG DVAVK+L V      QL+ F  EV +++
Sbjct: 2   DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           + RH N++LFMG  T  P L+IVT++    SLY  +H        +  + + +A   A+G
Sbjct: 60  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQG 116

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFA 829
           ++YLH     I+H DLKS N+ + ++ TVK+ DFGL+    + +     + ++G++++ A
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-42
 Identities = 53/178 (29%), Positives = 92/178 (51%), Gaps = 12/178 (6%)

Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           W  ++  EL + + +G G FG V   ++ G+ VAVK +      D   + FL E ++M +
Sbjct: 2   W-ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQ 56

Query: 713 VRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           +RH N+V  +G + + +  L IVTEY+ +GSL   +       ++     L+ +LDV + 
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEA 115

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YL       +H DL + N+LV ++   KV DFGL++  ++T     +    V + A
Sbjct: 116 MEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTA 168

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-41
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 9/178 (5%)

Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMK 711
           +E+  D+      +GAG+ G V +     S   +A K++   +       + +RE+ ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLH 59

Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
               P +V F GA      +SI  E++  GSL +++ +      + ++   ++++ V KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKG 116

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           + YL   +  I+H D+K  N+LV+    +K+CDFG+S    ++   + S  GT  + +
Sbjct: 117 LTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMS 171

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 2e-40
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 10/180 (5%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIM 710
           +W E+  + L + ER+GAG FG V    ++  + VAVK L            FL E  +M
Sbjct: 7   EW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLM 62

Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
           K+++H  +V     VT+ P   I+TEY+  GSL   +  P +G  +   + L MA  +A+
Sbjct: 63  KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 120

Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
           G+ ++   N   +H DL++ N+LV    + K+ DFGL+R  + N + + +     + + A
Sbjct: 121 GMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 8/179 (4%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           ++  V   +G GS+G   +      G  +  K L      + + +  + EV +++ ++HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 717 NVVLFMGAVTKRP--HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGIN 773
           N+V +   +  R    L IV EY   G L  +I +     + +D+   LR+   +   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 774 YLHNLN---PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             H  +     +LH DLK  N+ +D    VK+ DFGL+R   +    +K+  GT  + +
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 4e-40
 Identities = 44/181 (24%), Positives = 86/181 (47%), Gaps = 8/181 (4%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   +   +G G+FG V++A+   +    A KV+  +   +++L++++ E+ I+    HP
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V  + A     +L I+ E+   G++  ++        + + +   +       +NYLH
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH 127

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACN 836
           +    I+H DLK+ N+L   +  +K+ DFG+S     T     S  GT  + A     C 
Sbjct: 128 DNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 837 S 837
           +
Sbjct: 186 T 186

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 12/176 (6%)

Query: 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
           L     +G GSF TV++        +VA   L  +     + + F  E  ++K ++HPN+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 719 VLFMGA----VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           V F  +    V  +  + +VTE +  G+L   + R    ++M  +        + KG+ +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQF 127

Query: 775 LHNLNPPILHWDLKSPN-LLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LH   PPI+H DLK  N  +     +VK+ D GL+  K  +F  +K+V GT  F A
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMA 181

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 7e-39
 Identities = 58/188 (30%), Positives = 97/188 (51%), Gaps = 9/188 (4%)

Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLR 705
             LA D  EI  + L ++ ++G G FG V    W+G+  VA+K L          + FL+
Sbjct: 5   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQ 61

Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           E  +MK++RH  +V     V++ P   IVTEY+ +GSL   +     G+ +   + + MA
Sbjct: 62  EAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMA 119

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGT 824
             +A G+ Y+  +N   +H DL++ N+LV +N   KV DFGL+R  + N + + +     
Sbjct: 120 AQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177

Query: 825 VVFFAAHQ 832
           + + A   
Sbjct: 178 IKWTAPEA 185

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (363), Expect = 7e-39
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 9/181 (4%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAI 709
            W E+   ++ +K ++G G +G V+   W      VAVK L        +++EFL+E A+
Sbjct: 11  KW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAV 66

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           MK ++HPN+V  +G  T+ P   I+TE++  G+L   +      E +     L MA  ++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 125

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             + YL       +H DL + N LV +N  VKV DFGLSR       ++ + A   + + 
Sbjct: 126 SAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183

Query: 830 A 830
           A
Sbjct: 184 A 184

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 3e-38
 Identities = 41/168 (24%), Positives = 78/168 (46%), Gaps = 12/168 (7%)

Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLF 721
             +G GSFG V+ A        VA+K ++      ++  ++ ++EV  ++++RHPN + +
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
            G   +     +V EY    +   L       + + +     +     +G+ YLH+ N  
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN-- 135

Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           ++H D+K+ N+L+ +   VK+ DFG +   A       S  GT  + A
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMA 179

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 4e-38
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 37/224 (16%)

Query: 639 GPRYLNIEP---SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVK 688
              Y  ++       + W E   + L   + +G+G+FG V  A  +G         VAVK
Sbjct: 15  DNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L  +     + +  + E+ +M ++  H N+V  +GA T    + ++ EY   G L   +
Sbjct: 74  MLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132

Query: 748 HR--------------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL 787
                                      ++     L  A  VAKG+ +L       +H DL
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDL 190

Query: 788 KSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFA 829
            + N+LV     VK+CDFGL+R     + ++   +    V + A
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-37
 Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 22/196 (11%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIM 710
            + W+++  ++ +G G+FG V +A         D A+K +  +    D  ++F  E+ ++
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVL 64

Query: 711 KRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------------PAAGEMM 756
            ++  HPN++  +GA   R +L +  EY P G+L   + +              +    +
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 757 DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816
             ++ L  A DVA+G++YL       +H DL + N+LV +N+  K+ DFGLSR +   ++
Sbjct: 125 SSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYV 181

Query: 817 SSKSVAGTVVFFAAHQ 832
                   V + A   
Sbjct: 182 KKTMGRLPVRWMAIES 197

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 21/185 (11%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
             + ++E +G G FG V R +W G +VAVK+ + ++   ++      E+     +RH N+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59

Query: 719 VLFMGAVTKR----PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           + F+ A  K       L +V++Y   GSL+  ++R      +     +++AL  A G+ +
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAH 115

Query: 775 LHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN----TFISSKSVAGT 824
           LH         P I H DLKS N+LV KN T  + D GL+    +      I+     GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 825 VVFFA 829
             + A
Sbjct: 176 KRYMA 180

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 15/188 (7%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAI 709
           EI    + +++ +GAG FG V              VA+K L    + + Q ++FL E +I
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASI 80

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M +  HPNV+   G VTK   + I+TE++  GSL   + +          + + M   +A
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIA 138

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-----TFISSKSVAGT 824
            G+ YL   +   +H DL + N+LV+ N   KV DFGLSRF  +     T+ S+      
Sbjct: 139 AGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 825 VVFFAAHQ 832
           + + A   
Sbjct: 197 IRWTAPEA 204

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 5e-37
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 9/176 (5%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           I   EL   + +G+G FG VH   W +   VA+K +      +   ++F+ E  +M ++ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP +V   G   ++  + +V E++  G L   +       +      L M LDV +G+ Y
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAY 116

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS-SKSVAGTVVFFA 829
           L      ++H DL + N LV +N  +KV DFG++RF  +   + S      V + +
Sbjct: 117 LE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 8e-37
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 35/218 (16%)

Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLD 697
           + P L    LE   + +     +G G+FG V +A   G         VAVK+L  ++   
Sbjct: 1   LNPKLLS--LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASA 57

Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------- 749
           D   +F RE A+M    +PN+V  +G       + ++ EY+  G L   +          
Sbjct: 58  DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117

Query: 750 -------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796
                              +    +L +A  VA G+ YL       +H DL + N LV +
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE 175

Query: 797 NWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFAAHQ 832
           N  VK+ DFGLSR    A+ + +  + A  + +     
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 8e-37
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 9/176 (5%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
           I   +L   + +G G FG V   +W    DVA+K++      +D   EF+ E  +M  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           H  +V   G  TK+  + I+TEY+  G L   +           ++ L M  DV + + Y
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEY 115

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVVFFA 829
           L   +   LH DL + N LV+    VKV DFGLSR+   + + SS      V +  
Sbjct: 116 LE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 32/222 (14%)

Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVK 688
           G  Y+ I+P+       W E   + L   + +GAG+FG V  A  +G         VAVK
Sbjct: 1   GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59

Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
           +L     L ++ +  + E+ ++  +  H N+V  +GA T      ++TEY   G L   +
Sbjct: 60  MLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 748 HR---------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
            R                     +D    L  +  VAKG+ +L + N   +H DL + N+
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176

Query: 793 LVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFAAHQ 832
           L+      K+CDFGL+R     + ++   +    V + A   
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 55/186 (29%), Positives = 83/186 (44%), Gaps = 14/186 (7%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQ-LKEFLREVAI 709
           I   +L + E++G GSFG V R EW         VAVK L        + + +F+REV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M  + H N++   G V   P + +VTE  P GSL   + +             R A+ VA
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVA 121

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTVV 826
           +G+ YL +     +H DL + NLL+     VK+ DFGL R      + ++  +       
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 827 FFAAHQ 832
           + A   
Sbjct: 180 WCAPES 185

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 654 LEISWDELHVKERV-GAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVA 708
           L +  D L + +   G G+FG+V +  +       DVA+KVL  Q       +E +RE  
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQ 61

Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
           IM ++ +P +V  +G V +   L +V E    G L++ +      E +       +   V
Sbjct: 62  IMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQV 118

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTV 825
           + G+ YL   N   +H DL + N+L+      K+ DFGLS+      + + +  +    +
Sbjct: 119 SMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 826 VFFAAHQTA---CNSLALIFSLSGWL 848
            ++A         +S + ++S    +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTM 202

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 2e-36
 Identities = 44/174 (25%), Positives = 82/174 (47%), Gaps = 10/174 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQL-KEFLREVAIMKRVRH 715
           ++  +   +G G FG V+ A    S   +A+KVL         +  +  REV I   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           PN++   G       + ++ EY P G++YR + +       D++R      ++A  ++Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           H+    ++H D+K  NLL+     +K+ DFG S    ++     ++ GT+ +  
Sbjct: 123 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLP 172

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 3e-36
 Identities = 47/183 (25%), Positives = 90/183 (49%), Gaps = 11/183 (6%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREV 707
           D+ EI  + + +   +G G FG VH+  +   +   +AV + T ++   D ++E FL+E 
Sbjct: 1   DY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
             M++  HP++V  +G +T+   + I+ E    G L   +        +D    +  A  
Sbjct: 60  LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQ 116

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTVV 826
           ++  + YL +     +H D+ + N+LV  N  VK+ DFGLSR+ + +T+  +      + 
Sbjct: 117 LSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 827 FFA 829
           + A
Sbjct: 175 WMA 177

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 4e-35
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 10/175 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           ++  + + +G G++G V  A    ++  VAVK++ ++    D  +   +E+ I K + H 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           NVV F G   +     +  EY   G L+  I        M +    R    +  G+ YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVFFA 829
            +   I H D+K  NLL+D+   +K+ DFGL+      N       + GT+ + A
Sbjct: 121 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 42/170 (24%), Positives = 85/170 (50%), Gaps = 10/170 (5%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
              E++G G+ GTV+ A     G +VA++ + +Q     + +  + E+ +M+  ++PN+V
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIV 80

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
            ++ +      L +V EYL  GSL  ++        MD+ +   +  +  + + +LH+  
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
             ++H D+KS N+L+  + +VK+ DFG             ++ GT  + A
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-34
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
           EI    +  ++ +GAG FG V++     S       VA+K L    + + Q  +FL E  
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAG 61

Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
           IM +  H N++   G ++K   + I+TEY+  G+L + +            + + M   +
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGI 119

Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTV 825
           A G+ YL   N   +H DL + N+LV+ N   KV DFGLSR   +   ++ + +G  
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-34
 Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 19/209 (9%)

Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTV 692
           P Y +       D  E++ +++ +   +G GSFG V+     G         VA+K +  
Sbjct: 1   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN- 59

Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH---- 748
           +     +  EFL E ++MK     +VV  +G V++     ++ E + RG L   +     
Sbjct: 60  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119

Query: 749 ---RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805
                         + ++MA ++A G+ YL+      +H DL + N +V +++TVK+ DF
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDF 177

Query: 806 GLSRF--KANTFISSKSVAGTVVFFAAHQ 832
           G++R   + + +         V + +   
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPES 206

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-34
 Identities = 42/178 (23%), Positives = 81/178 (45%), Gaps = 14/178 (7%)

Query: 660 ELHVKERV-GAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
            L ++++  G+G+FGTV +  +        VAVK+L  +        E L E  +M+++ 
Sbjct: 7   LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           +P +V  +G + +     +V E    G L + + +      +  +  + +   V+ G+ Y
Sbjct: 67  NPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKY 122

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTVVFFA 829
           L   N   +H DL + N+L+      K+ DFGLS+      N + +       V ++A
Sbjct: 123 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 28/204 (13%)

Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFL 704
            W E   D L + + +G G+FG V  A+  G D       VAVK+L  +     + +  +
Sbjct: 7   KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 64

Query: 705 REVAIMKR-VRHPNVVLFMGAVTKRP-HLSIVTEYLPRGSLYRLIHR------------- 749
            E+ I+     H NVV  +GA TK    L ++ E+   G+L   +               
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
               + +     +  +  VAKG+ +L +     +H DL + N+L+ +   VK+CDFGL+R
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 182

Query: 810 F--KANTFISSKSVAGTVVFFAAH 831
              K   ++        + + A  
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPE 206

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  125 bits (315), Expect = 1e-32
 Identities = 45/189 (23%), Positives = 81/189 (42%), Gaps = 16/189 (8%)

Query: 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKE-------FLREVA 708
           ++    KE +G G    V R        + AVK++ V        +E        L+EV 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 709 IMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           I+++V  HPN++             +V + + +G L+  +        + ++   ++   
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRA 118

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
           + + I  LH LN  I+H DLK  N+L+D +  +K+ DFG S    +     + V GT  +
Sbjct: 119 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVCGTPSY 175

Query: 828 FAAHQTACN 836
            A     C+
Sbjct: 176 LAPEIIECS 184

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-32
 Identities = 33/157 (21%), Positives = 73/157 (46%), Gaps = 11/157 (7%)

Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
           +++  + E +G G FG VHR     S      K + V+           +E++I+   RH
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARH 60

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
            N++    +      L ++ E++    ++  I+       +++R  +     V + + +L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFL 118

Query: 776 HNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRF 810
           H+ N  I H+D++  N++    ++ T+K+ +FG +R 
Sbjct: 119 HSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  127 bits (319), Expect = 2e-32
 Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 10/156 (6%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + E +G+G+FG VHR      G     K +     LD        E++IM ++ HP
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHP 86

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
            ++    A   +  + ++ E+L  G L+  I        M +   +       +G+ ++H
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH 144

Query: 777 NLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRF 810
             +  I+H D+K  N++ +  K  +VK+ DFGL+  
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK 178

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-32
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 17/205 (8%)

Query: 640 PRYLNIEPSLAMDWLEISWDEL--HVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTV 692
              LN E   A+  + I    L  H  E +G G FG V+      +D      AVK L  
Sbjct: 6   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN- 64

Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-HLSIVTEYLPRGSLYRLIHRPA 751
           +     ++ +FL E  IMK   HPNV+  +G   +      +V  Y+  G L   I    
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE- 123

Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF- 810
                  +  +   L VAKG+ +L +     +H DL + N ++D+ +TVKV DFGL+R  
Sbjct: 124 -THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 811 ---KANTFISSKSVAGTVVFFAAHQ 832
              + ++  +       V + A   
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALES 205

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  126 bits (317), Expect = 4e-32
 Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 10/156 (6%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D   + E +G G+FG VHR      G++ A K +      +   +   +E+  M  +RHP
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
            +V    A      + ++ E++  G L+  +        M +   +     V KG+ ++H
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 777 NLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRF 810
             N   +H DLK  N++    ++  +K+ DFGL+  
Sbjct: 142 ENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-32
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 28/203 (13%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
           E+  D L + + +G G+FG V  AE  G D         VAVK+L   D  +  L + + 
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 67

Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------------PA 751
           E+ +MK + +H N++  +GA T+   L ++ EY  +G+L   +                 
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF- 810
             E +  +  +  A  VA+G+ YL   +   +H DL + N+LV ++  +K+ DFGL+R  
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 811 -KANTFISSKSVAGTVVFFAAHQ 832
              + +  + +    V + A   
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEA 208

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 8e-32
 Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 8/155 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRH 715
           ++    + +G GSF TV  A       + A+K+L  +  + +  +    RE  +M R+ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P  V           L     Y   G L + I +  +    D+        ++   + YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H     I+H DLK  N+L++++  +++ DFG ++ 
Sbjct: 125 H--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-31
 Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 14/182 (7%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVAI 709
           +   E    + +G+G+FGTV++  W          VA+K L  +       KE L E  +
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           M  V +P+V   +G       + ++T+ +P G L   +      + +  +  L   + +A
Sbjct: 65  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 121

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTVVF 827
           KG+NYL +    ++H DL + N+LV     VK+ DFGL++          ++     + +
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 828 FA 829
            A
Sbjct: 180 MA 181

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (306), Expect = 4e-31
 Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 8/174 (4%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           D    ++ +G G+F  V  AE       VA+K +  +  L+ +      E+A++ +++HP
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHP 67

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V          HL ++ + +  G L+  I          +R   R+   V   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLH 124

Query: 777 NLN-PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           +L                +D++  + + DFGLS+ +    + S +  GT  + A
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVA 177

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 9/175 (5%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-R 714
           ++  + + +G GSFG V  AE+       A+K L     L DD ++  + E  ++     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
           HP +         + +L  V EYL  G L   I         D  R    A ++  G+ +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118

Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
           LH+    I++ DLK  N+L+DK+  +K+ DFG+ +        + +  GT  + A
Sbjct: 119 LHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  121 bits (305), Expect = 2e-30
 Identities = 35/183 (19%), Positives = 74/183 (40%), Gaps = 13/183 (7%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ----LKEFLREVAI 709
           ++ ++  V   +G G FG V+       G   A+K L  +     Q           +++
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
           +     P +V    A      LS + + +  G L+  + +     +  +      A ++ 
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEII 117

Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFA 829
            G+ ++HN    +++ DLK  N+L+D++  V++ D GL+   +       +  GT  + A
Sbjct: 118 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMA 173

Query: 830 AHQ 832
              
Sbjct: 174 PEV 176

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 6e-30
 Identities = 41/179 (22%), Positives = 81/179 (45%), Gaps = 8/179 (4%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKR 712
           ++ ++    + +G G+FG V        G   A+K+L  +  +  D++   + E  +++ 
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
            RHP +     A      L  V EY   G L+  + R     +  + R      ++   +
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSAL 118

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAH 831
            YLH+    +++ D+K  NL++DK+  +K+ DFGL +   +   + K+  GT  + A  
Sbjct: 119 EYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  116 bits (290), Expect = 3e-29
 Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 6/157 (3%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
           ++ H  E++G G++G V++A+ + G   A+K + ++   +      +RE++I+K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
           +V     +  +  L +V E+L +     L         ++        L +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
               +LH DLK  NLL+++   +K+ DFGL+R     
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 10/173 (5%)

Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVL---TVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
           + +G G F TV++A    ++  VA+K +      +  D   +  LRE+ +++ + HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
             + A   + ++S+V +++       +        ++         L   +G+ YLH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH--Q 118

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
             ILH DLK  NLL+D+N  +K+ DFGL++   +   +      T  + A   
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 40/174 (22%), Positives = 80/174 (45%), Gaps = 6/174 (3%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           +     E++G G++G V++A     G  VA+K + +    +      +RE++++K + HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
           N+V  +  +     L +V E+L +     +      G  +   +       + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119

Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAA 830
             +  +LH DLK  NLL++    +K+ DFGL+R       +      T+ + A 
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (287), Expect = 2e-28
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 8/157 (5%)

Query: 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV 713
           S  +  +   +G GSFG VH       G   A+KVL  +  +   Q++    E  ++  V
Sbjct: 2   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
            HP ++   G       + ++ +Y+  G L+ L+ +    +          A +V   + 
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALE 118

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           YLH  +  I++ DLK  N+L+DKN  +K+ DFG +++
Sbjct: 119 YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKY 153

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  111 bits (278), Expect = 9e-28
 Identities = 50/184 (27%), Positives = 76/184 (41%), Gaps = 15/184 (8%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRH 715
           D   + E +G G    VH A       DVAVKVL      D      F RE      + H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 716 PNVVLFMGAV----TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           P +V             P   IV EY+   +L  ++H       M  +R + +  D  + 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 123

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTVVFF 828
           +N+ H     I+H D+K  N+++     VKV DFG++R      N+   + +V GT  + 
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 829 AAHQ 832
           +  Q
Sbjct: 182 SPEQ 185

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 6e-27
 Identities = 41/175 (23%), Positives = 82/175 (46%), Gaps = 15/175 (8%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
               ++G G+FG V +A     G  VA+K + +++  +      LRE+ I++ ++H NVV
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 720 LFMGAVTKRP--------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
             +     +          + +V ++        L +      + + +R ++M L+   G
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---G 129

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVV 826
           + Y+H     ILH D+K+ N+L+ ++  +K+ DFGL+R  +    S  +     V
Sbjct: 130 LYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 8e-27
 Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 20/158 (12%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
             + +G G  G V +          A+K+L           +  REV +  R  + P++V
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIV 68

Query: 720 ----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
               ++      R  L IV E L  G L+  I      +   +R    +   + + I YL
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYL 127

Query: 776 HNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRF 810
           H++N  I H D+K  NLL      N  +K+ DFG ++ 
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-26
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 13/155 (8%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
                +G G++G V  A  +     VA+K ++  +      +  LRE+ I+ R RH N++
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENII 69

Query: 720 LFMGAVTKRPHLS----IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
                +            +  +L    LY+L+      + +           + +G+ Y+
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYI 125

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           H+ N  +LH DLK  NLL++    +K+CDFGL+R 
Sbjct: 126 HSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 158

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-26
 Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 7/155 (4%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
              E++G G++GTV +A+       VA+K + + D  +      LRE+ ++K ++H N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
                +     L++V E+  +       +  +    +D          + KG+ + H+ N
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
             +LH DLK  NLL+++N  +K+ +FGL+R     
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 5e-26
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 20/165 (12%)

Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
           E+S+ +  V   +G GSFG V++A+    G  VA+K +          +   RE+ IM++
Sbjct: 19  EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69

Query: 713 VRHPNVVLFMGAVT------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
           + H N+V                +L++V +Y+P        H   A + +          
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 767 DVAKGINYLHNLNPPILHWDLK-SPNLLVDKNWTVKVCDFGLSRF 810
            + + + Y+H+    I H D+K    LL      +K+CDFG ++ 
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (269), Expect = 7e-26
 Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 8/162 (4%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
           D+    + +G GSFG V   +    G+  A+K+L  Q  +   Q++  L E  I++ V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
           P +V    +     +L +V EY+  G ++  + R        +      A  +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYL 157

Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
           H+L+  +++ DLK  NLL+D+   ++V DFG ++       +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-25
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--- 712
            +      +G G++G V +A      G  VA+K + VQ   +      +REVA+++    
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 713 VRHPNVVLFMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
             HPNVV      T     +   L++V E++ +     L   P  G  +       M   
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQ 124

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTVVF 827
           + +G+++LH+    ++H DLK  N+LV  +  +K+ DFGL+R   +  ++  SV  T+ +
Sbjct: 125 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWY 181

Query: 828 FAAHQ 832
            A   
Sbjct: 182 RAPEV 186

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-25
 Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 15/162 (9%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ----LKEFLREVAIMKR 712
           D     E +G+G F  V +      G   A K +  +     +     ++  REV+I+K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
           ++HPNV+        +  + ++ E +  G L+  +      E + +         +  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 126

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT----VKVCDFGLSRF 810
            YLH  +  I H+DLK  N+++         +K+ DFGL+  
Sbjct: 127 YYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 3e-25
 Identities = 35/184 (19%), Positives = 63/184 (34%), Gaps = 15/184 (8%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVR- 714
            V   +G+G FG+V+          VA+K +      D            EV ++K+V  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 715 -HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
               V+  +    +     ++ E                   + +         V + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVR 124

Query: 774 YLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQ 832
           + HN    +LH D+K  N+L+D N   +K+ DFG      +T        GT V+     
Sbjct: 125 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEW 180

Query: 833 TACN 836
              +
Sbjct: 181 IRYH 184

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 20/179 (11%)

Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
           +  ++G+GSFG ++       G +VA+K+  V      +  +   E  I K ++    + 
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIP 66

Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
            +         +++   L   SL  L +          +  L +A  +   I Y+H+ N 
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN- 123

Query: 781 PILHWDLKSPNLLV---DKNWTVKVCDFGLSRF-------KANTFISSKSVAGTVVFFA 829
             +H D+K  N L+    K   V + DFGL++        +   +  +K++ GT  + +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 9e-24
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 5/157 (3%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
              + VG+G++G V  A     G+ VA+K L      +   K   RE+ ++K +RH NV+
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 720 LFMGAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
             +   T    L   T+ YL    +   + +    E + + R   +   + KG+ Y+H  
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 140

Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815
                H DLK  NL V+++  +K+ DFGL+R   +  
Sbjct: 141 GII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM 175

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 2e-23
 Identities = 35/163 (21%), Positives = 69/163 (42%), Gaps = 13/163 (7%)

Query: 656 ISWDELHVKERVGAGSFGTVHRAE-----WHGSDVAVKVLTVQDFLDDQ--LKEFLREVA 708
           +  +   + + +G G++G V           G   A+KVL     +      +    E  
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 709 IMKRVRH-PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
           +++ +R  P +V    A      L ++ +Y+  G L+  + +    E   +        +
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGE 137

Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
           +   + +LH L   I++ D+K  N+L+D N  V + DFGLS+ 
Sbjct: 138 IVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 98.8 bits (245), Expect = 5e-23
 Identities = 34/166 (20%), Positives = 73/166 (43%), Gaps = 22/166 (13%)

Query: 654 LEISW---DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVA 708
             + W   D+  +  ++G G +  V  A        V VK+L        + K+  RE+ 
Sbjct: 27  HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIK 81

Query: 709 IMKRVR-HPNVVLFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
           I++ +R  PN++     V        ++V E++      +L         +         
Sbjct: 82  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYM 135

Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRF 810
            ++ K ++Y H++   I+H D+K  N+++D ++  +++ D+GL+ F
Sbjct: 136 YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 95.6 bits (237), Expect = 3e-22
 Identities = 31/183 (16%), Positives = 61/183 (33%), Gaps = 24/183 (13%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNV 718
            V  R+G GSFG +           VA+K             +   E    K +     +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGCTGI 63

Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
                   +  H  +V + L       L      G     +     A  +   +  +H  
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 779 NPPILHWDLKSPNLLVDK-----NWTVKVCDFGLSRFKANT-------FISSKSVAGTVV 826
           +  +++ D+K  N L+ +        + V DFG+ +F  +        +   K+++GT  
Sbjct: 121 S--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 827 FFA 829
           + +
Sbjct: 179 YMS 181

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (238), Expect = 5e-22
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 16/168 (9%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
              + +G+G+ G V  A       +VA+K L+         K   RE+ +MK V H N++
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 720 LFMGAVTKRP------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
             +   T +        + +V E +       +         +D  R   +   +  GI 
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIK 133

Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
           +LH  +  I+H DLK  N++V  + T+K+ DFGL+R    +F+ +  V
Sbjct: 134 HLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 1e-21
 Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 13/166 (7%)

Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
           +       VG+G++G+V  A     G  VAVK L+         K   RE+ ++K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 717 NVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
           NV+  +   T    L       +  +L    L  ++      + +       +   + +G
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRG 133

Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
           + Y+H+ +  I+H DLK  NL V+++  +K+ DFGL+R   +    
Sbjct: 134 LKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.6 bits (185), Expect = 3e-16
 Identities = 21/157 (13%), Positives = 44/157 (28%), Gaps = 20/157 (12%)

Query: 663 VKERVGAGSFGTVHRAEWH-GSDVAVKVL--------TVQDFLDDQLKEFLREVAIMKRV 713
           + + +G G    V         +  VK           V++  D     F        R 
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 714 RHPNVVLFMGAVTKRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
               +            L++   Y     ++   +        +       +   + + +
Sbjct: 64  EFRALQKLQ-------GLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
              +  +  I+H DL   N+LV     + + DF  S 
Sbjct: 117 AKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.7 bits (169), Expect = 3e-13
 Identities = 23/165 (13%), Positives = 58/165 (35%), Gaps = 20/165 (12%)

Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
            +  ++G G F TV  A+     + VA+K++       +       E+ +++RV   +  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNT 72

Query: 720 LFMGAVTKRP-------------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
                                   + +V  +   G     + +      +      +++ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF 810
            +  G++Y+H     I+H D+K  N+L++       +    ++  
Sbjct: 133 QLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	867
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.96
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.83
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.23
d2f4ma1	287	Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus)	91.85

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-44  Score=375.56  Aligned_cols=198  Identities=23%  Similarity=0.406  Sum_probs=177.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      .+++|++++.||+|+||+||+|++  +++.||||++.+..... ...+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999998  47789999998665433 235678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||||++|+|.+++.+..   .+++..+..++.||+.||+|||++|  ||||||||+||||+.++.+||+|||+++....
T Consensus        84 vmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999998633   4899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..  ....+||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       159 ~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  207 (263)
T d2j4za1         159 SR--RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  207 (263)
T ss_dssp             CC--CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Cc--ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence            43  356789999999999997654   89999999999999999999764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-44  Score=377.12  Aligned_cols=199  Identities=24%  Similarity=0.338  Sum_probs=173.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++...... +..+.+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            47899999999999999999998  4788999999865432 33467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t-  814 (867)
                      |||++|+|.+++..   ...+++..++.++.||+.||+|||++|  ||||||||+||||+.++.+||+|||+|+..... 
T Consensus        83 Ey~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          83 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             eccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999999875   335999999999999999999999999  999999999999999999999999999876432 


Q ss_pred             -cccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 -FISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 -~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                       .....+.+||+.|||||++.+..+    +|||||||++|+|++|.+||....
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence             223456799999999999987543    799999999999999999997543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=379.61  Aligned_cols=205  Identities=33%  Similarity=0.554  Sum_probs=176.3

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      ++|+|..++|++++.||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||++++++. .+.+
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~   78 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL   78 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence            3578999999999999999999999998765 5999999877666677889999999999999999999999875 4678


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +||||||++|+|.++++...  ..+++..++.++.||+.||+|||+++  ||||||||+||||+.++++||+|||+|+..
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99999999999999997633  35899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCC--cccccccCCCcccccccccCCC------ChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANT--FISSKSVAGTVVFFAAHQTACN------SLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t--~~s~~s~aGTp~YmAPEvl~~~------~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...  .....+..||+.|||||++.+.      ..+|||||||++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~  213 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  213 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence            432  2234567899999999998742      24799999999999999999998653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-44  Score=376.45  Aligned_cols=205  Identities=24%  Similarity=0.396  Sum_probs=167.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCeEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSI  733 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--~~~l~L  733 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++..........+.+.+|+++|++++|||||++++++.+  .+.+||
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            37899999999999999999998  47889999998887777778889999999999999999999999864  466899


Q ss_pred             EEeccCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          734 VTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLN---PPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~-~~~~l~e~~~l~ia~qIa~GL~YLHs~g---p~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      |||||++|+|.+++.+.. ....+++..++.++.||+.||+|||+++   .+||||||||+||||+.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999987521 2346999999999999999999999864   249999999999999999999999999999


Q ss_pred             cccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..........+.+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~  218 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  218 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence            87655444567899999999999987654   899999999999999999997643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-43  Score=383.65  Aligned_cols=202  Identities=21%  Similarity=0.339  Sum_probs=182.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      |+.++|++++.||+|+||+||+|+.  +|+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|++...+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            5678999999999999999999997  58889999998765432 34677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ||||||+||+|..++.+..   .+++..++.++.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|+...
T Consensus        82 iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             cceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            9999999999999998743   5899999999999999999999999  9999999999999999999999999999766


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .........+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            55555567899999999999998665   799999999999999999997643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-43  Score=376.34  Aligned_cols=196  Identities=24%  Similarity=0.375  Sum_probs=176.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++.......  .+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            5789999999999999999987  58899999998664332  3578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||+||+|.+++.+.    .+++..++.++.||+.||.|||++|  ||||||||+||||+.+|++||+|||+|+.......
T Consensus        98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            99999999988752    4899999999999999999999999  99999999999999999999999999998765555


Q ss_pred             cccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .....+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence            5567799999999999998655   899999999999999999997643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=382.85  Aligned_cols=198  Identities=24%  Similarity=0.390  Sum_probs=175.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      ++.-++|++++.||+|+||+||+|++  +|..||+|+++... .....+.+.+|+.+|++++|||||+++++|.+..++|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45668999999999999999999998  47789999997653 3344567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      ||||||+||+|.+++.+..   .+++..+..++.||+.||.|||+ ++  |+||||||+||||+.+|++||+|||+|+..
T Consensus        81 iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            9999999999999998643   48999999999999999999997 58  999999999999999999999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ....  ..+.+||+.|||||++.+..+   +|||||||++|+|++|+.||..
T Consensus       156 ~~~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         156 IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             HHHT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             CCCc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            5432  246799999999999987655   7999999999999999999965

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=366.52  Aligned_cols=197  Identities=25%  Similarity=0.400  Sum_probs=173.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEc--CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCeEEE
Q 002910          660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLSI  733 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~~--g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~----~~~l~L  733 (867)
                      .|++.+.||+|+||+||+|++.  +..||+|++..........+.+.+|+++|++++|||||+++++|..    ...+||
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            3577889999999999999984  6679999998877777777889999999999999999999999865    356899


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc-CCCcEEEEecCcccccc
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd-~~g~VKLsDFGLAr~~~  812 (867)
                      |||||++|+|.+++.+.   ..+++..++.++.||+.||+|||+++++||||||||+||||+ +++.+||+|||+++...
T Consensus        90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999999863   358999999999999999999999888899999999999996 58999999999998755


Q ss_pred             CCcccccccCCCcccccccccCC--CChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTAC--NSLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~--~~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...  ..+.+||+.|||||++.+  ...+|||||||++|+|++|..||...
T Consensus       167 ~~~--~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         167 ASF--AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             TTS--BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCc--cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            443  356799999999999875  33489999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=373.92  Aligned_cols=198  Identities=22%  Similarity=0.370  Sum_probs=173.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      ++|++++.||+|+||+||+|++  +++.||||++.+..... ...+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            7899999999999999999998  47789999998654432 34567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC-
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-  814 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t-  814 (867)
                      |||+||+|.+++...   ..+++..++.++.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+..... 
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999998864   35899999999999999999999999  999999999999999999999999999876532 


Q ss_pred             -cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          815 -FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       815 -~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                       .....+.+||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence             223356789999999999987655   79999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=373.29  Aligned_cols=198  Identities=26%  Similarity=0.405  Sum_probs=175.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|++++.||+|+||+||+|++  ++..||||++....  ....+.+.+|+++|++++|||||++++++.+.+.++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            5689999999999999999998  47789999997653  3345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||++|+|.+++.+.  ...+++..+..++.||+.||.|||++|  ||||||||+||||+.+|.+||+|||+|+.......
T Consensus        90 y~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          90 FCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999999987653  235899999999999999999999999  99999999999999999999999999987655444


Q ss_pred             cccccCCCcccccccccCC--------CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTAC--------NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~--------~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...+.+||+.|||||++..        +..+|||||||++|+|++|.+||....
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence            4557899999999999853        234899999999999999999998654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-42  Score=373.61  Aligned_cols=198  Identities=23%  Similarity=0.395  Sum_probs=177.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +.++|++++.||+|+||+||+|++  +|+.||||++.+..... ...+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            457999999999999999999998  47889999998764432 346778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||||.||+|..++...   ..+++..+..++.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|+....
T Consensus        82 vmE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          82 IMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             EECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeeecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999999998863   35888999999999999999999999  99999999999999999999999999988765


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ..   .+.+||+.|||||++.+..+   +|||||||++|+|++|..||....
T Consensus       157 ~~---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         157 VT---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             CB---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cc---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence            43   46799999999999987655   799999999999999999997643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-43  Score=370.79  Aligned_cols=203  Identities=29%  Similarity=0.473  Sum_probs=178.0

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      .+.|+|..++|++.+.||+|+||+||+|++  +++.||||+++....   ..+++.+|+.+|++++|||||+++++|.+.
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            356889999999999999999999999998  477899999876543   245789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      +.++||||||++|+|..++.... ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||++
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             CeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccce
Confidence            99999999999999999997643 346899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          809 RFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       809 r~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      +...... .......||+.|||||++.+..+   +|||||||++|+|++|..||+
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~  217 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  217 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence            9765432 33344578999999999887654   899999999999999766554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-42  Score=369.19  Aligned_cols=194  Identities=23%  Similarity=0.346  Sum_probs=173.1

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      .|++++.||+|+||+||+|++  +++.||||++...... ....+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            499999999999999999997  4778999999876654 3556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      ||.+|+|..++...   ..+++..++.++.||+.||.|||++|  ||||||||+||||+.++.+||+|||+++.....  
T Consensus        96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            99999998776542   35899999999999999999999999  999999999999999999999999999875443  


Q ss_pred             cccccCCCcccccccccCC------CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          817 SSKSVAGTVVFFAAHQTAC------NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~------~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                        ...+||+.|||||++.+      ...+|||||||++|+|++|..||....
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence              45689999999999864      234899999999999999999997643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-42  Score=368.69  Aligned_cols=196  Identities=24%  Similarity=0.370  Sum_probs=157.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      +.|++++.||+|+||+||+|++  +++.||||++.+..... ..+.+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5699999999999999999998  47789999998765433 34568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCccccccC
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGLAr~~~~  813 (867)
                      ||+||+|.+++...   ..+++..+..++.||+.||+|||+++  ||||||||+|||+.   .++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999763   35999999999999999999999999  99999999999994   578999999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. ...+.+||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       163 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         163 GS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence            32 2356789999999999997654   89999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=361.43  Aligned_cols=202  Identities=27%  Similarity=0.465  Sum_probs=173.9

Q ss_pred             cccccCCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       652 ~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +.|+|..++|++++.||+|+||+||+|+++ ++.||||++......   .+.+.+|+.+|++++|||||++++++.. +.
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~   81 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence            567899999999999999999999999995 567999999765433   3468999999999999999999998754 56


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      ++||||||++|+|.+++.... ...+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+|+.
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEE
Confidence            799999999999999887533 234899999999999999999999999  99999999999999999999999999998


Q ss_pred             ccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCC-CCccc
Q 002910          811 KANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEES-PQMRS  860 (867)
Q Consensus       811 ~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~-~Pf~s  860 (867)
                      ..... .......||+.|||||++.+..+   +|||||||++|+|+||. +|+..
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~  213 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            75433 33445689999999999986554   79999999999999964 55443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=356.39  Aligned_cols=198  Identities=26%  Similarity=0.477  Sum_probs=162.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      |+.++|++++.||+|+||+||+|++ +++.||||++.......   +++.+|+.+|++++|||||+++++|...+.++||
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            3457899999999999999999998 46679999987654333   4689999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      ||||++|+|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++++||+|||+++.....
T Consensus        79 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999998763  345889999999999999999999999  999999999999999999999999999876543


Q ss_pred             c-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcC-CCCccc
Q 002910          815 F-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE-SPQMRS  860 (867)
Q Consensus       815 ~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG-~~Pf~s  860 (867)
                      . .......||+.|||||++.+..+   +|||||||++|+|+++ .+||..
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence            2 22345689999999999997665   7999999999999995 565543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-41  Score=364.07  Aligned_cols=203  Identities=29%  Similarity=0.457  Sum_probs=163.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--Cc---eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--GS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g~---~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      ++..++|++.+.||+|+||+||+|++.  ++   .||||.+... ......++|.+|+.+|++++|||||++++++...+
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            456689999999999999999999983  22   3777776543 23456678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .++||||||++|+|.+++...  ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++++||+|||+++
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccce
Confidence            999999999999999988763  335899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc-----ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF-----ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~-----~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ......     .......||+.|||||++.+..+   +|||||||++|||++ |.+||....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            764321     11223468999999999886554   899999999999997 899998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-41  Score=370.16  Aligned_cols=197  Identities=23%  Similarity=0.389  Sum_probs=175.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++....  ....+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            47899999999999999999998  47889999997654  334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc--CCCcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd--~~g~VKLsDFGLAr~~~~  813 (867)
                      |||+||+|.+++...  ...+++..++.++.||+.||+|||++|  ||||||||+||||+  .++.+||+|||+++....
T Consensus       103 E~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         103 EFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999999653  335999999999999999999999999  99999999999995  468899999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. ...+.+||+.|||||++.+..+   +|||||||++|+|++|..||...
T Consensus       179 ~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  228 (350)
T d1koaa2         179 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  228 (350)
T ss_dssp             TS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence            43 2356799999999999997654   89999999999999999999754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.9e-42  Score=372.72  Aligned_cols=197  Identities=23%  Similarity=0.355  Sum_probs=177.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++.+..... ...+.+.+|+.+|+.++|||||++++++.....+++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            47999999999999999999998  48889999998655432 3466789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCC
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT  814 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t  814 (867)
                      |||+.+|+|..++.+..   .+++..++.++.||+.||.|||+++  ||||||||+||||+.+|++||+|||+|+.....
T Consensus       120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999997643   5899999999999999999999999  999999999999999999999999999887654


Q ss_pred             cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          815 FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       815 ~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      .   .+.+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       195 ~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  242 (350)
T d1rdqe_         195 T---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             B---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             c---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence            3   46789999999999998665   799999999999999999997653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=367.82  Aligned_cols=207  Identities=25%  Similarity=0.352  Sum_probs=173.9

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcCc-------eEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-------DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA  724 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g~-------~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga  724 (867)
                      .|+++.++|++++.||+|+||+||+|++.+.       .||+|++.... .......+.+|+.+|.++ +|||||+++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            4678889999999999999999999998432       48888876443 234456789999999998 89999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccc
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA--------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILH  784 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~~--------------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVH  784 (867)
                      |.+.+.++||||||++|+|.++|+....                    ...+++..++.++.||+.||+|||+++  |||
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH  187 (325)
T d1rjba_         110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH  187 (325)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred             EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence            9999999999999999999999976421                    134889999999999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCc
Q 002910          785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQM  858 (867)
Q Consensus       785 RDLKPeNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf  858 (867)
                      |||||+|||++.++++||+|||+|+......  ....+.+||+.|||||++.+..+   +|||||||++|+|++ |.+||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            9999999999999999999999998754432  22345678999999999886554   799999999999997 89999


Q ss_pred             cccc
Q 002910          859 RSLM  862 (867)
Q Consensus       859 ~sl~  862 (867)
                      ....
T Consensus       268 ~~~~  271 (325)
T d1rjba_         268 PGIP  271 (325)
T ss_dssp             TTCC
T ss_pred             CCCC
Confidence            7653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=358.15  Aligned_cols=197  Identities=23%  Similarity=0.374  Sum_probs=175.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch----HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~----~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~  732 (867)
                      +.|++++.||+|+||+||+|++  +|+.||||++.+.....    ...+.+.+|+.+|++++|||||+++++|.+...+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999998  47889999998765432    23577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC----cEEEEecCcc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLS  808 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g----~VKLsDFGLA  808 (867)
                      ||||||++|+|.+++....   .+++..++.++.||+.||+|||+++  ||||||||+|||++.++    .+||+|||++
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999998643   5999999999999999999999999  99999999999998776    5999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      +...... ...+..||+.|||||++.+..+   +|||||||++|+|++|..||...
T Consensus       165 ~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  219 (293)
T d1jksa_         165 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  219 (293)
T ss_dssp             EECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence            8765432 2356789999999999987544   89999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.3e-41  Score=368.09  Aligned_cols=197  Identities=21%  Similarity=0.332  Sum_probs=175.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++.....  ...+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999998  588899999986542  33457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc--CCCcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd--~~g~VKLsDFGLAr~~~~  813 (867)
                      |||+||+|.+++...  ...+++..++.++.||+.||+|||++|  ||||||||+||||+  .++.+||+|||+|+....
T Consensus       106 E~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         106 EFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             ECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999999887653  335899999999999999999999999  99999999999998  678999999999987754


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. ...+.+||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  231 (352)
T d1koba_         182 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE  231 (352)
T ss_dssp             TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence            33 2356789999999999998766   79999999999999999999764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-41  Score=363.20  Aligned_cols=200  Identities=24%  Similarity=0.337  Sum_probs=177.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccc-hHHHHHHHHHHHHHH-hcCCCCeeeEEeEEeeCCeEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK-RVRHPNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk-~LrHPNIVkl~ga~~~~~~l~L  733 (867)
                      +++|++++.||+|+||+||+|++  +++.||||++.+.... ....+.+.+|+.++. .++|||||++++++.+.+.+||
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            37899999999999999999998  5788999999865433 234566778888765 6899999999999999999999


Q ss_pred             EEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccC
Q 002910          734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       734 VmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~  813 (867)
                      |||||++|+|.+++....   .+++..+..++.||+.||+|||+++  |+||||||+|||++.++++||+|||+++....
T Consensus        81 vmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999998633   4899999999999999999999999  99999999999999999999999999987665


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ........+||+.|+|||++.+..+   +|||||||++|+|++|+.||....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence            5555567799999999999998665   899999999999999999997543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-41  Score=369.22  Aligned_cols=198  Identities=22%  Similarity=0.261  Sum_probs=171.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHH-HHHHH---HHHHHHHhcCCCCeeeEEeEEeeCCe
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQ-LKEFL---REVAIMKRVRHPNVVLFMGAVTKRPH  730 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~-~k~f~---~Ei~ILk~LrHPNIVkl~ga~~~~~~  730 (867)
                      +.++|++++.||+|+||+||+|++  +|+.||||++.+....... ...+.   +|+.+++.++|||||+++++|.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            568999999999999999999998  5788999999865543321 22233   44667777889999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|||||||+||+|.++|.+.   ..+++..++.++.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+.
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999999863   35889999999999999999999999  99999999999999999999999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....  ....+||+.|||||++..+    ..+|||||||++|+|++|..||...
T Consensus       157 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         157 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             CSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             cCCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            65543  3567899999999998743    3489999999999999999999754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-41  Score=356.25  Aligned_cols=202  Identities=22%  Similarity=0.364  Sum_probs=172.8

Q ss_pred             ccCCCCeEEEEE-eccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKER-VGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~-LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      -+..++|.+.+. ||+|+||+||+|.+.    +..||||+++... .....++|.+|+++|++++|||||++++++.. +
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            355678999885 999999999999873    3369999987543 34567889999999999999999999999865 4


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+|||||||++|+|.+++...  ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+++
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhh
Confidence            689999999999999998653  335899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ......   .......||+.|||||++.+..+   +|||||||++|||++ |..||....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence            764322   22335578999999999886554   899999999999997 899998654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=352.11  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=165.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWHG------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR  728 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~g------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~  728 (867)
                      +|..++|.+.+.||+|+||+||+|.+++      ..||||++.... ......+|.+|+.+|++++|||||++++++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            5667899999999999999999998843      259999986543 345566799999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcc
Q 002910          729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS  808 (867)
Q Consensus       729 ~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLA  808 (867)
                      ..+++|||||.+|++.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++++||+|||++
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchh
Confidence            9999999999999999988753  245899999999999999999999999  999999999999999999999999999


Q ss_pred             ccccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          809 RFKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       809 r~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      +......   .......||+.|||||++.+..+   +|||||||++|+|+++..|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence            8764322   22234578999999999987655   899999999999998654443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-41  Score=353.88  Aligned_cols=196  Identities=22%  Similarity=0.379  Sum_probs=163.5

Q ss_pred             eEEE-EEeccCCceEEEEEEEc----CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          661 LHVK-ERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       661 y~i~-e~LG~GsFG~VykA~~~----g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.+. +.||+|+||+||+|.+.    ++.||||+++.........+++.+|+.+|++++|||||+++++|.. +..+|||
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm   86 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM   86 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence            4443 46999999999999873    3469999997665555667789999999999999999999999865 4578999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      |||++|+|.++++..   ..+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+++......
T Consensus        87 E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          87 EMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             ECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            999999999999863   35899999999999999999999999  9999999999999999999999999998764322


Q ss_pred             ---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          816 ---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       816 ---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                         .......||+.|||||++.+..+   +|||||||++|+|++ |.+||....
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~  215 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  215 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence               22335589999999999987654   899999999999997 899998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=353.74  Aligned_cols=199  Identities=22%  Similarity=0.336  Sum_probs=170.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++..........+.+.+|+++|++++|||||+++++|.+.+++|||||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999998  47889999997665444446788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+.++.+ .++.... ...+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9966544 4443322 345899999999999999999999999  99999999999999999999999999988766555


Q ss_pred             cccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          817 SSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......||+.|+|||++....    .+|||||||++|+|++|+.||...
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence            556779999999999977644    489999999999999999999653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=349.32  Aligned_cols=199  Identities=26%  Similarity=0.435  Sum_probs=174.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       657 ~~~dy~i~e~LG~GsFG~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      +.++|++++.||+|+||+||+|+++ ++.||||++++.....   +++.+|+.+|++++|||||+++++|.+.+.+++||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            3478999999999999999999995 5579999998765543   46899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF  815 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~  815 (867)
                      ||+++|+|..++....  ..+++..+++++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++......
T Consensus        79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999999977643  35889999999999999999999999  9999999999999999999999999998765432


Q ss_pred             -ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          816 -ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       816 -~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                       .......||+.|+|||++.+..+   +|||||||++|+|++ |+.||....
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~  206 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  206 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence             23345689999999999986554   899999999999998 899998653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-40  Score=355.06  Aligned_cols=196  Identities=18%  Similarity=0.325  Sum_probs=173.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVm  735 (867)
                      .++|++++.||+|+||+||+|.+  +++.||||+++...   .....+.+|+.+|++++|||||+++++|.+.+++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            47899999999999999999998  47789999997654   33346789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC--CCcEEEEecCccccccC
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKAN  813 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~--~g~VKLsDFGLAr~~~~  813 (867)
                      |||+||+|.+++...  ...+++..++.++.||+.||+|||++|  |+||||||+|||++.  .+.+||+|||+++....
T Consensus        81 E~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            999999999999763  235899999999999999999999999  999999999999985  45899999999987654


Q ss_pred             CcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          814 TFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       814 t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .. ......+|+.|+|||.+.+..+   +|||||||++|+|++|.+||..-
T Consensus       157 ~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~  206 (321)
T d1tkia_         157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence            32 2346689999999999987655   79999999999999999999754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.4e-40  Score=348.52  Aligned_cols=199  Identities=24%  Similarity=0.387  Sum_probs=176.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-------HHHHHHHHHHHHHHhcC-CCCeeeEEeEEee
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-------DQLKEFLREVAIMKRVR-HPNVVLFMGAVTK  727 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-------~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~  727 (867)
                      .++|++++.||+|+||+||+|++  +++.||||++.+.....       ...+.+.+|+.+|++++ |||||+++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999998  57889999998765321       23456889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      .+.+|||||||++|+|.++|+...   .+++..++.++.||+.||+|||++|  ||||||||+||||+.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999997633   5899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCC---------CChHHHHHHHHHHHHHhcCCCCccccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTAC---------NSLALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~---------~~~SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ++...... ......||+.|+|||.+.+         +..+||||+||++|+|++|.+||....
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            98765433 3356789999999999873         345899999999999999999997653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=353.72  Aligned_cols=205  Identities=28%  Similarity=0.496  Sum_probs=169.3

Q ss_pred             CccccccccCCCCeEEEEEeccCCceEEEEEEEcC-ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 002910          648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT  726 (867)
Q Consensus       648 ~l~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~  726 (867)
                      .+..+.|+|..++|++++.||+|+||+||+|++++ +.||||++......   .+.|.+|+.+|++++|||||++++++.
T Consensus         6 ~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~   82 (285)
T d1fmka3           6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS   82 (285)
T ss_dssp             SSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence            34567889999999999999999999999999954 57999998765433   356899999999999999999999985


Q ss_pred             eCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       727 ~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                      . +.+++|||||++|+|..++.... ...+++..++.++.||+.||+|||+++  |+||||||+||||+.++++||+|||
T Consensus        83 ~-~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          83 E-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             c-CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccc
Confidence            4 56899999999999999887633 235899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCc-ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcc
Q 002910          807 LSRFKANTF-ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMR  859 (867)
Q Consensus       807 LAr~~~~t~-~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~  859 (867)
                      +++...... .......||+.|+|||++.+..+   +|||||||++|+|++|..|+.
T Consensus       159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence            998764332 23345689999999999976544   899999999999999655543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-40  Score=347.58  Aligned_cols=199  Identities=27%  Similarity=0.394  Sum_probs=167.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----eE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----HL  731 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~-~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~----~l  731 (867)
                      ++|++.+.||+|+||+||+|++  +++.||||+++...... ...+.+.+|+.+|++++|||||++++++....    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            6799999999999999999997  58889999998765543 45678999999999999999999999997654    38


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      |||||||+||+|..++...   ..+++..++.++.||+.||+|||++|  ||||||||+||||+.++.++|+|||+++..
T Consensus        87 ~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhh
Confidence            9999999999999988763   35899999999999999999999999  999999999999999999999999998765


Q ss_pred             cCC---cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          812 ANT---FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       812 ~~t---~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...   .......+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence            332   223456789999999999987654   899999999999999999997543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=347.95  Aligned_cols=204  Identities=22%  Similarity=0.364  Sum_probs=162.3

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC-----ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK  727 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-----~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~  727 (867)
                      +|+|..++|++++.||+|+||+||+|++..     ..||||.+... ......+.+.+|+.+|++++|||||++++++. 
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            368888999999999999999999998842     23677766432 23455678999999999999999999999996 


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      .+.++|||||+++|+|..++...  ...+++..++.++.||+.||.|||+++  ||||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCeEEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchh
Confidence            56789999999999999987653  345899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCC-cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          808 SRFKANT-FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       808 Ar~~~~t-~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ++..... ........||+.|+|||++.+..+   +|||||||++|+|++ |.+||....
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~  214 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  214 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence            9876543 223445678999999999986554   799999999999987 899987654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=353.41  Aligned_cols=194  Identities=22%  Similarity=0.293  Sum_probs=165.4

Q ss_pred             EEEEeccCCceEEEEEEE--cCceEEEEEEeecccch---HHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~---~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      .++.||+|+||+||+|++  +|+.||||++.......   ...+.+.+|+.+|++++|||||++++++...+++||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999987  47889999987654332   1235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +.++++..++..   ...+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            998887766654   345888999999999999999999999  999999999999999999999999999887766555


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ....+||+.|+|||++...    ..+|||||||++|+|++|.+||...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            5677999999999998743    3489999999999999999999653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=353.58  Aligned_cols=194  Identities=25%  Similarity=0.317  Sum_probs=166.9

Q ss_pred             CCCeEEEE-EeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEee----CC
Q 002910          658 WDELHVKE-RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK----RP  729 (867)
Q Consensus       658 ~~dy~i~e-~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~----~~  729 (867)
                      .++|.+.. .||+|+||+||+|++  +++.||||++...       ..+.+|+.++.++ +|||||+++++|++    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            47898875 699999999999997  5788999998753       3467899987654 79999999999975    46


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC---CCcEEEEecC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG  806 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~---~g~VKLsDFG  806 (867)
                      .+|||||||+||+|+++|.+.. ...+++..++.++.||+.||+|||++|  |+||||||+|||++.   .+.+||+|||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence            7899999999999999998643 345999999999999999999999999  999999999999975   5679999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      +++...... .....+||+.|||||++.+..+   +|||||||++|+|++|.+||....
T Consensus       160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            998765433 2356789999999999987655   799999999999999999997643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-40  Score=348.56  Aligned_cols=207  Identities=26%  Similarity=0.400  Sum_probs=175.9

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC-------ceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV  725 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g-------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~  725 (867)
                      .+++..++|++++.||+|+||+||+|++.+       +.||||++.... .....+++.+|+.+|++++||||++++++|
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            467788999999999999999999999854       569999986543 345567899999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccc
Q 002910          726 TKRPHLSIVTEYLPRGSLYRLIHRPA---------------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILH  784 (867)
Q Consensus       726 ~~~~~l~LVmEy~~gGSL~~~L~~~~---------------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVH  784 (867)
                      ...+.+++||||+++|+|.++++...                     ....+++..++.++.||+.||+|||+++  |||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH  163 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH  163 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence            99999999999999999999997422                     1234789999999999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCC-CCc
Q 002910          785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEES-PQM  858 (867)
Q Consensus       785 RDLKPeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~-~Pf  858 (867)
                      |||||+||||+.++++||+|||+|+.....  .....+.+||+.|+|||.+.+..+   +|||||||++|+|++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999999999999999999865432  223346689999999999987555   79999999999999885 677


Q ss_pred             cccc
Q 002910          859 RSLM  862 (867)
Q Consensus       859 ~sl~  862 (867)
                      ....
T Consensus       244 ~~~~  247 (301)
T d1lufa_         244 YGMA  247 (301)
T ss_dssp             TTSC
T ss_pred             CCCC
Confidence            7553

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-40  Score=347.73  Aligned_cols=198  Identities=27%  Similarity=0.469  Sum_probs=165.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCeEE
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLS  732 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-~~~l~  732 (867)
                      |+|+.++|++++.||+|+||.||+|+++|+.||||+++...    ..+.+.+|+++|++++|||||++++++.. .+.++
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence            68889999999999999999999999999999999987543    34578999999999999999999999854 56789


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      |||||+++|+|.++|.... ...+++..++.++.||+.||.|||+++  ||||||||+|||++.+|++||+|||+++...
T Consensus        78 lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999999997532 224899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          813 NTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       813 ~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ...   ....+|+.|+|||++.+..+   +|||||||++|||++ |++||...
T Consensus       155 ~~~---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~  204 (262)
T d1byga_         155 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  204 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             CCC---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence            443   45678999999999976554   899999999999998 68887654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.5e-40  Score=344.48  Aligned_cols=198  Identities=23%  Similarity=0.345  Sum_probs=171.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEec
Q 002910          659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY  737 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmEy  737 (867)
                      ++|++++.||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++++|||||+++++|...+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999998 478899999987665555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCccc
Q 002910          738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS  817 (867)
Q Consensus       738 ~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~s  817 (867)
                      +.++.+..+...   ...+++..+..++.||+.||+|||+++  ||||||||+||||+.++.+||+|||++.........
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            988877777654   345999999999999999999999999  999999999999999999999999999887665555


Q ss_pred             ccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          818 SKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       818 ~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....|++.|+|||.+.+.    ..+|||||||++|+|++|++||...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            5667899999999998753    4489999999999999999999754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-39  Score=346.98  Aligned_cols=210  Identities=23%  Similarity=0.314  Sum_probs=179.9

Q ss_pred             cccccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEE
Q 002910          650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM  722 (867)
Q Consensus       650 ~~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~  722 (867)
                      ..+.|+|..++|++++.||+|+||+||+|.++       ++.||||++.... .......+.+|+.+|++++|||||+++
T Consensus        11 ~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             CccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            34678999999999999999999999999874       3579999987543 345567799999999999999999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRP-------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD  795 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~-------~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd  795 (867)
                      +++...+.+++|||||++|+|.+++...       .....+++..+..++.||+.||.|||+++  |+||||||+||||+
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld  167 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA  167 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec
Confidence            9999999999999999999999998742       12234788999999999999999999999  99999999999999


Q ss_pred             CCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCC-CCccccc
Q 002910          796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEES-PQMRSLM  862 (867)
Q Consensus       796 ~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~-~Pf~sl~  862 (867)
                      .++++||+|||+++......  .......||+.|+|||.+.+..+   +|||||||++|+|++|. +||....
T Consensus       168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999998764432  22345578999999999886554   79999999999999984 7776543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=344.82  Aligned_cols=208  Identities=24%  Similarity=0.387  Sum_probs=165.5

Q ss_pred             ccccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       651 ~~~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      ...|+|..++|++++.||+|+||+||+|++.       ++.||||++.... .....+.+.+|..++.++ +|+|||.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            4567899999999999999999999999873       2469999987543 334456788888888776 689999999


Q ss_pred             eEEeeC-CeEEEEEeccCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCC
Q 002910          723 GAVTKR-PHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK  788 (867)
Q Consensus       723 ga~~~~-~~l~LVmEy~~gGSL~~~L~~~~-------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLK  788 (867)
                      +++... ..+++|||||++|+|.++|+...             ....+++..++.++.||+.||+|||+++  |||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlK  161 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  161 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCC
Confidence            988654 46899999999999999997532             1235889999999999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcC-CCCcccc
Q 002910          789 SPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEE-SPQMRSL  861 (867)
Q Consensus       789 PeNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG-~~Pf~sl  861 (867)
                      |+||||+.++++||+|||+|+.....  .......+||+.|||||++.+..+   +|||||||++|+|+++ .+||...
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999865432  223446689999999999987554   7999999999999987 4677554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-40  Score=345.32  Aligned_cols=198  Identities=20%  Similarity=0.270  Sum_probs=170.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccch----HHHHHHHHHHHHHHhcC--CCCeeeEEeEEeeCCe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVR--HPNVVLFMGAVTKRPH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~----~~~k~f~~Ei~ILk~Lr--HPNIVkl~ga~~~~~~  730 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++.+.....    ....++.+|+.+|++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            6899999999999999999998  47889999998654332    12334678999999997  8999999999999999


Q ss_pred             EEEEEeccCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-CCcEEEEecCcc
Q 002910          731 LSIVTEYLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLS  808 (867)
Q Consensus       731 l~LVmEy~~g-GSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-~g~VKLsDFGLA  808 (867)
                      +++||||+.+ +++.+++...   ..+++..++.++.||+.||+|||+++  ||||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 6888888753   35899999999999999999999999  999999999999985 579999999999


Q ss_pred             ccccCCcccccccCCCcccccccccCCCCh----HHHHHHHHHHHHHhcCCCCccccch
Q 002910          809 RFKANTFISSKSVAGTVVFFAAHQTACNSL----ALIFSLSGWLQSSFEESPQMRSLMF  863 (867)
Q Consensus       809 r~~~~t~~s~~s~aGTp~YmAPEvl~~~~~----SDIwSLG~lLyeM~tG~~Pf~sl~~  863 (867)
                      +......  ..+.+||+.|||||++.+..+    +|||||||++|+|++|..||.....
T Consensus       159 ~~~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~  215 (273)
T d1xwsa_         159 ALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE  215 (273)
T ss_dssp             EECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred             eeccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH
Confidence            8765543  356789999999999876443    7999999999999999999986543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-39  Score=345.40  Aligned_cols=198  Identities=24%  Similarity=0.391  Sum_probs=163.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc--Cc----eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWH--GS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL  731 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~--g~----~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l  731 (867)
                      .++|++++.||+|+||+||+|++.  |+    .||+|.+.... .....+++.+|+.+|++++|||||+++++|.+. ..
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            368999999999999999999884  33    47888775432 233457899999999999999999999999764 57


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK  811 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~  811 (867)
                      +++|||+.+|+|.+++...  ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++++||+|||+++..
T Consensus        86 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             eEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceec
Confidence            8889999999999988763  346899999999999999999999999  999999999999999999999999999876


Q ss_pred             cCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          812 ANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       812 ~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      ....  .......||+.|||||++.+..+   +|||||||++|+|+| |.+||...
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~  217 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  217 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            4422  22234578999999999987555   899999999999998 78888764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-39  Score=341.05  Aligned_cols=202  Identities=29%  Similarity=0.432  Sum_probs=162.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-----ceEEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP  729 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~~g-----~~VAVKvi~~~~~~-~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~  729 (867)
                      |..++|++.+.||+|+||+||+|++++     ..||||++.+.... .+..++|.+|+.+|++++|||||++++++.+ +
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            456899999999999999999998742     25899998776543 3556789999999999999999999999975 4


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      .+++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++  |+||||||+||||+.++.+||+|||+++
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             chheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhh
Confidence            6789999999999998887532  35899999999999999999999999  9999999999999999999999999999


Q ss_pred             cccCCc---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCccccc
Q 002910          810 FKANTF---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSLM  862 (867)
Q Consensus       810 ~~~~t~---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl~  862 (867)
                      ......   .......||+.|+|||++.+..+   +||||||+++|||++ |.+||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~  219 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  219 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence            764432   22334578889999999997665   799999999999997 899997653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=340.28  Aligned_cols=206  Identities=26%  Similarity=0.387  Sum_probs=177.1

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEc-------CceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA  724 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~-------g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga  724 (867)
                      .|++..++|++++.||+|+||+||+|++.       ++.||||+++... ......++.+|+.+++++ +|||||+++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            57899999999999999999999999873       3469999987544 344566899999999999 69999999999


Q ss_pred             EeeCCeEEEEEeccCCCCHHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          725 VTKRPHLSIVTEYLPRGSLYRLIHRPA---------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       725 ~~~~~~l~LVmEy~~gGSL~~~L~~~~---------------~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      +.+...++||||||++|+|..++++..               ....+++..++.++.||+.||+|||+++  ||||||||
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp  173 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA  173 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence            999999999999999999999998632               1235889999999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCC--cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t--~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||++.++.+||+|||+++.....  .......+||+.|+|||++.+..+   +|||||||++|+|++ |.+||...
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876542  233445689999999999986544   899999999999998 56666553

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-39  Score=342.26  Aligned_cols=203  Identities=25%  Similarity=0.481  Sum_probs=168.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc--Cce--EEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 002910          655 EISWDELHVKERVGAGSFGTVHRAEWH--GSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP  729 (867)
Q Consensus       655 ei~~~dy~i~e~LG~GsFG~VykA~~~--g~~--VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~ga~~~~~  729 (867)
                      .|++++|++.+.||+|+||+||+|+++  +..  ||||.+.... ..+..+.+.+|+++|.++ +|||||+++++|...+
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            357799999999999999999999984  343  6666664332 234567899999999998 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC
Q 002910          730 HLSIVTEYLPRGSLYRLIHRP-------------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK  796 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~-------------~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~  796 (867)
                      .++|||||+++|+|.++|+..             .....+++..++.++.||+.||.|||+++  ||||||||+|||++.
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence            999999999999999999753             22456899999999999999999999999  999999999999999


Q ss_pred             CCcEEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCC-CCcccc
Q 002910          797 NWTVKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEES-PQMRSL  861 (867)
Q Consensus       797 ~g~VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~-~Pf~sl  861 (867)
                      ++.+||+|||+++...... ......||+.|+|||.+.+..+   +|||||||++|+|++|. +||...
T Consensus       163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence            9999999999998654432 2345689999999999987655   79999999999999975 566543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-39  Score=339.51  Aligned_cols=198  Identities=26%  Similarity=0.387  Sum_probs=166.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc---CceEEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeEEee-----
Q 002910          659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVTK-----  727 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~---g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L---rHPNIVkl~ga~~~-----  727 (867)
                      ++|++++.||+|+||+||+|++.   ++.||||++............+.+|+.+|+.|   +|||||+++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            78999999999999999999983   45699999987654443334566788877765   79999999999853     


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ...++++|||+.++.+.......  ...+++..++.++.||+.||+|||+++  ||||||||+|||++..+.+||+|||+
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhh
Confidence            34689999999888776554432  345899999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++...... ......||+.|||||++.+..+   +|||||||++|+|++|.+||...
T Consensus       163 ~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         163 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            98654432 3457799999999999987665   89999999999999999999754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=338.83  Aligned_cols=206  Identities=26%  Similarity=0.418  Sum_probs=173.2

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC---------ceEEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g---------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~L-rHPNIVkl~  722 (867)
                      .|+|+.++|++++.||+|+||.||+|+..+         ..||||++.... ......++.+|..++.++ +|||||+++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            477889999999999999999999998632         359999987543 445567889999999888 799999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCC
Q 002910          723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS  789 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL~~~L~~~~~-------------~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKP  789 (867)
                      ++|.+++.+++|||||++|+|.++|.....             ...+++..++.++.||+.||+|||+++  ||||||||
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp  163 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA  163 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence            999999999999999999999999975431             245899999999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEEecCccccccCCc--ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhc-CCCCcccc
Q 002910          790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFE-ESPQMRSL  861 (867)
Q Consensus       790 eNILLd~~g~VKLsDFGLAr~~~~t~--~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~t-G~~Pf~sl  861 (867)
                      +|||++.++.+||+|||+++......  ......+||+.|+|||.+.+..+   +||||||+++|+|++ |.+||...
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            99999999999999999998765432  23345689999999999986555   899999999999997 68888654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-38  Score=338.83  Aligned_cols=191  Identities=28%  Similarity=0.447  Sum_probs=160.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHH--HHHHHHHhcCCCCeeeEEeEEeeCC----eEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFL--REVAIMKRVRHPNVVLFMGAVTKRP----HLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~--~Ei~ILk~LrHPNIVkl~ga~~~~~----~l~  732 (867)
                      ++|.+.+.||+|+||+||+|+++|+.||||++....   .  +.+.  .|+..+..++|||||++++++....    .+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---E--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---h--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            578999999999999999999999999999986442   2  2333  4455556789999999999997654    589


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------cCCCccccCCCCCcEEEcCCCcEEEEe
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN--------LNPPILHWDLKSPNLLVDKNWTVKVCD  804 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs--------~gp~IVHRDLKPeNILLd~~g~VKLsD  804 (867)
                      ||||||++|+|.++|++.    .+++..++.++.|++.||.|||.        ++  ||||||||+||||+.++++||+|
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEe
Confidence            999999999999999863    38899999999999999999996        46  99999999999999999999999


Q ss_pred             cCccccccCCc----ccccccCCCcccccccccCCCC---------hHHHHHHHHHHHHHhcCCCCccc
Q 002910          805 FGLSRFKANTF----ISSKSVAGTVVFFAAHQTACNS---------LALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       805 FGLAr~~~~t~----~s~~s~aGTp~YmAPEvl~~~~---------~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ||+++......    ......+||+.|||||++.+..         .+|||||||+||+|++|.+|+..
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            99998764322    2234568999999999988642         37999999999999999887744

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=326.56  Aligned_cols=197  Identities=21%  Similarity=0.297  Sum_probs=176.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCeEEEEEe
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++|++++.||+|+||+||+|++  +++.||||+++.........+++.+|+.+|+.++|||||+++++|......++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            6899999999999999999998  57789999998776656677889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCcc
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI  816 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~~  816 (867)
                      |+.+++|..++..   ...+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            9999999988875   345889999999999999999999999  99999999999999999999999999998766555


Q ss_pred             cccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCccc
Q 002910          817 SSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       817 s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                      ......+++.|+|||++...    ..+|||||||++|+|++|..||..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            45566788999999998754    348999999999999999988743

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-38  Score=340.55  Aligned_cols=194  Identities=24%  Similarity=0.335  Sum_probs=166.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------  729 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~------  729 (867)
                      .++|++++.||+|+||+||+|.+  +|+.||||++..........+.+.+|+.+|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47999999999999999999998  4888999999876666667788999999999999999999999997655      


Q ss_pred             eEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccc
Q 002910          730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR  809 (867)
Q Consensus       730 ~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr  809 (867)
                      ++||||||+ +++|..+++.    ..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccccee
Confidence            579999999 7788887764    24899999999999999999999999  9999999999999999999999999998


Q ss_pred             cccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ......   ....||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       170 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         170 QADSEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             ECCSSC---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCcc---ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            765543   467899999999998653    3489999999999999999999764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-38  Score=333.97  Aligned_cols=199  Identities=21%  Similarity=0.288  Sum_probs=166.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee--------
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--------  727 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~--------  727 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++..........+.+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            58999999999999999999998  47889999987766555556778999999999999999999998855        


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ...+|+||||+.++.+..+...   ...+++..++.++.||+.||.|||++|  ||||||||+||||+.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecce
Confidence            3468999999988777655443   345889999999999999999999999  99999999999999999999999999


Q ss_pred             cccccCC----cccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKANT----FISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~t----~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.....    .....+.+||+.|+|||++.+.    ..+|||||||++|+|++|.+||...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            9765422    2233456899999999998753    4489999999999999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=337.67  Aligned_cols=193  Identities=23%  Similarity=0.272  Sum_probs=161.9

Q ss_pred             CeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------CeE
Q 002910          660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PHL  731 (867)
Q Consensus       660 dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~~l  731 (867)
                      +|+.++.||+|+||+||+|++  +|+.||||++.....      ...+|+.+|++++|||||+++++|...      .++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            799999999999999999998  478899999976542      234799999999999999999998543      358


Q ss_pred             EEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCcccc
Q 002910          732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRF  810 (867)
Q Consensus       732 ~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~  810 (867)
                      +||||||+++.+..+.+.......+++..++.++.||+.||+|||++|  ||||||||+||||+.++ .+||+|||+++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence            999999987755544433333456999999999999999999999999  99999999999999775 899999999987


Q ss_pred             ccCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...... ..+.+||+.|+|||.+.+.    ..+|||||||++|+|++|++||...
T Consensus       173 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         173 LVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             CCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             ccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            654332 3467899999999987643    3489999999999999999999654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-37  Score=330.10  Aligned_cols=193  Identities=26%  Similarity=0.372  Sum_probs=163.6

Q ss_pred             EEEEeccCCceEEEEEEEcC---c--eEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCeEEEEEe
Q 002910          663 VKERVGAGSFGTVHRAEWHG---S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTE  736 (867)
Q Consensus       663 i~e~LG~GsFG~VykA~~~g---~--~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~-~~~l~LVmE  736 (867)
                      ..++||+|+||+||+|++..   +  .||||++... ......++|.+|+++|++++|||||++++++.. ++.+++|||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            36789999999999999832   2  4889988643 245667889999999999999999999999865 568999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCccccccCCc-
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-  815 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~~t~-  815 (867)
                      ||++|+|.++++..  ...+++..++.++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++...... 
T Consensus       110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999998863  335788899999999999999999999  9999999999999999999999999998754322 


Q ss_pred             ---ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          816 ---ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       816 ---~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                         .......||+.|+|||.+....+   +||||||+++|||++|..||+.
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence               22234578999999999886554   8999999999999998777754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-38  Score=337.71  Aligned_cols=201  Identities=19%  Similarity=0.305  Sum_probs=174.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-----cCceEEEEEEeecccch--HHHHHHHHHHHHHHhcCC-CCeeeEEeEEee
Q 002910          656 ISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRH-PNVVLFMGAVTK  727 (867)
Q Consensus       656 i~~~dy~i~e~LG~GsFG~VykA~~-----~g~~VAVKvi~~~~~~~--~~~k~f~~Ei~ILk~LrH-PNIVkl~ga~~~  727 (867)
                      +..++|++++.||+|+||+||+|+.     +|+.||||++++.....  ...+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            4568999999999999999999986     36789999997654322  234568899999999977 899999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCc
Q 002910          728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL  807 (867)
Q Consensus       728 ~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGL  807 (867)
                      ...+++||||+.+|+|.+++....   .+.+..+..++.||+.||.|||+++  ||||||||+||||+.+|.+||+|||+
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             CCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999999998643   4788999999999999999999999  99999999999999999999999999


Q ss_pred             cccccC-CcccccccCCCcccccccccCCCC-----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          808 SRFKAN-TFISSKSVAGTVVFFAAHQTACNS-----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       808 Ar~~~~-t~~s~~s~aGTp~YmAPEvl~~~~-----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++.... ......+..||+.|+|||.+.+..     .+|||||||+||+|++|..||...
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            987643 233345678999999999997543     489999999999999999999764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=333.43  Aligned_cols=196  Identities=23%  Similarity=0.346  Sum_probs=163.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----eEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----HLS  732 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~~----~l~  732 (867)
                      ++|++++.||+|+||+||+|..  +|+.||||++.+.. .....+.+++|+.+|++++|||||++++++....    ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            5699999999999999999987  58889999997644 3445678899999999999999999999987543    234


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~~~  812 (867)
                      ++|+|+.+|+|.+++...    .+++..+..++.||+.||+|||++|  ||||||||+||||+.++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            455667799999999752    4899999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCc---ccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          813 NTF---ISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       813 ~t~---~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ...   ......+||+.|+|||++...    ..+||||+||++|+|++|.+||...
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            321   223566899999999998643    3379999999999999999999654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.8e-37  Score=328.75  Aligned_cols=190  Identities=20%  Similarity=0.307  Sum_probs=164.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEee--CCeEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTK--RPHLS  732 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~--~~~l~  732 (867)
                      .++|++++.||+|+||+||+|++  +++.||||+++...     .+++.+|+.+|+.++ ||||++++++|..  ...++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            37899999999999999999998  47889999987543     356889999999996 9999999999974  45699


Q ss_pred             EEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCC-cEEEEecCccccc
Q 002910          733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFK  811 (867)
Q Consensus       733 LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g-~VKLsDFGLAr~~  811 (867)
                      +|||||.+++|..+.+      .+++..++.++.||+.||+|||++|  ||||||||+||||+.++ .+||+|||+|+..
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence            9999999999976543      3899999999999999999999999  99999999999998655 6999999999876


Q ss_pred             cCCcccccccCCCcccccccccCCC----ChHHHHHHHHHHHHHhcCCCCcccc
Q 002910          812 ANTFISSKSVAGTVVFFAAHQTACN----SLALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       812 ~~t~~s~~s~aGTp~YmAPEvl~~~----~~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .... .....++|+.|+|||.+.+.    ..+|||||||++|+|++|..||...
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         181 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            5432 23567899999999998753    3379999999999999999998653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=331.62  Aligned_cols=198  Identities=22%  Similarity=0.302  Sum_probs=168.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC---
Q 002910          654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR---  728 (867)
Q Consensus       654 ~ei~~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~---  728 (867)
                      |++. ++|++++.||+|+||+||+|++  +|+.||||++.+........+++.+|+.+|++++|||||++++++...   
T Consensus        14 ~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          14 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             EEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred             ccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence            4443 7899999999999999999987  588899999987766666777899999999999999999999998643   


Q ss_pred             --CeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecC
Q 002910          729 --PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG  806 (867)
Q Consensus       729 --~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFG  806 (867)
                        ...+++|+|+.+|+|.+++..    ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+|++|||
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             ccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccc
Confidence              334667778889999999964    24999999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCCcccccccCCCcccccccccCCCC----hHHHHHHHHHHHHHhcCCCCcccc
Q 002910          807 LSRFKANTFISSKSVAGTVVFFAAHQTACNS----LALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       807 LAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~----~SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ++......   ..+..||+.|+|||++.+..    .+|||||||++|+|++|.+||...
T Consensus       167 ~a~~~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         167 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             ---CCTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhcccCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            99765443   35678999999999977643    389999999999999999999654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-36  Score=319.86  Aligned_cols=195  Identities=18%  Similarity=0.234  Sum_probs=168.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCeEEEE
Q 002910          658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMGAVTKRPHLSIV  734 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH-PNIVkl~ga~~~~~~l~LV  734 (867)
                      .++|++++.||+|+||+||+|++  +|+.||||++.....    ...+.+|+++++.++| +||+.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            47899999999999999999997  478899999865432    2346778999999976 8999999999999999999


Q ss_pred             EeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcC-----CCcEEEEecCccc
Q 002910          735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFGLSR  809 (867)
Q Consensus       735 mEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~-----~g~VKLsDFGLAr  809 (867)
                      |||+ +++|.+++...  ...+++..+..++.|++.||+|||++|  ||||||||+||||+.     .+.+||+|||+|+
T Consensus        80 me~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          80 IDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999 78999988763  335899999999999999999999999  999999999999964     6789999999998


Q ss_pred             cccCC-------cccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          810 FKANT-------FISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       810 ~~~~t-------~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      .....       .....+.+||+.|||||++.+..+   +||||||+++|+|++|..||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~  216 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  216 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence            75432       123446789999999999998665   79999999999999999999743

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=329.45  Aligned_cols=194  Identities=24%  Similarity=0.309  Sum_probs=159.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Ce
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNIVkl~ga~~~~------~~  730 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++..........+++.+|+.+|++++|||||+++++|...      .+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999998  488899999988776667778899999999999999999999999643      67


Q ss_pred             EEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       731 l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      +|+|||||.++.+ +.+..     .+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence            8999999976555 44432     3889999999999999999999999  99999999999999999999999999886


Q ss_pred             ccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCcccc
Q 002910          811 KANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSL  861 (867)
Q Consensus       811 ~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl  861 (867)
                      ..... .....+||+.|+|||++.+..+   +||||+||++|+|++|++||...
T Consensus       169 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            65432 3356689999999999997554   89999999999999999999654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-36  Score=317.48  Aligned_cols=195  Identities=23%  Similarity=0.221  Sum_probs=161.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCeEEEEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVT  735 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-Vkl~ga~~~~~~l~LVm  735 (867)
                      ++|++++.||+|+||+||+|++  +|+.||||++......    .++.+|+++++.++|+|+ +.+.+++...+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            5699999999999999999998  4778999998765322    347789999999987765 45566667888899999


Q ss_pred             eccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEc---CCCcEEEEecCcccccc
Q 002910          736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA  812 (867)
Q Consensus       736 Ey~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd---~~g~VKLsDFGLAr~~~  812 (867)
                      ||+ +++|...+...  ...+++..++.++.||+.||+|||++|  ||||||||+|||++   .+..+||+|||+|+...
T Consensus        83 e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          83 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEc-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            999 56666666542  345899999999999999999999999  99999999999985   45679999999999765


Q ss_pred             CCc-------ccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccccc
Q 002910          813 NTF-------ISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRSLM  862 (867)
Q Consensus       813 ~t~-------~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~sl~  862 (867)
                      ...       ....+..||+.|||||++.+..+   +|||||||++|+|++|..||....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence            422       23356689999999999997654   899999999999999999997643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.8e-31  Score=287.71  Aligned_cols=194  Identities=15%  Similarity=0.213  Sum_probs=156.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEE--cCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-----------CCCeeeEEeEE
Q 002910          659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----------HPNVVLFMGAV  725 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-----------HPNIVkl~ga~  725 (867)
                      ++|++++.||+|+||+||+|+.  +|+.||||++++..   ...+.+.+|+.+|+.++           |+|||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            4599999999999999999987  58889999997653   23356778898888775           57899999887


Q ss_pred             ee--CCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCccccCCCCCcEEEcCCCc---
Q 002910          726 TK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWT---  799 (867)
Q Consensus       726 ~~--~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs-~gp~IVHRDLKPeNILLd~~g~---  799 (867)
                      ..  ....+++|+++..+..............+++..+..++.||+.||+|||+ +|  |+||||||+||||+.++.   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence            64  45677777776655443333333334568899999999999999999997 88  999999999999987654   


Q ss_pred             ---EEEEecCccccccCCcccccccCCCcccccccccCCCCh---HHHHHHHHHHHHHhcCCCCccc
Q 002910          800 ---VKVCDFGLSRFKANTFISSKSVAGTVVFFAAHQTACNSL---ALIFSLSGWLQSSFEESPQMRS  860 (867)
Q Consensus       800 ---VKLsDFGLAr~~~~t~~s~~s~aGTp~YmAPEvl~~~~~---SDIwSLG~lLyeM~tG~~Pf~s  860 (867)
                         +||+|||.++......   ...+||+.|+|||++.+..+   +|||||||++++|++|+.||..
T Consensus       168 ~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cceeeEeeccccccccccc---ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence               9999999998655432   56789999999999987544   8999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=2.1e-21  Score=192.07  Aligned_cols=136  Identities=16%  Similarity=0.133  Sum_probs=106.6

Q ss_pred             eEEEEEeccCCceEEEEEEE-cCceEEEEEEeecccc----------------hHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 002910          661 LHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL----------------DDQLKEFLREVAIMKRVRHPNVVLFMG  723 (867)
Q Consensus       661 y~i~e~LG~GsFG~VykA~~-~g~~VAVKvi~~~~~~----------------~~~~k~f~~Ei~ILk~LrHPNIVkl~g  723 (867)
                      +.++++||+|+||+||+|+. +|+.||||+++.....                ........+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35789999999999999986 6889999987642111                111234567889999999999998886


Q ss_pred             EEeeCCeEEEEEeccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCccccCCCCCcEEEcCCCcEEEE
Q 002910          724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC  803 (867)
Q Consensus       724 a~~~~~~l~LVmEy~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~gp~IVHRDLKPeNILLd~~g~VKLs  803 (867)
                      +..    .+++|||++++.+..          +.+.....++.|++.+|.|||++|  |+||||||+|||++++ .++|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEEC
T ss_pred             ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEE
Confidence            532    379999998866532          333445678999999999999999  9999999999999876 58999


Q ss_pred             ecCccccccC
Q 002910          804 DFGLSRFKAN  813 (867)
Q Consensus       804 DFGLAr~~~~  813 (867)
                      |||+++...+
T Consensus       145 DFG~a~~~~~  154 (191)
T d1zara2         145 DFPQSVEVGE  154 (191)
T ss_dssp             CCTTCEETTS
T ss_pred             ECCCcccCCC
Confidence            9999976644

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=4.4e-07  Score=90.94  Aligned_cols=143  Identities=13%  Similarity=0.027  Sum_probs=98.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCeEEEEEe
Q 002910          658 WDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTE  736 (867)
Q Consensus       658 ~~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~ga~~~~~~l~LVmE  736 (867)
                      ++.|++.+..+-++.+.||+....+..+.+|+.......  ....+.+|..++..+. +--+.+++.+....+..++||+
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            356677666555556799999888888889987644321  1224567888887764 3235677888888899999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 002910          737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-------------------------------------  779 (867)
Q Consensus       737 y~~gGSL~~~L~~~~~~~~l~e~~~l~ia~qIa~GL~YLHs~g-------------------------------------  779 (867)
                      +++|..+.......     ..   ...++.++...|..||+..                                     
T Consensus        91 ~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          91 EADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             eccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            99998886544221     11   1223445555566666321                                     


Q ss_pred             --------------------CCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          780 --------------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       780 --------------------p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                                          +.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                1378999999999999876677999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.76  E-value=5.1e-05  Score=75.08  Aligned_cols=140  Identities=19%  Similarity=0.149  Sum_probs=81.6

Q ss_pred             EeccCCc-eEEEEEEEc-CceEEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEeEEeeCCeEEEEEeccCCC
Q 002910          666 RVGAGSF-GTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       666 ~LG~GsF-G~VykA~~~-g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHP--NIVkl~ga~~~~~~l~LVmEy~~gG  741 (867)
                      .+..|.. +.||+.... +..+.+|.......     ..+..|...|+.+...  .+.+++.+....+..++||+|++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            4555553 689999875 44578887654332     2356677777766432  3567788888888899999999876


Q ss_pred             CHHH--------------H---HhcCC-CCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhcC--
Q 002910          742 SLYR--------------L---IHRPA-AGEMM--DQRRRLRMA--------------------LDVAKGINYLHNLN--  779 (867)
Q Consensus       742 SL~~--------------~---L~~~~-~~~~l--~e~~~l~ia--------------------~qIa~GL~YLHs~g--  779 (867)
                      .+..              .   ||... ....+  .......-.                    ......+..+....  
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            5531              1   11100 00000  000000000                    00111233333211  


Q ss_pred             ---CCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          780 ---PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       780 ---p~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                         +.+||+|+.|.|||++.+..+-|+||+.+..
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               1379999999999999877778999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.96  E-value=0.00081  Score=72.03  Aligned_cols=77  Identities=16%  Similarity=0.066  Sum_probs=47.5

Q ss_pred             EEEeccCCceEEEEEEE--cCceEEEEEEeeccc-c----hHHHHHHHHHHHHHHhcC-C--CCeeeEEeEEeeCCeEEE
Q 002910          664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-L----DDQLKEFLREVAIMKRVR-H--PNVVLFMGAVTKRPHLSI  733 (867)
Q Consensus       664 ~e~LG~GsFG~VykA~~--~g~~VAVKvi~~~~~-~----~~~~k~f~~Ei~ILk~Lr-H--PNIVkl~ga~~~~~~l~L  733 (867)
                      .+.||.|....||+...  .++.+.||.-..... .    .....+...|.+.|+.+. +  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45689999999999976  356788886542110 0    011234556888877663 2  345566654  4445678


Q ss_pred             EEeccCCCC
Q 002910          734 VTEYLPRGS  742 (867)
Q Consensus       734 VmEy~~gGS  742 (867)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.90  E-value=0.014  Score=60.08  Aligned_cols=66  Identities=15%  Similarity=0.116  Sum_probs=42.4

Q ss_pred             eEEEEEEE-cCceEEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-----eeEE--eEEeeCCeEEEEEeccCCC
Q 002910          673 GTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-----VLFM--GAVTKRPHLSIVTEYLPRG  741 (867)
Q Consensus       673 G~VykA~~-~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrHPNI-----Vkl~--ga~~~~~~l~LVmEy~~gG  741 (867)
                      -.||++.. +|+.|++|+.+....+.+   ++..|...|..|....|     +..-  ..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            58999987 678899999876543333   45567777776642222     1111  1234567788999999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.83  E-value=0.0076  Score=63.89  Aligned_cols=82  Identities=16%  Similarity=0.298  Sum_probs=52.5

Q ss_pred             ccccCCCCeEEEEEeccCCceEEEEEEEcC---------ceEEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEE
Q 002910          653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFM  722 (867)
Q Consensus       653 ~~ei~~~dy~i~e~LG~GsFG~VykA~~~g---------~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~Lr-HPNIVkl~  722 (867)
                      |-.+..+++++ +.|+-|-.=.+|++....         ..|.+++.-... .   .....+|..+++.+. +.-..+++
T Consensus        37 W~~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll  111 (395)
T d1nw1a_          37 WKTVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLY  111 (395)
T ss_dssp             HHHCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred             ccCCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEE
Confidence            43445566665 567778889999998632         346666654221 1   123457888888875 43345777


Q ss_pred             eEEeeCCeEEEEEeccCCCCH
Q 002910          723 GAVTKRPHLSIVTEYLPRGSL  743 (867)
Q Consensus       723 ga~~~~~~l~LVmEy~~gGSL  743 (867)
                      +++..    .+||||++|..|
T Consensus       112 ~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         112 GIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             EEETT----EEEECCCCEEEC
T ss_pred             EEcCC----ceEEEEeccccC
Confidence            77642    689999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.23  E-value=0.019  Score=58.16  Aligned_cols=146  Identities=9%  Similarity=-0.006  Sum_probs=76.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCceEEEEEEeecccchHHHHHHHHHHHHHHhcCC-----CCeeeEE---eEEeeCCe
Q 002910          659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-----PNVVLFM---GAVTKRPH  730 (867)
Q Consensus       659 ~dy~i~e~LG~GsFG~VykA~~~g~~VAVKvi~~~~~~~~~~k~f~~Ei~ILk~LrH-----PNIVkl~---ga~~~~~~  730 (867)
                      +.+.-.+.|..|.--+.|+.+.++..+++|+.....    ...++..|+++|..|..     |..+...   .+......
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~   93 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   93 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence            455556678888888999998877789999986431    12234456666666542     2222110   11223445


Q ss_pred             EEEEEeccCCCCHH--------------HHHhcCCC------CCCCCHH------------------HHHHHHHHHHHHH
Q 002910          731 LSIVTEYLPRGSLY--------------RLIHRPAA------GEMMDQR------------------RRLRMALDVAKGI  772 (867)
Q Consensus       731 l~LVmEy~~gGSL~--------------~~L~~~~~------~~~l~e~------------------~~l~ia~qIa~GL  772 (867)
                      ...++.++.+....              ..++....      .......                  .....+..+...+
T Consensus        94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  173 (316)
T d2ppqa1          94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  173 (316)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence            66667766553221              11110000      0000000                  0111122222222


Q ss_pred             HHHHh----cCCCccccCCCCCcEEEcCCCcEEEEecCcccc
Q 002910          773 NYLHN----LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF  810 (867)
Q Consensus       773 ~YLHs----~gp~IVHRDLKPeNILLd~~g~VKLsDFGLAr~  810 (867)
                      .-.+.    .|  +||+|+.+.|||++.+...-|.||+.|..
T Consensus       174 ~~~~~~~L~~g--iIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         174 AAHWPKDLPAG--VIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHCCCSSCEE--EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccccccc--cccCCcchhhhhcccccceeEeccccccc
Confidence            22221    33  99999999999999987779999999864

>d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Cysteine proteinases
superfamily: Cysteine proteinases
family: Transglutaminase core
domain: Peptide:N-glycanase 1, PNG1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=91.85  E-value=0.059  Score=55.44  Aligned_cols=45  Identities=16%  Similarity=0.137  Sum_probs=40.5

Q ss_pred             ccccccchhhHHHHHhhhhhcCCCceeeccccccCCCCcceEEEEecCCC
Q 002910          403 SLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDR  452 (867)
Q Consensus       403 ~l~~Gl~rHRALLFKvLAD~IglpcrLvrG~~y~~~~~~a~n~V~l~~~~  452 (867)
                      .-+.|.|.|-|.||=.|+=.+|+|||.|.|     -.+.+|++|-+....
T Consensus       137 ~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~-----~~~H~W~Ev~~~~~~  181 (287)
T d2f4ma1         137 ETRCGRCGEWANCFTLCCRALGFEARYVWD-----YTDHVWTEVYSPSQQ  181 (287)
T ss_dssp             HHCEESHHHHHHHHHHHHHHTTCCEEEEEE-----TTTEEEEEEEETTTT
T ss_pred             HhcCccHHHHHHHHHHHHHHcCCCeEEEec-----CCcceeEEEEecCCC
Confidence            457899999999999999999999999999     478999999996643